data_1x9l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1x9l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 121.656 0.741 . . . . 10.0 112.161 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -161.71 57.42 0.26 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.82 1.248 . . . . 10.0 109.035 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.45 64.68 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -128.94 146.5 50.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.891 1.276 . . . . 10.0 111.443 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.26 90.59 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 108.261 -1.936 . . . . 10.0 108.261 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.41 142.5 17.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.04 0.536 . . . . 10.0 111.847 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 p -125.16 146.13 49.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.28 138.59 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.923 -1.139 . . . . 10.0 107.923 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.34 110.59 17.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.109 0.48 . . . . 10.0 111.486 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.39 136.34 31.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.403 -0.808 . . . . 10.0 109.15 166.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.7 t -17.5 108.22 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.83 2.052 . . . . 10.0 114.837 -162.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.15 158.1 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.814 2.343 . . . . 10.0 110.572 167.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.16 58.64 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.499 2.133 . . . . 10.0 108.987 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.9 t -165.4 44.25 0.08 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.266 1.426 . . . . 10.0 108.589 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.5 mt 74.2 169.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.207 1.803 . . . . 10.0 109.723 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -46.91 -39.61 12.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.915 1.686 . . . . 10.0 113.87 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.79 151.72 20.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.741 1.216 . . . . 10.0 111.415 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -164.2 -172.66 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.849 -0.797 . . . . 10.0 108.849 -164.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.71 39.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.645 1.178 . . . . 10.0 110.141 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.03 149.29 26.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.764 0.665 . . . . 10.0 109.411 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -124.2 103.32 8.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 104.756 -2.313 . . . . 10.0 104.756 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -159.2 -172.65 3.85 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.927 0.891 . . . . 10.0 111.579 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 m -145.59 125.17 13.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.699 -1.251 . . . . 10.0 110.259 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.28 132.58 35.35 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 103.946 -2.613 . . . . 10.0 103.946 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.8 m -129.35 88.24 2.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 125.001 1.438 . . . . 10.0 107.609 -164.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.39 128.47 33.38 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.388 -0.227 . . . . 10.0 110.388 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -141.82 57.02 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.9 m -156.16 -40.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.307 1.443 . . . . 10.0 111.071 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 65.99 62.22 0.61 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.034 1.734 . . . . 10.0 112.662 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -132.79 155.44 81.17 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.833 1.653 . . . . 10.0 108.052 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 75.97 4.63 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.895 3.063 . . . . 10.0 111.471 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.36 147.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 99.63 5.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.541 1.537 . . . . 10.0 111.019 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.6 121.55 26.96 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.595 -2.002 . . . . 10.0 105.595 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.75 54.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 122.207 1.003 . . . . 10.0 108.587 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.21 148.96 16.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.471 -1.051 . . . . 10.0 110.471 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.21 59.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.054 1.742 . . . . 10.0 107.762 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.94 29.68 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -169.59 149.16 3.56 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 118.799 0.727 . . . . 10.0 110.199 -172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.78 49.65 2.53 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.844 2.362 . . . . 10.0 110.434 168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.55 -70.59 0.73 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.59 1.556 . . . . 10.0 107.202 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.48 147.27 33.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.144 1.378 . . . . 10.0 110.26 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -82.41 -36.4 26.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.948 0.899 . . . . 10.0 109.935 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.7 t -120.47 75.12 24.57 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.614 1.165 . . . . 10.0 110.94 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.84 101.09 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 10.0 110.413 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.4 mtt -109.51 128.55 55.26 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.091 1.757 . . . . 10.0 108.854 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.62 142.25 31.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.304 1.042 . . . . 10.0 108.821 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttm -148.24 153.14 38.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.663 0.785 . . . . 10.0 110.84 -173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -159.07 98.62 1.46 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.046 -1.034 . . . . 10.0 111.547 -161.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -138.94 59.48 1.62 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.795 0.807 . . . . 10.0 110.193 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.4 m -147.73 125.11 11.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.702 0.801 . . . . 10.0 109.436 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -77.47 64.12 2.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.251 1.421 . . . . 10.0 109.671 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 166.01 -20.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.489 2.716 . . . . 10.0 109.484 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.45 -149.41 6.0 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.672 -1.771 . . . . 10.0 108.672 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.48 -52.47 52.68 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 122.455 -0.438 . . . . 10.0 113.235 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -168.1 1.19 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.123 1.369 . . . . 10.0 110.356 -166.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.83 42.97 3.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.618 1.967 . . . . 10.0 108.134 -167.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -149.58 103.04 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.228 -1.149 . . . . 10.0 110.228 -171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.63 63.03 2.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.059 0.929 . . . . 10.0 108.773 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -131.36 167.09 19.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.644 1.977 . . . . 10.0 109.691 -172.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtm -79.67 75.7 6.33 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.037 -1.097 . . . . 10.0 108.037 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.13 163.67 43.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.495 -0.775 . . . . 10.0 111.498 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -37.26 -55.73 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.141 3.227 . . . . 10.0 112.632 161.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.9 p90 172.65 -165.3 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.275 2.63 . . . . 10.0 104.732 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -127.37 111.53 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.701 0.682 . . . . 10.0 110.945 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m -76.59 132.48 39.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 107.055 -1.461 . . . . 10.0 107.055 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.2 pt -100.95 100.95 14.14 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.084 1.354 . . . . 10.0 107.388 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.59 67.69 8.55 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.239 2.626 . . . . 10.0 110.211 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 58.38 177.93 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 -156.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 38.81 33.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.831 2.16 . . . . 10.0 116.831 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.07 70.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.971 1.272 . . . . 10.0 113.113 163.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -111.49 57.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.18 156.45 18.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.793 -0.447 . . . . 10.0 109.793 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.3 m -115.42 115.36 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -82.61 106.36 14.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -137.08 156.56 48.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.6 1.16 . . . . 10.0 110.26 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -47.44 -40.35 17.87 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.805 1.242 . . . . 10.0 113.93 -161.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -132.65 52.05 2.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.825 0.821 . . . . 10.0 109.909 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.9 63.78 0.22 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.8 t0 65.45 136.45 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 126.253 1.821 . . . . 10.0 109.891 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 179.82 -179.2 0.44 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.096 -1.003 . . . . 10.0 112.095 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.6 t -110.83 123.02 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 161.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.7 mtp -83.51 100.54 10.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 166.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.15 74.25 4.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.403 -1.703 . . . . 10.0 106.403 171.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.7 ttt -84.72 153.89 22.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.271 1.029 . . . . 10.0 110.567 -170.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 60.17 3.92 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.295 -0.878 . . . . 10.0 111.103 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.67 128.59 26.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.777 1.231 . . . . 10.0 111.008 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -76.45 -72.97 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.642 0.777 . . . . 10.0 111.67 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -116.43 156.98 46.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.509 1.124 . . . . 10.0 111.912 -163.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.75 144.16 99.51 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.091 2.527 . . . . 10.0 111.76 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.0 mt -118.33 142.58 47.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.726 1.61 . . . . 10.0 109.497 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.37 129.01 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.01 107.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 163.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 120.35 -13.34 10.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.675 -0.57 . . . . 10.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.75 -179.54 3.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 123.589 1.661 . . . . 10.0 108.525 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -154.2 129.66 9.87 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.517 -1.674 . . . . 10.0 106.907 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.15 145.79 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.31 -1.367 . . . . 10.0 107.31 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -73.9 143.47 45.76 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.809 -0.557 . . . . 10.0 109.732 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 tt -118.4 139.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 168.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -111.5 108.26 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.91 161.97 19.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -149.9 95.28 2.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.78 133.51 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 170.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -77.23 3.81 12.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.21 -15.57 35.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.375 0.67 . . . . 10.0 111.042 156.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.7 47.38 1.29 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.119 1.818 . . . . 10.0 109.935 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -109.95 155.35 21.88 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 86.0 m -156.35 73.15 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 103.919 -2.623 . . . . 10.0 103.919 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.71 127.85 54.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -161.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -92.68 132.87 36.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.912 1.685 . . . . 10.0 107.471 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.1 152.67 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.767 -1.938 . . . . 10.0 105.767 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.75 29.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.05 119.87 38.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.518 0.727 . . . . 10.0 109.643 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -83.17 127.15 33.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.82 98.45 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -159.27 139.67 12.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 114.643 1.349 . . . . 10.0 114.643 -170.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.907 0.861 . . . . 10.0 111.333 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -156.6 59.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.178 -0.952 . . . . 10.0 109.527 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.13 58.35 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 123.101 1.429 . . . . 10.0 110.336 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 138.76 16.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.271 -0.877 . . . . 10.0 109.542 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 166.1 54.82 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.435 -1.466 . . . . 10.0 109.435 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.02 156.28 22.42 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.026 0.913 . . . . 10.0 110.8 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.4 p -123.7 156.71 35.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.1 140.16 48.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 38.49 0.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.02 -145.23 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.351 1.06 . . . . 10.0 109.933 -171.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.6 t -92.15 108.28 29.42 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 105.236 -2.135 . . . . 10.0 105.236 155.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 166.63 27.97 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 N-CA-C 108.017 -1.571 . . . . 10.0 108.017 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.05 64.26 5.13 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.589 2.193 . . . . 10.0 110.441 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -166.99 58.91 0.08 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.05 1.34 . . . . 10.0 108.755 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm 76.3 164.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.795 1.638 . . . . 10.0 110.327 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -37.2 63.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.851 1.26 . . . . 10.0 111.768 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -47.22 148.9 1.1 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.147 1.779 . . . . 10.0 111.52 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.2 t -153.94 -167.11 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.141 -0.688 . . . . 10.0 109.141 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.68 158.23 43.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.965 0.906 . . . . 10.0 108.766 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.22 154.06 24.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 124.051 0.844 . . . . 10.0 109.167 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -122.04 123.24 41.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 103.691 -2.707 . . . . 10.0 103.691 166.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -156.97 -177.03 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 m -149.08 125.67 11.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.591 -1.262 . . . . 10.0 107.591 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.56 134.89 34.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.213 -1.773 . . . . 10.0 106.213 171.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -135.77 97.43 3.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.045 1.338 . . . . 10.0 108.628 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -84.1 152.61 24.23 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.713 0.688 . . . . 10.0 109.977 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -139.25 56.72 1.67 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.27 -1.752 . . . . 10.0 106.27 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.5 t -175.15 164.26 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.164 -2.532 . . . . 10.0 104.164 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.67 81.51 1.64 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.969 0.793 . . . . 10.0 108.952 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -146.38 148.95 36.14 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 124.666 1.186 . . . . 10.0 108.43 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.05 72.88 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.41 2.74 . . . . 10.0 109.761 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -83.29 156.99 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 165.44 28.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.475 0.71 . . . . 10.0 110.215 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.13 128.05 23.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.222 -2.51 . . . . 10.0 104.222 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.91 52.12 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 122.423 1.106 . . . . 10.0 108.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.47 150.77 20.67 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.366 -0.834 . . . . 10.0 111.269 165.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.47 61.96 0.55 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.804 2.442 . . . . 10.0 106.207 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.45 91.14 6.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 -172.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 t -104.88 133.6 20.07 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.795 1.238 . . . . 10.0 109.454 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.98 62.36 6.62 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.31 2.673 . . . . 10.0 109.001 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -162.97 -48.45 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.25 0.62 . . . . 10.0 111.093 -161.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.47 129.22 43.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -69.98 -34.04 72.85 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -128.84 73.07 81.55 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.19 0.996 . . . . 10.0 110.534 -170.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.8 122.68 9.07 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.198 1.932 . . . . 10.0 109.036 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.5 mtt -145.06 124.27 12.94 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.271 1.028 . . . . 10.0 110.015 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.8 mt -83.05 140.88 32.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.081 0.953 . . . . 10.0 109.925 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.9 ttm -141.07 152.17 44.6 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.596 1.158 . . . . 10.0 110.537 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -141.05 115.89 9.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.742 1.217 . . . . 10.0 111.284 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.31 0.5 OUTLIER -145.83 59.86 1.25 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.302 1.223 . . . . 10.0 114.302 164.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 t -143.84 120.83 11.37 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.416 -1.427 . . . . 10.0 109.854 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -77.59 61.5 2.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.224 1.41 . . . . 10.0 109.422 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.5 m -163.32 -58.15 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.045 1.338 . . . . 10.0 109.168 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.16 -93.43 1.71 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.663 -1.775 . . . . 10.0 108.663 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.72 97.93 2.02 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.354 0.978 . . . . 10.0 110.777 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -94.39 141.14 28.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 169.75 62.9 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 125.369 1.468 . . . . 10.0 109.817 145.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.2 37.94 4.71 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.045 1.307 . . . . 10.0 114.685 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 ttm 58.81 37.83 24.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.259 1.423 . . . . 10.0 111.64 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 161.78 14.27 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.353 0.661 . . . . 10.0 110.682 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.2 ttp -80.68 114.91 19.9 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.68 168.92 8.56 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -166.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -36.85 -58.15 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.246 2.631 . . . . 10.0 111.775 151.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 37.9 p90 166.54 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.555 2.742 . . . . 10.0 105.028 -169.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.92 106.79 11.96 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.62 0.768 . . . . 10.0 111.274 175.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.4 m -81.62 130.89 35.22 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 163.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -107.41 131.9 21.37 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.76 139.75 25.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.34 1.36 . . . . 10.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 59.45 -151.7 0.41 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.235 0.614 . . . . 10.0 112.319 159.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 51.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.411 . . . . 10.0 113.649 168.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.56 153.85 43.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.62 1.105 . . . . 10.0 111.843 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.6 t -146.48 90.63 1.96 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -84.69 160.87 20.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.016 -0.993 . . . . 10.0 110.316 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.2 m -130.89 99.5 4.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.85 122.92 28.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -155.63 154.55 31.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.984 1.313 . . . . 10.0 108.838 -170.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -70.54 76.6 0.58 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.979 0.512 . . . . 10.0 110.833 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 155.56 -94.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.771 3.628 . . . . 10.0 106.207 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.4 73.18 0.32 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.649 2.071 . . . . 10.0 113.898 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 67.22 134.66 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.024 2.53 . . . . 10.0 111.207 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -170.08 171.23 7.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.72 0.771 . . . . 10.0 112.004 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.8 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.698 -2.334 . . . . 10.0 104.698 167.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.5 mtm -82.83 144.43 30.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.964 -1.125 . . . . 10.0 107.964 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -120.25 78.79 1.39 Allowed 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 128.165 2.586 . . . . 10.0 105.154 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.8 mtt -83.69 154.56 23.59 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.15 54.54 32.13 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.22 141.48 57.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -104.43 -64.98 1.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.979 1.312 . . . . 10.0 109.464 -168.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -59.49 150.24 66.33 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 122.098 0.159 . . . . 10.0 110.914 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.42 102.89 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 N-CA-C 107.207 -1.882 . . . . 10.0 107.207 159.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 161.02 1.64 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.64 0.776 . . . . 10.0 113.034 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -133.13 129.39 37.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.178 -1.416 . . . . 10.0 107.178 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.77 94.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.574 -1.639 . . . . 10.0 106.574 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.9 15.65 8.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.618 1.104 . . . . 10.0 111.967 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 167.95 14.97 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.963 1.381 . . . . 10.0 107.791 159.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -155.1 77.41 1.01 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.218 -2.265 . . . . 10.0 107.877 -163.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -92.9 126.57 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 -169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -75.02 123.47 25.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 pt -115.05 133.52 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.877 1.271 . . . . 10.0 108.525 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -91.03 125.81 35.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.068 -0.716 . . . . 10.0 109.068 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 24.8 mt -81.63 172.99 12.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -153.28 101.99 2.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.41 1.084 . . . . 10.0 108.158 164.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.9 149.05 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 162.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -42.04 -35.98 1.02 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.234 1.014 . . . . 10.0 111.493 168.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -11.33 9.32 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.682 2.793 . . . . 10.0 112.256 -175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.73 7.87 70.77 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -82.23 73.41 9.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.581 -1.266 . . . . 10.0 107.581 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -84.22 66.56 9.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.765 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.6 174.42 11.6 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.039 0.936 . . . . 10.0 109.125 -167.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -120.94 128.64 52.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.73 143.43 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.007 -1.108 . . . . 10.0 108.007 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -84.92 126.62 33.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.611 -0.885 . . . . 10.0 108.611 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.1 110.55 22.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.334 1.454 . . . . 10.0 109.323 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -88.77 105.63 17.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.249 1.42 . . . . 10.0 108.968 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.94 95.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 -168.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 57.48 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.943 1.247 . . . . 10.0 114.323 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 122.584 1.183 . . . . 10.0 114.06 170.191 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.824 0.821 . . . . 10.0 110.567 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -157.12 58.19 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.297 -0.877 . . . . 10.0 109.358 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.36 56.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.078 0.942 . . . . 10.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -149.92 136.14 18.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.636 -1.246 . . . . 10.0 107.636 167.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.17 132.77 23.74 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.083 -1.607 . . . . 10.0 109.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.72 150.94 19.99 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.479 0.64 . . . . 10.0 111.633 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 p -116.53 123.68 48.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.962 0.905 . . . . 10.0 108.646 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.22 121.53 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.568 0.747 . . . . 10.0 109.687 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.14 4.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.685 -0.634 . . . . 10.0 111.467 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -41.04 122.64 1.81 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.636 0.653 . . . . 10.0 110.266 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -33.65 124.27 0.46 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 116.032 1.864 . . . . 10.0 116.032 -144.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.31 165.83 2.83 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.929 2.42 . . . . 10.0 112.512 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -79.0 54.51 5.2 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.187 1.925 . . . . 10.0 109.346 163.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.7 p -139.49 51.67 1.75 Allowed 'General case' 0 C--N 1.341 0.225 0 O-C-N 121.477 -0.764 . . . . 10.0 110.576 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.9 mt 86.5 173.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 127.608 2.363 . . . . 10.0 106.794 -167.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.57 50.63 0.24 Allowed 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.019 -1.05 . . . . 10.0 110.271 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.59 158.69 19.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.766 1.226 . . . . 10.0 109.432 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -157.82 169.15 25.27 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 157.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.01 153.23 25.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.91 147.49 23.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.469 1.106 . . . . 10.0 108.523 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -126.9 127.08 44.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.531 -2.396 . . . . 10.0 104.531 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.2 ptm -161.38 -174.63 4.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 10.0 107.06 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -125.5 117.35 23.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.049 0.94 . . . . 10.0 108.848 171.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.86 113.2 20.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.2 m -122.42 95.34 4.6 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.783 1.927 . . . . 10.0 108.616 -162.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -83.65 140.66 32.04 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.064 -0.397 . . . . 10.0 112.004 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -143.75 60.46 1.38 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -151.28 -39.95 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.916 1.286 . . . . 10.0 111.063 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t70 65.97 60.83 0.66 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.556 1.942 . . . . 10.0 110.339 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -140.89 152.15 64.67 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.256 1.823 . . . . 10.0 107.643 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.31 92.82 0.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.123 2.549 . . . . 10.0 110.658 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.96 145.85 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.412 0.625 . . . . 10.0 110.536 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -131.84 83.17 2.07 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.375 2.27 . . . . 10.0 109.792 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.56 72.55 9.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.359 -0.838 . . . . 10.0 111.293 -172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.08 56.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 121.776 -0.577 . . . . 10.0 110.908 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.39 28.21 Favored Glycine 0 C--N 1.334 0.437 0 O-C-N 121.096 -1.002 . . . . 10.0 111.258 162.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 60.38 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.099 0.96 . . . . 10.0 109.338 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.58 162.03 23.29 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.199 -0.938 . . . . 10.0 109.3 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 147.66 3.55 Favored Pre-proline 0 C--O 1.238 0.496 0 O-C-N 121.831 -0.543 . . . . 10.0 109.54 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.04 57.51 6.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.669 2.246 . . . . 10.0 109.038 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -143.42 -70.06 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.182 0.593 . . . . 10.0 109.983 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.33 167.03 11.93 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.911 1.284 . . . . 10.0 110.798 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.6 m -101.89 -39.83 7.18 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.601 1.16 . . . . 10.0 112.168 -157.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -108.95 90.91 8.32 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.533 1.133 . . . . 10.0 109.726 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.55 90.51 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.008 2.472 . . . . 10.0 109.862 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -108.91 114.19 27.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.849 0.833 . . . . 10.0 109.637 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.24 134.22 36.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.728 -0.841 . . . . 10.0 108.728 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.84 174.98 6.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.605 1.562 . . . . 10.0 108.035 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.2 t -159.88 135.06 8.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.96 56.75 0.53 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 122.507 1.146 . . . . 10.0 107.961 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.6 m -149.58 123.36 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.726 0.81 . . . . 10.0 109.848 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -70.47 80.95 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.7 t 143.9 -9.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.684 3.193 . . . . 10.0 110.507 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.54 -140.7 9.26 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.204 -1.558 . . . . 10.0 109.204 169.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.76 -54.25 39.14 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.633 -0.587 . . . . 10.0 111.633 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.3 tpt -169.92 -166.32 0.55 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.022 2.129 . . . . 10.0 107.479 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -121.69 60.58 0.95 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.65 89.47 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.455 -1.058 . . . . 10.0 110.455 -163.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -76.65 64.65 2.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.196 0.998 . . . . 10.0 110.687 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 167.75 10.71 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.832 2.053 . . . . 10.0 108.181 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.9 mtt -78.83 85.34 4.82 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.012 -1.477 . . . . 10.0 107.012 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.51 156.25 88.89 Favored Pre-proline 0 N--CA 1.453 -0.315 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -51.33 -38.55 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.866 2.377 . . . . 10.0 111.144 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -176.8 171.89 2.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.71 2.404 . . . . 10.0 104.872 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.76 98.11 8.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.34 131.12 37.94 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.95 109.77 60.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.43 69.8 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.723 2.282 . . . . 10.0 110.189 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.73 175.29 0.2 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 -167.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 35.72 23.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 118.651 2.834 . . . . 10.0 118.651 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -45.92 102.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.411 1.005 . . . . 10.0 112.057 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -131.25 55.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.925 -1.88 . . . . 10.0 105.925 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 164.29 11.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.2 m -128.85 114.74 16.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.997 -2.223 . . . . 10.0 104.997 -168.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.19 110.34 14.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.552 -2.388 . . . . 10.0 104.552 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -130.99 148.51 52.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.698 1.999 . . . . 10.0 108.981 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -26.56 -53.15 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.159 2.184 . . . . 10.0 113.896 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -139.95 64.85 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.389 0.676 . . . . 10.0 109.622 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.12 66.46 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t0 65.34 149.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.462 1.505 . . . . 10.0 109.824 -165.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 160.66 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.478 1.911 . . . . 10.0 111.539 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.56 128.26 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.191 -1.781 . . . . 10.0 106.191 166.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.5 mtm -92.63 109.06 20.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 168.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.32 77.6 9.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.224 -1.769 . . . . 10.0 106.224 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.76 154.34 23.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.86 74.65 1.26 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 121.212 -0.93 . . . . 10.0 110.992 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.24 138.64 16.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.664 1.232 . . . . 10.0 111.626 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -79.86 -59.39 2.75 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 162.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 179.11 -59.64 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.553 1.141 . . . . 10.0 112.763 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.68 89.11 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.84 1.694 . . . . 10.0 111.557 -166.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.82 156.53 44.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.832 1.253 . . . . 10.0 109.05 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.67 145.88 7.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.62 105.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.916 -1.512 . . . . 10.0 106.916 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.54 -60.83 0.26 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -71.99 -174.11 1.16 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.933 3.293 . . . . 10.0 111.618 -163.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.0 m -133.87 128.33 34.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.149 1.78 . . . . 10.0 106.664 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.53 140.09 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -77.97 126.21 30.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.319 -0.993 . . . . 10.0 108.319 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -80.28 179.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.23 -1.767 . . . . 10.0 106.23 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.4 m -144.31 114.24 7.31 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.835 -1.166 . . . . 10.0 108.838 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 140.85 31.62 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -147.08 86.5 1.64 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.129 -1.434 . . . . 10.0 107.129 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.06 145.76 28.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.339 0.256 . . . . 10.0 110.919 -169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -56.39 -24.58 45.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.553 1.141 . . . . 10.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.77 -26.63 14.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.778 1.231 . . . . 10.0 113.238 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.65 52.33 1.22 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 109.75 -1.34 . . . . 10.0 109.75 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -144.78 160.45 41.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 m -131.45 143.79 50.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.6 tp -151.96 154.56 36.29 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -137.98 62.51 1.57 Allowed 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.527 1.531 . . . . 10.0 109.706 -161.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.66 141.11 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.57 124.63 30.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.01 130.61 54.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.057 0.943 . . . . 10.0 109.945 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -84.34 126.75 33.49 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 t -87.12 100.78 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -146.59 123.14 11.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.366 1.866 . . . . 10.0 108.194 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 123.591 0.756 . . . . 10.0 110.36 172.53 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 121.229 0.538 . . . . 10.0 112.073 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.7 p -157.3 62.27 0.49 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -108.85 60.09 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 10.0 109.257 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -133.6 144.4 49.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.961 0.905 . . . . 10.0 110.954 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.94 86.84 1.11 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.38 139.84 29.18 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.809 0.444 . . . . 10.0 111.941 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -117.3 140.51 49.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.0 134.25 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.69 120.96 12.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.96 -68.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.0 110.322 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -142.43 104.96 5.48 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.728 1.611 . . . . 10.0 107.541 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -64.94 164.89 23.08 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.549 2.166 . . . . 10.0 109.882 171.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.75 66.71 5.77 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.784 2.989 . . . . 10.0 109.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -156.32 -48.01 0.07 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.064 2.146 . . . . 10.0 106.628 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mt 72.03 147.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.244 1.818 . . . . 10.0 108.672 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 75.53 -49.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.271 1.429 . . . . 10.0 111.766 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -79.67 153.94 28.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 168.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -171.9 172.57 4.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.144 1.378 . . . . 10.0 109.177 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . . . -157.07 161.76 39.47 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.61 0.764 . . . . 10.0 111.816 -172.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.03 140.4 29.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 124.401 1.063 . . . . 10.0 109.441 167.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 25.7 m-85 -136.18 112.83 10.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.392 -1.336 . . . . 10.0 107.392 -174.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -163.48 -172.23 2.85 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 125.149 1.38 . . . . 10.0 109.396 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -125.11 121.63 34.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 10.0 109.868 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.81 135.69 34.89 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 120.188 1.358 . . . . 10.0 107.62 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -117.75 78.53 1.25 Allowed 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.806 1.316 . . . . 10.0 109.876 -169.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.47 100.33 8.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.438 0.637 . . . . 10.0 109.867 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -109.4 54.68 0.65 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.11 0.964 . . . . 10.0 109.68 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 p -177.89 148.0 0.5 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -88.87 69.32 8.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.772 0.829 . . . . 10.0 109.576 -173.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.97 127.18 23.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.18 99.81 1.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.362 2.708 . . . . 10.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.9 141.79 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -126.62 97.37 4.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.011 1.325 . . . . 10.0 108.516 171.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 132.61 35.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.18 53.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.3 158.94 31.75 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.63 -0.988 . . . . 10.0 110.63 163.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.87 127.21 6.5 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 158.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.46 144.06 23.48 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -172.55 155.99 3.37 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 118.352 0.524 . . . . 10.0 111.223 -163.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.27 -5.5 13.98 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.802 2.334 . . . . 10.0 112.599 164.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.66 -57.26 4.25 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.505 1.048 . . . . 10.0 111.892 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.51 161.07 37.38 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.554 1.141 . . . . 10.0 111.871 -168.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -93.46 -41.31 9.86 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.701 1.2 . . . . 10.0 111.74 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t -115.86 82.45 10.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.685 1.594 . . . . 10.0 109.498 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.75 107.5 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.897 2.398 . . . . 10.0 109.988 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.8 mmt -122.76 122.19 38.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.418 1.487 . . . . 10.0 109.352 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.15 138.33 33.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.726 0.81 . . . . 10.0 109.292 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.03 12.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.877 1.271 . . . . 10.0 110.137 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -139.74 119.86 13.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.88 -1.155 . . . . 10.0 107.88 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -141.18 48.29 1.68 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.3 m -156.43 80.54 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.058 -1.026 . . . . 10.0 109.799 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.57 86.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.257 1.023 . . . . 10.0 110.592 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 165.89 -41.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 127.452 2.301 . . . . 10.0 108.486 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.41 -83.34 1.32 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.168 -2.773 . . . . 10.0 106.168 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.02 -138.62 6.1 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.053 -1.219 . . . . 10.0 110.053 160.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.2 mmt -108.06 -161.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.155 2.182 . . . . 10.0 109.79 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.55 76.26 1.48 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.63 82.32 0.16 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.686 -1.365 . . . . 10.0 109.686 -170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -77.64 60.61 2.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.159 0.981 . . . . 10.0 110.386 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -125.62 170.96 10.98 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.444 2.298 . . . . 10.0 107.481 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.8 mtt -80.24 72.87 7.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.87 155.8 75.91 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.076 -0.966 . . . . 10.0 109.62 176.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -60.69 -25.71 81.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.225 1.95 . . . . 10.0 112.359 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -175.73 179.57 1.37 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.394 1.878 . . . . 10.0 106.451 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -113.77 106.81 14.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.56 150.81 34.7 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.99 88.8 27.68 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.88 57.72 6.55 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.904 3.069 . . . . 10.0 110.718 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.47 154.95 0.06 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.698 1.237 . . . . 10.0 110.108 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 40.3 39.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.201 1.401 . . . . 10.0 114.733 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 69.56 0.17 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.619 -0.993 . . . . 10.0 110.619 160.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -84.55 57.0 4.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.324 -1.361 . . . . 10.0 107.324 167.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.76 171.62 8.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.849 0.833 . . . . 10.0 110.54 -167.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 t -128.4 128.98 45.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.147 -2.168 . . . . 10.0 105.147 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.92 103.58 9.73 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 104.092 -2.558 . . . . 10.0 104.092 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -147.42 175.21 10.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.685 -1.598 . . . . 10.0 106.685 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -39.63 -50.15 2.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.208 0.527 . . . . 10.0 111.877 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -98.76 16.15 23.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.219 2.608 . . . . 10.0 113.911 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.35 151.67 23.89 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 120.559 1.527 . . . . 10.0 111.362 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -34.98 97.41 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.043 1.737 . . . . 10.0 113.633 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -128.29 174.67 9.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.728 1.149 . . . . 10.0 112.003 -166.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.91 107.97 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.6 mtt -84.1 102.72 12.75 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 122.297 1.046 . . . . 10.0 108.906 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.54 70.0 10.18 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 105.669 -1.974 . . . . 10.0 105.669 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.5 ttm -83.72 148.53 27.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 -168.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.34 59.65 2.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.612 -1.395 . . . . 10.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 tt -50.47 128.06 19.12 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.307 1.843 . . . . 10.0 110.241 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.61 -71.64 0.54 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.071 0.549 . . . . 10.0 110.146 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.61 158.0 73.99 Favored Pre-proline 0 CA--C 1.533 0.319 0 O-C-N 121.982 -0.449 . . . . 10.0 110.135 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.3 73.86 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.317 2.012 . . . . 10.0 109.152 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.76 132.3 17.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 112.789 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -96.35 129.63 43.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.336 1.454 . . . . 10.0 109.492 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.4 105.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.08 16.2 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.912 -0.938 . . . . 10.0 112.313 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.19 -178.47 1.67 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.727 1.727 . . . . 10.0 108.735 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.9 m -155.66 124.59 6.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.614 -1.995 . . . . 10.0 105.614 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.97 145.14 29.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.92 130.33 39.2 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.162 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.9 pt -106.91 122.0 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 160.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 m -101.16 119.98 39.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 169.12 8.74 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.645 0.778 . . . . 10.0 110.029 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.65 96.6 2.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.17 1.788 . . . . 10.0 107.872 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.63 132.18 34.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.395 -0.595 . . . . 10.0 109.395 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 t -60.91 -15.49 31.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.262 0.625 . . . . 10.0 111.388 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 54.6 m-20 -67.17 -21.14 65.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.906 0.883 . . . . 10.0 112.059 171.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 131.33 -13.05 5.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.099 0.857 . . . . 10.0 112.418 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -81.07 73.02 8.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.872 1.336 . . . . 10.0 109.356 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.6 m -83.61 107.05 15.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 156.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.4 tp -156.11 149.42 24.56 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -106.22 131.03 53.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.295 2.238 . . . . 10.0 106.826 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.23 122.93 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.321 -1.733 . . . . 10.0 106.321 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.8 108.28 16.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.22 29.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.626 0.77 . . . . 10.0 109.665 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -82.26 127.21 32.97 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.342 -0.985 . . . . 10.0 108.342 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.1 t -90.0 91.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.204 -1.776 . . . . 10.0 106.204 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -158.67 140.01 13.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 166.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 169.59 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 122.277 1.037 . . . . 10.0 111.647 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -158.03 74.81 0.73 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.1 53.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 122.151 0.977 . . . . 10.0 110.281 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -152.7 139.11 18.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 163.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 147.62 35.55 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.092 -1.203 . . . . 10.0 110.092 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.12 152.52 29.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 10.0 110.443 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -133.44 125.73 29.67 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.751 -1.574 . . . . 10.0 106.751 170.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.47 137.84 45.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.436 1.095 . . . . 10.0 110.012 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.94 2.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.227 -0.589 . . . . 10.0 111.808 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.79 114.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.574 1.15 . . . . 10.0 111.286 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t 2.9 94.57 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.134 2.574 . . . . 10.0 113.365 -167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.23 169.22 20.02 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.95 1.767 . . . . 10.0 108.487 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.74 60.11 4.31 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.812 2.341 . . . . 10.0 109.887 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -160.17 40.61 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.234 1.414 . . . . 10.0 108.429 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 mm 69.48 -179.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.034 1.333 . . . . 10.0 109.081 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -55.55 -29.11 58.38 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.064 0.946 . . . . 10.0 112.108 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.42 135.9 7.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.784 1.634 . . . . 10.0 109.67 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 t -160.82 -171.21 3.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.29 167.41 30.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.403 1.081 . . . . 10.0 109.828 170.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.67 153.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.909 0.755 . . . . 10.0 111.208 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 33.0 m-85 -138.52 112.33 8.39 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.571 -1.64 . . . . 10.0 106.571 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -162.25 -171.96 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.02 1.728 . . . . 10.0 107.634 -168.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -128.01 145.72 50.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.648 0.658 . . . . 10.0 111.592 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.35 113.31 25.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.403 -2.073 . . . . 10.0 105.403 156.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.03 82.17 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.66 137.47 34.46 Favored 'General case' 0 C--N 1.337 0.06 0 O-C-N 121.689 -0.632 . . . . 10.0 110.335 -168.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -128.48 54.66 1.74 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -158.33 128.88 6.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.584 1.954 . . . . 10.0 105.774 170.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.59 61.92 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.863 0.865 . . . . 10.0 110.119 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -134.27 135.98 25.1 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.392 1.477 . . . . 10.0 108.602 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.15 100.58 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.495 2.796 . . . . 10.0 111.167 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.26 95.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.73 117.68 22.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.748 0.819 . . . . 10.0 110.604 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 123.37 33.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.424 1.49 . . . . 10.0 107.88 -174.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 7.1 p -143.54 55.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.695 0.759 . . . . 10.0 110.425 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.01 148.45 16.41 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.472 -1.451 . . . . 10.0 109.472 162.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.97 75.83 0.84 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.13 0.972 . . . . 10.0 109.029 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.53 157.52 16.18 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.498 0.719 . . . . 10.0 109.676 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -172.54 143.27 1.21 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.94 60.97 6.27 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.242 2.628 . . . . 10.0 109.777 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.68 -51.64 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.435 1.094 . . . . 10.0 108.471 -164.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.43 168.69 10.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.475 1.91 . . . . 10.0 109.837 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 m -134.6 -2.31 2.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.311 0.644 . . . . 10.0 112.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 m -152.11 70.44 7.71 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.852 -1.155 . . . . 10.0 109.885 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.61 128.9 11.35 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.84 2.36 . . . . 10.0 111.29 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 mmt -139.64 128.73 23.73 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.999 1.32 . . . . 10.0 109.453 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.46 136.87 33.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.683 0.793 . . . . 10.0 109.673 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.67 -179.36 3.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.875 1.67 . . . . 10.0 108.93 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.0 t -158.88 100.8 1.6 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.485 0.714 . . . . 10.0 109.687 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 t -149.96 56.82 0.96 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.257 -0.902 . . . . 10.0 109.24 -169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -124.46 146.36 48.98 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.926 1.29 . . . . 10.0 108.91 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -101.74 44.92 0.99 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.0 t -163.93 -52.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.243 0.617 . . . . 10.0 111.184 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.88 -110.4 0.57 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.24 -144.86 0.35 Allowed Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.098 0.949 . . . . 10.0 113.699 170.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.4 ttm -75.82 162.88 27.78 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.865 1.266 . . . . 10.0 109.952 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.6 49.94 0.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.999 1.72 . . . . 10.0 107.756 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.7 92.25 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.565 -1.014 . . . . 10.0 110.565 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 ttp -64.21 84.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.554 1.177 . . . . 10.0 112.052 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -133.28 156.66 47.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.214 2.606 . . . . 10.0 106.769 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.4 mtm -80.38 143.49 33.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.913 -1.514 . . . . 10.0 106.913 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.93 165.1 29.96 Favored Pre-proline 0 N--CA 1.455 -0.205 0 C-N-CA 123.686 0.794 . . . . 10.0 109.776 -171.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -43.51 -54.37 3.67 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.686 2.257 . . . . 10.0 110.404 158.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.42 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 175.36 -149.58 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.151 2.181 . . . . 10.0 108.613 -177.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.86 158.27 43.87 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.332 1.853 . . . . 10.0 106.054 160.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.5 m -97.47 124.57 41.73 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.52 -0.918 . . . . 10.0 108.52 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.49 121.73 68.05 Favored Pre-proline 0 N--CA 1.454 -0.232 0 N-CA-C 105.325 -2.102 . . . . 10.0 105.325 171.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.97 146.15 16.03 Favored 'Trans proline' 0 N--CA 1.441 -1.571 0 N-CA-C 109.261 -1.092 . . . . 10.0 109.261 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 47.36 -138.4 0.71 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.958 0.903 . . . . 10.0 112.539 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.67 32.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.747 2.419 . . . . 10.0 114.494 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.8 150.76 38.6 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.994 -1.066 . . . . 10.0 113.075 -169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -132.01 61.66 1.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.988 1.315 . . . . 10.0 108.359 -171.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.65 148.58 30.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.9 m -135.47 107.54 7.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.22 114.35 18.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -131.53 159.75 37.27 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.249 1.42 . . . . 10.0 109.845 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -25.0 -65.26 0.05 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.201 2.2 . . . . 10.0 113.566 -173.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.09 80.63 1.84 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.377 -1.712 . . . . 10.0 106.377 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.83 86.76 0.1 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 108.86 -1.696 . . . . 10.0 108.86 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 t0 40.95 74.61 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.129 1.771 . . . . 10.0 112.176 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -131.07 172.31 12.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.332 -1.758 . . . . 10.0 110.867 -154.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.7 108.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 125.668 1.587 . . . . 10.0 108.715 -173.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 33.0 mtp -83.04 96.39 8.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.405 0.682 . . . . 10.0 109.723 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.48 70.17 7.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.809 -1.552 . . . . 10.0 106.809 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.22 164.99 22.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.431 -1.322 . . . . 10.0 107.431 -168.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.28 46.57 20.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.323 -1.111 . . . . 10.0 110.323 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.4 mt -55.27 130.27 41.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.737 1.268 . . . . 10.0 108.917 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -69.17 0.13 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.506 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 173.97 -63.63 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.221 1.409 . . . . 10.0 112.91 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.09 50.14 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.544 2.163 . . . . 10.0 112.741 -159.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.54 157.01 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.212 1.005 . . . . 10.0 110.52 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 171.93 7.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.954 -1.128 . . . . 10.0 107.954 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.27 128.09 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 163.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 33.17 39.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.499 -0.64 . . . . 10.0 111.499 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.96 -172.7 4.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.462 1.125 . . . . 10.0 108.486 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.6 m -155.81 124.78 6.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.027 1.731 . . . . 10.0 107.499 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.89 152.5 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.96 -1.496 . . . . 10.0 106.96 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -70.87 132.23 44.95 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.0 154.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 106.125 -1.805 . . . . 10.0 106.125 155.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -129.82 128.49 42.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 158.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.41 156.39 24.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -147.7 69.41 1.14 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.69 117.69 21.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p 40.95 -99.79 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.585 1.554 . . . . 10.0 109.896 -167.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 42.79 0.93 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.27 2.228 . . . . 10.0 107.411 170.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.09 -48.12 0.23 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.22 1.866 . . . . 10.0 110.166 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -115.1 73.2 0.82 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.093 0.947 . . . . 10.0 108.637 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 m -86.29 100.94 12.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 160.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 mt -155.3 164.41 38.81 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 122.736 0.415 . . . . 10.0 110.547 -165.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -132.46 65.28 1.59 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.712 2.005 . . . . 10.0 109.553 -159.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.7 t -81.71 149.3 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 -171.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.32 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.151 -0.968 . . . . 10.0 109.626 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.66 120.48 40.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.844 1.258 . . . . 10.0 109.739 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -83.78 148.47 27.01 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 166.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.73 100.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -156.8 126.81 6.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.294 0.952 . . . . 10.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 118.441 0.564 . . . . 10.0 111.39 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 122.679 1.228 . . . . 10.0 112.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -78.43 66.26 3.94 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.526 3.131 . . . . 10.0 108.929 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.75 88.96 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.154 1.382 . . . . 10.0 108.951 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -147.94 134.42 19.71 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.67 154.81 47.59 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.589 1.09 . . . . 10.0 112.497 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.42 162.48 13.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.641 0.734 . . . . 10.0 112.22 -170.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 p -139.63 157.98 44.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.557 -1.275 . . . . 10.0 107.557 164.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.91 136.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.243 -1.392 . . . . 10.0 107.243 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.51 40.75 0.74 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.794 -1.191 . . . . 10.0 112.998 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.107 1.363 . . . . 10.0 110.111 -164.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.58 125.46 47.02 Favored Pre-proline 0 C--O 1.239 0.517 0 CA-C-N 120.095 1.316 . . . . 10.0 107.841 160.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.19 174.06 4.47 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.261 1.974 . . . . 10.0 108.693 162.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.95 54.84 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.215 1.943 . . . . 10.0 109.801 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 m -144.29 62.6 1.34 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.978 1.311 . . . . 10.0 107.711 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 mm 73.72 164.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.923 1.289 . . . . 10.0 109.723 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -77.38 50.07 0.76 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.217 1.407 . . . . 10.0 109.862 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -138.72 159.81 41.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.059 2.144 . . . . 10.0 108.46 -162.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.1 t -172.0 -179.43 2.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.472 1.109 . . . . 10.0 109.948 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.28 161.33 37.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.334 1.454 . . . . 10.0 109.157 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.96 156.54 21.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 165.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -130.19 108.63 10.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.17 -2.529 . . . . 10.0 104.17 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ptp -157.12 -176.8 6.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.681 1.192 . . . . 10.0 109.461 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.9 m -127.59 119.12 25.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.086 1.355 . . . . 10.0 109.053 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.32 109.23 12.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 103.605 -2.739 . . . . 10.0 103.605 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -95.93 70.65 2.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.482 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.51 130.25 35.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.272 -0.971 . . . . 10.0 109.829 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -136.1 56.26 1.83 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 p -157.83 166.14 33.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.312 0.577 . . . . 10.0 110.821 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -107.89 27.26 9.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.901 2.88 . . . . 10.0 110.33 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -114.73 134.4 22.41 Favored Pre-proline 0 C--N 1.342 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 107.609 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.63 122.01 8.48 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.113 1.875 . . . . 10.0 109.891 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.26 81.91 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -79.28 -180.0 7.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.062 0.458 . . . . 10.0 110.32 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.64 136.14 13.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.666 -2.346 . . . . 10.0 104.666 -170.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -151.55 54.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.276 0.944 . . . . 10.0 109.52 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.18 151.0 20.01 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.783 -1.198 . . . . 10.0 111.116 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.78 70.95 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.484 1.514 . . . . 10.0 108.392 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.64 140.71 32.02 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 t -168.21 145.04 3.35 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 118.562 0.619 . . . . 10.0 111.313 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.95 52.99 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.937 2.425 . . . . 10.0 110.023 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 tp -128.87 -61.24 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.439 1.096 . . . . 10.0 109.564 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.24 162.44 18.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.61 1.564 . . . . 10.0 109.601 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 m -87.86 -42.7 12.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.588 0.755 . . . . 10.0 110.625 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 t -123.38 89.97 50.76 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.654 1.182 . . . . 10.0 110.181 -163.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.68 85.11 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.89 2.393 . . . . 10.0 109.904 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.0 mtt -83.69 117.83 23.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.152 0.981 . . . . 10.0 108.618 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.16 128.63 33.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.458 -0.776 . . . . 10.0 109.571 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.76 144.68 39.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.918 1.287 . . . . 10.0 110.787 -174.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.89 170.11 13.43 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.467 0.651 . . . . 10.0 111.991 164.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -98.46 177.43 5.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.42 1.888 . . . . 10.0 113.527 164.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -95.21 72.05 3.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.046 1.739 . . . . 10.0 108.969 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.09 73.03 0.44 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.245 1.418 . . . . 10.0 112.921 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -164.39 54.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.31 -90.06 0.49 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 106.992 -2.443 . . . . 10.0 106.992 -167.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.37 173.87 19.06 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 117.223 0.511 . . . . 10.0 112.706 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mtp -53.75 -87.48 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.645 1.978 . . . . 10.0 115.547 -158.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -174.94 34.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.666 0.666 . . . . 10.0 111.922 -160.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.79 140.39 2.91 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.827 -0.909 . . . . 10.0 110.827 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.6 ttp -65.62 93.59 0.17 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.739 0.769 . . . . 10.0 110.062 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.26 161.38 38.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.432 0.693 . . . . 10.0 112.464 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 68.9 mtp -82.84 109.42 16.96 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.071 1.748 . . . . 10.0 110.081 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.09 166.51 10.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.391 0.676 . . . . 10.0 111.525 -170.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -37.73 -53.1 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.251 2.634 . . . . 10.0 111.027 156.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.6 p90 175.07 -172.18 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.056 2.142 . . . . 10.0 105.593 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.1 102.3 9.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.473 0.654 . . . . 10.0 110.548 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.7 m -76.8 120.85 22.52 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 pt -92.48 115.38 64.69 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.315 -1.365 . . . . 10.0 107.315 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.05 59.06 7.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.74 2.293 . . . . 10.0 108.514 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.73 -175.82 0.14 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.26 1.024 . . . . 10.0 109.551 -161.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 54.6 -2.34 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 118.024 2.602 . . . . 10.0 118.024 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.61 77.74 0.49 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.761 1.172 . . . . 10.0 111.986 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.4 t -82.43 56.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 166.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.59 -178.16 4.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.98 0.895 . . . . 10.0 110.656 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -127.75 129.13 46.56 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.18 1.792 . . . . 10.0 106.562 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.77 114.39 26.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 103.752 -2.685 . . . . 10.0 103.752 167.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.99 159.85 38.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.343 1.057 . . . . 10.0 109.971 -164.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -44.89 -54.6 6.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.153 1.381 . . . . 10.0 113.349 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.8 -63.31 1.24 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.783 0.833 . . . . 10.0 111.419 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.24 135.81 3.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -165.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 70.78 119.96 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 130.885 3.674 . . . . 10.0 106.246 -170.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 176.43 171.67 0.43 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.605 0.762 . . . . 10.0 109.242 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.22 123.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.139 -2.171 . . . . 10.0 105.139 154.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 69.0 mtp -82.84 101.6 11.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.104 -1.443 . . . . 10.0 107.104 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.38 74.3 8.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.708 1.603 . . . . 10.0 107.045 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 52.1 ttm -84.6 149.47 25.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.231 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.46 68.82 1.27 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.704 -0.959 . . . . 10.0 110.704 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -35.37 133.94 0.32 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.121 1.768 . . . . 10.0 112.985 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -67.53 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.745 -0.645 . . . . 10.0 111.689 157.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -168.9 -59.3 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 115.984 1.846 . . . . 10.0 115.984 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.39 75.66 4.81 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.904 1.736 . . . . 10.0 111.113 -166.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.17 48.32 2.41 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.389 1.076 . . . . 10.0 111.882 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -63.69 148.21 49.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.22 108.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.29 55.77 3.0 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -166.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 -179.8 4.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 153.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.1 m -155.66 134.93 12.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.284 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.01 136.7 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.656 -1.609 . . . . 10.0 106.656 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -79.23 114.76 18.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 167.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -81.2 -178.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 168.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 m -139.13 120.19 14.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 160.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 pp -83.69 172.65 12.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -156.72 103.39 2.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.45 120.69 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.06 -1.089 . . . . 10.0 108.06 157.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -48.33 -34.51 10.72 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.594 1.558 . . . . 10.0 111.053 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.1 -33.75 53.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.759 2.023 . . . . 10.0 111.806 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.82 56.84 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.231 0.92 . . . . 10.0 111.032 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -141.65 133.72 27.64 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.5 t -156.01 59.6 0.59 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.659 0.663 . . . . 10.0 110.754 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.98 148.97 27.27 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.005 0.522 . . . . 10.0 109.885 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -95.92 65.81 2.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 127.735 2.414 . . . . 10.0 108.262 -174.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.77 146.96 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -155.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.73 130.53 35.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.62 115.08 23.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.951 1.3 . . . . 10.0 109.453 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.7 m -84.41 132.73 34.55 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.37 120.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -159.7 94.1 1.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.057 0.844 . . . . 10.0 112.379 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 179.218 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.276 0.56 . . . . 10.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 p -156.13 57.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.507 -0.746 . . . . 10.0 109.995 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.24 58.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 CA-C-O 122.569 1.176 . . . . 10.0 110.632 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.95 155.75 41.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 164.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.52 -163.23 6.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.366 -1.094 . . . . 10.0 110.366 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.0 133.77 30.52 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -120.46 110.64 16.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.65 128.78 53.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.397 0.679 . . . . 10.0 109.375 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.08 110.34 12.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.873 0.368 . . . . 10.0 111.314 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.44 127.14 14.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.572 -0.728 . . . . 10.0 109.617 167.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -13.05 95.74 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 128.29 2.636 . . . . 10.0 113.281 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.47 178.86 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.692 2.261 . . . . 10.0 109.377 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -67.52 68.05 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.408 2.072 . . . . 10.0 108.548 156.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -153.8 35.28 0.44 Allowed 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 126.216 1.806 . . . . 10.0 108.206 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.401 ' CG2' ' H ' ' A' ' 43' ' ' ARG . 18.2 mt 64.8 -176.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.401 ' H ' ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -70.19 32.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.468 -1.395 . . . . 10.0 113.552 170.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 155.16 20.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 163.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -164.94 -178.15 5.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.669 -1.234 . . . . 10.0 107.669 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 165.0 29.32 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.883 0.873 . . . . 10.0 109.887 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.69 33.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.308 -1.314 . . . . 10.0 107.71 164.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.16 104.36 12.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 -173.4 4.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.49 1.116 . . . . 10.0 110.423 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.8 m -116.56 143.96 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.038 1.735 . . . . 10.0 107.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.42 121.7 40.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.723 -1.955 . . . . 10.0 105.723 158.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -129.42 114.93 16.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.583 1.553 . . . . 10.0 109.045 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -93.29 136.93 33.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.82 0.848 . . . . 10.0 112.317 -172.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -134.2 56.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.713 -1.218 . . . . 10.0 107.713 161.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -137.33 -51.5 0.65 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.82 0.848 . . . . 10.0 111.031 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.5 48.43 3.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.659 1.584 . . . . 10.0 110.449 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.69 137.99 31.06 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.63 119.04 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.876 2.384 . . . . 10.0 109.705 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 mt -122.96 135.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -98.6 99.73 10.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.385 1.074 . . . . 10.0 108.904 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.2 117.56 26.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.75 -1.944 . . . . 10.0 105.75 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.17 51.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.485 0.714 . . . . 10.0 109.488 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.95 138.34 5.35 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.925 -1.27 . . . . 10.0 109.925 160.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.56 66.57 0.49 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.257 1.423 . . . . 10.0 107.73 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.0 21.09 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.061 0.544 . . . . 10.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 t -173.46 140.22 0.85 Allowed Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.39 65.82 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.27 2.646 . . . . 10.0 108.932 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.26 -50.68 0.08 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.957 1.303 . . . . 10.0 108.766 -164.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.93 31.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m -88.98 -22.31 23.09 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 167.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -134.3 88.15 31.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.709 1.204 . . . . 10.0 108.492 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.79 124.36 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.324 2.683 . . . . 10.0 110.424 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -132.04 152.04 51.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.578 1.151 . . . . 10.0 108.95 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.1 157.06 18.45 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.236 0.615 . . . . 10.0 110.217 166.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.93 153.81 32.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.794 1.237 . . . . 10.0 109.354 -176.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -139.57 121.04 15.08 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.947 0.794 . . . . 10.0 112.408 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -146.88 51.22 1.1 Allowed 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.559 -1.338 . . . . 10.0 110.305 165.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.6 m -150.28 90.74 1.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.487 1.115 . . . . 10.0 111.85 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -34.67 -42.98 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.805 2.442 . . . . 10.0 113.566 172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -50.29 -26.29 4.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.644 1.178 . . . . 10.0 113.409 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.22 -51.41 0.11 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 -124.57 4.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.162 0.887 . . . . 10.0 111.245 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.3 tpp -141.74 -121.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.067 0.934 . . . . 10.0 111.186 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.07 62.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -166.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.32 87.36 0.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.795 -1.722 . . . . 10.0 108.795 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 64.43 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.463 -0.94 . . . . 10.0 108.463 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -147.08 172.89 13.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.674 2.39 . . . . 10.0 107.847 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttp -80.15 74.73 6.95 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.799 0.809 . . . . 10.0 109.054 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.73 160.81 24.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.701 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.23 80.14 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.957 2.438 . . . . 10.0 109.69 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 58.21 -164.95 0.18 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.954 2.102 . . . . 10.0 113.482 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.75 99.15 5.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.797 0.839 . . . . 10.0 109.27 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.0 m -82.15 125.46 30.91 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.726 -0.608 . . . . 10.0 109.649 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.33 122.11 60.34 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.34 65.45 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.816 2.344 . . . . 10.0 110.847 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.99 -175.32 0.15 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.877 0.871 . . . . 10.0 109.462 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . 0.258 0.1 OUTLIER 5.9 44.21 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 130.164 3.385 . . . . 10.0 118.831 -169.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -54.29 138.01 40.56 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.316 0.96 . . . . 10.0 113.534 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.8 m -149.85 59.63 0.99 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.433 1.493 . . . . 10.0 107.177 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.96 164.75 12.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.677 0.275 . . . . 10.0 110.524 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.8 m -124.19 104.73 9.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.54 122.21 27.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.63 -1.618 . . . . 10.0 106.63 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -156.17 157.51 36.04 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.606 1.963 . . . . 10.0 107.726 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 0.25 0.2 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.476 1.658 . . . . 10.0 115.476 -161.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.45 -72.04 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.994 1.717 . . . . 10.0 108.09 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.28 76.61 1.45 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 125.136 1.351 . . . . 10.0 111.176 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 70.03 134.58 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.095 1.758 . . . . 10.0 110.696 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -177.47 176.22 1.32 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.896 0.855 . . . . 10.0 113.013 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.59 121.37 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 157.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.2 mtp -82.22 104.99 12.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 165.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.63 74.52 6.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.628 1.971 . . . . 10.0 109.148 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -91.16 149.13 21.92 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.934 -0.479 . . . . 10.0 112.271 -170.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 33.56 3.0 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.582 0.993 . . . . 10.0 115.582 157.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 37.95 46.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 128.424 2.69 . . . . 10.0 116.769 160.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.092 -1.005 . . . . 10.0 112.719 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -133.11 151.72 78.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 107.086 -1.45 . . . . 10.0 107.086 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.39 75.06 2.5 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.003 2.468 . . . . 10.0 109.279 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mp -40.54 105.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.386 2.274 . . . . 10.0 113.3 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.73 131.64 34.41 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.1 p -60.67 103.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 162.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.69 -0.61 15.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.978 -0.901 . . . . 10.0 112.148 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.16 179.97 4.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 123.94 1.828 . . . . 10.0 108.281 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -155.81 132.75 10.59 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.534 -2.121 . . . . 10.0 106.55 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.75 143.88 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -79.22 124.64 28.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 tt -81.52 170.4 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -146.42 118.44 8.24 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.155 -0.966 . . . . 10.0 109.073 165.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.1 151.54 24.06 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.318 -1.364 . . . . 10.0 107.318 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -154.48 78.7 1.08 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.1 123.56 27.47 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p 44.89 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.175 1.79 . . . . 10.0 110.001 -161.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -164.32 58.36 0.15 Allowed 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.731 0.813 . . . . 10.0 109.521 156.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.71 27.44 1.63 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.22 61.04 1.17 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.186 0.994 . . . . 10.0 108.428 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.1 m -83.0 60.11 5.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.794 0.838 . . . . 10.0 110.27 -170.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.88 149.92 26.82 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -130.55 60.74 1.62 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.543 1.937 . . . . 10.0 109.509 -169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.0 151.12 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 121.938 -0.476 . . . . 10.0 109.991 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.96 119.6 24.64 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.364 -0.835 . . . . 10.0 109.294 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.85 133.45 42.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.222 1.009 . . . . 10.0 108.799 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.6 m -83.0 144.29 30.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.525 -1.287 . . . . 10.0 107.525 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.43 107.28 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -156.69 147.11 21.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.603 0.716 . . . . 10.0 111.024 171.68 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 121.092 0.472 . . . . 10.0 110.466 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 m -159.18 106.5 1.78 Allowed 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.948 -1.095 . . . . 10.0 109.505 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.23 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.63 0.65 . . . . 10.0 111.01 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -157.51 153.58 27.24 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 163.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.1 107.95 3.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.748 1.166 . . . . 10.0 112.178 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.73 153.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.746 0.818 . . . . 10.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 p -135.68 151.86 50.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.287 -1.375 . . . . 10.0 107.287 164.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.84 137.91 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.06 47.33 0.77 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.288 0.949 . . . . 10.0 113.416 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 28.89 -124.29 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.014 2.126 . . . . 10.0 111.243 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.38 118.89 55.63 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 157.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.8 168.49 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.038 2.492 . . . . 10.0 107.996 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.47 69.43 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.786 1.657 . . . . 10.0 108.846 170.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.412 ' CB ' HH12 ' A' ' 104' ' ' ARG . 7.4 m -155.84 38.67 0.37 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.645 1.178 . . . . 10.0 109.078 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.4 mm 68.34 178.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.361 1.064 . . . . 10.0 110.291 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -46.51 -33.59 4.17 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.37 2.268 . . . . 10.0 114.774 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.31 151.71 45.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.362 1.077 . . . . 10.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 t -161.65 175.4 12.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.634 -1.617 . . . . 10.0 106.634 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.02 160.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.07 0.548 . . . . 10.0 110.529 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.76 142.44 32.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.114 0.884 . . . . 10.0 108.855 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -117.93 108.62 15.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 165.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.74 -179.16 7.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.313 1.845 . . . . 10.0 106.332 -160.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -150.66 138.02 19.52 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.411 1.46 . . . . 10.0 110.071 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.97 116.37 27.97 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -93.76 87.25 5.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.843 1.657 . . . . 10.0 108.304 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -78.05 79.53 4.51 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 121.89 0.852 . . . . 10.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 58.28 4.64 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m -172.76 144.21 1.34 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.986 0.915 . . . . 10.0 108.796 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.09 49.12 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.447 1.499 . . . . 10.0 109.838 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.2 127.19 18.88 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.805 0.842 . . . . 10.0 109.376 -170.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -85.71 121.85 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.538 2.825 . . . . 10.0 110.702 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mp -150.44 116.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 150.08 30.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.347 0.521 . . . . 10.0 110.677 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 138.32 46.59 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 171.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.88 54.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.56 1.073 . . . . 10.0 108.914 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.04 144.35 9.64 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.623 -1.791 . . . . 10.0 108.623 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.98 65.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.571 1.548 . . . . 10.0 107.981 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.12 160.89 23.03 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t -173.75 152.2 1.98 Allowed Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 107.608 -1.256 . . . . 10.0 107.608 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.34 -1.41 11.32 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.603 2.202 . . . . 10.0 112.155 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.61 -53.67 5.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.608 1.163 . . . . 10.0 110.46 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.77 178.44 5.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.323 1.449 . . . . 10.0 110.62 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 m -143.13 0.63 1.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.314 -0.866 . . . . 10.0 112.456 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.6 m -148.07 80.41 8.7 Favored Pre-proline 0 N--CA 1.448 -0.551 0 O-C-N 120.589 -1.319 . . . . 10.0 108.06 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.87 98.39 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.972 3.115 . . . . 10.0 111.12 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -103.64 120.55 41.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.672 0.789 . . . . 10.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.87 140.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 ttm -145.08 149.0 34.29 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.667 0.787 . . . . 10.0 110.135 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -140.63 112.02 7.33 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.577 0.584 . . . . 10.0 112.577 -166.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -146.64 49.55 1.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.431 -1.418 . . . . 10.0 110.807 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -130.35 94.85 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.39 1.476 . . . . 10.0 108.92 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -68.79 85.38 0.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.885 1.674 . . . . 10.0 110.823 -163.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t 163.83 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.789 2.035 . . . . 10.0 107.784 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.11 84.37 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.722 -1.351 . . . . 10.0 109.722 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 -170.41 23.63 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.103 -1.599 . . . . 10.0 109.103 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.7 ttm -106.57 -136.98 0.36 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.611 0.764 . . . . 10.0 109.317 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.53 51.09 1.19 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.743 1.217 . . . . 10.0 108.075 -164.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 90.48 0.14 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.243 -1.543 . . . . 10.0 109.243 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.41 60.14 1.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.865 -1.161 . . . . 10.0 107.865 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -143.43 171.45 14.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.807 2.043 . . . . 10.0 107.921 -170.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 27.6 ttm -81.46 69.21 8.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.051 0.929 . . . . 10.0 110.482 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.04 163.99 14.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.326 1.05 . . . . 10.0 109.676 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.407 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 38.1 Cg_exo -52.2 -36.77 68.38 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.552 2.168 . . . . 10.0 112.673 170.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.407 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.68 -156.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.75 2.02 . . . . 10.0 110.681 -164.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.16 131.26 47.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.645 -1.613 . . . . 10.0 106.645 162.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 m -95.67 106.05 18.11 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -85.16 109.71 23.11 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -88.21 52.22 2.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.368 1.379 . . . . 10.0 110.655 -167.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.44 163.85 0.14 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.74 0.781 . . . . 10.0 110.993 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.82 20.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.678 1.591 . . . . 10.0 112.718 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.31 69.77 1.09 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 124.935 1.255 . . . . 10.0 110.253 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -84.69 57.7 4.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -94.44 155.46 16.94 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.283 -175.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.1 t -126.05 117.16 22.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 -165.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.99 128.32 34.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.76 165.84 35.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.678 0.791 . . . . 10.0 109.4 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.412 HH12 ' CB ' ' A' ' 41' ' ' SER . 2.6 ttp180 -67.4 89.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.488 -0.758 . . . . 10.0 110.606 174.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 131.02 -70.21 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 131.342 3.857 . . . . 10.0 108.112 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.02 71.23 0.96 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 125.448 1.499 . . . . 10.0 112.506 -167.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 66.61 138.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.41 1.884 . . . . 10.0 110.367 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -179.38 179.41 0.62 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.181 0.592 . . . . 10.0 110.789 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.3 t -114.84 128.79 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 156.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 77.1 mtp -82.25 94.2 7.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 166.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.84 65.5 7.0 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.193 -1.41 . . . . 10.0 107.193 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 21.0 ptm -84.71 179.57 7.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.274 1.035 . . . . 10.0 110.17 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 47.44 45.61 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.901 -1.28 . . . . 10.0 109.901 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.49 118.93 10.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.204 1.002 . . . . 10.0 109.18 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -61.57 2.43 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 117.443 0.111 . . . . 10.0 111.226 -171.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.1 mtt-85 -166.54 -59.58 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.23 1.412 . . . . 10.0 111.86 -162.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.25 69.6 7.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 120.848 1.339 . . . . 10.0 112.934 -165.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 56.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.261 -0.9 . . . . 10.0 111.875 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 96.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.217 -0.927 . . . . 10.0 109.258 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.63 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.471 1.108 . . . . 10.0 109.512 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.13 -10.05 5.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.324 -0.709 . . . . 10.0 113.003 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.464 ' CG ' ' H ' ' A' ' 123' ' ' THR . 12.3 tt0 -78.82 -177.89 5.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.838 1.304 . . . . 10.0 108.369 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 122' ' ' GLU . 19.0 m -150.9 131.55 13.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.758 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.55 141.42 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.378 1.471 . . . . 10.0 107.32 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -68.25 127.82 34.3 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.544 -0.722 . . . . 10.0 109.927 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.6 tt -82.27 173.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.401 -1.703 . . . . 10.0 106.401 162.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 38.9 m -144.55 115.69 7.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.311 -0.868 . . . . 10.0 109.439 160.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 pp -87.7 173.0 9.28 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.829 0.307 . . . . 10.0 111.829 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -156.99 109.38 2.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.004 0.922 . . . . 10.0 108.972 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.55 126.34 32.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 160.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 t -79.86 62.5 4.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.754 0.788 . . . . 10.0 108.909 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.81 -65.86 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.727 2.411 . . . . 10.0 107.14 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 -79.11 0.45 Allowed Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.609 -0.723 . . . . 10.0 113.778 -167.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 -177.8 5.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.871 -0.782 . . . . 10.0 112.982 -175.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 m -128.74 142.26 51.06 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.48 3.512 . . . . 10.0 103.606 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.25 147.13 22.02 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -121.16 59.45 0.94 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.05 1.74 . . . . 10.0 110.088 -157.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.1 t -78.32 147.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -161.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.36 109.88 16.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.56 43.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.145 0.978 . . . . 10.0 110.527 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.8 m -83.51 126.79 33.15 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.669 0.388 . . . . 10.0 110.256 -177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.4 t -91.31 97.37 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.72 -1.956 . . . . 10.0 105.72 -173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 102.33 2.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.766 -0.584 . . . . 10.0 110.753 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.339 0.135 0 C-N-CA 124.58 1.152 . . . . 10.0 110.266 162.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 122.027 0.918 . . . . 10.0 112.083 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.4 p -153.91 54.2 0.71 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.667 1.587 . . . . 10.0 107.209 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -83.66 63.51 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -137.19 154.21 50.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.831 1.252 . . . . 10.0 110.967 -169.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.91 136.79 13.68 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.913 -2.075 . . . . 10.0 107.913 168.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.59 25.3 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.605 1.203 . . . . 10.0 109.995 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 p -134.56 141.75 46.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.2 134.04 67.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.69 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 36.08 -122.55 0.15 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.933 1.693 . . . . 10.0 111.031 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.48 109.69 58.12 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.963 0.905 . . . . 10.0 108.85 169.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.57 163.45 27.19 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.959 2.439 . . . . 10.0 110.394 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.42 61.0 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.914 2.41 . . . . 10.0 109.421 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -160.49 47.8 0.24 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.379 1.072 . . . . 10.0 108.522 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 mm 75.45 167.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.444 1.498 . . . . 10.0 109.17 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -26.7 63.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.95 0.722 . . . . 10.0 112.95 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.91 140.12 1.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.632 2.373 . . . . 10.0 110.807 172.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -159.98 -178.63 7.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.14 157.85 43.24 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.401 0.68 . . . . 10.0 110.654 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.7 150.3 25.21 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 124.001 0.813 . . . . 10.0 110.097 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -128.45 103.62 7.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.442 -2.059 . . . . 10.0 105.442 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -159.82 -176.67 5.84 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.969 0.508 . . . . 10.0 110.909 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -133.71 122.9 24.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.14 0.976 . . . . 10.0 111.501 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mp -80.52 132.45 35.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.214 -2.513 . . . . 10.0 104.214 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -130.56 104.76 7.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 124.58 1.175 . . . . 10.0 107.982 -160.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.82 130.34 35.03 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 117.804 0.274 . . . . 10.0 111.199 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -140.93 59.29 1.54 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -168.02 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.015 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 65.9 78.46 0.27 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.253 1.421 . . . . 10.0 111.512 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -146.22 154.72 50.25 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.732 1.613 . . . . 10.0 108.533 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.52 72.93 6.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.651 2.901 . . . . 10.0 111.768 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.4 115.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -89.11 144.73 25.92 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.477 -0.765 . . . . 10.0 109.372 168.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.99 126.83 49.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 56.63 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.876 0.845 . . . . 10.0 110.044 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.98 150.77 21.21 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.004 -1.238 . . . . 10.0 110.004 163.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.08 58.84 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.252 1.021 . . . . 10.0 108.805 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.82 139.74 31.7 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.898 -0.501 . . . . 10.0 109.791 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 t -160.76 145.6 10.69 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.94 57.37 4.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.178 2.586 . . . . 10.0 109.878 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 tt -139.74 -63.06 0.51 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.357 1.463 . . . . 10.0 107.849 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.74 146.71 27.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.674 1.19 . . . . 10.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.1 m -82.07 -38.32 25.08 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.725 0.81 . . . . 10.0 109.196 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.61 80.13 39.23 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.012 0.925 . . . . 10.0 110.182 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.74 92.93 1.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.829 2.353 . . . . 10.0 109.993 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.7 mtt -103.62 131.18 51.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.598 1.159 . . . . 10.0 110.115 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.76 144.62 29.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.482 1.113 . . . . 10.0 109.087 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.5 ttm -146.27 157.78 43.83 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.431 0.692 . . . . 10.0 110.775 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -155.1 107.13 2.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.873 0.844 . . . . 10.0 112.531 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 t -146.2 57.98 1.21 Allowed 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.793 -1.192 . . . . 10.0 111.023 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -150.24 93.46 2.0 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.277 1.431 . . . . 10.0 109.829 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -32.09 -46.06 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 128.682 2.793 . . . . 10.0 113.27 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -54.91 -23.59 19.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.267 1.427 . . . . 10.0 114.032 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.85 -50.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.437 -1.065 . . . . 10.0 110.437 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.93 -162.63 32.21 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.271 0.938 . . . . 10.0 111.621 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 ttt -81.72 -159.79 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.415 0.686 . . . . 10.0 109.3 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.579 1.152 . . . . 10.0 108.078 -167.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.28 108.86 0.36 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.015 -1.634 . . . . 10.0 109.015 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.88 65.6 1.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 10.0 109.86 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -125.63 165.1 19.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.343 2.257 . . . . 10.0 109.718 -170.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 35.2 ttm -81.47 72.82 8.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.879 0.847 . . . . 10.0 109.93 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.03 159.33 47.86 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.938 0.895 . . . . 10.0 111.195 173.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 95.3 Cg_endo -61.85 -30.86 84.8 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.907 2.404 . . . . 10.0 112.507 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.405 ' CZ3' ' HB2' ' A' ' 90' ' ' PRO . 44.4 p90 177.88 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.797 2.439 . . . . 10.0 105.344 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.14 115.72 18.84 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.58 0.705 . . . . 10.0 110.959 168.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 m -78.27 126.5 30.88 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.7 pt -100.77 103.07 22.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.182 0.901 . . . . 10.0 109.043 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.86 70.19 6.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.227 1.951 . . . . 10.0 111.347 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 60.43 168.96 0.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.611 -0.68 . . . . 10.0 109.796 -163.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 41.59 31.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.768 1.766 . . . . 10.0 115.768 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.05 72.26 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 124.41 1.005 . . . . 10.0 113.209 167.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -107.26 57.23 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.518 -1.66 . . . . 10.0 106.518 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -93.73 151.9 19.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.546 1.138 . . . . 10.0 108.1 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.6 m -119.19 117.13 27.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.885 -1.894 . . . . 10.0 105.885 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.31 102.17 10.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.217 -2.142 . . . . 10.0 105.217 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.02 156.77 48.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.463 1.505 . . . . 10.0 110.428 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -48.96 -42.99 39.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.287 1.035 . . . . 10.0 112.303 -166.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -114.31 29.84 7.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.771 0.828 . . . . 10.0 111.897 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.18 69.13 0.19 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 121.346 -0.847 . . . . 10.0 111.387 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.2 t70 64.96 138.99 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 126.381 1.872 . . . . 10.0 110.524 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -178.09 179.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 10.0 111.149 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -110.86 122.0 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 162.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 67.2 mtp -83.86 100.24 10.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 165.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.19 73.24 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.5 154.64 20.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.966 0.906 . . . . 10.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.27 66.34 2.24 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.93 141.68 44.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.344 0.658 . . . . 10.0 112.106 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -86.44 -48.65 8.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 10.0 112.549 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -144.48 158.94 53.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.624 0.77 . . . . 10.0 110.559 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -67.65 160.51 47.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.559 2.84 . . . . 10.0 111.911 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.42 159.61 41.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.769 1.628 . . . . 10.0 108.179 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -113.16 144.43 42.68 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.615 0.643 . . . . 10.0 109.503 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.88 104.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 165.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.68 -13.73 6.46 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.166 -0.797 . . . . 10.0 111.61 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -178.25 3.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.787 1.755 . . . . 10.0 109.119 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.0 m -155.56 131.36 9.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.031 -1.895 . . . . 10.0 107.708 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.66 149.57 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -84.71 130.99 34.62 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -103.99 130.24 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.077 0.951 . . . . 10.0 109.147 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 m -103.1 107.46 18.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 166.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.29 154.3 26.62 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 160.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -150.23 90.15 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.27 143.31 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -50.54 -36.32 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.44 1.096 . . . . 10.0 110.876 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -70.11 44.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 10.0 112.649 173.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.04 48.54 38.61 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.219 1.866 . . . . 10.0 113.206 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -110.57 146.75 35.54 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 171.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.0 m -156.41 101.32 2.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.742 2.017 . . . . 10.0 105.659 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -112.05 -178.46 3.43 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.843 0.747 . . . . 10.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -149.93 64.03 0.98 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.744 2.017 . . . . 10.0 108.614 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.73 156.74 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.12 130.77 35.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.81 112.55 23.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.698 1.199 . . . . 10.0 109.222 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 m -83.86 125.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.7 112.84 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -158.09 125.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.686 -0.673 . . . . 10.0 109.693 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 126.289 1.836 . . . . 10.0 110.025 176.109 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 122.365 1.079 . . . . 10.0 109.301 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.8 p -156.75 82.72 0.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.214 -0.903 . . . . 10.0 108.694 -165.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 55.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 123.113 1.435 . . . . 10.0 107.377 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -83.89 129.94 34.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.721 -1.582 . . . . 10.0 107.05 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.66 -39.06 78.14 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.708 -0.557 . . . . 10.0 111.708 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 68.73 116.84 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.736 2.414 . . . . 10.0 113.33 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p -116.28 91.92 3.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.577 1.951 . . . . 10.0 108.789 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.445 -0.946 . . . . 10.0 108.445 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.92 42.92 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.67 -133.94 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.347 1.459 . . . . 10.0 110.208 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.4 t -104.05 110.75 64.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 160.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.89 172.04 10.24 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.115 2.543 . . . . 10.0 108.93 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.02 59.6 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 10.0 109.882 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -157.8 50.88 0.43 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 10.0 109.844 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 mm 66.36 174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.869 0.868 . . . . 10.0 110.291 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -69.07 22.85 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.245 1.418 . . . . 10.0 114.379 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.492 ' CG ' HH21 ' A' ' 104' ' ' ARG . 0.0 OUTLIER -94.45 157.62 15.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.807 1.185 . . . . 10.0 108.161 168.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -172.5 179.73 2.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.39 -1.707 . . . . 10.0 106.39 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.91 173.29 16.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.385 0.274 . . . . 10.0 111.004 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.14 149.22 26.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 125.202 1.564 . . . . 10.0 109.056 165.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.28 71.1 1.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.549 1.14 . . . . 10.0 108.237 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -174.06 4.76 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.79 1.236 . . . . 10.0 109.417 -159.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -123.94 141.26 52.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.041 1.292 . . . . 10.0 109.598 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 150.18 25.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.314 -1.736 . . . . 10.0 106.314 161.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -140.42 118.11 11.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.219 0.949 . . . . 10.0 110.879 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.27 132.91 37.7 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.77 58.6 1.72 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.745 -1.205 . . . . 10.0 107.745 166.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -163.9 -46.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.267 1.027 . . . . 10.0 109.594 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . 0.318 95.4 m-20 67.01 54.91 0.73 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.474 1.91 . . . . 10.0 110.583 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -131.23 150.87 77.73 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.425 1.89 . . . . 10.0 107.803 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.16 86.27 1.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.542 2.828 . . . . 10.0 111.275 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.15 119.61 59.49 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -83.87 150.66 25.58 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.681 0.392 . . . . 10.0 110.431 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.21 143.42 50.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.847 -0.797 . . . . 10.0 108.847 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 p -151.62 56.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.08 145.67 11.57 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.299 -1.12 . . . . 10.0 110.299 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.09 69.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.49 107.41 15.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.325 -1.361 . . . . 10.0 107.325 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -125.22 146.39 53.84 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.652 0.781 . . . . 10.0 110.494 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.1 -12.27 19.43 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.85 2.367 . . . . 10.0 110.985 166.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 tp -80.97 -57.26 3.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.328 0.967 . . . . 10.0 111.507 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.96 139.68 38.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.07 0.948 . . . . 10.0 112.297 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 m -75.86 -42.03 50.65 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.384 -0.823 . . . . 10.0 110.144 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.96 81.94 50.41 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.947 0.899 . . . . 10.0 109.391 -167.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.01 86.34 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.66 2.907 . . . . 10.0 110.527 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.58 127.58 34.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.08 141.63 31.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.5 ttm -148.96 157.85 43.73 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.665 0.786 . . . . 10.0 110.063 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -155.11 102.38 2.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.561 0.696 . . . . 10.0 112.546 -157.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -150.58 53.98 0.89 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.812 -1.18 . . . . 10.0 113.13 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -116.22 100.57 8.01 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.918 1.287 . . . . 10.0 109.054 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -46.65 -44.86 18.77 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 126.167 1.787 . . . . 10.0 111.871 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 t -82.96 23.25 0.85 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.05 -67.16 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.535 1.061 . . . . 10.0 111.111 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.87 96.76 0.44 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.391 1.472 . . . . 10.0 111.765 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.88 -159.4 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.258 1.823 . . . . 10.0 114.014 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.21 39.0 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.882 0.873 . . . . 10.0 109.54 -166.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.63 105.95 0.27 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -77.47 55.42 1.27 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.306 1.042 . . . . 10.0 110.844 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.96 165.44 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.831 2.052 . . . . 10.0 109.379 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.6 ttm -81.89 69.78 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.312 1.053 . . . . 10.0 110.334 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -60.07 165.02 5.32 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.469 1.907 . . . . 10.0 111.741 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.48 -38.63 54.31 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.333 2.689 . . . . 10.0 113.579 164.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -165.8 0.04 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.987 1.315 . . . . 10.0 112.512 -161.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.2 116.18 25.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.068 1.347 . . . . 10.0 108.012 159.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.3 m -83.34 136.87 34.2 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.1 140.44 38.09 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.26 -178.19 4.44 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.354 2.036 . . . . 10.0 111.456 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.17 139.56 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 151.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 58.67 17.32 4.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.822 1.045 . . . . 10.0 113.822 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.94 97.45 0.25 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.064 -1.614 . . . . 10.0 109.064 166.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -138.72 79.35 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.876 -2.268 . . . . 10.0 104.876 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 pp -103.37 -177.0 3.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.56 -0.745 . . . . 10.0 110.494 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 99.58 6.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.817 1.647 . . . . 10.0 106.792 -165.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.88 93.7 5.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -118.97 140.09 50.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.804 2.042 . . . . 10.0 108.259 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.492 HH21 ' CG ' ' A' ' 44' ' ' ASP . 4.5 tmt_? -55.33 -21.3 14.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 -167.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -90.25 -71.62 0.61 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.487 1.515 . . . . 10.0 109.749 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.45 80.9 1.6 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.596 1.57 . . . . 10.0 111.524 -166.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 64.46 133.67 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.74 0 C-N-CA 126.0 1.72 . . . . 10.0 110.37 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -178.17 178.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.752 -1.218 . . . . 10.0 111.629 -169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.48 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 162.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.8 mtp -81.76 98.27 8.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.376 -1.712 . . . . 10.0 106.376 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.11 67.55 9.2 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.927 1.291 . . . . 10.0 108.34 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.1 mtp -84.38 157.09 21.55 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.921 0.867 . . . . 10.0 111.601 -166.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.02 60.7 3.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.554 -1.018 . . . . 10.0 110.554 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.23 129.95 44.23 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.612 0.706 . . . . 10.0 111.9 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -105.2 -59.61 1.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.472 1.509 . . . . 10.0 110.83 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -59.58 142.47 87.44 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.5 132.8 32.3 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.107 1.871 . . . . 10.0 109.526 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.4 ' H ' ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.83 161.16 29.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.108 0.563 . . . . 10.0 111.52 175.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 120.19 3.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.473 -2.047 . . . . 10.0 105.473 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.37 116.54 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.3 62.72 1.7 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.206 -1.957 . . . . 10.0 108.206 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -133.35 -172.99 3.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 159.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.9 m -152.54 123.25 7.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.388 -1.278 . . . . 10.0 107.894 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.59 126.67 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.423 1.089 . . . . 10.0 108.528 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -70.82 128.18 35.15 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 pt -114.43 148.04 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.245 1.418 . . . . 10.0 107.877 168.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -110.24 133.49 53.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.001 0.92 . . . . 10.0 109.114 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -83.65 155.58 23.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.024 -1.473 . . . . 10.0 107.024 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -155.43 86.09 1.07 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.643 -1.243 . . . . 10.0 107.643 168.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.63 25.96 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.028 -0.42 . . . . 10.0 110.059 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.8 t -54.26 -31.57 53.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.802 1.241 . . . . 10.0 112.108 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.78 -32.8 14.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.664 1.186 . . . . 10.0 112.896 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 104.19 8.66 38.23 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.082 1.325 . . . . 10.0 110.046 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 95.3 8.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.1 t -83.87 147.93 27.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.098 -0.955 . . . . 10.0 108.498 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tp -157.03 174.91 14.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -134.78 139.22 44.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.62 140.0 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.51 98.63 10.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.685 -0.858 . . . . 10.0 108.685 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.98 123.36 29.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.957 0.903 . . . . 10.0 110.36 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -83.75 137.51 33.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.41 112.27 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -148.57 107.48 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.084 0.954 . . . . 10.0 109.58 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? . . . . . 0 N--CA 1.461 0.121 0 C-N-CA 123.744 0.817 . . . . 10.0 113.012 -177.279 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 122.178 0.989 . . . . 10.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -153.11 59.47 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -162.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.53 55.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.38 138.27 37.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.238 1.015 . . . . 10.0 108.482 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.55 -136.06 4.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.798 -2.121 . . . . 10.0 107.798 163.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.91 143.68 14.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.998 0.899 . . . . 10.0 109.802 162.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.2 p -133.59 153.58 51.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.142 -1.799 . . . . 10.0 106.142 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -128.08 138.93 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 125.128 1.371 . . . . 10.0 107.372 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.07 37.76 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.128 0.788 . . . . 10.0 113.128 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 31.86 -124.99 0.05 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.337 1.855 . . . . 10.0 110.456 -161.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.61 112.13 58.84 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 105.927 -1.879 . . . . 10.0 105.927 162.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 160.48 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.977 1.785 . . . . 10.0 108.68 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.17 61.73 5.85 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.523 2.148 . . . . 10.0 110.615 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -163.42 62.22 0.17 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.427 1.091 . . . . 10.0 108.264 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt 77.07 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.52 1.528 . . . . 10.0 110.339 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 39.03 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.196 0.998 . . . . 10.0 113.509 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 158.43 16.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.305 -1.368 . . . . 10.0 107.305 161.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 t -156.62 -169.15 2.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.89 -1.522 . . . . 10.0 106.89 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.96 160.46 42.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.999 -1.111 . . . . 10.0 107.999 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.43 161.8 22.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 165.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -134.73 102.47 5.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.762 -1.57 . . . . 10.0 106.762 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -170.0 2.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.747 2.019 . . . . 10.0 109.503 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m -147.85 124.77 11.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.371 -1.456 . . . . 10.0 109.049 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.16 129.56 34.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 171.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -121.65 95.53 4.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.022 0.826 . . . . 10.0 110.302 -158.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.26 58.62 1.65 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.015 1.388 . . . . 10.0 112.454 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 174.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -179.98 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.95 1.093 . . . . 10.0 113.95 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.13 84.76 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.456 1.503 . . . . 10.0 112.164 -167.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -147.59 144.32 19.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.011 0.925 . . . . 10.0 109.729 165.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -88.14 100.62 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.813 3.009 . . . . 10.0 111.485 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.59 103.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.815 0.846 . . . . 10.0 109.299 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 96.78 8.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.029 -1.044 . . . . 10.0 110.019 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.02 124.44 29.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.386 0.674 . . . . 10.0 109.906 -175.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.69 54.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 122.265 1.031 . . . . 10.0 109.535 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.23 145.33 11.06 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.79 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.895 1.678 . . . . 10.0 107.296 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.18 149.08 29.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -169.65 151.87 4.46 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 -164.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.72 -3.55 13.36 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.736 2.291 . . . . 10.0 111.964 167.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -101.79 -40.51 6.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.512 1.125 . . . . 10.0 113.437 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.31 126.23 46.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.443 1.097 . . . . 10.0 110.046 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 m -72.81 -30.66 64.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.327 0.651 . . . . 10.0 109.783 172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 m -131.13 67.75 81.01 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 124.983 1.313 . . . . 10.0 110.105 -171.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.39 114.12 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.752 2.301 . . . . 10.0 110.527 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -141.07 141.66 34.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.886 0.474 . . . . 10.0 110.815 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.95 149.81 26.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.727 1.211 . . . . 10.0 109.781 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.69 169.32 21.89 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.474 1.51 . . . . 10.0 109.88 -171.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 t -143.8 158.77 43.45 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 121.203 -0.199 . . . . 10.0 110.884 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.42 59.55 0.63 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.435 -0.791 . . . . 10.0 109.201 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -155.56 130.91 9.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -71.34 -39.69 71.18 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -44.61 96.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.602 1.161 . . . . 10.0 111.488 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.96 -129.01 3.35 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.051 -0.82 . . . . 10.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -69.57 1.25 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.528 0.585 . . . . 10.0 113.339 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -170.01 163.83 9.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.282 1.033 . . . . 10.0 109.592 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.68 54.41 2.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.08 67.05 0.56 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.483 -0.647 . . . . 10.0 111.483 -156.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.07 64.27 5.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.067 0.937 . . . . 10.0 110.069 -171.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -136.4 168.67 19.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.008 2.123 . . . . 10.0 109.394 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 61.4 mtp -81.35 73.76 8.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.57 0.7 . . . . 10.0 109.355 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.49 159.8 83.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.513 -0.767 . . . . 10.0 110.731 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -42.92 -52.2 4.86 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.634 2.889 . . . . 10.0 112.099 163.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 173.4 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 127.195 2.198 . . . . 10.0 108.52 -175.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.5 138.92 52.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 161.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -84.99 98.56 10.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.261 -1.755 . . . . 10.0 106.261 160.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.51 121.97 80.38 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.104 -1.813 . . . . 10.0 106.104 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.15 -173.98 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.621 2.214 . . . . 10.0 111.774 -166.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.88 149.3 1.87 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 154.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.5 6.96 0.12 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.112 1.365 . . . . 10.0 114.156 -166.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.29 84.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -109.7 61.18 0.6 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.337 1.455 . . . . 10.0 107.782 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mp -86.07 154.07 21.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.683 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.0 p -114.47 110.85 20.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.45 -2.056 . . . . 10.0 105.45 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.78 109.51 16.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.291 -2.114 . . . . 10.0 105.291 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.45 170.12 22.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.212 0.915 . . . . 10.0 111.12 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.429 HH21 ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -35.55 -45.81 0.37 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.567 1.147 . . . . 10.0 112.622 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.429 ' CG ' HH21 ' A' ' 104' ' ' ARG . 7.3 m-20 -135.91 98.47 3.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.729 1.612 . . . . 10.0 106.776 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.83 116.46 1.12 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.803 1.668 . . . . 10.0 110.296 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 23.86 65.64 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.078 2.951 . . . . 10.0 114.184 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -119.14 164.8 15.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -164.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.0 121.01 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 47.9 mtp -83.19 99.47 9.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.49 -1.3 . . . . 10.0 107.49 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.17 58.74 3.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 171.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 40.8 ttp -84.57 161.8 20.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.566 1.146 . . . . 10.0 110.784 -168.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.13 -4.32 30.11 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.059 -1.411 . . . . 10.0 114.809 155.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 tp 47.41 89.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.253 1.821 . . . . 10.0 113.054 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -96.05 -40.47 9.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.443 1.097 . . . . 10.0 110.534 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.75 152.66 68.78 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 105.765 -1.939 . . . . 10.0 105.765 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -57.8 120.71 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.825 2.35 . . . . 10.0 111.725 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.16 73.65 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -74.39 104.9 5.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.859 1.264 . . . . 10.0 109.765 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 p -42.0 116.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.551 1.141 . . . . 10.0 111.425 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 116.46 -27.82 7.82 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.999 -0.89 . . . . 10.0 111.196 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -173.82 3.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.67 1.7 . . . . 10.0 110.082 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.7 m -150.35 130.26 13.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.371 -1.74 . . . . 10.0 107.749 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.03 134.11 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.383 1.073 . . . . 10.0 108.537 -170.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.76 110.87 8.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 pt -85.27 -179.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 160.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.0 m -147.08 121.53 9.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.403 -0.811 . . . . 10.0 109.147 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.3 177.52 7.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.654 0.381 . . . . 10.0 111.441 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -156.95 99.48 1.83 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.596 1.558 . . . . 10.0 107.96 171.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.82 33.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.949 -0.469 . . . . 10.0 109.89 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.2 t -82.94 61.36 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -169.54 -60.1 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 129.08 2.952 . . . . 10.0 105.482 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.42 -92.27 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.687 -1.142 . . . . 10.0 111.61 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -160.55 173.22 15.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.813 -0.816 . . . . 10.0 109.739 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 t -94.49 144.73 25.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.145 -1.798 . . . . 10.0 106.145 153.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.3 tp -156.45 143.76 19.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -87.97 132.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.955 1.702 . . . . 10.0 106.918 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.39 125.66 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.586 -1.265 . . . . 10.0 107.586 -164.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 111.37 18.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.029 -0.73 . . . . 10.0 109.029 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.08 119.17 38.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.079 0.952 . . . . 10.0 110.496 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -83.62 126.89 33.31 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.865 0.466 . . . . 10.0 110.387 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.25 110.29 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.628 -1.249 . . . . 10.0 107.628 -165.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -158.11 150.24 21.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.095 0.861 . . . . 10.0 110.86 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.344 0 CA-C-N 119.113 0.87 . . . . 10.0 112.573 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.029 0.442 . . . . 10.0 110.833 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 p -156.48 53.34 0.54 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.315 0.646 . . . . 10.0 110.181 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.74 80.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 165.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.42 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -123.91 133.08 53.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 128.252 2.621 . . . . 10.0 108.407 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.06 97.09 1.29 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.27 -1.532 . . . . 10.0 109.27 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.12 9.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.705 0.753 . . . . 10.0 111.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.3 p -115.96 149.61 38.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.737 -1.208 . . . . 10.0 107.737 163.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.96 142.16 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.46 16.97 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.832 0.825 . . . . 10.0 111.044 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.792 1.637 . . . . 10.0 110.811 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 t 45.45 74.66 0.76 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.741 1.616 . . . . 10.0 111.144 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.26 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.296 2.664 . . . . 10.0 110.044 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.16 77.68 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.801 3.001 . . . . 10.0 112.473 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 t -157.11 -49.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.374 3.07 . . . . 10.0 106.008 165.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 67.56 162.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 C-N-CA 125.615 1.566 . . . . 10.0 107.438 -161.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 72.79 -50.18 0.7 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.428 1.491 . . . . 10.0 111.89 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.23 155.64 16.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.008 1.723 . . . . 10.0 109.69 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -164.41 -176.73 4.52 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 10.0 108.045 162.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 153.91 34.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.487 1.115 . . . . 10.0 110.73 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.59 150.03 22.58 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.073 0.858 . . . . 10.0 110.442 170.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -125.0 123.75 40.53 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -160.66 -172.41 3.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.228 1.411 . . . . 10.0 107.701 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 m -144.86 122.59 11.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.444 -0.785 . . . . 10.0 109.598 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.42 102.77 10.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.332 -1.729 . . . . 10.0 106.332 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 m -92.56 94.16 8.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.651 -1.613 . . . . 10.0 106.653 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.86 56.03 3.27 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.79 -0.569 . . . . 10.0 110.434 -167.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -91.76 111.09 22.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.34 0.59 . . . . 10.0 109.5 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 133.27 -19.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 131.564 3.946 . . . . 10.0 106.942 -165.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.78 61.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.638 -1.245 . . . . 10.0 107.638 150.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -145.04 137.45 13.4 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.319 1.848 . . . . 10.0 110.633 -170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.69 92.83 0.94 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 10.0 112.212 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.77 112.11 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.957 0.903 . . . . 10.0 108.924 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 168.64 17.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.675 0.79 . . . . 10.0 110.48 174.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.93 127.78 35.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.41 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.522 0.677 . . . . 10.0 109.755 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.4 147.25 13.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.191 -1.164 . . . . 10.0 110.191 163.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.22 66.95 0.51 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.019 1.327 . . . . 10.0 109.665 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.48 145.04 28.34 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.706 -0.849 . . . . 10.0 108.706 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 t -170.35 151.58 3.8 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 118.943 0.792 . . . . 10.0 110.47 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.86 45.79 0.96 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.992 2.461 . . . . 10.0 111.323 166.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.16 -77.28 0.47 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.929 1.291 . . . . 10.0 108.609 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.92 143.53 55.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.032 0.533 . . . . 10.0 110.948 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 m -96.72 -29.22 13.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.609 0.763 . . . . 10.0 109.64 165.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.0 t -126.03 67.41 61.86 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.074 1.75 . . . . 10.0 109.092 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.73 106.1 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.679 2.253 . . . . 10.0 109.777 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 128.56 53.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.222 1.009 . . . . 10.0 109.478 -174.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.73 136.8 35.44 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.229 -1.026 . . . . 10.0 108.229 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 ttp -136.07 152.44 50.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.055 1.342 . . . . 10.0 108.812 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -148.19 110.24 4.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.413 0.685 . . . . 10.0 110.058 -166.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -141.41 55.95 1.53 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.447 -0.783 . . . . 10.0 111.828 175.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -137.2 110.57 7.92 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.039 1.336 . . . . 10.0 109.093 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -52.27 -42.65 63.87 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.461 1.104 . . . . 10.0 111.195 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.3 p -82.45 16.53 2.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.901 1.28 . . . . 10.0 112.334 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.95 -142.99 5.2 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.396 1.474 . . . . 10.0 110.1 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.01 -68.63 1.58 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 117.169 0.484 . . . . 10.0 112.266 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -144.67 169.9 17.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.568 1.547 . . . . 10.0 108.24 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -117.71 54.5 0.9 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.93 75.01 0.22 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 118.742 -1.032 . . . . 10.0 111.591 -166.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 ttp -49.36 98.36 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 122.324 1.059 . . . . 10.0 111.717 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -155.76 166.53 33.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.274 2.229 . . . . 10.0 105.955 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.8 mtm -80.82 132.62 35.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.031 -1.47 . . . . 10.0 107.031 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -134.64 168.22 18.91 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.733 . . . . 10.0 110.668 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -37.74 -56.4 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.63 2.887 . . . . 10.0 111.464 159.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 178.47 -159.27 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.47 1.508 . . . . 10.0 110.258 -175.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 142.78 51.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 126.386 1.874 . . . . 10.0 106.362 161.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m -110.47 134.87 51.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.005 -1.85 . . . . 10.0 106.005 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 pp -121.83 138.94 29.31 Favored Pre-proline 0 N--CA 1.452 -0.35 0 N-CA-C 106.679 -1.601 . . . . 10.0 106.679 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.87 176.48 8.94 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.862 1.708 . . . . 10.0 110.699 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.6 129.74 8.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.88 -1.054 . . . . 10.0 109.63 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 59.15 26.27 14.97 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 129.674 3.19 . . . . 10.0 113.342 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.69 144.71 45.96 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.965 -0.854 . . . . 10.0 110.965 167.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -129.21 65.42 1.46 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.572 -2.01 . . . . 10.0 105.572 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.25 129.25 34.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.943 -2.243 . . . . 10.0 104.943 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.8 m -123.45 93.45 3.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.013 -2.217 . . . . 10.0 105.013 -158.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.82 122.45 26.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 -162.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -151.86 154.33 35.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.956 1.303 . . . . 10.0 108.47 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -8.53 6.91 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.507 1.299 . . . . 10.0 114.507 -164.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 37.67 1.48 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.812 0.733 . . . . 10.0 110.979 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.45 64.97 0.22 Allowed Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.37 -1.092 . . . . 10.0 110.37 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 t0 70.01 133.78 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.199 1.799 . . . . 10.0 109.748 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -177.19 169.82 2.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.574 -0.704 . . . . 10.0 110.728 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.95 115.64 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.527 -2.027 . . . . 10.0 105.527 169.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 81.5 mtp -83.84 95.92 8.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.88 65.39 6.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 10.0 107.891 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 75.8 mtp -82.6 162.53 21.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.847 0.832 . . . . 10.0 110.782 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.99 69.66 1.38 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.429 -1.068 . . . . 10.0 110.429 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.33 82.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.672 0.789 . . . . 10.0 109.611 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -55.92 -47.25 77.85 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.892 -0.505 . . . . 10.0 112.084 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -114.05 155.5 45.34 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.937 -1.135 . . . . 10.0 107.937 157.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.56 173.83 12.65 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.447 2.765 . . . . 10.0 110.034 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.38 175.37 8.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.144 1.378 . . . . 10.0 110.113 -174.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.31 150.3 49.65 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.36 1.464 . . . . 10.0 107.953 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.8 t -69.79 134.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.46 42.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.074 -0.81 . . . . 10.0 111.074 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.64 -169.37 1.7 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.84 1.305 . . . . 10.0 108.813 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 m -154.74 82.78 1.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.027 -1.472 . . . . 10.0 107.027 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -89.83 126.49 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.883 -1.154 . . . . 10.0 107.883 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.31 150.88 45.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.102 -0.639 . . . . 10.0 110.372 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.98 148.61 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.379 -1.712 . . . . 10.0 106.379 170.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -123.15 117.59 25.72 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.79 157.04 18.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.481 -0.563 . . . . 10.0 109.481 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -157.38 86.23 0.94 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.578 1.551 . . . . 10.0 107.895 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.74 157.61 23.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.096 -0.377 . . . . 10.0 110.046 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 t -54.36 -32.77 57.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.523 1.129 . . . . 10.0 112.504 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -5.74 4.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.918 0.887 . . . . 10.0 113.063 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.21 9.67 65.07 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.404 1.002 . . . . 10.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -79.34 95.1 5.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 105.916 -1.883 . . . . 10.0 105.916 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -116.37 123.97 48.91 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.076 1.751 . . . . 10.0 107.141 -171.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.4 tp -155.55 141.59 18.28 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -102.52 132.98 48.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.477 1.911 . . . . 10.0 106.742 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.87 162.14 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.05 131.86 54.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.868 1.267 . . . . 10.0 107.604 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.77 133.81 55.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.643 1.177 . . . . 10.0 109.892 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -83.89 128.33 34.47 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.87 108.1 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.324 -1.362 . . . . 10.0 107.324 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -157.58 125.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.582 -0.895 . . . . 10.0 108.582 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 pttt . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.37 0.605 . . . . 10.0 111.357 176.298 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.785 0.803 . . . . 10.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -157.85 55.17 0.48 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 -165.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.57 58.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.11 0.957 . . . . 10.0 108.981 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 -179.91 4.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.112 1.365 . . . . 10.0 110.396 171.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.0 -136.92 3.51 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.056 -2.418 . . . . 10.0 107.056 166.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.98 132.4 6.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.981 1.39 . . . . 10.0 110.683 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.7 p -126.76 135.2 50.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.288 -1.745 . . . . 10.0 106.288 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.7 t -121.71 135.29 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 119.158 0.89 . . . . 10.0 109.061 -171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.83 44.62 0.56 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.631 0.974 . . . . 10.0 113.631 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 26.77 -119.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.643 1.977 . . . . 10.0 111.546 -164.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.69 113.94 50.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.093 -1.817 . . . . 10.0 106.093 161.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.97 163.99 20.65 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.17 1.913 . . . . 10.0 108.774 168.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.92 62.41 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.449 2.1 . . . . 10.0 110.523 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.5 p -163.4 62.31 0.17 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.209 1.004 . . . . 10.0 108.628 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 mt 75.15 160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.932 1.293 . . . . 10.0 110.222 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -66.76 25.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.741 1.386 . . . . 10.0 114.741 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.95 158.44 15.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 168.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -165.39 -175.54 3.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.728 -1.953 . . . . 10.0 105.728 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.56 168.98 24.93 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.319 -0.622 . . . . 10.0 109.319 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.47 161.09 22.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -131.4 104.7 7.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.632 -1.988 . . . . 10.0 105.632 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -171.16 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.139 1.775 . . . . 10.0 110.443 -169.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -152.29 129.57 11.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.718 -1.238 . . . . 10.0 108.029 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.11 135.44 33.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 m -123.96 104.27 8.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 124.168 0.918 . . . . 10.0 110.581 -167.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.18 113.18 15.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.706 -0.479 . . . . 10.0 109.706 167.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -135.36 68.44 1.46 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.668 -1.604 . . . . 10.0 106.668 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -178.5 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.388 1.475 . . . . 10.0 111.473 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' HE ' ' A' ' 97' ' ' ARG . 84.0 m-20 72.72 78.13 0.15 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.551 1.94 . . . . 10.0 112.17 -171.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -143.16 147.0 38.97 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.331 0.652 . . . . 10.0 109.817 168.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.29 112.23 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.759 2.973 . . . . 10.0 111.001 173.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.92 99.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.71 103.94 12.59 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.109 -0.994 . . . . 10.0 111.139 -173.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -82.68 124.95 30.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.697 0.799 . . . . 10.0 110.201 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.66 54.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.117 0.961 . . . . 10.0 109.626 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.65 144.49 10.0 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -1.323 . . . . 10.0 109.792 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.45 66.73 0.56 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.972 1.709 . . . . 10.0 107.205 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 148.71 28.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 t -170.3 151.78 3.9 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 109.879 -0.415 . . . . 10.0 109.879 -164.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.28 -1.41 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.802 2.335 . . . . 10.0 112.021 167.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -104.82 -35.91 7.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.471 1.108 . . . . 10.0 113.415 -163.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.43 124.29 48.97 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.558 1.143 . . . . 10.0 109.844 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -29.79 65.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.795 0.838 . . . . 10.0 110.108 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.7 m -135.36 68.43 68.14 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.024 1.33 . . . . 10.0 109.959 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.1 115.76 4.22 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.616 2.21 . . . . 10.0 110.365 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -139.34 140.4 37.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.821 0.448 . . . . 10.0 111.203 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mt -83.57 145.83 28.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 10.0 109.8 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.65 169.37 18.12 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 125.596 1.558 . . . . 10.0 109.817 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 t -145.71 157.44 43.95 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.318 -0.238 . . . . 10.0 110.677 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.54 61.14 0.61 Allowed 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.342 -0.849 . . . . 10.0 109.25 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -155.15 138.63 15.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -80.55 -39.21 28.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.38 -44.99 95.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.798 1.239 . . . . 10.0 111.514 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.94 -126.7 3.49 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.065 -0.814 . . . . 10.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.4 -75.3 0.33 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.828 0.727 . . . . 10.0 113.923 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -163.73 160.98 23.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.774 0.83 . . . . 10.0 109.972 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.97 53.81 2.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.621 -1.251 . . . . 10.0 107.621 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.67 71.2 0.5 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.324 -0.709 . . . . 10.0 111.962 -156.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.51 64.32 4.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.182 0.991 . . . . 10.0 110.24 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -136.11 170.26 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.971 2.108 . . . . 10.0 109.275 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.86 72.79 7.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.52 0.728 . . . . 10.0 109.155 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.1 158.8 86.52 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.341 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -44.49 -53.41 4.96 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.373 2.715 . . . . 10.0 111.995 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 174.3 -157.62 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.021 2.129 . . . . 10.0 108.931 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.76 139.9 51.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.646 -1.613 . . . . 10.0 106.646 165.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.1 m -88.4 100.13 12.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.444 -1.687 . . . . 10.0 106.444 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.31 123.11 79.49 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 106.095 -1.817 . . . . 10.0 106.095 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.17 -172.24 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.566 2.177 . . . . 10.0 111.771 -168.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.83 149.23 3.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 155.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.415 ' HE ' ' CG ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER 52.21 7.61 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.809 1.411 . . . . 10.0 114.809 -165.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 90.74 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.885 -1.286 . . . . 10.0 109.885 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -115.93 64.78 0.7 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.134 1.774 . . . . 10.0 107.326 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -88.73 154.68 20.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.648 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -118.5 109.76 16.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 -167.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -83.62 102.99 12.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -152.07 170.62 19.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.816 0.735 . . . . 10.0 111.295 -170.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -36.55 -47.38 0.63 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.772 1.229 . . . . 10.0 111.712 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 104' ' ' ARG . 6.2 m-20 -129.93 95.05 3.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.776 1.63 . . . . 10.0 107.75 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.7 117.68 1.1 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.7 -1.056 . . . . 10.0 111.264 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.2 t0 24.86 64.79 0.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.565 2.746 . . . . 10.0 113.533 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -116.59 159.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.269 0.557 . . . . 10.0 112.419 -165.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.77 114.53 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.769 -1.937 . . . . 10.0 105.769 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 mtp -81.98 96.92 7.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.802 -1.184 . . . . 10.0 107.802 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.0 mt -81.0 59.41 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 46.5 ttp -82.99 158.4 22.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.387 0.675 . . . . 10.0 110.474 -169.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.16 -7.93 9.15 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.097 -1.39 . . . . 10.0 115.207 156.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.7 tp 46.63 68.54 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.243 1.417 . . . . 10.0 111.777 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -77.92 -37.71 47.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.432 0.693 . . . . 10.0 110.695 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.73 153.02 67.4 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 105.747 -1.946 . . . . 10.0 105.747 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.21 109.97 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.885 2.39 . . . . 10.0 111.415 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.04 99.81 1.14 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -97.8 115.78 28.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.228 1.411 . . . . 10.0 108.673 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -46.97 120.0 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.238 0.615 . . . . 10.0 110.067 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.88 -23.71 18.64 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.704 -1.053 . . . . 10.0 111.766 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -175.02 3.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.723 1.725 . . . . 10.0 109.55 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -153.9 131.74 11.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.284 -1.78 . . . . 10.0 107.493 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.7 136.84 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.404 1.082 . . . . 10.0 108.676 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.9 114.15 15.36 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.2 pt -92.88 176.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.747 0.819 . . . . 10.0 109.068 164.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.2 m -147.75 125.41 11.81 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.596 -0.69 . . . . 10.0 109.609 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 pp -91.77 179.18 5.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.22 0.608 . . . . 10.0 111.92 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -157.74 103.46 1.9 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.826 1.65 . . . . 10.0 108.068 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.18 123.35 33.93 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.006 -0.434 . . . . 10.0 110.488 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -83.0 64.0 7.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -174.86 -61.2 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.916 2.887 . . . . 10.0 105.47 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.75 -96.81 0.6 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.629 -1.169 . . . . 10.0 111.567 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -160.47 175.86 12.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.857 -0.79 . . . . 10.0 109.619 -171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.6 t -90.42 150.36 21.87 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.868 1.667 . . . . 10.0 107.007 156.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.9 tp -155.16 142.89 19.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.801 -1.925 . . . . 10.0 105.801 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.89 132.18 37.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.198 1.799 . . . . 10.0 106.667 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.48 128.36 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.686 -1.227 . . . . 10.0 107.686 -166.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.65 108.03 16.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.26 118.89 31.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.005 0.922 . . . . 10.0 109.838 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.4 m -83.95 132.41 34.77 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.42 111.34 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -157.67 116.98 3.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.577 0.626 . . . . 10.0 111.283 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 pttm . . . . . 0 C--O 1.225 -0.217 0 O-C-N 121.731 -0.605 . . . . 10.0 111.088 173.98 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -160.45 54.06 0.32 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.124 0.964 . . . . 10.0 109.974 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.75 64.74 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 120.984 -1.073 . . . . 10.0 110.774 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -155.35 149.9 26.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.131 0.572 . . . . 10.0 109.731 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.61 145.42 17.83 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.001 -1.64 . . . . 10.0 109.001 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.45 161.0 22.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.264 1.032 . . . . 10.0 111.302 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -123.41 139.97 53.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.907 -1.516 . . . . 10.0 106.907 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.92 136.71 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 107.358 -1.349 . . . . 10.0 107.358 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.45 41.46 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 34.94 -137.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.956 2.102 . . . . 10.0 112.083 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.75 108.75 47.59 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 160.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.31 166.6 29.13 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 N-CA-C 107.528 -1.758 . . . . 10.0 107.528 166.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.36 64.78 3.62 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.048 2.499 . . . . 10.0 111.032 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.3 t -164.55 56.51 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.842 1.257 . . . . 10.0 108.985 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt 71.56 170.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.589 1.156 . . . . 10.0 109.005 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -44.92 -41.35 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.064 -1.023 . . . . 10.0 112.747 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -51.43 141.35 15.73 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 127.072 2.149 . . . . 10.0 111.983 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -162.03 -172.45 3.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.652 -165.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.34 159.09 44.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.792 0.837 . . . . 10.0 111.555 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.09 144.07 26.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.94 1.296 . . . . 10.0 109.238 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -128.53 119.22 24.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.569 -2.752 . . . . 10.0 103.569 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 ptp -161.04 -173.9 4.11 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.367 1.067 . . . . 10.0 108.522 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -131.39 135.85 47.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.216 1.407 . . . . 10.0 108.111 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.88 120.97 37.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 103.952 -2.611 . . . . 10.0 103.952 160.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -110.55 79.74 1.24 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.424 -1.324 . . . . 10.0 107.424 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -81.33 92.9 6.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.317 0.58 . . . . 10.0 110.433 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -83.31 57.11 3.82 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.798 -0.564 . . . . 10.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 t -171.1 157.96 5.37 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.936 0.895 . . . . 10.0 109.182 166.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.78 61.96 6.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -134.91 117.46 12.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.783 0.833 . . . . 10.0 111.04 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 122.82 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.094 2.529 . . . . 10.0 110.337 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.61 106.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.499 0.72 . . . . 10.0 109.08 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 121.46 32.61 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.204 -0.935 . . . . 10.0 111.563 -171.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.288 0.0 OUTLIER -102.59 128.06 49.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.047 -0.408 . . . . 10.0 110.22 -171.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.59 57.21 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.536 1.16 . . . . 10.0 109.079 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.78 153.23 24.22 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.939 -1.665 . . . . 10.0 108.939 166.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.94 62.19 0.46 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 168.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.92 138.87 32.24 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -168.82 151.32 4.94 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 118.602 0.637 . . . . 10.0 109.693 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.94 56.37 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.77 2.313 . . . . 10.0 109.656 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.7 mt -136.55 -82.33 0.38 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.97 1.708 . . . . 10.0 107.982 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.74 136.86 45.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.043 0.937 . . . . 10.0 111.681 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.8 m -81.48 -31.43 32.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.251 0.62 . . . . 10.0 109.433 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.2 t -119.82 72.2 16.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.503 1.121 . . . . 10.0 111.448 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.84 97.22 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.916 2.411 . . . . 10.0 111.153 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.7 mmt -105.23 128.72 53.56 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.378 1.071 . . . . 10.0 110.063 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 145.28 28.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.926 0.89 . . . . 10.0 110.105 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.05 163.85 31.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.888 1.275 . . . . 10.0 111.507 172.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.413 ' CG2' ' H ' ' A' ' 83' ' ' MET 0.25 26.1 m -102.0 164.23 11.82 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.485 3.114 . . . . 10.0 110.805 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.8 t -95.93 173.98 7.17 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.367 1.067 . . . . 10.0 112.837 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -99.26 55.82 1.0 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.003 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.9 p80 171.87 -170.33 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.698 2.399 . . . . 10.0 107.69 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 m -46.84 171.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.881 2.872 . . . . 10.0 114.654 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.92 -65.72 2.2 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.908 -2.077 . . . . 10.0 107.908 -169.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.62 -146.61 2.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.474 -1.05 . . . . 10.0 110.474 155.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.413 ' H ' ' CG2' ' A' ' 76' ' ' THR . 65.8 mtt -114.1 -82.47 0.6 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.865 1.266 . . . . 10.0 109.922 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.02 51.81 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.841 1.256 . . . . 10.0 109.385 -172.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.18 147.48 4.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.051 -0.595 . . . . 10.0 113.905 166.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -78.3 43.6 0.46 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.126 1.77 . . . . 10.0 112.047 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -83.04 157.77 22.75 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.572 0.749 . . . . 10.0 109.872 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.3 ttp -81.49 70.38 8.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.417 1.103 . . . . 10.0 109.36 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -58.09 162.02 6.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.876 1.671 . . . . 10.0 111.718 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 50.3 Cg_exo -47.57 -37.65 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.553 2.836 . . . . 10.0 113.341 163.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.423 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.91 -158.56 0.01 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.978 1.311 . . . . 10.0 111.049 -161.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.55 115.04 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.937 0.495 . . . . 10.0 110.05 164.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -84.46 103.14 13.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 159.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.28 120.16 76.45 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 105.998 -1.852 . . . . 10.0 105.998 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -85.89 137.16 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 109.283 -1.083 . . . . 10.0 109.283 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 50.73 -137.25 1.16 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.302 0.641 . . . . 10.0 110.911 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.89 59.39 0.1 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.291 2.237 . . . . 10.0 112.316 176.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 87.1 0.12 Allowed Glycine 0 N--CA 1.441 -0.974 0 O-C-N 121.583 -0.698 . . . . 10.0 111.372 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.1 m -86.4 67.67 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.63 1.572 . . . . 10.0 107.602 163.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -102.82 175.48 5.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.833 -0.802 . . . . 10.0 108.833 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -155.85 129.88 8.67 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.675 0.75 . . . . 10.0 110.437 -169.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.92 126.14 32.71 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.52 1.528 . . . . 10.0 108.574 -168.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.29 154.58 42.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.548 1.939 . . . . 10.0 109.123 -170.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -27.81 59.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.073 0.949 . . . . 10.0 112.855 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -78.55 -59.99 2.56 Favored 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 121.473 -0.767 . . . . 10.0 111.406 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.88 136.87 5.55 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.833 -1.307 . . . . 10.0 109.833 -167.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t0 70.06 120.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 129.063 2.945 . . . . 10.0 106.761 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 177.42 171.17 0.58 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.549 1.522 . . . . 10.0 111.759 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.36 124.4 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 105.066 -2.198 . . . . 10.0 105.066 156.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.4 mtm -82.32 96.69 7.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 161.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.52 69.18 5.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.911 -1.514 . . . . 10.0 106.911 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 66.4 mtp -85.37 166.95 15.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.967 0.889 . . . . 10.0 112.961 -169.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.96 57.8 17.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.081 -1.208 . . . . 10.0 110.081 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.36 123.38 17.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.075 0.938 . . . . 10.0 109.098 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.82 -61.91 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.595 0.358 . . . . 10.0 111.423 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -70.75 157.18 90.78 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.076 0.55 . . . . 10.0 111.354 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.98 139.62 39.89 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.577 2.184 . . . . 10.0 110.288 169.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -88.05 179.43 6.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.005 1.322 . . . . 10.0 111.592 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 100.64 0.93 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.64 117.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.208 -1.034 . . . . 10.0 108.208 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.15 -13.28 31.35 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.194 -0.781 . . . . 10.0 111.995 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -77.78 -169.85 1.66 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.493 1.615 . . . . 10.0 108.303 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.8 m -155.3 137.27 14.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.3 154.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.22 -1.4 . . . . 10.0 107.22 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -80.52 145.67 31.71 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.9 tt -108.71 146.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.7 m -117.57 111.82 19.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.871 -1.899 . . . . 10.0 105.871 172.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 145.71 24.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 125.935 1.694 . . . . 10.0 107.258 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -144.27 97.58 3.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.45 142.28 32.05 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.3 t -62.14 -29.05 70.07 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.695 -1.253 . . . . 10.0 111.082 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.664 -0.647 . . . . 10.0 110.595 171.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.81 91.16 0.13 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.177 1.37 . . . . 10.0 110.602 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 53.61 1.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.521 0.728 . . . . 10.0 110.643 -174.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.5 m -157.8 87.8 0.95 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.934 0.494 . . . . 10.0 110.896 -170.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mt -153.94 156.06 36.79 Favored 'General case' 0 C--O 1.23 0.036 0 CA-C-N 119.085 0.857 . . . . 10.0 109.109 167.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.32 136.28 19.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.4 163.63 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.55 137.66 32.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.387 0.675 . . . . 10.0 110.359 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.34 114.34 24.18 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.205 1.802 . . . . 10.0 109.318 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -83.01 125.3 31.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.297 1.439 . . . . 10.0 108.203 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.84 97.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 O-C-N 120.513 -1.367 . . . . 10.0 108.305 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -147.44 103.03 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.315 0.646 . . . . 10.0 110.917 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 pttp . . . . . 0 CA--C 1.536 0.437 0 O-C-N 121.952 -0.468 . . . . 10.0 110.3 161.035 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 122.123 0.963 . . . . 10.0 110.554 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -155.08 58.02 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.237 1.015 . . . . 10.0 108.777 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.56 85.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -145.52 158.67 43.81 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.107 1.763 . . . . 10.0 107.586 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.62 -163.08 32.74 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.437 -1.865 . . . . 10.0 108.437 161.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.55 149.51 23.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.994 0.897 . . . . 10.0 109.96 169.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.6 p -133.76 153.99 51.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 170.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.4 133.55 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 123.514 0.726 . . . . 10.0 109.928 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.17 110.45 7.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.82 34.65 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.464 -0.772 . . . . 10.0 109.112 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -19.35 99.31 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 127.523 2.329 . . . . 10.0 113.558 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 163.01 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.688 2.926 . . . . 10.0 109.683 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.09 52.58 3.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.22 1.947 . . . . 10.0 110.164 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -157.68 56.0 0.49 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.182 -1.044 . . . . 10.0 108.182 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt 70.08 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.333 1.053 . . . . 10.0 109.008 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.457 HH11 ' CG ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -50.6 -42.71 56.25 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' CG ' HH11 ' A' ' 43' ' ' ARG . 63.4 m-20 -59.09 127.32 31.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.706 0.765 . . . . 10.0 109.929 -163.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -145.68 -165.84 2.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.315 -1.311 . . . . 10.0 111.21 -164.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.86 157.94 41.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.611 1.164 . . . . 10.0 112.107 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.42 158.95 20.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.492 -0.777 . . . . 10.0 110.022 165.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.3 128.14 48.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 163.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -157.64 177.8 10.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 p -98.19 168.81 10.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.39 146.4 46.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.364 -1.717 . . . . 10.0 106.364 163.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.6 m -140.79 111.66 7.04 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.975 0.797 . . . . 10.0 112.302 -166.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 119.69 24.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.314 0.506 . . . . 10.0 109.652 167.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 80.74 1.63 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.971 -1.122 . . . . 10.0 107.971 157.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m 164.53 -19.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 129.184 2.994 . . . . 10.0 109.557 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 74.13 53.24 0.1 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.495 0.589 . . . . 10.0 110.407 140.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -145.98 157.71 49.96 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 125.004 1.322 . . . . 10.0 109.129 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.31 70.59 7.14 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.543 2.829 . . . . 10.0 111.301 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mm -85.89 152.01 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.44 0.638 . . . . 10.0 109.653 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -139.26 81.83 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.592 2.357 . . . . 10.0 108.791 -162.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.01 63.4 7.07 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.155 0.982 . . . . 10.0 111.961 -166.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.39 60.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.481 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 149.2 18.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.365 -1.398 . . . . 10.0 113.304 163.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.28 59.89 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.505 1.522 . . . . 10.0 108.891 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.29 132.88 35.3 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.726 -0.609 . . . . 10.0 109.604 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 t -161.69 150.09 12.64 Favored Pre-proline 0 C--O 1.24 0.568 0 O-C-N 121.464 -0.772 . . . . 10.0 111.198 -168.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.57 42.84 1.23 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.895 2.396 . . . . 10.0 111.115 170.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.07 -68.34 0.83 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.058 1.343 . . . . 10.0 109.169 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.23 138.74 31.18 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.777 1.231 . . . . 10.0 110.517 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -78.77 -34.71 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 165.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t -121.65 73.65 32.66 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 124.939 1.296 . . . . 10.0 110.034 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.74 114.27 3.99 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.455 2.104 . . . . 10.0 109.728 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.6 mtp -129.3 133.63 47.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.925 0.89 . . . . 10.0 110.129 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -84.37 149.74 25.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.647 1.179 . . . . 10.0 111.156 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -174.47 3.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.98 1.312 . . . . 10.0 113.126 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -159.68 134.32 7.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.937 1.295 . . . . 10.0 108.55 -172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 t -92.0 -174.05 3.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.466 1.127 . . . . 10.0 112.246 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.7 m -80.04 72.29 6.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.791 -1.55 . . . . 10.0 107.581 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 m80 75.06 165.07 0.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.609 1.964 . . . . 10.0 111.4 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m 67.93 -67.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.989 1.716 . . . . 10.0 111.608 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.16 87.26 0.99 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.31 -2.316 . . . . 10.0 107.31 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.55 -160.7 54.15 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 112.156 -0.378 . . . . 10.0 112.156 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.2 mtt -69.65 -73.78 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.466 1.284 . . . . 10.0 114.466 -166.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.06 66.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.477 0.711 . . . . 10.0 109.341 -159.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.59 170.1 32.89 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.925 0.774 . . . . 10.0 114.309 164.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.9 56.49 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.585 2.354 . . . . 10.0 113.372 -157.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -97.2 155.57 16.79 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.374 1.87 . . . . 10.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.4 mtm -79.25 76.34 5.79 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.349 -1.723 . . . . 10.0 106.349 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.34 153.08 77.45 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.099 -1.41 . . . . 10.0 109.631 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -36.88 -52.33 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.743 2.962 . . . . 10.0 112.748 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -179.41 175.69 0.89 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.286 2.634 . . . . 10.0 104.778 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.09 100.84 12.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 m -76.49 136.7 39.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 pt -106.54 98.65 21.0 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.66 52.85 4.51 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.919 3.079 . . . . 10.0 111.903 -160.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.62 144.23 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.6 1.19 . . . . 10.0 110.578 -157.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 61.06 3.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.508 1.923 . . . . 10.0 113.706 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.5 110.21 3.14 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.998 -1.641 . . . . 10.0 108.998 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.2 m -149.93 76.55 1.29 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 -165.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.08 -158.55 0.69 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.652 -166.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.5 m -151.83 118.63 5.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.877 -1.527 . . . . 10.0 106.877 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.34 120.79 26.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.46 155.0 32.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.112 1.365 . . . . 10.0 108.285 -159.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -80.49 51.04 1.38 Allowed 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.622 -0.673 . . . . 10.0 111.264 -173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.63 -71.02 0.73 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.083 1.753 . . . . 10.0 107.187 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -55.75 0.04 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.287 -1.125 . . . . 10.0 110.287 -166.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -99.59 129.21 45.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 125.177 1.391 . . . . 10.0 107.335 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 178.0 179.22 0.32 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.11 122.33 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.104 -2.554 . . . . 10.0 104.104 158.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.7 mtp -82.27 102.5 11.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.951 -1.5 . . . . 10.0 106.951 164.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.5 77.54 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 10.0 106.882 171.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.73 165.69 13.54 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.681 0.753 . . . . 10.0 111.571 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.57 69.95 1.22 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.1 tp -46.62 134.68 9.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.541 1.136 . . . . 10.0 110.391 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -119.51 -60.32 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.229 0.612 . . . . 10.0 111.553 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -93.91 143.48 26.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.574 0.75 . . . . 10.0 109.085 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.43 159.98 51.08 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.222 2.615 . . . . 10.0 111.349 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.71 156.94 36.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.368 1.467 . . . . 10.0 110.61 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 144.98 48.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.772 1.229 . . . . 10.0 108.869 170.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.15 69.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 10.0 108.744 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.18 -15.88 0.59 Allowed Glycine 0 CA--C 1.524 0.646 0 O-C-N 120.536 -1.352 . . . . 10.0 112.648 -159.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -177.42 0.56 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.958 1.837 . . . . 10.0 108.913 171.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.1 m -155.08 128.74 8.57 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.062 -1.881 . . . . 10.0 106.186 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.31 146.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -75.93 132.9 40.55 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.51 126.68 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 164.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.9 103.02 13.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.29 119.59 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -130.2 82.45 2.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.321 1.449 . . . . 10.0 107.256 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.79 154.4 24.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.024 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -60.89 -14.49 22.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.588 0.355 . . . . 10.0 111.526 168.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -9.59 20.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.692 1.197 . . . . 10.0 111.865 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.99 56.62 1.92 Allowed Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.503 1.049 . . . . 10.0 111.305 164.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -138.55 176.89 8.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.067 0.547 . . . . 10.0 110.147 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 m -155.49 88.69 1.15 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.716 -1.957 . . . . 10.0 105.716 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.0 172.14 10.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.5 93.16 2.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.603 -1.999 . . . . 10.0 105.603 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.1 t -102.02 137.74 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.56 115.46 22.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.52 123.23 46.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.864 0.866 . . . . 10.0 110.092 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 m -82.82 126.17 32.13 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.931 0.493 . . . . 10.0 109.819 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -84.26 104.8 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 O-C-N 120.688 -1.257 . . . . 10.0 107.929 -174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -141.64 106.87 4.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.738 1.615 . . . . 10.0 109.521 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 tttt . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 128.145 2.578 . . . . 10.0 111.736 175.133 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 107.661 -1.237 . . . . 10.0 107.661 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.1 t -158.22 93.91 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.709 -1.219 . . . . 10.0 107.709 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.31 57.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.434 1.112 . . . . 10.0 108.413 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.54 145.28 40.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.028 -1.471 . . . . 10.0 107.028 164.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.89 132.1 23.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.834 -1.706 . . . . 10.0 108.834 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.74 149.21 41.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.84 0.82 . . . . 10.0 109.791 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -136.93 148.28 46.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.8 t -130.9 139.21 51.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.01 45.64 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.06 -112.04 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.816 1.246 . . . . 10.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.47 140.9 29.88 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 140.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.59 155.7 46.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.451 1.434 . . . . 10.0 108.63 162.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.7 61.36 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.354 2.036 . . . . 10.0 109.641 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -162.22 70.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.956 -1.498 . . . . 10.0 106.956 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt 87.94 154.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.546 2.338 . . . . 10.0 110.009 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -83.82 22.56 1.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.469 1.108 . . . . 10.0 113.121 -168.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.87 -179.88 4.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.068 1.747 . . . . 10.0 109.198 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.1 t -160.71 -177.65 6.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -0.919 . . . . 10.0 108.518 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.09 154.59 39.47 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.626 -0.715 . . . . 10.0 109.22 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.87 147.76 26.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.058 0.849 . . . . 10.0 109.229 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -124.44 102.02 7.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.42 -176.71 5.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.945 0.898 . . . . 10.0 109.187 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -131.81 131.92 43.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.724 0.81 . . . . 10.0 110.257 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.94 109.2 17.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.5 m -108.18 111.26 23.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.179 1.791 . . . . 10.0 108.378 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.96 136.13 36.56 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 112.368 0.507 . . . . 10.0 112.368 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -144.94 58.76 1.3 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 161.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -160.18 -25.22 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 65.78 51.31 1.43 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.194 0.998 . . . . 10.0 111.992 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -143.3 158.59 57.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.66 1.184 . . . . 10.0 109.102 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.81 82.7 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.271 2.647 . . . . 10.0 110.015 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mm -96.83 146.81 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.305 -0.861 . . . . 10.0 108.989 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 87.71 1.6 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.322 1.058 . . . . 10.0 111.145 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.26 73.64 9.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.811 1.644 . . . . 10.0 112.498 -164.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 8.3 p -82.22 57.75 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.592 -0.693 . . . . 10.0 112.516 -173.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.83 151.82 22.6 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 121.002 -1.061 . . . . 10.0 110.804 163.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 62.71 0.38 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.123 0.969 . . . . 10.0 108.436 168.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.82 23.32 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.652 -0.655 . . . . 10.0 109.963 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -163.7 149.68 9.65 Favored Pre-proline 0 CA--C 1.529 0.159 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.81 3.58 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.077 1.852 . . . . 10.0 113.026 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -49.14 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.639 1.109 . . . . 10.0 109.915 173.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.9 156.06 43.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.358 1.063 . . . . 10.0 110.171 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -87.99 -39.76 14.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.729 1.211 . . . . 10.0 112.568 -159.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -116.43 84.24 14.39 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.232 1.013 . . . . 10.0 109.722 -166.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.15 116.95 3.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.256 2.637 . . . . 10.0 110.785 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -121.58 151.0 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.413 1.085 . . . . 10.0 108.676 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.49 143.3 30.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.619 0.768 . . . . 10.0 109.061 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 ttp -134.6 162.8 31.27 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.948 1.299 . . . . 10.0 108.788 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 134.0 10.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.626 -0.671 . . . . 10.0 111.682 169.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 t -150.01 47.67 0.92 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.504 -0.316 . . . . 10.0 111.822 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.8 m -135.86 99.23 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.725 0.81 . . . . 10.0 109.285 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -46.67 -38.24 9.47 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.616 1.966 . . . . 10.0 114.221 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 t -75.52 0.71 16.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.998 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.42 -122.66 3.29 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.922 1.249 . . . . 10.0 111.631 -174.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.23 -66.98 2.23 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.129 0.871 . . . . 10.0 113.011 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.8 ttt -148.59 -140.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.839 1.255 . . . . 10.0 108.835 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.01 52.65 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.392 -0.818 . . . . 10.0 108.986 -163.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.62 93.76 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.834 -0.907 . . . . 10.0 110.834 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -61.85 95.38 0.06 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.894 0.854 . . . . 10.0 109.775 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -151.3 176.22 11.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.615 1.566 . . . . 10.0 107.351 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 39.1 mtp -79.59 123.05 27.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.83 164.02 37.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.636 -0.876 . . . . 10.0 108.636 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -47.24 -56.12 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.365 2.043 . . . . 10.0 110.419 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.505 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 174.95 -135.07 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.359 2.263 . . . . 10.0 109.022 -176.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 155.16 40.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.061 2.144 . . . . 10.0 105.303 168.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.7 m -98.98 122.01 41.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.908 -1.516 . . . . 10.0 106.908 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.23 116.6 65.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.896 -1.89 . . . . 10.0 105.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.73 70.03 7.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.676 1.584 . . . . 10.0 109.892 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.23 174.11 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.151 0.58 . . . . 10.0 110.619 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.95 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 117.406 2.373 . . . . 10.0 117.406 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.41 105.87 0.25 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.806 1.194 . . . . 10.0 112.147 -165.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 m -110.81 57.32 0.62 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.969 -1.863 . . . . 10.0 105.969 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.3 tp -83.28 152.62 25.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -136.95 147.6 46.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.62 123.8 50.98 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.088 2.155 . . . . 10.0 106.047 -164.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.74 152.39 37.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.527 1.131 . . . . 10.0 108.467 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -44.83 -31.04 1.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.499 1.296 . . . . 10.0 114.499 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.11 -51.99 21.9 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.931 0.892 . . . . 10.0 111.913 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.06 133.05 6.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.26 1.41 . . . . 10.0 110.96 -151.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 38.82 58.4 1.74 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 127.657 2.383 . . . . 10.0 112.82 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -122.46 170.72 9.69 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.866 -1.97 . . . . 10.0 109.476 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -108.65 134.55 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 80.9 mtp -103.41 105.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.21 88.68 7.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.045 -1.094 . . . . 10.0 108.045 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.73 147.18 27.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.525 0.73 . . . . 10.0 110.607 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.75 69.12 1.33 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.163 -0.798 . . . . 10.0 112.266 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 pp -48.36 151.29 1.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.942 0.871 . . . . 10.0 113.155 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -84.58 -71.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.736 0.414 . . . . 10.0 109.953 165.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 173.62 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.206 1.402 . . . . 10.0 112.481 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.15 75.57 4.15 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.211 1.941 . . . . 10.0 110.923 -171.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.76 116.49 18.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.475 1.51 . . . . 10.0 108.788 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -135.54 127.49 29.54 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.074 -1.454 . . . . 10.0 107.074 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.17 90.45 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.35 -45.49 0.51 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.454 -1.058 . . . . 10.0 110.454 -162.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -172.39 1.83 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 123.837 1.779 . . . . 10.0 111.328 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.9 m -149.95 130.72 14.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.095 -1.866 . . . . 10.0 106.918 170.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.05 148.8 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.22 151.26 45.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.921 0.782 . . . . 10.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -115.19 152.16 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -131.29 107.5 9.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.425 -1.694 . . . . 10.0 106.425 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 148.86 26.28 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.81 -1.541 . . . . 10.0 108.974 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.44 100.93 2.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.61 -1.256 . . . . 10.0 107.61 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.84 148.22 30.06 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 172.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.4 t -55.09 -38.36 68.01 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.524 1.056 . . . . 10.0 111.446 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -34.98 70.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.19 1.796 . . . . 10.0 110.705 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.11 75.55 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.74 1.638 . . . . 10.0 109.543 -168.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -83.89 51.26 2.0 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.275 -0.544 . . . . 10.0 110.633 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -161.28 103.53 1.26 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.667 1.187 . . . . 10.0 109.37 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.43 151.58 27.97 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 108.218 -1.03 . . . . 10.0 108.218 160.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -138.84 129.89 26.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.917 -1.883 . . . . 10.0 105.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -142.35 170.47 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.55 -1.648 . . . . 10.0 106.55 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.32 136.87 38.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.113 0.965 . . . . 10.0 109.589 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.44 118.65 32.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.982 1.313 . . . . 10.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -82.38 130.32 35.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.28 105.72 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -146.37 100.71 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.936 0.895 . . . . 10.0 109.571 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt . . . . . 0 N--CA 1.464 0.241 0 C-N-CA 124.866 1.266 . . . . 10.0 111.268 179.828 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 113.195 0.813 . . . . 10.0 113.195 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -155.3 51.01 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.72 67.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -138.55 161.31 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.465 1.506 . . . . 10.0 110.65 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.43 73.48 0.38 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.916 1.246 . . . . 10.0 110.002 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -36.03 116.28 0.38 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.544 1.538 . . . . 10.0 111.482 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.5 m -118.58 107.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.6 126.44 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.209 1.404 . . . . 10.0 109.058 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.61 119.3 10.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.512 0.672 . . . . 10.0 109.363 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.94 129.81 39.08 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.583 -1.265 . . . . 10.0 107.583 164.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -30.5 109.72 0.27 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 126.04 1.736 . . . . 10.0 111.778 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.45 170.6 7.9 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.233 1.955 . . . . 10.0 109.889 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.62 57.51 3.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.237 1.958 . . . . 10.0 108.988 166.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m -157.29 43.73 0.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.709 1.204 . . . . 10.0 109.26 -175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mm 76.03 168.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.831 1.653 . . . . 10.0 111.856 170.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -62.59 -11.52 17.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.161 2.584 . . . . 10.0 114.35 -170.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -72.04 157.94 36.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.368 -0.832 . . . . 10.0 109.657 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -168.52 -174.71 2.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.65 38.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.266 1.026 . . . . 10.0 111.18 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.32 140.39 35.68 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.001 0.92 . . . . 10.0 109.607 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.34 110.85 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.91 -173.2 3.97 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.486 1.114 . . . . 10.0 109.562 -172.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -106.39 164.93 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 166.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.43 149.91 47.77 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.684 -1.599 . . . . 10.0 106.684 160.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 m -151.63 110.42 3.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.942 0.349 . . . . 10.0 111.942 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.42 142.82 33.97 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.243 1.017 . . . . 10.0 109.447 168.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -137.99 66.0 1.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.407 -1.331 . . . . 10.0 107.407 163.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 p 179.57 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 -171.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 84.01 67.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.772 2.029 . . . . 10.0 108.859 156.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -126.4 159.42 63.09 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 125.649 1.58 . . . . 10.0 107.372 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 70.11 6.27 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.551 2.168 . . . . 10.0 110.746 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.52 90.4 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 4.2 ptpp? -83.57 91.23 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.223 1.011 . . . . 10.0 111.428 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.92 68.52 8.34 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 10.0 112.945 -161.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.23 60.69 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.357 -0.839 . . . . 10.0 112.185 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.34 161.18 31.92 Favored Glycine 0 CA--C 1.521 0.45 0 O-C-N 121.013 -1.055 . . . . 10.0 111.329 157.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.08 57.31 0.47 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.436 1.094 . . . . 10.0 108.417 164.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.39 149.81 26.47 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 t -166.66 146.05 4.78 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.11 68.36 4.05 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.421 2.081 . . . . 10.0 108.032 166.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 tp -154.02 -65.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.774 0.83 . . . . 10.0 109.836 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.99 146.67 30.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.89 0.876 . . . . 10.0 109.989 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -87.18 -34.24 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 10.0 109.287 169.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -122.71 71.06 38.9 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.538 1.535 . . . . 10.0 109.89 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.6 104.45 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.067 2.511 . . . . 10.0 111.428 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -129.43 166.78 18.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.325 1.05 . . . . 10.0 110.279 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.6 144.34 43.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.281 1.432 . . . . 10.0 109.6 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 ttp -141.86 152.66 43.83 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.108 1.363 . . . . 10.0 108.123 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.29 108.6 4.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 -161.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.9 m -139.28 62.58 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.91 -1.119 . . . . 10.0 110.111 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -154.05 120.56 5.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.14 -0.936 . . . . 10.0 110.221 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.406 ' CD2' ' CB ' ' A' ' 84' ' ' ALA . 53.1 m80 -70.11 70.12 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.47 1.108 . . . . 10.0 112.188 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.9 p -168.62 -57.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.364 0.984 . . . . 10.0 113.015 171.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.31 -78.39 0.6 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.54 -141.81 11.32 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.543 0.592 . . . . 10.0 111.862 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.98 176.27 6.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.756 . . . . 10.0 109.786 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' CB ' ' CD2' ' A' ' 79' ' ' HIS . . . -124.59 52.19 1.55 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.713 1.605 . . . . 10.0 107.772 -169.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.98 112.48 0.54 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.174 -1.17 . . . . 10.0 110.174 -171.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 27.25 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.837 1.655 . . . . 10.0 114.181 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -83.03 161.59 21.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.589 1.556 . . . . 10.0 109.42 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.5 ttp -81.42 121.91 26.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.92 166.88 12.39 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 118.468 0.577 . . . . 10.0 111.514 -171.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -37.92 -59.95 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.297 2.665 . . . . 10.0 111.56 156.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.71 -172.41 0.53 Allowed 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.042 1.127 . . . . 10.0 114.042 -171.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.65 107.38 19.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.849 1.66 . . . . 10.0 106.856 165.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.0 m -83.92 129.02 34.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.5 pt -114.02 95.33 37.8 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 107.228 -1.397 . . . . 10.0 107.228 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.9 70.35 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.866 1.711 . . . . 10.0 112.508 -157.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.55 152.41 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.709 1.242 . . . . 10.0 111.109 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 36.96 37.2 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.875 1.27 . . . . 10.0 111.869 -155.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 93.21 0.14 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.362 -1.095 . . . . 10.0 110.362 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -138.79 107.17 5.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.6 -171.84 2.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.639 0.776 . . . . 10.0 110.802 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.6 t -140.15 143.51 36.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 103.04 -2.948 . . . . 10.0 103.04 -172.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.68 116.67 19.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.304 -2.48 . . . . 10.0 104.304 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.99 161.55 41.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.736 1.214 . . . . 10.0 108.745 -165.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.0 ttp-105 -62.57 122.89 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.672 -0.694 . . . . 10.0 109.326 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.3 t0 48.76 60.82 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 10.0 112.608 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.34 62.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.897 -1.281 . . . . 10.0 109.897 164.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 t0 79.02 127.58 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.108 1.763 . . . . 10.0 110.045 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -177.08 157.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.312 0.505 . . . . 10.0 111.465 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.14 123.18 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 105.932 -1.877 . . . . 10.0 105.932 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.1 mtm -94.38 104.9 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.236 1.017 . . . . 10.0 109.095 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.65 68.74 8.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.289 -1.745 . . . . 10.0 106.289 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 23.3 ttt -82.12 154.73 25.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.487 0.661 . . . . 10.0 110.276 -166.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.64 60.92 6.39 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.001 -1.24 . . . . 10.0 110.001 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.82 117.9 4.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -69.83 0.62 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.848 0.749 . . . . 10.0 111.479 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -66.19 156.06 85.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.736 1.214 . . . . 10.0 111.377 -173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.55 148.62 92.32 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.503 1.469 . . . . 10.0 109.603 165.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.19 147.09 32.07 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.776 1.23 . . . . 10.0 109.587 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -111.98 145.56 39.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.759 1.223 . . . . 10.0 108.659 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.87 99.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.34 -3.89 6.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.058 1.313 . . . . 10.0 112.025 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -75.66 -174.18 2.45 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 123.733 1.73 . . . . 10.0 109.887 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.2 m -153.74 134.17 13.5 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 112.861 -1.972 . . . . 10.0 107.562 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.13 143.54 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.123 0.969 . . . . 10.0 108.689 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.18 119.44 21.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.2 tt -81.99 159.75 3.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.4 m -128.54 114.71 17.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.092 -1.818 . . . . 10.0 106.092 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.96 134.26 34.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -126.73 71.42 1.3 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.879 0.872 . . . . 10.0 109.405 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.36 138.49 39.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.652 -1.24 . . . . 10.0 107.652 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -57.42 -34.36 68.85 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.755 0.707 . . . . 10.0 112.905 -166.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.4 m-20 -65.15 -27.65 68.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.453 1.501 . . . . 10.0 111.734 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.37 81.67 0.12 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.312 -1.915 . . . . 10.0 108.312 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -80.81 53.78 2.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.943 0.497 . . . . 10.0 111.59 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.1 m -158.7 83.88 0.82 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.134 1.374 . . . . 10.0 109.583 -172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 157.29 45.39 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 168.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -149.03 140.86 23.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.2 t -148.23 147.6 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.87 107.76 16.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.66 138.73 31.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -82.25 150.27 27.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.106 -1.442 . . . . 10.0 107.106 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.43 113.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 164.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -158.73 143.22 15.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.754 -0.832 . . . . 10.0 108.754 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.553 1.141 . . . . 10.0 111.489 177.613 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.775 0.798 . . . . 10.0 111.685 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 t -158.98 81.18 0.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.202 1.001 . . . . 10.0 108.762 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.8 85.56 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.733 0.777 . . . . 10.0 109.527 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -157.98 155.79 30.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 162.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.03 137.35 19.8 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.353 -1.099 . . . . 10.0 110.353 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.91 115.69 23.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.77 0.785 . . . . 10.0 110.042 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -109.48 158.21 18.19 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.757 -1.201 . . . . 10.0 107.757 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.17 137.55 54.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.5 113.33 13.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.4 127.03 21.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 117.761 -1.114 . . . . 10.0 109.004 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -11.48 102.32 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 127.358 2.263 . . . . 10.0 113.065 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.3 168.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.733 2.288 . . . . 10.0 109.382 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.68 43.32 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.268 1.979 . . . . 10.0 110.545 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -133.96 34.54 3.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.943 2.097 . . . . 10.0 107.578 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 mm 73.76 172.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.897 1.279 . . . . 10.0 109.784 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.79 40.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.699 1.6 . . . . 10.0 113.948 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.07 158.97 15.17 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 156.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -157.68 -165.88 1.87 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 155.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.01 174.46 11.26 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.63 161.43 26.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -130.3 102.3 6.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.35 -2.833 . . . . 10.0 103.35 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.2 ttp -158.59 -178.84 7.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.12 2.568 . . . . 10.0 106.142 -172.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 m -152.98 141.01 20.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.823 -1.917 . . . . 10.0 105.823 166.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -82.29 136.03 35.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 170.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 m -120.78 80.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.069 2.148 . . . . 10.0 108.544 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -81.91 89.7 6.39 Favored 'General case' 0 N--CA 1.46 0.045 0 O-C-N 121.2 -0.938 . . . . 10.0 109.128 -172.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 57.51 3.96 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.244 -0.91 . . . . 10.0 110.189 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t 179.11 149.64 0.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.174 1.79 . . . . 10.0 107.506 167.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.65 67.33 5.39 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.496 1.118 . . . . 10.0 108.895 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -130.71 122.47 19.64 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 10.0 109.736 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.86 116.3 3.14 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.535 2.823 . . . . 10.0 111.032 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.92 96.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.604 0.638 . . . . 10.0 109.649 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -80.4 132.84 35.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.312 0.645 . . . . 10.0 111.022 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.75 140.19 46.59 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.318 1.047 . . . . 10.0 110.209 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.09 56.25 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.923 0.868 . . . . 10.0 110.171 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 154.54 25.59 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 119.82 -1.181 . . . . 10.0 111.971 163.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.23 72.28 0.93 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.304 1.842 . . . . 10.0 106.505 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.39 145.63 28.1 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t 35.8 68.59 1.31 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.778 0.831 . . . . 10.0 109.963 -156.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.19 -86.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.349 2.033 . . . . 10.0 110.079 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.03 43.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.077 -1.453 . . . . 10.0 107.077 156.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -167.31 -157.2 0.23 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -40.03 6.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.714 0.688 . . . . 10.0 110.868 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -122.09 106.23 36.44 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 125.403 1.481 . . . . 10.0 108.588 -169.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.12 139.65 7.28 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.23 2.62 . . . . 10.0 110.497 173.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -138.31 127.76 24.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.87 139.4 35.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.4 ttm -141.87 154.82 45.41 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.144 0.978 . . . . 10.0 111.429 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -148.47 120.16 8.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 t -156.43 54.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.644 0.778 . . . . 10.0 112.101 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -137.73 179.5 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.618 0.767 . . . . 10.0 111.499 168.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -91.18 -40.32 11.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.312 0.645 . . . . 10.0 110.165 -171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.1 t -81.71 -147.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 160.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.35 -140.68 42.41 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.09 -67.42 1.7 Allowed Glycine 0 CA--C 1.536 1.365 0 CA-C-N 117.252 0.526 . . . . 10.0 113.145 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.14 174.17 12.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.637 1.975 . . . . 10.0 108.377 -169.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.86 45.42 2.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 10.0 107.8 -159.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.59 84.42 0.12 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 117.574 -1.681 . . . . 10.0 112.902 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 mtt -40.34 98.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.437 0 C-N-CA 126.045 1.738 . . . . 10.0 110.602 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.31 166.23 26.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.705 1.202 . . . . 10.0 109.388 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.5 mtp -77.67 71.16 4.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.7 146.7 98.36 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.963 -1.017 . . . . 10.0 108.534 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -33.59 -51.49 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.205 3.27 . . . . 10.0 113.547 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -179.08 -176.76 0.44 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.44 1.896 . . . . 10.0 106.582 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 102.29 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 10.0 110.294 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 m -75.21 122.51 23.76 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -108.73 90.83 7.93 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.163 0.985 . . . . 10.0 108.709 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.04 140.91 35.46 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 120.75 0.966 . . . . 10.0 109.741 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.41 -140.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.256 1.023 . . . . 10.0 112.412 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.19 38.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.958 2.503 . . . . 10.0 114.516 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.0 144.16 10.5 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 121.832 0.684 . . . . 10.0 112.883 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.265 7.2 t -134.48 99.3 4.32 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.863 -1.532 . . . . 10.0 106.863 158.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.84 126.26 55.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.046 -2.205 . . . . 10.0 105.046 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 m -82.01 153.23 26.29 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.708 -0.849 . . . . 10.0 108.708 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.67 76.55 1.64 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.984 -1.487 . . . . 10.0 106.984 176.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 158.49 44.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.738 0.815 . . . . 10.0 110.198 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -73.72 60.81 0.71 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.081 0.952 . . . . 10.0 112.123 -168.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -176.23 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.154 1.381 . . . . 10.0 109.784 -164.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.4 74.33 0.27 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 123.336 0.494 . . . . 10.0 112.101 -161.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 69.13 139.74 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 128.296 2.638 . . . . 10.0 109.211 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 175.65 178.44 0.18 Allowed 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.091 0.556 . . . . 10.0 112.42 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 t -108.67 118.21 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.7 mtp -80.43 103.19 10.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.545 -1.65 . . . . 10.0 106.545 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.84 105.47 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.584 -1.189 . . . . 10.0 109.178 169.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -111.59 152.69 27.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.15 1.38 . . . . 10.0 111.22 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.79 -6.82 6.95 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.528 -1.707 . . . . 10.0 115.957 155.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 77.29 92.46 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.677 1.739 . . . . 10.0 111.067 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -70.39 -56.44 6.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.66 -0.65 . . . . 10.0 110.3 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 149.86 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 129.833 3.253 . . . . 10.0 110.767 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.33 66.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.043 2.495 . . . . 10.0 114.311 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.49 96.62 10.68 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.106 -0.996 . . . . 10.0 109.481 158.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -137.71 147.8 45.11 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 162.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.07 68.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.872 0.869 . . . . 10.0 108.951 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.69 8.24 0.7 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.376 -1.236 . . . . 10.0 113.187 -168.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.66 173.0 5.52 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 119.797 1.799 . . . . 10.0 108.481 161.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 m -156.34 129.96 8.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.849 -1.523 . . . . 10.0 109.356 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.54 140.55 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.204 0.602 . . . . 10.0 109.766 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -70.05 123.12 20.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 108.971 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.9 tt -102.2 141.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.68 -1.23 . . . . 10.0 107.68 166.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.6 m -119.78 110.1 16.38 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 171.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.03 173.1 10.77 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 122.183 -0.323 . . . . 10.0 111.8 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.62 96.72 2.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.527 1.131 . . . . 10.0 108.022 -172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.75 143.12 29.35 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.68 -0.637 . . . . 10.0 110.647 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p -58.29 -23.13 55.36 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.713 0.805 . . . . 10.0 113.019 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.71 -17.7 16.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.987 0.915 . . . . 10.0 112.081 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.09 30.22 3.24 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.896 1.712 . . . . 10.0 110.578 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -90.36 166.9 13.04 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-N 117.334 0.567 . . . . 10.0 110.301 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.8 m -158.49 59.49 0.44 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.077 -2.194 . . . . 10.0 105.077 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.1 tp -85.18 141.9 29.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.848 -1.167 . . . . 10.0 107.848 -174.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -111.48 136.42 50.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.0 t -136.3 159.38 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.217 -1.771 . . . . 10.0 106.217 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.68 109.57 21.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.936 0.894 . . . . 10.0 108.879 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.36 118.48 24.26 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -94.83 127.38 40.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.178 0.991 . . . . 10.0 109.28 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 51.1 t -86.76 104.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 120.762 -1.211 . . . . 10.0 108.951 -175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -141.59 116.3 9.72 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.578 1.151 . . . . 10.0 108.451 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.6 mttm . . . . . 0 C--N 1.341 0.223 0 C-N-CA 124.781 1.232 . . . . 10.0 112.164 175.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.964 0.888 . . . . 10.0 109.119 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -153.67 58.05 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.445 -0.785 . . . . 10.0 109.163 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.15 67.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 162.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -97.66 166.04 11.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.903 -1.499 . . . . 10.0 108.928 164.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.91 -145.96 19.74 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.581 -1.807 . . . . 10.0 108.581 160.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.02 115.73 0.73 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.97 1.708 . . . . 10.0 108.458 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.3 p -124.66 138.47 54.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.17 147.34 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.726 0.81 . . . . 10.0 109.54 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.63 113.53 25.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.375 0.534 . . . . 10.0 111.103 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.45 128.99 34.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.926 0.49 . . . . 10.0 110.095 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -20.7 103.87 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 127.024 2.13 . . . . 10.0 112.924 -164.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -62.15 167.01 11.54 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.314 2.676 . . . . 10.0 110.476 171.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.54 57.8 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.647 2.231 . . . . 10.0 109.127 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -154.44 42.8 0.5 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.881 1.272 . . . . 10.0 109.313 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.7 mt 77.43 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.438 1.495 . . . . 10.0 109.098 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -36.34 -46.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.304 1.842 . . . . 10.0 111.603 168.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.57 141.28 1.05 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.24 2.616 . . . . 10.0 112.727 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -158.67 -175.47 5.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 172.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.51 158.32 43.88 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.542 1.137 . . . . 10.0 110.596 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.6 163.25 13.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 124.109 0.881 . . . . 10.0 110.51 171.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -134.06 130.57 37.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.516 -2.031 . . . . 10.0 105.516 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -156.04 -176.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.848 1.659 . . . . 10.0 108.5 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 137.43 36.58 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 161.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.28 149.37 23.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.634 -0.876 . . . . 10.0 108.634 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -135.84 85.76 2.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.291 0.994 . . . . 10.0 111.632 -157.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 113.73 12.4 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 121.354 -0.841 . . . . 10.0 109.156 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -128.36 57.65 1.57 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 164.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 m -163.46 -33.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.129 1.372 . . . . 10.0 112.134 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 60.42 59.66 2.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.079 0.854 . . . . 10.0 111.26 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -143.3 147.13 39.07 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.972 0.909 . . . . 10.0 109.907 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -86.36 84.34 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.906 3.071 . . . . 10.0 112.408 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.31 94.24 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -80.36 134.51 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.621 -0.674 . . . . 10.0 110.919 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.38 115.89 30.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.881 1.672 . . . . 10.0 107.375 -165.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.69 47.78 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.997 . . . . 10.0 108.855 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.84 156.82 29.0 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.766 -1.209 . . . . 10.0 111.339 159.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.28 59.74 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.656 1.582 . . . . 10.0 107.846 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 132.52 33.8 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 t -157.91 139.55 9.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.88 65.16 5.96 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.671 2.914 . . . . 10.0 109.42 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -157.54 -57.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 -164.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.48 152.21 25.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.277 0.631 . . . . 10.0 109.31 171.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.2 m -107.13 -18.83 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.939 0.895 . . . . 10.0 110.219 160.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.6 m -133.1 64.45 70.47 Favored Pre-proline 0 N--CA 1.445 -0.689 0 C-N-CA 124.469 1.108 . . . . 10.0 109.028 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 101.32 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.178 2.585 . . . . 10.0 109.905 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.06 126.18 54.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 10.0 109.251 -171.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.58 146.03 31.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.045 0.538 . . . . 10.0 109.717 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.03 166.7 26.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.758 1.223 . . . . 10.0 111.527 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.254 40.7 m -137.96 133.87 34.23 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.004 1.44 . . . . 10.0 111.898 -156.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 t -83.55 -178.99 7.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 123.995 1.855 . . . . 10.0 113.873 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.4 m -79.88 66.61 5.41 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 129.561 3.144 . . . . 10.0 109.803 -160.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 60.71 65.33 1.05 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.167 1.387 . . . . 10.0 110.735 172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.3 t -161.53 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.294 1.037 . . . . 10.0 108.369 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.31 -125.46 3.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 10.0 110.504 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.36 -49.95 8.16 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.527 1.371 . . . . 10.0 116.527 -168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.35 -82.46 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.749 1.275 . . . . 10.0 111.229 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.0 74.77 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.729 1.212 . . . . 10.0 108.07 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.77 159.65 27.69 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.01 1.29 . . . . 10.0 113.656 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.1 ttp -77.61 62.37 2.52 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.088 1.355 . . . . 10.0 111.417 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -81.81 162.64 22.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.1 ttm -80.03 74.11 6.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.72 142.79 61.91 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.818 -1.083 . . . . 10.0 109.046 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.26 -18.28 64.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.845 1.697 . . . . 10.0 113.597 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -178.14 174.27 1.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.659 -1.978 . . . . 10.0 105.659 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 tp -97.6 101.14 12.58 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.448 1.022 . . . . 10.0 109.667 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -76.3 123.9 26.65 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.539 -0.911 . . . . 10.0 108.539 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.9 pt -115.26 115.28 42.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.18 -170.24 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.605 2.204 . . . . 10.0 110.737 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.43 149.66 20.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 158.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.87 17.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.168 1.349 . . . . 10.0 113.563 -166.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 83.62 0.41 Allowed Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 108.815 -1.714 . . . . 10.0 108.815 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.1 t -121.9 108.33 13.31 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 166.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 -172.33 2.68 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.335 0.654 . . . . 10.0 109.955 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.3 t -143.81 122.49 12.57 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 104.041 -2.577 . . . . 10.0 104.041 -164.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.78 123.92 47.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.57 -1.641 . . . . 10.0 106.57 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.63 155.39 41.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.171 1.389 . . . . 10.0 108.533 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 55.57 0.89 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.644 0.778 . . . . 10.0 111.181 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.55 -57.3 0.44 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.69 -75.48 0.3 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.689 0.661 . . . . 10.0 112.051 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.0 133.2 44.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 -171.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 174.51 178.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 120.115 1.325 . . . . 10.0 109.861 -176.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.76 122.57 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.137 -2.171 . . . . 10.0 105.137 158.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.0 mtp -81.37 96.83 7.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.25 61.82 3.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 22.2 ptm -89.97 177.91 6.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.115 0.959 . . . . 10.0 110.544 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.21 46.62 86.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 109.13 -1.588 . . . . 10.0 109.13 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.55 119.74 15.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 10.0 110.321 -168.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -64.16 -73.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.055 0.542 . . . . 10.0 111.705 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -95.2 152.98 39.79 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.7 0.8 . . . . 10.0 112.21 -160.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.66 100.68 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.571 2.181 . . . . 10.0 109.154 170.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 42.0 mt -77.72 158.4 29.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.032 -0.417 . . . . 10.0 111.032 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 142.31 47.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.717 1.207 . . . . 10.0 109.07 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.35 72.32 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.174 1.39 . . . . 10.0 109.214 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 151.76 -12.6 0.75 Allowed Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.962 -1.086 . . . . 10.0 112.614 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.89 179.27 2.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 123.693 1.711 . . . . 10.0 109.404 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -155.05 127.41 7.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.693 -2.049 . . . . 10.0 108.48 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -127.34 148.57 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -71.24 144.66 49.99 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.579 -0.7 . . . . 10.0 110.316 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.3 tt -123.19 139.3 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.1 m -117.39 119.24 34.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.2 176.89 8.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 10.0 111.723 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -154.09 90.8 1.38 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.202 1.001 . . . . 10.0 109.023 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.74 153.24 21.86 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.135 -0.978 . . . . 10.0 110.989 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 p -46.45 -39.32 10.42 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 -165.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.38 18.35 0.56 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.767 0.827 . . . . 10.0 111.925 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 32.92 35.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.851 -1.3 . . . . 10.0 109.851 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.55 94.71 7.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 125.83 47.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.264 1.826 . . . . 10.0 107.064 169.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.6 144.29 50.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 103.796 -2.668 . . . . 10.0 103.796 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -107.95 113.84 27.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.571 -2.381 . . . . 10.0 104.571 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.27 153.1 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -171.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.94 112.06 22.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.55 -0.907 . . . . 10.0 108.55 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.13 109.73 20.11 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.486 0.714 . . . . 10.0 109.135 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 m -90.31 124.64 35.07 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.935 0.894 . . . . 10.0 108.911 -175.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.76 108.22 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.172 -0.955 . . . . 10.0 109.078 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -136.73 111.63 8.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.262 . . . . 10.0 108.169 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 C--O 1.232 0.155 0 CA-C-N 119.154 0.888 . . . . 10.0 110.731 172.757 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 122.256 1.026 . . . . 10.0 110.526 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -158.35 60.35 0.45 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.497 0.719 . . . . 10.0 109.508 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.96 52.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 122.125 0.964 . . . . 10.0 110.511 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -157.24 145.6 19.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.53 130.49 10.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.794 -1.723 . . . . 10.0 108.794 168.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 159.35 31.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.051 0.926 . . . . 10.0 111.291 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 p -122.39 148.57 44.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.316 -1.364 . . . . 10.0 107.316 165.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.41 134.51 58.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.0 26.29 0.06 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -166.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.21 -138.18 0.71 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.412 1.485 . . . . 10.0 109.692 -170.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.25 110.76 40.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 167.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.32 175.1 11.05 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.252 2.634 . . . . 10.0 109.472 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.78 72.04 3.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.531 2.154 . . . . 10.0 109.627 168.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -152.54 -57.41 0.14 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.722 2.409 . . . . 10.0 106.299 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt 66.37 150.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.141 1.776 . . . . 10.0 108.563 -163.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 74.91 -51.51 0.67 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.292 1.837 . . . . 10.0 111.757 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.31 138.01 37.01 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -150.45 178.57 8.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.659 1.184 . . . . 10.0 108.193 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.15 161.7 41.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.938 0.895 . . . . 10.0 109.458 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.41 160.81 14.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.263 0.977 . . . . 10.0 111.284 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.14 134.96 51.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.275 -2.491 . . . . 10.0 104.275 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 ttt -158.82 177.26 11.36 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.794 -1.187 . . . . 10.0 107.794 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 t -133.27 142.36 48.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 152.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.52 105.77 16.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.287 -2.486 . . . . 10.0 104.287 163.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.84 106.36 15.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.281 1.832 . . . . 10.0 110.427 -170.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.61 129.82 34.74 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.337 0.655 . . . . 10.0 110.206 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -138.98 58.42 1.64 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 158.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -157.98 -50.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.937 2.095 . . . . 10.0 108.103 -171.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 74.58 58.86 0.07 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.207 1.803 . . . . 10.0 110.384 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -123.86 146.29 50.3 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 126.048 1.739 . . . . 10.0 106.456 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.72 121.02 6.4 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.692 2.261 . . . . 10.0 109.554 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.57 146.39 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -117.7 145.47 44.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.316 1.447 . . . . 10.0 107.763 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.09 131.68 17.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.485 -2.413 . . . . 10.0 104.485 -171.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.6 55.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.233 1.016 . . . . 10.0 109.034 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.49 149.09 17.48 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.871 -1.292 . . . . 10.0 109.871 167.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -155.54 59.74 0.62 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.758 1.223 . . . . 10.0 108.14 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.19 35.23 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.339 0.656 . . . . 10.0 110.21 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -159.05 144.11 11.7 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 107.143 -1.429 . . . . 10.0 107.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.61 39.74 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.519 2.146 . . . . 10.0 112.738 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -108.82 -54.61 2.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.734 1.613 . . . . 10.0 108.34 -170.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.38 160.41 30.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.974 1.309 . . . . 10.0 107.947 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -83.15 -40.26 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.512 0.725 . . . . 10.0 111.874 -165.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.9 t -119.15 95.53 49.39 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.478 1.111 . . . . 10.0 110.647 -162.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.61 92.2 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.958 2.439 . . . . 10.0 110.36 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 83.8 mtp -103.75 116.51 32.45 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.879 1.272 . . . . 10.0 108.893 -172.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 mp -81.54 134.9 35.57 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.435 0.694 . . . . 10.0 109.735 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.52 -179.83 3.84 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.667 1.187 . . . . 10.0 109.336 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 t -158.79 143.27 15.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.277 -2.49 . . . . 10.0 104.277 159.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.28 5.7 t -156.89 63.68 0.51 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.738 1.608 . . . . 10.0 110.486 167.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -146.04 -178.74 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.72 -0.612 . . . . 10.0 109.665 172.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.57 148.76 22.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m 71.2 -53.8 0.67 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.552 1.541 . . . . 10.0 111.913 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.55 141.16 47.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 17.65 -90.14 0.01 OUTLIER Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.699 2.095 . . . . 10.0 115.585 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.4 mtt -145.39 173.98 11.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.395 1.878 . . . . 10.0 109.454 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.22 47.05 0.98 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.768 1.627 . . . . 10.0 107.128 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.72 102.2 0.22 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.813 -1.315 . . . . 10.0 109.813 -167.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 63.85 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.279 1.831 . . . . 10.0 111.89 -170.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -113.98 165.81 12.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.827 2.051 . . . . 10.0 109.933 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.8 mtm -78.38 98.02 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.716 -1.587 . . . . 10.0 106.716 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.66 161.72 47.06 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 119.47 -0.3 . . . . 10.0 110.387 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -43.17 -50.02 6.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.247 2.631 . . . . 10.0 111.241 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.3 p90 177.52 -170.0 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.194 2.598 . . . . 10.0 104.967 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -127.8 106.6 9.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.754 0.788 . . . . 10.0 110.421 169.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 145.77 36.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.04 140.9 40.07 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.527 1.058 . . . . 10.0 111.266 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.1 -174.21 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.123 2.549 . . . . 10.0 111.968 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.4 143.48 23.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 156.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 52.15 27.07 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.58 0.956 . . . . 10.0 113.58 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.74 96.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.837 -1.705 . . . . 10.0 108.837 167.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -126.59 55.71 1.51 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.706 1.202 . . . . 10.0 108.645 -173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.21 166.61 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.158 0.98 . . . . 10.0 112.397 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 105.4 3.95 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.9 119.4 23.89 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.503 -1.665 . . . . 10.0 106.503 -171.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -127.83 144.7 51.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.458 1.903 . . . . 10.0 107.456 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -61.71 119.42 8.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.99 37.18 3.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.218 1.407 . . . . 10.0 112.334 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -169.73 74.31 0.11 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.774 -1.73 . . . . 10.0 108.774 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.9 t0 63.41 130.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.967 2.507 . . . . 10.0 111.749 -168.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -177.1 175.82 1.48 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.365 0.984 . . . . 10.0 111.782 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.92 130.27 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.025 -1.843 . . . . 10.0 106.025 163.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 78.6 mtp -88.76 103.21 15.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.747 1.219 . . . . 10.0 107.759 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.27 81.42 8.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.711 -1.589 . . . . 10.0 106.711 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 51.3 ttm -84.79 152.34 23.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.313 1.045 . . . . 10.0 109.639 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.92 53.2 3.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.381 -1.087 . . . . 10.0 110.381 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.8 122.58 5.09 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 125.147 1.379 . . . . 10.0 109.11 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -72.9 -64.16 1.02 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.61 -58.48 0.0 OUTLIER Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 118.276 -0.868 . . . . 10.0 112.987 167.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.73 58.7 5.41 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.805 1.67 . . . . 10.0 111.334 -163.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.69 167.26 22.14 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.839 -0.538 . . . . 10.0 109.717 165.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -149.33 123.56 9.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.253 -1.758 . . . . 10.0 106.253 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.93 120.64 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.66 -4.19 50.16 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.414 -1.214 . . . . 10.0 112.478 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.03 169.4 11.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 119.944 1.872 . . . . 10.0 111.357 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.9 m -132.32 96.75 3.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 111.599 -2.546 . . . . 10.0 108.045 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.12 140.39 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -66.11 130.77 44.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.3 112.19 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 173.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.1 m -94.31 107.04 19.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.44 -0.8 . . . . 10.0 109.541 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.28 171.96 14.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.09 103.36 2.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.05 126.73 32.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.7 t -47.85 -38.53 16.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.51 1.524 . . . . 10.0 111.019 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.1 -35.19 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.019 1.727 . . . . 10.0 113.089 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.28 67.73 0.17 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.126 -1.189 . . . . 10.0 110.126 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -129.76 151.85 49.89 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 m -152.72 55.57 0.79 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.649 1.579 . . . . 10.0 107.823 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.49 128.76 34.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 62.43 0.87 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 127.551 2.34 . . . . 10.0 107.222 -161.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -84.49 153.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.396 -1.274 . . . . 10.0 108.96 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.68 113.44 18.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.922 -1.111 . . . . 10.0 108.999 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.0 146.27 32.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.398 1.079 . . . . 10.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.7 m -103.7 128.64 51.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.559 0.344 . . . . 10.0 110.702 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.34 91.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.899 -1.148 . . . . 10.0 107.899 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -155.66 135.83 13.0 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 121.435 -0.79 . . . . 10.0 110.754 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.259 0 C-N-CA 125.749 1.619 . . . . 10.0 111.868 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.38 79.73 1.46 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.278 -1.29 . . . . 10.0 110.732 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . 2.174 0.2 OUTLIER -95.46 24.79 4.87 Favored 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 134.799 5.239 . . . . 10.0 113.622 -1.489 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 2.334 1.7 t -58.57 85.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.179 0.991 . . . . 10.0 110.28 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . 2.281 25.0 ptt? -62.05 -158.34 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.448 1.899 . . . . 10.0 110.019 149.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . 2.553 63.2 Cg_endo 51.62 -167.87 0.0 OUTLIER 'Cis proline' 0 C--N 1.351 0.71 0 CA-C-N 122.475 1.92 . . . . 10.0 114.07 6.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 61.87 -94.41 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.751 1.76 . . . . 10.0 115.751 162.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . 2.299 1.2 p-80 -136.79 -58.48 0.72 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 129.95 3.3 . . . . 10.0 109.508 117.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 2.344 19.0 m -13.79 -76.21 0.0 OUTLIER Pre-proline 0 C--N 1.348 0.501 1 C-N-CA 134.73 5.212 . . . . 10.0 114.34 -12.245 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . 2.54 32.1 Cg_exo 61.61 -109.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.719 2.279 . . . . 10.0 109.723 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -23.32 66.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 1 C-N-CA 128.331 6.02 . . . . 10.0 121.006 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.64 52.19 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 132.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 2.453 8.7 pt20 59.51 -164.06 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.258 -145.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t 71.52 26.36 3.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.732 1.382 . . . . 10.0 114.732 172.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.08 50.99 5.25 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 141.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . 0.538 0.7 OUTLIER -28.85 -91.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-O 115.949 -1.771 . . . . 10.0 115.239 -105.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . 0.27 . . 55.88 34.33 23.33 Favored 'General case' 0 CA--C 1.532 0.27 2 C-N-CA 134.161 4.984 . . . . 10.0 116.548 -7.321 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.24 106.58 8.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.065 0.848 . . . . 10.0 112.253 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 93.03 -64.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 1 C-N-CA 133.067 4.547 . . . . 10.0 115.909 -14.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp 165.01 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.249 1.42 . . . . 10.0 109.221 -151.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.13 156.22 18.74 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.523 -0.736 . . . . 10.0 109.949 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.92 25.4 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.557 -1.817 . . . . 10.0 108.557 -144.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 80.82 -54.93 0.32 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.45 2.3 . . . . 10.0 110.266 168.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.82 -65.03 0.36 Allowed 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.133 1.373 . . . . 10.0 107.494 -166.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 162.5 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.808 1 C-N-CA 131.852 4.061 . . . . 10.0 105.368 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 tt -101.78 122.21 48.31 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 168.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -58.75 129.42 32.14 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.779 -1.662 . . . . 10.0 107.779 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -84.11 52.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.656 0.741 . . . . 10.0 112.161 -148.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -161.71 57.42 0.26 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.82 1.248 . . . . 10.0 109.035 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.45 64.68 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -128.94 146.5 50.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.891 1.276 . . . . 10.0 111.443 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.26 90.59 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 108.261 -1.936 . . . . 10.0 108.261 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.41 142.5 17.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.04 0.536 . . . . 10.0 111.847 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 p -125.16 146.13 49.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.28 138.59 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.923 -1.139 . . . . 10.0 107.923 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.34 110.59 17.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.109 0.48 . . . . 10.0 111.486 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.39 136.34 31.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.403 -0.808 . . . . 10.0 109.15 166.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.7 t -17.5 108.22 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.83 2.052 . . . . 10.0 114.837 -162.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.15 158.1 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.814 2.343 . . . . 10.0 110.572 167.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.16 58.64 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.499 2.133 . . . . 10.0 108.987 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.9 t -165.4 44.25 0.08 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.266 1.426 . . . . 10.0 108.589 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.5 mt 74.2 169.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.207 1.803 . . . . 10.0 109.723 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -46.91 -39.61 12.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.915 1.686 . . . . 10.0 113.87 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.79 151.72 20.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.741 1.216 . . . . 10.0 111.415 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -164.2 -172.66 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.849 -0.797 . . . . 10.0 108.849 -164.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.71 39.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.645 1.178 . . . . 10.0 110.141 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.03 149.29 26.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.764 0.665 . . . . 10.0 109.411 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -124.2 103.32 8.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 104.756 -2.313 . . . . 10.0 104.756 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -159.2 -172.65 3.85 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.927 0.891 . . . . 10.0 111.579 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 m -145.59 125.17 13.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.699 -1.251 . . . . 10.0 110.259 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.28 132.58 35.35 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 103.946 -2.613 . . . . 10.0 103.946 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.8 m -129.35 88.24 2.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 125.001 1.438 . . . . 10.0 107.609 -164.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.39 128.47 33.38 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.388 -0.227 . . . . 10.0 110.388 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -141.82 57.02 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.9 m -156.16 -40.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.307 1.443 . . . . 10.0 111.071 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 65.99 62.22 0.61 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.034 1.734 . . . . 10.0 112.662 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -132.79 155.44 81.17 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.833 1.653 . . . . 10.0 108.052 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 75.97 4.63 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.895 3.063 . . . . 10.0 111.471 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.36 147.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 99.63 5.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.541 1.537 . . . . 10.0 111.019 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.6 121.55 26.96 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.595 -2.002 . . . . 10.0 105.595 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.75 54.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 122.207 1.003 . . . . 10.0 108.587 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.21 148.96 16.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.471 -1.051 . . . . 10.0 110.471 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.21 59.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.054 1.742 . . . . 10.0 107.762 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.94 29.68 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -169.59 149.16 3.56 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 118.799 0.727 . . . . 10.0 110.199 -172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.78 49.65 2.53 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.844 2.362 . . . . 10.0 110.434 168.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.55 -70.59 0.73 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.59 1.556 . . . . 10.0 107.202 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.48 147.27 33.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.144 1.378 . . . . 10.0 110.26 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -82.41 -36.4 26.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.948 0.899 . . . . 10.0 109.935 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.7 t -120.47 75.12 24.57 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.614 1.165 . . . . 10.0 110.94 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.84 101.09 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 10.0 110.413 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.4 mtt -109.51 128.55 55.26 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.091 1.757 . . . . 10.0 108.854 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.62 142.25 31.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.304 1.042 . . . . 10.0 108.821 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttm -148.24 153.14 38.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.663 0.785 . . . . 10.0 110.84 -173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.0 t -159.07 98.62 1.46 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.046 -1.034 . . . . 10.0 111.547 -161.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -138.94 59.48 1.62 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.795 0.807 . . . . 10.0 110.193 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.4 m -147.73 125.11 11.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.702 0.801 . . . . 10.0 109.436 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -77.47 64.12 2.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.251 1.421 . . . . 10.0 109.671 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 166.01 -20.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.489 2.716 . . . . 10.0 109.484 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.45 -149.41 6.0 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.672 -1.771 . . . . 10.0 108.672 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.48 -52.47 52.68 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 122.455 -0.438 . . . . 10.0 113.235 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -168.1 1.19 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.123 1.369 . . . . 10.0 110.356 -166.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.83 42.97 3.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.618 1.967 . . . . 10.0 108.134 -167.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -149.58 103.04 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.228 -1.149 . . . . 10.0 110.228 -171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.63 63.03 2.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.059 0.929 . . . . 10.0 108.773 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -131.36 167.09 19.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.644 1.977 . . . . 10.0 109.691 -172.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtm -79.67 75.7 6.33 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.037 -1.097 . . . . 10.0 108.037 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.13 163.67 43.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.495 -0.775 . . . . 10.0 111.498 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -37.26 -55.73 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.141 3.227 . . . . 10.0 112.632 161.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.9 p90 172.65 -165.3 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.275 2.63 . . . . 10.0 104.732 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -127.37 111.53 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.701 0.682 . . . . 10.0 110.945 168.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m -76.59 132.48 39.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 107.055 -1.461 . . . . 10.0 107.055 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.2 pt -100.95 100.95 14.14 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.084 1.354 . . . . 10.0 107.388 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.59 67.69 8.55 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.239 2.626 . . . . 10.0 110.211 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 58.38 177.93 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 -156.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 38.81 33.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.831 2.16 . . . . 10.0 116.831 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.07 70.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.971 1.272 . . . . 10.0 113.113 163.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -111.49 57.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.18 156.45 18.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.793 -0.447 . . . . 10.0 109.793 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.3 m -115.42 115.36 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -82.61 106.36 14.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -137.08 156.56 48.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.6 1.16 . . . . 10.0 110.26 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -47.44 -40.35 17.87 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.805 1.242 . . . . 10.0 113.93 -161.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -132.65 52.05 2.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.825 0.821 . . . . 10.0 109.909 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.9 63.78 0.22 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.8 t0 65.45 136.45 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 126.253 1.821 . . . . 10.0 109.891 -172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 179.82 -179.2 0.44 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.096 -1.003 . . . . 10.0 112.095 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.6 t -110.83 123.02 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 161.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.7 mtp -83.51 100.54 10.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 166.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.15 74.25 4.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.403 -1.703 . . . . 10.0 106.403 171.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.7 ttt -84.72 153.89 22.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.271 1.029 . . . . 10.0 110.567 -170.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 60.17 3.92 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.295 -0.878 . . . . 10.0 111.103 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.67 128.59 26.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.777 1.231 . . . . 10.0 111.008 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -76.45 -72.97 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.642 0.777 . . . . 10.0 111.67 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -116.43 156.98 46.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.509 1.124 . . . . 10.0 111.912 -163.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.75 144.16 99.51 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.091 2.527 . . . . 10.0 111.76 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.0 mt -118.33 142.58 47.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.726 1.61 . . . . 10.0 109.497 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.37 129.01 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.01 107.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 163.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 120.35 -13.34 10.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.675 -0.57 . . . . 10.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.75 -179.54 3.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 123.589 1.661 . . . . 10.0 108.525 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -154.2 129.66 9.87 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.517 -1.674 . . . . 10.0 106.907 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.15 145.79 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.31 -1.367 . . . . 10.0 107.31 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -73.9 143.47 45.76 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.809 -0.557 . . . . 10.0 109.732 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 tt -118.4 139.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 168.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -111.5 108.26 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.91 161.97 19.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -149.9 95.28 2.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.78 133.51 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 170.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -77.23 3.81 12.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.21 -15.57 35.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.375 0.67 . . . . 10.0 111.042 156.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.7 47.38 1.29 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.119 1.818 . . . . 10.0 109.935 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -109.95 155.35 21.88 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 86.0 m -156.35 73.15 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 103.919 -2.623 . . . . 10.0 103.919 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.71 127.85 54.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -161.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -92.68 132.87 36.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.912 1.685 . . . . 10.0 107.471 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.1 152.67 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.767 -1.938 . . . . 10.0 105.767 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.75 29.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.05 119.87 38.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.518 0.727 . . . . 10.0 109.643 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -83.17 127.15 33.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.82 98.45 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -159.27 139.67 12.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -61.16 -51.48 68.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.643 1.349 . . . . 10.0 114.643 -170.338 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 65.47 110.68 0.03 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.525 1.13 . . . . 10.0 111.606 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.9 pt 43.73 53.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.322 1.049 . . . . 10.0 112.121 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.32 163.15 27.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.836 1.254 . . . . 10.0 108.244 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.16 28.27 70.4 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 108.733 -1.747 . . . . 10.0 108.733 -151.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 C--O 1.261 1.69 0 C-N-CA 130.198 3.399 . . . . 10.0 102.374 176.116 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.1 171.25 37.96 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.03 -2.028 . . . . 10.0 108.03 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -163.83 162.82 23.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.847 -1.538 . . . . 10.0 106.847 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -160.52 174.68 13.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.2 ttt -158.03 88.83 2.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.18 1.392 . . . . 10.0 108.389 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -70.99 158.02 56.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.925 1.75 . . . . 10.0 109.991 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.78 163.98 31.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -165.36 168.9 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -152.99 122.83 3.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 172.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.55 141.49 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.331 2.021 . . . . 10.0 109.896 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.56 165.52 31.46 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.33 2.02 . . . . 10.0 109.9 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.92 151.93 27.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.054 -1.091 . . . . 10.0 108.054 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -171.04 173.56 5.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.508 1.523 . . . . 10.0 107.453 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -164.27 -179.94 6.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.61 68.65 0.74 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.213 1.405 . . . . 10.0 109.935 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.56 146.51 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.248 1.965 . . . . 10.0 110.259 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.26 156.12 23.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.35 162.1 16.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.894 1.278 . . . . 10.0 107.569 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -147.75 168.25 22.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.799 1.24 . . . . 10.0 108.184 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 173.63 12.81 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 171.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.45 178.13 9.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.58 177.04 43.32 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.104 -1.998 . . . . 10.0 108.104 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.08 173.56 15.0 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.549 -1.278 . . . . 10.0 107.549 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -142.51 166.05 25.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.684 -1.228 . . . . 10.0 107.684 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.75 165.07 37.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.9 138.14 12.14 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.566 0.747 . . . . 10.0 109.035 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.41 173.08 13.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.815 2.343 . . . . 10.0 110.438 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -81.89 62.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.907 0.861 . . . . 10.0 111.333 -166.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -156.6 59.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.178 -0.952 . . . . 10.0 109.527 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.13 58.35 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 123.101 1.429 . . . . 10.0 110.336 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 138.76 16.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.271 -0.877 . . . . 10.0 109.542 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 166.1 54.82 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.435 -1.466 . . . . 10.0 109.435 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.02 156.28 22.42 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.026 0.913 . . . . 10.0 110.8 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.4 p -123.7 156.71 35.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.1 140.16 48.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 38.49 0.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.02 -145.23 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.351 1.06 . . . . 10.0 109.933 -171.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.6 t -92.15 108.28 29.42 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 105.236 -2.135 . . . . 10.0 105.236 155.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 166.63 27.97 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 N-CA-C 108.017 -1.571 . . . . 10.0 108.017 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.05 64.26 5.13 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.589 2.193 . . . . 10.0 110.441 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -166.99 58.91 0.08 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.05 1.34 . . . . 10.0 108.755 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm 76.3 164.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.795 1.638 . . . . 10.0 110.327 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -37.2 63.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.851 1.26 . . . . 10.0 111.768 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -47.22 148.9 1.1 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.147 1.779 . . . . 10.0 111.52 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.2 t -153.94 -167.11 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.141 -0.688 . . . . 10.0 109.141 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.68 158.23 43.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.965 0.906 . . . . 10.0 108.766 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.22 154.06 24.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 124.051 0.844 . . . . 10.0 109.167 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -122.04 123.24 41.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 103.691 -2.707 . . . . 10.0 103.691 166.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -156.97 -177.03 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 m -149.08 125.67 11.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.591 -1.262 . . . . 10.0 107.591 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.56 134.89 34.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.213 -1.773 . . . . 10.0 106.213 171.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -135.77 97.43 3.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.045 1.338 . . . . 10.0 108.628 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -84.1 152.61 24.23 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.713 0.688 . . . . 10.0 109.977 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -139.25 56.72 1.67 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.27 -1.752 . . . . 10.0 106.27 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.5 t -175.15 164.26 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.164 -2.532 . . . . 10.0 104.164 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.67 81.51 1.64 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.969 0.793 . . . . 10.0 108.952 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -146.38 148.95 36.14 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 124.666 1.186 . . . . 10.0 108.43 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.05 72.88 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.41 2.74 . . . . 10.0 109.761 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -83.29 156.99 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 165.44 28.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.475 0.71 . . . . 10.0 110.215 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.13 128.05 23.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.222 -2.51 . . . . 10.0 104.222 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.91 52.12 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 122.423 1.106 . . . . 10.0 108.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.47 150.77 20.67 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.366 -0.834 . . . . 10.0 111.269 165.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.47 61.96 0.55 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.804 2.442 . . . . 10.0 106.207 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.45 91.14 6.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 -172.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.1 t -104.88 133.6 20.07 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.795 1.238 . . . . 10.0 109.454 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.98 62.36 6.62 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.31 2.673 . . . . 10.0 109.001 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -162.97 -48.45 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.25 0.62 . . . . 10.0 111.093 -161.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.47 129.22 43.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -69.98 -34.04 72.85 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -128.84 73.07 81.55 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.19 0.996 . . . . 10.0 110.534 -170.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.8 122.68 9.07 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.198 1.932 . . . . 10.0 109.036 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.5 mtt -145.06 124.27 12.94 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.271 1.028 . . . . 10.0 110.015 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.8 mt -83.05 140.88 32.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.081 0.953 . . . . 10.0 109.925 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.9 ttm -141.07 152.17 44.6 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.596 1.158 . . . . 10.0 110.537 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -141.05 115.89 9.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.742 1.217 . . . . 10.0 111.284 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.31 0.5 OUTLIER -145.83 59.86 1.25 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.302 1.223 . . . . 10.0 114.302 164.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 t -143.84 120.83 11.37 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.416 -1.427 . . . . 10.0 109.854 171.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -77.59 61.5 2.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.224 1.41 . . . . 10.0 109.422 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.5 m -163.32 -58.15 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.045 1.338 . . . . 10.0 109.168 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.16 -93.43 1.71 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.663 -1.775 . . . . 10.0 108.663 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.72 97.93 2.02 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.354 0.978 . . . . 10.0 110.777 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -94.39 141.14 28.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 169.75 62.9 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 125.369 1.468 . . . . 10.0 109.817 145.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.2 37.94 4.71 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.045 1.307 . . . . 10.0 114.685 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 ttm 58.81 37.83 24.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.259 1.423 . . . . 10.0 111.64 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 161.78 14.27 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.353 0.661 . . . . 10.0 110.682 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.2 ttp -80.68 114.91 19.9 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.68 168.92 8.56 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -166.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -36.85 -58.15 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.246 2.631 . . . . 10.0 111.775 151.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 37.9 p90 166.54 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.555 2.742 . . . . 10.0 105.028 -169.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.92 106.79 11.96 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.62 0.768 . . . . 10.0 111.274 175.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.4 m -81.62 130.89 35.22 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 163.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -107.41 131.9 21.37 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.76 139.75 25.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.34 1.36 . . . . 10.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 59.45 -151.7 0.41 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.235 0.614 . . . . 10.0 112.319 159.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 51.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.411 . . . . 10.0 113.649 168.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.56 153.85 43.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.62 1.105 . . . . 10.0 111.843 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.6 t -146.48 90.63 1.96 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 162.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -84.69 160.87 20.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.016 -0.993 . . . . 10.0 110.316 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.2 m -130.89 99.5 4.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.85 122.92 28.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -155.63 154.55 31.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.984 1.313 . . . . 10.0 108.838 -170.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -70.54 76.6 0.58 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.979 0.512 . . . . 10.0 110.833 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 155.56 -94.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.771 3.628 . . . . 10.0 106.207 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.4 73.18 0.32 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.649 2.071 . . . . 10.0 113.898 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 67.22 134.66 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.024 2.53 . . . . 10.0 111.207 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -170.08 171.23 7.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.72 0.771 . . . . 10.0 112.004 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.8 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.698 -2.334 . . . . 10.0 104.698 167.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.5 mtm -82.83 144.43 30.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.964 -1.125 . . . . 10.0 107.964 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -120.25 78.79 1.39 Allowed 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 128.165 2.586 . . . . 10.0 105.154 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.8 mtt -83.69 154.56 23.59 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.15 54.54 32.13 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.22 141.48 57.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -104.43 -64.98 1.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.979 1.312 . . . . 10.0 109.464 -168.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -59.49 150.24 66.33 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 122.098 0.159 . . . . 10.0 110.914 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.42 102.89 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 N-CA-C 107.207 -1.882 . . . . 10.0 107.207 159.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 161.02 1.64 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.64 0.776 . . . . 10.0 113.034 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -133.13 129.39 37.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.178 -1.416 . . . . 10.0 107.178 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.77 94.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.574 -1.639 . . . . 10.0 106.574 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.9 15.65 8.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.618 1.104 . . . . 10.0 111.967 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 167.95 14.97 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.963 1.381 . . . . 10.0 107.791 159.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -155.1 77.41 1.01 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.218 -2.265 . . . . 10.0 107.877 -163.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -92.9 126.57 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 -169.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -75.02 123.47 25.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 12.6 pt -115.05 133.52 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.877 1.271 . . . . 10.0 108.525 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -91.03 125.81 35.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.068 -0.716 . . . . 10.0 109.068 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 24.8 mt -81.63 172.99 12.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -153.28 101.99 2.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.41 1.084 . . . . 10.0 108.158 164.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.9 149.05 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 162.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -42.04 -35.98 1.02 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.234 1.014 . . . . 10.0 111.493 168.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -11.33 9.32 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.682 2.793 . . . . 10.0 112.256 -175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.73 7.87 70.77 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -82.23 73.41 9.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.581 -1.266 . . . . 10.0 107.581 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -84.22 66.56 9.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.765 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.6 174.42 11.6 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.039 0.936 . . . . 10.0 109.125 -167.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -120.94 128.64 52.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.73 143.43 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.007 -1.108 . . . . 10.0 108.007 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -84.92 126.62 33.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.611 -0.885 . . . . 10.0 108.611 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.1 110.55 22.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.334 1.454 . . . . 10.0 109.323 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -88.77 105.63 17.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.249 1.42 . . . . 10.0 108.968 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.94 95.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 -168.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 57.48 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.943 1.247 . . . . 10.0 114.323 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt 62.04 169.91 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 122.584 1.183 . . . . 10.0 114.06 170.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -75.09 95.22 3.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.0 mt 75.17 -47.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.311 1.844 . . . . 10.0 111.963 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -34.48 123.52 0.52 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.586 1.954 . . . . 10.0 113.178 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 -96.61 0.7 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.268 -1.133 . . . . 10.0 110.268 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.188 1.795 . . . . 10.0 106.578 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.4 162.15 16.22 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.212 -1.155 . . . . 10.0 110.212 -168.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -109.13 -159.9 0.7 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.364 1.466 . . . . 10.0 109.027 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -155.62 -175.94 5.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.558 -1.645 . . . . 10.0 106.558 165.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.9 ptm -155.94 146.43 16.07 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 124.5 1.12 . . . . 10.0 108.845 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.61 165.02 29.6 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.729 2.286 . . . . 10.0 110.63 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 71.55 1.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.357 0.663 . . . . 10.0 109.26 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -70.01 74.74 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.105 0.962 . . . . 10.0 111.818 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -58.05 144.6 75.45 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -66.49 157.37 60.88 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 N-CA-C 108.529 -1.373 . . . . 10.0 108.529 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.81 -179.36 5.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.398 2.732 . . . . 10.0 109.848 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.16 151.47 40.14 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -117.92 158.88 24.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.126 0.97 . . . . 10.0 110.406 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -164.7 169.41 16.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.12 144.7 4.81 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.787 0.835 . . . . 10.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -80.46 -172.29 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.236 2.624 . . . . 10.0 109.636 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.83 161.89 35.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 133.89 11.7 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.187 0.595 . . . . 10.0 109.574 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -60.27 161.9 6.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.099 1.36 . . . . 10.0 111.165 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -145.33 -175.22 4.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.146 1.379 . . . . 10.0 107.725 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.04 54.88 6.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.024 0.93 . . . . 10.0 111.389 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.05 70.49 1.0 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.64 69.82 0.44 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.219 1.408 . . . . 10.0 111.085 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.68 87.91 0.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.014 1.726 . . . . 10.0 109.457 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -171.92 -44.44 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.004 1.321 . . . . 10.0 110.919 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.7 127.5 87.23 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 121.984 -0.447 . . . . 10.0 110.429 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.58 166.77 28.63 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.388 2.059 . . . . 10.0 110.356 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.19 60.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.141 0.976 . . . . 10.0 110.567 -166.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -157.12 58.19 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.297 -0.877 . . . . 10.0 109.358 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.36 56.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.078 0.942 . . . . 10.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -149.92 136.14 18.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.636 -1.246 . . . . 10.0 107.636 167.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.17 132.77 23.74 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.083 -1.607 . . . . 10.0 109.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.72 150.94 19.99 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.479 0.64 . . . . 10.0 111.633 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 p -116.53 123.68 48.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.962 0.905 . . . . 10.0 108.646 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.22 121.53 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.568 0.747 . . . . 10.0 109.687 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.14 4.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.685 -0.634 . . . . 10.0 111.467 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -41.04 122.64 1.81 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.636 0.653 . . . . 10.0 110.266 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -33.65 124.27 0.46 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 116.032 1.864 . . . . 10.0 116.032 -144.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.31 165.83 2.83 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.929 2.42 . . . . 10.0 112.512 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -79.0 54.51 5.2 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.187 1.925 . . . . 10.0 109.346 163.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.7 p -139.49 51.67 1.75 Allowed 'General case' 0 C--N 1.341 0.225 0 O-C-N 121.477 -0.764 . . . . 10.0 110.576 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.9 mt 86.5 173.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 127.608 2.363 . . . . 10.0 106.794 -167.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -72.57 50.63 0.24 Allowed 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.019 -1.05 . . . . 10.0 110.271 165.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.59 158.69 19.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.766 1.226 . . . . 10.0 109.432 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -157.82 169.15 25.27 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 157.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.01 153.23 25.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -173.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.91 147.49 23.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.469 1.106 . . . . 10.0 108.523 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -126.9 127.08 44.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.531 -2.396 . . . . 10.0 104.531 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.2 ptm -161.38 -174.63 4.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 10.0 107.06 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -125.5 117.35 23.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.049 0.94 . . . . 10.0 108.848 171.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.86 113.2 20.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.2 m -122.42 95.34 4.6 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.783 1.927 . . . . 10.0 108.616 -162.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -83.65 140.66 32.04 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.064 -0.397 . . . . 10.0 112.004 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -143.75 60.46 1.38 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -151.28 -39.95 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.916 1.286 . . . . 10.0 111.063 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t70 65.97 60.83 0.66 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.556 1.942 . . . . 10.0 110.339 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -140.89 152.15 64.67 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.256 1.823 . . . . 10.0 107.643 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.31 92.82 0.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.123 2.549 . . . . 10.0 110.658 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.96 145.85 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.412 0.625 . . . . 10.0 110.536 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -131.84 83.17 2.07 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.375 2.27 . . . . 10.0 109.792 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.56 72.55 9.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.359 -0.838 . . . . 10.0 111.293 -172.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.08 56.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 121.776 -0.577 . . . . 10.0 110.908 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.39 28.21 Favored Glycine 0 C--N 1.334 0.437 0 O-C-N 121.096 -1.002 . . . . 10.0 111.258 162.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 60.38 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.099 0.96 . . . . 10.0 109.338 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.58 162.03 23.29 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.199 -0.938 . . . . 10.0 109.3 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 147.66 3.55 Favored Pre-proline 0 C--O 1.238 0.496 0 O-C-N 121.831 -0.543 . . . . 10.0 109.54 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.04 57.51 6.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.669 2.246 . . . . 10.0 109.038 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -143.42 -70.06 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.182 0.593 . . . . 10.0 109.983 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.33 167.03 11.93 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.911 1.284 . . . . 10.0 110.798 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.6 m -101.89 -39.83 7.18 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.601 1.16 . . . . 10.0 112.168 -157.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -108.95 90.91 8.32 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.533 1.133 . . . . 10.0 109.726 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.55 90.51 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.008 2.472 . . . . 10.0 109.862 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -108.91 114.19 27.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.849 0.833 . . . . 10.0 109.637 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.24 134.22 36.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.728 -0.841 . . . . 10.0 108.728 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.84 174.98 6.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.605 1.562 . . . . 10.0 108.035 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.2 t -159.88 135.06 8.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 173.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.96 56.75 0.53 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 122.507 1.146 . . . . 10.0 107.961 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.6 m -149.58 123.36 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.726 0.81 . . . . 10.0 109.848 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -70.47 80.95 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.7 t 143.9 -9.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.684 3.193 . . . . 10.0 110.507 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.54 -140.7 9.26 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.204 -1.558 . . . . 10.0 109.204 169.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.76 -54.25 39.14 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.633 -0.587 . . . . 10.0 111.633 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.3 tpt -169.92 -166.32 0.55 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.022 2.129 . . . . 10.0 107.479 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -121.69 60.58 0.95 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.65 89.47 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.455 -1.058 . . . . 10.0 110.455 -163.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -76.65 64.65 2.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.196 0.998 . . . . 10.0 110.687 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 167.75 10.71 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.832 2.053 . . . . 10.0 108.181 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.9 mtt -78.83 85.34 4.82 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.012 -1.477 . . . . 10.0 107.012 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.51 156.25 88.89 Favored Pre-proline 0 N--CA 1.453 -0.315 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -51.33 -38.55 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.866 2.377 . . . . 10.0 111.144 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 30.6 p90 -176.8 171.89 2.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.71 2.404 . . . . 10.0 104.872 174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.76 98.11 8.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.34 131.12 37.94 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.95 109.77 60.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.43 69.8 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.723 2.282 . . . . 10.0 110.189 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.73 175.29 0.2 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 -167.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 35.72 23.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 118.651 2.834 . . . . 10.0 118.651 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -45.92 102.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.411 1.005 . . . . 10.0 112.057 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -131.25 55.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.925 -1.88 . . . . 10.0 105.925 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.7 164.29 11.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.2 m -128.85 114.74 16.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.997 -2.223 . . . . 10.0 104.997 -168.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.19 110.34 14.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.552 -2.388 . . . . 10.0 104.552 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -130.99 148.51 52.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.698 1.999 . . . . 10.0 108.981 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -26.56 -53.15 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.159 2.184 . . . . 10.0 113.896 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -139.95 64.85 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.389 0.676 . . . . 10.0 109.622 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.12 66.46 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t0 65.34 149.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.462 1.505 . . . . 10.0 109.824 -165.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 160.66 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.478 1.911 . . . . 10.0 111.539 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.56 128.26 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.191 -1.781 . . . . 10.0 106.191 166.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.5 mtm -92.63 109.06 20.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 168.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.32 77.6 9.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.224 -1.769 . . . . 10.0 106.224 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.76 154.34 23.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.86 74.65 1.26 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 121.212 -0.93 . . . . 10.0 110.992 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.24 138.64 16.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.664 1.232 . . . . 10.0 111.626 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -79.86 -59.39 2.75 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 162.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 179.11 -59.64 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.553 1.141 . . . . 10.0 112.763 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.68 89.11 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.84 1.694 . . . . 10.0 111.557 -166.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.82 156.53 44.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.832 1.253 . . . . 10.0 109.05 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.67 145.88 7.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.62 105.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.916 -1.512 . . . . 10.0 106.916 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.54 -60.83 0.26 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -71.99 -174.11 1.16 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.933 3.293 . . . . 10.0 111.618 -163.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.0 m -133.87 128.33 34.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.149 1.78 . . . . 10.0 106.664 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.53 140.09 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -77.97 126.21 30.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.319 -0.993 . . . . 10.0 108.319 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -80.28 179.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.23 -1.767 . . . . 10.0 106.23 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.4 m -144.31 114.24 7.31 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.835 -1.166 . . . . 10.0 108.838 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 140.85 31.62 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -147.08 86.5 1.64 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.129 -1.434 . . . . 10.0 107.129 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.06 145.76 28.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.339 0.256 . . . . 10.0 110.919 -169.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -56.39 -24.58 45.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.553 1.141 . . . . 10.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.77 -26.63 14.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.778 1.231 . . . . 10.0 113.238 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.65 52.33 1.22 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 109.75 -1.34 . . . . 10.0 109.75 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -144.78 160.45 41.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 m -131.45 143.79 50.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.6 tp -151.96 154.56 36.29 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -137.98 62.51 1.57 Allowed 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.527 1.531 . . . . 10.0 109.706 -161.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.66 141.11 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.57 124.63 30.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.01 130.61 54.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.057 0.943 . . . . 10.0 109.945 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -84.34 126.75 33.49 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 7.8 t -87.12 100.78 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -146.59 123.14 11.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.366 1.866 . . . . 10.0 108.194 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.68 -50.6 69.84 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.591 0.756 . . . . 10.0 110.36 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 62.0 -171.56 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.133 -0.692 . . . . 10.0 109.133 -159.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.3 pt -67.26 145.2 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -149.17 -179.42 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.81 56.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.634 -1.387 . . . . 10.0 109.634 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 C--O 1.262 1.721 0 N-CA-C 102.404 -3.184 . . . . 10.0 102.404 -135.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.28 -178.79 47.61 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.369 -2.292 . . . . 10.0 107.369 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -160.01 164.25 33.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.0 m -152.53 147.06 25.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.61 151.69 54.53 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.329 1.452 . . . . 10.0 108.561 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.27 177.03 7.77 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.642 2.228 . . . . 10.0 110.52 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.68 30.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -148.72 176.18 10.58 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.598 1.159 . . . . 10.0 108.042 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -154.07 135.45 8.84 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 106.846 -1.539 . . . . 10.0 106.846 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.86 159.42 48.28 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.167 1.911 . . . . 10.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.81 -178.69 4.29 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.231 2.621 . . . . 10.0 110.448 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.47 164.89 28.67 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.915 1.286 . . . . 10.0 107.649 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -144.25 166.94 23.64 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.582 1.153 . . . . 10.0 108.339 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 p -138.74 141.52 38.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.528 1.531 . . . . 10.0 107.396 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.83 149.76 66.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.495 1.118 . . . . 10.0 108.941 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.85 178.41 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.136 2.557 . . . . 10.0 110.692 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.1 166.52 32.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.96 1.304 . . . . 10.0 107.613 174.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.16 168.84 21.85 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.634 1.174 . . . . 10.0 107.923 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.33 148.6 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.94 136.96 7.2 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.05 1.34 . . . . 10.0 107.748 174.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.77 172.29 17.96 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.302 -1.369 . . . . 10.0 107.302 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.67 -160.01 28.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.303 -1.119 . . . . 10.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.32 -157.11 0.27 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 10.0 110.146 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 59.57 -143.21 0.58 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.195 0.598 . . . . 10.0 109.712 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.47 148.6 26.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tt -94.48 122.07 61.89 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.85 159.35 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.907 1.738 . . . . 10.0 109.607 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.5 m -82.45 53.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.229 0.538 . . . . 10.0 112.073 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.7 p -157.3 62.27 0.49 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -108.85 60.09 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 10.0 109.257 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -133.6 144.4 49.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.961 0.905 . . . . 10.0 110.954 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.94 86.84 1.11 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.38 139.84 29.18 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.809 0.444 . . . . 10.0 111.941 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -117.3 140.51 49.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.0 134.25 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.69 120.96 12.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.96 -68.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.0 110.322 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -142.43 104.96 5.48 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.728 1.611 . . . . 10.0 107.541 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -64.94 164.89 23.08 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.549 2.166 . . . . 10.0 109.882 171.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.75 66.71 5.77 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.784 2.989 . . . . 10.0 109.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -156.32 -48.01 0.07 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.064 2.146 . . . . 10.0 106.628 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mt 72.03 147.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.244 1.818 . . . . 10.0 108.672 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 75.53 -49.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.271 1.429 . . . . 10.0 111.766 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -79.67 153.94 28.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 168.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -171.9 172.57 4.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.144 1.378 . . . . 10.0 109.177 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 48' ' ' TYR . . . -157.07 161.76 39.47 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.61 0.764 . . . . 10.0 111.816 -172.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.03 140.4 29.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 124.401 1.063 . . . . 10.0 109.441 167.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 46' ' ' ALA . 25.7 m-85 -136.18 112.83 10.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.392 -1.336 . . . . 10.0 107.392 -174.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -163.48 -172.23 2.85 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 125.149 1.38 . . . . 10.0 109.396 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -125.11 121.63 34.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 10.0 109.868 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.81 135.69 34.89 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 120.188 1.358 . . . . 10.0 107.62 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -117.75 78.53 1.25 Allowed 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.806 1.316 . . . . 10.0 109.876 -169.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.47 100.33 8.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.438 0.637 . . . . 10.0 109.867 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -109.4 54.68 0.65 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.11 0.964 . . . . 10.0 109.68 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 p -177.89 148.0 0.5 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 175.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -88.87 69.32 8.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.772 0.829 . . . . 10.0 109.576 -173.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.97 127.18 23.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.18 99.81 1.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.362 2.708 . . . . 10.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.9 141.79 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -126.62 97.37 4.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.011 1.325 . . . . 10.0 108.516 171.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.42 132.61 35.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 175.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.18 53.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.3 158.94 31.75 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.63 -0.988 . . . . 10.0 110.63 163.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.87 127.21 6.5 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 158.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.46 144.06 23.48 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -172.55 155.99 3.37 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 118.352 0.524 . . . . 10.0 111.223 -163.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.27 -5.5 13.98 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.802 2.334 . . . . 10.0 112.599 164.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.66 -57.26 4.25 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.505 1.048 . . . . 10.0 111.892 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.51 161.07 37.38 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.554 1.141 . . . . 10.0 111.871 -168.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -93.46 -41.31 9.86 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.701 1.2 . . . . 10.0 111.74 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t -115.86 82.45 10.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.685 1.594 . . . . 10.0 109.498 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.75 107.5 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.897 2.398 . . . . 10.0 109.988 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.8 mmt -122.76 122.19 38.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.418 1.487 . . . . 10.0 109.352 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.15 138.33 33.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.726 0.81 . . . . 10.0 109.292 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.03 12.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.877 1.271 . . . . 10.0 110.137 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -139.74 119.86 13.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.88 -1.155 . . . . 10.0 107.88 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -141.18 48.29 1.68 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.3 m -156.43 80.54 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.058 -1.026 . . . . 10.0 109.799 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.57 86.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.257 1.023 . . . . 10.0 110.592 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 165.89 -41.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 127.452 2.301 . . . . 10.0 108.486 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.41 -83.34 1.32 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.168 -2.773 . . . . 10.0 106.168 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.02 -138.62 6.1 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.053 -1.219 . . . . 10.0 110.053 160.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.2 mmt -108.06 -161.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.155 2.182 . . . . 10.0 109.79 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.55 76.26 1.48 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.63 82.32 0.16 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.686 -1.365 . . . . 10.0 109.686 -170.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -77.64 60.61 2.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.159 0.981 . . . . 10.0 110.386 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -125.62 170.96 10.98 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.444 2.298 . . . . 10.0 107.481 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.8 mtt -80.24 72.87 7.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.87 155.8 75.91 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.076 -0.966 . . . . 10.0 109.62 176.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -60.69 -25.71 81.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.225 1.95 . . . . 10.0 112.359 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -175.73 179.57 1.37 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.394 1.878 . . . . 10.0 106.451 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -113.77 106.81 14.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.56 150.81 34.7 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.99 88.8 27.68 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.88 57.72 6.55 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.904 3.069 . . . . 10.0 110.718 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.47 154.95 0.06 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.698 1.237 . . . . 10.0 110.108 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 40.3 39.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.201 1.401 . . . . 10.0 114.733 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 69.56 0.17 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.619 -0.993 . . . . 10.0 110.619 160.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -84.55 57.0 4.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.324 -1.361 . . . . 10.0 107.324 167.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.76 171.62 8.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.849 0.833 . . . . 10.0 110.54 -167.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 t -128.4 128.98 45.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.147 -2.168 . . . . 10.0 105.147 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.92 103.58 9.73 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 104.092 -2.558 . . . . 10.0 104.092 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -147.42 175.21 10.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.685 -1.598 . . . . 10.0 106.685 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -39.63 -50.15 2.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.208 0.527 . . . . 10.0 111.877 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -98.76 16.15 23.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.219 2.608 . . . . 10.0 113.911 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.35 151.67 23.89 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 120.559 1.527 . . . . 10.0 111.362 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -34.98 97.41 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.043 1.737 . . . . 10.0 113.633 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -128.29 174.67 9.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.728 1.149 . . . . 10.0 112.003 -166.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.91 107.97 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.6 mtt -84.1 102.72 12.75 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 122.297 1.046 . . . . 10.0 108.906 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.54 70.0 10.18 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 105.669 -1.974 . . . . 10.0 105.669 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.5 ttm -83.72 148.53 27.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 -168.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.34 59.65 2.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.612 -1.395 . . . . 10.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 tt -50.47 128.06 19.12 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.307 1.843 . . . . 10.0 110.241 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.61 -71.64 0.54 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.071 0.549 . . . . 10.0 110.146 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.61 158.0 73.99 Favored Pre-proline 0 CA--C 1.533 0.319 0 O-C-N 121.982 -0.449 . . . . 10.0 110.135 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.3 73.86 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.317 2.012 . . . . 10.0 109.152 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.76 132.3 17.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 112.789 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -96.35 129.63 43.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.336 1.454 . . . . 10.0 109.492 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.4 105.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.08 16.2 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.912 -0.938 . . . . 10.0 112.313 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.19 -178.47 1.67 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.727 1.727 . . . . 10.0 108.735 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.9 m -155.66 124.59 6.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.614 -1.995 . . . . 10.0 105.614 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.97 145.14 29.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.92 130.33 39.2 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.162 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.9 pt -106.91 122.0 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 160.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 m -101.16 119.98 39.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 169.12 8.74 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.645 0.778 . . . . 10.0 110.029 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.65 96.6 2.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.17 1.788 . . . . 10.0 107.872 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.63 132.18 34.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.395 -0.595 . . . . 10.0 109.395 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 t -60.91 -15.49 31.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.262 0.625 . . . . 10.0 111.388 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.406 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 54.6 m-20 -67.17 -21.14 65.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.906 0.883 . . . . 10.0 112.059 171.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 131.33 -13.05 5.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.099 0.857 . . . . 10.0 112.418 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -81.07 73.02 8.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.872 1.336 . . . . 10.0 109.356 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.6 m -83.61 107.05 15.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 156.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.4 tp -156.11 149.42 24.56 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -106.22 131.03 53.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.295 2.238 . . . . 10.0 106.826 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.23 122.93 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.321 -1.733 . . . . 10.0 106.321 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.8 108.28 16.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.22 29.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.626 0.77 . . . . 10.0 109.665 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -82.26 127.21 32.97 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.342 -0.985 . . . . 10.0 108.342 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.1 t -90.0 91.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.204 -1.776 . . . . 10.0 106.204 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -158.67 140.01 13.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 166.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.07 153.12 39.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -145.53 141.02 27.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.023 -2.214 . . . . 10.0 105.023 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.4 pt 44.85 37.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.252 1.421 . . . . 10.0 112.315 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -150.28 95.26 2.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.101 -1.444 . . . . 10.0 107.101 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.53 -59.03 4.12 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.077 -1.609 . . . . 10.0 109.077 -162.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 105.472 -2.048 . . . . 10.0 105.472 161.062 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 106.657 -1.608 . . . . 10.0 106.657 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.49 152.95 8.61 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -168.88 172.24 7.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 t -160.75 179.37 8.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.729 . . . . 10.0 109.408 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.24 74.85 0.73 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.363 1.865 . . . . 10.0 108.042 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.82 154.85 67.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.894 1.729 . . . . 10.0 109.757 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.62 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -158.25 167.63 29.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.04 -1.467 . . . . 10.0 107.04 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -157.23 69.06 4.33 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.149 1.379 . . . . 10.0 108.566 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.35 151.69 82.7 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.187 1.925 . . . . 10.0 110.639 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.89 176.12 10.3 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.197 2.598 . . . . 10.0 111.03 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.3 164.81 29.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.058 1.343 . . . . 10.0 107.529 173.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -161.14 164.03 30.9 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -156.25 -175.25 5.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.98 87.14 2.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.831 1.252 . . . . 10.0 109.344 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.5 162.8 39.19 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.242 1.961 . . . . 10.0 110.599 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.19 171.96 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.258 1.423 . . . . 10.0 107.302 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.85 166.05 32.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.864 0.866 . . . . 10.0 108.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -78.33 -172.55 2.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.397 0.679 . . . . 10.0 110.332 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -156.47 174.48 15.37 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.241 1.016 . . . . 10.0 108.459 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.07 -146.75 0.44 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.432 1.093 . . . . 10.0 110.574 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.34 -63.12 2.6 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.241 -0.743 . . . . 10.0 111.241 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.72 97.22 0.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.446 0.698 . . . . 10.0 110.04 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.23 75.36 0.71 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.463 0.705 . . . . 10.0 110.941 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -158.13 172.82 17.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.442 1.897 . . . . 10.0 106.769 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tt -143.27 128.89 10.08 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 118.597 0.635 . . . . 10.0 109.739 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.86 177.48 8.75 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.634 2.222 . . . . 10.0 109.647 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.32 61.29 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.277 1.037 . . . . 10.0 111.647 -166.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -158.03 74.81 0.73 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.1 53.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 122.151 0.977 . . . . 10.0 110.281 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -152.7 139.11 18.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 163.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 147.62 35.55 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.092 -1.203 . . . . 10.0 110.092 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.12 152.52 29.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 10.0 110.443 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -133.44 125.73 29.67 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.751 -1.574 . . . . 10.0 106.751 170.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.47 137.84 45.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.436 1.095 . . . . 10.0 110.012 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.94 2.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.227 -0.589 . . . . 10.0 111.808 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.79 114.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.574 1.15 . . . . 10.0 111.286 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t 2.9 94.57 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.134 2.574 . . . . 10.0 113.365 -167.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.23 169.22 20.02 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.95 1.767 . . . . 10.0 108.487 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.74 60.11 4.31 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.812 2.341 . . . . 10.0 109.887 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -160.17 40.61 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.234 1.414 . . . . 10.0 108.429 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 mm 69.48 -179.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.034 1.333 . . . . 10.0 109.081 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -55.55 -29.11 58.38 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.064 0.946 . . . . 10.0 112.108 176.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.42 135.9 7.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.784 1.634 . . . . 10.0 109.67 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 t -160.82 -171.21 3.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -156.29 167.41 30.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.403 1.081 . . . . 10.0 109.828 170.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.67 153.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.909 0.755 . . . . 10.0 111.208 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CZ ' ' HA ' ' A' ' 104' ' ' ARG . 33.0 m-85 -138.52 112.33 8.39 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.571 -1.64 . . . . 10.0 106.571 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -162.25 -171.96 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.02 1.728 . . . . 10.0 107.634 -168.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -128.01 145.72 50.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.648 0.658 . . . . 10.0 111.592 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.35 113.31 25.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.403 -2.073 . . . . 10.0 105.403 156.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.03 82.17 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.66 137.47 34.46 Favored 'General case' 0 C--N 1.337 0.06 0 O-C-N 121.689 -0.632 . . . . 10.0 110.335 -168.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -128.48 54.66 1.74 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -158.33 128.88 6.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.584 1.954 . . . . 10.0 105.774 170.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.59 61.92 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.863 0.865 . . . . 10.0 110.119 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -134.27 135.98 25.1 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.392 1.477 . . . . 10.0 108.602 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.15 100.58 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.495 2.796 . . . . 10.0 111.167 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.26 95.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.73 117.68 22.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.748 0.819 . . . . 10.0 110.604 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 123.37 33.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.424 1.49 . . . . 10.0 107.88 -174.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.42 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 7.1 p -143.54 55.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.695 0.759 . . . . 10.0 110.425 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.01 148.45 16.41 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.472 -1.451 . . . . 10.0 109.472 162.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.97 75.83 0.84 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.13 0.972 . . . . 10.0 109.029 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.53 157.52 16.18 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.498 0.719 . . . . 10.0 109.676 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -172.54 143.27 1.21 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.94 60.97 6.27 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.242 2.628 . . . . 10.0 109.777 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.68 -51.64 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.435 1.094 . . . . 10.0 108.471 -164.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.43 168.69 10.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.475 1.91 . . . . 10.0 109.837 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 m -134.6 -2.31 2.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.311 0.644 . . . . 10.0 112.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 m -152.11 70.44 7.71 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.852 -1.155 . . . . 10.0 109.885 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.61 128.9 11.35 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.84 2.36 . . . . 10.0 111.29 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 mmt -139.64 128.73 23.73 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.999 1.32 . . . . 10.0 109.453 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.46 136.87 33.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.683 0.793 . . . . 10.0 109.673 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.67 -179.36 3.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.875 1.67 . . . . 10.0 108.93 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.0 t -158.88 100.8 1.6 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.485 0.714 . . . . 10.0 109.687 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 t -149.96 56.82 0.96 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.257 -0.902 . . . . 10.0 109.24 -169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -124.46 146.36 48.98 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.926 1.29 . . . . 10.0 108.91 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -101.74 44.92 0.99 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.0 t -163.93 -52.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.243 0.617 . . . . 10.0 111.184 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.88 -110.4 0.57 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.24 -144.86 0.35 Allowed Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.098 0.949 . . . . 10.0 113.699 170.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.4 ttm -75.82 162.88 27.78 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.865 1.266 . . . . 10.0 109.952 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.6 49.94 0.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.999 1.72 . . . . 10.0 107.756 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.7 92.25 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.565 -1.014 . . . . 10.0 110.565 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 ttp -64.21 84.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.554 1.177 . . . . 10.0 112.052 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -133.28 156.66 47.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.214 2.606 . . . . 10.0 106.769 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.4 mtm -80.38 143.49 33.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.913 -1.514 . . . . 10.0 106.913 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.93 165.1 29.96 Favored Pre-proline 0 N--CA 1.455 -0.205 0 C-N-CA 123.686 0.794 . . . . 10.0 109.776 -171.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -43.51 -54.37 3.67 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.686 2.257 . . . . 10.0 110.404 158.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.42 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 175.36 -149.58 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.151 2.181 . . . . 10.0 108.613 -177.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.86 158.27 43.87 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.332 1.853 . . . . 10.0 106.054 160.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.5 m -97.47 124.57 41.73 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.52 -0.918 . . . . 10.0 108.52 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.49 121.73 68.05 Favored Pre-proline 0 N--CA 1.454 -0.232 0 N-CA-C 105.325 -2.102 . . . . 10.0 105.325 171.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.97 146.15 16.03 Favored 'Trans proline' 0 N--CA 1.441 -1.571 0 N-CA-C 109.261 -1.092 . . . . 10.0 109.261 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 47.36 -138.4 0.71 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.958 0.903 . . . . 10.0 112.539 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.67 32.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.747 2.419 . . . . 10.0 114.494 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.8 150.76 38.6 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.994 -1.066 . . . . 10.0 113.075 -169.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -132.01 61.66 1.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.988 1.315 . . . . 10.0 108.359 -171.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.65 148.58 30.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.9 m -135.47 107.54 7.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.22 114.35 18.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -131.53 159.75 37.27 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.249 1.42 . . . . 10.0 109.845 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.408 ' HA ' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -25.0 -65.26 0.05 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.201 2.2 . . . . 10.0 113.566 -173.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.09 80.63 1.84 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.377 -1.712 . . . . 10.0 106.377 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.83 86.76 0.1 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 108.86 -1.696 . . . . 10.0 108.86 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 t0 40.95 74.61 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.129 1.771 . . . . 10.0 112.176 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -131.07 172.31 12.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.332 -1.758 . . . . 10.0 110.867 -154.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.7 108.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 125.668 1.587 . . . . 10.0 108.715 -173.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 33.0 mtp -83.04 96.39 8.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.405 0.682 . . . . 10.0 109.723 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.48 70.17 7.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.809 -1.552 . . . . 10.0 106.809 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.22 164.99 22.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.431 -1.322 . . . . 10.0 107.431 -168.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.28 46.57 20.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.323 -1.111 . . . . 10.0 110.323 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.4 mt -55.27 130.27 41.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.737 1.268 . . . . 10.0 108.917 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -69.17 0.13 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.506 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 173.97 -63.63 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.221 1.409 . . . . 10.0 112.91 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.09 50.14 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.544 2.163 . . . . 10.0 112.741 -159.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.54 157.01 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.212 1.005 . . . . 10.0 110.52 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 171.93 7.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.954 -1.128 . . . . 10.0 107.954 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.27 128.09 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 163.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 33.17 39.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.499 -0.64 . . . . 10.0 111.499 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.96 -172.7 4.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.462 1.125 . . . . 10.0 108.486 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.6 m -155.81 124.78 6.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.027 1.731 . . . . 10.0 107.499 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.89 152.5 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.96 -1.496 . . . . 10.0 106.96 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -70.87 132.23 44.95 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.0 154.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 106.125 -1.805 . . . . 10.0 106.125 155.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -129.82 128.49 42.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 158.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.41 156.39 24.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -147.7 69.41 1.14 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.69 117.69 21.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p 40.95 -99.79 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.585 1.554 . . . . 10.0 109.896 -167.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 42.79 0.93 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.27 2.228 . . . . 10.0 107.411 170.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.09 -48.12 0.23 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.22 1.866 . . . . 10.0 110.166 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -115.1 73.2 0.82 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.093 0.947 . . . . 10.0 108.637 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 m -86.29 100.94 12.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 160.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 mt -155.3 164.41 38.81 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 122.736 0.415 . . . . 10.0 110.547 -165.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -132.46 65.28 1.59 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.712 2.005 . . . . 10.0 109.553 -159.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.7 t -81.71 149.3 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 -171.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.32 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.151 -0.968 . . . . 10.0 109.626 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.66 120.48 40.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.844 1.258 . . . . 10.0 109.739 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -83.78 148.47 27.01 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 166.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.73 100.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -156.8 126.81 6.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.294 0.952 . . . . 10.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 98.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.441 0.564 . . . . 10.0 111.39 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -72.45 75.84 1.04 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.496 0.718 . . . . 10.0 109.958 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.5 mt 67.5 77.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.45 1.1 . . . . 10.0 108.877 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -145.91 105.93 4.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.56 -64.31 3.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.27 -1.932 . . . . 10.0 108.27 -158.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 105.886 -1.894 . . . . 10.0 105.886 165.465 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 117.907 -1.044 . . . . 10.0 108.374 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.96 76.59 1.16 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.519 -1.032 . . . . 10.0 110.519 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -155.25 157.5 37.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.246 -1.39 . . . . 10.0 107.246 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -173.51 -178.56 1.68 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.611 1.564 . . . . 10.0 107.87 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.56 75.55 0.29 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.387 1.875 . . . . 10.0 108.435 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.18 145.15 30.49 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.241 1.961 . . . . 10.0 110.062 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.66 161.17 23.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.272 1.029 . . . . 10.0 108.29 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -163.45 177.71 8.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.853 -1.536 . . . . 10.0 106.853 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -167.99 68.06 0.81 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.408 1.083 . . . . 10.0 109.724 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.06 121.47 8.65 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.321 2.014 . . . . 10.0 110.19 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.89 168.58 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.86 2.373 . . . . 10.0 111.28 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.74 36.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.19 1.396 . . . . 10.0 107.438 172.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -172.58 172.31 4.31 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.185 1.394 . . . . 10.0 108.289 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -164.43 -179.27 5.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.881 1.272 . . . . 10.0 107.6 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 74.41 0.53 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.461 1.505 . . . . 10.0 109.773 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.72 130.76 18.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.371 2.047 . . . . 10.0 111.301 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.06 86.88 0.56 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.31 0.644 . . . . 10.0 109.815 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.34 0.15 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.865 1.266 . . . . 10.0 112.677 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -74.94 70.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.772 1.229 . . . . 10.0 109.921 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -71.04 75.94 0.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.963 0.905 . . . . 10.0 110.873 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.25 78.5 0.06 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.74 1.216 . . . . 10.0 111.061 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.49 120.67 5.09 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.897 1.236 . . . . 10.0 112.252 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.4 1.53 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.131 0.972 . . . . 10.0 111.698 -175.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 73.71 147.7 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.572 1.949 . . . . 10.0 112.445 172.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.24 167.55 30.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.302 1.041 . . . . 10.0 108.495 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.68 158.04 73.89 Favored Pre-proline 0 N--CA 1.443 -0.812 0 C-N-CA 125.602 1.561 . . . . 10.0 107.439 172.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 -36.11 1.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.177 1.251 . . . . 10.0 111.462 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -135.89 172.49 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 122.679 1.228 . . . . 10.0 112.047 -171.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -78.43 66.26 3.94 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.526 3.131 . . . . 10.0 108.929 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.75 88.96 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.154 1.382 . . . . 10.0 108.951 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -147.94 134.42 19.71 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.67 154.81 47.59 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.589 1.09 . . . . 10.0 112.497 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.42 162.48 13.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.641 0.734 . . . . 10.0 112.22 -170.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 p -139.63 157.98 44.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.557 -1.275 . . . . 10.0 107.557 164.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.91 136.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.243 -1.392 . . . . 10.0 107.243 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.51 40.75 0.74 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.794 -1.191 . . . . 10.0 112.998 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.107 1.363 . . . . 10.0 110.111 -164.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.58 125.46 47.02 Favored Pre-proline 0 C--O 1.239 0.517 0 CA-C-N 120.095 1.316 . . . . 10.0 107.841 160.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.19 174.06 4.47 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.261 1.974 . . . . 10.0 108.693 162.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.95 54.84 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.215 1.943 . . . . 10.0 109.801 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 m -144.29 62.6 1.34 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.978 1.311 . . . . 10.0 107.711 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 mm 73.72 164.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.923 1.289 . . . . 10.0 109.723 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -77.38 50.07 0.76 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.217 1.407 . . . . 10.0 109.862 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -138.72 159.81 41.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.059 2.144 . . . . 10.0 108.46 -162.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.1 t -172.0 -179.43 2.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.472 1.109 . . . . 10.0 109.948 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.28 161.33 37.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.334 1.454 . . . . 10.0 109.157 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.96 156.54 21.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 165.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -130.19 108.63 10.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.17 -2.529 . . . . 10.0 104.17 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ptp -157.12 -176.8 6.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.681 1.192 . . . . 10.0 109.461 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.9 m -127.59 119.12 25.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.086 1.355 . . . . 10.0 109.053 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.32 109.23 12.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 103.605 -2.739 . . . . 10.0 103.605 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -95.93 70.65 2.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.482 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.51 130.25 35.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.272 -0.971 . . . . 10.0 109.829 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -136.1 56.26 1.83 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 p -157.83 166.14 33.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.312 0.577 . . . . 10.0 110.821 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -107.89 27.26 9.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.901 2.88 . . . . 10.0 110.33 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -114.73 134.4 22.41 Favored Pre-proline 0 C--N 1.342 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 107.609 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.63 122.01 8.48 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.113 1.875 . . . . 10.0 109.891 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.26 81.91 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -79.28 -180.0 7.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.062 0.458 . . . . 10.0 110.32 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.64 136.14 13.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.666 -2.346 . . . . 10.0 104.666 -170.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -151.55 54.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.276 0.944 . . . . 10.0 109.52 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.18 151.0 20.01 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.783 -1.198 . . . . 10.0 111.116 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.78 70.95 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.484 1.514 . . . . 10.0 108.392 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.64 140.71 32.02 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 t -168.21 145.04 3.35 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 118.562 0.619 . . . . 10.0 111.313 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.95 52.99 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.937 2.425 . . . . 10.0 110.023 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 tp -128.87 -61.24 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.439 1.096 . . . . 10.0 109.564 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.24 162.44 18.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.61 1.564 . . . . 10.0 109.601 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 m -87.86 -42.7 12.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.588 0.755 . . . . 10.0 110.625 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 t -123.38 89.97 50.76 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.654 1.182 . . . . 10.0 110.181 -163.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.68 85.11 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.89 2.393 . . . . 10.0 109.904 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.0 mtt -83.69 117.83 23.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.152 0.981 . . . . 10.0 108.618 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.16 128.63 33.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.458 -0.776 . . . . 10.0 109.571 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.76 144.68 39.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.918 1.287 . . . . 10.0 110.787 -174.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.89 170.11 13.43 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.467 0.651 . . . . 10.0 111.991 164.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -98.46 177.43 5.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.42 1.888 . . . . 10.0 113.527 164.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -95.21 72.05 3.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.046 1.739 . . . . 10.0 108.969 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.09 73.03 0.44 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.245 1.418 . . . . 10.0 112.921 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -164.39 54.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.31 -90.06 0.49 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 106.992 -2.443 . . . . 10.0 106.992 -167.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.37 173.87 19.06 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 117.223 0.511 . . . . 10.0 112.706 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mtp -53.75 -87.48 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.645 1.978 . . . . 10.0 115.547 -158.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -174.94 34.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.666 0.666 . . . . 10.0 111.922 -160.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.79 140.39 2.91 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.827 -0.909 . . . . 10.0 110.827 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.6 ttp -65.62 93.59 0.17 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.739 0.769 . . . . 10.0 110.062 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.26 161.38 38.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.432 0.693 . . . . 10.0 112.464 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 68.9 mtp -82.84 109.42 16.96 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.071 1.748 . . . . 10.0 110.081 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.09 166.51 10.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.391 0.676 . . . . 10.0 111.525 -170.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -37.73 -53.1 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.251 2.634 . . . . 10.0 111.027 156.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 44.6 p90 175.07 -172.18 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.056 2.142 . . . . 10.0 105.593 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -116.1 102.3 9.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.473 0.654 . . . . 10.0 110.548 174.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.7 m -76.8 120.85 22.52 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 pt -92.48 115.38 64.69 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.315 -1.365 . . . . 10.0 107.315 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.05 59.06 7.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.74 2.293 . . . . 10.0 108.514 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.73 -175.82 0.14 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.26 1.024 . . . . 10.0 109.551 -161.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 54.6 -2.34 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 118.024 2.602 . . . . 10.0 118.024 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.61 77.74 0.49 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.761 1.172 . . . . 10.0 111.986 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.4 t -82.43 56.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 166.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.59 -178.16 4.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.98 0.895 . . . . 10.0 110.656 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -127.75 129.13 46.56 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.18 1.792 . . . . 10.0 106.562 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.77 114.39 26.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 103.752 -2.685 . . . . 10.0 103.752 167.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.99 159.85 38.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.343 1.057 . . . . 10.0 109.971 -164.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -44.89 -54.6 6.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.153 1.381 . . . . 10.0 113.349 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.8 -63.31 1.24 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.783 0.833 . . . . 10.0 111.419 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.24 135.81 3.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -165.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 70.78 119.96 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 130.885 3.674 . . . . 10.0 106.246 -170.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 176.43 171.67 0.43 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.605 0.762 . . . . 10.0 109.242 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.22 123.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.139 -2.171 . . . . 10.0 105.139 154.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 69.0 mtp -82.84 101.6 11.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.104 -1.443 . . . . 10.0 107.104 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.38 74.3 8.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.708 1.603 . . . . 10.0 107.045 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 52.1 ttm -84.6 149.47 25.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.231 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.46 68.82 1.27 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.704 -0.959 . . . . 10.0 110.704 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -35.37 133.94 0.32 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.121 1.768 . . . . 10.0 112.985 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -67.53 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.745 -0.645 . . . . 10.0 111.689 157.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -168.9 -59.3 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 115.984 1.846 . . . . 10.0 115.984 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.39 75.66 4.81 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.904 1.736 . . . . 10.0 111.113 -166.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.17 48.32 2.41 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.389 1.076 . . . . 10.0 111.882 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -63.69 148.21 49.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.22 108.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.29 55.77 3.0 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -166.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 -179.8 4.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 153.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.1 m -155.66 134.93 12.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.284 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.01 136.7 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.656 -1.609 . . . . 10.0 106.656 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -79.23 114.76 18.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 167.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -81.2 -178.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 168.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 m -139.13 120.19 14.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 160.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 pp -83.69 172.65 12.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -156.72 103.39 2.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.45 120.69 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.06 -1.089 . . . . 10.0 108.06 157.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -48.33 -34.51 10.72 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.594 1.558 . . . . 10.0 111.053 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.1 -33.75 53.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.759 2.023 . . . . 10.0 111.806 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.82 56.84 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.231 0.92 . . . . 10.0 111.032 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 -141.65 133.72 27.64 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 172.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.5 t -156.01 59.6 0.59 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.659 0.663 . . . . 10.0 110.754 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.98 148.97 27.27 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.005 0.522 . . . . 10.0 109.885 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -95.92 65.81 2.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 127.735 2.414 . . . . 10.0 108.262 -174.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.77 146.96 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -155.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.73 130.53 35.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.62 115.08 23.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.951 1.3 . . . . 10.0 109.453 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.7 m -84.41 132.73 34.55 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.37 120.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -159.7 94.1 1.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.057 0.844 . . . . 10.0 112.379 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -65.96 -39.05 90.09 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.18 60.98 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.852 0.861 . . . . 10.0 110.87 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.7 mm -144.28 -54.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 127.93 2.492 . . . . 10.0 106.018 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -52.66 -59.11 4.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.849 1.66 . . . . 10.0 110.784 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.05 34.22 58.77 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.16 -1.356 . . . . 10.0 115.796 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 129.841 3.256 . . . . 10.0 104.363 162.326 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.606 -1.627 . . . . 10.0 106.606 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.87 165.03 7.15 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -167.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -107.28 157.19 18.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.319 1.448 . . . . 10.0 109.402 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.4 p -145.23 170.57 16.02 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.374 1.47 . . . . 10.0 107.112 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.24 148.45 21.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.904 -1.147 . . . . 10.0 107.904 175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.43 68.37 6.89 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.141 2.56 . . . . 10.0 110.317 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.56 64.8 1.22 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.687 0.795 . . . . 10.0 110.734 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -146.44 174.61 11.23 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.59 1.556 . . . . 10.0 108.577 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 m -153.43 134.77 8.54 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 106.148 -1.797 . . . . 10.0 106.148 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 144.78 48.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.673 1.582 . . . . 10.0 109.953 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.16 -35.93 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.536 2.157 . . . . 10.0 110.327 173.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.99 123.86 21.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.17 0.588 . . . . 10.0 110.186 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -65.51 163.02 16.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.288 0.635 . . . . 10.0 109.843 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -42.51 135.93 2.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.819 1.648 . . . . 10.0 112.032 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.05 140.59 69.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 10.0 111.294 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.37 151.4 53.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.908 2.405 . . . . 10.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.83 96.3 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.044 0.537 . . . . 10.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 67.53 -65.31 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.228 1.811 . . . . 10.0 113.344 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -72.45 71.56 0.94 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.103 . . . . 10.0 110.745 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -152.77 -81.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.848 0.459 . . . . 10.0 110.02 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.12 170.94 8.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.355 1.062 . . . . 10.0 110.39 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.48 -71.31 1.29 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.595 0.617 . . . . 10.0 112.239 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.73 109.6 0.59 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.394 1.078 . . . . 10.0 112.377 -168.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -77.64 131.84 37.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 168.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 176.45 -47.52 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.551 1.94 . . . . 10.0 108.631 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.29 128.68 85.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.954 0.901 . . . . 10.0 110.533 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.21 179.11 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.706 2.271 . . . . 10.0 110.36 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.23 56.1 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.688 -0.632 . . . . 10.0 111.237 -165.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 p -156.13 57.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.507 -0.746 . . . . 10.0 109.995 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.24 58.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 CA-C-O 122.569 1.176 . . . . 10.0 110.632 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.95 155.75 41.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 164.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.52 -163.23 6.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.366 -1.094 . . . . 10.0 110.366 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.0 133.77 30.52 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -120.46 110.64 16.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.65 128.78 53.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.397 0.679 . . . . 10.0 109.375 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.08 110.34 12.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.873 0.368 . . . . 10.0 111.314 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.44 127.14 14.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.572 -0.728 . . . . 10.0 109.617 167.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -13.05 95.74 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 128.29 2.636 . . . . 10.0 113.281 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.47 178.86 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.692 2.261 . . . . 10.0 109.377 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -67.52 68.05 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.408 2.072 . . . . 10.0 108.548 156.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -153.8 35.28 0.44 Allowed 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 126.216 1.806 . . . . 10.0 108.206 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.401 ' CG2' ' H ' ' A' ' 43' ' ' ARG . 18.2 mt 64.8 -176.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.401 ' H ' ' CG2' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -70.19 32.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.468 -1.395 . . . . 10.0 113.552 170.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 155.16 20.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 163.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -164.94 -178.15 5.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.669 -1.234 . . . . 10.0 107.669 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 165.0 29.32 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.883 0.873 . . . . 10.0 109.887 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.69 33.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.308 -1.314 . . . . 10.0 107.71 164.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.16 104.36 12.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 -173.4 4.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.49 1.116 . . . . 10.0 110.423 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.8 m -116.56 143.96 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.038 1.735 . . . . 10.0 107.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.42 121.7 40.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.723 -1.955 . . . . 10.0 105.723 158.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -129.42 114.93 16.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.583 1.553 . . . . 10.0 109.045 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -93.29 136.93 33.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.82 0.848 . . . . 10.0 112.317 -172.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -134.2 56.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.713 -1.218 . . . . 10.0 107.713 161.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -137.33 -51.5 0.65 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.82 0.848 . . . . 10.0 111.031 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.5 48.43 3.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.659 1.584 . . . . 10.0 110.449 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.69 137.99 31.06 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.63 119.04 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.876 2.384 . . . . 10.0 109.705 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 mt -122.96 135.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -98.6 99.73 10.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.385 1.074 . . . . 10.0 108.904 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.2 117.56 26.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.75 -1.944 . . . . 10.0 105.75 -178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.17 51.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.485 0.714 . . . . 10.0 109.488 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.95 138.34 5.35 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.925 -1.27 . . . . 10.0 109.925 160.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.56 66.57 0.49 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.257 1.423 . . . . 10.0 107.73 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.0 21.09 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.061 0.544 . . . . 10.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 t -173.46 140.22 0.85 Allowed Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.39 65.82 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.27 2.646 . . . . 10.0 108.932 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.26 -50.68 0.08 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.957 1.303 . . . . 10.0 108.766 -164.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.93 31.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m -88.98 -22.31 23.09 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 167.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -134.3 88.15 31.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.709 1.204 . . . . 10.0 108.492 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.79 124.36 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.324 2.683 . . . . 10.0 110.424 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -132.04 152.04 51.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.578 1.151 . . . . 10.0 108.95 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.1 157.06 18.45 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.236 0.615 . . . . 10.0 110.217 166.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.93 153.81 32.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.794 1.237 . . . . 10.0 109.354 -176.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.1 t -139.57 121.04 15.08 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.947 0.794 . . . . 10.0 112.408 -173.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -146.88 51.22 1.1 Allowed 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.559 -1.338 . . . . 10.0 110.305 165.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.6 m -150.28 90.74 1.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.487 1.115 . . . . 10.0 111.85 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -34.67 -42.98 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.805 2.442 . . . . 10.0 113.566 172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -50.29 -26.29 4.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.644 1.178 . . . . 10.0 113.409 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.22 -51.41 0.11 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 -124.57 4.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.162 0.887 . . . . 10.0 111.245 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.3 tpp -141.74 -121.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.067 0.934 . . . . 10.0 111.186 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.07 62.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -166.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.32 87.36 0.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.795 -1.722 . . . . 10.0 108.795 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 64.43 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.463 -0.94 . . . . 10.0 108.463 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -147.08 172.89 13.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.674 2.39 . . . . 10.0 107.847 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttp -80.15 74.73 6.95 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.799 0.809 . . . . 10.0 109.054 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.73 160.81 24.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.701 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.23 80.14 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.957 2.438 . . . . 10.0 109.69 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 58.21 -164.95 0.18 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.954 2.102 . . . . 10.0 113.482 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.75 99.15 5.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.797 0.839 . . . . 10.0 109.27 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.0 m -82.15 125.46 30.91 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.726 -0.608 . . . . 10.0 109.649 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.33 122.11 60.34 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.34 65.45 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.816 2.344 . . . . 10.0 110.847 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.99 -175.32 0.15 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.877 0.871 . . . . 10.0 109.462 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . 0.258 0.1 OUTLIER 5.9 44.21 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 130.164 3.385 . . . . 10.0 118.831 -169.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -54.29 138.01 40.56 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.316 0.96 . . . . 10.0 113.534 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.8 m -149.85 59.63 0.99 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.433 1.493 . . . . 10.0 107.177 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.96 164.75 12.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.677 0.275 . . . . 10.0 110.524 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.8 m -124.19 104.73 9.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.54 122.21 27.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.63 -1.618 . . . . 10.0 106.63 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -156.17 157.51 36.04 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.606 1.963 . . . . 10.0 107.726 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 0.25 0.2 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.476 1.658 . . . . 10.0 115.476 -161.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.45 -72.04 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.994 1.717 . . . . 10.0 108.09 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.28 76.61 1.45 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 125.136 1.351 . . . . 10.0 111.176 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.9 t70 70.03 134.58 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.095 1.758 . . . . 10.0 110.696 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -177.47 176.22 1.32 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.896 0.855 . . . . 10.0 113.013 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.59 121.37 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 157.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.2 mtp -82.22 104.99 12.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 165.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.63 74.52 6.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.628 1.971 . . . . 10.0 109.148 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -91.16 149.13 21.92 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.934 -0.479 . . . . 10.0 112.271 -170.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 33.56 3.0 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.582 0.993 . . . . 10.0 115.582 157.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 37.95 46.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 128.424 2.69 . . . . 10.0 116.769 160.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.092 -1.005 . . . . 10.0 112.719 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -133.11 151.72 78.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 107.086 -1.45 . . . . 10.0 107.086 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.39 75.06 2.5 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.003 2.468 . . . . 10.0 109.279 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mp -40.54 105.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.386 2.274 . . . . 10.0 113.3 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.73 131.64 34.41 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.1 p -60.67 103.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 162.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.69 -0.61 15.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.978 -0.901 . . . . 10.0 112.148 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.16 179.97 4.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 123.94 1.828 . . . . 10.0 108.281 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -155.81 132.75 10.59 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.534 -2.121 . . . . 10.0 106.55 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.75 143.88 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -79.22 124.64 28.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 tt -81.52 170.4 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -146.42 118.44 8.24 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.155 -0.966 . . . . 10.0 109.073 165.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.1 151.54 24.06 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.318 -1.364 . . . . 10.0 107.318 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -154.48 78.7 1.08 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.1 123.56 27.47 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p 44.89 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.175 1.79 . . . . 10.0 110.001 -161.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -164.32 58.36 0.15 Allowed 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.731 0.813 . . . . 10.0 109.521 156.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.71 27.44 1.63 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.22 61.04 1.17 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.186 0.994 . . . . 10.0 108.428 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.1 m -83.0 60.11 5.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.794 0.838 . . . . 10.0 110.27 -170.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.88 149.92 26.82 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -130.55 60.74 1.62 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.543 1.937 . . . . 10.0 109.509 -169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.0 151.12 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 121.938 -0.476 . . . . 10.0 109.991 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.96 119.6 24.64 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.364 -0.835 . . . . 10.0 109.294 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.85 133.45 42.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.222 1.009 . . . . 10.0 108.799 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.6 m -83.0 144.29 30.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.525 -1.287 . . . . 10.0 107.525 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.43 107.28 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 172.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -156.69 147.11 21.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -63.7 162.55 13.03 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.603 0.716 . . . . 10.0 111.024 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -145.66 107.38 4.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.024 1.33 . . . . 10.0 107.433 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp 56.4 78.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.106 1.362 . . . . 10.0 109.262 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.01 121.84 1.06 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.037 -2.208 . . . . 10.0 105.037 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.43 41.33 11.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.701 -1.76 . . . . 10.0 108.701 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 . . . . . 0 C--O 1.256 1.436 0 C-N-CA 125.689 1.596 . . . . 10.0 109.209 -167.43 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 106.697 -1.594 . . . . 10.0 106.697 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.73 166.09 2.34 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 108.931 -1.668 . . . . 10.0 108.931 -137.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -170.2 172.71 6.16 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.527 1.531 . . . . 10.0 106.888 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -134.37 173.58 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.262 1.425 . . . . 10.0 108.514 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.7 ptm -148.73 150.58 33.53 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 108.299 -1.001 . . . . 10.0 108.299 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.07 178.28 7.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.987 2.458 . . . . 10.0 110.359 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.38 159.08 44.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -165.33 174.26 10.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -139.59 148.0 54.3 Favored Pre-proline 0 C--O 1.232 0.138 0 C-N-CA 125.001 1.32 . . . . 10.0 108.417 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -65.84 159.95 46.29 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 N-CA-C 108.803 -1.268 . . . . 10.0 108.803 162.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.08 -173.76 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.488 2.792 . . . . 10.0 110.053 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.14 166.48 23.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.007 1.323 . . . . 10.0 107.447 170.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -158.88 171.13 20.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.085 0.954 . . . . 10.0 108.688 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.3 p -134.3 -179.69 5.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.851 1.66 . . . . 10.0 107.727 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.53 148.36 67.13 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 -174.14 2.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.292 2.662 . . . . 10.0 110.474 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.85 170.71 15.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.149 1.38 . . . . 10.0 107.486 170.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.4 13.59 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.412 1.085 . . . . 10.0 108.321 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -139.16 163.44 32.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.933 1.293 . . . . 10.0 107.598 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -73.51 155.36 39.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.97 176.69 10.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.9 167.33 35.9 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 107.451 -2.26 . . . . 10.0 107.451 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.16 -73.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.828 0.814 . . . . 10.0 111.942 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -144.56 45.06 1.4 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.864 . . . . 10.0 109.076 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.24 -168.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.573 1.149 . . . . 10.0 109.985 -167.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 151.51 94.25 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.794 -0.622 . . . . 10.0 109.653 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.15 -90.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.932 2.421 . . . . 10.0 110.29 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.35 49.31 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.824 0.849 . . . . 10.0 110.466 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 m -159.18 106.5 1.78 Allowed 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.948 -1.095 . . . . 10.0 109.505 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.23 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.63 0.65 . . . . 10.0 111.01 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -157.51 153.58 27.24 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 163.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.1 107.95 3.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.748 1.166 . . . . 10.0 112.178 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.73 153.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.746 0.818 . . . . 10.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 p -135.68 151.86 50.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.287 -1.375 . . . . 10.0 107.287 164.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.84 137.91 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.06 47.33 0.77 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.288 0.949 . . . . 10.0 113.416 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 28.89 -124.29 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.014 2.126 . . . . 10.0 111.243 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.38 118.89 55.63 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 157.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.8 168.49 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.038 2.492 . . . . 10.0 107.996 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.47 69.43 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.786 1.657 . . . . 10.0 108.846 170.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.412 ' CB ' HH12 ' A' ' 104' ' ' ARG . 7.4 m -155.84 38.67 0.37 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.645 1.178 . . . . 10.0 109.078 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.4 mm 68.34 178.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.361 1.064 . . . . 10.0 110.291 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -46.51 -33.59 4.17 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.37 2.268 . . . . 10.0 114.774 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.31 151.71 45.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.362 1.077 . . . . 10.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 t -161.65 175.4 12.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.634 -1.617 . . . . 10.0 106.634 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.02 160.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.07 0.548 . . . . 10.0 110.529 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.76 142.44 32.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.114 0.884 . . . . 10.0 108.855 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -117.93 108.62 15.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 165.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.74 -179.16 7.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.313 1.845 . . . . 10.0 106.332 -160.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -150.66 138.02 19.52 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.411 1.46 . . . . 10.0 110.071 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.97 116.37 27.97 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -93.76 87.25 5.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.843 1.657 . . . . 10.0 108.304 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -78.05 79.53 4.51 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 121.89 0.852 . . . . 10.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 58.28 4.64 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m -172.76 144.21 1.34 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.986 0.915 . . . . 10.0 108.796 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.09 49.12 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.447 1.499 . . . . 10.0 109.838 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.2 127.19 18.88 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.805 0.842 . . . . 10.0 109.376 -170.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -85.71 121.85 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.538 2.825 . . . . 10.0 110.702 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mp -150.44 116.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 150.08 30.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.347 0.521 . . . . 10.0 110.677 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.04 138.32 46.59 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 171.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.88 54.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.56 1.073 . . . . 10.0 108.914 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.04 144.35 9.64 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.623 -1.791 . . . . 10.0 108.623 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.98 65.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.571 1.548 . . . . 10.0 107.981 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.12 160.89 23.03 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t -173.75 152.2 1.98 Allowed Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 107.608 -1.256 . . . . 10.0 107.608 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.34 -1.41 11.32 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.603 2.202 . . . . 10.0 112.155 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.61 -53.67 5.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.608 1.163 . . . . 10.0 110.46 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.77 178.44 5.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.323 1.449 . . . . 10.0 110.62 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 m -143.13 0.63 1.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.314 -0.866 . . . . 10.0 112.456 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.6 m -148.07 80.41 8.7 Favored Pre-proline 0 N--CA 1.448 -0.551 0 O-C-N 120.589 -1.319 . . . . 10.0 108.06 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.87 98.39 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.972 3.115 . . . . 10.0 111.12 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -103.64 120.55 41.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.672 0.789 . . . . 10.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.87 140.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 ttm -145.08 149.0 34.29 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.667 0.787 . . . . 10.0 110.135 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -140.63 112.02 7.33 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.577 0.584 . . . . 10.0 112.577 -166.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -146.64 49.55 1.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.431 -1.418 . . . . 10.0 110.807 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -130.35 94.85 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.39 1.476 . . . . 10.0 108.92 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -68.79 85.38 0.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.885 1.674 . . . . 10.0 110.823 -163.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t 163.83 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.789 2.035 . . . . 10.0 107.784 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.11 84.37 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.722 -1.351 . . . . 10.0 109.722 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 -170.41 23.63 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.103 -1.599 . . . . 10.0 109.103 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.7 ttm -106.57 -136.98 0.36 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.611 0.764 . . . . 10.0 109.317 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.53 51.09 1.19 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.743 1.217 . . . . 10.0 108.075 -164.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 90.48 0.14 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.243 -1.543 . . . . 10.0 109.243 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.41 60.14 1.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.865 -1.161 . . . . 10.0 107.865 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -143.43 171.45 14.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.807 2.043 . . . . 10.0 107.921 -170.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 27.6 ttm -81.46 69.21 8.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.051 0.929 . . . . 10.0 110.482 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.04 163.99 14.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.326 1.05 . . . . 10.0 109.676 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.407 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 38.1 Cg_exo -52.2 -36.77 68.38 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.552 2.168 . . . . 10.0 112.673 170.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.407 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.68 -156.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.75 2.02 . . . . 10.0 110.681 -164.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.16 131.26 47.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.645 -1.613 . . . . 10.0 106.645 162.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 m -95.67 106.05 18.11 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -85.16 109.71 23.11 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -88.21 52.22 2.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.368 1.379 . . . . 10.0 110.655 -167.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.44 163.85 0.14 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.74 0.781 . . . . 10.0 110.993 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.82 20.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.678 1.591 . . . . 10.0 112.718 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.31 69.77 1.09 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 124.935 1.255 . . . . 10.0 110.253 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -84.69 57.7 4.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -94.44 155.46 16.94 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.283 -175.557 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.1 t -126.05 117.16 22.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 -165.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.99 128.32 34.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.76 165.84 35.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.678 0.791 . . . . 10.0 109.4 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.412 HH12 ' CB ' ' A' ' 41' ' ' SER . 2.6 ttp180 -67.4 89.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.488 -0.758 . . . . 10.0 110.606 174.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 131.02 -70.21 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 131.342 3.857 . . . . 10.0 108.112 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.02 71.23 0.96 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 125.448 1.499 . . . . 10.0 112.506 -167.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 66.61 138.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.41 1.884 . . . . 10.0 110.367 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -179.38 179.41 0.62 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.181 0.592 . . . . 10.0 110.789 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.3 t -114.84 128.79 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 156.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 77.1 mtp -82.25 94.2 7.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 166.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.84 65.5 7.0 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.193 -1.41 . . . . 10.0 107.193 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 21.0 ptm -84.71 179.57 7.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.274 1.035 . . . . 10.0 110.17 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 47.44 45.61 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.901 -1.28 . . . . 10.0 109.901 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.49 118.93 10.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.204 1.002 . . . . 10.0 109.18 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -61.57 2.43 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 117.443 0.111 . . . . 10.0 111.226 -171.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.1 mtt-85 -166.54 -59.58 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.23 1.412 . . . . 10.0 111.86 -162.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.25 69.6 7.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 120.848 1.339 . . . . 10.0 112.934 -165.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 56.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.261 -0.9 . . . . 10.0 111.875 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 96.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.217 -0.927 . . . . 10.0 109.258 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.63 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.471 1.108 . . . . 10.0 109.512 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.13 -10.05 5.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.324 -0.709 . . . . 10.0 113.003 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' CG ' ' H ' ' A' ' 123' ' ' THR . 12.3 tt0 -78.82 -177.89 5.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.838 1.304 . . . . 10.0 108.369 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.464 ' H ' ' CG ' ' A' ' 122' ' ' GLU . 19.0 m -150.9 131.55 13.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.758 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.55 141.42 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.378 1.471 . . . . 10.0 107.32 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -68.25 127.82 34.3 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.544 -0.722 . . . . 10.0 109.927 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.6 tt -82.27 173.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.401 -1.703 . . . . 10.0 106.401 162.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 38.9 m -144.55 115.69 7.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.311 -0.868 . . . . 10.0 109.439 160.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 pp -87.7 173.0 9.28 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.829 0.307 . . . . 10.0 111.829 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -156.99 109.38 2.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.004 0.922 . . . . 10.0 108.972 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.55 126.34 32.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 160.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 t -79.86 62.5 4.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.754 0.788 . . . . 10.0 108.909 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.81 -65.86 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.727 2.411 . . . . 10.0 107.14 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 -79.11 0.45 Allowed Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.609 -0.723 . . . . 10.0 113.778 -167.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 -177.8 5.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.871 -0.782 . . . . 10.0 112.982 -175.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 m -128.74 142.26 51.06 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.48 3.512 . . . . 10.0 103.606 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.25 147.13 22.02 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -121.16 59.45 0.94 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.05 1.74 . . . . 10.0 110.088 -157.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.1 t -78.32 147.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -161.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.36 109.88 16.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.56 43.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.145 0.978 . . . . 10.0 110.527 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.8 m -83.51 126.79 33.15 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.669 0.388 . . . . 10.0 110.256 -177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.4 t -91.31 97.37 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.72 -1.956 . . . . 10.0 105.72 -173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 102.33 2.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.766 -0.584 . . . . 10.0 110.753 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -63.24 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.58 1.152 . . . . 10.0 110.266 162.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.86 -164.89 0.24 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.703 0.801 . . . . 10.0 111.929 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.4 pt -57.09 -31.21 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.169 0.588 . . . . 10.0 111.573 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -58.8 -63.48 1.28 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.145 0.978 . . . . 10.0 109.506 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.47 56.22 4.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.933 -0.867 . . . . 10.0 110.933 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.15 1.78 . . . . 10.0 107.086 170.41 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 2.456 9.8 ptm . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.91 54.62 2.15 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.607 -1.107 . . . . 10.0 111.054 -169.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 43.33 89.05 0.01 OUTLIER 'General case' 0 C--N 1.346 0.451 1 C-N-CA 132.107 4.163 . . . . 10.0 114.349 1.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.4 0.5 OUTLIER 77.97 -24.92 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.326 3.851 . . . . 10.0 113.666 9.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 87.7 mtp 44.7 96.93 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.076 1.75 . . . . 10.0 115.175 161.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -61.1 30.66 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.9 3.733 . . . . 10.0 117.195 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.24 62.15 1.23 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . 2.443 63.2 t-80 61.77 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -148.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 2.454 0.2 OUTLIER 52.54 -133.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 -165.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . 2.547 54.0 Cg_exo 62.91 -102.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.9 2.4 . . . . 10.0 108.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . 2.411 8.7 Cg_endo 22.04 116.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.755 1 C-N-CA 127.475 5.45 . . . . 10.0 116.482 154.25 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . 2.445 . . 41.22 19.99 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 O-C-N 117.556 -3.215 . . . . 10.0 112.976 56.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 2.383 5.6 tp60 47.23 84.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.959 2.104 . . . . 10.0 112.148 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 84.4 148.71 0.07 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.443 1.897 . . . . 10.0 106.538 -178.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' N ' ' CD ' ' A' ' 16' ' ' PRO 0.308 . . 83.74 19.62 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.843 1 C-N-CA 135.07 5.348 . . . . 10.0 116.241 13.553 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 15' ' ' ALA 0.337 37.6 Cg_endo -64.62 -83.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 CA-C-N 122.883 2.065 . . . . 10.0 115.021 -170.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . 0.599 . . 79.52 -19.16 0.46 Allowed 'General case' 0 N--CA 1.466 0.372 3 C-N-CA 138.642 6.777 . . . . 10.0 117.485 -4.5 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.21 108.53 21.28 Favored 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 105.622 -1.992 . . . . 10.0 105.622 157.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 177.28 -58.59 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.381 1.473 . . . . 10.0 110.8 -160.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 2.469 0.0 OUTLIER 106.38 -110.54 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 130.795 3.638 . . . . 10.0 106.284 9.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 2.424 . . 73.06 39.06 0.65 Allowed 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -108.26 98.96 1.27 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.882 1.706 . . . . 10.0 111.811 -165.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . 0.288 . . 41.61 -117.78 0.38 Allowed 'General case' 0 CA--C 1.536 0.419 1 C-N-CA 132.533 4.333 . . . . 10.0 116.202 -2.24 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 42.75 -135.57 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 -160.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.52 136.33 17.2 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.131 -2.174 . . . . 10.0 105.131 160.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tt -106.48 130.09 23.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.16 127.97 24.86 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 N-CA-C 106.732 -2.064 . . . . 10.0 106.732 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.38 54.2 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 122.027 0.918 . . . . 10.0 112.083 -153.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.4 p -153.91 54.2 0.71 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.667 1.587 . . . . 10.0 107.209 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -83.66 63.51 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -137.19 154.21 50.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.831 1.252 . . . . 10.0 110.967 -169.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.91 136.79 13.68 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.913 -2.075 . . . . 10.0 107.913 168.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.59 25.3 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.605 1.203 . . . . 10.0 109.995 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 p -134.56 141.75 46.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.2 134.04 67.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.69 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 36.08 -122.55 0.15 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.933 1.693 . . . . 10.0 111.031 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.48 109.69 58.12 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.963 0.905 . . . . 10.0 108.85 169.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.57 163.45 27.19 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.959 2.439 . . . . 10.0 110.394 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.42 61.0 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.914 2.41 . . . . 10.0 109.421 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -160.49 47.8 0.24 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.379 1.072 . . . . 10.0 108.522 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 mm 75.45 167.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.444 1.498 . . . . 10.0 109.17 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -26.7 63.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.95 0.722 . . . . 10.0 112.95 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.91 140.12 1.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.632 2.373 . . . . 10.0 110.807 172.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -159.98 -178.63 7.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.14 157.85 43.24 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.401 0.68 . . . . 10.0 110.654 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.7 150.3 25.21 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 124.001 0.813 . . . . 10.0 110.097 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -128.45 103.62 7.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.442 -2.059 . . . . 10.0 105.442 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -159.82 -176.67 5.84 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.969 0.508 . . . . 10.0 110.909 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -133.71 122.9 24.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.14 0.976 . . . . 10.0 111.501 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mp -80.52 132.45 35.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.214 -2.513 . . . . 10.0 104.214 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -130.56 104.76 7.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 124.58 1.175 . . . . 10.0 107.982 -160.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.82 130.34 35.03 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 117.804 0.274 . . . . 10.0 111.199 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -140.93 59.29 1.54 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -168.02 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.015 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 65.9 78.46 0.27 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.253 1.421 . . . . 10.0 111.512 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -146.22 154.72 50.25 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.732 1.613 . . . . 10.0 108.533 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.52 72.93 6.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.651 2.901 . . . . 10.0 111.768 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.4 115.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -89.11 144.73 25.92 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.477 -0.765 . . . . 10.0 109.372 168.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.99 126.83 49.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 56.63 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.876 0.845 . . . . 10.0 110.044 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.98 150.77 21.21 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.004 -1.238 . . . . 10.0 110.004 163.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.08 58.84 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.252 1.021 . . . . 10.0 108.805 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.82 139.74 31.7 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.898 -0.501 . . . . 10.0 109.791 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 t -160.76 145.6 10.69 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.94 57.37 4.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.178 2.586 . . . . 10.0 109.878 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 tt -139.74 -63.06 0.51 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.357 1.463 . . . . 10.0 107.849 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.74 146.71 27.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.674 1.19 . . . . 10.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.1 m -82.07 -38.32 25.08 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.725 0.81 . . . . 10.0 109.196 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.61 80.13 39.23 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.012 0.925 . . . . 10.0 110.182 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.74 92.93 1.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.829 2.353 . . . . 10.0 109.993 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.7 mtt -103.62 131.18 51.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.598 1.159 . . . . 10.0 110.115 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.76 144.62 29.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.482 1.113 . . . . 10.0 109.087 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.5 ttm -146.27 157.78 43.83 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.431 0.692 . . . . 10.0 110.775 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.0 t -155.1 107.13 2.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.873 0.844 . . . . 10.0 112.531 -162.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 t -146.2 57.98 1.21 Allowed 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.793 -1.192 . . . . 10.0 111.023 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -150.24 93.46 2.0 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.277 1.431 . . . . 10.0 109.829 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -32.09 -46.06 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 128.682 2.793 . . . . 10.0 113.27 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -54.91 -23.59 19.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.267 1.427 . . . . 10.0 114.032 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.85 -50.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.437 -1.065 . . . . 10.0 110.437 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.93 -162.63 32.21 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.271 0.938 . . . . 10.0 111.621 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 ttt -81.72 -159.79 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.415 0.686 . . . . 10.0 109.3 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.579 1.152 . . . . 10.0 108.078 -167.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.28 108.86 0.36 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.015 -1.634 . . . . 10.0 109.015 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.88 65.6 1.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 10.0 109.86 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -125.63 165.1 19.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.343 2.257 . . . . 10.0 109.718 -170.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 35.2 ttm -81.47 72.82 8.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.879 0.847 . . . . 10.0 109.93 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.3 m -63.03 159.33 47.86 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.938 0.895 . . . . 10.0 111.195 173.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.405 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 95.3 Cg_endo -61.85 -30.86 84.8 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.907 2.404 . . . . 10.0 112.507 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.405 ' CZ3' ' HB2' ' A' ' 90' ' ' PRO . 44.4 p90 177.88 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.797 2.439 . . . . 10.0 105.344 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.14 115.72 18.84 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.58 0.705 . . . . 10.0 110.959 168.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 m -78.27 126.5 30.88 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.7 pt -100.77 103.07 22.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.182 0.901 . . . . 10.0 109.043 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.86 70.19 6.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.227 1.951 . . . . 10.0 111.347 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 60.43 168.96 0.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.611 -0.68 . . . . 10.0 109.796 -163.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 41.59 31.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.768 1.766 . . . . 10.0 115.768 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.05 72.26 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 124.41 1.005 . . . . 10.0 113.209 167.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -107.26 57.23 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.518 -1.66 . . . . 10.0 106.518 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -93.73 151.9 19.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.546 1.138 . . . . 10.0 108.1 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.6 m -119.19 117.13 27.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.885 -1.894 . . . . 10.0 105.885 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.31 102.17 10.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.217 -2.142 . . . . 10.0 105.217 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.02 156.77 48.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.463 1.505 . . . . 10.0 110.428 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -48.96 -42.99 39.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.287 1.035 . . . . 10.0 112.303 -166.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -114.31 29.84 7.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.771 0.828 . . . . 10.0 111.897 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.18 69.13 0.19 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 121.346 -0.847 . . . . 10.0 111.387 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.2 t70 64.96 138.99 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 126.381 1.872 . . . . 10.0 110.524 -175.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -178.09 179.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 10.0 111.149 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -110.86 122.0 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 162.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 67.2 mtp -83.86 100.24 10.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 165.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.19 73.24 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.5 154.64 20.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.966 0.906 . . . . 10.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.27 66.34 2.24 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.93 141.68 44.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.344 0.658 . . . . 10.0 112.106 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -86.44 -48.65 8.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 10.0 112.549 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -144.48 158.94 53.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.624 0.77 . . . . 10.0 110.559 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -67.65 160.51 47.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.559 2.84 . . . . 10.0 111.911 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.42 159.61 41.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.769 1.628 . . . . 10.0 108.179 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -113.16 144.43 42.68 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.615 0.643 . . . . 10.0 109.503 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.88 104.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 165.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.68 -13.73 6.46 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.166 -0.797 . . . . 10.0 111.61 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -178.25 3.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.787 1.755 . . . . 10.0 109.119 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.0 m -155.56 131.36 9.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.031 -1.895 . . . . 10.0 107.708 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.66 149.57 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -84.71 130.99 34.62 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -103.99 130.24 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.077 0.951 . . . . 10.0 109.147 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 m -103.1 107.46 18.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 166.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.29 154.3 26.62 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 160.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -150.23 90.15 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.27 143.31 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -50.54 -36.32 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.44 1.096 . . . . 10.0 110.876 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -70.11 44.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 10.0 112.649 173.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.04 48.54 38.61 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.219 1.866 . . . . 10.0 113.206 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -110.57 146.75 35.54 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 171.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.0 m -156.41 101.32 2.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.742 2.017 . . . . 10.0 105.659 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -112.05 -178.46 3.43 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.843 0.747 . . . . 10.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -149.93 64.03 0.98 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.744 2.017 . . . . 10.0 108.614 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.73 156.74 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.12 130.77 35.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.81 112.55 23.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.698 1.199 . . . . 10.0 109.222 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 m -83.86 125.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.7 112.84 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -158.09 125.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.686 -0.673 . . . . 10.0 109.693 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt -41.97 -71.63 0.08 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.289 1.836 . . . . 10.0 110.025 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.91 102.65 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.54 1.536 . . . . 10.0 114.777 157.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.314 35.8 pt 53.18 64.62 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 123.448 1.594 . . . . 10.0 109.574 -166.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.24 149.26 30.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.353 -2.832 . . . . 10.0 103.353 -167.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.68 33.24 66.85 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.733 -1.347 . . . . 10.0 109.733 -162.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.537 2.735 . . . . 10.0 104.458 176.832 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 105.739 -1.949 . . . . 10.0 105.739 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.4 -161.29 9.45 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.375 0.988 . . . . 10.0 110.927 171.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 110.11 149.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 129.639 3.176 . . . . 10.0 108.452 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.0 p -146.84 154.89 41.87 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.2 tpt -121.66 108.81 34.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.62 1.168 . . . . 10.0 108.466 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.37 171.9 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.594 2.196 . . . . 10.0 110.496 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.32 157.14 29.89 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.611 1.164 . . . . 10.0 108.07 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -155.06 178.06 10.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.88 1.672 . . . . 10.0 107.39 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -146.03 146.82 29.75 Favored Pre-proline 0 C--O 1.232 0.174 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.49 164.55 35.29 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.842 1.695 . . . . 10.0 108.938 163.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.47 -171.42 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.941 3.094 . . . . 10.0 109.603 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.91 160.79 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.296 -1.001 . . . . 10.0 108.296 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -147.31 161.45 40.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.628 1.571 . . . . 10.0 107.031 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -140.79 131.97 26.45 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.841 0.856 . . . . 10.0 108.84 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 119.2 57.55 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.909 0.884 . . . . 10.0 109.843 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.94 -166.97 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.793 2.328 . . . . 10.0 110.055 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -164.53 154.71 14.27 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.75 156.38 43.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.833 1.253 . . . . 10.0 107.862 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -147.52 157.94 43.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.45 143.29 51.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 165.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 157.53 25.68 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 172.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.03 -143.62 2.58 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.553 -1.019 . . . . 10.0 110.553 175.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.19 64.51 1.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.642 0.777 . . . . 10.0 111.526 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 39.91 66.68 0.56 Allowed 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.89 2.076 . . . . 10.0 112.806 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.85 167.05 30.99 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.176 1.39 . . . . 10.0 108.331 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 155.52 73.22 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.294 1.437 . . . . 10.0 108.463 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.28 -85.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.007 2.471 . . . . 10.0 110.42 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.5 m -140.47 48.0 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 122.365 1.079 . . . . 10.0 109.301 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.8 p -156.75 82.72 0.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.214 -0.903 . . . . 10.0 108.694 -165.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 55.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 123.113 1.435 . . . . 10.0 107.377 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -83.89 129.94 34.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.721 -1.582 . . . . 10.0 107.05 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.66 -39.06 78.14 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.708 -0.557 . . . . 10.0 111.708 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 68.73 116.84 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.736 2.414 . . . . 10.0 113.33 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p -116.28 91.92 3.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.577 1.951 . . . . 10.0 108.789 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.445 -0.946 . . . . 10.0 108.445 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.92 42.92 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.67 -133.94 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.347 1.459 . . . . 10.0 110.208 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.4 t -104.05 110.75 64.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 160.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.89 172.04 10.24 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.115 2.543 . . . . 10.0 108.93 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.02 59.6 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 10.0 109.882 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -157.8 50.88 0.43 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 10.0 109.844 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.7 mm 66.36 174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.869 0.868 . . . . 10.0 110.291 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.1 tpp180 -69.07 22.85 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.245 1.418 . . . . 10.0 114.379 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.492 ' CG ' HH21 ' A' ' 104' ' ' ARG . 0.0 OUTLIER -94.45 157.62 15.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.807 1.185 . . . . 10.0 108.161 168.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -172.5 179.73 2.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.39 -1.707 . . . . 10.0 106.39 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.91 173.29 16.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.385 0.274 . . . . 10.0 111.004 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.14 149.22 26.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 125.202 1.564 . . . . 10.0 109.056 165.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.28 71.1 1.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.549 1.14 . . . . 10.0 108.237 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -174.06 4.76 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.79 1.236 . . . . 10.0 109.417 -159.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -123.94 141.26 52.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.041 1.292 . . . . 10.0 109.598 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 150.18 25.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.314 -1.736 . . . . 10.0 106.314 161.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -140.42 118.11 11.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.219 0.949 . . . . 10.0 110.879 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.27 132.91 37.7 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.77 58.6 1.72 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.745 -1.205 . . . . 10.0 107.745 166.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -163.9 -46.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.267 1.027 . . . . 10.0 109.594 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . 0.318 95.4 m-20 67.01 54.91 0.73 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.474 1.91 . . . . 10.0 110.583 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -131.23 150.87 77.73 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.425 1.89 . . . . 10.0 107.803 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.16 86.27 1.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.542 2.828 . . . . 10.0 111.275 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.15 119.61 59.49 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -83.87 150.66 25.58 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.681 0.392 . . . . 10.0 110.431 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.21 143.42 50.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.847 -0.797 . . . . 10.0 108.847 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 p -151.62 56.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.08 145.67 11.57 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.299 -1.12 . . . . 10.0 110.299 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.09 69.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.49 107.41 15.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.325 -1.361 . . . . 10.0 107.325 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -125.22 146.39 53.84 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.652 0.781 . . . . 10.0 110.494 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.1 -12.27 19.43 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.85 2.367 . . . . 10.0 110.985 166.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 tp -80.97 -57.26 3.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.328 0.967 . . . . 10.0 111.507 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.96 139.68 38.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.07 0.948 . . . . 10.0 112.297 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 m -75.86 -42.03 50.65 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.384 -0.823 . . . . 10.0 110.144 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.96 81.94 50.41 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.947 0.899 . . . . 10.0 109.391 -167.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.01 86.34 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.66 2.907 . . . . 10.0 110.527 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.58 127.58 34.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.08 141.63 31.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.5 ttm -148.96 157.85 43.73 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.665 0.786 . . . . 10.0 110.063 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.7 t -155.11 102.38 2.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.561 0.696 . . . . 10.0 112.546 -157.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.8 t -150.58 53.98 0.89 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.812 -1.18 . . . . 10.0 113.13 168.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -116.22 100.57 8.01 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.918 1.287 . . . . 10.0 109.054 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -46.65 -44.86 18.77 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 126.167 1.787 . . . . 10.0 111.871 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 t -82.96 23.25 0.85 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.05 -67.16 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.535 1.061 . . . . 10.0 111.111 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.87 96.76 0.44 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.391 1.472 . . . . 10.0 111.765 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.88 -159.4 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.258 1.823 . . . . 10.0 114.014 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.21 39.0 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.882 0.873 . . . . 10.0 109.54 -166.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.63 105.95 0.27 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -77.47 55.42 1.27 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.306 1.042 . . . . 10.0 110.844 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.96 165.44 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.831 2.052 . . . . 10.0 109.379 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.6 ttm -81.89 69.78 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.312 1.053 . . . . 10.0 110.334 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 m -60.07 165.02 5.32 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.469 1.907 . . . . 10.0 111.741 172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.48 -38.63 54.31 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.333 2.689 . . . . 10.0 113.579 164.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -165.8 0.04 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.987 1.315 . . . . 10.0 112.512 -161.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.2 116.18 25.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.068 1.347 . . . . 10.0 108.012 159.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.3 m -83.34 136.87 34.2 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.1 140.44 38.09 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.26 -178.19 4.44 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.354 2.036 . . . . 10.0 111.456 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.17 139.56 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 151.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 58.67 17.32 4.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.822 1.045 . . . . 10.0 113.822 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.94 97.45 0.25 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.064 -1.614 . . . . 10.0 109.064 166.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -138.72 79.35 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.876 -2.268 . . . . 10.0 104.876 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 pp -103.37 -177.0 3.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.56 -0.745 . . . . 10.0 110.494 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 99.58 6.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.817 1.647 . . . . 10.0 106.792 -165.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.88 93.7 5.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -118.97 140.09 50.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.804 2.042 . . . . 10.0 108.259 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.492 HH21 ' CG ' ' A' ' 44' ' ' ASP . 4.5 tmt_? -55.33 -21.3 14.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 -167.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -90.25 -71.62 0.61 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.487 1.515 . . . . 10.0 109.749 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.45 80.9 1.6 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.596 1.57 . . . . 10.0 111.524 -166.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 64.46 133.67 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.74 0 C-N-CA 126.0 1.72 . . . . 10.0 110.37 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -178.17 178.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.752 -1.218 . . . . 10.0 111.629 -169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.48 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 162.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.8 mtp -81.76 98.27 8.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.376 -1.712 . . . . 10.0 106.376 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.11 67.55 9.2 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.927 1.291 . . . . 10.0 108.34 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.1 mtp -84.38 157.09 21.55 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.921 0.867 . . . . 10.0 111.601 -166.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.02 60.7 3.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.554 -1.018 . . . . 10.0 110.554 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.23 129.95 44.23 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.612 0.706 . . . . 10.0 111.9 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -105.2 -59.61 1.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.472 1.509 . . . . 10.0 110.83 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -59.58 142.47 87.44 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.5 132.8 32.3 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.107 1.871 . . . . 10.0 109.526 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.4 ' H ' ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.83 161.16 29.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.108 0.563 . . . . 10.0 111.52 175.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 120.19 3.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.473 -2.047 . . . . 10.0 105.473 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.37 116.54 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.3 62.72 1.7 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.206 -1.957 . . . . 10.0 108.206 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -133.35 -172.99 3.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 159.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.9 m -152.54 123.25 7.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.388 -1.278 . . . . 10.0 107.894 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.59 126.67 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.423 1.089 . . . . 10.0 108.528 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -70.82 128.18 35.15 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 pt -114.43 148.04 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.245 1.418 . . . . 10.0 107.877 168.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -110.24 133.49 53.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.001 0.92 . . . . 10.0 109.114 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.1 tt -83.65 155.58 23.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.024 -1.473 . . . . 10.0 107.024 172.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -155.43 86.09 1.07 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.643 -1.243 . . . . 10.0 107.643 168.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.63 25.96 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.028 -0.42 . . . . 10.0 110.059 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.8 t -54.26 -31.57 53.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.802 1.241 . . . . 10.0 112.108 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.78 -32.8 14.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.664 1.186 . . . . 10.0 112.896 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 104.19 8.66 38.23 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.082 1.325 . . . . 10.0 110.046 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 95.3 8.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.1 t -83.87 147.93 27.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.098 -0.955 . . . . 10.0 108.498 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tp -157.03 174.91 14.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -134.78 139.22 44.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.62 140.0 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.51 98.63 10.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.685 -0.858 . . . . 10.0 108.685 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.98 123.36 29.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.957 0.903 . . . . 10.0 110.36 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -83.75 137.51 33.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.41 112.27 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -148.57 107.48 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.084 0.954 . . . . 10.0 109.58 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -99.64 -177.13 3.48 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.744 0.817 . . . . 10.0 113.012 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 75.15 -168.92 0.09 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.674 1.989 . . . . 10.0 108.169 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -53.02 120.83 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 109.028 -0.731 . . . . 10.0 109.028 170.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.27 165.97 28.38 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -170.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.91 62.04 0.9 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 125.27 1.415 . . . . 10.0 111.773 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.096 0 N-CA-C 105.109 -2.182 . . . . 10.0 105.109 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.6 151.02 6.25 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -170.04 158.93 7.33 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.541 -1.652 . . . . 10.0 106.541 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t -164.32 178.69 7.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.1 ttm -163.62 69.07 1.73 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.337 1.455 . . . . 10.0 108.922 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.96 136.72 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.277 1.985 . . . . 10.0 110.011 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.09 155.52 20.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 10.0 107.819 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -164.41 167.07 20.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.522 -1.658 . . . . 10.0 106.522 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -166.06 67.09 1.06 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.387 1.075 . . . . 10.0 109.571 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -69.38 118.93 5.98 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.333 2.022 . . . . 10.0 109.923 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.81 153.03 22.58 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.305 2.003 . . . . 10.0 110.582 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.25 143.01 14.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 172.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -171.16 162.13 6.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.87 1.268 . . . . 10.0 108.112 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -169.8 -178.52 2.98 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.53 1.532 . . . . 10.0 107.001 171.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.15 65.46 0.69 Allowed Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.569 1.148 . . . . 10.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.46 128.14 14.13 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.293 1.996 . . . . 10.0 109.872 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.63 149.72 17.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.57 8.44 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.56 1.544 . . . . 10.0 107.088 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -162.88 157.95 21.9 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -159.7 174.78 14.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.663 1.985 . . . . 10.0 106.446 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.91 175.74 8.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.668 1.187 . . . . 10.0 107.964 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.01 161.53 33.46 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.191 -2.364 . . . . 10.0 107.191 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -169.74 -174.2 1.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.43 1.092 . . . . 10.0 108.255 -175.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 73.29 175.42 0.27 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.236 1.814 . . . . 10.0 111.888 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.7 9.5 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.974 1.709 . . . . 10.0 106.903 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.27 134.88 9.49 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.1 153.5 62.65 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.649 1.566 . . . . 10.0 108.601 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.7 53.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 122.178 0.989 . . . . 10.0 110.86 -170.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -153.11 59.47 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -162.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.53 55.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.38 138.27 37.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.238 1.015 . . . . 10.0 108.482 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.55 -136.06 4.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.798 -2.121 . . . . 10.0 107.798 163.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.91 143.68 14.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.998 0.899 . . . . 10.0 109.802 162.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.2 p -133.59 153.58 51.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.142 -1.799 . . . . 10.0 106.142 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -128.08 138.93 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 125.128 1.371 . . . . 10.0 107.372 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.07 37.76 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.128 0.788 . . . . 10.0 113.128 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 31.86 -124.99 0.05 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.337 1.855 . . . . 10.0 110.456 -161.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.61 112.13 58.84 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 105.927 -1.879 . . . . 10.0 105.927 162.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 160.48 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.977 1.785 . . . . 10.0 108.68 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.17 61.73 5.85 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.523 2.148 . . . . 10.0 110.615 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -163.42 62.22 0.17 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.427 1.091 . . . . 10.0 108.264 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt 77.07 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.52 1.528 . . . . 10.0 110.339 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 39.03 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.196 0.998 . . . . 10.0 113.509 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 158.43 16.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.305 -1.368 . . . . 10.0 107.305 161.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 t -156.62 -169.15 2.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.89 -1.522 . . . . 10.0 106.89 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.96 160.46 42.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.999 -1.111 . . . . 10.0 107.999 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.43 161.8 22.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 165.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -134.73 102.47 5.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.762 -1.57 . . . . 10.0 106.762 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -170.0 2.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.747 2.019 . . . . 10.0 109.503 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m -147.85 124.77 11.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.371 -1.456 . . . . 10.0 109.049 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.16 129.56 34.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 171.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -121.65 95.53 4.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.022 0.826 . . . . 10.0 110.302 -158.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.26 58.62 1.65 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.015 1.388 . . . . 10.0 112.454 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 174.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -179.98 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.95 1.093 . . . . 10.0 113.95 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.13 84.76 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.456 1.503 . . . . 10.0 112.164 -167.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -147.59 144.32 19.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.011 0.925 . . . . 10.0 109.729 165.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -88.14 100.62 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.813 3.009 . . . . 10.0 111.485 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.59 103.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.815 0.846 . . . . 10.0 109.299 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 96.78 8.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.029 -1.044 . . . . 10.0 110.019 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.02 124.44 29.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.386 0.674 . . . . 10.0 109.906 -175.158 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.69 54.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 122.265 1.031 . . . . 10.0 109.535 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.23 145.33 11.06 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.79 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.895 1.678 . . . . 10.0 107.296 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.18 149.08 29.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -169.65 151.87 4.46 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 -164.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.72 -3.55 13.36 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.736 2.291 . . . . 10.0 111.964 167.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -101.79 -40.51 6.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.512 1.125 . . . . 10.0 113.437 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.31 126.23 46.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.443 1.097 . . . . 10.0 110.046 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 m -72.81 -30.66 64.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.327 0.651 . . . . 10.0 109.783 172.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 m -131.13 67.75 81.01 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 124.983 1.313 . . . . 10.0 110.105 -171.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.39 114.12 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.752 2.301 . . . . 10.0 110.527 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -141.07 141.66 34.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.886 0.474 . . . . 10.0 110.815 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.95 149.81 26.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.727 1.211 . . . . 10.0 109.781 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.69 169.32 21.89 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.474 1.51 . . . . 10.0 109.88 -171.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 t -143.8 158.77 43.45 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 121.203 -0.199 . . . . 10.0 110.884 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.42 59.55 0.63 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.435 -0.791 . . . . 10.0 109.201 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -155.56 130.91 9.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -71.34 -39.69 71.18 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -44.61 96.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.602 1.161 . . . . 10.0 111.488 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.96 -129.01 3.35 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.051 -0.82 . . . . 10.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -69.57 1.25 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.528 0.585 . . . . 10.0 113.339 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -170.01 163.83 9.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.282 1.033 . . . . 10.0 109.592 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.68 54.41 2.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 175.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.08 67.05 0.56 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.483 -0.647 . . . . 10.0 111.483 -156.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.07 64.27 5.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.067 0.937 . . . . 10.0 110.069 -171.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -136.4 168.67 19.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.008 2.123 . . . . 10.0 109.394 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 61.4 mtp -81.35 73.76 8.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.57 0.7 . . . . 10.0 109.355 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.49 159.8 83.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.513 -0.767 . . . . 10.0 110.731 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -42.92 -52.2 4.86 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.634 2.889 . . . . 10.0 112.099 163.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 173.4 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 127.195 2.198 . . . . 10.0 108.52 -175.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -128.5 138.92 52.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 161.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -84.99 98.56 10.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.261 -1.755 . . . . 10.0 106.261 160.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.51 121.97 80.38 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.104 -1.813 . . . . 10.0 106.104 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.15 -173.98 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.621 2.214 . . . . 10.0 111.774 -166.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.88 149.3 1.87 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 154.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.5 6.96 0.12 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.112 1.365 . . . . 10.0 114.156 -166.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.29 84.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -109.7 61.18 0.6 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.337 1.455 . . . . 10.0 107.782 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mp -86.07 154.07 21.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.683 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.0 p -114.47 110.85 20.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.45 -2.056 . . . . 10.0 105.45 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.78 109.51 16.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.291 -2.114 . . . . 10.0 105.291 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.45 170.12 22.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.212 0.915 . . . . 10.0 111.12 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.429 HH21 ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -35.55 -45.81 0.37 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.567 1.147 . . . . 10.0 112.622 179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.429 ' CG ' HH21 ' A' ' 104' ' ' ARG . 7.3 m-20 -135.91 98.47 3.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.729 1.612 . . . . 10.0 106.776 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.83 116.46 1.12 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.803 1.668 . . . . 10.0 110.296 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 23.86 65.64 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.078 2.951 . . . . 10.0 114.184 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -119.14 164.8 15.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -164.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.0 121.01 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 47.9 mtp -83.19 99.47 9.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.49 -1.3 . . . . 10.0 107.49 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.17 58.74 3.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 171.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 40.8 ttp -84.57 161.8 20.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.566 1.146 . . . . 10.0 110.784 -168.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.13 -4.32 30.11 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.059 -1.411 . . . . 10.0 114.809 155.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 tp 47.41 89.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.253 1.821 . . . . 10.0 113.054 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -96.05 -40.47 9.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.443 1.097 . . . . 10.0 110.534 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.75 152.66 68.78 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 105.765 -1.939 . . . . 10.0 105.765 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -57.8 120.71 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.825 2.35 . . . . 10.0 111.725 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.16 73.65 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -74.39 104.9 5.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.859 1.264 . . . . 10.0 109.765 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 p -42.0 116.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.551 1.141 . . . . 10.0 111.425 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 116.46 -27.82 7.82 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.999 -0.89 . . . . 10.0 111.196 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -173.82 3.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.67 1.7 . . . . 10.0 110.082 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.7 m -150.35 130.26 13.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.371 -1.74 . . . . 10.0 107.749 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.03 134.11 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.383 1.073 . . . . 10.0 108.537 -170.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.76 110.87 8.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 pt -85.27 -179.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 160.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.0 m -147.08 121.53 9.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.403 -0.811 . . . . 10.0 109.147 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.3 177.52 7.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.654 0.381 . . . . 10.0 111.441 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -156.95 99.48 1.83 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.596 1.558 . . . . 10.0 107.96 171.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.82 33.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.949 -0.469 . . . . 10.0 109.89 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.2 t -82.94 61.36 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -169.54 -60.1 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 129.08 2.952 . . . . 10.0 105.482 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.42 -92.27 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.687 -1.142 . . . . 10.0 111.61 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -160.55 173.22 15.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.813 -0.816 . . . . 10.0 109.739 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 t -94.49 144.73 25.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.145 -1.798 . . . . 10.0 106.145 153.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.3 tp -156.45 143.76 19.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -87.97 132.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.955 1.702 . . . . 10.0 106.918 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.39 125.66 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.586 -1.265 . . . . 10.0 107.586 -164.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 111.37 18.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.029 -0.73 . . . . 10.0 109.029 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.08 119.17 38.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.079 0.952 . . . . 10.0 110.496 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -83.62 126.89 33.31 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.865 0.466 . . . . 10.0 110.387 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.25 110.29 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.628 -1.249 . . . . 10.0 107.628 -165.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -158.11 150.24 21.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.095 0.861 . . . . 10.0 110.86 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.38 150.8 24.19 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.113 0.87 . . . . 10.0 112.573 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.257 1.4 p-10 56.85 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.04 2.136 . . . . 10.0 112.715 -172.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.02 116.2 2.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 103.913 -2.625 . . . . 10.0 103.913 167.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -150.92 107.67 3.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.756 -1.572 . . . . 10.0 106.756 -157.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.46 -70.56 0.67 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.127 -1.589 . . . . 10.0 109.127 -160.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 103.839 -2.652 . . . . 10.0 103.839 163.331 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.0 173.02 23.95 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -173.55 -174.6 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.249 1.82 . . . . 10.0 106.537 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -158.98 -177.84 6.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.33 108.03 1.52 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.185 1.394 . . . . 10.0 107.953 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.33 155.86 16.75 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.676 2.25 . . . . 10.0 110.228 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.61 173.06 15.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.418 1.087 . . . . 10.0 108.148 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -160.45 -173.9 4.22 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.763 1.225 . . . . 10.0 107.719 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 m -150.13 135.28 9.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.306 -1.739 . . . . 10.0 106.306 169.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.59 158.56 55.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.165 1.91 . . . . 10.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.59 179.32 6.05 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.261 2.641 . . . . 10.0 110.822 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.79 169.91 18.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.011 1.324 . . . . 10.0 107.669 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -160.75 -179.59 7.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.326 1.051 . . . . 10.0 108.468 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -159.75 -173.31 4.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.07 -1.455 . . . . 10.0 107.07 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.86 108.84 1.29 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.717 1.207 . . . . 10.0 109.304 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.69 177.26 9.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.493 2.129 . . . . 10.0 110.192 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.22 169.58 23.84 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.565 1.146 . . . . 10.0 108.0 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.38 169.27 24.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.669 1.188 . . . . 10.0 107.954 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -146.64 179.09 7.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.315 1.446 . . . . 10.0 107.702 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -155.06 174.69 14.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.61 -176.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.768 1.227 . . . . 10.0 107.867 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.82 -177.72 29.31 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 107.691 -2.164 . . . . 10.0 107.691 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.81 -59.44 0.44 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 117.794 0.797 . . . . 10.0 110.516 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 123.81 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.589 0.356 . . . . 10.0 110.655 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.37 -68.78 0.82 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.757 0.823 . . . . 10.0 110.389 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -158.84 131.36 4.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.27 159.13 54.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.62 1.546 . . . . 10.0 109.676 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m -81.86 53.68 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.903 -0.498 . . . . 10.0 110.833 -171.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 p -156.48 53.34 0.54 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.315 0.646 . . . . 10.0 110.181 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.74 80.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 165.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.42 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -123.91 133.08 53.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 128.252 2.621 . . . . 10.0 108.407 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.06 97.09 1.29 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.27 -1.532 . . . . 10.0 109.27 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.12 9.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.705 0.753 . . . . 10.0 111.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.3 p -115.96 149.61 38.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.737 -1.208 . . . . 10.0 107.737 163.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.96 142.16 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.46 16.97 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.832 0.825 . . . . 10.0 111.044 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.792 1.637 . . . . 10.0 110.811 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 t 45.45 74.66 0.76 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.741 1.616 . . . . 10.0 111.144 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.26 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.296 2.664 . . . . 10.0 110.044 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.16 77.68 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.801 3.001 . . . . 10.0 112.473 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 t -157.11 -49.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.374 3.07 . . . . 10.0 106.008 165.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 67.56 162.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 C-N-CA 125.615 1.566 . . . . 10.0 107.438 -161.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 72.79 -50.18 0.7 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.428 1.491 . . . . 10.0 111.89 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.23 155.64 16.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.008 1.723 . . . . 10.0 109.69 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -164.41 -176.73 4.52 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 10.0 108.045 162.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 153.91 34.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.487 1.115 . . . . 10.0 110.73 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.59 150.03 22.58 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.073 0.858 . . . . 10.0 110.442 170.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -125.0 123.75 40.53 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -160.66 -172.41 3.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.228 1.411 . . . . 10.0 107.701 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 m -144.86 122.59 11.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.444 -0.785 . . . . 10.0 109.598 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.42 102.77 10.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.332 -1.729 . . . . 10.0 106.332 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 m -92.56 94.16 8.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.651 -1.613 . . . . 10.0 106.653 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.86 56.03 3.27 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.79 -0.569 . . . . 10.0 110.434 -167.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -91.76 111.09 22.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.34 0.59 . . . . 10.0 109.5 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 133.27 -19.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 131.564 3.946 . . . . 10.0 106.942 -165.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.78 61.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.638 -1.245 . . . . 10.0 107.638 150.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -145.04 137.45 13.4 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.319 1.848 . . . . 10.0 110.633 -170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.69 92.83 0.94 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 10.0 112.212 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.77 112.11 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.957 0.903 . . . . 10.0 108.924 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 168.64 17.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.675 0.79 . . . . 10.0 110.48 174.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -132.93 127.78 35.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.41 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.522 0.677 . . . . 10.0 109.755 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.4 147.25 13.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.191 -1.164 . . . . 10.0 110.191 163.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.22 66.95 0.51 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.019 1.327 . . . . 10.0 109.665 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.48 145.04 28.34 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.706 -0.849 . . . . 10.0 108.706 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 t -170.35 151.58 3.8 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 118.943 0.792 . . . . 10.0 110.47 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.86 45.79 0.96 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.992 2.461 . . . . 10.0 111.323 166.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.16 -77.28 0.47 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.929 1.291 . . . . 10.0 108.609 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.92 143.53 55.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.032 0.533 . . . . 10.0 110.948 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 m -96.72 -29.22 13.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.609 0.763 . . . . 10.0 109.64 165.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.0 t -126.03 67.41 61.86 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.074 1.75 . . . . 10.0 109.092 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.73 106.1 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.679 2.253 . . . . 10.0 109.777 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 128.56 53.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.222 1.009 . . . . 10.0 109.478 -174.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.73 136.8 35.44 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.229 -1.026 . . . . 10.0 108.229 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 ttp -136.07 152.44 50.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.055 1.342 . . . . 10.0 108.812 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -148.19 110.24 4.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.413 0.685 . . . . 10.0 110.058 -166.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -141.41 55.95 1.53 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.447 -0.783 . . . . 10.0 111.828 175.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -137.2 110.57 7.92 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.039 1.336 . . . . 10.0 109.093 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -52.27 -42.65 63.87 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.461 1.104 . . . . 10.0 111.195 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.3 p -82.45 16.53 2.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.901 1.28 . . . . 10.0 112.334 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.95 -142.99 5.2 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.396 1.474 . . . . 10.0 110.1 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.01 -68.63 1.58 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 117.169 0.484 . . . . 10.0 112.266 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -144.67 169.9 17.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.568 1.547 . . . . 10.0 108.24 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -117.71 54.5 0.9 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.93 75.01 0.22 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 118.742 -1.032 . . . . 10.0 111.591 -166.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 ttp -49.36 98.36 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 122.324 1.059 . . . . 10.0 111.717 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -155.76 166.53 33.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.274 2.229 . . . . 10.0 105.955 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.8 mtm -80.82 132.62 35.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.031 -1.47 . . . . 10.0 107.031 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -134.64 168.22 18.91 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.733 . . . . 10.0 110.668 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -37.74 -56.4 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.63 2.887 . . . . 10.0 111.464 159.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 178.47 -159.27 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.47 1.508 . . . . 10.0 110.258 -175.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.54 142.78 51.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 126.386 1.874 . . . . 10.0 106.362 161.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m -110.47 134.87 51.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.005 -1.85 . . . . 10.0 106.005 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 pp -121.83 138.94 29.31 Favored Pre-proline 0 N--CA 1.452 -0.35 0 N-CA-C 106.679 -1.601 . . . . 10.0 106.679 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.87 176.48 8.94 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.862 1.708 . . . . 10.0 110.699 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.6 129.74 8.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.88 -1.054 . . . . 10.0 109.63 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 59.15 26.27 14.97 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 129.674 3.19 . . . . 10.0 113.342 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.69 144.71 45.96 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.965 -0.854 . . . . 10.0 110.965 167.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -129.21 65.42 1.46 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.572 -2.01 . . . . 10.0 105.572 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.25 129.25 34.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.943 -2.243 . . . . 10.0 104.943 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.8 m -123.45 93.45 3.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.013 -2.217 . . . . 10.0 105.013 -158.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.82 122.45 26.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 -162.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -151.86 154.33 35.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.956 1.303 . . . . 10.0 108.47 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -8.53 6.91 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.507 1.299 . . . . 10.0 114.507 -164.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 37.67 1.48 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.812 0.733 . . . . 10.0 110.979 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.45 64.97 0.22 Allowed Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.37 -1.092 . . . . 10.0 110.37 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 t0 70.01 133.78 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.199 1.799 . . . . 10.0 109.748 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -177.19 169.82 2.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.574 -0.704 . . . . 10.0 110.728 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.95 115.64 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.527 -2.027 . . . . 10.0 105.527 169.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 81.5 mtp -83.84 95.92 8.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.88 65.39 6.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 10.0 107.891 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 75.8 mtp -82.6 162.53 21.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.847 0.832 . . . . 10.0 110.782 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.99 69.66 1.38 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.429 -1.068 . . . . 10.0 110.429 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.33 82.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.672 0.789 . . . . 10.0 109.611 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -55.92 -47.25 77.85 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.892 -0.505 . . . . 10.0 112.084 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -114.05 155.5 45.34 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.937 -1.135 . . . . 10.0 107.937 157.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.56 173.83 12.65 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.447 2.765 . . . . 10.0 110.034 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.38 175.37 8.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.144 1.378 . . . . 10.0 110.113 -174.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.31 150.3 49.65 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.36 1.464 . . . . 10.0 107.953 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.8 t -69.79 134.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.46 42.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.074 -0.81 . . . . 10.0 111.074 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.64 -169.37 1.7 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.84 1.305 . . . . 10.0 108.813 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 m -154.74 82.78 1.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.027 -1.472 . . . . 10.0 107.027 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -89.83 126.49 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.883 -1.154 . . . . 10.0 107.883 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.31 150.88 45.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.102 -0.639 . . . . 10.0 110.372 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.98 148.61 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.379 -1.712 . . . . 10.0 106.379 170.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -123.15 117.59 25.72 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.79 157.04 18.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.481 -0.563 . . . . 10.0 109.481 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -157.38 86.23 0.94 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.578 1.551 . . . . 10.0 107.895 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.74 157.61 23.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.096 -0.377 . . . . 10.0 110.046 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 t -54.36 -32.77 57.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.523 1.129 . . . . 10.0 112.504 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -5.74 4.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.918 0.887 . . . . 10.0 113.063 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.21 9.67 65.07 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.404 1.002 . . . . 10.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -79.34 95.1 5.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 105.916 -1.883 . . . . 10.0 105.916 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -116.37 123.97 48.91 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.076 1.751 . . . . 10.0 107.141 -171.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.4 tp -155.55 141.59 18.28 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -102.52 132.98 48.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.477 1.911 . . . . 10.0 106.742 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.87 162.14 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.05 131.86 54.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.868 1.267 . . . . 10.0 107.604 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.77 133.81 55.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.643 1.177 . . . . 10.0 109.892 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -83.89 128.33 34.47 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.87 108.1 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.324 -1.362 . . . . 10.0 107.324 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -157.58 125.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.582 -0.895 . . . . 10.0 108.582 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' NZ ' ' OXT' ' A' ' 149' ' ' ARG . 5.5 pttt -71.7 73.11 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.37 0.605 . . . . 10.0 111.357 176.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -52.02 104.54 0.09 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 109.199 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.275 10.9 pt 60.67 -23.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 128.147 2.579 . . . . 10.0 116.821 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -51.58 115.86 1.83 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.023 1.329 . . . . 10.0 110.854 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.59 -62.75 2.32 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 10.0 110.911 -171.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.424 ' OXT' ' NZ ' ' A' ' 144' ' ' LYS . 23.3 ttm105 . . . . . 0 C--O 1.247 0.952 0 C-N-CA 127.782 2.433 . . . . 10.0 109.562 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 106.629 -1.619 . . . . 10.0 106.629 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.61 124.97 1.27 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.28 -1.128 . . . . 10.0 110.28 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -165.43 155.39 13.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -166.54 -179.46 4.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.166 -1.42 . . . . 10.0 107.166 169.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.7 ttm -167.3 71.44 0.99 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.658 1.583 . . . . 10.0 108.712 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -71.48 143.74 43.51 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.222 1.948 . . . . 10.0 109.893 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.35 151.44 15.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.173 -1.047 . . . . 10.0 108.173 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -164.17 169.44 17.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.534 -1.654 . . . . 10.0 106.534 171.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -172.51 68.67 0.4 Allowed Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 10.0 109.898 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.15 118.66 5.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.254 1.969 . . . . 10.0 110.113 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.99 159.4 18.27 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.519 2.146 . . . . 10.0 110.787 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.32 150.5 16.41 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.758 -1.201 . . . . 10.0 107.758 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -169.92 157.39 6.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.773 1.229 . . . . 10.0 108.276 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -169.14 174.4 6.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.405 1.482 . . . . 10.0 107.172 168.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.2 68.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 10.0 110.5 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.19 145.23 38.7 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.115 1.877 . . . . 10.0 110.056 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.4 152.2 16.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.034 0.934 . . . . 10.0 108.507 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.39 156.62 8.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.587 1.555 . . . . 10.0 107.01 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -164.02 160.78 22.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -177.59 169.68 2.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.261 2.224 . . . . 10.0 106.641 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.21 -177.41 2.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.784 1.634 . . . . 10.0 107.215 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.16 164.86 32.07 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.51 -2.236 . . . . 10.0 107.51 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.27 -177.39 3.65 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.263 1.025 . . . . 10.0 108.58 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 71.12 178.21 0.26 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.072 1.749 . . . . 10.0 111.76 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.04 178.18 9.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.87 1.668 . . . . 10.0 106.952 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.15 132.18 8.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.22 150.49 87.44 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.605 1.537 . . . . 10.0 109.002 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.04 51.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 121.785 0.803 . . . . 10.0 111.168 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -157.85 55.17 0.48 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 -165.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.57 58.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.11 0.957 . . . . 10.0 108.981 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.9 -179.91 4.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.112 1.365 . . . . 10.0 110.396 171.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.0 -136.92 3.51 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.056 -2.418 . . . . 10.0 107.056 166.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.98 132.4 6.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.981 1.39 . . . . 10.0 110.683 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.7 p -126.76 135.2 50.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.288 -1.745 . . . . 10.0 106.288 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.7 t -121.71 135.29 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 119.158 0.89 . . . . 10.0 109.061 -171.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.83 44.62 0.56 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.631 0.974 . . . . 10.0 113.631 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 26.77 -119.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.643 1.977 . . . . 10.0 111.546 -164.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.69 113.94 50.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.093 -1.817 . . . . 10.0 106.093 161.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.97 163.99 20.65 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.17 1.913 . . . . 10.0 108.774 168.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.92 62.41 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.449 2.1 . . . . 10.0 110.523 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.5 p -163.4 62.31 0.17 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.209 1.004 . . . . 10.0 108.628 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 mt 75.15 160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.932 1.293 . . . . 10.0 110.222 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -66.76 25.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.741 1.386 . . . . 10.0 114.741 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.95 158.44 15.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 168.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -165.39 -175.54 3.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.728 -1.953 . . . . 10.0 105.728 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.56 168.98 24.93 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.319 -0.622 . . . . 10.0 109.319 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.47 161.09 22.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -131.4 104.7 7.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.632 -1.988 . . . . 10.0 105.632 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -171.16 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.139 1.775 . . . . 10.0 110.443 -169.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -152.29 129.57 11.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.718 -1.238 . . . . 10.0 108.029 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.11 135.44 33.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 m -123.96 104.27 8.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 124.168 0.918 . . . . 10.0 110.581 -167.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.18 113.18 15.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.706 -0.479 . . . . 10.0 109.706 167.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -135.36 68.44 1.46 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.668 -1.604 . . . . 10.0 106.668 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -178.5 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.388 1.475 . . . . 10.0 111.473 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' CG ' ' HE ' ' A' ' 97' ' ' ARG . 84.0 m-20 72.72 78.13 0.15 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.551 1.94 . . . . 10.0 112.17 -171.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -143.16 147.0 38.97 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.331 0.652 . . . . 10.0 109.817 168.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -86.29 112.23 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.759 2.973 . . . . 10.0 111.001 173.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -123.92 99.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.71 103.94 12.59 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.109 -0.994 . . . . 10.0 111.139 -173.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -82.68 124.95 30.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.697 0.799 . . . . 10.0 110.201 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.66 54.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.117 0.961 . . . . 10.0 109.626 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.65 144.49 10.0 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -1.323 . . . . 10.0 109.792 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.45 66.73 0.56 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.972 1.709 . . . . 10.0 107.205 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 148.71 28.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 t -170.3 151.78 3.9 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 109.879 -0.415 . . . . 10.0 109.879 -164.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.28 -1.41 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.802 2.335 . . . . 10.0 112.021 167.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -104.82 -35.91 7.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.471 1.108 . . . . 10.0 113.415 -163.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.43 124.29 48.97 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.558 1.143 . . . . 10.0 109.844 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -29.79 65.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.795 0.838 . . . . 10.0 110.108 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.7 m -135.36 68.43 68.14 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.024 1.33 . . . . 10.0 109.959 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.1 115.76 4.22 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.616 2.21 . . . . 10.0 110.365 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -139.34 140.4 37.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.821 0.448 . . . . 10.0 111.203 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mt -83.57 145.83 28.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 10.0 109.8 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.65 169.37 18.12 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 125.596 1.558 . . . . 10.0 109.817 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 t -145.71 157.44 43.95 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.318 -0.238 . . . . 10.0 110.677 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.54 61.14 0.61 Allowed 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.342 -0.849 . . . . 10.0 109.25 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -155.15 138.63 15.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -80.55 -39.21 28.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.38 -44.99 95.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.798 1.239 . . . . 10.0 111.514 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.94 -126.7 3.49 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.065 -0.814 . . . . 10.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.4 -75.3 0.33 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.828 0.727 . . . . 10.0 113.923 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -163.73 160.98 23.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.774 0.83 . . . . 10.0 109.972 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.97 53.81 2.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.621 -1.251 . . . . 10.0 107.621 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.67 71.2 0.5 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.324 -0.709 . . . . 10.0 111.962 -156.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.51 64.32 4.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.182 0.991 . . . . 10.0 110.24 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -136.11 170.26 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.971 2.108 . . . . 10.0 109.275 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.86 72.79 7.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.52 0.728 . . . . 10.0 109.155 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.1 158.8 86.52 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.341 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -44.49 -53.41 4.96 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.373 2.715 . . . . 10.0 111.995 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 174.3 -157.62 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.021 2.129 . . . . 10.0 108.931 -175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -128.76 139.9 51.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.646 -1.613 . . . . 10.0 106.646 165.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.1 m -88.4 100.13 12.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.444 -1.687 . . . . 10.0 106.444 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.31 123.11 79.49 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 106.095 -1.817 . . . . 10.0 106.095 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.17 -172.24 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.566 2.177 . . . . 10.0 111.771 -168.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.83 149.23 3.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 155.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.415 ' HE ' ' CG ' ' A' ' 56' ' ' ASP . 0.0 OUTLIER 52.21 7.61 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.809 1.411 . . . . 10.0 114.809 -165.37 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 90.74 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.885 -1.286 . . . . 10.0 109.885 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -115.93 64.78 0.7 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.134 1.774 . . . . 10.0 107.326 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -88.73 154.68 20.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.648 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -118.5 109.76 16.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 -167.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -83.62 102.99 12.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -152.07 170.62 19.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.816 0.735 . . . . 10.0 111.295 -170.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.405 HH21 ' CG ' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -36.55 -47.38 0.63 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.772 1.229 . . . . 10.0 111.712 179.312 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 104' ' ' ARG . 6.2 m-20 -129.93 95.05 3.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.776 1.63 . . . . 10.0 107.75 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.7 117.68 1.1 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.7 -1.056 . . . . 10.0 111.264 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.2 t0 24.86 64.79 0.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.565 2.746 . . . . 10.0 113.533 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -116.59 159.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.269 0.557 . . . . 10.0 112.419 -165.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.77 114.53 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.769 -1.937 . . . . 10.0 105.769 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 mtp -81.98 96.92 7.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.802 -1.184 . . . . 10.0 107.802 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.0 mt -81.0 59.41 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 46.5 ttp -82.99 158.4 22.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.387 0.675 . . . . 10.0 110.474 -169.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.16 -7.93 9.15 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.097 -1.39 . . . . 10.0 115.207 156.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.7 tp 46.63 68.54 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.243 1.417 . . . . 10.0 111.777 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -77.92 -37.71 47.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.432 0.693 . . . . 10.0 110.695 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.73 153.02 67.4 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 105.747 -1.946 . . . . 10.0 105.747 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.21 109.97 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.885 2.39 . . . . 10.0 111.415 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.04 99.81 1.14 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -97.8 115.78 28.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.228 1.411 . . . . 10.0 108.673 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -46.97 120.0 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.238 0.615 . . . . 10.0 110.067 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.88 -23.71 18.64 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.704 -1.053 . . . . 10.0 111.766 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -175.02 3.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.723 1.725 . . . . 10.0 109.55 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -153.9 131.74 11.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.284 -1.78 . . . . 10.0 107.493 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.7 136.84 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.404 1.082 . . . . 10.0 108.676 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.9 114.15 15.36 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.2 pt -92.88 176.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.747 0.819 . . . . 10.0 109.068 164.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.2 m -147.75 125.41 11.81 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.596 -0.69 . . . . 10.0 109.609 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 pp -91.77 179.18 5.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.22 0.608 . . . . 10.0 111.92 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -157.74 103.46 1.9 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.826 1.65 . . . . 10.0 108.068 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.18 123.35 33.93 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.006 -0.434 . . . . 10.0 110.488 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -83.0 64.0 7.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -174.86 -61.2 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.916 2.887 . . . . 10.0 105.47 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.75 -96.81 0.6 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.629 -1.169 . . . . 10.0 111.567 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -160.47 175.86 12.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.857 -0.79 . . . . 10.0 109.619 -171.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.6 t -90.42 150.36 21.87 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.868 1.667 . . . . 10.0 107.007 156.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.9 tp -155.16 142.89 19.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.801 -1.925 . . . . 10.0 105.801 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.89 132.18 37.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.198 1.799 . . . . 10.0 106.667 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.48 128.36 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.686 -1.227 . . . . 10.0 107.686 -166.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.65 108.03 16.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.26 118.89 31.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.005 0.922 . . . . 10.0 109.838 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.4 m -83.95 132.41 34.77 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.42 111.34 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.432 ' NZ ' ' OXT' ' A' ' 149' ' ' ARG . 31.9 pttt -157.67 116.98 3.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.577 0.626 . . . . 10.0 111.283 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -84.73 175.43 9.19 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.731 -0.605 . . . . 10.0 111.088 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 56.04 179.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.677 1.591 . . . . 10.0 112.191 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.28 111.79 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 104.39 -2.448 . . . . 10.0 104.39 165.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -146.8 134.26 20.83 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 -171.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.3 -69.24 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.437 1.494 . . . . 10.0 113.046 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . 0.432 ' OXT' ' NZ ' ' A' ' 143' ' ' LYS . 27.4 mtt180 . . . . . 0 C--O 1.247 0.948 0 C-N-CA 128.457 2.703 . . . . 10.0 105.611 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.53 -35.32 36.7 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.303 0.956 . . . . 10.0 111.365 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -141.79 -177.56 5.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t 177.58 152.99 0.26 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.031 2.933 . . . . 10.0 106.149 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.0 ttt -151.81 132.46 7.46 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -175.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.32 178.49 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.097 2.531 . . . . 10.0 110.661 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.07 166.77 31.43 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.829 1.251 . . . . 10.0 107.693 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -162.87 171.91 15.94 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -153.04 140.52 13.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.158 -1.053 . . . . 10.0 108.158 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 155.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.355 2.037 . . . . 10.0 111.052 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.75 176.05 10.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.22 2.613 . . . . 10.0 110.387 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 156.36 41.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.37 167.61 17.58 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.791 -1.559 . . . . 10.0 106.791 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -150.42 -179.83 7.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 170.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.06 104.67 1.56 Allowed Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 10.0 109.46 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.07 107.04 2.39 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.191 1.927 . . . . 10.0 110.342 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.79 74.01 0.42 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.703 0.801 . . . . 10.0 110.537 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.45 66.28 0.47 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.179 1.392 . . . . 10.0 112.801 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -64.72 157.25 27.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.084 0.554 . . . . 10.0 109.647 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -165.28 148.36 8.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 -174.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.13 -175.81 2.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 107.714 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.51 42.93 79.67 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.095 0.379 . . . . 10.0 112.465 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.32 -44.87 43.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.669 0.388 . . . . 10.0 111.43 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.06 167.15 19.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.24 0.616 . . . . 10.0 112.243 -174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.36 175.31 10.63 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.626 1.571 . . . . 10.0 108.315 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tt -153.79 131.81 6.43 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.65 140.7 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.145 1.897 . . . . 10.0 109.491 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.17 54.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.007 0.523 . . . . 10.0 112.329 -158.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -160.45 54.06 0.32 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.124 0.964 . . . . 10.0 109.974 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.75 64.74 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 120.984 -1.073 . . . . 10.0 110.774 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -155.35 149.9 26.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.131 0.572 . . . . 10.0 109.731 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.61 145.42 17.83 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.001 -1.64 . . . . 10.0 109.001 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.45 161.0 22.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.264 1.032 . . . . 10.0 111.302 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -123.41 139.97 53.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.907 -1.516 . . . . 10.0 106.907 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.92 136.71 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 107.358 -1.349 . . . . 10.0 107.358 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.45 41.46 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 34.94 -137.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.956 2.102 . . . . 10.0 112.083 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.75 108.75 47.59 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 160.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.31 166.6 29.13 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 N-CA-C 107.528 -1.758 . . . . 10.0 107.528 166.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.36 64.78 3.62 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.048 2.499 . . . . 10.0 111.032 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.3 t -164.55 56.51 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.842 1.257 . . . . 10.0 108.985 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt 71.56 170.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.589 1.156 . . . . 10.0 109.005 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -44.92 -41.35 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.064 -1.023 . . . . 10.0 112.747 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -51.43 141.35 15.73 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 127.072 2.149 . . . . 10.0 111.983 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.3 t -162.03 -172.45 3.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.652 -165.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.34 159.09 44.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.792 0.837 . . . . 10.0 111.555 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.09 144.07 26.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.94 1.296 . . . . 10.0 109.238 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -128.53 119.22 24.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.569 -2.752 . . . . 10.0 103.569 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 ptp -161.04 -173.9 4.11 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.367 1.067 . . . . 10.0 108.522 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -131.39 135.85 47.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.216 1.407 . . . . 10.0 108.111 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.88 120.97 37.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 103.952 -2.611 . . . . 10.0 103.952 160.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -110.55 79.74 1.24 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.424 -1.324 . . . . 10.0 107.424 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -81.33 92.9 6.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.317 0.58 . . . . 10.0 110.433 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -83.31 57.11 3.82 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.798 -0.564 . . . . 10.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 t -171.1 157.96 5.37 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.936 0.895 . . . . 10.0 109.182 166.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.78 61.96 6.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -134.91 117.46 12.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.783 0.833 . . . . 10.0 111.04 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 122.82 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.094 2.529 . . . . 10.0 110.337 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.61 106.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.499 0.72 . . . . 10.0 109.08 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 121.46 32.61 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.204 -0.935 . . . . 10.0 111.563 -171.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.288 0.0 OUTLIER -102.59 128.06 49.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.047 -0.408 . . . . 10.0 110.22 -171.509 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.59 57.21 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.536 1.16 . . . . 10.0 109.079 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.78 153.23 24.22 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.939 -1.665 . . . . 10.0 108.939 166.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.94 62.19 0.46 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 168.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.92 138.87 32.24 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -168.82 151.32 4.94 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 118.602 0.637 . . . . 10.0 109.693 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.94 56.37 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.77 2.313 . . . . 10.0 109.656 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.7 mt -136.55 -82.33 0.38 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.97 1.708 . . . . 10.0 107.982 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.74 136.86 45.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.043 0.937 . . . . 10.0 111.681 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.8 m -81.48 -31.43 32.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.251 0.62 . . . . 10.0 109.433 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.2 t -119.82 72.2 16.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.503 1.121 . . . . 10.0 111.448 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.84 97.22 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.916 2.411 . . . . 10.0 111.153 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.7 mmt -105.23 128.72 53.56 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.378 1.071 . . . . 10.0 110.063 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 145.28 28.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.926 0.89 . . . . 10.0 110.105 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.05 163.85 31.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.888 1.275 . . . . 10.0 111.507 172.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.413 ' CG2' ' H ' ' A' ' 83' ' ' MET 0.25 26.1 m -102.0 164.23 11.82 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.485 3.114 . . . . 10.0 110.805 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.8 t -95.93 173.98 7.17 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.367 1.067 . . . . 10.0 112.837 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -99.26 55.82 1.0 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.003 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.9 p80 171.87 -170.33 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.698 2.399 . . . . 10.0 107.69 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 m -46.84 171.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.881 2.872 . . . . 10.0 114.654 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.92 -65.72 2.2 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.908 -2.077 . . . . 10.0 107.908 -169.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.62 -146.61 2.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.474 -1.05 . . . . 10.0 110.474 155.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.413 ' H ' ' CG2' ' A' ' 76' ' ' THR . 65.8 mtt -114.1 -82.47 0.6 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.865 1.266 . . . . 10.0 109.922 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.02 51.81 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.841 1.256 . . . . 10.0 109.385 -172.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.18 147.48 4.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.051 -0.595 . . . . 10.0 113.905 166.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -78.3 43.6 0.46 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.126 1.77 . . . . 10.0 112.047 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -83.04 157.77 22.75 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.572 0.749 . . . . 10.0 109.872 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.3 ttp -81.49 70.38 8.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.417 1.103 . . . . 10.0 109.36 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -58.09 162.02 6.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.876 1.671 . . . . 10.0 111.718 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 50.3 Cg_exo -47.57 -37.65 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.553 2.836 . . . . 10.0 113.341 163.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.423 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.91 -158.56 0.01 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.978 1.311 . . . . 10.0 111.049 -161.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.55 115.04 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.937 0.495 . . . . 10.0 110.05 164.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -84.46 103.14 13.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 159.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.28 120.16 76.45 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 105.998 -1.852 . . . . 10.0 105.998 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -85.89 137.16 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 109.283 -1.083 . . . . 10.0 109.283 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 50.73 -137.25 1.16 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.302 0.641 . . . . 10.0 110.911 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.89 59.39 0.1 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.291 2.237 . . . . 10.0 112.316 176.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 87.1 0.12 Allowed Glycine 0 N--CA 1.441 -0.974 0 O-C-N 121.583 -0.698 . . . . 10.0 111.372 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.1 m -86.4 67.67 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.63 1.572 . . . . 10.0 107.602 163.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -102.82 175.48 5.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.833 -0.802 . . . . 10.0 108.833 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -155.85 129.88 8.67 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.675 0.75 . . . . 10.0 110.437 -169.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.92 126.14 32.71 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.52 1.528 . . . . 10.0 108.574 -168.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.29 154.58 42.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.548 1.939 . . . . 10.0 109.123 -170.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.62 -27.81 59.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.073 0.949 . . . . 10.0 112.855 176.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -78.55 -59.99 2.56 Favored 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 121.473 -0.767 . . . . 10.0 111.406 178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.88 136.87 5.55 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.833 -1.307 . . . . 10.0 109.833 -167.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t0 70.06 120.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 129.063 2.945 . . . . 10.0 106.761 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 177.42 171.17 0.58 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.549 1.522 . . . . 10.0 111.759 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.36 124.4 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 105.066 -2.198 . . . . 10.0 105.066 156.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.4 mtm -82.32 96.69 7.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 161.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.52 69.18 5.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.911 -1.514 . . . . 10.0 106.911 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 66.4 mtp -85.37 166.95 15.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.967 0.889 . . . . 10.0 112.961 -169.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.96 57.8 17.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.081 -1.208 . . . . 10.0 110.081 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.36 123.38 17.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.075 0.938 . . . . 10.0 109.098 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.82 -61.91 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.595 0.358 . . . . 10.0 111.423 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -70.75 157.18 90.78 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.076 0.55 . . . . 10.0 111.354 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.98 139.62 39.89 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.577 2.184 . . . . 10.0 110.288 169.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -88.05 179.43 6.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.005 1.322 . . . . 10.0 111.592 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 100.64 0.93 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.64 117.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.208 -1.034 . . . . 10.0 108.208 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.15 -13.28 31.35 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.194 -0.781 . . . . 10.0 111.995 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -77.78 -169.85 1.66 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.493 1.615 . . . . 10.0 108.303 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.8 m -155.3 137.27 14.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.3 154.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.22 -1.4 . . . . 10.0 107.22 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -80.52 145.67 31.71 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 17.9 tt -108.71 146.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 162.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.7 m -117.57 111.82 19.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.871 -1.899 . . . . 10.0 105.871 172.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 145.71 24.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 125.935 1.694 . . . . 10.0 107.258 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -144.27 97.58 3.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.45 142.28 32.05 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.3 t -62.14 -29.05 70.07 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.695 -1.253 . . . . 10.0 111.082 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.664 -0.647 . . . . 10.0 110.595 171.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.81 91.16 0.13 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.177 1.37 . . . . 10.0 110.602 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 53.61 1.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.521 0.728 . . . . 10.0 110.643 -174.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.5 m -157.8 87.8 0.95 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.934 0.494 . . . . 10.0 110.896 -170.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mt -153.94 156.06 36.79 Favored 'General case' 0 C--O 1.23 0.036 0 CA-C-N 119.085 0.857 . . . . 10.0 109.109 167.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.32 136.28 19.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.4 163.63 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.55 137.66 32.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.387 0.675 . . . . 10.0 110.359 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.34 114.34 24.18 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.205 1.802 . . . . 10.0 109.318 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -83.01 125.3 31.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.297 1.439 . . . . 10.0 108.203 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.84 97.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 O-C-N 120.513 -1.367 . . . . 10.0 108.305 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -147.44 103.03 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.315 0.646 . . . . 10.0 110.917 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -52.11 127.44 21.64 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.952 -0.468 . . . . 10.0 110.3 161.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -149.13 143.16 25.81 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 mp 43.16 55.66 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.418 1.104 . . . . 10.0 108.663 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -83.22 51.45 1.97 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.103 -0.953 . . . . 10.0 112.365 -158.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.71 -55.02 0.4 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.836 -0.906 . . . . 10.0 110.836 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.491 0 C-N-CA 126.596 1.958 . . . . 10.0 110.388 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.96 148.79 11.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.118 -1.593 . . . . 10.0 109.118 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -119.98 67.41 0.82 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.046 1.738 . . . . 10.0 109.36 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 p -73.04 75.68 1.21 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.559 0.744 . . . . 10.0 109.919 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 60.4 ttp -93.47 106.38 20.36 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.996 1.318 . . . . 10.0 109.818 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.21 175.04 11.58 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.253 1.969 . . . . 10.0 110.316 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.37 165.57 30.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.874 1.27 . . . . 10.0 107.669 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -160.39 165.86 30.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -167.25 69.15 0.95 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 10.0 109.497 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.51 122.4 9.61 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.197 1.932 . . . . 10.0 110.007 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 168.3 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.719 2.279 . . . . 10.0 110.895 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 142.09 20.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.794 -1.188 . . . . 10.0 107.794 173.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -167.04 164.89 15.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.516 -1.661 . . . . 10.0 106.516 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -158.99 -177.24 6.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 173.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.98 73.31 1.26 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.584 1.553 . . . . 10.0 109.691 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.04 78.01 2.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.016 2.477 . . . . 10.0 111.164 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 152.22 17.89 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.033 0.533 . . . . 10.0 110.769 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.34 171.84 19.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.206 1.002 . . . . 10.0 108.927 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -143.84 174.96 10.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.542 1.537 . . . . 10.0 107.761 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -137.52 107.76 6.43 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.377 1.071 . . . . 10.0 108.871 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.7 98.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.101 0.56 . . . . 10.0 111.419 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.36 -59.96 3.99 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.907 -0.496 . . . . 10.0 111.957 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.8 149.71 43.84 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.997 0.919 . . . . 10.0 109.431 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 69.12 142.87 0.04 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.885 1.674 . . . . 10.0 110.29 -168.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 70.85 -39.77 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.714 1.605 . . . . 10.0 113.931 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 tt -51.65 120.31 15.34 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.442 1.497 . . . . 10.0 109.602 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -68.16 165.3 28.94 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.416 1.411 . . . . 10.0 108.583 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.09 56.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.123 0.963 . . . . 10.0 110.554 -169.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -155.08 58.02 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.237 1.015 . . . . 10.0 108.777 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.56 85.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -145.52 158.67 43.81 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.107 1.763 . . . . 10.0 107.586 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.62 -163.08 32.74 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.437 -1.865 . . . . 10.0 108.437 161.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.55 149.51 23.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.994 0.897 . . . . 10.0 109.96 169.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.6 p -133.76 153.99 51.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 170.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.4 133.55 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 123.514 0.726 . . . . 10.0 109.928 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.17 110.45 7.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.82 34.65 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.464 -0.772 . . . . 10.0 109.112 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -19.35 99.31 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 127.523 2.329 . . . . 10.0 113.558 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 163.01 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.688 2.926 . . . . 10.0 109.683 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.09 52.58 3.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.22 1.947 . . . . 10.0 110.164 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -157.68 56.0 0.49 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.182 -1.044 . . . . 10.0 108.182 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt 70.08 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.333 1.053 . . . . 10.0 109.008 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.457 HH11 ' CG ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -50.6 -42.71 56.25 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' CG ' HH11 ' A' ' 43' ' ' ARG . 63.4 m-20 -59.09 127.32 31.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.706 0.765 . . . . 10.0 109.929 -163.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -145.68 -165.84 2.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.315 -1.311 . . . . 10.0 111.21 -164.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.86 157.94 41.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.611 1.164 . . . . 10.0 112.107 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.42 158.95 20.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.492 -0.777 . . . . 10.0 110.022 165.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.3 128.14 48.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 163.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -157.64 177.8 10.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 p -98.19 168.81 10.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.39 146.4 46.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.364 -1.717 . . . . 10.0 106.364 163.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.6 m -140.79 111.66 7.04 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.975 0.797 . . . . 10.0 112.302 -166.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 119.69 24.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.314 0.506 . . . . 10.0 109.652 167.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 80.74 1.63 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.971 -1.122 . . . . 10.0 107.971 157.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m 164.53 -19.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 129.184 2.994 . . . . 10.0 109.557 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 74.13 53.24 0.1 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.495 0.589 . . . . 10.0 110.407 140.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -145.98 157.71 49.96 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 125.004 1.322 . . . . 10.0 109.129 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.31 70.59 7.14 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.543 2.829 . . . . 10.0 111.301 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mm -85.89 152.01 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.44 0.638 . . . . 10.0 109.653 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -139.26 81.83 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.592 2.357 . . . . 10.0 108.791 -162.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.01 63.4 7.07 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.155 0.982 . . . . 10.0 111.961 -166.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.39 60.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.481 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 149.2 18.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.365 -1.398 . . . . 10.0 113.304 163.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.28 59.89 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.505 1.522 . . . . 10.0 108.891 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.29 132.88 35.3 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.726 -0.609 . . . . 10.0 109.604 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 t -161.69 150.09 12.64 Favored Pre-proline 0 C--O 1.24 0.568 0 O-C-N 121.464 -0.772 . . . . 10.0 111.198 -168.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.57 42.84 1.23 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.895 2.396 . . . . 10.0 111.115 170.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.07 -68.34 0.83 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.058 1.343 . . . . 10.0 109.169 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.23 138.74 31.18 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.777 1.231 . . . . 10.0 110.517 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -78.77 -34.71 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 165.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t -121.65 73.65 32.66 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 124.939 1.296 . . . . 10.0 110.034 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.74 114.27 3.99 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.455 2.104 . . . . 10.0 109.728 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.6 mtp -129.3 133.63 47.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.925 0.89 . . . . 10.0 110.129 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -84.37 149.74 25.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.647 1.179 . . . . 10.0 111.156 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -174.47 3.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.98 1.312 . . . . 10.0 113.126 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -159.68 134.32 7.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.937 1.295 . . . . 10.0 108.55 -172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.4 t -92.0 -174.05 3.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.466 1.127 . . . . 10.0 112.246 173.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.7 m -80.04 72.29 6.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.791 -1.55 . . . . 10.0 107.581 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 m80 75.06 165.07 0.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.609 1.964 . . . . 10.0 111.4 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m 67.93 -67.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.989 1.716 . . . . 10.0 111.608 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.16 87.26 0.99 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.31 -2.316 . . . . 10.0 107.31 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.55 -160.7 54.15 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 112.156 -0.378 . . . . 10.0 112.156 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.2 mtt -69.65 -73.78 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.466 1.284 . . . . 10.0 114.466 -166.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.06 66.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.477 0.711 . . . . 10.0 109.341 -159.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.59 170.1 32.89 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.925 0.774 . . . . 10.0 114.309 164.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.9 56.49 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.585 2.354 . . . . 10.0 113.372 -157.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -97.2 155.57 16.79 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.374 1.87 . . . . 10.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.4 mtm -79.25 76.34 5.79 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.349 -1.723 . . . . 10.0 106.349 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.34 153.08 77.45 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.099 -1.41 . . . . 10.0 109.631 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -36.88 -52.33 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.743 2.962 . . . . 10.0 112.748 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -179.41 175.69 0.89 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.286 2.634 . . . . 10.0 104.778 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.09 100.84 12.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 m -76.49 136.7 39.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 pt -106.54 98.65 21.0 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.66 52.85 4.51 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.919 3.079 . . . . 10.0 111.903 -160.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.62 144.23 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.6 1.19 . . . . 10.0 110.578 -157.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 61.06 3.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.508 1.923 . . . . 10.0 113.706 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.5 110.21 3.14 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.998 -1.641 . . . . 10.0 108.998 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.2 m -149.93 76.55 1.29 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 -165.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.08 -158.55 0.69 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.652 -166.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.5 m -151.83 118.63 5.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.877 -1.527 . . . . 10.0 106.877 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.34 120.79 26.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.46 155.0 32.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.112 1.365 . . . . 10.0 108.285 -159.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -80.49 51.04 1.38 Allowed 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.622 -0.673 . . . . 10.0 111.264 -173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.63 -71.02 0.73 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.083 1.753 . . . . 10.0 107.187 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -139.45 -55.75 0.04 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.287 -1.125 . . . . 10.0 110.287 -166.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -99.59 129.21 45.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 125.177 1.391 . . . . 10.0 107.335 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 178.0 179.22 0.32 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.11 122.33 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.104 -2.554 . . . . 10.0 104.104 158.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.7 mtp -82.27 102.5 11.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.951 -1.5 . . . . 10.0 106.951 164.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.5 77.54 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 10.0 106.882 171.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.73 165.69 13.54 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.681 0.753 . . . . 10.0 111.571 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.57 69.95 1.22 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.1 tp -46.62 134.68 9.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.541 1.136 . . . . 10.0 110.391 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -119.51 -60.32 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.229 0.612 . . . . 10.0 111.553 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -93.91 143.48 26.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.574 0.75 . . . . 10.0 109.085 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.43 159.98 51.08 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.222 2.615 . . . . 10.0 111.349 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.71 156.94 36.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.368 1.467 . . . . 10.0 110.61 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 144.98 48.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.772 1.229 . . . . 10.0 108.869 170.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.15 69.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 10.0 108.744 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.18 -15.88 0.59 Allowed Glycine 0 CA--C 1.524 0.646 0 O-C-N 120.536 -1.352 . . . . 10.0 112.648 -159.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -177.42 0.56 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.958 1.837 . . . . 10.0 108.913 171.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.1 m -155.08 128.74 8.57 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.062 -1.881 . . . . 10.0 106.186 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.31 146.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -75.93 132.9 40.55 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.51 126.68 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 164.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.9 103.02 13.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.29 119.59 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -130.2 82.45 2.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.321 1.449 . . . . 10.0 107.256 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.79 154.4 24.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.024 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -60.89 -14.49 22.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.588 0.355 . . . . 10.0 111.526 168.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -9.59 20.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.692 1.197 . . . . 10.0 111.865 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.99 56.62 1.92 Allowed Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.503 1.049 . . . . 10.0 111.305 164.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -138.55 176.89 8.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.067 0.547 . . . . 10.0 110.147 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 m -155.49 88.69 1.15 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.716 -1.957 . . . . 10.0 105.716 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.0 172.14 10.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.5 93.16 2.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.603 -1.999 . . . . 10.0 105.603 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.1 t -102.02 137.74 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.56 115.46 22.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.52 123.23 46.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.864 0.866 . . . . 10.0 110.092 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 m -82.82 126.17 32.13 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.931 0.493 . . . . 10.0 109.819 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -84.26 104.8 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 O-C-N 120.688 -1.257 . . . . 10.0 107.929 -174.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -141.64 106.87 4.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.738 1.615 . . . . 10.0 109.521 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -40.32 -80.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.145 2.578 . . . . 10.0 111.736 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.42 107.38 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.641 1.576 . . . . 10.0 113.608 159.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mt 72.26 70.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 126.545 1.938 . . . . 10.0 106.83 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.49 30.67 5.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.355 1.462 . . . . 10.0 112.658 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.9 -49.64 53.01 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 172.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 103.693 -2.706 . . . . 10.0 103.693 160.143 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.89 167.85 29.15 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.125 -1.99 . . . . 10.0 108.125 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -165.91 173.59 10.37 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 t -170.96 158.04 5.55 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.849 1.26 . . . . 10.0 107.867 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 88.8 mtp -139.59 73.9 34.56 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.973 1.309 . . . . 10.0 108.646 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.38 155.18 70.09 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.186 1.924 . . . . 10.0 110.023 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.9 169.04 25.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.932 -1.136 . . . . 10.0 107.932 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -160.06 -179.82 8.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 t -157.71 91.38 2.28 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.45 138.33 29.66 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.558 1.505 . . . . 10.0 109.168 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.47 142.07 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.359 2.039 . . . . 10.0 110.056 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.57 161.64 35.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -161.95 -66.02 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p 49.02 53.33 12.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.079 0.952 . . . . 10.0 111.567 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.11 78.31 4.32 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.256 1.022 . . . . 10.0 110.186 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.99 169.43 21.37 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.146 1.897 . . . . 10.0 109.977 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.77 165.31 36.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.03 143.73 21.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -162.02 64.57 0.24 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.328 1.051 . . . . 10.0 108.323 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -152.63 156.62 39.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.76 -124.59 0.28 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.08 -179.42 41.65 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 107.393 -2.283 . . . . 10.0 107.393 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.22 169.91 23.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.53 146.01 54.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -161.61 -179.44 7.29 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.44 159.78 47.76 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 119.011 -0.519 . . . . 10.0 110.318 175.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.03 -91.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.878 1.718 . . . . 10.0 110.548 -172.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.06 56.53 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 107.661 -1.237 . . . . 10.0 107.661 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.1 t -158.22 93.91 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.709 -1.219 . . . . 10.0 107.709 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.31 57.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.434 1.112 . . . . 10.0 108.413 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.54 145.28 40.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.028 -1.471 . . . . 10.0 107.028 164.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.89 132.1 23.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.834 -1.706 . . . . 10.0 108.834 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.74 149.21 41.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.84 0.82 . . . . 10.0 109.791 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -136.93 148.28 46.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.8 t -130.9 139.21 51.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.01 45.64 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.06 -112.04 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.816 1.246 . . . . 10.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.47 140.9 29.88 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 140.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.59 155.7 46.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.451 1.434 . . . . 10.0 108.63 162.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.7 61.36 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.354 2.036 . . . . 10.0 109.641 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -162.22 70.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.956 -1.498 . . . . 10.0 106.956 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt 87.94 154.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.546 2.338 . . . . 10.0 110.009 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -83.82 22.56 1.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.469 1.108 . . . . 10.0 113.121 -168.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.87 -179.88 4.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.068 1.747 . . . . 10.0 109.198 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.1 t -160.71 -177.65 6.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -0.919 . . . . 10.0 108.518 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.09 154.59 39.47 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.626 -0.715 . . . . 10.0 109.22 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.87 147.76 26.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.058 0.849 . . . . 10.0 109.229 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -124.44 102.02 7.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.42 -176.71 5.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.945 0.898 . . . . 10.0 109.187 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -131.81 131.92 43.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.724 0.81 . . . . 10.0 110.257 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.94 109.2 17.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.5 m -108.18 111.26 23.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.179 1.791 . . . . 10.0 108.378 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.96 136.13 36.56 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 112.368 0.507 . . . . 10.0 112.368 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -144.94 58.76 1.3 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 161.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -160.18 -25.22 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 65.78 51.31 1.43 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.194 0.998 . . . . 10.0 111.992 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -143.3 158.59 57.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.66 1.184 . . . . 10.0 109.102 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.81 82.7 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.271 2.647 . . . . 10.0 110.015 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mm -96.83 146.81 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.305 -0.861 . . . . 10.0 108.989 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.46 87.71 1.6 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.322 1.058 . . . . 10.0 111.145 -172.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.26 73.64 9.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.811 1.644 . . . . 10.0 112.498 -164.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 8.3 p -82.22 57.75 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.592 -0.693 . . . . 10.0 112.516 -173.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.83 151.82 22.6 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 121.002 -1.061 . . . . 10.0 110.804 163.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 62.71 0.38 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.123 0.969 . . . . 10.0 108.436 168.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.82 23.32 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.652 -0.655 . . . . 10.0 109.963 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -163.7 149.68 9.65 Favored Pre-proline 0 CA--C 1.529 0.159 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.81 3.58 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.077 1.852 . . . . 10.0 113.026 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -49.14 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.639 1.109 . . . . 10.0 109.915 173.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.9 156.06 43.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.358 1.063 . . . . 10.0 110.171 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -87.99 -39.76 14.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.729 1.211 . . . . 10.0 112.568 -159.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -116.43 84.24 14.39 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.232 1.013 . . . . 10.0 109.722 -166.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.15 116.95 3.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.256 2.637 . . . . 10.0 110.785 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -121.58 151.0 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.413 1.085 . . . . 10.0 108.676 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.49 143.3 30.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.619 0.768 . . . . 10.0 109.061 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 ttp -134.6 162.8 31.27 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.948 1.299 . . . . 10.0 108.788 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 134.0 10.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.626 -0.671 . . . . 10.0 111.682 169.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 t -150.01 47.67 0.92 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.504 -0.316 . . . . 10.0 111.822 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.8 m -135.86 99.23 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.725 0.81 . . . . 10.0 109.285 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -46.67 -38.24 9.47 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.616 1.966 . . . . 10.0 114.221 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 t -75.52 0.71 16.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.998 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -117.42 -122.66 3.29 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.922 1.249 . . . . 10.0 111.631 -174.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.23 -66.98 2.23 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.129 0.871 . . . . 10.0 113.011 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.8 ttt -148.59 -140.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.839 1.255 . . . . 10.0 108.835 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.01 52.65 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.392 -0.818 . . . . 10.0 108.986 -163.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.62 93.76 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.834 -0.907 . . . . 10.0 110.834 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -61.85 95.38 0.06 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.894 0.854 . . . . 10.0 109.775 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -151.3 176.22 11.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.615 1.566 . . . . 10.0 107.351 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 39.1 mtp -79.59 123.05 27.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.83 164.02 37.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.636 -0.876 . . . . 10.0 108.636 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -47.24 -56.12 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.365 2.043 . . . . 10.0 110.419 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.505 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 174.95 -135.07 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.359 2.263 . . . . 10.0 109.022 -176.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 155.16 40.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.061 2.144 . . . . 10.0 105.303 168.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.7 m -98.98 122.01 41.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.908 -1.516 . . . . 10.0 106.908 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.23 116.6 65.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.896 -1.89 . . . . 10.0 105.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.73 70.03 7.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.676 1.584 . . . . 10.0 109.892 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.23 174.11 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.151 0.58 . . . . 10.0 110.619 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.95 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 117.406 2.373 . . . . 10.0 117.406 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.41 105.87 0.25 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.806 1.194 . . . . 10.0 112.147 -165.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 m -110.81 57.32 0.62 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.969 -1.863 . . . . 10.0 105.969 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 23.3 tp -83.28 152.62 25.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -136.95 147.6 46.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.62 123.8 50.98 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.088 2.155 . . . . 10.0 106.047 -164.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.74 152.39 37.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.527 1.131 . . . . 10.0 108.467 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -44.83 -31.04 1.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.499 1.296 . . . . 10.0 114.499 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.11 -51.99 21.9 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.931 0.892 . . . . 10.0 111.913 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.06 133.05 6.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.26 1.41 . . . . 10.0 110.96 -151.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 38.82 58.4 1.74 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 127.657 2.383 . . . . 10.0 112.82 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -122.46 170.72 9.69 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.866 -1.97 . . . . 10.0 109.476 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -108.65 134.55 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 80.9 mtp -103.41 105.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.21 88.68 7.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.045 -1.094 . . . . 10.0 108.045 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.73 147.18 27.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.525 0.73 . . . . 10.0 110.607 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.75 69.12 1.33 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.163 -0.798 . . . . 10.0 112.266 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 pp -48.36 151.29 1.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.942 0.871 . . . . 10.0 113.155 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -84.58 -71.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.736 0.414 . . . . 10.0 109.953 165.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 173.62 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.206 1.402 . . . . 10.0 112.481 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.15 75.57 4.15 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.211 1.941 . . . . 10.0 110.923 -171.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.76 116.49 18.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.475 1.51 . . . . 10.0 108.788 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -135.54 127.49 29.54 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.074 -1.454 . . . . 10.0 107.074 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.17 90.45 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.35 -45.49 0.51 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.454 -1.058 . . . . 10.0 110.454 -162.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -172.39 1.83 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 123.837 1.779 . . . . 10.0 111.328 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.9 m -149.95 130.72 14.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.095 -1.866 . . . . 10.0 106.918 170.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.05 148.8 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.22 151.26 45.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.921 0.782 . . . . 10.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -115.19 152.16 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -131.29 107.5 9.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.425 -1.694 . . . . 10.0 106.425 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 148.86 26.28 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.81 -1.541 . . . . 10.0 108.974 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.44 100.93 2.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.61 -1.256 . . . . 10.0 107.61 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.84 148.22 30.06 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 172.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.4 t -55.09 -38.36 68.01 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.524 1.056 . . . . 10.0 111.446 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -34.98 70.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.19 1.796 . . . . 10.0 110.705 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.11 75.55 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.74 1.638 . . . . 10.0 109.543 -168.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -83.89 51.26 2.0 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.275 -0.544 . . . . 10.0 110.633 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -161.28 103.53 1.26 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.667 1.187 . . . . 10.0 109.37 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.43 151.58 27.97 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 108.218 -1.03 . . . . 10.0 108.218 160.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -138.84 129.89 26.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.917 -1.883 . . . . 10.0 105.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -142.35 170.47 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.55 -1.648 . . . . 10.0 106.55 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.32 136.87 38.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.113 0.965 . . . . 10.0 109.589 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.44 118.65 32.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.982 1.313 . . . . 10.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -82.38 130.32 35.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.28 105.72 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -146.37 100.71 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.936 0.895 . . . . 10.0 109.571 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -50.17 -72.13 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.866 1.266 . . . . 10.0 111.268 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.35 139.52 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.276 1.831 . . . . 10.0 111.752 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.1 pt 40.02 45.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.523 1.529 . . . . 10.0 113.332 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.58 173.05 10.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.111 0.482 . . . . 10.0 110.969 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.63 -48.83 2.98 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 111.684 -0.567 . . . . 10.0 111.684 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 124.769 1.228 . . . . 10.0 108.63 170.711 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 106.376 -1.713 . . . . 10.0 106.376 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.3 138.21 4.96 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -175.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -153.73 162.83 40.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.497 -1.668 . . . . 10.0 106.497 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -165.24 171.75 13.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.715 -1.217 . . . . 10.0 107.715 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 mtt -152.98 152.63 28.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.223 1.809 . . . . 10.0 107.167 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.97 171.68 16.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.496 2.13 . . . . 10.0 109.929 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.6 165.9 35.06 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.25 -1.019 . . . . 10.0 108.25 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -98.74 -177.43 3.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.007 0.923 . . . . 10.0 108.7 172.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -149.16 140.65 14.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.4 161.8 34.24 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.532 2.155 . . . . 10.0 110.883 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.96 78.41 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.011 2.474 . . . . 10.0 108.989 170.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.16 120.04 2.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.973 1.309 . . . . 10.0 111.614 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -154.61 152.08 29.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t -170.1 -53.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 10.0 109.113 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.75 149.7 24.5 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.34 61.63 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.256 2.637 . . . . 10.0 110.683 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -157.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.8 0.84 . . . . 10.0 109.705 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.3 79.49 0.82 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.482 0.713 . . . . 10.0 109.257 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -153.0 146.16 24.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -75.28 64.76 1.52 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.413 1.085 . . . . 10.0 111.84 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.92 66.75 0.8 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.249 1.02 . . . . 10.0 111.812 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.28 122.87 19.53 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.891 -0.884 . . . . 10.0 110.891 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.56 -45.36 83.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.519 0.66 . . . . 10.0 112.208 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 61.21 -159.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.455 1.102 . . . . 10.0 111.155 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -164.0 175.88 9.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.666 1.587 . . . . 10.0 107.416 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -132.98 128.65 20.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.475 1.11 . . . . 10.0 108.813 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.35 149.48 50.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.325 2.017 . . . . 10.0 108.957 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.04 52.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 113.195 0.813 . . . . 10.0 113.195 -155.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -155.3 51.01 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.72 67.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -138.55 161.31 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.465 1.506 . . . . 10.0 110.65 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.43 73.48 0.38 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.916 1.246 . . . . 10.0 110.002 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -36.03 116.28 0.38 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.544 1.538 . . . . 10.0 111.482 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.5 m -118.58 107.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.6 126.44 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.209 1.404 . . . . 10.0 109.058 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.61 119.3 10.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.512 0.672 . . . . 10.0 109.363 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.94 129.81 39.08 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.583 -1.265 . . . . 10.0 107.583 164.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -30.5 109.72 0.27 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 126.04 1.736 . . . . 10.0 111.778 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.45 170.6 7.9 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.233 1.955 . . . . 10.0 109.889 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.62 57.51 3.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.237 1.958 . . . . 10.0 108.988 166.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m -157.29 43.73 0.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.709 1.204 . . . . 10.0 109.26 -175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 22.0 mm 76.03 168.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.831 1.653 . . . . 10.0 111.856 170.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 10.5 tpt180 -62.59 -11.52 17.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.161 2.584 . . . . 10.0 114.35 -170.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -72.04 157.94 36.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.368 -0.832 . . . . 10.0 109.657 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -168.52 -174.71 2.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.65 38.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.266 1.026 . . . . 10.0 111.18 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.32 140.39 35.68 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.001 0.92 . . . . 10.0 109.607 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.34 110.85 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.91 -173.2 3.97 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.486 1.114 . . . . 10.0 109.562 -172.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -106.39 164.93 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 166.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.43 149.91 47.77 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.684 -1.599 . . . . 10.0 106.684 160.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 m -151.63 110.42 3.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.942 0.349 . . . . 10.0 111.942 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.42 142.82 33.97 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.243 1.017 . . . . 10.0 109.447 168.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -137.99 66.0 1.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.407 -1.331 . . . . 10.0 107.407 163.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 p 179.57 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 -171.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 84.01 67.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.772 2.029 . . . . 10.0 108.859 156.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -126.4 159.42 63.09 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 125.649 1.58 . . . . 10.0 107.372 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 70.11 6.27 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.551 2.168 . . . . 10.0 110.746 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.52 90.4 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 4.2 ptpp? -83.57 91.23 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.223 1.011 . . . . 10.0 111.428 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.92 68.52 8.34 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 10.0 112.945 -161.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.8 p -82.23 60.69 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.357 -0.839 . . . . 10.0 112.185 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.34 161.18 31.92 Favored Glycine 0 CA--C 1.521 0.45 0 O-C-N 121.013 -1.055 . . . . 10.0 111.329 157.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.08 57.31 0.47 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.436 1.094 . . . . 10.0 108.417 164.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.39 149.81 26.47 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 t -166.66 146.05 4.78 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.11 68.36 4.05 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.421 2.081 . . . . 10.0 108.032 166.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 tp -154.02 -65.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.774 0.83 . . . . 10.0 109.836 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.99 146.67 30.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.89 0.876 . . . . 10.0 109.989 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -87.18 -34.24 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 10.0 109.287 169.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -122.71 71.06 38.9 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.538 1.535 . . . . 10.0 109.89 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.6 104.45 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.067 2.511 . . . . 10.0 111.428 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -129.43 166.78 18.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.325 1.05 . . . . 10.0 110.279 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.6 144.34 43.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.281 1.432 . . . . 10.0 109.6 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 ttp -141.86 152.66 43.83 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.108 1.363 . . . . 10.0 108.123 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.29 108.6 4.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 -161.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.9 m -139.28 62.58 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.91 -1.119 . . . . 10.0 110.111 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -154.05 120.56 5.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.14 -0.936 . . . . 10.0 110.221 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.406 ' CD2' ' CB ' ' A' ' 84' ' ' ALA . 53.1 m80 -70.11 70.12 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.47 1.108 . . . . 10.0 112.188 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.9 p -168.62 -57.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.364 0.984 . . . . 10.0 113.015 171.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.31 -78.39 0.6 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.54 -141.81 11.32 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.543 0.592 . . . . 10.0 111.862 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.98 176.27 6.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.756 . . . . 10.0 109.786 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' CB ' ' CD2' ' A' ' 79' ' ' HIS . . . -124.59 52.19 1.55 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.713 1.605 . . . . 10.0 107.772 -169.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.98 112.48 0.54 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.174 -1.17 . . . . 10.0 110.174 -171.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 27.25 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.837 1.655 . . . . 10.0 114.181 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -83.03 161.59 21.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.589 1.556 . . . . 10.0 109.42 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.5 ttp -81.42 121.91 26.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.92 166.88 12.39 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 118.468 0.577 . . . . 10.0 111.514 -171.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -37.92 -59.95 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.297 2.665 . . . . 10.0 111.56 156.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -175.71 -172.41 0.53 Allowed 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.042 1.127 . . . . 10.0 114.042 -171.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.65 107.38 19.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.849 1.66 . . . . 10.0 106.856 165.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.0 m -83.92 129.02 34.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.5 pt -114.02 95.33 37.8 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 107.228 -1.397 . . . . 10.0 107.228 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.9 70.35 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.866 1.711 . . . . 10.0 112.508 -157.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.55 152.41 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.709 1.242 . . . . 10.0 111.109 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 36.96 37.2 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.875 1.27 . . . . 10.0 111.869 -155.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 93.21 0.14 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.362 -1.095 . . . . 10.0 110.362 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -138.79 107.17 5.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.6 -171.84 2.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.639 0.776 . . . . 10.0 110.802 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.6 t -140.15 143.51 36.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 103.04 -2.948 . . . . 10.0 103.04 -172.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.68 116.67 19.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.304 -2.48 . . . . 10.0 104.304 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.99 161.55 41.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.736 1.214 . . . . 10.0 108.745 -165.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.0 ttp-105 -62.57 122.89 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.672 -0.694 . . . . 10.0 109.326 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.3 t0 48.76 60.82 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 10.0 112.608 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.34 62.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.897 -1.281 . . . . 10.0 109.897 164.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.2 t0 79.02 127.58 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.108 1.763 . . . . 10.0 110.045 -175.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -177.08 157.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.312 0.505 . . . . 10.0 111.465 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.14 123.18 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 105.932 -1.877 . . . . 10.0 105.932 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.1 mtm -94.38 104.9 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.236 1.017 . . . . 10.0 109.095 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.65 68.74 8.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.289 -1.745 . . . . 10.0 106.289 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 23.3 ttt -82.12 154.73 25.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.487 0.661 . . . . 10.0 110.276 -166.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.64 60.92 6.39 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.001 -1.24 . . . . 10.0 110.001 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.82 117.9 4.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -69.83 0.62 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.848 0.749 . . . . 10.0 111.479 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -66.19 156.06 85.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.736 1.214 . . . . 10.0 111.377 -173.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.55 148.62 92.32 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.503 1.469 . . . . 10.0 109.603 165.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.19 147.09 32.07 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.776 1.23 . . . . 10.0 109.587 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -111.98 145.56 39.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.759 1.223 . . . . 10.0 108.659 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.87 99.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.34 -3.89 6.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.058 1.313 . . . . 10.0 112.025 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -75.66 -174.18 2.45 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 123.733 1.73 . . . . 10.0 109.887 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.2 m -153.74 134.17 13.5 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 112.861 -1.972 . . . . 10.0 107.562 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.13 143.54 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.123 0.969 . . . . 10.0 108.689 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.18 119.44 21.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.2 tt -81.99 159.75 3.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.4 m -128.54 114.71 17.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.092 -1.818 . . . . 10.0 106.092 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.96 134.26 34.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -126.73 71.42 1.3 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.879 0.872 . . . . 10.0 109.405 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.36 138.49 39.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.652 -1.24 . . . . 10.0 107.652 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -57.42 -34.36 68.85 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.755 0.707 . . . . 10.0 112.905 -166.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.4 m-20 -65.15 -27.65 68.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.453 1.501 . . . . 10.0 111.734 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.37 81.67 0.12 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.312 -1.915 . . . . 10.0 108.312 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -80.81 53.78 2.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.943 0.497 . . . . 10.0 111.59 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.1 m -158.7 83.88 0.82 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.134 1.374 . . . . 10.0 109.583 -172.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 157.29 45.39 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 168.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -149.03 140.86 23.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.2 t -148.23 147.6 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.87 107.76 16.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.66 138.73 31.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -82.25 150.27 27.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.106 -1.442 . . . . 10.0 107.106 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.43 113.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 164.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -158.73 143.22 15.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.754 -0.832 . . . . 10.0 108.754 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -68.28 -87.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.553 1.141 . . . . 10.0 111.489 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 74.63 148.16 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.234 1.814 . . . . 10.0 111.879 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 36.7 pt 34.74 50.28 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.311 1.844 . . . . 10.0 113.211 -176.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -169.84 73.66 0.08 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.909 -0.494 . . . . 10.0 110.776 -166.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -124.93 10.1 7.93 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.116 0.865 . . . . 10.0 111.772 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.42 67.12 1.25 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.114 -1.594 . . . . 10.0 109.114 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -154.41 172.41 17.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.632 1.173 . . . . 10.0 108.679 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -157.04 -171.35 3.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.275 -1.38 . . . . 10.0 107.275 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.8 mtp -144.12 148.19 40.6 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.063 1.345 . . . . 10.0 108.25 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.36 175.7 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.974 2.449 . . . . 10.0 110.196 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.26 142.65 30.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.754 0.822 . . . . 10.0 108.979 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -73.67 74.21 1.52 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.928 0.891 . . . . 10.0 110.678 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 m -83.37 105.49 5.47 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 10.0 109.688 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.63 159.04 35.67 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.719 1.613 . . . . 10.0 110.245 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.58 66.39 5.63 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.054 2.503 . . . . 10.0 109.298 170.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.18 172.58 14.1 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.489 1.116 . . . . 10.0 109.13 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.86 159.85 41.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -157.49 155.37 30.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.441 -1.688 . . . . 10.0 106.441 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.0 80.4 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.57 43.79 1.51 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.996 2.464 . . . . 10.0 112.814 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.96 52.52 1.77 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.736 -1.227 . . . . 10.0 109.37 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.23 -82.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.1 1.36 . . . . 10.0 112.802 -161.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -79.65 70.83 6.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.77 -65.39 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.729 1.212 . . . . 10.0 109.5 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 68.33 -53.78 0.53 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.768 2.027 . . . . 10.0 114.798 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.26 63.67 1.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.01 1.291 . . . . 10.0 114.31 -167.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -64.67 1.02 Allowed 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 162.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 58.9 57.49 3.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.505 1.122 . . . . 10.0 111.715 172.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.68 -155.06 0.34 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.219 1.407 . . . . 10.0 109.997 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tt -160.09 130.38 3.54 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.75 158.79 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.01 1.806 . . . . 10.0 109.108 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.7 m -82.24 56.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.775 0.798 . . . . 10.0 111.685 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 t -158.98 81.18 0.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.202 1.001 . . . . 10.0 108.762 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.8 85.56 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.733 0.777 . . . . 10.0 109.527 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -157.98 155.79 30.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 162.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.03 137.35 19.8 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.353 -1.099 . . . . 10.0 110.353 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.91 115.69 23.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.77 0.785 . . . . 10.0 110.042 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -109.48 158.21 18.19 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.757 -1.201 . . . . 10.0 107.757 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.17 137.55 54.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.5 113.33 13.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.4 127.03 21.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 117.761 -1.114 . . . . 10.0 109.004 174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -11.48 102.32 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 127.358 2.263 . . . . 10.0 113.065 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.3 168.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.733 2.288 . . . . 10.0 109.382 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.68 43.32 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.268 1.979 . . . . 10.0 110.545 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -133.96 34.54 3.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.943 2.097 . . . . 10.0 107.578 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.3 mm 73.76 172.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.897 1.279 . . . . 10.0 109.784 177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -72.79 40.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.699 1.6 . . . . 10.0 113.948 -175.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.07 158.97 15.17 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 156.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -157.68 -165.88 1.87 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 155.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.01 174.46 11.26 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.63 161.43 26.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -130.3 102.3 6.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.35 -2.833 . . . . 10.0 103.35 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.2 ttp -158.59 -178.84 7.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.12 2.568 . . . . 10.0 106.142 -172.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 m -152.98 141.01 20.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.823 -1.917 . . . . 10.0 105.823 166.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.2 mp -82.29 136.03 35.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 170.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 m -120.78 80.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.069 2.148 . . . . 10.0 108.544 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -81.91 89.7 6.39 Favored 'General case' 0 N--CA 1.46 0.045 0 O-C-N 121.2 -0.938 . . . . 10.0 109.128 -172.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 57.51 3.96 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.244 -0.91 . . . . 10.0 110.189 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t 179.11 149.64 0.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.174 1.79 . . . . 10.0 107.506 167.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.65 67.33 5.39 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.496 1.118 . . . . 10.0 108.895 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -130.71 122.47 19.64 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 10.0 109.736 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.86 116.3 3.14 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.535 2.823 . . . . 10.0 111.032 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.92 96.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.604 0.638 . . . . 10.0 109.649 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -80.4 132.84 35.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.312 0.645 . . . . 10.0 111.022 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.75 140.19 46.59 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.318 1.047 . . . . 10.0 110.209 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.4 p -146.09 56.25 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.923 0.868 . . . . 10.0 110.171 -178.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 154.54 25.59 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 119.82 -1.181 . . . . 10.0 111.971 163.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.23 72.28 0.93 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.304 1.842 . . . . 10.0 106.505 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.39 145.63 28.1 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t 35.8 68.59 1.31 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.778 0.831 . . . . 10.0 109.963 -156.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.19 -86.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.349 2.033 . . . . 10.0 110.079 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.03 43.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.077 -1.453 . . . . 10.0 107.077 156.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -167.31 -157.2 0.23 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -176.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -40.03 6.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.714 0.688 . . . . 10.0 110.868 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -122.09 106.23 36.44 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 125.403 1.481 . . . . 10.0 108.588 -169.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.12 139.65 7.28 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.23 2.62 . . . . 10.0 110.497 173.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -138.31 127.76 24.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.87 139.4 35.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.4 ttm -141.87 154.82 45.41 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.144 0.978 . . . . 10.0 111.429 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -148.47 120.16 8.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.9 t -156.43 54.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.644 0.778 . . . . 10.0 112.101 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -137.73 179.5 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.618 0.767 . . . . 10.0 111.499 168.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -91.18 -40.32 11.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.312 0.645 . . . . 10.0 110.165 -171.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.1 t -81.71 -147.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 160.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.35 -140.68 42.41 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.09 -67.42 1.7 Allowed Glycine 0 CA--C 1.536 1.365 0 CA-C-N 117.252 0.526 . . . . 10.0 113.145 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.14 174.17 12.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.637 1.975 . . . . 10.0 108.377 -169.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.86 45.42 2.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 10.0 107.8 -159.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.59 84.42 0.12 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 117.574 -1.681 . . . . 10.0 112.902 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 mtt -40.34 98.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.437 0 C-N-CA 126.045 1.738 . . . . 10.0 110.602 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.31 166.23 26.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.705 1.202 . . . . 10.0 109.388 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.5 mtp -77.67 71.16 4.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.7 146.7 98.36 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.963 -1.017 . . . . 10.0 108.534 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -33.59 -51.49 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.205 3.27 . . . . 10.0 113.547 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -179.08 -176.76 0.44 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.44 1.896 . . . . 10.0 106.582 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 102.29 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 10.0 110.294 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 m -75.21 122.51 23.76 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pt -108.73 90.83 7.93 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.163 0.985 . . . . 10.0 108.709 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.04 140.91 35.46 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 120.75 0.966 . . . . 10.0 109.741 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.41 -140.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.256 1.023 . . . . 10.0 112.412 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.19 38.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.958 2.503 . . . . 10.0 114.516 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.0 144.16 10.5 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 121.832 0.684 . . . . 10.0 112.883 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . 0.265 7.2 t -134.48 99.3 4.32 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.863 -1.532 . . . . 10.0 106.863 158.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.84 126.26 55.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.046 -2.205 . . . . 10.0 105.046 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 m -82.01 153.23 26.29 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.708 -0.849 . . . . 10.0 108.708 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.67 76.55 1.64 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.984 -1.487 . . . . 10.0 106.984 176.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 158.49 44.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.738 0.815 . . . . 10.0 110.198 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -73.72 60.81 0.71 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.081 0.952 . . . . 10.0 112.123 -168.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -176.23 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.154 1.381 . . . . 10.0 109.784 -164.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.4 74.33 0.27 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 123.336 0.494 . . . . 10.0 112.101 -161.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 69.13 139.74 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 128.296 2.638 . . . . 10.0 109.211 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 175.65 178.44 0.18 Allowed 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.091 0.556 . . . . 10.0 112.42 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 t -108.67 118.21 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.7 mtp -80.43 103.19 10.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.545 -1.65 . . . . 10.0 106.545 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.84 105.47 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.584 -1.189 . . . . 10.0 109.178 169.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -111.59 152.69 27.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.15 1.38 . . . . 10.0 111.22 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.79 -6.82 6.95 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.528 -1.707 . . . . 10.0 115.957 155.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 77.29 92.46 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.677 1.739 . . . . 10.0 111.067 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -70.39 -56.44 6.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.66 -0.65 . . . . 10.0 110.3 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 149.86 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 129.833 3.253 . . . . 10.0 110.767 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.33 66.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.043 2.495 . . . . 10.0 114.311 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.49 96.62 10.68 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.106 -0.996 . . . . 10.0 109.481 158.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -137.71 147.8 45.11 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 162.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.07 68.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.872 0.869 . . . . 10.0 108.951 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.69 8.24 0.7 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.376 -1.236 . . . . 10.0 113.187 -168.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.66 173.0 5.52 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 119.797 1.799 . . . . 10.0 108.481 161.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 m -156.34 129.96 8.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.849 -1.523 . . . . 10.0 109.356 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.54 140.55 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.204 0.602 . . . . 10.0 109.766 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -70.05 123.12 20.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 108.971 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.9 tt -102.2 141.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.68 -1.23 . . . . 10.0 107.68 166.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.6 m -119.78 110.1 16.38 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 171.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.03 173.1 10.77 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 122.183 -0.323 . . . . 10.0 111.8 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.62 96.72 2.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.527 1.131 . . . . 10.0 108.022 -172.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.75 143.12 29.35 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.68 -0.637 . . . . 10.0 110.647 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p -58.29 -23.13 55.36 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.713 0.805 . . . . 10.0 113.019 -177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.71 -17.7 16.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.987 0.915 . . . . 10.0 112.081 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.09 30.22 3.24 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.896 1.712 . . . . 10.0 110.578 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -90.36 166.9 13.04 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-N 117.334 0.567 . . . . 10.0 110.301 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.8 m -158.49 59.49 0.44 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.077 -2.194 . . . . 10.0 105.077 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.1 tp -85.18 141.9 29.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.848 -1.167 . . . . 10.0 107.848 -174.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -111.48 136.42 50.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.0 t -136.3 159.38 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.217 -1.771 . . . . 10.0 106.217 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.68 109.57 21.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.936 0.894 . . . . 10.0 108.879 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.36 118.48 24.26 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -94.83 127.38 40.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.178 0.991 . . . . 10.0 109.28 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 51.1 t -86.76 104.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 120.762 -1.211 . . . . 10.0 108.951 -175.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -141.59 116.3 9.72 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.578 1.151 . . . . 10.0 108.451 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -41.5 -63.0 0.77 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.781 1.232 . . . . 10.0 112.164 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 57.97 -161.83 0.23 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.7 78.47 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.225 -1.028 . . . . 10.0 108.225 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.58 31.73 0.06 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -168.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.45 -78.61 0.45 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.243 0.925 . . . . 10.0 110.971 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.917 1.687 . . . . 10.0 106.567 -174.538 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 106.94 -1.504 . . . . 10.0 106.94 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.88 44.45 61.38 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.05 0.844 . . . . 10.0 112.8 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -156.31 132.35 9.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -159.14 151.9 21.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.049 -2.574 . . . . 10.0 104.049 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -156.67 145.91 15.11 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.76 175.42 11.02 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.07 2.513 . . . . 10.0 110.275 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.0 24.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 169.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -168.67 154.53 6.68 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -61.01 135.22 93.14 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.594 0.757 . . . . 10.0 110.299 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.49 161.82 39.43 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.778 1.652 . . . . 10.0 109.89 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 77.21 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.31 2.673 . . . . 10.0 110.794 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.91 75.1 0.2 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.619 1.168 . . . . 10.0 110.315 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -42.98 128.59 4.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.497 1.519 . . . . 10.0 112.357 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -163.28 144.62 9.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 105.241 -2.133 . . . . 10.0 105.241 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.16 148.37 14.51 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 107.785 -1.191 . . . . 10.0 107.785 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.34 140.53 30.58 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.42 2.08 . . . . 10.0 109.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.71 57.78 1.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.378 0.671 . . . . 10.0 110.453 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.46 155.14 16.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.306 1.042 . . . . 10.0 110.193 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -71.85 69.32 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 10.0 109.728 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -145.06 -45.51 0.23 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.588 1.955 . . . . 10.0 109.056 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.46 26.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.942 0.897 . . . . 10.0 111.49 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.77 165.63 32.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.922 -2.071 . . . . 10.0 107.922 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.48 172.98 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.504 1.521 . . . . 10.0 106.961 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -143.91 162.15 36.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.91 158.28 21.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.464 1.106 . . . . 10.0 108.034 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.77 152.27 67.85 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 108.344 -0.984 . . . . 10.0 108.344 166.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -65.57 164.91 24.58 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.659 1.573 . . . . 10.0 108.946 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.12 58.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.964 0.888 . . . . 10.0 109.119 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -153.67 58.05 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.445 -0.785 . . . . 10.0 109.163 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.15 67.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 162.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -97.66 166.04 11.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.903 -1.499 . . . . 10.0 108.928 164.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.91 -145.96 19.74 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.581 -1.807 . . . . 10.0 108.581 160.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.02 115.73 0.73 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.97 1.708 . . . . 10.0 108.458 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.3 p -124.66 138.47 54.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.17 147.34 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.726 0.81 . . . . 10.0 109.54 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.63 113.53 25.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.375 0.534 . . . . 10.0 111.103 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.45 128.99 34.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.926 0.49 . . . . 10.0 110.095 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -20.7 103.87 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 127.024 2.13 . . . . 10.0 112.924 -164.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -62.15 167.01 11.54 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.314 2.676 . . . . 10.0 110.476 171.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.54 57.8 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.647 2.231 . . . . 10.0 109.127 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -154.44 42.8 0.5 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.881 1.272 . . . . 10.0 109.313 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.7 mt 77.43 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.438 1.495 . . . . 10.0 109.098 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -36.34 -46.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.304 1.842 . . . . 10.0 111.603 168.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.57 141.28 1.05 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.24 2.616 . . . . 10.0 112.727 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -158.67 -175.47 5.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 172.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.51 158.32 43.88 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.542 1.137 . . . . 10.0 110.596 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.6 163.25 13.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 124.109 0.881 . . . . 10.0 110.51 171.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -134.06 130.57 37.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.516 -2.031 . . . . 10.0 105.516 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -156.04 -176.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.848 1.659 . . . . 10.0 108.5 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 137.43 36.58 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 161.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.28 149.37 23.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.634 -0.876 . . . . 10.0 108.634 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -135.84 85.76 2.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.291 0.994 . . . . 10.0 111.632 -157.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 113.73 12.4 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 121.354 -0.841 . . . . 10.0 109.156 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -128.36 57.65 1.57 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 164.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 m -163.46 -33.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.129 1.372 . . . . 10.0 112.134 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 60.42 59.66 2.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.079 0.854 . . . . 10.0 111.26 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -143.3 147.13 39.07 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.972 0.909 . . . . 10.0 109.907 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -86.36 84.34 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.906 3.071 . . . . 10.0 112.408 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.31 94.24 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -80.36 134.51 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.621 -0.674 . . . . 10.0 110.919 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.38 115.89 30.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.881 1.672 . . . . 10.0 107.375 -165.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.69 47.78 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.997 . . . . 10.0 108.855 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.84 156.82 29.0 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.766 -1.209 . . . . 10.0 111.339 159.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.28 59.74 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.656 1.582 . . . . 10.0 107.846 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 132.52 33.8 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 t -157.91 139.55 9.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.88 65.16 5.96 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.671 2.914 . . . . 10.0 109.42 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -157.54 -57.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 -164.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.48 152.21 25.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.277 0.631 . . . . 10.0 109.31 171.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.2 m -107.13 -18.83 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.939 0.895 . . . . 10.0 110.219 160.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.6 m -133.1 64.45 70.47 Favored Pre-proline 0 N--CA 1.445 -0.689 0 C-N-CA 124.469 1.108 . . . . 10.0 109.028 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 101.32 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.178 2.585 . . . . 10.0 109.905 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.06 126.18 54.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 10.0 109.251 -171.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.58 146.03 31.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.045 0.538 . . . . 10.0 109.717 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -148.03 166.7 26.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.758 1.223 . . . . 10.0 111.527 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.254 40.7 m -137.96 133.87 34.23 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.004 1.44 . . . . 10.0 111.898 -156.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 t -83.55 -178.99 7.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 123.995 1.855 . . . . 10.0 113.873 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.4 m -79.88 66.61 5.41 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 129.561 3.144 . . . . 10.0 109.803 -160.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 60.71 65.33 1.05 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.167 1.387 . . . . 10.0 110.735 172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.3 t -161.53 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.294 1.037 . . . . 10.0 108.369 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.31 -125.46 3.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 10.0 110.504 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.36 -49.95 8.16 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.527 1.371 . . . . 10.0 116.527 -168.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.35 -82.46 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.749 1.275 . . . . 10.0 111.229 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.0 74.77 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.729 1.212 . . . . 10.0 108.07 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.77 159.65 27.69 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.01 1.29 . . . . 10.0 113.656 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 40.1 ttp -77.61 62.37 2.52 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.088 1.355 . . . . 10.0 111.417 -168.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -81.81 162.64 22.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.1 ttm -80.03 74.11 6.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.72 142.79 61.91 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.818 -1.083 . . . . 10.0 109.046 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.26 -18.28 64.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.845 1.697 . . . . 10.0 113.597 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -178.14 174.27 1.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.659 -1.978 . . . . 10.0 105.659 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 tp -97.6 101.14 12.58 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.448 1.022 . . . . 10.0 109.667 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -76.3 123.9 26.65 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.539 -0.911 . . . . 10.0 108.539 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.9 pt -115.26 115.28 42.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.18 -170.24 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.605 2.204 . . . . 10.0 110.737 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.43 149.66 20.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 158.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.87 17.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.168 1.349 . . . . 10.0 113.563 -166.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 83.62 0.41 Allowed Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 108.815 -1.714 . . . . 10.0 108.815 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.1 t -121.9 108.33 13.31 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 166.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 -172.33 2.68 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.335 0.654 . . . . 10.0 109.955 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.3 t -143.81 122.49 12.57 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 104.041 -2.577 . . . . 10.0 104.041 -164.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.78 123.92 47.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.57 -1.641 . . . . 10.0 106.57 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.63 155.39 41.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.171 1.389 . . . . 10.0 108.533 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 55.57 0.89 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.644 0.778 . . . . 10.0 111.181 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.55 -57.3 0.44 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.69 -75.48 0.3 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.689 0.661 . . . . 10.0 112.051 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -100.0 133.2 44.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 -171.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 174.51 178.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 120.115 1.325 . . . . 10.0 109.861 -176.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.76 122.57 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.137 -2.171 . . . . 10.0 105.137 158.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.0 mtp -81.37 96.83 7.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.25 61.82 3.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 22.2 ptm -89.97 177.91 6.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.115 0.959 . . . . 10.0 110.544 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.21 46.62 86.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 109.13 -1.588 . . . . 10.0 109.13 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.55 119.74 15.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 10.0 110.321 -168.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -64.16 -73.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.055 0.542 . . . . 10.0 111.705 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -95.2 152.98 39.79 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.7 0.8 . . . . 10.0 112.21 -160.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.66 100.68 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.571 2.181 . . . . 10.0 109.154 170.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 42.0 mt -77.72 158.4 29.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.032 -0.417 . . . . 10.0 111.032 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 142.31 47.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.717 1.207 . . . . 10.0 109.07 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.35 72.32 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.174 1.39 . . . . 10.0 109.214 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 151.76 -12.6 0.75 Allowed Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.962 -1.086 . . . . 10.0 112.614 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.89 179.27 2.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 123.693 1.711 . . . . 10.0 109.404 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -155.05 127.41 7.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.693 -2.049 . . . . 10.0 108.48 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -127.34 148.57 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -71.24 144.66 49.99 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.579 -0.7 . . . . 10.0 110.316 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.3 tt -123.19 139.3 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.1 m -117.39 119.24 34.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.2 176.89 8.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 10.0 111.723 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -154.09 90.8 1.38 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.202 1.001 . . . . 10.0 109.023 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -86.74 153.24 21.86 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.135 -0.978 . . . . 10.0 110.989 170.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 p -46.45 -39.32 10.42 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 -165.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.38 18.35 0.56 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.767 0.827 . . . . 10.0 111.925 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 32.92 35.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.851 -1.3 . . . . 10.0 109.851 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.55 94.71 7.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 125.83 47.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.264 1.826 . . . . 10.0 107.064 169.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.6 144.29 50.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 103.796 -2.668 . . . . 10.0 103.796 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -107.95 113.84 27.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.571 -2.381 . . . . 10.0 104.571 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.27 153.1 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -171.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.94 112.06 22.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.55 -0.907 . . . . 10.0 108.55 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.13 109.73 20.11 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.486 0.714 . . . . 10.0 109.135 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 m -90.31 124.64 35.07 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.935 0.894 . . . . 10.0 108.911 -175.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.76 108.22 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.172 -0.955 . . . . 10.0 109.078 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -136.73 111.63 8.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.262 . . . . 10.0 108.169 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.74 123.04 22.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.154 0.888 . . . . 10.0 110.731 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.66 167.6 9.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.543 1.137 . . . . 10.0 108.066 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.0 pt 40.71 42.14 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.154 1.781 . . . . 10.0 113.734 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -94.62 86.99 4.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.316 0.579 . . . . 10.0 110.392 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.56 101.28 0.12 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.459 -1.456 . . . . 10.0 109.459 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 116.478 -1.725 . . . . 10.0 110.208 169.91 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.73 -169.25 5.6 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 -150.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -171.09 173.14 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.887 2.075 . . . . 10.0 106.08 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -160.08 175.32 13.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.035 0.834 . . . . 10.0 109.367 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.9 ttp -162.29 135.51 4.56 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.043 1.337 . . . . 10.0 107.784 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.08 177.77 8.47 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.703 2.269 . . . . 10.0 110.811 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.18 164.55 37.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.794 1.238 . . . . 10.0 107.926 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -158.75 172.93 17.35 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.752 1.621 . . . . 10.0 107.549 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 t -153.54 142.71 14.74 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.049 -1.463 . . . . 10.0 107.049 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.94 155.02 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.432 2.088 . . . . 10.0 111.313 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.37 -178.68 4.77 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.371 2.714 . . . . 10.0 110.292 171.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.19 44.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.508 1.123 . . . . 10.0 108.087 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -166.4 165.9 16.85 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.83 -1.545 . . . . 10.0 106.83 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 t -140.35 159.29 42.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.713 -1.217 . . . . 10.0 107.713 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.13 157.94 65.04 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 164.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.1 -169.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.408 2.739 . . . . 10.0 109.413 166.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.91 167.76 24.85 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.43 170.75 20.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.52 1.128 . . . . 10.0 108.162 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -138.05 -71.5 0.42 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 10.0 108.843 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 tptt 76.46 146.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.014 1.726 . . . . 10.0 110.964 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.29 171.63 14.62 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.496 1.518 . . . . 10.0 106.95 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.61 108.5 0.22 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.04 -1.224 . . . . 10.0 110.04 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.34 63.53 1.96 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.709 0.754 . . . . 10.0 110.608 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -124.37 111.25 15.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.233 1.413 . . . . 10.0 108.586 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.66 -47.84 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.289 0.636 . . . . 10.0 111.301 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.1 121.07 82.78 Favored Pre-proline 0 N--CA 1.451 -0.423 0 C-N-CA 123.52 0.728 . . . . 10.0 109.71 -170.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -68.44 166.03 26.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.656 2.237 . . . . 10.0 110.595 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.52 61.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 122.256 1.026 . . . . 10.0 110.526 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -158.35 60.35 0.45 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.497 0.719 . . . . 10.0 109.508 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.96 52.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 122.125 0.964 . . . . 10.0 110.511 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -157.24 145.6 19.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.53 130.49 10.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.794 -1.723 . . . . 10.0 108.794 168.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 159.35 31.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.051 0.926 . . . . 10.0 111.291 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 p -122.39 148.57 44.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.316 -1.364 . . . . 10.0 107.316 165.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.41 134.51 58.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.0 26.29 0.06 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -166.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.21 -138.18 0.71 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.412 1.485 . . . . 10.0 109.692 -170.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.25 110.76 40.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 167.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.32 175.1 11.05 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.252 2.634 . . . . 10.0 109.472 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.78 72.04 3.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.531 2.154 . . . . 10.0 109.627 168.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -152.54 -57.41 0.14 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.722 2.409 . . . . 10.0 106.299 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt 66.37 150.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.141 1.776 . . . . 10.0 108.563 -163.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 74.91 -51.51 0.67 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.292 1.837 . . . . 10.0 111.757 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.31 138.01 37.01 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -150.45 178.57 8.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.659 1.184 . . . . 10.0 108.193 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.15 161.7 41.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.938 0.895 . . . . 10.0 109.458 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.41 160.81 14.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.263 0.977 . . . . 10.0 111.284 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.14 134.96 51.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.275 -2.491 . . . . 10.0 104.275 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 ttt -158.82 177.26 11.36 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.794 -1.187 . . . . 10.0 107.794 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 t -133.27 142.36 48.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 152.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.52 105.77 16.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.287 -2.486 . . . . 10.0 104.287 163.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.84 106.36 15.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.281 1.832 . . . . 10.0 110.427 -170.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.61 129.82 34.74 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.337 0.655 . . . . 10.0 110.206 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -138.98 58.42 1.64 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 158.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -157.98 -50.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.937 2.095 . . . . 10.0 108.103 -171.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 74.58 58.86 0.07 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.207 1.803 . . . . 10.0 110.384 170.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -123.86 146.29 50.3 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 126.048 1.739 . . . . 10.0 106.456 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.72 121.02 6.4 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.692 2.261 . . . . 10.0 109.554 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.57 146.39 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -117.7 145.47 44.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.316 1.447 . . . . 10.0 107.763 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.09 131.68 17.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.485 -2.413 . . . . 10.0 104.485 -171.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.6 55.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.233 1.016 . . . . 10.0 109.034 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.49 149.09 17.48 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.871 -1.292 . . . . 10.0 109.871 167.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -155.54 59.74 0.62 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.758 1.223 . . . . 10.0 108.14 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.19 35.23 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.339 0.656 . . . . 10.0 110.21 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -159.05 144.11 11.7 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 107.143 -1.429 . . . . 10.0 107.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.61 39.74 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.519 2.146 . . . . 10.0 112.738 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -108.82 -54.61 2.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.734 1.613 . . . . 10.0 108.34 -170.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.38 160.41 30.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.974 1.309 . . . . 10.0 107.947 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -83.15 -40.26 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.512 0.725 . . . . 10.0 111.874 -165.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.9 t -119.15 95.53 49.39 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.478 1.111 . . . . 10.0 110.647 -162.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.61 92.2 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.958 2.439 . . . . 10.0 110.36 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 83.8 mtp -103.75 116.51 32.45 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.879 1.272 . . . . 10.0 108.893 -172.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 mp -81.54 134.9 35.57 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.435 0.694 . . . . 10.0 109.735 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.52 -179.83 3.84 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.667 1.187 . . . . 10.0 109.336 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 t -158.79 143.27 15.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.277 -2.49 . . . . 10.0 104.277 159.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.28 5.7 t -156.89 63.68 0.51 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.738 1.608 . . . . 10.0 110.486 167.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -146.04 -178.74 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.72 -0.612 . . . . 10.0 109.665 172.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.57 148.76 22.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m 71.2 -53.8 0.67 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.552 1.541 . . . . 10.0 111.913 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.55 141.16 47.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 17.65 -90.14 0.01 OUTLIER Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.699 2.095 . . . . 10.0 115.585 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.4 mtt -145.39 173.98 11.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.395 1.878 . . . . 10.0 109.454 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.22 47.05 0.98 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.768 1.627 . . . . 10.0 107.128 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.72 102.2 0.22 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.813 -1.315 . . . . 10.0 109.813 -167.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 63.85 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.279 1.831 . . . . 10.0 111.89 -170.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -113.98 165.81 12.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.827 2.051 . . . . 10.0 109.933 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.8 mtm -78.38 98.02 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.716 -1.587 . . . . 10.0 106.716 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.66 161.72 47.06 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 119.47 -0.3 . . . . 10.0 110.387 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -43.17 -50.02 6.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.247 2.631 . . . . 10.0 111.241 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.3 p90 177.52 -170.0 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.194 2.598 . . . . 10.0 104.967 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -127.8 106.6 9.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.754 0.788 . . . . 10.0 110.421 169.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 145.77 36.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.04 140.9 40.07 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.527 1.058 . . . . 10.0 111.266 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.1 -174.21 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.123 2.549 . . . . 10.0 111.968 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.4 143.48 23.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 156.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.1 mmt-85 52.15 27.07 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.58 0.956 . . . . 10.0 113.58 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.74 96.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.837 -1.705 . . . . 10.0 108.837 167.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -126.59 55.71 1.51 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.706 1.202 . . . . 10.0 108.645 -173.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.21 166.61 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.158 0.98 . . . . 10.0 112.397 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 105.4 3.95 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.9 119.4 23.89 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.503 -1.665 . . . . 10.0 106.503 -171.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -127.83 144.7 51.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.458 1.903 . . . . 10.0 107.456 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -61.71 119.42 8.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.99 37.18 3.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.218 1.407 . . . . 10.0 112.334 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -169.73 74.31 0.11 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.774 -1.73 . . . . 10.0 108.774 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.9 t0 63.41 130.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.967 2.507 . . . . 10.0 111.749 -168.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -177.1 175.82 1.48 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.365 0.984 . . . . 10.0 111.782 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.92 130.27 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.025 -1.843 . . . . 10.0 106.025 163.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 78.6 mtp -88.76 103.21 15.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.747 1.219 . . . . 10.0 107.759 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.27 81.42 8.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.711 -1.589 . . . . 10.0 106.711 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 51.3 ttm -84.79 152.34 23.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.313 1.045 . . . . 10.0 109.639 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.92 53.2 3.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.381 -1.087 . . . . 10.0 110.381 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.8 122.58 5.09 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 125.147 1.379 . . . . 10.0 109.11 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -72.9 -64.16 1.02 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.61 -58.48 0.0 OUTLIER Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 118.276 -0.868 . . . . 10.0 112.987 167.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.73 58.7 5.41 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.805 1.67 . . . . 10.0 111.334 -163.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.69 167.26 22.14 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.839 -0.538 . . . . 10.0 109.717 165.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -149.33 123.56 9.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.253 -1.758 . . . . 10.0 106.253 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.93 120.64 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.66 -4.19 50.16 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.414 -1.214 . . . . 10.0 112.478 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.03 169.4 11.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 119.944 1.872 . . . . 10.0 111.357 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.9 m -132.32 96.75 3.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 111.599 -2.546 . . . . 10.0 108.045 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.12 140.39 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -66.11 130.77 44.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.3 112.19 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 173.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.1 m -94.31 107.04 19.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.44 -0.8 . . . . 10.0 109.541 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.28 171.96 14.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.09 103.36 2.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.05 126.73 32.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.7 t -47.85 -38.53 16.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.51 1.524 . . . . 10.0 111.019 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.1 -35.19 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.019 1.727 . . . . 10.0 113.089 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.28 67.73 0.17 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.126 -1.189 . . . . 10.0 110.126 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -129.76 151.85 49.89 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 m -152.72 55.57 0.79 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.649 1.579 . . . . 10.0 107.823 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.49 128.76 34.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 62.43 0.87 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 127.551 2.34 . . . . 10.0 107.222 -161.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -84.49 153.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.396 -1.274 . . . . 10.0 108.96 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.68 113.44 18.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.922 -1.111 . . . . 10.0 108.999 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.0 146.27 32.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.398 1.079 . . . . 10.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.7 m -103.7 128.64 51.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.559 0.344 . . . . 10.0 110.702 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.34 91.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.899 -1.148 . . . . 10.0 107.899 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -155.66 135.83 13.0 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 121.435 -0.79 . . . . 10.0 110.754 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.76 -44.43 28.23 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.749 1.619 . . . . 10.0 111.868 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.66 76.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.167 0.987 . . . . 10.0 112.342 166.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.4 mm 54.8 47.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 122.5 1.143 . . . . 10.0 109.679 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -138.14 100.63 4.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 104.433 -2.432 . . . . 10.0 104.433 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.26 -44.76 1.09 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.155 -1.578 . . . . 10.0 109.155 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.259 1.557 0 N-CA-C 102.744 -3.058 . . . . 10.0 102.744 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 121.656 0.741 . . . . 10.0 112.161 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -161.71 57.42 0.26 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.82 1.248 . . . . 10.0 109.035 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.45 64.68 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -128.94 146.5 50.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.891 1.276 . . . . 10.0 111.443 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.26 90.59 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 108.261 -1.936 . . . . 10.0 108.261 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.41 142.5 17.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.04 0.536 . . . . 10.0 111.847 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 p -125.16 146.13 49.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.28 138.59 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.923 -1.139 . . . . 10.0 107.923 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.34 110.59 17.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.109 0.48 . . . . 10.0 111.486 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.39 136.34 31.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.403 -0.808 . . . . 10.0 109.15 166.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.7 t -17.5 108.22 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.83 2.052 . . . . 10.0 114.837 -162.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.15 158.1 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.814 2.343 . . . . 10.0 110.572 167.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.16 58.64 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.499 2.133 . . . . 10.0 108.987 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.9 t -165.4 44.25 0.08 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.266 1.426 . . . . 10.0 108.589 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' ARG . 16.5 mt 74.2 169.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.207 1.803 . . . . 10.0 109.723 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 42' ' ' ILE . 11.4 ptm180 -46.91 -39.61 12.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.915 1.686 . . . . 10.0 113.87 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.79 151.72 20.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.741 1.216 . . . . 10.0 111.415 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -164.2 -172.66 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.849 -0.797 . . . . 10.0 108.849 -164.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.71 39.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.645 1.178 . . . . 10.0 110.141 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.03 149.29 26.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.764 0.665 . . . . 10.0 109.411 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -124.2 103.32 8.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 104.756 -2.313 . . . . 10.0 104.756 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -159.2 -172.65 3.85 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.927 0.891 . . . . 10.0 111.579 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 m -145.59 125.17 13.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.699 -1.251 . . . . 10.0 110.259 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.28 132.58 35.35 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 103.946 -2.613 . . . . 10.0 103.946 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.8 m -129.35 88.24 2.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 125.001 1.438 . . . . 10.0 107.609 -164.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.39 128.47 33.38 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.388 -0.227 . . . . 10.0 110.388 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -141.82 57.02 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.9 m -156.16 -40.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.307 1.443 . . . . 10.0 111.071 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 65.99 62.22 0.61 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.034 1.734 . . . . 10.0 112.662 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -132.79 155.44 81.17 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.833 1.653 . . . . 10.0 108.052 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 75.97 4.63 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.895 3.063 . . . . 10.0 111.471 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.36 147.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 99.63 5.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.541 1.537 . . . . 10.0 111.019 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -82.6 121.55 26.96 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.595 -2.002 . . . . 10.0 105.595 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.75 54.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 122.207 1.003 . . . . 10.0 108.587 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.21 148.96 16.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.471 -1.051 . . . . 10.0 110.471 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.21 59.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.054 1.742 . . . . 10.0 107.762 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.94 29.68 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -169.59 149.16 3.56 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 118.799 0.727 . . . . 10.0 110.199 -172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.78 49.65 2.53 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.844 2.362 . . . . 10.0 110.434 168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.55 -70.59 0.73 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.59 1.556 . . . . 10.0 107.202 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.48 147.27 33.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.144 1.378 . . . . 10.0 110.26 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -82.41 -36.4 26.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.948 0.899 . . . . 10.0 109.935 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.7 t -120.47 75.12 24.57 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.614 1.165 . . . . 10.0 110.94 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.84 101.09 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 10.0 110.413 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.4 mtt -109.51 128.55 55.26 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.091 1.757 . . . . 10.0 108.854 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.62 142.25 31.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.304 1.042 . . . . 10.0 108.821 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttm -148.24 153.14 38.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.663 0.785 . . . . 10.0 110.84 -173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.0 t -159.07 98.62 1.46 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.046 -1.034 . . . . 10.0 111.547 -161.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -138.94 59.48 1.62 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.795 0.807 . . . . 10.0 110.193 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.4 m -147.73 125.11 11.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.702 0.801 . . . . 10.0 109.436 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -77.47 64.12 2.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.251 1.421 . . . . 10.0 109.671 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 166.01 -20.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.489 2.716 . . . . 10.0 109.484 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.45 -149.41 6.0 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.672 -1.771 . . . . 10.0 108.672 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.48 -52.47 52.68 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 122.455 -0.438 . . . . 10.0 113.235 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -168.1 1.19 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.123 1.369 . . . . 10.0 110.356 -166.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.83 42.97 3.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.618 1.967 . . . . 10.0 108.134 -167.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -149.58 103.04 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.228 -1.149 . . . . 10.0 110.228 -171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.63 63.03 2.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.059 0.929 . . . . 10.0 108.773 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -131.36 167.09 19.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.644 1.977 . . . . 10.0 109.691 -172.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtm -79.67 75.7 6.33 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.037 -1.097 . . . . 10.0 108.037 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.13 163.67 43.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.495 -0.775 . . . . 10.0 111.498 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -37.26 -55.73 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.141 3.227 . . . . 10.0 112.632 161.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.9 p90 172.65 -165.3 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.275 2.63 . . . . 10.0 104.732 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.4 pt? -127.37 111.53 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.701 0.682 . . . . 10.0 110.945 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m -76.59 132.48 39.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 107.055 -1.461 . . . . 10.0 107.055 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.2 pt -100.95 100.95 14.14 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.084 1.354 . . . . 10.0 107.388 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.59 67.69 8.55 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.239 2.626 . . . . 10.0 110.211 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 58.38 177.93 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 -156.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 38.81 33.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.831 2.16 . . . . 10.0 116.831 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.07 70.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.971 1.272 . . . . 10.0 113.113 163.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -111.49 57.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.18 156.45 18.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.793 -0.447 . . . . 10.0 109.793 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.3 m -115.42 115.36 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -82.61 106.36 14.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -137.08 156.56 48.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.6 1.16 . . . . 10.0 110.26 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -47.44 -40.35 17.87 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.805 1.242 . . . . 10.0 113.93 -161.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -132.65 52.05 2.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.825 0.821 . . . . 10.0 109.909 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.9 63.78 0.22 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 19.8 t0 65.45 136.45 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 126.253 1.821 . . . . 10.0 109.891 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 179.82 -179.2 0.44 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.096 -1.003 . . . . 10.0 112.095 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.6 t -110.83 123.02 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 161.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.7 mtp -83.51 100.54 10.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 166.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.15 74.25 4.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.403 -1.703 . . . . 10.0 106.403 171.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.7 ttt -84.72 153.89 22.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.271 1.029 . . . . 10.0 110.567 -170.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 60.17 3.92 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.295 -0.878 . . . . 10.0 111.103 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.67 128.59 26.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.777 1.231 . . . . 10.0 111.008 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -76.45 -72.97 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.642 0.777 . . . . 10.0 111.67 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -116.43 156.98 46.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.509 1.124 . . . . 10.0 111.912 -163.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.75 144.16 99.51 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.091 2.527 . . . . 10.0 111.76 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.0 mt -118.33 142.58 47.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.726 1.61 . . . . 10.0 109.497 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.37 129.01 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.01 107.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 163.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 120.35 -13.34 10.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.675 -0.57 . . . . 10.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.75 -179.54 3.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 123.589 1.661 . . . . 10.0 108.525 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -154.2 129.66 9.87 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.517 -1.674 . . . . 10.0 106.907 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.15 145.79 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.31 -1.367 . . . . 10.0 107.31 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -73.9 143.47 45.76 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.809 -0.557 . . . . 10.0 109.732 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 tt -118.4 139.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 168.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -111.5 108.26 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.91 161.97 19.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -149.9 95.28 2.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.78 133.51 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 170.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -77.23 3.81 12.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.21 -15.57 35.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.375 0.67 . . . . 10.0 111.042 156.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.7 47.38 1.29 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.119 1.818 . . . . 10.0 109.935 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -109.95 155.35 21.88 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 86.0 m -156.35 73.15 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 103.919 -2.623 . . . . 10.0 103.919 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.71 127.85 54.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -161.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -92.68 132.87 36.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.912 1.685 . . . . 10.0 107.471 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.1 152.67 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.767 -1.938 . . . . 10.0 105.767 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.75 29.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.05 119.87 38.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.518 0.727 . . . . 10.0 109.643 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -83.17 127.15 33.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.82 98.45 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -159.27 139.67 12.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 114.643 1.349 . . . . 10.0 114.643 -170.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.605 HG22 ' HG ' ' A' ' 51' ' ' LEU . 9.9 p . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.907 0.861 . . . . 10.0 111.333 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -156.6 59.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.178 -0.952 . . . . 10.0 109.527 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.13 58.35 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 123.101 1.429 . . . . 10.0 110.336 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 138.76 16.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.271 -0.877 . . . . 10.0 109.542 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 166.1 54.82 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.435 -1.466 . . . . 10.0 109.435 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.02 156.28 22.42 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.026 0.913 . . . . 10.0 110.8 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.4 p -123.7 156.71 35.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.1 140.16 48.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 38.49 0.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.02 -145.23 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.351 1.06 . . . . 10.0 109.933 -171.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.6 t -92.15 108.28 29.42 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 105.236 -2.135 . . . . 10.0 105.236 155.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 166.63 27.97 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 N-CA-C 108.017 -1.571 . . . . 10.0 108.017 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.05 64.26 5.13 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.589 2.193 . . . . 10.0 110.441 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -166.99 58.91 0.08 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.05 1.34 . . . . 10.0 108.755 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm 76.3 164.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.795 1.638 . . . . 10.0 110.327 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -37.2 63.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.851 1.26 . . . . 10.0 111.768 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -47.22 148.9 1.1 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.147 1.779 . . . . 10.0 111.52 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.2 t -153.94 -167.11 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.141 -0.688 . . . . 10.0 109.141 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.68 158.23 43.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.965 0.906 . . . . 10.0 108.766 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.22 154.06 24.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 124.051 0.844 . . . . 10.0 109.167 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -122.04 123.24 41.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 103.691 -2.707 . . . . 10.0 103.691 166.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -156.97 -177.03 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 m -149.08 125.67 11.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.591 -1.262 . . . . 10.0 107.591 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -83.56 134.89 34.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.213 -1.773 . . . . 10.0 106.213 171.441 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -135.77 97.43 3.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.045 1.338 . . . . 10.0 108.628 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -84.1 152.61 24.23 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.713 0.688 . . . . 10.0 109.977 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -139.25 56.72 1.67 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.27 -1.752 . . . . 10.0 106.27 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.5 t -175.15 164.26 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.164 -2.532 . . . . 10.0 104.164 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.67 81.51 1.64 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.969 0.793 . . . . 10.0 108.952 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.38 148.95 36.14 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 124.666 1.186 . . . . 10.0 108.43 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.05 72.88 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.41 2.74 . . . . 10.0 109.761 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -83.29 156.99 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 165.44 28.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.475 0.71 . . . . 10.0 110.215 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.455 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -139.13 128.05 23.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.222 -2.51 . . . . 10.0 104.222 179.043 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.91 52.12 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 122.423 1.106 . . . . 10.0 108.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.47 150.77 20.67 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.366 -0.834 . . . . 10.0 111.269 165.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.47 61.96 0.55 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.804 2.442 . . . . 10.0 106.207 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.45 91.14 6.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 -172.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 69' ' ' ALA . 5.1 t -104.88 133.6 20.07 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.795 1.238 . . . . 10.0 109.454 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.98 62.36 6.62 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.31 2.673 . . . . 10.0 109.001 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -162.97 -48.45 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.25 0.62 . . . . 10.0 111.093 -161.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 66' ' ' THR . . . -96.47 129.22 43.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -69.98 -34.04 72.85 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -128.84 73.07 81.55 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.19 0.996 . . . . 10.0 110.534 -170.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.8 122.68 9.07 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.198 1.932 . . . . 10.0 109.036 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.5 mtt -145.06 124.27 12.94 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.271 1.028 . . . . 10.0 110.015 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.8 mt -83.05 140.88 32.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.081 0.953 . . . . 10.0 109.925 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.9 ttm -141.07 152.17 44.6 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.596 1.158 . . . . 10.0 110.537 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -141.05 115.89 9.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.742 1.217 . . . . 10.0 111.284 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' THR 0.31 0.5 OUTLIER -145.83 59.86 1.25 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.302 1.223 . . . . 10.0 114.302 164.819 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 100' ' ' LEU . 1.1 t -143.84 120.83 11.37 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.416 -1.427 . . . . 10.0 109.854 171.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.59 61.5 2.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.224 1.41 . . . . 10.0 109.422 -173.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.5 m -163.32 -58.15 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.045 1.338 . . . . 10.0 109.168 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -95.16 -93.43 1.71 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.663 -1.775 . . . . 10.0 108.663 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.72 97.93 2.02 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.354 0.978 . . . . 10.0 110.777 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -94.39 141.14 28.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 169.75 62.9 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 125.369 1.468 . . . . 10.0 109.817 145.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.2 37.94 4.71 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.045 1.307 . . . . 10.0 114.685 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 ttm 58.81 37.83 24.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.259 1.423 . . . . 10.0 111.64 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 161.78 14.27 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.353 0.661 . . . . 10.0 110.682 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.2 ttp -80.68 114.91 19.9 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.68 168.92 8.56 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -166.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.416 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.9 Cg_endo -36.85 -58.15 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.246 2.631 . . . . 10.0 111.775 151.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 37.9 p90 166.54 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.555 2.742 . . . . 10.0 105.028 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.92 106.79 11.96 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.62 0.768 . . . . 10.0 111.274 175.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.4 m -81.62 130.89 35.22 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 163.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -107.41 131.9 21.37 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.76 139.75 25.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.34 1.36 . . . . 10.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 59.45 -151.7 0.41 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.235 0.614 . . . . 10.0 112.319 159.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 51.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.411 . . . . 10.0 113.649 168.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.56 153.85 43.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.62 1.105 . . . . 10.0 111.843 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.6 t -146.48 90.63 1.96 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 162.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 81' ' ' GLY . 15.8 tp -84.69 160.87 20.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.016 -0.993 . . . . 10.0 110.316 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.2 m -130.89 99.5 4.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.85 122.92 28.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -155.63 154.55 31.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.984 1.313 . . . . 10.0 108.838 -170.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -70.54 76.6 0.58 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.979 0.512 . . . . 10.0 110.833 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 155.56 -94.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.771 3.628 . . . . 10.0 106.207 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.4 73.18 0.32 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.649 2.071 . . . . 10.0 113.898 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 67.22 134.66 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.024 2.53 . . . . 10.0 111.207 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -170.08 171.23 7.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.72 0.771 . . . . 10.0 112.004 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.8 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.698 -2.334 . . . . 10.0 104.698 167.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.5 mtm -82.83 144.43 30.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.964 -1.125 . . . . 10.0 107.964 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -120.25 78.79 1.39 Allowed 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 128.165 2.586 . . . . 10.0 105.154 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.8 mtt -83.69 154.56 23.59 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.15 54.54 32.13 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.22 141.48 57.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -104.43 -64.98 1.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.979 1.312 . . . . 10.0 109.464 -168.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -59.49 150.24 66.33 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 122.098 0.159 . . . . 10.0 110.914 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.42 102.89 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 N-CA-C 107.207 -1.882 . . . . 10.0 107.207 159.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 161.02 1.64 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.64 0.776 . . . . 10.0 113.034 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -133.13 129.39 37.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.178 -1.416 . . . . 10.0 107.178 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.77 94.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.574 -1.639 . . . . 10.0 106.574 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.9 15.65 8.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.618 1.104 . . . . 10.0 111.967 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 167.95 14.97 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.963 1.381 . . . . 10.0 107.791 159.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -155.1 77.41 1.01 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.218 -2.265 . . . . 10.0 107.877 -163.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -92.9 126.57 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 -169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -75.02 123.47 25.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 126' ' ' ILE . 12.6 pt -115.05 133.52 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.877 1.271 . . . . 10.0 108.525 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -91.03 125.81 35.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.068 -0.716 . . . . 10.0 109.068 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 24.8 mt -81.63 172.99 12.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -153.28 101.99 2.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.41 1.084 . . . . 10.0 108.158 164.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.9 149.05 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 162.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -42.04 -35.98 1.02 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.234 1.014 . . . . 10.0 111.493 168.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -11.33 9.32 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.682 2.793 . . . . 10.0 112.256 -175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.73 7.87 70.77 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -82.23 73.41 9.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.581 -1.266 . . . . 10.0 107.581 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -84.22 66.56 9.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.765 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.6 174.42 11.6 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.039 0.936 . . . . 10.0 109.125 -167.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -120.94 128.64 52.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.73 143.43 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.007 -1.108 . . . . 10.0 108.007 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -84.92 126.62 33.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.611 -0.885 . . . . 10.0 108.611 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.1 110.55 22.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.334 1.454 . . . . 10.0 109.323 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -88.77 105.63 17.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.249 1.42 . . . . 10.0 108.968 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.94 95.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 -168.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 57.48 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.943 1.247 . . . . 10.0 114.323 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 122.584 1.183 . . . . 10.0 114.06 170.191 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.824 0.821 . . . . 10.0 110.567 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -157.12 58.19 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.297 -0.877 . . . . 10.0 109.358 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.36 56.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.078 0.942 . . . . 10.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -149.92 136.14 18.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.636 -1.246 . . . . 10.0 107.636 167.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.17 132.77 23.74 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.083 -1.607 . . . . 10.0 109.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.72 150.94 19.99 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.479 0.64 . . . . 10.0 111.633 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 p -116.53 123.68 48.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.962 0.905 . . . . 10.0 108.646 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.22 121.53 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.568 0.747 . . . . 10.0 109.687 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.14 4.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.685 -0.634 . . . . 10.0 111.467 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -41.04 122.64 1.81 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.636 0.653 . . . . 10.0 110.266 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -33.65 124.27 0.46 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 116.032 1.864 . . . . 10.0 116.032 -144.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.31 165.83 2.83 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.929 2.42 . . . . 10.0 112.512 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -79.0 54.51 5.2 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.187 1.925 . . . . 10.0 109.346 163.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.7 p -139.49 51.67 1.75 Allowed 'General case' 0 C--N 1.341 0.225 0 O-C-N 121.477 -0.764 . . . . 10.0 110.576 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 43' ' ' ARG . 23.9 mt 86.5 173.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 127.608 2.363 . . . . 10.0 106.794 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 42' ' ' ILE . 18.6 ptt180 -72.57 50.63 0.24 Allowed 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.019 -1.05 . . . . 10.0 110.271 165.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.59 158.69 19.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.766 1.226 . . . . 10.0 109.432 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -157.82 169.15 25.27 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 157.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.01 153.23 25.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -173.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.91 147.49 23.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.469 1.106 . . . . 10.0 108.523 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -126.9 127.08 44.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.531 -2.396 . . . . 10.0 104.531 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.2 ptm -161.38 -174.63 4.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 10.0 107.06 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -125.5 117.35 23.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.049 0.94 . . . . 10.0 108.848 171.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.86 113.2 20.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.2 m -122.42 95.34 4.6 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.783 1.927 . . . . 10.0 108.616 -162.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -83.65 140.66 32.04 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.064 -0.397 . . . . 10.0 112.004 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -143.75 60.46 1.38 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -151.28 -39.95 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.916 1.286 . . . . 10.0 111.063 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t70 65.97 60.83 0.66 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.556 1.942 . . . . 10.0 110.339 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -140.89 152.15 64.67 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.256 1.823 . . . . 10.0 107.643 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.31 92.82 0.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.123 2.549 . . . . 10.0 110.658 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.96 145.85 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.412 0.625 . . . . 10.0 110.536 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -131.84 83.17 2.07 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.375 2.27 . . . . 10.0 109.792 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.56 72.55 9.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.359 -0.838 . . . . 10.0 111.293 -172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.08 56.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 121.776 -0.577 . . . . 10.0 110.908 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.39 28.21 Favored Glycine 0 C--N 1.334 0.437 0 O-C-N 121.096 -1.002 . . . . 10.0 111.258 162.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 60.38 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.099 0.96 . . . . 10.0 109.338 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.58 162.03 23.29 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.199 -0.938 . . . . 10.0 109.3 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 147.66 3.55 Favored Pre-proline 0 C--O 1.238 0.496 0 O-C-N 121.831 -0.543 . . . . 10.0 109.54 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.04 57.51 6.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.669 2.246 . . . . 10.0 109.038 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -143.42 -70.06 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.182 0.593 . . . . 10.0 109.983 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.33 167.03 11.93 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.911 1.284 . . . . 10.0 110.798 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.6 m -101.89 -39.83 7.18 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.601 1.16 . . . . 10.0 112.168 -157.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -108.95 90.91 8.32 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.533 1.133 . . . . 10.0 109.726 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.55 90.51 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.008 2.472 . . . . 10.0 109.862 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -108.91 114.19 27.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.849 0.833 . . . . 10.0 109.637 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.24 134.22 36.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.728 -0.841 . . . . 10.0 108.728 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.84 174.98 6.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.605 1.562 . . . . 10.0 108.035 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.2 t -159.88 135.06 8.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 173.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.96 56.75 0.53 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 122.507 1.146 . . . . 10.0 107.961 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.6 m -149.58 123.36 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.726 0.81 . . . . 10.0 109.848 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -70.47 80.95 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.7 t 143.9 -9.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.684 3.193 . . . . 10.0 110.507 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.54 -140.7 9.26 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.204 -1.558 . . . . 10.0 109.204 169.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.76 -54.25 39.14 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.633 -0.587 . . . . 10.0 111.633 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.3 tpt -169.92 -166.32 0.55 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.022 2.129 . . . . 10.0 107.479 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -121.69 60.58 0.95 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.65 89.47 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.455 -1.058 . . . . 10.0 110.455 -163.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -76.65 64.65 2.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.196 0.998 . . . . 10.0 110.687 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 167.75 10.71 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.832 2.053 . . . . 10.0 108.181 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.9 mtt -78.83 85.34 4.82 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.012 -1.477 . . . . 10.0 107.012 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.51 156.25 88.89 Favored Pre-proline 0 N--CA 1.453 -0.315 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -51.33 -38.55 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.866 2.377 . . . . 10.0 111.144 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.494 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 30.6 p90 -176.8 171.89 2.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.71 2.404 . . . . 10.0 104.872 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.76 98.11 8.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.494 ' HG1' ' HE1' ' A' ' 91' ' ' TRP . 0.3 OUTLIER -77.34 131.12 37.94 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.95 109.77 60.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.43 69.8 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.723 2.282 . . . . 10.0 110.189 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.73 175.29 0.2 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 -167.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 35.72 23.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 118.651 2.834 . . . . 10.0 118.651 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -45.92 102.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.411 1.005 . . . . 10.0 112.057 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -131.25 55.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.925 -1.88 . . . . 10.0 105.925 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' H ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -101.7 164.29 11.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.2 m -128.85 114.74 16.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.997 -2.223 . . . . 10.0 104.997 -168.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.19 110.34 14.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.552 -2.388 . . . . 10.0 104.552 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -130.99 148.51 52.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.698 1.999 . . . . 10.0 108.981 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -26.56 -53.15 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.159 2.184 . . . . 10.0 113.896 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -139.95 64.85 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.389 0.676 . . . . 10.0 109.622 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.12 66.46 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 9.2 t0 65.34 149.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.462 1.505 . . . . 10.0 109.824 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 160.66 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.478 1.911 . . . . 10.0 111.539 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.56 128.26 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.191 -1.781 . . . . 10.0 106.191 166.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.5 mtm -92.63 109.06 20.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 168.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.32 77.6 9.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.224 -1.769 . . . . 10.0 106.224 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.76 154.34 23.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.86 74.65 1.26 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 121.212 -0.93 . . . . 10.0 110.992 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.24 138.64 16.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.664 1.232 . . . . 10.0 111.626 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -79.86 -59.39 2.75 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 162.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 179.11 -59.64 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.553 1.141 . . . . 10.0 112.763 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.68 89.11 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.84 1.694 . . . . 10.0 111.557 -166.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.82 156.53 44.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.832 1.253 . . . . 10.0 109.05 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.67 145.88 7.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.62 105.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.916 -1.512 . . . . 10.0 106.916 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.54 -60.83 0.26 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -71.99 -174.11 1.16 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.933 3.293 . . . . 10.0 111.618 -163.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.0 m -133.87 128.33 34.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.149 1.78 . . . . 10.0 106.664 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.53 140.09 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -77.97 126.21 30.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.319 -0.993 . . . . 10.0 108.319 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -80.28 179.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.23 -1.767 . . . . 10.0 106.23 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.4 m -144.31 114.24 7.31 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.835 -1.166 . . . . 10.0 108.838 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 140.85 31.62 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -147.08 86.5 1.64 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.129 -1.434 . . . . 10.0 107.129 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.06 145.76 28.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.339 0.256 . . . . 10.0 110.919 -169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -56.39 -24.58 45.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.553 1.141 . . . . 10.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.77 -26.63 14.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.778 1.231 . . . . 10.0 113.238 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.65 52.33 1.22 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 109.75 -1.34 . . . . 10.0 109.75 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -144.78 160.45 41.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 m -131.45 143.79 50.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.6 tp -151.96 154.56 36.29 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -137.98 62.51 1.57 Allowed 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.527 1.531 . . . . 10.0 109.706 -161.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.66 141.11 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.57 124.63 30.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.01 130.61 54.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.057 0.943 . . . . 10.0 109.945 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -84.34 126.75 33.49 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 37' ' ' ALA . 7.8 t -87.12 100.78 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 -174.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -146.59 123.14 11.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.366 1.866 . . . . 10.0 108.194 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 123.591 0.756 . . . . 10.0 110.36 172.53 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 121.229 0.538 . . . . 10.0 112.073 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.7 p -157.3 62.27 0.49 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -108.85 60.09 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 10.0 109.257 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -133.6 144.4 49.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.961 0.905 . . . . 10.0 110.954 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.94 86.84 1.11 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.38 139.84 29.18 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.809 0.444 . . . . 10.0 111.941 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -117.3 140.51 49.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.0 134.25 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.69 120.96 12.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.96 -68.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.0 110.322 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -142.43 104.96 5.48 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.728 1.611 . . . . 10.0 107.541 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -64.94 164.89 23.08 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.549 2.166 . . . . 10.0 109.882 171.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.75 66.71 5.77 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.784 2.989 . . . . 10.0 109.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -156.32 -48.01 0.07 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.064 2.146 . . . . 10.0 106.628 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mt 72.03 147.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.244 1.818 . . . . 10.0 108.672 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 75.53 -49.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.271 1.429 . . . . 10.0 111.766 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -79.67 153.94 28.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 168.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -171.9 172.57 4.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.144 1.378 . . . . 10.0 109.177 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -157.07 161.76 39.47 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.61 0.764 . . . . 10.0 111.816 -172.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.03 140.4 29.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 124.401 1.063 . . . . 10.0 109.441 167.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 25.7 m-85 -136.18 112.83 10.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.392 -1.336 . . . . 10.0 107.392 -174.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -163.48 -172.23 2.85 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 125.149 1.38 . . . . 10.0 109.396 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -125.11 121.63 34.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 10.0 109.868 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.81 135.69 34.89 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 120.188 1.358 . . . . 10.0 107.62 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -117.75 78.53 1.25 Allowed 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.806 1.316 . . . . 10.0 109.876 -169.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.47 100.33 8.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.438 0.637 . . . . 10.0 109.867 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -109.4 54.68 0.65 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.11 0.964 . . . . 10.0 109.68 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 p -177.89 148.0 0.5 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -88.87 69.32 8.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.772 0.829 . . . . 10.0 109.576 -173.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.97 127.18 23.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.18 99.81 1.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.362 2.708 . . . . 10.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.9 141.79 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -126.62 97.37 4.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.011 1.325 . . . . 10.0 108.516 171.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -81.42 132.61 35.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 175.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.18 53.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.3 158.94 31.75 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.63 -0.988 . . . . 10.0 110.63 163.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.87 127.21 6.5 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 158.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.46 144.06 23.48 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -172.55 155.99 3.37 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 118.352 0.524 . . . . 10.0 111.223 -163.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.27 -5.5 13.98 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.802 2.334 . . . . 10.0 112.599 164.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.66 -57.26 4.25 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.505 1.048 . . . . 10.0 111.892 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.51 161.07 37.38 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.554 1.141 . . . . 10.0 111.871 -168.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -93.46 -41.31 9.86 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.701 1.2 . . . . 10.0 111.74 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t -115.86 82.45 10.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.685 1.594 . . . . 10.0 109.498 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.75 107.5 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.897 2.398 . . . . 10.0 109.988 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.8 mmt -122.76 122.19 38.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.418 1.487 . . . . 10.0 109.352 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.15 138.33 33.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.726 0.81 . . . . 10.0 109.292 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.03 12.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.877 1.271 . . . . 10.0 110.137 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -139.74 119.86 13.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.88 -1.155 . . . . 10.0 107.88 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -141.18 48.29 1.68 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.3 m -156.43 80.54 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.058 -1.026 . . . . 10.0 109.799 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.57 86.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.257 1.023 . . . . 10.0 110.592 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 165.89 -41.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 127.452 2.301 . . . . 10.0 108.486 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.41 -83.34 1.32 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.168 -2.773 . . . . 10.0 106.168 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.02 -138.62 6.1 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.053 -1.219 . . . . 10.0 110.053 160.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.2 mmt -108.06 -161.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.155 2.182 . . . . 10.0 109.79 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.55 76.26 1.48 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.63 82.32 0.16 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.686 -1.365 . . . . 10.0 109.686 -170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -77.64 60.61 2.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.159 0.981 . . . . 10.0 110.386 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -125.62 170.96 10.98 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.444 2.298 . . . . 10.0 107.481 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.8 mtt -80.24 72.87 7.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.87 155.8 75.91 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.076 -0.966 . . . . 10.0 109.62 176.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -60.69 -25.71 81.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.225 1.95 . . . . 10.0 112.359 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -175.73 179.57 1.37 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.394 1.878 . . . . 10.0 106.451 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -113.77 106.81 14.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.56 150.81 34.7 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.99 88.8 27.68 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.88 57.72 6.55 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.904 3.069 . . . . 10.0 110.718 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.47 154.95 0.06 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.698 1.237 . . . . 10.0 110.108 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 40.3 39.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.201 1.401 . . . . 10.0 114.733 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 69.56 0.17 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.619 -0.993 . . . . 10.0 110.619 160.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -84.55 57.0 4.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.324 -1.361 . . . . 10.0 107.324 167.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.76 171.62 8.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.849 0.833 . . . . 10.0 110.54 -167.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 t -128.4 128.98 45.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.147 -2.168 . . . . 10.0 105.147 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.92 103.58 9.73 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 104.092 -2.558 . . . . 10.0 104.092 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -147.42 175.21 10.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.685 -1.598 . . . . 10.0 106.685 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -39.63 -50.15 2.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.208 0.527 . . . . 10.0 111.877 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -98.76 16.15 23.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.219 2.608 . . . . 10.0 113.911 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.35 151.67 23.89 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 120.559 1.527 . . . . 10.0 111.362 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -34.98 97.41 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.043 1.737 . . . . 10.0 113.633 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -128.29 174.67 9.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.728 1.149 . . . . 10.0 112.003 -166.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.91 107.97 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.6 mtt -84.1 102.72 12.75 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 122.297 1.046 . . . . 10.0 108.906 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.54 70.0 10.18 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 105.669 -1.974 . . . . 10.0 105.669 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.5 ttm -83.72 148.53 27.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 -168.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.34 59.65 2.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.612 -1.395 . . . . 10.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 tt -50.47 128.06 19.12 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.307 1.843 . . . . 10.0 110.241 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.61 -71.64 0.54 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.071 0.549 . . . . 10.0 110.146 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.61 158.0 73.99 Favored Pre-proline 0 CA--C 1.533 0.319 0 O-C-N 121.982 -0.449 . . . . 10.0 110.135 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.3 73.86 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.317 2.012 . . . . 10.0 109.152 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.76 132.3 17.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 112.789 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -96.35 129.63 43.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.336 1.454 . . . . 10.0 109.492 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.4 105.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.08 16.2 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.912 -0.938 . . . . 10.0 112.313 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.19 -178.47 1.67 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.727 1.727 . . . . 10.0 108.735 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.9 m -155.66 124.59 6.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.614 -1.995 . . . . 10.0 105.614 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.97 145.14 29.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.92 130.33 39.2 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.162 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.9 pt -106.91 122.0 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 160.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 m -101.16 119.98 39.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 169.12 8.74 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.645 0.778 . . . . 10.0 110.029 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.65 96.6 2.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.17 1.788 . . . . 10.0 107.872 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.63 132.18 34.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.395 -0.595 . . . . 10.0 109.395 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 t -60.91 -15.49 31.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.262 0.625 . . . . 10.0 111.388 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.432 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 54.6 m-20 -67.17 -21.14 65.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.906 0.883 . . . . 10.0 112.059 171.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 131.33 -13.05 5.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.099 0.857 . . . . 10.0 112.418 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -81.07 73.02 8.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.872 1.336 . . . . 10.0 109.356 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.6 m -83.61 107.05 15.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 156.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.4 tp -156.11 149.42 24.56 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -106.22 131.03 53.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.295 2.238 . . . . 10.0 106.826 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.23 122.93 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.321 -1.733 . . . . 10.0 106.321 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.8 108.28 16.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.22 29.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.626 0.77 . . . . 10.0 109.665 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -82.26 127.21 32.97 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.342 -0.985 . . . . 10.0 108.342 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.1 t -90.0 91.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.204 -1.776 . . . . 10.0 106.204 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -158.67 140.01 13.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 166.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 169.59 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 122.277 1.037 . . . . 10.0 111.647 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -158.03 74.81 0.73 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.1 53.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 122.151 0.977 . . . . 10.0 110.281 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -152.7 139.11 18.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 163.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 147.62 35.55 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.092 -1.203 . . . . 10.0 110.092 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.12 152.52 29.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 10.0 110.443 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -133.44 125.73 29.67 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.751 -1.574 . . . . 10.0 106.751 170.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.47 137.84 45.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.436 1.095 . . . . 10.0 110.012 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.94 2.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.227 -0.589 . . . . 10.0 111.808 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.79 114.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.574 1.15 . . . . 10.0 111.286 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t 2.9 94.57 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.134 2.574 . . . . 10.0 113.365 -167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.23 169.22 20.02 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.95 1.767 . . . . 10.0 108.487 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.74 60.11 4.31 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.812 2.341 . . . . 10.0 109.887 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -160.17 40.61 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.234 1.414 . . . . 10.0 108.429 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 43' ' ' ARG . 9.4 mm 69.48 -179.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.034 1.333 . . . . 10.0 109.081 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.588 ' H ' HG22 ' A' ' 42' ' ' ILE . 9.0 ptm180 -55.55 -29.11 58.38 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.064 0.946 . . . . 10.0 112.108 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.42 135.9 7.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.784 1.634 . . . . 10.0 109.67 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 t -160.82 -171.21 3.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -156.29 167.41 30.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.403 1.081 . . . . 10.0 109.828 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.67 153.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.909 0.755 . . . . 10.0 111.208 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 33.0 m-85 -138.52 112.33 8.39 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.571 -1.64 . . . . 10.0 106.571 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -162.25 -171.96 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.02 1.728 . . . . 10.0 107.634 -168.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -128.01 145.72 50.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.648 0.658 . . . . 10.0 111.592 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.35 113.31 25.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.403 -2.073 . . . . 10.0 105.403 156.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.03 82.17 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.66 137.47 34.46 Favored 'General case' 0 C--N 1.337 0.06 0 O-C-N 121.689 -0.632 . . . . 10.0 110.335 -168.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -128.48 54.66 1.74 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -158.33 128.88 6.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.584 1.954 . . . . 10.0 105.774 170.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.59 61.92 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.863 0.865 . . . . 10.0 110.119 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -134.27 135.98 25.1 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.392 1.477 . . . . 10.0 108.602 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.15 100.58 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.495 2.796 . . . . 10.0 111.167 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.26 95.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.73 117.68 22.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.748 0.819 . . . . 10.0 110.604 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.8 OUTLIER -88.8 123.37 33.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.424 1.49 . . . . 10.0 107.88 -174.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 7.1 p -143.54 55.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.695 0.759 . . . . 10.0 110.425 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.01 148.45 16.41 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.472 -1.451 . . . . 10.0 109.472 162.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.97 75.83 0.84 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.13 0.972 . . . . 10.0 109.029 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.53 157.52 16.18 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.498 0.719 . . . . 10.0 109.676 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -172.54 143.27 1.21 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.94 60.97 6.27 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.242 2.628 . . . . 10.0 109.777 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.68 -51.64 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.435 1.094 . . . . 10.0 108.471 -164.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.43 168.69 10.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.475 1.91 . . . . 10.0 109.837 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 m -134.6 -2.31 2.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.311 0.644 . . . . 10.0 112.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 m -152.11 70.44 7.71 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.852 -1.155 . . . . 10.0 109.885 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.61 128.9 11.35 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.84 2.36 . . . . 10.0 111.29 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 mmt -139.64 128.73 23.73 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.999 1.32 . . . . 10.0 109.453 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.46 136.87 33.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.683 0.793 . . . . 10.0 109.673 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.67 -179.36 3.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.875 1.67 . . . . 10.0 108.93 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.0 t -158.88 100.8 1.6 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.485 0.714 . . . . 10.0 109.687 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 t -149.96 56.82 0.96 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.257 -0.902 . . . . 10.0 109.24 -169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -124.46 146.36 48.98 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.926 1.29 . . . . 10.0 108.91 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -101.74 44.92 0.99 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.0 t -163.93 -52.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.243 0.617 . . . . 10.0 111.184 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.88 -110.4 0.57 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.24 -144.86 0.35 Allowed Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.098 0.949 . . . . 10.0 113.699 170.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.4 ttm -75.82 162.88 27.78 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.865 1.266 . . . . 10.0 109.952 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.6 49.94 0.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.999 1.72 . . . . 10.0 107.756 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.7 92.25 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.565 -1.014 . . . . 10.0 110.565 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 ttp -64.21 84.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.554 1.177 . . . . 10.0 112.052 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -133.28 156.66 47.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.214 2.606 . . . . 10.0 106.769 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.4 mtm -80.38 143.49 33.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.913 -1.514 . . . . 10.0 106.913 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.93 165.1 29.96 Favored Pre-proline 0 N--CA 1.455 -0.205 0 C-N-CA 123.686 0.794 . . . . 10.0 109.776 -171.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -43.51 -54.37 3.67 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.686 2.257 . . . . 10.0 110.404 158.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.424 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 175.36 -149.58 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.151 2.181 . . . . 10.0 108.613 -177.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.86 158.27 43.87 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.332 1.853 . . . . 10.0 106.054 160.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.5 m -97.47 124.57 41.73 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.52 -0.918 . . . . 10.0 108.52 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.49 121.73 68.05 Favored Pre-proline 0 N--CA 1.454 -0.232 0 N-CA-C 105.325 -2.102 . . . . 10.0 105.325 171.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.97 146.15 16.03 Favored 'Trans proline' 0 N--CA 1.441 -1.571 0 N-CA-C 109.261 -1.092 . . . . 10.0 109.261 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 47.36 -138.4 0.71 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.958 0.903 . . . . 10.0 112.539 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.67 32.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.747 2.419 . . . . 10.0 114.494 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.8 150.76 38.6 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.994 -1.066 . . . . 10.0 113.075 -169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -132.01 61.66 1.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.988 1.315 . . . . 10.0 108.359 -171.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.65 148.58 30.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.9 m -135.47 107.54 7.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.22 114.35 18.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -131.53 159.75 37.27 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.249 1.42 . . . . 10.0 109.845 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -25.0 -65.26 0.05 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.201 2.2 . . . . 10.0 113.566 -173.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.09 80.63 1.84 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.377 -1.712 . . . . 10.0 106.377 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.83 86.76 0.1 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 108.86 -1.696 . . . . 10.0 108.86 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 t0 40.95 74.61 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.129 1.771 . . . . 10.0 112.176 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -131.07 172.31 12.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.332 -1.758 . . . . 10.0 110.867 -154.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.7 108.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 125.668 1.587 . . . . 10.0 108.715 -173.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 33.0 mtp -83.04 96.39 8.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.405 0.682 . . . . 10.0 109.723 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.48 70.17 7.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.809 -1.552 . . . . 10.0 106.809 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.22 164.99 22.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.431 -1.322 . . . . 10.0 107.431 -168.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.28 46.57 20.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.323 -1.111 . . . . 10.0 110.323 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.4 mt -55.27 130.27 41.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.737 1.268 . . . . 10.0 108.917 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -69.17 0.13 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.506 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 173.97 -63.63 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.221 1.409 . . . . 10.0 112.91 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.09 50.14 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.544 2.163 . . . . 10.0 112.741 -159.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.54 157.01 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.212 1.005 . . . . 10.0 110.52 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 171.93 7.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.954 -1.128 . . . . 10.0 107.954 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.27 128.09 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 163.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 33.17 39.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.499 -0.64 . . . . 10.0 111.499 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.96 -172.7 4.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.462 1.125 . . . . 10.0 108.486 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.6 m -155.81 124.78 6.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.027 1.731 . . . . 10.0 107.499 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.89 152.5 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.96 -1.496 . . . . 10.0 106.96 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -70.87 132.23 44.95 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.0 154.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 106.125 -1.805 . . . . 10.0 106.125 155.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -129.82 128.49 42.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 158.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.41 156.39 24.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -147.7 69.41 1.14 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.69 117.69 21.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p 40.95 -99.79 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.585 1.554 . . . . 10.0 109.896 -167.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 42.79 0.93 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.27 2.228 . . . . 10.0 107.411 170.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.09 -48.12 0.23 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.22 1.866 . . . . 10.0 110.166 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -115.1 73.2 0.82 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.093 0.947 . . . . 10.0 108.637 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 m -86.29 100.94 12.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 160.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 mt -155.3 164.41 38.81 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 122.736 0.415 . . . . 10.0 110.547 -165.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -132.46 65.28 1.59 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.712 2.005 . . . . 10.0 109.553 -159.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.7 t -81.71 149.3 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 -171.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.32 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.151 -0.968 . . . . 10.0 109.626 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.66 120.48 40.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.844 1.258 . . . . 10.0 109.739 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -83.78 148.47 27.01 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 166.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.73 100.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -156.8 126.81 6.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.294 0.952 . . . . 10.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 118.441 0.564 . . . . 10.0 111.39 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 122.679 1.228 . . . . 10.0 112.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -78.43 66.26 3.94 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.526 3.131 . . . . 10.0 108.929 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.75 88.96 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.154 1.382 . . . . 10.0 108.951 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -147.94 134.42 19.71 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.67 154.81 47.59 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.589 1.09 . . . . 10.0 112.497 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.42 162.48 13.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.641 0.734 . . . . 10.0 112.22 -170.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 p -139.63 157.98 44.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.557 -1.275 . . . . 10.0 107.557 164.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.91 136.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.243 -1.392 . . . . 10.0 107.243 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.51 40.75 0.74 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.794 -1.191 . . . . 10.0 112.998 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . . . 41.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.107 1.363 . . . . 10.0 110.111 -164.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.58 125.46 47.02 Favored Pre-proline 0 C--O 1.239 0.517 0 CA-C-N 120.095 1.316 . . . . 10.0 107.841 160.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.19 174.06 4.47 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.261 1.974 . . . . 10.0 108.693 162.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.95 54.84 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.215 1.943 . . . . 10.0 109.801 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 m -144.29 62.6 1.34 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.978 1.311 . . . . 10.0 107.711 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 mm 73.72 164.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.923 1.289 . . . . 10.0 109.723 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -77.38 50.07 0.76 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.217 1.407 . . . . 10.0 109.862 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -138.72 159.81 41.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.059 2.144 . . . . 10.0 108.46 -162.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.1 t -172.0 -179.43 2.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.472 1.109 . . . . 10.0 109.948 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.28 161.33 37.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.334 1.454 . . . . 10.0 109.157 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.96 156.54 21.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 165.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -130.19 108.63 10.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.17 -2.529 . . . . 10.0 104.17 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ptp -157.12 -176.8 6.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.681 1.192 . . . . 10.0 109.461 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.9 m -127.59 119.12 25.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.086 1.355 . . . . 10.0 109.053 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.32 109.23 12.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 103.605 -2.739 . . . . 10.0 103.605 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -95.93 70.65 2.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.482 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.51 130.25 35.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.272 -0.971 . . . . 10.0 109.829 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -136.1 56.26 1.83 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 p -157.83 166.14 33.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.312 0.577 . . . . 10.0 110.821 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -107.89 27.26 9.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.901 2.88 . . . . 10.0 110.33 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -114.73 134.4 22.41 Favored Pre-proline 0 C--N 1.342 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 107.609 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.63 122.01 8.48 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.113 1.875 . . . . 10.0 109.891 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.26 81.91 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -79.28 -180.0 7.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.062 0.458 . . . . 10.0 110.32 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -155.64 136.14 13.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.666 -2.346 . . . . 10.0 104.666 -170.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -151.55 54.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.276 0.944 . . . . 10.0 109.52 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.18 151.0 20.01 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.783 -1.198 . . . . 10.0 111.116 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.78 70.95 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.484 1.514 . . . . 10.0 108.392 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.64 140.71 32.02 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 t -168.21 145.04 3.35 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 118.562 0.619 . . . . 10.0 111.313 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.95 52.99 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.937 2.425 . . . . 10.0 110.023 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 tp -128.87 -61.24 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.439 1.096 . . . . 10.0 109.564 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.24 162.44 18.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.61 1.564 . . . . 10.0 109.601 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 m -87.86 -42.7 12.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.588 0.755 . . . . 10.0 110.625 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 t -123.38 89.97 50.76 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.654 1.182 . . . . 10.0 110.181 -163.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.68 85.11 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.89 2.393 . . . . 10.0 109.904 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.0 mtt -83.69 117.83 23.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.152 0.981 . . . . 10.0 108.618 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.16 128.63 33.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.458 -0.776 . . . . 10.0 109.571 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.76 144.68 39.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.918 1.287 . . . . 10.0 110.787 -174.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.89 170.11 13.43 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.467 0.651 . . . . 10.0 111.991 164.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -98.46 177.43 5.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.42 1.888 . . . . 10.0 113.527 164.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -95.21 72.05 3.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.046 1.739 . . . . 10.0 108.969 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.09 73.03 0.44 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.245 1.418 . . . . 10.0 112.921 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -164.39 54.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.31 -90.06 0.49 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 106.992 -2.443 . . . . 10.0 106.992 -167.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.37 173.87 19.06 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 117.223 0.511 . . . . 10.0 112.706 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mtp -53.75 -87.48 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.645 1.978 . . . . 10.0 115.547 -158.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -174.94 34.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.666 0.666 . . . . 10.0 111.922 -160.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.79 140.39 2.91 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.827 -0.909 . . . . 10.0 110.827 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.6 ttp -65.62 93.59 0.17 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.739 0.769 . . . . 10.0 110.062 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.26 161.38 38.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.432 0.693 . . . . 10.0 112.464 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 68.9 mtp -82.84 109.42 16.96 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.071 1.748 . . . . 10.0 110.081 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.09 166.51 10.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.391 0.676 . . . . 10.0 111.525 -170.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.414 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.4 Cg_endo -37.73 -53.1 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.251 2.634 . . . . 10.0 111.027 156.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 44.6 p90 175.07 -172.18 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.056 2.142 . . . . 10.0 105.593 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.3 pt? -116.1 102.3 9.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.473 0.654 . . . . 10.0 110.548 174.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.7 m -76.8 120.85 22.52 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 pt -92.48 115.38 64.69 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.315 -1.365 . . . . 10.0 107.315 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.05 59.06 7.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.74 2.293 . . . . 10.0 108.514 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.73 -175.82 0.14 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.26 1.024 . . . . 10.0 109.551 -161.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 54.6 -2.34 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 118.024 2.602 . . . . 10.0 118.024 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.61 77.74 0.49 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.761 1.172 . . . . 10.0 111.986 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.4 t -82.43 56.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 166.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.59 -178.16 4.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.98 0.895 . . . . 10.0 110.656 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -127.75 129.13 46.56 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.18 1.792 . . . . 10.0 106.562 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.77 114.39 26.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 103.752 -2.685 . . . . 10.0 103.752 167.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.99 159.85 38.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.343 1.057 . . . . 10.0 109.971 -164.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -44.89 -54.6 6.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.153 1.381 . . . . 10.0 113.349 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.8 -63.31 1.24 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.783 0.833 . . . . 10.0 111.419 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.24 135.81 3.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -165.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 70.78 119.96 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 130.885 3.674 . . . . 10.0 106.246 -170.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 176.43 171.67 0.43 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.605 0.762 . . . . 10.0 109.242 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.22 123.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.139 -2.171 . . . . 10.0 105.139 154.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 69.0 mtp -82.84 101.6 11.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.104 -1.443 . . . . 10.0 107.104 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.38 74.3 8.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.708 1.603 . . . . 10.0 107.045 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 52.1 ttm -84.6 149.47 25.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.231 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.46 68.82 1.27 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.704 -0.959 . . . . 10.0 110.704 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -35.37 133.94 0.32 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.121 1.768 . . . . 10.0 112.985 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -67.53 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.745 -0.645 . . . . 10.0 111.689 157.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -168.9 -59.3 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 115.984 1.846 . . . . 10.0 115.984 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.39 75.66 4.81 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.904 1.736 . . . . 10.0 111.113 -166.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.17 48.32 2.41 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.389 1.076 . . . . 10.0 111.882 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -63.69 148.21 49.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.22 108.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.29 55.77 3.0 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -166.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 -179.8 4.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 153.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.1 m -155.66 134.93 12.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.284 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.01 136.7 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.656 -1.609 . . . . 10.0 106.656 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -79.23 114.76 18.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 167.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -81.2 -178.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 168.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 m -139.13 120.19 14.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 160.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 pp -83.69 172.65 12.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -156.72 103.39 2.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 134' ' ' ARG . . . -84.45 120.69 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.06 -1.089 . . . . 10.0 108.06 157.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -48.33 -34.51 10.72 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.594 1.558 . . . . 10.0 111.053 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.1 -33.75 53.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.759 2.023 . . . . 10.0 111.806 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.82 56.84 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.231 0.92 . . . . 10.0 111.032 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 130' ' ' ALA . 68.2 ttt180 -141.65 133.72 27.64 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.5 t -156.01 59.6 0.59 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.659 0.663 . . . . 10.0 110.754 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.98 148.97 27.27 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.005 0.522 . . . . 10.0 109.885 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -95.92 65.81 2.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 127.735 2.414 . . . . 10.0 108.262 -174.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.77 146.96 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -155.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.73 130.53 35.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.62 115.08 23.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.951 1.3 . . . . 10.0 109.453 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.7 m -84.41 132.73 34.55 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.37 120.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -159.7 94.1 1.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.057 0.844 . . . . 10.0 112.379 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 15.9 ptmt . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.276 0.56 . . . . 10.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 p -156.13 57.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.507 -0.746 . . . . 10.0 109.995 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.24 58.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 CA-C-O 122.569 1.176 . . . . 10.0 110.632 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.95 155.75 41.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 164.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.52 -163.23 6.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.366 -1.094 . . . . 10.0 110.366 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.0 133.77 30.52 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -120.46 110.64 16.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.65 128.78 53.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.397 0.679 . . . . 10.0 109.375 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.08 110.34 12.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.873 0.368 . . . . 10.0 111.314 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.44 127.14 14.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.572 -0.728 . . . . 10.0 109.617 167.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -13.05 95.74 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 128.29 2.636 . . . . 10.0 113.281 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.47 178.86 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.692 2.261 . . . . 10.0 109.377 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -67.52 68.05 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.408 2.072 . . . . 10.0 108.548 156.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -153.8 35.28 0.44 Allowed 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 126.216 1.806 . . . . 10.0 108.206 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 43' ' ' ARG . 18.2 mt 64.8 -176.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -70.19 32.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.468 -1.395 . . . . 10.0 113.552 170.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 155.16 20.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 163.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -164.94 -178.15 5.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.669 -1.234 . . . . 10.0 107.669 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 165.0 29.32 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.883 0.873 . . . . 10.0 109.887 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.69 33.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.308 -1.314 . . . . 10.0 107.71 164.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.16 104.36 12.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 -173.4 4.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.49 1.116 . . . . 10.0 110.423 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.8 m -116.56 143.96 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.038 1.735 . . . . 10.0 107.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.42 121.7 40.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.723 -1.955 . . . . 10.0 105.723 158.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -129.42 114.93 16.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.583 1.553 . . . . 10.0 109.045 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -93.29 136.93 33.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.82 0.848 . . . . 10.0 112.317 -172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -134.2 56.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.713 -1.218 . . . . 10.0 107.713 161.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -137.33 -51.5 0.65 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.82 0.848 . . . . 10.0 111.031 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.5 48.43 3.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.659 1.584 . . . . 10.0 110.449 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.69 137.99 31.06 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.63 119.04 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.876 2.384 . . . . 10.0 109.705 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 mt -122.96 135.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -98.6 99.73 10.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.385 1.074 . . . . 10.0 108.904 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -87.2 117.56 26.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.75 -1.944 . . . . 10.0 105.75 -178.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.17 51.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.485 0.714 . . . . 10.0 109.488 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.95 138.34 5.35 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.925 -1.27 . . . . 10.0 109.925 160.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.56 66.57 0.49 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.257 1.423 . . . . 10.0 107.73 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.0 21.09 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.061 0.544 . . . . 10.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 t -173.46 140.22 0.85 Allowed Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.39 65.82 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.27 2.646 . . . . 10.0 108.932 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.26 -50.68 0.08 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.957 1.303 . . . . 10.0 108.766 -164.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.93 31.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m -88.98 -22.31 23.09 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 167.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -134.3 88.15 31.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.709 1.204 . . . . 10.0 108.492 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.79 124.36 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.324 2.683 . . . . 10.0 110.424 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -132.04 152.04 51.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.578 1.151 . . . . 10.0 108.95 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.1 157.06 18.45 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.236 0.615 . . . . 10.0 110.217 166.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.93 153.81 32.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.794 1.237 . . . . 10.0 109.354 -176.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 15.1 t -139.57 121.04 15.08 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.947 0.794 . . . . 10.0 112.408 -173.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -146.88 51.22 1.1 Allowed 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.559 -1.338 . . . . 10.0 110.305 165.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.6 m -150.28 90.74 1.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.487 1.115 . . . . 10.0 111.85 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -34.67 -42.98 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.805 2.442 . . . . 10.0 113.566 172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -50.29 -26.29 4.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.644 1.178 . . . . 10.0 113.409 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.22 -51.41 0.11 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 -124.57 4.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.162 0.887 . . . . 10.0 111.245 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.3 tpp -141.74 -121.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.067 0.934 . . . . 10.0 111.186 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.07 62.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -166.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.32 87.36 0.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.795 -1.722 . . . . 10.0 108.795 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 64.43 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.463 -0.94 . . . . 10.0 108.463 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -147.08 172.89 13.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.674 2.39 . . . . 10.0 107.847 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttp -80.15 74.73 6.95 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.799 0.809 . . . . 10.0 109.054 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.73 160.81 24.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.701 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.23 80.14 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.957 2.438 . . . . 10.0 109.69 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 58.21 -164.95 0.18 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.954 2.102 . . . . 10.0 113.482 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.75 99.15 5.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.797 0.839 . . . . 10.0 109.27 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.0 m -82.15 125.46 30.91 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.726 -0.608 . . . . 10.0 109.649 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.33 122.11 60.34 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.34 65.45 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.816 2.344 . . . . 10.0 110.847 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.99 -175.32 0.15 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.877 0.871 . . . . 10.0 109.462 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . 0.258 0.1 OUTLIER 5.9 44.21 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 130.164 3.385 . . . . 10.0 118.831 -169.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -54.29 138.01 40.56 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.316 0.96 . . . . 10.0 113.534 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.8 m -149.85 59.63 0.99 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.433 1.493 . . . . 10.0 107.177 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.96 164.75 12.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.677 0.275 . . . . 10.0 110.524 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.8 m -124.19 104.73 9.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.54 122.21 27.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.63 -1.618 . . . . 10.0 106.63 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -156.17 157.51 36.04 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.606 1.963 . . . . 10.0 107.726 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 0.25 0.2 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.476 1.658 . . . . 10.0 115.476 -161.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.45 -72.04 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.994 1.717 . . . . 10.0 108.09 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.28 76.61 1.45 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 125.136 1.351 . . . . 10.0 111.176 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 8.9 t70 70.03 134.58 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.095 1.758 . . . . 10.0 110.696 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -177.47 176.22 1.32 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.896 0.855 . . . . 10.0 113.013 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.59 121.37 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 157.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.2 mtp -82.22 104.99 12.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 165.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.63 74.52 6.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.628 1.971 . . . . 10.0 109.148 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -91.16 149.13 21.92 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.934 -0.479 . . . . 10.0 112.271 -170.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 33.56 3.0 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.582 0.993 . . . . 10.0 115.582 157.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 37.95 46.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 128.424 2.69 . . . . 10.0 116.769 160.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.092 -1.005 . . . . 10.0 112.719 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -133.11 151.72 78.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 107.086 -1.45 . . . . 10.0 107.086 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.39 75.06 2.5 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.003 2.468 . . . . 10.0 109.279 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mp -40.54 105.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.386 2.274 . . . . 10.0 113.3 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.73 131.64 34.41 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.1 p -60.67 103.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 162.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.69 -0.61 15.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.978 -0.901 . . . . 10.0 112.148 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.16 179.97 4.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 123.94 1.828 . . . . 10.0 108.281 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -155.81 132.75 10.59 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.534 -2.121 . . . . 10.0 106.55 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.75 143.88 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -79.22 124.64 28.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 tt -81.52 170.4 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -146.42 118.44 8.24 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.155 -0.966 . . . . 10.0 109.073 165.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.1 151.54 24.06 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.318 -1.364 . . . . 10.0 107.318 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -154.48 78.7 1.08 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.1 123.56 27.47 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p 44.89 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.175 1.79 . . . . 10.0 110.001 -161.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -164.32 58.36 0.15 Allowed 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.731 0.813 . . . . 10.0 109.521 156.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.71 27.44 1.63 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.22 61.04 1.17 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.186 0.994 . . . . 10.0 108.428 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.1 m -83.0 60.11 5.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.794 0.838 . . . . 10.0 110.27 -170.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.88 149.92 26.82 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -130.55 60.74 1.62 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.543 1.937 . . . . 10.0 109.509 -169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.0 151.12 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 121.938 -0.476 . . . . 10.0 109.991 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.96 119.6 24.64 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.364 -0.835 . . . . 10.0 109.294 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.85 133.45 42.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.222 1.009 . . . . 10.0 108.799 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.6 m -83.0 144.29 30.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.525 -1.287 . . . . 10.0 107.525 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.43 107.28 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -156.69 147.11 21.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.603 0.716 . . . . 10.0 111.024 171.68 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 121.092 0.472 . . . . 10.0 110.466 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 m -159.18 106.5 1.78 Allowed 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.948 -1.095 . . . . 10.0 109.505 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.23 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.63 0.65 . . . . 10.0 111.01 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -157.51 153.58 27.24 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 163.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.1 107.95 3.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.748 1.166 . . . . 10.0 112.178 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.73 153.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.746 0.818 . . . . 10.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 p -135.68 151.86 50.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.287 -1.375 . . . . 10.0 107.287 164.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.84 137.91 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.06 47.33 0.77 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.288 0.949 . . . . 10.0 113.416 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 28.89 -124.29 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.014 2.126 . . . . 10.0 111.243 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.38 118.89 55.63 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 157.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.8 168.49 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.038 2.492 . . . . 10.0 107.996 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.47 69.43 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.786 1.657 . . . . 10.0 108.846 170.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.433 ' CB ' HH12 ' A' ' 104' ' ' ARG . 7.4 m -155.84 38.67 0.37 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.645 1.178 . . . . 10.0 109.078 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.4 mm 68.34 178.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.361 1.064 . . . . 10.0 110.291 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.4 tpt180 -46.51 -33.59 4.17 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.37 2.268 . . . . 10.0 114.774 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.31 151.71 45.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.362 1.077 . . . . 10.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 t -161.65 175.4 12.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.634 -1.617 . . . . 10.0 106.634 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.02 160.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.07 0.548 . . . . 10.0 110.529 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.76 142.44 32.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.114 0.884 . . . . 10.0 108.855 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -117.93 108.62 15.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 165.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.74 -179.16 7.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.313 1.845 . . . . 10.0 106.332 -160.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -150.66 138.02 19.52 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.411 1.46 . . . . 10.0 110.071 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.97 116.37 27.97 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -93.76 87.25 5.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.843 1.657 . . . . 10.0 108.304 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -78.05 79.53 4.51 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 121.89 0.852 . . . . 10.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 58.28 4.64 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m -172.76 144.21 1.34 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.986 0.915 . . . . 10.0 108.796 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.09 49.12 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.447 1.499 . . . . 10.0 109.838 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.2 127.19 18.88 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.805 0.842 . . . . 10.0 109.376 -170.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -85.71 121.85 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.538 2.825 . . . . 10.0 110.702 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mp -150.44 116.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 150.08 30.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.347 0.521 . . . . 10.0 110.677 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.415 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -110.04 138.32 46.59 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 171.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.88 54.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.56 1.073 . . . . 10.0 108.914 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.04 144.35 9.64 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.623 -1.791 . . . . 10.0 108.623 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.98 65.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.571 1.548 . . . . 10.0 107.981 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.12 160.89 23.03 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t -173.75 152.2 1.98 Allowed Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 107.608 -1.256 . . . . 10.0 107.608 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.34 -1.41 11.32 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.603 2.202 . . . . 10.0 112.155 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.61 -53.67 5.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.608 1.163 . . . . 10.0 110.46 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.77 178.44 5.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.323 1.449 . . . . 10.0 110.62 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 m -143.13 0.63 1.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.314 -0.866 . . . . 10.0 112.456 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.6 m -148.07 80.41 8.7 Favored Pre-proline 0 N--CA 1.448 -0.551 0 O-C-N 120.589 -1.319 . . . . 10.0 108.06 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.87 98.39 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.972 3.115 . . . . 10.0 111.12 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -103.64 120.55 41.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.672 0.789 . . . . 10.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.87 140.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 ttm -145.08 149.0 34.29 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.667 0.787 . . . . 10.0 110.135 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -140.63 112.02 7.33 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.577 0.584 . . . . 10.0 112.577 -166.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -146.64 49.55 1.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.431 -1.418 . . . . 10.0 110.807 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -130.35 94.85 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.39 1.476 . . . . 10.0 108.92 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -68.79 85.38 0.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.885 1.674 . . . . 10.0 110.823 -163.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t 163.83 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.789 2.035 . . . . 10.0 107.784 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.11 84.37 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.722 -1.351 . . . . 10.0 109.722 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 -170.41 23.63 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.103 -1.599 . . . . 10.0 109.103 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.7 ttm -106.57 -136.98 0.36 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.611 0.764 . . . . 10.0 109.317 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.53 51.09 1.19 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.743 1.217 . . . . 10.0 108.075 -164.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 90.48 0.14 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.243 -1.543 . . . . 10.0 109.243 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.41 60.14 1.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.865 -1.161 . . . . 10.0 107.865 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -143.43 171.45 14.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.807 2.043 . . . . 10.0 107.921 -170.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 27.6 ttm -81.46 69.21 8.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.051 0.929 . . . . 10.0 110.482 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.04 163.99 14.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.326 1.05 . . . . 10.0 109.676 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -52.2 -36.77 68.38 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.552 2.168 . . . . 10.0 112.673 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 -156.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.75 2.02 . . . . 10.0 110.681 -164.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.16 131.26 47.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.645 -1.613 . . . . 10.0 106.645 162.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 m -95.67 106.05 18.11 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -85.16 109.71 23.11 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -88.21 52.22 2.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.368 1.379 . . . . 10.0 110.655 -167.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.44 163.85 0.14 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.74 0.781 . . . . 10.0 110.993 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.82 20.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.678 1.591 . . . . 10.0 112.718 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.31 69.77 1.09 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 124.935 1.255 . . . . 10.0 110.253 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -84.69 57.7 4.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -94.44 155.46 16.94 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.283 -175.557 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.1 t -126.05 117.16 22.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 -165.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.99 128.32 34.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.76 165.84 35.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.678 0.791 . . . . 10.0 109.4 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.433 HH12 ' CB ' ' A' ' 41' ' ' SER . 2.6 ttp180 -67.4 89.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.488 -0.758 . . . . 10.0 110.606 174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 131.02 -70.21 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 131.342 3.857 . . . . 10.0 108.112 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.02 71.23 0.96 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 125.448 1.499 . . . . 10.0 112.506 -167.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 66.61 138.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.41 1.884 . . . . 10.0 110.367 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -179.38 179.41 0.62 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.181 0.592 . . . . 10.0 110.789 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.3 t -114.84 128.79 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 156.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 77.1 mtp -82.25 94.2 7.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 166.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.84 65.5 7.0 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.193 -1.41 . . . . 10.0 107.193 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 21.0 ptm -84.71 179.57 7.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.274 1.035 . . . . 10.0 110.17 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 47.44 45.61 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.901 -1.28 . . . . 10.0 109.901 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.49 118.93 10.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.204 1.002 . . . . 10.0 109.18 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -61.57 2.43 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 117.443 0.111 . . . . 10.0 111.226 -171.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.1 mtt-85 -166.54 -59.58 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.23 1.412 . . . . 10.0 111.86 -162.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.25 69.6 7.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 120.848 1.339 . . . . 10.0 112.934 -165.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 56.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.261 -0.9 . . . . 10.0 111.875 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 96.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.217 -0.927 . . . . 10.0 109.258 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.63 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.471 1.108 . . . . 10.0 109.512 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.13 -10.05 5.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.324 -0.709 . . . . 10.0 113.003 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -78.82 -177.89 5.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.838 1.304 . . . . 10.0 108.369 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.0 m -150.9 131.55 13.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.758 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.55 141.42 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.378 1.471 . . . . 10.0 107.32 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -68.25 127.82 34.3 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.544 -0.722 . . . . 10.0 109.927 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 126' ' ' ILE . 8.6 tt -82.27 173.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.401 -1.703 . . . . 10.0 106.401 162.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 38.9 m -144.55 115.69 7.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.311 -0.868 . . . . 10.0 109.439 160.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 pp -87.7 173.0 9.28 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.829 0.307 . . . . 10.0 111.829 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -156.99 109.38 2.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.004 0.922 . . . . 10.0 108.972 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.55 126.34 32.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 160.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 t -79.86 62.5 4.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.754 0.788 . . . . 10.0 108.909 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.81 -65.86 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.727 2.411 . . . . 10.0 107.14 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 -79.11 0.45 Allowed Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.609 -0.723 . . . . 10.0 113.778 -167.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 -177.8 5.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.871 -0.782 . . . . 10.0 112.982 -175.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 m -128.74 142.26 51.06 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.48 3.512 . . . . 10.0 103.606 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.25 147.13 22.02 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -121.16 59.45 0.94 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.05 1.74 . . . . 10.0 110.088 -157.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.1 t -78.32 147.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -161.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.36 109.88 16.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.56 43.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.145 0.978 . . . . 10.0 110.527 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.8 m -83.51 126.79 33.15 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.669 0.388 . . . . 10.0 110.256 -177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.4 t -91.31 97.37 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.72 -1.956 . . . . 10.0 105.72 -173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 102.33 2.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.766 -0.584 . . . . 10.0 110.753 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.339 0.135 0 C-N-CA 124.58 1.152 . . . . 10.0 110.266 162.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 122.027 0.918 . . . . 10.0 112.083 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.4 p -153.91 54.2 0.71 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.667 1.587 . . . . 10.0 107.209 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -83.66 63.51 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -137.19 154.21 50.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.831 1.252 . . . . 10.0 110.967 -169.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.91 136.79 13.68 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.913 -2.075 . . . . 10.0 107.913 168.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.59 25.3 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.605 1.203 . . . . 10.0 109.995 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 p -134.56 141.75 46.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.2 134.04 67.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.69 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 36.08 -122.55 0.15 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.933 1.693 . . . . 10.0 111.031 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.48 109.69 58.12 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.963 0.905 . . . . 10.0 108.85 169.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.57 163.45 27.19 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.959 2.439 . . . . 10.0 110.394 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.42 61.0 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.914 2.41 . . . . 10.0 109.421 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -160.49 47.8 0.24 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.379 1.072 . . . . 10.0 108.522 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.9 mm 75.45 167.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.444 1.498 . . . . 10.0 109.17 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -58.2 -26.7 63.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.95 0.722 . . . . 10.0 112.95 -177.451 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.91 140.12 1.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.632 2.373 . . . . 10.0 110.807 172.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -159.98 -178.63 7.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.14 157.85 43.24 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.401 0.68 . . . . 10.0 110.654 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.7 150.3 25.21 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 124.001 0.813 . . . . 10.0 110.097 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -128.45 103.62 7.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.442 -2.059 . . . . 10.0 105.442 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -159.82 -176.67 5.84 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.969 0.508 . . . . 10.0 110.909 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -133.71 122.9 24.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.14 0.976 . . . . 10.0 111.501 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mp -80.52 132.45 35.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.214 -2.513 . . . . 10.0 104.214 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -130.56 104.76 7.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 124.58 1.175 . . . . 10.0 107.982 -160.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.82 130.34 35.03 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 117.804 0.274 . . . . 10.0 111.199 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -140.93 59.29 1.54 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -168.02 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.015 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 65.9 78.46 0.27 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.253 1.421 . . . . 10.0 111.512 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.72 50.25 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.732 1.613 . . . . 10.0 108.533 170.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.52 72.93 6.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.651 2.901 . . . . 10.0 111.768 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.4 115.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -89.11 144.73 25.92 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.477 -0.765 . . . . 10.0 109.372 168.092 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -121.99 126.83 49.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 56.63 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.876 0.845 . . . . 10.0 110.044 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.98 150.77 21.21 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.004 -1.238 . . . . 10.0 110.004 163.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.08 58.84 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.252 1.021 . . . . 10.0 108.805 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.82 139.74 31.7 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.898 -0.501 . . . . 10.0 109.791 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 t -160.76 145.6 10.69 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.94 57.37 4.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.178 2.586 . . . . 10.0 109.878 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 tt -139.74 -63.06 0.51 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.357 1.463 . . . . 10.0 107.849 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.74 146.71 27.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.674 1.19 . . . . 10.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.1 m -82.07 -38.32 25.08 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.725 0.81 . . . . 10.0 109.196 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.61 80.13 39.23 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.012 0.925 . . . . 10.0 110.182 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.74 92.93 1.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.829 2.353 . . . . 10.0 109.993 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.7 mtt -103.62 131.18 51.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.598 1.159 . . . . 10.0 110.115 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.76 144.62 29.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.482 1.113 . . . . 10.0 109.087 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.5 ttm -146.27 157.78 43.83 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.431 0.692 . . . . 10.0 110.775 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 13.0 t -155.1 107.13 2.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.873 0.844 . . . . 10.0 112.531 -162.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 t -146.2 57.98 1.21 Allowed 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.793 -1.192 . . . . 10.0 111.023 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -150.24 93.46 2.0 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.277 1.431 . . . . 10.0 109.829 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -32.09 -46.06 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 128.682 2.793 . . . . 10.0 113.27 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -54.91 -23.59 19.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.267 1.427 . . . . 10.0 114.032 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.85 -50.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.437 -1.065 . . . . 10.0 110.437 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.93 -162.63 32.21 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.271 0.938 . . . . 10.0 111.621 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 ttt -81.72 -159.79 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.415 0.686 . . . . 10.0 109.3 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.579 1.152 . . . . 10.0 108.078 -167.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.28 108.86 0.36 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.015 -1.634 . . . . 10.0 109.015 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.88 65.6 1.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 10.0 109.86 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -125.63 165.1 19.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.343 2.257 . . . . 10.0 109.718 -170.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 35.2 ttm -81.47 72.82 8.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.879 0.847 . . . . 10.0 109.93 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 76' ' ' THR . 16.3 m -63.03 159.33 47.86 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.938 0.895 . . . . 10.0 111.195 173.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 95.3 Cg_endo -61.85 -30.86 84.8 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.907 2.404 . . . . 10.0 112.507 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 90' ' ' PRO . 44.4 p90 177.88 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.797 2.439 . . . . 10.0 105.344 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -128.14 115.72 18.84 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.58 0.705 . . . . 10.0 110.959 168.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 m -78.27 126.5 30.88 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.7 pt -100.77 103.07 22.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.182 0.901 . . . . 10.0 109.043 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.86 70.19 6.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.227 1.951 . . . . 10.0 111.347 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 60.43 168.96 0.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.611 -0.68 . . . . 10.0 109.796 -163.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 41.59 31.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.768 1.766 . . . . 10.0 115.768 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.05 72.26 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 124.41 1.005 . . . . 10.0 113.209 167.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -107.26 57.23 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.518 -1.66 . . . . 10.0 106.518 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -93.73 151.9 19.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.546 1.138 . . . . 10.0 108.1 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.6 m -119.19 117.13 27.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.885 -1.894 . . . . 10.0 105.885 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.31 102.17 10.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.217 -2.142 . . . . 10.0 105.217 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.02 156.77 48.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.463 1.505 . . . . 10.0 110.428 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -48.96 -42.99 39.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.287 1.035 . . . . 10.0 112.303 -166.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -114.31 29.84 7.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.771 0.828 . . . . 10.0 111.897 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.18 69.13 0.19 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 121.346 -0.847 . . . . 10.0 111.387 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 10.2 t70 64.96 138.99 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 126.381 1.872 . . . . 10.0 110.524 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -178.09 179.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 10.0 111.149 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -110.86 122.0 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 162.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 67.2 mtp -83.86 100.24 10.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 165.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.19 73.24 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.5 154.64 20.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.966 0.906 . . . . 10.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.27 66.34 2.24 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.93 141.68 44.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.344 0.658 . . . . 10.0 112.106 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -86.44 -48.65 8.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 10.0 112.549 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -144.48 158.94 53.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.624 0.77 . . . . 10.0 110.559 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -67.65 160.51 47.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.559 2.84 . . . . 10.0 111.911 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.42 159.61 41.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.769 1.628 . . . . 10.0 108.179 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -113.16 144.43 42.68 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.615 0.643 . . . . 10.0 109.503 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.88 104.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 165.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.68 -13.73 6.46 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.166 -0.797 . . . . 10.0 111.61 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -178.25 3.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.787 1.755 . . . . 10.0 109.119 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.0 m -155.56 131.36 9.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.031 -1.895 . . . . 10.0 107.708 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.66 149.57 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -84.71 130.99 34.62 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -103.99 130.24 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.077 0.951 . . . . 10.0 109.147 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 m -103.1 107.46 18.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 166.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.29 154.3 26.62 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 160.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -150.23 90.15 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.27 143.31 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -50.54 -36.32 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.44 1.096 . . . . 10.0 110.876 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -70.11 44.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 10.0 112.649 173.366 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.04 48.54 38.61 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.219 1.866 . . . . 10.0 113.206 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -110.57 146.75 35.54 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 171.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.0 m -156.41 101.32 2.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.742 2.017 . . . . 10.0 105.659 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -112.05 -178.46 3.43 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.843 0.747 . . . . 10.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -149.93 64.03 0.98 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.744 2.017 . . . . 10.0 108.614 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.73 156.74 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.12 130.77 35.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.81 112.55 23.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.698 1.199 . . . . 10.0 109.222 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 m -83.86 125.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.7 112.84 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -158.09 125.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.686 -0.673 . . . . 10.0 109.693 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 126.289 1.836 . . . . 10.0 110.025 176.109 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 122.365 1.079 . . . . 10.0 109.301 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.8 p -156.75 82.72 0.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.214 -0.903 . . . . 10.0 108.694 -165.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 55.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 123.113 1.435 . . . . 10.0 107.377 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -83.89 129.94 34.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.721 -1.582 . . . . 10.0 107.05 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.66 -39.06 78.14 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.708 -0.557 . . . . 10.0 111.708 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 68.73 116.84 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.736 2.414 . . . . 10.0 113.33 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p -116.28 91.92 3.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.577 1.951 . . . . 10.0 108.789 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.445 -0.946 . . . . 10.0 108.445 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.92 42.92 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.67 -133.94 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.347 1.459 . . . . 10.0 110.208 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.4 t -104.05 110.75 64.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 160.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.89 172.04 10.24 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.115 2.543 . . . . 10.0 108.93 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.02 59.6 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 10.0 109.882 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -157.8 50.88 0.43 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 10.0 109.844 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.7 mm 66.36 174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.869 0.868 . . . . 10.0 110.291 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.582 ' H ' HG22 ' A' ' 42' ' ' ILE . 8.1 tpp180 -69.07 22.85 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.245 1.418 . . . . 10.0 114.379 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.486 ' CG ' HH21 ' A' ' 104' ' ' ARG . 0.0 OUTLIER -94.45 157.62 15.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.807 1.185 . . . . 10.0 108.161 168.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -172.5 179.73 2.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.39 -1.707 . . . . 10.0 106.39 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.91 173.29 16.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.385 0.274 . . . . 10.0 111.004 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.14 149.22 26.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 125.202 1.564 . . . . 10.0 109.056 165.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.28 71.1 1.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.549 1.14 . . . . 10.0 108.237 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -174.06 4.76 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.79 1.236 . . . . 10.0 109.417 -159.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -123.94 141.26 52.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.041 1.292 . . . . 10.0 109.598 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 150.18 25.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.314 -1.736 . . . . 10.0 106.314 161.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -140.42 118.11 11.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.219 0.949 . . . . 10.0 110.879 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.27 132.91 37.7 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.77 58.6 1.72 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.745 -1.205 . . . . 10.0 107.745 166.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -163.9 -46.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.267 1.027 . . . . 10.0 109.594 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . 0.318 95.4 m-20 67.01 54.91 0.73 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.474 1.91 . . . . 10.0 110.583 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -131.23 150.87 77.73 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.425 1.89 . . . . 10.0 107.803 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.16 86.27 1.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.542 2.828 . . . . 10.0 111.275 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.15 119.61 59.49 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -83.87 150.66 25.58 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.681 0.392 . . . . 10.0 110.431 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.472 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.21 143.42 50.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.847 -0.797 . . . . 10.0 108.847 173.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 p -151.62 56.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.08 145.67 11.57 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.299 -1.12 . . . . 10.0 110.299 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.09 69.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.49 107.41 15.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.325 -1.361 . . . . 10.0 107.325 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -125.22 146.39 53.84 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.652 0.781 . . . . 10.0 110.494 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.1 -12.27 19.43 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.85 2.367 . . . . 10.0 110.985 166.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 tp -80.97 -57.26 3.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.328 0.967 . . . . 10.0 111.507 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.96 139.68 38.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.07 0.948 . . . . 10.0 112.297 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 m -75.86 -42.03 50.65 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.384 -0.823 . . . . 10.0 110.144 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.96 81.94 50.41 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.947 0.899 . . . . 10.0 109.391 -167.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.01 86.34 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.66 2.907 . . . . 10.0 110.527 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.58 127.58 34.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.08 141.63 31.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.5 ttm -148.96 157.85 43.73 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.665 0.786 . . . . 10.0 110.063 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 89' ' ' VAL . 6.7 t -155.11 102.38 2.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.561 0.696 . . . . 10.0 112.546 -157.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 86' ' ' MET . 8.8 t -150.58 53.98 0.89 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.812 -1.18 . . . . 10.0 113.13 168.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -116.22 100.57 8.01 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.918 1.287 . . . . 10.0 109.054 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -46.65 -44.86 18.77 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 126.167 1.787 . . . . 10.0 111.871 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 t -82.96 23.25 0.85 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.05 -67.16 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.535 1.061 . . . . 10.0 111.111 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.87 96.76 0.44 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.391 1.472 . . . . 10.0 111.765 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.88 -159.4 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.258 1.823 . . . . 10.0 114.014 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.21 39.0 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.882 0.873 . . . . 10.0 109.54 -166.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.63 105.95 0.27 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.445 ' HB2' HG21 ' A' ' 77' ' ' THR . 1.2 tmm? -77.47 55.42 1.27 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.306 1.042 . . . . 10.0 110.844 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.96 165.44 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.831 2.052 . . . . 10.0 109.379 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.6 ttm -81.89 69.78 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.312 1.053 . . . . 10.0 110.334 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 76' ' ' THR . 16.5 m -60.07 165.02 5.32 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.469 1.907 . . . . 10.0 111.741 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.48 -38.63 54.31 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.333 2.689 . . . . 10.0 113.579 164.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -165.8 0.04 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.987 1.315 . . . . 10.0 112.512 -161.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.2 116.18 25.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.068 1.347 . . . . 10.0 108.012 159.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.3 m -83.34 136.87 34.2 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.1 140.44 38.09 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.26 -178.19 4.44 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.354 2.036 . . . . 10.0 111.456 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.17 139.56 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 151.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 58.67 17.32 4.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.822 1.045 . . . . 10.0 113.822 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.94 97.45 0.25 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.064 -1.614 . . . . 10.0 109.064 166.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -138.72 79.35 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.876 -2.268 . . . . 10.0 104.876 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 pp -103.37 -177.0 3.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.56 -0.745 . . . . 10.0 110.494 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 99.58 6.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.817 1.647 . . . . 10.0 106.792 -165.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.88 93.7 5.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -118.97 140.09 50.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.804 2.042 . . . . 10.0 108.259 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 44' ' ' ASP . 4.5 tmt_? -55.33 -21.3 14.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 -167.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -90.25 -71.62 0.61 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.487 1.515 . . . . 10.0 109.749 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.45 80.9 1.6 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.596 1.57 . . . . 10.0 111.524 -166.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 64.46 133.67 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.74 0 C-N-CA 126.0 1.72 . . . . 10.0 110.37 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -178.17 178.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.752 -1.218 . . . . 10.0 111.629 -169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.48 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 162.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.8 mtp -81.76 98.27 8.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.376 -1.712 . . . . 10.0 106.376 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.11 67.55 9.2 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.927 1.291 . . . . 10.0 108.34 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.1 mtp -84.38 157.09 21.55 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.921 0.867 . . . . 10.0 111.601 -166.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.02 60.7 3.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.554 -1.018 . . . . 10.0 110.554 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.23 129.95 44.23 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.612 0.706 . . . . 10.0 111.9 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -105.2 -59.61 1.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.472 1.509 . . . . 10.0 110.83 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -59.58 142.47 87.44 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.5 132.8 32.3 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.107 1.871 . . . . 10.0 109.526 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.435 ' CD1' ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.83 161.16 29.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.108 0.563 . . . . 10.0 111.52 175.105 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 120.19 3.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.473 -2.047 . . . . 10.0 105.473 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.37 116.54 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.3 62.72 1.7 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.206 -1.957 . . . . 10.0 108.206 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -133.35 -172.99 3.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 159.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.9 m -152.54 123.25 7.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.388 -1.278 . . . . 10.0 107.894 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.59 126.67 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.423 1.089 . . . . 10.0 108.528 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -70.82 128.18 35.15 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 pt -114.43 148.04 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.245 1.418 . . . . 10.0 107.877 168.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -110.24 133.49 53.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.001 0.92 . . . . 10.0 109.114 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 129' ' ' LYS . 1.1 tt -83.65 155.58 23.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.024 -1.473 . . . . 10.0 107.024 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' H ' HD23 ' A' ' 128' ' ' LEU . 82.5 tttt -155.43 86.09 1.07 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.643 -1.243 . . . . 10.0 107.643 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.63 25.96 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.028 -0.42 . . . . 10.0 110.059 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.8 t -54.26 -31.57 53.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.802 1.241 . . . . 10.0 112.108 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.78 -32.8 14.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.664 1.186 . . . . 10.0 112.896 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 104.19 8.66 38.23 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.082 1.325 . . . . 10.0 110.046 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 95.3 8.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.1 t -83.87 147.93 27.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.098 -0.955 . . . . 10.0 108.498 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tp -157.03 174.91 14.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -134.78 139.22 44.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.62 140.0 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.51 98.63 10.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.685 -0.858 . . . . 10.0 108.685 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.98 123.36 29.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.957 0.903 . . . . 10.0 110.36 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -83.75 137.51 33.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.41 112.27 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -148.57 107.48 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.084 0.954 . . . . 10.0 109.58 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? . . . . . 0 N--CA 1.461 0.121 0 C-N-CA 123.744 0.817 . . . . 10.0 113.012 -177.279 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 122.178 0.989 . . . . 10.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -153.11 59.47 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -162.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.53 55.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -100.38 138.27 37.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.238 1.015 . . . . 10.0 108.482 165.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.55 -136.06 4.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.798 -2.121 . . . . 10.0 107.798 163.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.91 143.68 14.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.998 0.899 . . . . 10.0 109.802 162.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.2 p -133.59 153.58 51.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.142 -1.799 . . . . 10.0 106.142 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -128.08 138.93 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 125.128 1.371 . . . . 10.0 107.372 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.07 37.76 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.128 0.788 . . . . 10.0 113.128 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 31.86 -124.99 0.05 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.337 1.855 . . . . 10.0 110.456 -161.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.61 112.13 58.84 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 105.927 -1.879 . . . . 10.0 105.927 162.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 160.48 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.977 1.785 . . . . 10.0 108.68 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.17 61.73 5.85 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.523 2.148 . . . . 10.0 110.615 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -163.42 62.22 0.17 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.427 1.091 . . . . 10.0 108.264 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt 77.07 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.52 1.528 . . . . 10.0 110.339 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 39.03 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.196 0.998 . . . . 10.0 113.509 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 158.43 16.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.305 -1.368 . . . . 10.0 107.305 161.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 t -156.62 -169.15 2.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.89 -1.522 . . . . 10.0 106.89 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.96 160.46 42.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.999 -1.111 . . . . 10.0 107.999 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.43 161.8 22.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 165.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -134.73 102.47 5.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.762 -1.57 . . . . 10.0 106.762 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -170.0 2.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.747 2.019 . . . . 10.0 109.503 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m -147.85 124.77 11.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.371 -1.456 . . . . 10.0 109.049 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.16 129.56 34.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 171.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -121.65 95.53 4.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.022 0.826 . . . . 10.0 110.302 -158.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.26 58.62 1.65 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.015 1.388 . . . . 10.0 112.454 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 174.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -179.98 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.95 1.093 . . . . 10.0 113.95 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.13 84.76 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.456 1.503 . . . . 10.0 112.164 -167.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -147.59 144.32 19.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.011 0.925 . . . . 10.0 109.729 165.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -88.14 100.62 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.813 3.009 . . . . 10.0 111.485 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.59 103.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.815 0.846 . . . . 10.0 109.299 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 96.78 8.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.029 -1.044 . . . . 10.0 110.019 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.02 124.44 29.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.386 0.674 . . . . 10.0 109.906 -175.158 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.69 54.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 122.265 1.031 . . . . 10.0 109.535 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.23 145.33 11.06 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.79 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.895 1.678 . . . . 10.0 107.296 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.18 149.08 29.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -169.65 151.87 4.46 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 -164.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.72 -3.55 13.36 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.736 2.291 . . . . 10.0 111.964 167.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -101.79 -40.51 6.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.512 1.125 . . . . 10.0 113.437 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.31 126.23 46.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.443 1.097 . . . . 10.0 110.046 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 m -72.81 -30.66 64.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.327 0.651 . . . . 10.0 109.783 172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 m -131.13 67.75 81.01 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 124.983 1.313 . . . . 10.0 110.105 -171.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.39 114.12 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.752 2.301 . . . . 10.0 110.527 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -141.07 141.66 34.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.886 0.474 . . . . 10.0 110.815 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.95 149.81 26.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.727 1.211 . . . . 10.0 109.781 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.69 169.32 21.89 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.474 1.51 . . . . 10.0 109.88 -171.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 t -143.8 158.77 43.45 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 121.203 -0.199 . . . . 10.0 110.884 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.42 59.55 0.63 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.435 -0.791 . . . . 10.0 109.201 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -155.56 130.91 9.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -71.34 -39.69 71.18 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -44.61 96.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.602 1.161 . . . . 10.0 111.488 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.96 -129.01 3.35 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.051 -0.82 . . . . 10.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -69.57 1.25 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.528 0.585 . . . . 10.0 113.339 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -170.01 163.83 9.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.282 1.033 . . . . 10.0 109.592 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.68 54.41 2.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.08 67.05 0.56 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.483 -0.647 . . . . 10.0 111.483 -156.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.07 64.27 5.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.067 0.937 . . . . 10.0 110.069 -171.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -136.4 168.67 19.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.008 2.123 . . . . 10.0 109.394 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 61.4 mtp -81.35 73.76 8.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.57 0.7 . . . . 10.0 109.355 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.49 159.8 83.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.513 -0.767 . . . . 10.0 110.731 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -42.92 -52.2 4.86 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.634 2.889 . . . . 10.0 112.099 163.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.48 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 173.4 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 127.195 2.198 . . . . 10.0 108.52 -175.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.0 mm? -128.5 138.92 52.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 161.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -84.99 98.56 10.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.261 -1.755 . . . . 10.0 106.261 160.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.51 121.97 80.38 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.104 -1.813 . . . . 10.0 106.104 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.15 -173.98 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.621 2.214 . . . . 10.0 111.774 -166.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.88 149.3 1.87 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 154.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.5 6.96 0.12 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.112 1.365 . . . . 10.0 114.156 -166.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.29 84.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -109.7 61.18 0.6 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.337 1.455 . . . . 10.0 107.782 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mp -86.07 154.07 21.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.683 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.0 p -114.47 110.85 20.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.45 -2.056 . . . . 10.0 105.45 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.78 109.51 16.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.291 -2.114 . . . . 10.0 105.291 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.45 170.12 22.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.212 0.915 . . . . 10.0 111.12 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.55 -45.81 0.37 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.567 1.147 . . . . 10.0 112.622 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.91 98.47 3.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.729 1.612 . . . . 10.0 106.776 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.83 116.46 1.12 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.803 1.668 . . . . 10.0 110.296 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 23.86 65.64 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.078 2.951 . . . . 10.0 114.184 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -119.14 164.8 15.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -164.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.0 121.01 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 47.9 mtp -83.19 99.47 9.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.49 -1.3 . . . . 10.0 107.49 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.17 58.74 3.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 171.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 40.8 ttp -84.57 161.8 20.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.566 1.146 . . . . 10.0 110.784 -168.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.13 -4.32 30.11 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.059 -1.411 . . . . 10.0 114.809 155.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 tp 47.41 89.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.253 1.821 . . . . 10.0 113.054 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -96.05 -40.47 9.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.443 1.097 . . . . 10.0 110.534 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.75 152.66 68.78 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 105.765 -1.939 . . . . 10.0 105.765 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -57.8 120.71 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.825 2.35 . . . . 10.0 111.725 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.16 73.65 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -74.39 104.9 5.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.859 1.264 . . . . 10.0 109.765 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 p -42.0 116.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.551 1.141 . . . . 10.0 111.425 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 116.46 -27.82 7.82 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.999 -0.89 . . . . 10.0 111.196 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -173.82 3.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.67 1.7 . . . . 10.0 110.082 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.7 m -150.35 130.26 13.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.371 -1.74 . . . . 10.0 107.749 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.03 134.11 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.383 1.073 . . . . 10.0 108.537 -170.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.76 110.87 8.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 pt -85.27 -179.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 160.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.0 m -147.08 121.53 9.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.403 -0.811 . . . . 10.0 109.147 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.3 177.52 7.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.654 0.381 . . . . 10.0 111.441 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -156.95 99.48 1.83 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.596 1.558 . . . . 10.0 107.96 171.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.82 33.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.949 -0.469 . . . . 10.0 109.89 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.2 t -82.94 61.36 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -169.54 -60.1 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 129.08 2.952 . . . . 10.0 105.482 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.42 -92.27 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.687 -1.142 . . . . 10.0 111.61 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -160.55 173.22 15.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.813 -0.816 . . . . 10.0 109.739 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 t -94.49 144.73 25.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.145 -1.798 . . . . 10.0 106.145 153.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.3 tp -156.45 143.76 19.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -87.97 132.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.955 1.702 . . . . 10.0 106.918 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.39 125.66 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.586 -1.265 . . . . 10.0 107.586 -164.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 111.37 18.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.029 -0.73 . . . . 10.0 109.029 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.08 119.17 38.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.079 0.952 . . . . 10.0 110.496 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -83.62 126.89 33.31 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.865 0.466 . . . . 10.0 110.387 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.25 110.29 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.628 -1.249 . . . . 10.0 107.628 -165.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -158.11 150.24 21.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.095 0.861 . . . . 10.0 110.86 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.344 0 CA-C-N 119.113 0.87 . . . . 10.0 112.573 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.029 0.442 . . . . 10.0 110.833 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 p -156.48 53.34 0.54 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.315 0.646 . . . . 10.0 110.181 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.74 80.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 165.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -123.91 133.08 53.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 128.252 2.621 . . . . 10.0 108.407 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.06 97.09 1.29 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.27 -1.532 . . . . 10.0 109.27 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.12 9.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.705 0.753 . . . . 10.0 111.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.3 p -115.96 149.61 38.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.737 -1.208 . . . . 10.0 107.737 163.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.96 142.16 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.46 16.97 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.832 0.825 . . . . 10.0 111.044 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.792 1.637 . . . . 10.0 110.811 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 t 45.45 74.66 0.76 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.741 1.616 . . . . 10.0 111.144 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.26 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.296 2.664 . . . . 10.0 110.044 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.16 77.68 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.801 3.001 . . . . 10.0 112.473 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 t -157.11 -49.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.374 3.07 . . . . 10.0 106.008 165.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 67.56 162.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 C-N-CA 125.615 1.566 . . . . 10.0 107.438 -161.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 72.79 -50.18 0.7 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.428 1.491 . . . . 10.0 111.89 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.23 155.64 16.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.008 1.723 . . . . 10.0 109.69 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -164.41 -176.73 4.52 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 10.0 108.045 162.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 153.91 34.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.487 1.115 . . . . 10.0 110.73 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.59 150.03 22.58 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.073 0.858 . . . . 10.0 110.442 170.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -125.0 123.75 40.53 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -160.66 -172.41 3.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.228 1.411 . . . . 10.0 107.701 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 m -144.86 122.59 11.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.444 -0.785 . . . . 10.0 109.598 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.42 102.77 10.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.332 -1.729 . . . . 10.0 106.332 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 m -92.56 94.16 8.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.651 -1.613 . . . . 10.0 106.653 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.86 56.03 3.27 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.79 -0.569 . . . . 10.0 110.434 -167.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -91.76 111.09 22.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.34 0.59 . . . . 10.0 109.5 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 133.27 -19.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 131.564 3.946 . . . . 10.0 106.942 -165.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.78 61.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.638 -1.245 . . . . 10.0 107.638 150.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -145.04 137.45 13.4 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.319 1.848 . . . . 10.0 110.633 -170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.69 92.83 0.94 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 10.0 112.212 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.77 112.11 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.957 0.903 . . . . 10.0 108.924 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 168.64 17.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.675 0.79 . . . . 10.0 110.48 174.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -132.93 127.78 35.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.41 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.522 0.677 . . . . 10.0 109.755 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.4 147.25 13.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.191 -1.164 . . . . 10.0 110.191 163.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.22 66.95 0.51 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.019 1.327 . . . . 10.0 109.665 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.48 145.04 28.34 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.706 -0.849 . . . . 10.0 108.706 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 t -170.35 151.58 3.8 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 118.943 0.792 . . . . 10.0 110.47 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.86 45.79 0.96 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.992 2.461 . . . . 10.0 111.323 166.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.16 -77.28 0.47 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.929 1.291 . . . . 10.0 108.609 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.92 143.53 55.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.032 0.533 . . . . 10.0 110.948 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 m -96.72 -29.22 13.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.609 0.763 . . . . 10.0 109.64 165.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.0 t -126.03 67.41 61.86 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.074 1.75 . . . . 10.0 109.092 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.73 106.1 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.679 2.253 . . . . 10.0 109.777 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 128.56 53.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.222 1.009 . . . . 10.0 109.478 -174.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.73 136.8 35.44 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.229 -1.026 . . . . 10.0 108.229 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 ttp -136.07 152.44 50.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.055 1.342 . . . . 10.0 108.812 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -148.19 110.24 4.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.413 0.685 . . . . 10.0 110.058 -166.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -141.41 55.95 1.53 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.447 -0.783 . . . . 10.0 111.828 175.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -137.2 110.57 7.92 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.039 1.336 . . . . 10.0 109.093 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -52.27 -42.65 63.87 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.461 1.104 . . . . 10.0 111.195 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.3 p -82.45 16.53 2.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.901 1.28 . . . . 10.0 112.334 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.95 -142.99 5.2 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.396 1.474 . . . . 10.0 110.1 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.01 -68.63 1.58 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 117.169 0.484 . . . . 10.0 112.266 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -144.67 169.9 17.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.568 1.547 . . . . 10.0 108.24 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -117.71 54.5 0.9 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.93 75.01 0.22 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 118.742 -1.032 . . . . 10.0 111.591 -166.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 ttp -49.36 98.36 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 122.324 1.059 . . . . 10.0 111.717 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -155.76 166.53 33.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.274 2.229 . . . . 10.0 105.955 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.8 mtm -80.82 132.62 35.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.031 -1.47 . . . . 10.0 107.031 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -134.64 168.22 18.91 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.733 . . . . 10.0 110.668 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -37.74 -56.4 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.63 2.887 . . . . 10.0 111.464 159.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 178.47 -159.27 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.47 1.508 . . . . 10.0 110.258 -175.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -124.54 142.78 51.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 126.386 1.874 . . . . 10.0 106.362 161.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m -110.47 134.87 51.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.005 -1.85 . . . . 10.0 106.005 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 pp -121.83 138.94 29.31 Favored Pre-proline 0 N--CA 1.452 -0.35 0 N-CA-C 106.679 -1.601 . . . . 10.0 106.679 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.87 176.48 8.94 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.862 1.708 . . . . 10.0 110.699 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.6 129.74 8.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.88 -1.054 . . . . 10.0 109.63 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 59.15 26.27 14.97 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 129.674 3.19 . . . . 10.0 113.342 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.69 144.71 45.96 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.965 -0.854 . . . . 10.0 110.965 167.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -129.21 65.42 1.46 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.572 -2.01 . . . . 10.0 105.572 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.25 129.25 34.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.943 -2.243 . . . . 10.0 104.943 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.8 m -123.45 93.45 3.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.013 -2.217 . . . . 10.0 105.013 -158.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.82 122.45 26.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 -162.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -151.86 154.33 35.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.956 1.303 . . . . 10.0 108.47 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -8.53 6.91 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.507 1.299 . . . . 10.0 114.507 -164.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 37.67 1.48 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.812 0.733 . . . . 10.0 110.979 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.45 64.97 0.22 Allowed Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.37 -1.092 . . . . 10.0 110.37 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 t0 70.01 133.78 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.199 1.799 . . . . 10.0 109.748 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -177.19 169.82 2.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.574 -0.704 . . . . 10.0 110.728 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.95 115.64 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.527 -2.027 . . . . 10.0 105.527 169.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 81.5 mtp -83.84 95.92 8.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.88 65.39 6.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 10.0 107.891 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 75.8 mtp -82.6 162.53 21.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.847 0.832 . . . . 10.0 110.782 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.99 69.66 1.38 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.429 -1.068 . . . . 10.0 110.429 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.33 82.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.672 0.789 . . . . 10.0 109.611 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -55.92 -47.25 77.85 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.892 -0.505 . . . . 10.0 112.084 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -114.05 155.5 45.34 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.937 -1.135 . . . . 10.0 107.937 157.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.56 173.83 12.65 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.447 2.765 . . . . 10.0 110.034 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.38 175.37 8.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.144 1.378 . . . . 10.0 110.113 -174.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.31 150.3 49.65 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.36 1.464 . . . . 10.0 107.953 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.8 t -69.79 134.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.46 42.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.074 -0.81 . . . . 10.0 111.074 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.64 -169.37 1.7 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.84 1.305 . . . . 10.0 108.813 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 m -154.74 82.78 1.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.027 -1.472 . . . . 10.0 107.027 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -89.83 126.49 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.883 -1.154 . . . . 10.0 107.883 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.31 150.88 45.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.102 -0.639 . . . . 10.0 110.372 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.98 148.61 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.379 -1.712 . . . . 10.0 106.379 170.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -123.15 117.59 25.72 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.79 157.04 18.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.481 -0.563 . . . . 10.0 109.481 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -157.38 86.23 0.94 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.578 1.551 . . . . 10.0 107.895 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.74 157.61 23.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.096 -0.377 . . . . 10.0 110.046 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 t -54.36 -32.77 57.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.523 1.129 . . . . 10.0 112.504 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -5.74 4.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.918 0.887 . . . . 10.0 113.063 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.21 9.67 65.07 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.404 1.002 . . . . 10.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -79.34 95.1 5.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 105.916 -1.883 . . . . 10.0 105.916 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -116.37 123.97 48.91 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.076 1.751 . . . . 10.0 107.141 -171.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.4 tp -155.55 141.59 18.28 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -102.52 132.98 48.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.477 1.911 . . . . 10.0 106.742 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.87 162.14 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.05 131.86 54.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.868 1.267 . . . . 10.0 107.604 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.77 133.81 55.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.643 1.177 . . . . 10.0 109.892 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -83.89 128.33 34.47 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.87 108.1 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.324 -1.362 . . . . 10.0 107.324 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -157.58 125.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.582 -0.895 . . . . 10.0 108.582 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 pttt . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.37 0.605 . . . . 10.0 111.357 176.298 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.785 0.803 . . . . 10.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -157.85 55.17 0.48 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 -165.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.57 58.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.11 0.957 . . . . 10.0 108.981 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 -179.91 4.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.112 1.365 . . . . 10.0 110.396 171.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.0 -136.92 3.51 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.056 -2.418 . . . . 10.0 107.056 166.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.98 132.4 6.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.981 1.39 . . . . 10.0 110.683 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.7 p -126.76 135.2 50.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.288 -1.745 . . . . 10.0 106.288 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.7 t -121.71 135.29 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 119.158 0.89 . . . . 10.0 109.061 -171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.83 44.62 0.56 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.631 0.974 . . . . 10.0 113.631 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 26.77 -119.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.643 1.977 . . . . 10.0 111.546 -164.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.69 113.94 50.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.093 -1.817 . . . . 10.0 106.093 161.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.97 163.99 20.65 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.17 1.913 . . . . 10.0 108.774 168.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.92 62.41 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.449 2.1 . . . . 10.0 110.523 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.5 p -163.4 62.31 0.17 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.209 1.004 . . . . 10.0 108.628 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 mt 75.15 160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.932 1.293 . . . . 10.0 110.222 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -66.76 25.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.741 1.386 . . . . 10.0 114.741 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.95 158.44 15.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 168.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -165.39 -175.54 3.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.728 -1.953 . . . . 10.0 105.728 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.56 168.98 24.93 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.319 -0.622 . . . . 10.0 109.319 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.47 161.09 22.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -131.4 104.7 7.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.632 -1.988 . . . . 10.0 105.632 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -171.16 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.139 1.775 . . . . 10.0 110.443 -169.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -152.29 129.57 11.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.718 -1.238 . . . . 10.0 108.029 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.11 135.44 33.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 m -123.96 104.27 8.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 124.168 0.918 . . . . 10.0 110.581 -167.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.18 113.18 15.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.706 -0.479 . . . . 10.0 109.706 167.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -135.36 68.44 1.46 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.668 -1.604 . . . . 10.0 106.668 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -178.5 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.388 1.475 . . . . 10.0 111.473 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 72.72 78.13 0.15 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.551 1.94 . . . . 10.0 112.17 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 147.0 38.97 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.331 0.652 . . . . 10.0 109.817 168.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.513 ' C ' HD12 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -86.29 112.23 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.759 2.973 . . . . 10.0 111.001 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 58' ' ' PRO . 1.7 mp -123.92 99.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.71 103.94 12.59 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.109 -0.994 . . . . 10.0 111.139 -173.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -82.68 124.95 30.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.697 0.799 . . . . 10.0 110.201 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.66 54.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.117 0.961 . . . . 10.0 109.626 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.65 144.49 10.0 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -1.323 . . . . 10.0 109.792 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.45 66.73 0.56 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.972 1.709 . . . . 10.0 107.205 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 148.71 28.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 t -170.3 151.78 3.9 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 109.879 -0.415 . . . . 10.0 109.879 -164.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.28 -1.41 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.802 2.335 . . . . 10.0 112.021 167.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -104.82 -35.91 7.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.471 1.108 . . . . 10.0 113.415 -163.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.43 124.29 48.97 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.558 1.143 . . . . 10.0 109.844 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -29.79 65.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.795 0.838 . . . . 10.0 110.108 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.7 m -135.36 68.43 68.14 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.024 1.33 . . . . 10.0 109.959 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.1 115.76 4.22 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.616 2.21 . . . . 10.0 110.365 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -139.34 140.4 37.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.821 0.448 . . . . 10.0 111.203 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mt -83.57 145.83 28.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 10.0 109.8 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.65 169.37 18.12 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 125.596 1.558 . . . . 10.0 109.817 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 t -145.71 157.44 43.95 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.318 -0.238 . . . . 10.0 110.677 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.54 61.14 0.61 Allowed 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.342 -0.849 . . . . 10.0 109.25 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -155.15 138.63 15.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -80.55 -39.21 28.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.38 -44.99 95.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.798 1.239 . . . . 10.0 111.514 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.94 -126.7 3.49 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.065 -0.814 . . . . 10.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.4 -75.3 0.33 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.828 0.727 . . . . 10.0 113.923 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -163.73 160.98 23.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.774 0.83 . . . . 10.0 109.972 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.97 53.81 2.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.621 -1.251 . . . . 10.0 107.621 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.67 71.2 0.5 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.324 -0.709 . . . . 10.0 111.962 -156.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.51 64.32 4.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.182 0.991 . . . . 10.0 110.24 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -136.11 170.26 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.971 2.108 . . . . 10.0 109.275 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.86 72.79 7.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.52 0.728 . . . . 10.0 109.155 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.1 158.8 86.52 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.341 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -44.49 -53.41 4.96 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.373 2.715 . . . . 10.0 111.995 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.52 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 174.3 -157.62 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.021 2.129 . . . . 10.0 108.931 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.52 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.1 mm? -128.76 139.9 51.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.646 -1.613 . . . . 10.0 106.646 165.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.1 m -88.4 100.13 12.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.444 -1.687 . . . . 10.0 106.444 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.31 123.11 79.49 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 106.095 -1.817 . . . . 10.0 106.095 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.17 -172.24 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.566 2.177 . . . . 10.0 111.771 -168.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.83 149.23 3.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 155.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.21 7.61 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.809 1.411 . . . . 10.0 114.809 -165.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 90.74 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.885 -1.286 . . . . 10.0 109.885 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -115.93 64.78 0.7 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.134 1.774 . . . . 10.0 107.326 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -88.73 154.68 20.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.648 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -118.5 109.76 16.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 -167.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -83.62 102.99 12.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -152.07 170.62 19.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.816 0.735 . . . . 10.0 111.295 -170.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -36.55 -47.38 0.63 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.772 1.229 . . . . 10.0 111.712 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -129.93 95.05 3.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.776 1.63 . . . . 10.0 107.75 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.7 117.68 1.1 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.7 -1.056 . . . . 10.0 111.264 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.2 t0 24.86 64.79 0.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.565 2.746 . . . . 10.0 113.533 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -116.59 159.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.269 0.557 . . . . 10.0 112.419 -165.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.77 114.53 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.769 -1.937 . . . . 10.0 105.769 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 mtp -81.98 96.92 7.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.802 -1.184 . . . . 10.0 107.802 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.0 mt -81.0 59.41 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 46.5 ttp -82.99 158.4 22.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.387 0.675 . . . . 10.0 110.474 -169.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.16 -7.93 9.15 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.097 -1.39 . . . . 10.0 115.207 156.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.7 tp 46.63 68.54 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.243 1.417 . . . . 10.0 111.777 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -77.92 -37.71 47.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.432 0.693 . . . . 10.0 110.695 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.73 153.02 67.4 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 105.747 -1.946 . . . . 10.0 105.747 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.21 109.97 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.885 2.39 . . . . 10.0 111.415 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.04 99.81 1.14 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -97.8 115.78 28.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.228 1.411 . . . . 10.0 108.673 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -46.97 120.0 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.238 0.615 . . . . 10.0 110.067 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.88 -23.71 18.64 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.704 -1.053 . . . . 10.0 111.766 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -175.02 3.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.723 1.725 . . . . 10.0 109.55 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -153.9 131.74 11.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.284 -1.78 . . . . 10.0 107.493 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.7 136.84 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.404 1.082 . . . . 10.0 108.676 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.9 114.15 15.36 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.2 pt -92.88 176.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.747 0.819 . . . . 10.0 109.068 164.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.2 m -147.75 125.41 11.81 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.596 -0.69 . . . . 10.0 109.609 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 pp -91.77 179.18 5.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.22 0.608 . . . . 10.0 111.92 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -157.74 103.46 1.9 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.826 1.65 . . . . 10.0 108.068 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.18 123.35 33.93 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.006 -0.434 . . . . 10.0 110.488 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -83.0 64.0 7.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -174.86 -61.2 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.916 2.887 . . . . 10.0 105.47 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.75 -96.81 0.6 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.629 -1.169 . . . . 10.0 111.567 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -160.47 175.86 12.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.857 -0.79 . . . . 10.0 109.619 -171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.6 t -90.42 150.36 21.87 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.868 1.667 . . . . 10.0 107.007 156.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.9 tp -155.16 142.89 19.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.801 -1.925 . . . . 10.0 105.801 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.89 132.18 37.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.198 1.799 . . . . 10.0 106.667 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.48 128.36 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.686 -1.227 . . . . 10.0 107.686 -166.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.65 108.03 16.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.26 118.89 31.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.005 0.922 . . . . 10.0 109.838 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.4 m -83.95 132.41 34.77 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.42 111.34 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -157.67 116.98 3.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.577 0.626 . . . . 10.0 111.283 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 pttm . . . . . 0 C--O 1.225 -0.217 0 O-C-N 121.731 -0.605 . . . . 10.0 111.088 173.98 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -160.45 54.06 0.32 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.124 0.964 . . . . 10.0 109.974 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.75 64.74 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 120.984 -1.073 . . . . 10.0 110.774 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -155.35 149.9 26.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.131 0.572 . . . . 10.0 109.731 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.61 145.42 17.83 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.001 -1.64 . . . . 10.0 109.001 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.45 161.0 22.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.264 1.032 . . . . 10.0 111.302 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -123.41 139.97 53.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.907 -1.516 . . . . 10.0 106.907 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.92 136.71 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 107.358 -1.349 . . . . 10.0 107.358 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.45 41.46 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 34.94 -137.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.956 2.102 . . . . 10.0 112.083 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.75 108.75 47.59 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 160.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.31 166.6 29.13 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 N-CA-C 107.528 -1.758 . . . . 10.0 107.528 166.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.36 64.78 3.62 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.048 2.499 . . . . 10.0 111.032 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.3 t -164.55 56.51 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.842 1.257 . . . . 10.0 108.985 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt 71.56 170.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.589 1.156 . . . . 10.0 109.005 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -44.92 -41.35 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.064 -1.023 . . . . 10.0 112.747 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -51.43 141.35 15.73 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 127.072 2.149 . . . . 10.0 111.983 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 114' ' ' LEU . 14.3 t -162.03 -172.45 3.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.652 -165.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.34 159.09 44.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.792 0.837 . . . . 10.0 111.555 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.09 144.07 26.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.94 1.296 . . . . 10.0 109.238 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -128.53 119.22 24.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.569 -2.752 . . . . 10.0 103.569 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 ptp -161.04 -173.9 4.11 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.367 1.067 . . . . 10.0 108.522 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -131.39 135.85 47.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.216 1.407 . . . . 10.0 108.111 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.88 120.97 37.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 103.952 -2.611 . . . . 10.0 103.952 160.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -110.55 79.74 1.24 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.424 -1.324 . . . . 10.0 107.424 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -81.33 92.9 6.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.317 0.58 . . . . 10.0 110.433 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -83.31 57.11 3.82 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.798 -0.564 . . . . 10.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 t -171.1 157.96 5.37 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.936 0.895 . . . . 10.0 109.182 166.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.78 61.96 6.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -134.91 117.46 12.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.783 0.833 . . . . 10.0 111.04 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 122.82 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.094 2.529 . . . . 10.0 110.337 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.61 106.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.499 0.72 . . . . 10.0 109.08 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 121.46 32.61 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.204 -0.935 . . . . 10.0 111.563 -171.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.288 0.0 OUTLIER -102.59 128.06 49.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.047 -0.408 . . . . 10.0 110.22 -171.509 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.59 57.21 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.536 1.16 . . . . 10.0 109.079 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.78 153.23 24.22 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.939 -1.665 . . . . 10.0 108.939 166.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.94 62.19 0.46 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 168.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.92 138.87 32.24 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -168.82 151.32 4.94 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 118.602 0.637 . . . . 10.0 109.693 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.94 56.37 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.77 2.313 . . . . 10.0 109.656 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.7 mt -136.55 -82.33 0.38 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.97 1.708 . . . . 10.0 107.982 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.74 136.86 45.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.043 0.937 . . . . 10.0 111.681 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.8 m -81.48 -31.43 32.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.251 0.62 . . . . 10.0 109.433 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.2 t -119.82 72.2 16.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.503 1.121 . . . . 10.0 111.448 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.84 97.22 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.916 2.411 . . . . 10.0 111.153 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.7 mmt -105.23 128.72 53.56 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.378 1.071 . . . . 10.0 110.063 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 145.28 28.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.926 0.89 . . . . 10.0 110.105 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.05 163.85 31.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.888 1.275 . . . . 10.0 111.507 172.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.451 ' CG2' ' H ' ' A' ' 83' ' ' MET 0.25 26.1 m -102.0 164.23 11.82 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.485 3.114 . . . . 10.0 110.805 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.8 t -95.93 173.98 7.17 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.367 1.067 . . . . 10.0 112.837 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -99.26 55.82 1.0 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.003 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.9 p80 171.87 -170.33 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.698 2.399 . . . . 10.0 107.69 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 m -46.84 171.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.881 2.872 . . . . 10.0 114.654 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.92 -65.72 2.2 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.908 -2.077 . . . . 10.0 107.908 -169.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.62 -146.61 2.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.474 -1.05 . . . . 10.0 110.474 155.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.451 ' H ' ' CG2' ' A' ' 76' ' ' THR . 65.8 mtt -114.1 -82.47 0.6 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.865 1.266 . . . . 10.0 109.922 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.02 51.81 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.841 1.256 . . . . 10.0 109.385 -172.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.18 147.48 4.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.051 -0.595 . . . . 10.0 113.905 166.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -78.3 43.6 0.46 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.126 1.77 . . . . 10.0 112.047 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -83.04 157.77 22.75 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.572 0.749 . . . . 10.0 109.872 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.3 ttp -81.49 70.38 8.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.417 1.103 . . . . 10.0 109.36 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -58.09 162.02 6.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.876 1.671 . . . . 10.0 111.718 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 50.3 Cg_exo -47.57 -37.65 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.553 2.836 . . . . 10.0 113.341 163.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.91 -158.56 0.01 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.978 1.311 . . . . 10.0 111.049 -161.11 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.55 115.04 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.937 0.495 . . . . 10.0 110.05 164.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -84.46 103.14 13.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 159.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.28 120.16 76.45 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 105.998 -1.852 . . . . 10.0 105.998 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -85.89 137.16 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 109.283 -1.083 . . . . 10.0 109.283 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 50.73 -137.25 1.16 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.302 0.641 . . . . 10.0 110.911 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.89 59.39 0.1 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.291 2.237 . . . . 10.0 112.316 176.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 87.1 0.12 Allowed Glycine 0 N--CA 1.441 -0.974 0 O-C-N 121.583 -0.698 . . . . 10.0 111.372 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.1 m -86.4 67.67 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.63 1.572 . . . . 10.0 107.602 163.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.5 pt? -102.82 175.48 5.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.833 -0.802 . . . . 10.0 108.833 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -155.85 129.88 8.67 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.675 0.75 . . . . 10.0 110.437 -169.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.92 126.14 32.71 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.52 1.528 . . . . 10.0 108.574 -168.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.29 154.58 42.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.548 1.939 . . . . 10.0 109.123 -170.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.438 HH21 ' HA ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -56.62 -27.81 59.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.073 0.949 . . . . 10.0 112.855 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.438 ' HA ' HH21 ' A' ' 104' ' ' ARG . 36.1 m-20 -78.55 -59.99 2.56 Favored 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 121.473 -0.767 . . . . 10.0 111.406 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.88 136.87 5.55 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.833 -1.307 . . . . 10.0 109.833 -167.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t0 70.06 120.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 129.063 2.945 . . . . 10.0 106.761 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 177.42 171.17 0.58 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.549 1.522 . . . . 10.0 111.759 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.36 124.4 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 105.066 -2.198 . . . . 10.0 105.066 156.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.4 mtm -82.32 96.69 7.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 161.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.52 69.18 5.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.911 -1.514 . . . . 10.0 106.911 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 66.4 mtp -85.37 166.95 15.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.967 0.889 . . . . 10.0 112.961 -169.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.96 57.8 17.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.081 -1.208 . . . . 10.0 110.081 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 45' ' ' THR . 86.5 mt -61.36 123.38 17.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.075 0.938 . . . . 10.0 109.098 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.82 -61.91 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.595 0.358 . . . . 10.0 111.423 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -70.75 157.18 90.78 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.076 0.55 . . . . 10.0 111.354 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.98 139.62 39.89 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.577 2.184 . . . . 10.0 110.288 169.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -88.05 179.43 6.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.005 1.322 . . . . 10.0 111.592 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 100.64 0.93 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.64 117.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.208 -1.034 . . . . 10.0 108.208 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.15 -13.28 31.35 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.194 -0.781 . . . . 10.0 111.995 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -77.78 -169.85 1.66 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.493 1.615 . . . . 10.0 108.303 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.8 m -155.3 137.27 14.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.3 154.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.22 -1.4 . . . . 10.0 107.22 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -80.52 145.67 31.71 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 126' ' ' ILE . 17.9 tt -108.71 146.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 162.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.7 m -117.57 111.82 19.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.871 -1.899 . . . . 10.0 105.871 172.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 145.71 24.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 125.935 1.694 . . . . 10.0 107.258 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -144.27 97.58 3.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.45 142.28 32.05 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.3 t -62.14 -29.05 70.07 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.695 -1.253 . . . . 10.0 111.082 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.664 -0.647 . . . . 10.0 110.595 171.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.81 91.16 0.13 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.177 1.37 . . . . 10.0 110.602 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 53.61 1.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.521 0.728 . . . . 10.0 110.643 -174.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.5 m -157.8 87.8 0.95 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.934 0.494 . . . . 10.0 110.896 -170.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mt -153.94 156.06 36.79 Favored 'General case' 0 C--O 1.23 0.036 0 CA-C-N 119.085 0.857 . . . . 10.0 109.109 167.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -149.32 136.28 19.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.4 163.63 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.55 137.66 32.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.387 0.675 . . . . 10.0 110.359 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.34 114.34 24.18 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.205 1.802 . . . . 10.0 109.318 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -83.01 125.3 31.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.297 1.439 . . . . 10.0 108.203 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.84 97.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 O-C-N 120.513 -1.367 . . . . 10.0 108.305 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -147.44 103.03 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.315 0.646 . . . . 10.0 110.917 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 pttp . . . . . 0 CA--C 1.536 0.437 0 O-C-N 121.952 -0.468 . . . . 10.0 110.3 161.035 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 122.123 0.963 . . . . 10.0 110.554 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -155.08 58.02 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.237 1.015 . . . . 10.0 108.777 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.56 85.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -145.52 158.67 43.81 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.107 1.763 . . . . 10.0 107.586 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.62 -163.08 32.74 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.437 -1.865 . . . . 10.0 108.437 161.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.55 149.51 23.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.994 0.897 . . . . 10.0 109.96 169.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.6 p -133.76 153.99 51.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 170.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.4 133.55 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 123.514 0.726 . . . . 10.0 109.928 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.17 110.45 7.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.82 34.65 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.464 -0.772 . . . . 10.0 109.112 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -19.35 99.31 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 127.523 2.329 . . . . 10.0 113.558 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 163.01 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.688 2.926 . . . . 10.0 109.683 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.09 52.58 3.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.22 1.947 . . . . 10.0 110.164 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -157.68 56.0 0.49 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.182 -1.044 . . . . 10.0 108.182 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt 70.08 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.333 1.053 . . . . 10.0 109.008 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.462 HH11 ' CG ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -50.6 -42.71 56.25 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' CG ' HH11 ' A' ' 43' ' ' ARG . 63.4 m-20 -59.09 127.32 31.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.706 0.765 . . . . 10.0 109.929 -163.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -145.68 -165.84 2.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.315 -1.311 . . . . 10.0 111.21 -164.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.86 157.94 41.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.611 1.164 . . . . 10.0 112.107 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.42 158.95 20.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.492 -0.777 . . . . 10.0 110.022 165.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.3 128.14 48.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 163.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -157.64 177.8 10.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 p -98.19 168.81 10.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.39 146.4 46.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.364 -1.717 . . . . 10.0 106.364 163.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.6 m -140.79 111.66 7.04 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.975 0.797 . . . . 10.0 112.302 -166.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 119.69 24.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.314 0.506 . . . . 10.0 109.652 167.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 80.74 1.63 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.971 -1.122 . . . . 10.0 107.971 157.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m 164.53 -19.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 129.184 2.994 . . . . 10.0 109.557 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 74.13 53.24 0.1 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.495 0.589 . . . . 10.0 110.407 140.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -145.98 157.71 49.96 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 125.004 1.322 . . . . 10.0 109.129 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.31 70.59 7.14 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.543 2.829 . . . . 10.0 111.301 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mm -85.89 152.01 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.44 0.638 . . . . 10.0 109.653 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -139.26 81.83 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.592 2.357 . . . . 10.0 108.791 -162.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.01 63.4 7.07 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.155 0.982 . . . . 10.0 111.961 -166.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.39 60.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.481 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 149.2 18.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.365 -1.398 . . . . 10.0 113.304 163.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.28 59.89 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.505 1.522 . . . . 10.0 108.891 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.29 132.88 35.3 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.726 -0.609 . . . . 10.0 109.604 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 t -161.69 150.09 12.64 Favored Pre-proline 0 C--O 1.24 0.568 0 O-C-N 121.464 -0.772 . . . . 10.0 111.198 -168.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.57 42.84 1.23 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.895 2.396 . . . . 10.0 111.115 170.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.07 -68.34 0.83 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.058 1.343 . . . . 10.0 109.169 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.23 138.74 31.18 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.777 1.231 . . . . 10.0 110.517 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -78.77 -34.71 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 165.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t -121.65 73.65 32.66 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 124.939 1.296 . . . . 10.0 110.034 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.74 114.27 3.99 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.455 2.104 . . . . 10.0 109.728 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.6 mtp -129.3 133.63 47.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.925 0.89 . . . . 10.0 110.129 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -84.37 149.74 25.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.647 1.179 . . . . 10.0 111.156 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -174.47 3.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.98 1.312 . . . . 10.0 113.126 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -159.68 134.32 7.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.937 1.295 . . . . 10.0 108.55 -172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 4.4 t -92.0 -174.05 3.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.466 1.127 . . . . 10.0 112.246 173.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.7 m -80.04 72.29 6.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.791 -1.55 . . . . 10.0 107.581 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 m80 75.06 165.07 0.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.609 1.964 . . . . 10.0 111.4 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m 67.93 -67.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.989 1.716 . . . . 10.0 111.608 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.16 87.26 0.99 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.31 -2.316 . . . . 10.0 107.31 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.55 -160.7 54.15 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 112.156 -0.378 . . . . 10.0 112.156 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.2 mtt -69.65 -73.78 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.466 1.284 . . . . 10.0 114.466 -166.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.06 66.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.477 0.711 . . . . 10.0 109.341 -159.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.59 170.1 32.89 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.925 0.774 . . . . 10.0 114.309 164.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.9 56.49 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.585 2.354 . . . . 10.0 113.372 -157.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -97.2 155.57 16.79 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.374 1.87 . . . . 10.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.4 mtm -79.25 76.34 5.79 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.349 -1.723 . . . . 10.0 106.349 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.34 153.08 77.45 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.099 -1.41 . . . . 10.0 109.631 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -36.88 -52.33 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.743 2.962 . . . . 10.0 112.748 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -179.41 175.69 0.89 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.286 2.634 . . . . 10.0 104.778 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.09 100.84 12.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 m -76.49 136.7 39.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 pt -106.54 98.65 21.0 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.66 52.85 4.51 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.919 3.079 . . . . 10.0 111.903 -160.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.62 144.23 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.6 1.19 . . . . 10.0 110.578 -157.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 61.06 3.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.508 1.923 . . . . 10.0 113.706 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.5 110.21 3.14 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.998 -1.641 . . . . 10.0 108.998 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.2 m -149.93 76.55 1.29 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 -165.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.08 -158.55 0.69 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.652 -166.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.5 m -151.83 118.63 5.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.877 -1.527 . . . . 10.0 106.877 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.34 120.79 26.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.46 155.0 32.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.112 1.365 . . . . 10.0 108.285 -159.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -80.49 51.04 1.38 Allowed 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.622 -0.673 . . . . 10.0 111.264 -173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.63 -71.02 0.73 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.083 1.753 . . . . 10.0 107.187 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 77' ' ' THR . . . -139.45 -55.75 0.04 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.287 -1.125 . . . . 10.0 110.287 -166.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' N ' ' HB ' ' A' ' 77' ' ' THR . 9.2 t70 -99.59 129.21 45.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 125.177 1.391 . . . . 10.0 107.335 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 178.0 179.22 0.32 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.11 122.33 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.104 -2.554 . . . . 10.0 104.104 158.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.7 mtp -82.27 102.5 11.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.951 -1.5 . . . . 10.0 106.951 164.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.5 77.54 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 10.0 106.882 171.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.73 165.69 13.54 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.681 0.753 . . . . 10.0 111.571 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.57 69.95 1.22 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.1 tp -46.62 134.68 9.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.541 1.136 . . . . 10.0 110.391 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -119.51 -60.32 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.229 0.612 . . . . 10.0 111.553 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -93.91 143.48 26.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.574 0.75 . . . . 10.0 109.085 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.43 159.98 51.08 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.222 2.615 . . . . 10.0 111.349 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.71 156.94 36.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.368 1.467 . . . . 10.0 110.61 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 144.98 48.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.772 1.229 . . . . 10.0 108.869 170.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.15 69.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 10.0 108.744 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.18 -15.88 0.59 Allowed Glycine 0 CA--C 1.524 0.646 0 O-C-N 120.536 -1.352 . . . . 10.0 112.648 -159.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -177.42 0.56 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.958 1.837 . . . . 10.0 108.913 171.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.1 m -155.08 128.74 8.57 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.062 -1.881 . . . . 10.0 106.186 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.31 146.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -75.93 132.9 40.55 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.51 126.68 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 164.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.9 103.02 13.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.29 119.59 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -130.2 82.45 2.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.321 1.449 . . . . 10.0 107.256 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.79 154.4 24.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.024 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -60.89 -14.49 22.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.588 0.355 . . . . 10.0 111.526 168.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -9.59 20.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.692 1.197 . . . . 10.0 111.865 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.99 56.62 1.92 Allowed Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.503 1.049 . . . . 10.0 111.305 164.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -138.55 176.89 8.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.067 0.547 . . . . 10.0 110.147 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 m -155.49 88.69 1.15 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.716 -1.957 . . . . 10.0 105.716 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.0 172.14 10.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.5 93.16 2.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.603 -1.999 . . . . 10.0 105.603 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.1 t -102.02 137.74 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.56 115.46 22.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.52 123.23 46.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.864 0.866 . . . . 10.0 110.092 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 m -82.82 126.17 32.13 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.931 0.493 . . . . 10.0 109.819 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -84.26 104.8 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 O-C-N 120.688 -1.257 . . . . 10.0 107.929 -174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -141.64 106.87 4.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.738 1.615 . . . . 10.0 109.521 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 tttt . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 128.145 2.578 . . . . 10.0 111.736 175.133 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 107.661 -1.237 . . . . 10.0 107.661 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.1 t -158.22 93.91 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.709 -1.219 . . . . 10.0 107.709 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.31 57.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.434 1.112 . . . . 10.0 108.413 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.54 145.28 40.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.028 -1.471 . . . . 10.0 107.028 164.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.89 132.1 23.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.834 -1.706 . . . . 10.0 108.834 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.74 149.21 41.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.84 0.82 . . . . 10.0 109.791 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -136.93 148.28 46.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.8 t -130.9 139.21 51.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.01 45.64 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.06 -112.04 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.816 1.246 . . . . 10.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.47 140.9 29.88 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 140.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.59 155.7 46.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.451 1.434 . . . . 10.0 108.63 162.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.7 61.36 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.354 2.036 . . . . 10.0 109.641 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -162.22 70.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.956 -1.498 . . . . 10.0 106.956 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt 87.94 154.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.546 2.338 . . . . 10.0 110.009 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -83.82 22.56 1.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.469 1.108 . . . . 10.0 113.121 -168.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.87 -179.88 4.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.068 1.747 . . . . 10.0 109.198 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.1 t -160.71 -177.65 6.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -0.919 . . . . 10.0 108.518 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.09 154.59 39.47 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.626 -0.715 . . . . 10.0 109.22 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.87 147.76 26.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.058 0.849 . . . . 10.0 109.229 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -124.44 102.02 7.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.42 -176.71 5.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.945 0.898 . . . . 10.0 109.187 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -131.81 131.92 43.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.724 0.81 . . . . 10.0 110.257 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.94 109.2 17.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.5 m -108.18 111.26 23.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.179 1.791 . . . . 10.0 108.378 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.96 136.13 36.56 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 112.368 0.507 . . . . 10.0 112.368 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -144.94 58.76 1.3 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 161.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -160.18 -25.22 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 65.78 51.31 1.43 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.194 0.998 . . . . 10.0 111.992 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -143.3 158.59 57.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.66 1.184 . . . . 10.0 109.102 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.81 82.7 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.271 2.647 . . . . 10.0 110.015 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mm -96.83 146.81 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.305 -0.861 . . . . 10.0 108.989 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' NE1' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -148.46 87.71 1.6 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.322 1.058 . . . . 10.0 111.145 -172.402 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.26 73.64 9.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.811 1.644 . . . . 10.0 112.498 -164.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 8.3 p -82.22 57.75 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.592 -0.693 . . . . 10.0 112.516 -173.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.83 151.82 22.6 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 121.002 -1.061 . . . . 10.0 110.804 163.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 62.71 0.38 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.123 0.969 . . . . 10.0 108.436 168.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.82 23.32 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.652 -0.655 . . . . 10.0 109.963 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -163.7 149.68 9.65 Favored Pre-proline 0 CA--C 1.529 0.159 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.81 3.58 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.077 1.852 . . . . 10.0 113.026 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -49.14 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.639 1.109 . . . . 10.0 109.915 173.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.9 156.06 43.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.358 1.063 . . . . 10.0 110.171 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -87.99 -39.76 14.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.729 1.211 . . . . 10.0 112.568 -159.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -116.43 84.24 14.39 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.232 1.013 . . . . 10.0 109.722 -166.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.15 116.95 3.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.256 2.637 . . . . 10.0 110.785 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -121.58 151.0 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.413 1.085 . . . . 10.0 108.676 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.49 143.3 30.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.619 0.768 . . . . 10.0 109.061 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 ttp -134.6 162.8 31.27 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.948 1.299 . . . . 10.0 108.788 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 134.0 10.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.626 -0.671 . . . . 10.0 111.682 169.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 t -150.01 47.67 0.92 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.504 -0.316 . . . . 10.0 111.822 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.8 m -135.86 99.23 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.725 0.81 . . . . 10.0 109.285 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -46.67 -38.24 9.47 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.616 1.966 . . . . 10.0 114.221 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 t -75.52 0.71 16.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.998 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -117.42 -122.66 3.29 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.922 1.249 . . . . 10.0 111.631 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.23 -66.98 2.23 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.129 0.871 . . . . 10.0 113.011 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.8 ttt -148.59 -140.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.839 1.255 . . . . 10.0 108.835 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.01 52.65 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.392 -0.818 . . . . 10.0 108.986 -163.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.62 93.76 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.834 -0.907 . . . . 10.0 110.834 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -61.85 95.38 0.06 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.894 0.854 . . . . 10.0 109.775 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -151.3 176.22 11.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.615 1.566 . . . . 10.0 107.351 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 39.1 mtp -79.59 123.05 27.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.83 164.02 37.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.636 -0.876 . . . . 10.0 108.636 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -47.24 -56.12 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.365 2.043 . . . . 10.0 110.419 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.556 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 174.95 -135.07 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.359 2.263 . . . . 10.0 109.022 -176.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 155.16 40.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.061 2.144 . . . . 10.0 105.303 168.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.7 m -98.98 122.01 41.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.908 -1.516 . . . . 10.0 106.908 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.23 116.6 65.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.896 -1.89 . . . . 10.0 105.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.73 70.03 7.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.676 1.584 . . . . 10.0 109.892 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.23 174.11 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.151 0.58 . . . . 10.0 110.619 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.95 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 117.406 2.373 . . . . 10.0 117.406 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.41 105.87 0.25 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.806 1.194 . . . . 10.0 112.147 -165.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 m -110.81 57.32 0.62 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.969 -1.863 . . . . 10.0 105.969 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 ' HA3' ' A' ' 81' ' ' GLY . 23.3 tp -83.28 152.62 25.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -136.95 147.6 46.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.62 123.8 50.98 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.088 2.155 . . . . 10.0 106.047 -164.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.74 152.39 37.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.527 1.131 . . . . 10.0 108.467 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -44.83 -31.04 1.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.499 1.296 . . . . 10.0 114.499 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.11 -51.99 21.9 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.931 0.892 . . . . 10.0 111.913 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.06 133.05 6.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.26 1.41 . . . . 10.0 110.96 -151.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 38.82 58.4 1.74 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 127.657 2.383 . . . . 10.0 112.82 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -122.46 170.72 9.69 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.866 -1.97 . . . . 10.0 109.476 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -108.65 134.55 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 80.9 mtp -103.41 105.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.21 88.68 7.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.045 -1.094 . . . . 10.0 108.045 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.73 147.18 27.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.525 0.73 . . . . 10.0 110.607 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.75 69.12 1.33 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.163 -0.798 . . . . 10.0 112.266 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 pp -48.36 151.29 1.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.942 0.871 . . . . 10.0 113.155 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -84.58 -71.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.736 0.414 . . . . 10.0 109.953 165.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 173.62 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.206 1.402 . . . . 10.0 112.481 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.15 75.57 4.15 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.211 1.941 . . . . 10.0 110.923 -171.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.76 116.49 18.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.475 1.51 . . . . 10.0 108.788 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -135.54 127.49 29.54 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.074 -1.454 . . . . 10.0 107.074 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.17 90.45 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.35 -45.49 0.51 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.454 -1.058 . . . . 10.0 110.454 -162.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -172.39 1.83 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 123.837 1.779 . . . . 10.0 111.328 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.9 m -149.95 130.72 14.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.095 -1.866 . . . . 10.0 106.918 170.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.05 148.8 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.22 151.26 45.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.921 0.782 . . . . 10.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -115.19 152.16 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -131.29 107.5 9.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.425 -1.694 . . . . 10.0 106.425 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 148.86 26.28 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.81 -1.541 . . . . 10.0 108.974 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.44 100.93 2.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.61 -1.256 . . . . 10.0 107.61 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.84 148.22 30.06 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 172.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.4 t -55.09 -38.36 68.01 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.524 1.056 . . . . 10.0 111.446 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -34.98 70.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.19 1.796 . . . . 10.0 110.705 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.11 75.55 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.74 1.638 . . . . 10.0 109.543 -168.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -83.89 51.26 2.0 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.275 -0.544 . . . . 10.0 110.633 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -161.28 103.53 1.26 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.667 1.187 . . . . 10.0 109.37 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.43 151.58 27.97 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 108.218 -1.03 . . . . 10.0 108.218 160.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -138.84 129.89 26.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.917 -1.883 . . . . 10.0 105.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -142.35 170.47 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.55 -1.648 . . . . 10.0 106.55 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.32 136.87 38.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.113 0.965 . . . . 10.0 109.589 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.44 118.65 32.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.982 1.313 . . . . 10.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -82.38 130.32 35.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.28 105.72 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -146.37 100.71 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.936 0.895 . . . . 10.0 109.571 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt . . . . . 0 N--CA 1.464 0.241 0 C-N-CA 124.866 1.266 . . . . 10.0 111.268 179.828 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 113.195 0.813 . . . . 10.0 113.195 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -155.3 51.01 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.72 67.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -138.55 161.31 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.465 1.506 . . . . 10.0 110.65 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.43 73.48 0.38 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.916 1.246 . . . . 10.0 110.002 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -36.03 116.28 0.38 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.544 1.538 . . . . 10.0 111.482 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.5 m -118.58 107.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.6 126.44 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.209 1.404 . . . . 10.0 109.058 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.61 119.3 10.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.512 0.672 . . . . 10.0 109.363 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.94 129.81 39.08 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.583 -1.265 . . . . 10.0 107.583 164.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -30.5 109.72 0.27 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 126.04 1.736 . . . . 10.0 111.778 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.45 170.6 7.9 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.233 1.955 . . . . 10.0 109.889 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.62 57.51 3.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.237 1.958 . . . . 10.0 108.988 166.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m -157.29 43.73 0.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.709 1.204 . . . . 10.0 109.26 -175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 43' ' ' ARG . 22.0 mm 76.03 168.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.831 1.653 . . . . 10.0 111.856 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 42' ' ' ILE . 10.5 tpt180 -62.59 -11.52 17.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.161 2.584 . . . . 10.0 114.35 -170.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -72.04 157.94 36.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.368 -0.832 . . . . 10.0 109.657 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -168.52 -174.71 2.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.65 38.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.266 1.026 . . . . 10.0 111.18 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.32 140.39 35.68 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.001 0.92 . . . . 10.0 109.607 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.34 110.85 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.91 -173.2 3.97 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.486 1.114 . . . . 10.0 109.562 -172.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -106.39 164.93 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 166.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.43 149.91 47.77 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.684 -1.599 . . . . 10.0 106.684 160.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 m -151.63 110.42 3.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.942 0.349 . . . . 10.0 111.942 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.42 142.82 33.97 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.243 1.017 . . . . 10.0 109.447 168.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -137.99 66.0 1.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.407 -1.331 . . . . 10.0 107.407 163.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 p 179.57 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 -171.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 84.01 67.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.772 2.029 . . . . 10.0 108.859 156.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -126.4 159.42 63.09 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 125.649 1.58 . . . . 10.0 107.372 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 70.11 6.27 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.551 2.168 . . . . 10.0 110.746 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.52 90.4 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 4.2 ptpp? -83.57 91.23 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.223 1.011 . . . . 10.0 111.428 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.92 68.52 8.34 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 10.0 112.945 -161.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.426 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 6.8 p -82.23 60.69 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.357 -0.839 . . . . 10.0 112.185 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.34 161.18 31.92 Favored Glycine 0 CA--C 1.521 0.45 0 O-C-N 121.013 -1.055 . . . . 10.0 111.329 157.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.08 57.31 0.47 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.436 1.094 . . . . 10.0 108.417 164.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.39 149.81 26.47 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 t -166.66 146.05 4.78 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.11 68.36 4.05 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.421 2.081 . . . . 10.0 108.032 166.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 tp -154.02 -65.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.774 0.83 . . . . 10.0 109.836 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.99 146.67 30.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.89 0.876 . . . . 10.0 109.989 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -87.18 -34.24 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 10.0 109.287 169.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -122.71 71.06 38.9 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.538 1.535 . . . . 10.0 109.89 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.6 104.45 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.067 2.511 . . . . 10.0 111.428 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -129.43 166.78 18.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.325 1.05 . . . . 10.0 110.279 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.6 144.34 43.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.281 1.432 . . . . 10.0 109.6 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 ttp -141.86 152.66 43.83 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.108 1.363 . . . . 10.0 108.123 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.29 108.6 4.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 -161.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' CA ' ' A' ' 107' ' ' ASP . 22.9 m -139.28 62.58 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.91 -1.119 . . . . 10.0 110.111 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -154.05 120.56 5.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.14 -0.936 . . . . 10.0 110.221 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.406 ' CD2' ' CB ' ' A' ' 84' ' ' ALA . 53.1 m80 -70.11 70.12 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.47 1.108 . . . . 10.0 112.188 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.9 p -168.62 -57.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.364 0.984 . . . . 10.0 113.015 171.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.31 -78.39 0.6 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.54 -141.81 11.32 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.543 0.592 . . . . 10.0 111.862 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.98 176.27 6.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.756 . . . . 10.0 109.786 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' CB ' ' CD2' ' A' ' 79' ' ' HIS . . . -124.59 52.19 1.55 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.713 1.605 . . . . 10.0 107.772 -169.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.98 112.48 0.54 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.174 -1.17 . . . . 10.0 110.174 -171.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 27.25 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.837 1.655 . . . . 10.0 114.181 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -83.03 161.59 21.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.589 1.556 . . . . 10.0 109.42 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.5 ttp -81.42 121.91 26.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.92 166.88 12.39 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 118.468 0.577 . . . . 10.0 111.514 -171.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -37.92 -59.95 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.297 2.665 . . . . 10.0 111.56 156.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -175.71 -172.41 0.53 Allowed 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.042 1.127 . . . . 10.0 114.042 -171.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.65 107.38 19.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.849 1.66 . . . . 10.0 106.856 165.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.0 m -83.92 129.02 34.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.5 pt -114.02 95.33 37.8 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 107.228 -1.397 . . . . 10.0 107.228 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.9 70.35 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.866 1.711 . . . . 10.0 112.508 -157.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.55 152.41 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.709 1.242 . . . . 10.0 111.109 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 36.96 37.2 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.875 1.27 . . . . 10.0 111.869 -155.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 93.21 0.14 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.362 -1.095 . . . . 10.0 110.362 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -138.79 107.17 5.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.6 -171.84 2.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.639 0.776 . . . . 10.0 110.802 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.6 t -140.15 143.51 36.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 103.04 -2.948 . . . . 10.0 103.04 -172.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.68 116.67 19.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.304 -2.48 . . . . 10.0 104.304 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.99 161.55 41.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.736 1.214 . . . . 10.0 108.745 -165.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.0 ttp-105 -62.57 122.89 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.672 -0.694 . . . . 10.0 109.326 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.3 t0 48.76 60.82 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 10.0 112.608 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.34 62.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.897 -1.281 . . . . 10.0 109.897 164.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.423 ' CA ' ' H ' ' A' ' 77' ' ' THR . 7.2 t0 79.02 127.58 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.108 1.763 . . . . 10.0 110.045 -175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -177.08 157.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.312 0.505 . . . . 10.0 111.465 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.14 123.18 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 105.932 -1.877 . . . . 10.0 105.932 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.1 mtm -94.38 104.9 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.236 1.017 . . . . 10.0 109.095 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.65 68.74 8.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.289 -1.745 . . . . 10.0 106.289 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 23.3 ttt -82.12 154.73 25.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.487 0.661 . . . . 10.0 110.276 -166.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.64 60.92 6.39 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.001 -1.24 . . . . 10.0 110.001 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.82 117.9 4.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -69.83 0.62 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.848 0.749 . . . . 10.0 111.479 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -66.19 156.06 85.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.736 1.214 . . . . 10.0 111.377 -173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.55 148.62 92.32 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.503 1.469 . . . . 10.0 109.603 165.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.19 147.09 32.07 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.776 1.23 . . . . 10.0 109.587 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -111.98 145.56 39.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.759 1.223 . . . . 10.0 108.659 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.87 99.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.34 -3.89 6.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.058 1.313 . . . . 10.0 112.025 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -75.66 -174.18 2.45 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 123.733 1.73 . . . . 10.0 109.887 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.2 m -153.74 134.17 13.5 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 112.861 -1.972 . . . . 10.0 107.562 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.13 143.54 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.123 0.969 . . . . 10.0 108.689 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.18 119.44 21.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.2 tt -81.99 159.75 3.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.4 m -128.54 114.71 17.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.092 -1.818 . . . . 10.0 106.092 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.96 134.26 34.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -126.73 71.42 1.3 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.879 0.872 . . . . 10.0 109.405 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.36 138.49 39.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.652 -1.24 . . . . 10.0 107.652 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -57.42 -34.36 68.85 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.755 0.707 . . . . 10.0 112.905 -166.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.4 m-20 -65.15 -27.65 68.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.453 1.501 . . . . 10.0 111.734 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.37 81.67 0.12 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.312 -1.915 . . . . 10.0 108.312 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -80.81 53.78 2.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.943 0.497 . . . . 10.0 111.59 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.1 m -158.7 83.88 0.82 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.134 1.374 . . . . 10.0 109.583 -172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 157.29 45.39 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 168.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -149.03 140.86 23.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.2 t -148.23 147.6 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.87 107.76 16.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.66 138.73 31.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -82.25 150.27 27.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.106 -1.442 . . . . 10.0 107.106 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.43 113.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 164.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -158.73 143.22 15.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.754 -0.832 . . . . 10.0 108.754 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.553 1.141 . . . . 10.0 111.489 177.613 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.775 0.798 . . . . 10.0 111.685 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 t -158.98 81.18 0.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.202 1.001 . . . . 10.0 108.762 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.8 85.56 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.733 0.777 . . . . 10.0 109.527 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -157.98 155.79 30.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 162.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.03 137.35 19.8 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.353 -1.099 . . . . 10.0 110.353 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.91 115.69 23.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.77 0.785 . . . . 10.0 110.042 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -109.48 158.21 18.19 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.757 -1.201 . . . . 10.0 107.757 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.17 137.55 54.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.5 113.33 13.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -52.4 127.03 21.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 117.761 -1.114 . . . . 10.0 109.004 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -11.48 102.32 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 127.358 2.263 . . . . 10.0 113.065 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.3 168.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.733 2.288 . . . . 10.0 109.382 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.68 43.32 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.268 1.979 . . . . 10.0 110.545 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -133.96 34.54 3.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.943 2.097 . . . . 10.0 107.578 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.3 mm 73.76 172.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.897 1.279 . . . . 10.0 109.784 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.59 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -72.79 40.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.699 1.6 . . . . 10.0 113.948 -175.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.07 158.97 15.17 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 156.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -157.68 -165.88 1.87 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 155.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.01 174.46 11.26 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.63 161.43 26.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -130.3 102.3 6.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.35 -2.833 . . . . 10.0 103.35 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.2 ttp -158.59 -178.84 7.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.12 2.568 . . . . 10.0 106.142 -172.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 m -152.98 141.01 20.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.823 -1.917 . . . . 10.0 105.823 166.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.546 HD23 HD13 ' A' ' 94' ' ' ILE . 3.2 mp -82.29 136.03 35.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 170.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 m -120.78 80.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.069 2.148 . . . . 10.0 108.544 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.91 89.7 6.39 Favored 'General case' 0 N--CA 1.46 0.045 0 O-C-N 121.2 -0.938 . . . . 10.0 109.128 -172.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 57.51 3.96 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.244 -0.91 . . . . 10.0 110.189 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t 179.11 149.64 0.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.174 1.79 . . . . 10.0 107.506 167.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.65 67.33 5.39 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.496 1.118 . . . . 10.0 108.895 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -130.71 122.47 19.64 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 10.0 109.736 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.86 116.3 3.14 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.535 2.823 . . . . 10.0 111.032 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.92 96.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.604 0.638 . . . . 10.0 109.649 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -80.4 132.84 35.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.312 0.645 . . . . 10.0 111.022 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.75 140.19 46.59 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.318 1.047 . . . . 10.0 110.209 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 131' ' ' THR . 10.4 p -146.09 56.25 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.923 0.868 . . . . 10.0 110.171 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 154.54 25.59 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 119.82 -1.181 . . . . 10.0 111.971 163.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.23 72.28 0.93 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.304 1.842 . . . . 10.0 106.505 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.39 145.63 28.1 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t 35.8 68.59 1.31 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.778 0.831 . . . . 10.0 109.963 -156.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.19 -86.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.349 2.033 . . . . 10.0 110.079 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.03 43.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.077 -1.453 . . . . 10.0 107.077 156.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HB1' ' C ' ' A' ' 112' ' ' MET . . . -167.31 -157.2 0.23 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -176.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -40.03 6.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.714 0.688 . . . . 10.0 110.868 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -122.09 106.23 36.44 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 125.403 1.481 . . . . 10.0 108.588 -169.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.12 139.65 7.28 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.23 2.62 . . . . 10.0 110.497 173.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -138.31 127.76 24.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.87 139.4 35.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.4 ttm -141.87 154.82 45.41 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.144 0.978 . . . . 10.0 111.429 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -148.47 120.16 8.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CG ' ' A' ' 86' ' ' MET . 6.9 t -156.43 54.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.644 0.778 . . . . 10.0 112.101 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -137.73 179.5 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.618 0.767 . . . . 10.0 111.499 168.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -91.18 -40.32 11.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.312 0.645 . . . . 10.0 110.165 -171.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.1 t -81.71 -147.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 160.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.35 -140.68 42.41 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.09 -67.42 1.7 Allowed Glycine 0 CA--C 1.536 1.365 0 CA-C-N 117.252 0.526 . . . . 10.0 113.145 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.14 174.17 12.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.637 1.975 . . . . 10.0 108.377 -169.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.86 45.42 2.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 10.0 107.8 -159.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.59 84.42 0.12 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 117.574 -1.681 . . . . 10.0 112.902 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.406 ' CG ' HG21 ' A' ' 77' ' ' THR . 1.7 mtt -40.34 98.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.437 0 C-N-CA 126.045 1.738 . . . . 10.0 110.602 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.31 166.23 26.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.705 1.202 . . . . 10.0 109.388 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.5 mtp -77.67 71.16 4.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.7 146.7 98.36 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.963 -1.017 . . . . 10.0 108.534 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -33.59 -51.49 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.205 3.27 . . . . 10.0 113.547 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -179.08 -176.76 0.44 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.44 1.896 . . . . 10.0 106.582 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 102.29 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 10.0 110.294 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 m -75.21 122.51 23.76 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.546 HD13 HD23 ' A' ' 51' ' ' LEU . 2.2 pt -108.73 90.83 7.93 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.163 0.985 . . . . 10.0 108.709 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.04 140.91 35.46 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 120.75 0.966 . . . . 10.0 109.741 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.41 -140.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.256 1.023 . . . . 10.0 112.412 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.19 38.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.958 2.503 . . . . 10.0 114.516 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.0 144.16 10.5 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 121.832 0.684 . . . . 10.0 112.883 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' LEU 0.265 7.2 t -134.48 99.3 4.32 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.863 -1.532 . . . . 10.0 106.863 158.198 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.84 126.26 55.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.046 -2.205 . . . . 10.0 105.046 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 m -82.01 153.23 26.29 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.708 -0.849 . . . . 10.0 108.708 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.67 76.55 1.64 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.984 -1.487 . . . . 10.0 106.984 176.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 158.49 44.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.738 0.815 . . . . 10.0 110.198 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -73.72 60.81 0.71 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.081 0.952 . . . . 10.0 112.123 -168.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -176.23 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.154 1.381 . . . . 10.0 109.784 -164.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.4 74.33 0.27 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 123.336 0.494 . . . . 10.0 112.101 -161.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 69.13 139.74 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 128.296 2.638 . . . . 10.0 109.211 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 175.65 178.44 0.18 Allowed 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.091 0.556 . . . . 10.0 112.42 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 t -108.67 118.21 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.7 mtp -80.43 103.19 10.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.545 -1.65 . . . . 10.0 106.545 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.84 105.47 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.584 -1.189 . . . . 10.0 109.178 169.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.471 ' C ' ' HB1' ' A' ' 69' ' ' ALA . 26.8 ttt -111.59 152.69 27.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.15 1.38 . . . . 10.0 111.22 -172.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.79 -6.82 6.95 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.528 -1.707 . . . . 10.0 115.957 155.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 77.29 92.46 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.677 1.739 . . . . 10.0 111.067 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -70.39 -56.44 6.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.66 -0.65 . . . . 10.0 110.3 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 149.86 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 129.833 3.253 . . . . 10.0 110.767 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.33 66.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.043 2.495 . . . . 10.0 114.311 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.49 96.62 10.68 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.106 -0.996 . . . . 10.0 109.481 158.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -137.71 147.8 45.11 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 162.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.07 68.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.872 0.869 . . . . 10.0 108.951 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.69 8.24 0.7 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.376 -1.236 . . . . 10.0 113.187 -168.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.66 173.0 5.52 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 119.797 1.799 . . . . 10.0 108.481 161.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 m -156.34 129.96 8.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.849 -1.523 . . . . 10.0 109.356 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.54 140.55 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.204 0.602 . . . . 10.0 109.766 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -70.05 123.12 20.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 108.971 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.9 tt -102.2 141.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.68 -1.23 . . . . 10.0 107.68 166.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.6 m -119.78 110.1 16.38 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 171.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.03 173.1 10.77 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 122.183 -0.323 . . . . 10.0 111.8 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.62 96.72 2.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.527 1.131 . . . . 10.0 108.022 -172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.75 143.12 29.35 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.68 -0.637 . . . . 10.0 110.647 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 62' ' ' VAL . 58.8 p -58.29 -23.13 55.36 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.713 0.805 . . . . 10.0 113.019 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.71 -17.7 16.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.987 0.915 . . . . 10.0 112.081 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.09 30.22 3.24 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.896 1.712 . . . . 10.0 110.578 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -90.36 166.9 13.04 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-N 117.334 0.567 . . . . 10.0 110.301 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.8 m -158.49 59.49 0.44 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.077 -2.194 . . . . 10.0 105.077 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.1 tp -85.18 141.9 29.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.848 -1.167 . . . . 10.0 107.848 -174.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -111.48 136.42 50.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.0 t -136.3 159.38 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.217 -1.771 . . . . 10.0 106.217 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.68 109.57 21.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.936 0.894 . . . . 10.0 108.879 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.36 118.48 24.26 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -94.83 127.38 40.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.178 0.991 . . . . 10.0 109.28 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 37' ' ' ALA . 51.1 t -86.76 104.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 120.762 -1.211 . . . . 10.0 108.951 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -141.59 116.3 9.72 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.578 1.151 . . . . 10.0 108.451 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.6 mttm . . . . . 0 C--N 1.341 0.223 0 C-N-CA 124.781 1.232 . . . . 10.0 112.164 175.965 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.964 0.888 . . . . 10.0 109.119 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -153.67 58.05 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.445 -0.785 . . . . 10.0 109.163 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.15 67.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 162.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -97.66 166.04 11.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.903 -1.499 . . . . 10.0 108.928 164.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.91 -145.96 19.74 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.581 -1.807 . . . . 10.0 108.581 160.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.02 115.73 0.73 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.97 1.708 . . . . 10.0 108.458 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.3 p -124.66 138.47 54.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.17 147.34 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.726 0.81 . . . . 10.0 109.54 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.63 113.53 25.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.375 0.534 . . . . 10.0 111.103 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.45 128.99 34.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.926 0.49 . . . . 10.0 110.095 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -20.7 103.87 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 127.024 2.13 . . . . 10.0 112.924 -164.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -62.15 167.01 11.54 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.314 2.676 . . . . 10.0 110.476 171.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.54 57.8 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.647 2.231 . . . . 10.0 109.127 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -154.44 42.8 0.5 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.881 1.272 . . . . 10.0 109.313 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.7 mt 77.43 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.438 1.495 . . . . 10.0 109.098 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -36.34 -46.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.304 1.842 . . . . 10.0 111.603 168.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.57 141.28 1.05 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.24 2.616 . . . . 10.0 112.727 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -158.67 -175.47 5.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 172.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.51 158.32 43.88 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.542 1.137 . . . . 10.0 110.596 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' SD ' ' A' ' 49' ' ' MET . . . -93.6 163.25 13.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 124.109 0.881 . . . . 10.0 110.51 171.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -134.06 130.57 37.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.516 -2.031 . . . . 10.0 105.516 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.405 ' SD ' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mpp? -156.04 -176.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.848 1.659 . . . . 10.0 108.5 -173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 137.43 36.58 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 161.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.28 149.37 23.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.634 -0.876 . . . . 10.0 108.634 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -135.84 85.76 2.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.291 0.994 . . . . 10.0 111.632 -157.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 113.73 12.4 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 121.354 -0.841 . . . . 10.0 109.156 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -128.36 57.65 1.57 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 164.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 m -163.46 -33.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.129 1.372 . . . . 10.0 112.134 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 60.42 59.66 2.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.079 0.854 . . . . 10.0 111.26 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -143.3 147.13 39.07 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.972 0.909 . . . . 10.0 109.907 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -86.36 84.34 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.906 3.071 . . . . 10.0 112.408 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.31 94.24 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -80.36 134.51 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.621 -0.674 . . . . 10.0 110.919 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 61' ' ' LEU . 1.2 tm? -99.38 115.89 30.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.881 1.672 . . . . 10.0 107.375 -165.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.69 47.78 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.997 . . . . 10.0 108.855 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.84 156.82 29.0 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.766 -1.209 . . . . 10.0 111.339 159.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.28 59.74 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.656 1.582 . . . . 10.0 107.846 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 132.52 33.8 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 t -157.91 139.55 9.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.88 65.16 5.96 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.671 2.914 . . . . 10.0 109.42 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -157.54 -57.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 -164.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.48 152.21 25.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.277 0.631 . . . . 10.0 109.31 171.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.2 m -107.13 -18.83 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.939 0.895 . . . . 10.0 110.219 160.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.6 m -133.1 64.45 70.47 Favored Pre-proline 0 N--CA 1.445 -0.689 0 C-N-CA 124.469 1.108 . . . . 10.0 109.028 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 101.32 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.178 2.585 . . . . 10.0 109.905 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.06 126.18 54.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 10.0 109.251 -171.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.58 146.03 31.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.045 0.538 . . . . 10.0 109.717 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 86' ' ' MET . 0.3 OUTLIER -148.03 166.7 26.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.758 1.223 . . . . 10.0 111.527 179.393 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.254 40.7 m -137.96 133.87 34.23 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.004 1.44 . . . . 10.0 111.898 -156.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.447 ' HB ' ' N ' ' A' ' 107' ' ' ASP . 9.2 t -83.55 -178.99 7.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 123.995 1.855 . . . . 10.0 113.873 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.4 m -79.88 66.61 5.41 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 129.561 3.144 . . . . 10.0 109.803 -160.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 60.71 65.33 1.05 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.167 1.387 . . . . 10.0 110.735 172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.3 t -161.53 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.294 1.037 . . . . 10.0 108.369 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.31 -125.46 3.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 10.0 110.504 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.36 -49.95 8.16 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.527 1.371 . . . . 10.0 116.527 -168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.35 -82.46 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.749 1.275 . . . . 10.0 111.229 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.0 74.77 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.729 1.212 . . . . 10.0 108.07 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.77 159.65 27.69 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.01 1.29 . . . . 10.0 113.656 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 75' ' ' MET . 40.1 ttp -77.61 62.37 2.52 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.088 1.355 . . . . 10.0 111.417 -168.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -81.81 162.64 22.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.1 ttm -80.03 74.11 6.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.72 142.79 61.91 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.818 -1.083 . . . . 10.0 109.046 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.26 -18.28 64.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.845 1.697 . . . . 10.0 113.597 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -178.14 174.27 1.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.659 -1.978 . . . . 10.0 105.659 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 tp -97.6 101.14 12.58 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.448 1.022 . . . . 10.0 109.667 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -76.3 123.9 26.65 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.539 -0.911 . . . . 10.0 108.539 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.9 pt -115.26 115.28 42.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.18 -170.24 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.605 2.204 . . . . 10.0 110.737 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.43 149.66 20.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 158.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.87 17.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.168 1.349 . . . . 10.0 113.563 -166.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 83.62 0.41 Allowed Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 108.815 -1.714 . . . . 10.0 108.815 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.1 t -121.9 108.33 13.31 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 166.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 -172.33 2.68 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.335 0.654 . . . . 10.0 109.955 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.3 t -143.81 122.49 12.57 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 104.041 -2.577 . . . . 10.0 104.041 -164.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.78 123.92 47.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.57 -1.641 . . . . 10.0 106.57 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.63 155.39 41.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.171 1.389 . . . . 10.0 108.533 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 55.57 0.89 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.644 0.778 . . . . 10.0 111.181 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.55 -57.3 0.44 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.69 -75.48 0.3 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.689 0.661 . . . . 10.0 112.051 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -100.0 133.2 44.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 -171.393 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 174.51 178.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 120.115 1.325 . . . . 10.0 109.861 -176.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.76 122.57 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.137 -2.171 . . . . 10.0 105.137 158.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.0 mtp -81.37 96.83 7.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.25 61.82 3.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 22.2 ptm -89.97 177.91 6.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.115 0.959 . . . . 10.0 110.544 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.21 46.62 86.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 109.13 -1.588 . . . . 10.0 109.13 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.55 119.74 15.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 10.0 110.321 -168.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -64.16 -73.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.055 0.542 . . . . 10.0 111.705 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -95.2 152.98 39.79 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.7 0.8 . . . . 10.0 112.21 -160.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.66 100.68 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.571 2.181 . . . . 10.0 109.154 170.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 42.0 mt -77.72 158.4 29.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.032 -0.417 . . . . 10.0 111.032 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 142.31 47.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.717 1.207 . . . . 10.0 109.07 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.35 72.32 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.174 1.39 . . . . 10.0 109.214 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 151.76 -12.6 0.75 Allowed Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.962 -1.086 . . . . 10.0 112.614 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.89 179.27 2.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 123.693 1.711 . . . . 10.0 109.404 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -155.05 127.41 7.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.693 -2.049 . . . . 10.0 108.48 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -127.34 148.57 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -71.24 144.66 49.99 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.579 -0.7 . . . . 10.0 110.316 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.3 tt -123.19 139.3 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.1 m -117.39 119.24 34.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.2 176.89 8.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 10.0 111.723 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -154.09 90.8 1.38 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.202 1.001 . . . . 10.0 109.023 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 134' ' ' ARG . . . -86.74 153.24 21.86 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.135 -0.978 . . . . 10.0 110.989 170.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 p -46.45 -39.32 10.42 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 -165.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.38 18.35 0.56 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.767 0.827 . . . . 10.0 111.925 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 32.92 35.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.851 -1.3 . . . . 10.0 109.851 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.431 ' CB ' ' HB3' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -82.55 94.71 7.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -178.373 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 125.83 47.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.264 1.826 . . . . 10.0 107.064 169.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.6 144.29 50.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 103.796 -2.668 . . . . 10.0 103.796 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -107.95 113.84 27.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.571 -2.381 . . . . 10.0 104.571 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.27 153.1 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -171.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.94 112.06 22.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.55 -0.907 . . . . 10.0 108.55 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.13 109.73 20.11 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.486 0.714 . . . . 10.0 109.135 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 m -90.31 124.64 35.07 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.935 0.894 . . . . 10.0 108.911 -175.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.76 108.22 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.172 -0.955 . . . . 10.0 109.078 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -136.73 111.63 8.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.262 . . . . 10.0 108.169 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 C--O 1.232 0.155 0 CA-C-N 119.154 0.888 . . . . 10.0 110.731 172.757 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 122.256 1.026 . . . . 10.0 110.526 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -158.35 60.35 0.45 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.497 0.719 . . . . 10.0 109.508 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.96 52.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 122.125 0.964 . . . . 10.0 110.511 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -157.24 145.6 19.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.53 130.49 10.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.794 -1.723 . . . . 10.0 108.794 168.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 159.35 31.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.051 0.926 . . . . 10.0 111.291 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 p -122.39 148.57 44.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.316 -1.364 . . . . 10.0 107.316 165.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.41 134.51 58.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.0 26.29 0.06 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -166.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.21 -138.18 0.71 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.412 1.485 . . . . 10.0 109.692 -170.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.25 110.76 40.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 167.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.32 175.1 11.05 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.252 2.634 . . . . 10.0 109.472 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.78 72.04 3.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.531 2.154 . . . . 10.0 109.627 168.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -152.54 -57.41 0.14 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.722 2.409 . . . . 10.0 106.299 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt 66.37 150.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.141 1.776 . . . . 10.0 108.563 -163.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 74.91 -51.51 0.67 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.292 1.837 . . . . 10.0 111.757 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.31 138.01 37.01 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -150.45 178.57 8.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.659 1.184 . . . . 10.0 108.193 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.15 161.7 41.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.938 0.895 . . . . 10.0 109.458 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.41 160.81 14.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.263 0.977 . . . . 10.0 111.284 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.14 134.96 51.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.275 -2.491 . . . . 10.0 104.275 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 ttt -158.82 177.26 11.36 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.794 -1.187 . . . . 10.0 107.794 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 t -133.27 142.36 48.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 152.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.52 105.77 16.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.287 -2.486 . . . . 10.0 104.287 163.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.84 106.36 15.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.281 1.832 . . . . 10.0 110.427 -170.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.61 129.82 34.74 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.337 0.655 . . . . 10.0 110.206 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -138.98 58.42 1.64 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 158.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -157.98 -50.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.937 2.095 . . . . 10.0 108.103 -171.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 97' ' ' ARG . 40.8 m-20 74.58 58.86 0.07 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.207 1.803 . . . . 10.0 110.384 170.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -123.86 146.29 50.3 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 126.048 1.739 . . . . 10.0 106.456 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.72 121.02 6.4 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.692 2.261 . . . . 10.0 109.554 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.57 146.39 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -117.7 145.47 44.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.316 1.447 . . . . 10.0 107.763 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.09 131.68 17.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.485 -2.413 . . . . 10.0 104.485 -171.14 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.6 55.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.233 1.016 . . . . 10.0 109.034 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.49 149.09 17.48 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.871 -1.292 . . . . 10.0 109.871 167.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -155.54 59.74 0.62 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.758 1.223 . . . . 10.0 108.14 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.19 35.23 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.339 0.656 . . . . 10.0 110.21 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -159.05 144.11 11.7 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 107.143 -1.429 . . . . 10.0 107.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.61 39.74 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.519 2.146 . . . . 10.0 112.738 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -108.82 -54.61 2.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.734 1.613 . . . . 10.0 108.34 -170.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.38 160.41 30.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.974 1.309 . . . . 10.0 107.947 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -83.15 -40.26 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.512 0.725 . . . . 10.0 111.874 -165.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.9 t -119.15 95.53 49.39 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.478 1.111 . . . . 10.0 110.647 -162.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.61 92.2 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.958 2.439 . . . . 10.0 110.36 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 83.8 mtp -103.75 116.51 32.45 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.879 1.272 . . . . 10.0 108.893 -172.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 mp -81.54 134.9 35.57 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.435 0.694 . . . . 10.0 109.735 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.52 -179.83 3.84 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.667 1.187 . . . . 10.0 109.336 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 t -158.79 143.27 15.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.277 -2.49 . . . . 10.0 104.277 159.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.28 5.7 t -156.89 63.68 0.51 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.738 1.608 . . . . 10.0 110.486 167.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -146.04 -178.74 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.72 -0.612 . . . . 10.0 109.665 172.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.57 148.76 22.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m 71.2 -53.8 0.67 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.552 1.541 . . . . 10.0 111.913 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.55 141.16 47.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 17.65 -90.14 0.01 OUTLIER Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.699 2.095 . . . . 10.0 115.585 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.4 mtt -145.39 173.98 11.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.395 1.878 . . . . 10.0 109.454 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.22 47.05 0.98 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.768 1.627 . . . . 10.0 107.128 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.72 102.2 0.22 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.813 -1.315 . . . . 10.0 109.813 -167.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 63.85 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.279 1.831 . . . . 10.0 111.89 -170.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -113.98 165.81 12.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.827 2.051 . . . . 10.0 109.933 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.8 mtm -78.38 98.02 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.716 -1.587 . . . . 10.0 106.716 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.66 161.72 47.06 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 119.47 -0.3 . . . . 10.0 110.387 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -43.17 -50.02 6.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.247 2.631 . . . . 10.0 111.241 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.3 p90 177.52 -170.0 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.194 2.598 . . . . 10.0 104.967 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -127.8 106.6 9.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.754 0.788 . . . . 10.0 110.421 169.175 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 145.77 36.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.04 140.9 40.07 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.527 1.058 . . . . 10.0 111.266 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.1 -174.21 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.123 2.549 . . . . 10.0 111.968 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.4 143.48 23.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 156.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 37.1 mmt-85 52.15 27.07 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.58 0.956 . . . . 10.0 113.58 -163.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.74 96.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.837 -1.705 . . . . 10.0 108.837 167.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -126.59 55.71 1.51 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.706 1.202 . . . . 10.0 108.645 -173.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.21 166.61 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.158 0.98 . . . . 10.0 112.397 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 105.4 3.95 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.9 119.4 23.89 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.503 -1.665 . . . . 10.0 106.503 -171.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -127.83 144.7 51.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.458 1.903 . . . . 10.0 107.456 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -61.71 119.42 8.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.99 37.18 3.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.218 1.407 . . . . 10.0 112.334 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -169.73 74.31 0.11 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.774 -1.73 . . . . 10.0 108.774 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.9 t0 63.41 130.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.967 2.507 . . . . 10.0 111.749 -168.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -177.1 175.82 1.48 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.365 0.984 . . . . 10.0 111.782 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.92 130.27 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.025 -1.843 . . . . 10.0 106.025 163.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 78.6 mtp -88.76 103.21 15.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.747 1.219 . . . . 10.0 107.759 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.27 81.42 8.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.711 -1.589 . . . . 10.0 106.711 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 51.3 ttm -84.79 152.34 23.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.313 1.045 . . . . 10.0 109.639 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.92 53.2 3.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.381 -1.087 . . . . 10.0 110.381 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.8 122.58 5.09 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 125.147 1.379 . . . . 10.0 109.11 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -72.9 -64.16 1.02 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.61 -58.48 0.0 OUTLIER Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 118.276 -0.868 . . . . 10.0 112.987 167.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.73 58.7 5.41 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.805 1.67 . . . . 10.0 111.334 -163.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.69 167.26 22.14 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.839 -0.538 . . . . 10.0 109.717 165.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -149.33 123.56 9.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.253 -1.758 . . . . 10.0 106.253 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.93 120.64 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.66 -4.19 50.16 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.414 -1.214 . . . . 10.0 112.478 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.03 169.4 11.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 119.944 1.872 . . . . 10.0 111.357 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.9 m -132.32 96.75 3.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 111.599 -2.546 . . . . 10.0 108.045 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.12 140.39 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -66.11 130.77 44.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.3 112.19 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 173.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.1 m -94.31 107.04 19.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.44 -0.8 . . . . 10.0 109.541 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.28 171.96 14.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.09 103.36 2.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.05 126.73 32.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.7 t -47.85 -38.53 16.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.51 1.524 . . . . 10.0 111.019 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.1 -35.19 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.019 1.727 . . . . 10.0 113.089 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.28 67.73 0.17 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.126 -1.189 . . . . 10.0 110.126 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -129.76 151.85 49.89 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 m -152.72 55.57 0.79 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.649 1.579 . . . . 10.0 107.823 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.49 128.76 34.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 62.43 0.87 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 127.551 2.34 . . . . 10.0 107.222 -161.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -84.49 153.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.396 -1.274 . . . . 10.0 108.96 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.68 113.44 18.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.922 -1.111 . . . . 10.0 108.999 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.0 146.27 32.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.398 1.079 . . . . 10.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.7 m -103.7 128.64 51.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.559 0.344 . . . . 10.0 110.702 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.34 91.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.899 -1.148 . . . . 10.0 107.899 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -155.66 135.83 13.0 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 121.435 -0.79 . . . . 10.0 110.754 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.259 0 C-N-CA 125.749 1.619 . . . . 10.0 111.868 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.407 ' HA2' ' CG ' ' A' ' 3' ' ' HIS . . . 100.38 79.73 1.46 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.278 -1.29 . . . . 10.0 110.732 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' CG ' ' HA2' ' A' ' 2' ' ' GLY 2.174 0.2 OUTLIER -95.46 24.79 4.87 Favored 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 134.799 5.239 . . . . 10.0 113.622 -1.489 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 2.334 1.7 t -58.57 85.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.179 0.991 . . . . 10.0 110.28 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' PRO 2.281 25.0 ptt? -62.05 -158.34 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.448 1.899 . . . . 10.0 110.019 149.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' MET 2.553 63.2 Cg_endo 51.62 -167.87 0.0 OUTLIER 'Cis proline' 0 C--N 1.351 0.71 0 CA-C-N 122.475 1.92 . . . . 10.0 114.07 6.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 61.87 -94.41 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.751 1.76 . . . . 10.0 115.751 162.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . 2.299 1.2 p-80 -136.79 -58.48 0.72 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 129.95 3.3 . . . . 10.0 109.508 117.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 2.344 19.0 m -13.79 -76.21 0.0 OUTLIER Pre-proline 0 C--N 1.348 0.501 1 C-N-CA 134.73 5.212 . . . . 10.0 114.34 -12.245 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . 2.54 32.1 Cg_exo 61.61 -109.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.719 2.279 . . . . 10.0 109.723 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -23.32 66.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 1 C-N-CA 128.331 6.02 . . . . 10.0 121.006 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.64 52.19 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 132.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 2.453 8.7 pt20 59.51 -164.06 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.258 -145.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t 71.52 26.36 3.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.732 1.382 . . . . 10.0 114.732 172.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.08 50.99 5.25 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 141.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . 0.538 0.7 OUTLIER -28.85 -91.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-O 115.949 -1.771 . . . . 10.0 115.239 -105.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . 0.27 . . 55.88 34.33 23.33 Favored 'General case' 0 CA--C 1.532 0.27 2 C-N-CA 134.161 4.984 . . . . 10.0 116.548 -7.321 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.24 106.58 8.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.065 0.848 . . . . 10.0 112.253 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 93.03 -64.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 1 C-N-CA 133.067 4.547 . . . . 10.0 115.909 -14.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp 165.01 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.249 1.42 . . . . 10.0 109.221 -151.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.13 156.22 18.74 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.523 -0.736 . . . . 10.0 109.949 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.92 25.4 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.557 -1.817 . . . . 10.0 108.557 -144.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 80.82 -54.93 0.32 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.45 2.3 . . . . 10.0 110.266 168.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.82 -65.03 0.36 Allowed 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.133 1.373 . . . . 10.0 107.494 -166.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 162.5 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.808 1 C-N-CA 131.852 4.061 . . . . 10.0 105.368 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 54' ' ' LYS . 4.6 tt -101.78 122.21 48.31 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 168.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -58.75 129.42 32.14 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.779 -1.662 . . . . 10.0 107.779 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -84.11 52.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.656 0.741 . . . . 10.0 112.161 -148.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -161.71 57.42 0.26 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.82 1.248 . . . . 10.0 109.035 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.45 64.68 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -128.94 146.5 50.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.891 1.276 . . . . 10.0 111.443 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.26 90.59 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 108.261 -1.936 . . . . 10.0 108.261 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.41 142.5 17.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.04 0.536 . . . . 10.0 111.847 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 p -125.16 146.13 49.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.28 138.59 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.923 -1.139 . . . . 10.0 107.923 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.34 110.59 17.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.109 0.48 . . . . 10.0 111.486 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.39 136.34 31.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.403 -0.808 . . . . 10.0 109.15 166.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.7 t -17.5 108.22 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.83 2.052 . . . . 10.0 114.837 -162.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.15 158.1 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.814 2.343 . . . . 10.0 110.572 167.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.16 58.64 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.499 2.133 . . . . 10.0 108.987 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.9 t -165.4 44.25 0.08 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.266 1.426 . . . . 10.0 108.589 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' ARG . 16.5 mt 74.2 169.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.207 1.803 . . . . 10.0 109.723 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 42' ' ' ILE . 11.4 ptm180 -46.91 -39.61 12.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.915 1.686 . . . . 10.0 113.87 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.79 151.72 20.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.741 1.216 . . . . 10.0 111.415 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -164.2 -172.66 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.849 -0.797 . . . . 10.0 108.849 -164.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.71 39.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.645 1.178 . . . . 10.0 110.141 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.03 149.29 26.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.764 0.665 . . . . 10.0 109.411 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -124.2 103.32 8.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 104.756 -2.313 . . . . 10.0 104.756 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -159.2 -172.65 3.85 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.927 0.891 . . . . 10.0 111.579 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 m -145.59 125.17 13.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.699 -1.251 . . . . 10.0 110.259 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.28 132.58 35.35 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 103.946 -2.613 . . . . 10.0 103.946 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.8 m -129.35 88.24 2.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 125.001 1.438 . . . . 10.0 107.609 -164.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.39 128.47 33.38 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.388 -0.227 . . . . 10.0 110.388 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HB2' HD22 ' A' ' 26' ' ' LEU . 32.1 mmmt -141.82 57.02 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.9 m -156.16 -40.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.307 1.443 . . . . 10.0 111.071 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 65.99 62.22 0.61 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.034 1.734 . . . . 10.0 112.662 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -132.79 155.44 81.17 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.833 1.653 . . . . 10.0 108.052 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 75.97 4.63 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.895 3.063 . . . . 10.0 111.471 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.36 147.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 99.63 5.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.541 1.537 . . . . 10.0 111.019 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -82.6 121.55 26.96 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.595 -2.002 . . . . 10.0 105.595 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.75 54.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 122.207 1.003 . . . . 10.0 108.587 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.21 148.96 16.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.471 -1.051 . . . . 10.0 110.471 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.21 59.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.054 1.742 . . . . 10.0 107.762 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.94 29.68 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -169.59 149.16 3.56 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 118.799 0.727 . . . . 10.0 110.199 -172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.78 49.65 2.53 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.844 2.362 . . . . 10.0 110.434 168.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.55 -70.59 0.73 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.59 1.556 . . . . 10.0 107.202 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.48 147.27 33.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.144 1.378 . . . . 10.0 110.26 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -82.41 -36.4 26.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.948 0.899 . . . . 10.0 109.935 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.7 t -120.47 75.12 24.57 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.614 1.165 . . . . 10.0 110.94 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.84 101.09 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 10.0 110.413 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.4 mtt -109.51 128.55 55.26 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.091 1.757 . . . . 10.0 108.854 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.62 142.25 31.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.304 1.042 . . . . 10.0 108.821 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttm -148.24 153.14 38.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.663 0.785 . . . . 10.0 110.84 -173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.0 t -159.07 98.62 1.46 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.046 -1.034 . . . . 10.0 111.547 -161.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -138.94 59.48 1.62 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.795 0.807 . . . . 10.0 110.193 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.4 m -147.73 125.11 11.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.702 0.801 . . . . 10.0 109.436 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -77.47 64.12 2.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.251 1.421 . . . . 10.0 109.671 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 166.01 -20.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.489 2.716 . . . . 10.0 109.484 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.45 -149.41 6.0 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.672 -1.771 . . . . 10.0 108.672 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.48 -52.47 52.68 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 122.455 -0.438 . . . . 10.0 113.235 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -168.1 1.19 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.123 1.369 . . . . 10.0 110.356 -166.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.83 42.97 3.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.618 1.967 . . . . 10.0 108.134 -167.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -149.58 103.04 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.228 -1.149 . . . . 10.0 110.228 -171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.63 63.03 2.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.059 0.929 . . . . 10.0 108.773 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -131.36 167.09 19.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.644 1.977 . . . . 10.0 109.691 -172.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtm -79.67 75.7 6.33 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.037 -1.097 . . . . 10.0 108.037 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.13 163.67 43.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.495 -0.775 . . . . 10.0 111.498 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -37.26 -55.73 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.141 3.227 . . . . 10.0 112.632 161.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.9 p90 172.65 -165.3 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.275 2.63 . . . . 10.0 104.732 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.4 pt? -127.37 111.53 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.701 0.682 . . . . 10.0 110.945 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m -76.59 132.48 39.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 107.055 -1.461 . . . . 10.0 107.055 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.2 pt -100.95 100.95 14.14 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.084 1.354 . . . . 10.0 107.388 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.59 67.69 8.55 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.239 2.626 . . . . 10.0 110.211 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 58.38 177.93 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 -156.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 38.81 33.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.831 2.16 . . . . 10.0 116.831 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.07 70.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.971 1.272 . . . . 10.0 113.113 163.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -111.49 57.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.18 156.45 18.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.793 -0.447 . . . . 10.0 109.793 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.3 m -115.42 115.36 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -82.61 106.36 14.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -137.08 156.56 48.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.6 1.16 . . . . 10.0 110.26 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -47.44 -40.35 17.87 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.805 1.242 . . . . 10.0 113.93 -161.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -132.65 52.05 2.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.825 0.821 . . . . 10.0 109.909 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.9 63.78 0.22 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 19.8 t0 65.45 136.45 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 126.253 1.821 . . . . 10.0 109.891 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 179.82 -179.2 0.44 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.096 -1.003 . . . . 10.0 112.095 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.6 t -110.83 123.02 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 161.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.7 mtp -83.51 100.54 10.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 166.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.15 74.25 4.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.403 -1.703 . . . . 10.0 106.403 171.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.7 ttt -84.72 153.89 22.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.271 1.029 . . . . 10.0 110.567 -170.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 60.17 3.92 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.295 -0.878 . . . . 10.0 111.103 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.67 128.59 26.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.777 1.231 . . . . 10.0 111.008 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -76.45 -72.97 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.642 0.777 . . . . 10.0 111.67 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -116.43 156.98 46.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.509 1.124 . . . . 10.0 111.912 -163.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.75 144.16 99.51 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.091 2.527 . . . . 10.0 111.76 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.0 mt -118.33 142.58 47.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.726 1.61 . . . . 10.0 109.497 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.37 129.01 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.01 107.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 163.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 120.35 -13.34 10.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.675 -0.57 . . . . 10.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.75 -179.54 3.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 123.589 1.661 . . . . 10.0 108.525 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -154.2 129.66 9.87 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.517 -1.674 . . . . 10.0 106.907 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.15 145.79 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.31 -1.367 . . . . 10.0 107.31 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -73.9 143.47 45.76 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.809 -0.557 . . . . 10.0 109.732 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 tt -118.4 139.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 168.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -111.5 108.26 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.91 161.97 19.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -149.9 95.28 2.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.78 133.51 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 170.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -77.23 3.81 12.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.21 -15.57 35.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.375 0.67 . . . . 10.0 111.042 156.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.7 47.38 1.29 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.119 1.818 . . . . 10.0 109.935 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -109.95 155.35 21.88 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 86.0 m -156.35 73.15 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 103.919 -2.623 . . . . 10.0 103.919 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.71 127.85 54.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -161.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -92.68 132.87 36.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.912 1.685 . . . . 10.0 107.471 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.1 152.67 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.767 -1.938 . . . . 10.0 105.767 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.75 29.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.05 119.87 38.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.518 0.727 . . . . 10.0 109.643 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -83.17 127.15 33.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.82 98.45 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -159.27 139.67 12.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -61.16 -51.48 68.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.643 1.349 . . . . 10.0 114.643 -170.338 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 65.47 110.68 0.03 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.525 1.13 . . . . 10.0 111.606 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.9 pt 43.73 53.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.322 1.049 . . . . 10.0 112.121 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.32 163.15 27.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.836 1.254 . . . . 10.0 108.244 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.16 28.27 70.4 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 108.733 -1.747 . . . . 10.0 108.733 -151.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 C--O 1.261 1.69 0 C-N-CA 130.198 3.399 . . . . 10.0 102.374 176.116 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.1 171.25 37.96 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.03 -2.028 . . . . 10.0 108.03 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -163.83 162.82 23.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.847 -1.538 . . . . 10.0 106.847 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -160.52 174.68 13.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.2 ttt -158.03 88.83 2.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.18 1.392 . . . . 10.0 108.389 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -70.99 158.02 56.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.925 1.75 . . . . 10.0 109.991 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.78 163.98 31.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -165.36 168.9 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -152.99 122.83 3.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 172.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.55 141.49 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.331 2.021 . . . . 10.0 109.896 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.56 165.52 31.46 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.33 2.02 . . . . 10.0 109.9 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.92 151.93 27.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.054 -1.091 . . . . 10.0 108.054 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -171.04 173.56 5.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.508 1.523 . . . . 10.0 107.453 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -164.27 -179.94 6.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.61 68.65 0.74 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.213 1.405 . . . . 10.0 109.935 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.56 146.51 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.248 1.965 . . . . 10.0 110.259 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.26 156.12 23.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.35 162.1 16.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.894 1.278 . . . . 10.0 107.569 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -147.75 168.25 22.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.799 1.24 . . . . 10.0 108.184 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 173.63 12.81 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 171.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.45 178.13 9.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.58 177.04 43.32 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.104 -1.998 . . . . 10.0 108.104 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.08 173.56 15.0 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.549 -1.278 . . . . 10.0 107.549 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -142.51 166.05 25.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.684 -1.228 . . . . 10.0 107.684 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.75 165.07 37.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.9 138.14 12.14 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.566 0.747 . . . . 10.0 109.035 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.41 173.08 13.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.815 2.343 . . . . 10.0 110.438 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.605 HG22 ' HG ' ' A' ' 51' ' ' LEU . 9.9 p -81.89 62.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.907 0.861 . . . . 10.0 111.333 -166.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -156.6 59.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.178 -0.952 . . . . 10.0 109.527 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.13 58.35 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 123.101 1.429 . . . . 10.0 110.336 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 138.76 16.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.271 -0.877 . . . . 10.0 109.542 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 166.1 54.82 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.435 -1.466 . . . . 10.0 109.435 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.02 156.28 22.42 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.026 0.913 . . . . 10.0 110.8 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.4 p -123.7 156.71 35.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.1 140.16 48.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 38.49 0.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.02 -145.23 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.351 1.06 . . . . 10.0 109.933 -171.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.6 t -92.15 108.28 29.42 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 105.236 -2.135 . . . . 10.0 105.236 155.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 166.63 27.97 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 N-CA-C 108.017 -1.571 . . . . 10.0 108.017 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.05 64.26 5.13 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.589 2.193 . . . . 10.0 110.441 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -166.99 58.91 0.08 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.05 1.34 . . . . 10.0 108.755 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm 76.3 164.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.795 1.638 . . . . 10.0 110.327 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -37.2 63.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.851 1.26 . . . . 10.0 111.768 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -47.22 148.9 1.1 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.147 1.779 . . . . 10.0 111.52 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.2 t -153.94 -167.11 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.141 -0.688 . . . . 10.0 109.141 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.68 158.23 43.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.965 0.906 . . . . 10.0 108.766 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.22 154.06 24.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 124.051 0.844 . . . . 10.0 109.167 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -122.04 123.24 41.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 103.691 -2.707 . . . . 10.0 103.691 166.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -156.97 -177.03 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 m -149.08 125.67 11.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.591 -1.262 . . . . 10.0 107.591 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -83.56 134.89 34.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.213 -1.773 . . . . 10.0 106.213 171.441 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -135.77 97.43 3.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.045 1.338 . . . . 10.0 108.628 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -84.1 152.61 24.23 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.713 0.688 . . . . 10.0 109.977 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -139.25 56.72 1.67 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.27 -1.752 . . . . 10.0 106.27 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.5 t -175.15 164.26 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.164 -2.532 . . . . 10.0 104.164 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.67 81.51 1.64 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.969 0.793 . . . . 10.0 108.952 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.38 148.95 36.14 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 124.666 1.186 . . . . 10.0 108.43 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.05 72.88 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.41 2.74 . . . . 10.0 109.761 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -83.29 156.99 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 165.44 28.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.475 0.71 . . . . 10.0 110.215 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.455 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -139.13 128.05 23.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.222 -2.51 . . . . 10.0 104.222 179.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.91 52.12 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 122.423 1.106 . . . . 10.0 108.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.47 150.77 20.67 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.366 -0.834 . . . . 10.0 111.269 165.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.47 61.96 0.55 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.804 2.442 . . . . 10.0 106.207 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.45 91.14 6.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 -172.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 69' ' ' ALA . 5.1 t -104.88 133.6 20.07 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.795 1.238 . . . . 10.0 109.454 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.98 62.36 6.62 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.31 2.673 . . . . 10.0 109.001 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -162.97 -48.45 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.25 0.62 . . . . 10.0 111.093 -161.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 66' ' ' THR . . . -96.47 129.22 43.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -69.98 -34.04 72.85 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -128.84 73.07 81.55 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.19 0.996 . . . . 10.0 110.534 -170.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.8 122.68 9.07 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.198 1.932 . . . . 10.0 109.036 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.5 mtt -145.06 124.27 12.94 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.271 1.028 . . . . 10.0 110.015 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.8 mt -83.05 140.88 32.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.081 0.953 . . . . 10.0 109.925 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.9 ttm -141.07 152.17 44.6 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.596 1.158 . . . . 10.0 110.537 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -141.05 115.89 9.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.742 1.217 . . . . 10.0 111.284 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' THR 0.31 0.5 OUTLIER -145.83 59.86 1.25 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.302 1.223 . . . . 10.0 114.302 164.819 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 100' ' ' LEU . 1.1 t -143.84 120.83 11.37 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.416 -1.427 . . . . 10.0 109.854 171.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.59 61.5 2.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.224 1.41 . . . . 10.0 109.422 -173.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.5 m -163.32 -58.15 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.045 1.338 . . . . 10.0 109.168 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -95.16 -93.43 1.71 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.663 -1.775 . . . . 10.0 108.663 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.72 97.93 2.02 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.354 0.978 . . . . 10.0 110.777 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -94.39 141.14 28.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 169.75 62.9 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 125.369 1.468 . . . . 10.0 109.817 145.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.2 37.94 4.71 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.045 1.307 . . . . 10.0 114.685 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 ttm 58.81 37.83 24.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.259 1.423 . . . . 10.0 111.64 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 161.78 14.27 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.353 0.661 . . . . 10.0 110.682 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.2 ttp -80.68 114.91 19.9 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.68 168.92 8.56 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -166.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.416 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.9 Cg_endo -36.85 -58.15 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.246 2.631 . . . . 10.0 111.775 151.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 37.9 p90 166.54 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.555 2.742 . . . . 10.0 105.028 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.92 106.79 11.96 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.62 0.768 . . . . 10.0 111.274 175.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.4 m -81.62 130.89 35.22 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 163.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -107.41 131.9 21.37 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.76 139.75 25.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.34 1.36 . . . . 10.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 59.45 -151.7 0.41 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.235 0.614 . . . . 10.0 112.319 159.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 51.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.411 . . . . 10.0 113.649 168.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.56 153.85 43.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.62 1.105 . . . . 10.0 111.843 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.6 t -146.48 90.63 1.96 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 162.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 81' ' ' GLY . 15.8 tp -84.69 160.87 20.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.016 -0.993 . . . . 10.0 110.316 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.2 m -130.89 99.5 4.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.85 122.92 28.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -155.63 154.55 31.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.984 1.313 . . . . 10.0 108.838 -170.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -70.54 76.6 0.58 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.979 0.512 . . . . 10.0 110.833 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 155.56 -94.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.771 3.628 . . . . 10.0 106.207 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.4 73.18 0.32 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.649 2.071 . . . . 10.0 113.898 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 67.22 134.66 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.024 2.53 . . . . 10.0 111.207 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -170.08 171.23 7.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.72 0.771 . . . . 10.0 112.004 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.8 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.698 -2.334 . . . . 10.0 104.698 167.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.5 mtm -82.83 144.43 30.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.964 -1.125 . . . . 10.0 107.964 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -120.25 78.79 1.39 Allowed 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 128.165 2.586 . . . . 10.0 105.154 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.8 mtt -83.69 154.56 23.59 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.15 54.54 32.13 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.22 141.48 57.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -104.43 -64.98 1.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.979 1.312 . . . . 10.0 109.464 -168.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -59.49 150.24 66.33 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 122.098 0.159 . . . . 10.0 110.914 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.42 102.89 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 N-CA-C 107.207 -1.882 . . . . 10.0 107.207 159.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 161.02 1.64 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.64 0.776 . . . . 10.0 113.034 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -133.13 129.39 37.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.178 -1.416 . . . . 10.0 107.178 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.77 94.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.574 -1.639 . . . . 10.0 106.574 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.9 15.65 8.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.618 1.104 . . . . 10.0 111.967 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 167.95 14.97 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.963 1.381 . . . . 10.0 107.791 159.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -155.1 77.41 1.01 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.218 -2.265 . . . . 10.0 107.877 -163.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -92.9 126.57 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 -169.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -75.02 123.47 25.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 126' ' ' ILE . 12.6 pt -115.05 133.52 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.877 1.271 . . . . 10.0 108.525 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -91.03 125.81 35.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.068 -0.716 . . . . 10.0 109.068 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 24.8 mt -81.63 172.99 12.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -153.28 101.99 2.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.41 1.084 . . . . 10.0 108.158 164.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.9 149.05 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 162.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -42.04 -35.98 1.02 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.234 1.014 . . . . 10.0 111.493 168.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -11.33 9.32 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.682 2.793 . . . . 10.0 112.256 -175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.73 7.87 70.77 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -82.23 73.41 9.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.581 -1.266 . . . . 10.0 107.581 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -84.22 66.56 9.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.765 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.6 174.42 11.6 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.039 0.936 . . . . 10.0 109.125 -167.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -120.94 128.64 52.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.73 143.43 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.007 -1.108 . . . . 10.0 108.007 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -84.92 126.62 33.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.611 -0.885 . . . . 10.0 108.611 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.1 110.55 22.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.334 1.454 . . . . 10.0 109.323 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -88.77 105.63 17.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.249 1.42 . . . . 10.0 108.968 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.94 95.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 -168.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 57.48 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.943 1.247 . . . . 10.0 114.323 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt 62.04 169.91 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 122.584 1.183 . . . . 10.0 114.06 170.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -75.09 95.22 3.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.0 mt 75.17 -47.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.311 1.844 . . . . 10.0 111.963 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -34.48 123.52 0.52 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.586 1.954 . . . . 10.0 113.178 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 -96.61 0.7 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.268 -1.133 . . . . 10.0 110.268 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.188 1.795 . . . . 10.0 106.578 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.4 162.15 16.22 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.212 -1.155 . . . . 10.0 110.212 -168.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -109.13 -159.9 0.7 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.364 1.466 . . . . 10.0 109.027 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -155.62 -175.94 5.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.558 -1.645 . . . . 10.0 106.558 165.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.9 ptm -155.94 146.43 16.07 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 124.5 1.12 . . . . 10.0 108.845 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.61 165.02 29.6 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.729 2.286 . . . . 10.0 110.63 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 71.55 1.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.357 0.663 . . . . 10.0 109.26 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -70.01 74.74 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.105 0.962 . . . . 10.0 111.818 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -58.05 144.6 75.45 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -66.49 157.37 60.88 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 N-CA-C 108.529 -1.373 . . . . 10.0 108.529 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.81 -179.36 5.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.398 2.732 . . . . 10.0 109.848 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.16 151.47 40.14 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -117.92 158.88 24.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.126 0.97 . . . . 10.0 110.406 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -164.7 169.41 16.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.12 144.7 4.81 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.787 0.835 . . . . 10.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -80.46 -172.29 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.236 2.624 . . . . 10.0 109.636 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.83 161.89 35.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 133.89 11.7 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.187 0.595 . . . . 10.0 109.574 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -60.27 161.9 6.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.099 1.36 . . . . 10.0 111.165 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -145.33 -175.22 4.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.146 1.379 . . . . 10.0 107.725 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.04 54.88 6.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.024 0.93 . . . . 10.0 111.389 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.05 70.49 1.0 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.64 69.82 0.44 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.219 1.408 . . . . 10.0 111.085 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.68 87.91 0.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.014 1.726 . . . . 10.0 109.457 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -171.92 -44.44 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.004 1.321 . . . . 10.0 110.919 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.7 127.5 87.23 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 121.984 -0.447 . . . . 10.0 110.429 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.58 166.77 28.63 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.388 2.059 . . . . 10.0 110.356 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' VAL . 7.1 p -82.19 60.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.141 0.976 . . . . 10.0 110.567 -166.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -157.12 58.19 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.297 -0.877 . . . . 10.0 109.358 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.36 56.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.078 0.942 . . . . 10.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -149.92 136.14 18.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.636 -1.246 . . . . 10.0 107.636 167.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.17 132.77 23.74 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.083 -1.607 . . . . 10.0 109.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.72 150.94 19.99 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.479 0.64 . . . . 10.0 111.633 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 p -116.53 123.68 48.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.962 0.905 . . . . 10.0 108.646 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.22 121.53 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.568 0.747 . . . . 10.0 109.687 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.14 4.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.685 -0.634 . . . . 10.0 111.467 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -41.04 122.64 1.81 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.636 0.653 . . . . 10.0 110.266 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -33.65 124.27 0.46 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 116.032 1.864 . . . . 10.0 116.032 -144.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.31 165.83 2.83 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.929 2.42 . . . . 10.0 112.512 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -79.0 54.51 5.2 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.187 1.925 . . . . 10.0 109.346 163.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.7 p -139.49 51.67 1.75 Allowed 'General case' 0 C--N 1.341 0.225 0 O-C-N 121.477 -0.764 . . . . 10.0 110.576 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 43' ' ' ARG . 23.9 mt 86.5 173.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 127.608 2.363 . . . . 10.0 106.794 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 42' ' ' ILE . 18.6 ptt180 -72.57 50.63 0.24 Allowed 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.019 -1.05 . . . . 10.0 110.271 165.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.59 158.69 19.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.766 1.226 . . . . 10.0 109.432 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -157.82 169.15 25.27 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 157.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.01 153.23 25.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -173.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.91 147.49 23.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.469 1.106 . . . . 10.0 108.523 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -126.9 127.08 44.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.531 -2.396 . . . . 10.0 104.531 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.2 ptm -161.38 -174.63 4.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 10.0 107.06 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -125.5 117.35 23.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.049 0.94 . . . . 10.0 108.848 171.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.86 113.2 20.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.2 m -122.42 95.34 4.6 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.783 1.927 . . . . 10.0 108.616 -162.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -83.65 140.66 32.04 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.064 -0.397 . . . . 10.0 112.004 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -143.75 60.46 1.38 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -151.28 -39.95 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.916 1.286 . . . . 10.0 111.063 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t70 65.97 60.83 0.66 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.556 1.942 . . . . 10.0 110.339 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -140.89 152.15 64.67 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.256 1.823 . . . . 10.0 107.643 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.31 92.82 0.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.123 2.549 . . . . 10.0 110.658 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.96 145.85 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.412 0.625 . . . . 10.0 110.536 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -131.84 83.17 2.07 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.375 2.27 . . . . 10.0 109.792 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.56 72.55 9.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.359 -0.838 . . . . 10.0 111.293 -172.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.08 56.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 121.776 -0.577 . . . . 10.0 110.908 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.39 28.21 Favored Glycine 0 C--N 1.334 0.437 0 O-C-N 121.096 -1.002 . . . . 10.0 111.258 162.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 60.38 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.099 0.96 . . . . 10.0 109.338 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.58 162.03 23.29 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.199 -0.938 . . . . 10.0 109.3 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 147.66 3.55 Favored Pre-proline 0 C--O 1.238 0.496 0 O-C-N 121.831 -0.543 . . . . 10.0 109.54 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.04 57.51 6.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.669 2.246 . . . . 10.0 109.038 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -143.42 -70.06 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.182 0.593 . . . . 10.0 109.983 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.33 167.03 11.93 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.911 1.284 . . . . 10.0 110.798 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.6 m -101.89 -39.83 7.18 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.601 1.16 . . . . 10.0 112.168 -157.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -108.95 90.91 8.32 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.533 1.133 . . . . 10.0 109.726 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.55 90.51 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.008 2.472 . . . . 10.0 109.862 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -108.91 114.19 27.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.849 0.833 . . . . 10.0 109.637 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.24 134.22 36.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.728 -0.841 . . . . 10.0 108.728 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.84 174.98 6.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.605 1.562 . . . . 10.0 108.035 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.2 t -159.88 135.06 8.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 173.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.96 56.75 0.53 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 122.507 1.146 . . . . 10.0 107.961 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.6 m -149.58 123.36 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.726 0.81 . . . . 10.0 109.848 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -70.47 80.95 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.7 t 143.9 -9.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.684 3.193 . . . . 10.0 110.507 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.54 -140.7 9.26 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.204 -1.558 . . . . 10.0 109.204 169.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.76 -54.25 39.14 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.633 -0.587 . . . . 10.0 111.633 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.3 tpt -169.92 -166.32 0.55 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.022 2.129 . . . . 10.0 107.479 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -121.69 60.58 0.95 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.65 89.47 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.455 -1.058 . . . . 10.0 110.455 -163.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -76.65 64.65 2.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.196 0.998 . . . . 10.0 110.687 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 167.75 10.71 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.832 2.053 . . . . 10.0 108.181 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.9 mtt -78.83 85.34 4.82 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.012 -1.477 . . . . 10.0 107.012 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.51 156.25 88.89 Favored Pre-proline 0 N--CA 1.453 -0.315 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -51.33 -38.55 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.866 2.377 . . . . 10.0 111.144 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.494 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 30.6 p90 -176.8 171.89 2.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.71 2.404 . . . . 10.0 104.872 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.76 98.11 8.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.494 ' HG1' ' HE1' ' A' ' 91' ' ' TRP . 0.3 OUTLIER -77.34 131.12 37.94 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.95 109.77 60.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.43 69.8 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.723 2.282 . . . . 10.0 110.189 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.73 175.29 0.2 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 -167.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 35.72 23.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 118.651 2.834 . . . . 10.0 118.651 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -45.92 102.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.411 1.005 . . . . 10.0 112.057 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -131.25 55.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.925 -1.88 . . . . 10.0 105.925 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' H ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -101.7 164.29 11.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.2 m -128.85 114.74 16.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.997 -2.223 . . . . 10.0 104.997 -168.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.19 110.34 14.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.552 -2.388 . . . . 10.0 104.552 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -130.99 148.51 52.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.698 1.999 . . . . 10.0 108.981 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -26.56 -53.15 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.159 2.184 . . . . 10.0 113.896 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -139.95 64.85 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.389 0.676 . . . . 10.0 109.622 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.12 66.46 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 9.2 t0 65.34 149.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.462 1.505 . . . . 10.0 109.824 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 160.66 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.478 1.911 . . . . 10.0 111.539 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.56 128.26 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.191 -1.781 . . . . 10.0 106.191 166.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.5 mtm -92.63 109.06 20.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 168.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.32 77.6 9.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.224 -1.769 . . . . 10.0 106.224 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.76 154.34 23.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.86 74.65 1.26 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 121.212 -0.93 . . . . 10.0 110.992 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.24 138.64 16.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.664 1.232 . . . . 10.0 111.626 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -79.86 -59.39 2.75 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 162.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 179.11 -59.64 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.553 1.141 . . . . 10.0 112.763 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.68 89.11 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.84 1.694 . . . . 10.0 111.557 -166.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.82 156.53 44.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.832 1.253 . . . . 10.0 109.05 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.67 145.88 7.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.62 105.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.916 -1.512 . . . . 10.0 106.916 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.54 -60.83 0.26 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -71.99 -174.11 1.16 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.933 3.293 . . . . 10.0 111.618 -163.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.0 m -133.87 128.33 34.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.149 1.78 . . . . 10.0 106.664 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.53 140.09 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -77.97 126.21 30.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.319 -0.993 . . . . 10.0 108.319 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -80.28 179.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.23 -1.767 . . . . 10.0 106.23 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.4 m -144.31 114.24 7.31 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.835 -1.166 . . . . 10.0 108.838 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 140.85 31.62 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -147.08 86.5 1.64 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.129 -1.434 . . . . 10.0 107.129 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.06 145.76 28.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.339 0.256 . . . . 10.0 110.919 -169.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -56.39 -24.58 45.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.553 1.141 . . . . 10.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.77 -26.63 14.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.778 1.231 . . . . 10.0 113.238 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.65 52.33 1.22 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 109.75 -1.34 . . . . 10.0 109.75 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -144.78 160.45 41.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 m -131.45 143.79 50.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.6 tp -151.96 154.56 36.29 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -137.98 62.51 1.57 Allowed 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.527 1.531 . . . . 10.0 109.706 -161.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.66 141.11 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.57 124.63 30.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.01 130.61 54.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.057 0.943 . . . . 10.0 109.945 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -84.34 126.75 33.49 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 37' ' ' ALA . 7.8 t -87.12 100.78 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 -174.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -146.59 123.14 11.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.366 1.866 . . . . 10.0 108.194 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.68 -50.6 69.84 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.591 0.756 . . . . 10.0 110.36 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 62.0 -171.56 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.133 -0.692 . . . . 10.0 109.133 -159.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.3 pt -67.26 145.2 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -149.17 -179.42 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.81 56.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.634 -1.387 . . . . 10.0 109.634 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 C--O 1.262 1.721 0 N-CA-C 102.404 -3.184 . . . . 10.0 102.404 -135.845 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.28 -178.79 47.61 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.369 -2.292 . . . . 10.0 107.369 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -160.01 164.25 33.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.0 m -152.53 147.06 25.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.61 151.69 54.53 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.329 1.452 . . . . 10.0 108.561 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.27 177.03 7.77 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.642 2.228 . . . . 10.0 110.52 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.68 30.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -148.72 176.18 10.58 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.598 1.159 . . . . 10.0 108.042 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -154.07 135.45 8.84 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 106.846 -1.539 . . . . 10.0 106.846 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.86 159.42 48.28 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.167 1.911 . . . . 10.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.81 -178.69 4.29 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.231 2.621 . . . . 10.0 110.448 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.47 164.89 28.67 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.915 1.286 . . . . 10.0 107.649 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -144.25 166.94 23.64 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.582 1.153 . . . . 10.0 108.339 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 p -138.74 141.52 38.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.528 1.531 . . . . 10.0 107.396 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.83 149.76 66.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.495 1.118 . . . . 10.0 108.941 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.85 178.41 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.136 2.557 . . . . 10.0 110.692 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.1 166.52 32.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.96 1.304 . . . . 10.0 107.613 174.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.16 168.84 21.85 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.634 1.174 . . . . 10.0 107.923 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.33 148.6 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.94 136.96 7.2 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.05 1.34 . . . . 10.0 107.748 174.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.77 172.29 17.96 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.302 -1.369 . . . . 10.0 107.302 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.67 -160.01 28.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.303 -1.119 . . . . 10.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.32 -157.11 0.27 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 10.0 110.146 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 59.57 -143.21 0.58 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.195 0.598 . . . . 10.0 109.712 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.47 148.6 26.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tt -94.48 122.07 61.89 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.85 159.35 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.907 1.738 . . . . 10.0 109.607 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.5 m -82.45 53.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.229 0.538 . . . . 10.0 112.073 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.7 p -157.3 62.27 0.49 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -108.85 60.09 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 10.0 109.257 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -133.6 144.4 49.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.961 0.905 . . . . 10.0 110.954 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.94 86.84 1.11 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.38 139.84 29.18 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.809 0.444 . . . . 10.0 111.941 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -117.3 140.51 49.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.0 134.25 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.69 120.96 12.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.96 -68.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.0 110.322 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -142.43 104.96 5.48 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.728 1.611 . . . . 10.0 107.541 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -64.94 164.89 23.08 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.549 2.166 . . . . 10.0 109.882 171.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.75 66.71 5.77 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.784 2.989 . . . . 10.0 109.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -156.32 -48.01 0.07 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.064 2.146 . . . . 10.0 106.628 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mt 72.03 147.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.244 1.818 . . . . 10.0 108.672 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 75.53 -49.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.271 1.429 . . . . 10.0 111.766 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -79.67 153.94 28.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 168.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -171.9 172.57 4.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.144 1.378 . . . . 10.0 109.177 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -157.07 161.76 39.47 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.61 0.764 . . . . 10.0 111.816 -172.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.03 140.4 29.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 124.401 1.063 . . . . 10.0 109.441 167.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 25.7 m-85 -136.18 112.83 10.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.392 -1.336 . . . . 10.0 107.392 -174.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -163.48 -172.23 2.85 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 125.149 1.38 . . . . 10.0 109.396 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -125.11 121.63 34.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 10.0 109.868 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.81 135.69 34.89 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 120.188 1.358 . . . . 10.0 107.62 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -117.75 78.53 1.25 Allowed 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.806 1.316 . . . . 10.0 109.876 -169.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.47 100.33 8.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.438 0.637 . . . . 10.0 109.867 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -109.4 54.68 0.65 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.11 0.964 . . . . 10.0 109.68 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 p -177.89 148.0 0.5 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 175.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -88.87 69.32 8.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.772 0.829 . . . . 10.0 109.576 -173.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.97 127.18 23.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.18 99.81 1.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.362 2.708 . . . . 10.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.9 141.79 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -126.62 97.37 4.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.011 1.325 . . . . 10.0 108.516 171.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -81.42 132.61 35.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 175.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.18 53.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.3 158.94 31.75 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.63 -0.988 . . . . 10.0 110.63 163.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.87 127.21 6.5 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 158.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.46 144.06 23.48 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -172.55 155.99 3.37 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 118.352 0.524 . . . . 10.0 111.223 -163.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.27 -5.5 13.98 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.802 2.334 . . . . 10.0 112.599 164.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.66 -57.26 4.25 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.505 1.048 . . . . 10.0 111.892 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.51 161.07 37.38 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.554 1.141 . . . . 10.0 111.871 -168.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -93.46 -41.31 9.86 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.701 1.2 . . . . 10.0 111.74 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t -115.86 82.45 10.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.685 1.594 . . . . 10.0 109.498 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.75 107.5 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.897 2.398 . . . . 10.0 109.988 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.8 mmt -122.76 122.19 38.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.418 1.487 . . . . 10.0 109.352 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.15 138.33 33.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.726 0.81 . . . . 10.0 109.292 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.03 12.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.877 1.271 . . . . 10.0 110.137 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -139.74 119.86 13.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.88 -1.155 . . . . 10.0 107.88 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -141.18 48.29 1.68 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.3 m -156.43 80.54 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.058 -1.026 . . . . 10.0 109.799 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.57 86.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.257 1.023 . . . . 10.0 110.592 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 165.89 -41.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 127.452 2.301 . . . . 10.0 108.486 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.41 -83.34 1.32 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.168 -2.773 . . . . 10.0 106.168 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.02 -138.62 6.1 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.053 -1.219 . . . . 10.0 110.053 160.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.2 mmt -108.06 -161.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.155 2.182 . . . . 10.0 109.79 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.55 76.26 1.48 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.63 82.32 0.16 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.686 -1.365 . . . . 10.0 109.686 -170.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -77.64 60.61 2.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.159 0.981 . . . . 10.0 110.386 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -125.62 170.96 10.98 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.444 2.298 . . . . 10.0 107.481 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.8 mtt -80.24 72.87 7.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.87 155.8 75.91 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.076 -0.966 . . . . 10.0 109.62 176.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -60.69 -25.71 81.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.225 1.95 . . . . 10.0 112.359 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -175.73 179.57 1.37 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.394 1.878 . . . . 10.0 106.451 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -113.77 106.81 14.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.56 150.81 34.7 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.99 88.8 27.68 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.88 57.72 6.55 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.904 3.069 . . . . 10.0 110.718 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.47 154.95 0.06 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.698 1.237 . . . . 10.0 110.108 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 40.3 39.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.201 1.401 . . . . 10.0 114.733 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 69.56 0.17 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.619 -0.993 . . . . 10.0 110.619 160.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -84.55 57.0 4.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.324 -1.361 . . . . 10.0 107.324 167.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.76 171.62 8.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.849 0.833 . . . . 10.0 110.54 -167.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 t -128.4 128.98 45.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.147 -2.168 . . . . 10.0 105.147 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.92 103.58 9.73 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 104.092 -2.558 . . . . 10.0 104.092 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -147.42 175.21 10.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.685 -1.598 . . . . 10.0 106.685 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -39.63 -50.15 2.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.208 0.527 . . . . 10.0 111.877 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -98.76 16.15 23.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.219 2.608 . . . . 10.0 113.911 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.35 151.67 23.89 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 120.559 1.527 . . . . 10.0 111.362 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -34.98 97.41 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.043 1.737 . . . . 10.0 113.633 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -128.29 174.67 9.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.728 1.149 . . . . 10.0 112.003 -166.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.91 107.97 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.6 mtt -84.1 102.72 12.75 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 122.297 1.046 . . . . 10.0 108.906 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.54 70.0 10.18 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 105.669 -1.974 . . . . 10.0 105.669 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.5 ttm -83.72 148.53 27.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 -168.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.34 59.65 2.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.612 -1.395 . . . . 10.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 tt -50.47 128.06 19.12 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.307 1.843 . . . . 10.0 110.241 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.61 -71.64 0.54 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.071 0.549 . . . . 10.0 110.146 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.61 158.0 73.99 Favored Pre-proline 0 CA--C 1.533 0.319 0 O-C-N 121.982 -0.449 . . . . 10.0 110.135 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.3 73.86 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.317 2.012 . . . . 10.0 109.152 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.76 132.3 17.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 112.789 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -96.35 129.63 43.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.336 1.454 . . . . 10.0 109.492 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.4 105.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.08 16.2 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.912 -0.938 . . . . 10.0 112.313 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.19 -178.47 1.67 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.727 1.727 . . . . 10.0 108.735 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.9 m -155.66 124.59 6.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.614 -1.995 . . . . 10.0 105.614 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.97 145.14 29.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.92 130.33 39.2 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.162 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.9 pt -106.91 122.0 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 160.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 m -101.16 119.98 39.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 169.12 8.74 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.645 0.778 . . . . 10.0 110.029 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.65 96.6 2.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.17 1.788 . . . . 10.0 107.872 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.63 132.18 34.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.395 -0.595 . . . . 10.0 109.395 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 t -60.91 -15.49 31.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.262 0.625 . . . . 10.0 111.388 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.432 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 54.6 m-20 -67.17 -21.14 65.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.906 0.883 . . . . 10.0 112.059 171.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 131.33 -13.05 5.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.099 0.857 . . . . 10.0 112.418 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -81.07 73.02 8.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.872 1.336 . . . . 10.0 109.356 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.6 m -83.61 107.05 15.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 156.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.4 tp -156.11 149.42 24.56 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -106.22 131.03 53.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.295 2.238 . . . . 10.0 106.826 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.23 122.93 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.321 -1.733 . . . . 10.0 106.321 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.8 108.28 16.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.22 29.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.626 0.77 . . . . 10.0 109.665 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -82.26 127.21 32.97 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.342 -0.985 . . . . 10.0 108.342 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.1 t -90.0 91.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.204 -1.776 . . . . 10.0 106.204 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -158.67 140.01 13.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 166.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.07 153.12 39.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -145.53 141.02 27.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.023 -2.214 . . . . 10.0 105.023 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.4 pt 44.85 37.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.252 1.421 . . . . 10.0 112.315 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -150.28 95.26 2.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.101 -1.444 . . . . 10.0 107.101 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.53 -59.03 4.12 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.077 -1.609 . . . . 10.0 109.077 -162.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 105.472 -2.048 . . . . 10.0 105.472 161.062 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 106.657 -1.608 . . . . 10.0 106.657 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.49 152.95 8.61 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -168.88 172.24 7.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 t -160.75 179.37 8.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.729 . . . . 10.0 109.408 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.24 74.85 0.73 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.363 1.865 . . . . 10.0 108.042 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.82 154.85 67.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.894 1.729 . . . . 10.0 109.757 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.62 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -158.25 167.63 29.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.04 -1.467 . . . . 10.0 107.04 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -157.23 69.06 4.33 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.149 1.379 . . . . 10.0 108.566 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.35 151.69 82.7 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.187 1.925 . . . . 10.0 110.639 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.89 176.12 10.3 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.197 2.598 . . . . 10.0 111.03 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.3 164.81 29.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.058 1.343 . . . . 10.0 107.529 173.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -161.14 164.03 30.9 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -156.25 -175.25 5.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.98 87.14 2.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.831 1.252 . . . . 10.0 109.344 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.5 162.8 39.19 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.242 1.961 . . . . 10.0 110.599 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.19 171.96 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.258 1.423 . . . . 10.0 107.302 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.85 166.05 32.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.864 0.866 . . . . 10.0 108.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -78.33 -172.55 2.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.397 0.679 . . . . 10.0 110.332 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -156.47 174.48 15.37 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.241 1.016 . . . . 10.0 108.459 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.07 -146.75 0.44 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.432 1.093 . . . . 10.0 110.574 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.34 -63.12 2.6 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.241 -0.743 . . . . 10.0 111.241 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.72 97.22 0.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.446 0.698 . . . . 10.0 110.04 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.23 75.36 0.71 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.463 0.705 . . . . 10.0 110.941 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -158.13 172.82 17.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.442 1.897 . . . . 10.0 106.769 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tt -143.27 128.89 10.08 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 118.597 0.635 . . . . 10.0 109.739 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.86 177.48 8.75 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.634 2.222 . . . . 10.0 109.647 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.32 61.29 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.277 1.037 . . . . 10.0 111.647 -166.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -158.03 74.81 0.73 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.1 53.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 122.151 0.977 . . . . 10.0 110.281 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -152.7 139.11 18.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 163.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 147.62 35.55 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.092 -1.203 . . . . 10.0 110.092 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.12 152.52 29.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 10.0 110.443 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -133.44 125.73 29.67 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.751 -1.574 . . . . 10.0 106.751 170.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.47 137.84 45.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.436 1.095 . . . . 10.0 110.012 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.94 2.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.227 -0.589 . . . . 10.0 111.808 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.79 114.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.574 1.15 . . . . 10.0 111.286 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t 2.9 94.57 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.134 2.574 . . . . 10.0 113.365 -167.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.23 169.22 20.02 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.95 1.767 . . . . 10.0 108.487 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.74 60.11 4.31 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.812 2.341 . . . . 10.0 109.887 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -160.17 40.61 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.234 1.414 . . . . 10.0 108.429 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 43' ' ' ARG . 9.4 mm 69.48 -179.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.034 1.333 . . . . 10.0 109.081 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.588 ' H ' HG22 ' A' ' 42' ' ' ILE . 9.0 ptm180 -55.55 -29.11 58.38 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.064 0.946 . . . . 10.0 112.108 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.42 135.9 7.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.784 1.634 . . . . 10.0 109.67 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 t -160.82 -171.21 3.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -156.29 167.41 30.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.403 1.081 . . . . 10.0 109.828 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.67 153.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.909 0.755 . . . . 10.0 111.208 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 33.0 m-85 -138.52 112.33 8.39 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.571 -1.64 . . . . 10.0 106.571 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -162.25 -171.96 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.02 1.728 . . . . 10.0 107.634 -168.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -128.01 145.72 50.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.648 0.658 . . . . 10.0 111.592 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.35 113.31 25.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.403 -2.073 . . . . 10.0 105.403 156.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.03 82.17 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.66 137.47 34.46 Favored 'General case' 0 C--N 1.337 0.06 0 O-C-N 121.689 -0.632 . . . . 10.0 110.335 -168.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -128.48 54.66 1.74 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -158.33 128.88 6.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.584 1.954 . . . . 10.0 105.774 170.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.59 61.92 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.863 0.865 . . . . 10.0 110.119 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -134.27 135.98 25.1 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.392 1.477 . . . . 10.0 108.602 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.15 100.58 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.495 2.796 . . . . 10.0 111.167 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.26 95.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.73 117.68 22.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.748 0.819 . . . . 10.0 110.604 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.8 OUTLIER -88.8 123.37 33.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.424 1.49 . . . . 10.0 107.88 -174.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 7.1 p -143.54 55.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.695 0.759 . . . . 10.0 110.425 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.01 148.45 16.41 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.472 -1.451 . . . . 10.0 109.472 162.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.97 75.83 0.84 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.13 0.972 . . . . 10.0 109.029 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.53 157.52 16.18 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.498 0.719 . . . . 10.0 109.676 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -172.54 143.27 1.21 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.94 60.97 6.27 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.242 2.628 . . . . 10.0 109.777 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.68 -51.64 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.435 1.094 . . . . 10.0 108.471 -164.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.43 168.69 10.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.475 1.91 . . . . 10.0 109.837 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 m -134.6 -2.31 2.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.311 0.644 . . . . 10.0 112.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 m -152.11 70.44 7.71 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.852 -1.155 . . . . 10.0 109.885 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.61 128.9 11.35 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.84 2.36 . . . . 10.0 111.29 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 mmt -139.64 128.73 23.73 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.999 1.32 . . . . 10.0 109.453 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.46 136.87 33.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.683 0.793 . . . . 10.0 109.673 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.67 -179.36 3.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.875 1.67 . . . . 10.0 108.93 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.0 t -158.88 100.8 1.6 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.485 0.714 . . . . 10.0 109.687 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 t -149.96 56.82 0.96 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.257 -0.902 . . . . 10.0 109.24 -169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -124.46 146.36 48.98 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.926 1.29 . . . . 10.0 108.91 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -101.74 44.92 0.99 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.0 t -163.93 -52.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.243 0.617 . . . . 10.0 111.184 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.88 -110.4 0.57 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.24 -144.86 0.35 Allowed Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.098 0.949 . . . . 10.0 113.699 170.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.4 ttm -75.82 162.88 27.78 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.865 1.266 . . . . 10.0 109.952 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.6 49.94 0.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.999 1.72 . . . . 10.0 107.756 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.7 92.25 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.565 -1.014 . . . . 10.0 110.565 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 ttp -64.21 84.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.554 1.177 . . . . 10.0 112.052 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -133.28 156.66 47.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.214 2.606 . . . . 10.0 106.769 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.4 mtm -80.38 143.49 33.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.913 -1.514 . . . . 10.0 106.913 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.93 165.1 29.96 Favored Pre-proline 0 N--CA 1.455 -0.205 0 C-N-CA 123.686 0.794 . . . . 10.0 109.776 -171.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -43.51 -54.37 3.67 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.686 2.257 . . . . 10.0 110.404 158.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.424 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 175.36 -149.58 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.151 2.181 . . . . 10.0 108.613 -177.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.86 158.27 43.87 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.332 1.853 . . . . 10.0 106.054 160.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.5 m -97.47 124.57 41.73 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.52 -0.918 . . . . 10.0 108.52 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.49 121.73 68.05 Favored Pre-proline 0 N--CA 1.454 -0.232 0 N-CA-C 105.325 -2.102 . . . . 10.0 105.325 171.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.97 146.15 16.03 Favored 'Trans proline' 0 N--CA 1.441 -1.571 0 N-CA-C 109.261 -1.092 . . . . 10.0 109.261 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 47.36 -138.4 0.71 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.958 0.903 . . . . 10.0 112.539 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.67 32.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.747 2.419 . . . . 10.0 114.494 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.8 150.76 38.6 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.994 -1.066 . . . . 10.0 113.075 -169.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -132.01 61.66 1.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.988 1.315 . . . . 10.0 108.359 -171.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.65 148.58 30.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.9 m -135.47 107.54 7.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.22 114.35 18.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -131.53 159.75 37.27 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.249 1.42 . . . . 10.0 109.845 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -25.0 -65.26 0.05 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.201 2.2 . . . . 10.0 113.566 -173.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.09 80.63 1.84 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.377 -1.712 . . . . 10.0 106.377 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.83 86.76 0.1 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 108.86 -1.696 . . . . 10.0 108.86 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 t0 40.95 74.61 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.129 1.771 . . . . 10.0 112.176 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -131.07 172.31 12.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.332 -1.758 . . . . 10.0 110.867 -154.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.7 108.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 125.668 1.587 . . . . 10.0 108.715 -173.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 33.0 mtp -83.04 96.39 8.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.405 0.682 . . . . 10.0 109.723 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.48 70.17 7.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.809 -1.552 . . . . 10.0 106.809 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.22 164.99 22.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.431 -1.322 . . . . 10.0 107.431 -168.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.28 46.57 20.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.323 -1.111 . . . . 10.0 110.323 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.4 mt -55.27 130.27 41.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.737 1.268 . . . . 10.0 108.917 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -69.17 0.13 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.506 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 173.97 -63.63 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.221 1.409 . . . . 10.0 112.91 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.09 50.14 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.544 2.163 . . . . 10.0 112.741 -159.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.54 157.01 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.212 1.005 . . . . 10.0 110.52 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 171.93 7.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.954 -1.128 . . . . 10.0 107.954 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.27 128.09 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 163.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 33.17 39.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.499 -0.64 . . . . 10.0 111.499 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.96 -172.7 4.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.462 1.125 . . . . 10.0 108.486 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.6 m -155.81 124.78 6.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.027 1.731 . . . . 10.0 107.499 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.89 152.5 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.96 -1.496 . . . . 10.0 106.96 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -70.87 132.23 44.95 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.0 154.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 106.125 -1.805 . . . . 10.0 106.125 155.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -129.82 128.49 42.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 158.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.41 156.39 24.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -147.7 69.41 1.14 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.69 117.69 21.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p 40.95 -99.79 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.585 1.554 . . . . 10.0 109.896 -167.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 42.79 0.93 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.27 2.228 . . . . 10.0 107.411 170.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.09 -48.12 0.23 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.22 1.866 . . . . 10.0 110.166 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -115.1 73.2 0.82 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.093 0.947 . . . . 10.0 108.637 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 m -86.29 100.94 12.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 160.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 mt -155.3 164.41 38.81 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 122.736 0.415 . . . . 10.0 110.547 -165.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -132.46 65.28 1.59 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.712 2.005 . . . . 10.0 109.553 -159.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.7 t -81.71 149.3 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 -171.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.32 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.151 -0.968 . . . . 10.0 109.626 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.66 120.48 40.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.844 1.258 . . . . 10.0 109.739 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -83.78 148.47 27.01 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 166.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.73 100.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -156.8 126.81 6.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.294 0.952 . . . . 10.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 98.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.441 0.564 . . . . 10.0 111.39 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -72.45 75.84 1.04 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.496 0.718 . . . . 10.0 109.958 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.5 mt 67.5 77.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.45 1.1 . . . . 10.0 108.877 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -145.91 105.93 4.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.56 -64.31 3.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.27 -1.932 . . . . 10.0 108.27 -158.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 105.886 -1.894 . . . . 10.0 105.886 165.465 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 117.907 -1.044 . . . . 10.0 108.374 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.96 76.59 1.16 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.519 -1.032 . . . . 10.0 110.519 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -155.25 157.5 37.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.246 -1.39 . . . . 10.0 107.246 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -173.51 -178.56 1.68 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.611 1.564 . . . . 10.0 107.87 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.56 75.55 0.29 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.387 1.875 . . . . 10.0 108.435 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.18 145.15 30.49 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.241 1.961 . . . . 10.0 110.062 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.66 161.17 23.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.272 1.029 . . . . 10.0 108.29 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -163.45 177.71 8.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.853 -1.536 . . . . 10.0 106.853 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -167.99 68.06 0.81 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.408 1.083 . . . . 10.0 109.724 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.06 121.47 8.65 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.321 2.014 . . . . 10.0 110.19 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.89 168.58 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.86 2.373 . . . . 10.0 111.28 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.74 36.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.19 1.396 . . . . 10.0 107.438 172.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -172.58 172.31 4.31 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.185 1.394 . . . . 10.0 108.289 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -164.43 -179.27 5.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.881 1.272 . . . . 10.0 107.6 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 74.41 0.53 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.461 1.505 . . . . 10.0 109.773 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.72 130.76 18.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.371 2.047 . . . . 10.0 111.301 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.06 86.88 0.56 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.31 0.644 . . . . 10.0 109.815 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.34 0.15 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.865 1.266 . . . . 10.0 112.677 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -74.94 70.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.772 1.229 . . . . 10.0 109.921 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -71.04 75.94 0.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.963 0.905 . . . . 10.0 110.873 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.25 78.5 0.06 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.74 1.216 . . . . 10.0 111.061 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.49 120.67 5.09 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.897 1.236 . . . . 10.0 112.252 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.4 1.53 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.131 0.972 . . . . 10.0 111.698 -175.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 73.71 147.7 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.572 1.949 . . . . 10.0 112.445 172.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.24 167.55 30.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.302 1.041 . . . . 10.0 108.495 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.68 158.04 73.89 Favored Pre-proline 0 N--CA 1.443 -0.812 0 C-N-CA 125.602 1.561 . . . . 10.0 107.439 172.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 -36.11 1.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.177 1.251 . . . . 10.0 111.462 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -135.89 172.49 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 122.679 1.228 . . . . 10.0 112.047 -171.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -78.43 66.26 3.94 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.526 3.131 . . . . 10.0 108.929 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.75 88.96 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.154 1.382 . . . . 10.0 108.951 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -147.94 134.42 19.71 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.67 154.81 47.59 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.589 1.09 . . . . 10.0 112.497 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.42 162.48 13.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.641 0.734 . . . . 10.0 112.22 -170.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 p -139.63 157.98 44.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.557 -1.275 . . . . 10.0 107.557 164.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.91 136.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.243 -1.392 . . . . 10.0 107.243 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.51 40.75 0.74 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.794 -1.191 . . . . 10.0 112.998 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . . . 41.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.107 1.363 . . . . 10.0 110.111 -164.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.58 125.46 47.02 Favored Pre-proline 0 C--O 1.239 0.517 0 CA-C-N 120.095 1.316 . . . . 10.0 107.841 160.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.19 174.06 4.47 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.261 1.974 . . . . 10.0 108.693 162.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.95 54.84 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.215 1.943 . . . . 10.0 109.801 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 m -144.29 62.6 1.34 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.978 1.311 . . . . 10.0 107.711 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 mm 73.72 164.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.923 1.289 . . . . 10.0 109.723 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -77.38 50.07 0.76 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.217 1.407 . . . . 10.0 109.862 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -138.72 159.81 41.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.059 2.144 . . . . 10.0 108.46 -162.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.1 t -172.0 -179.43 2.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.472 1.109 . . . . 10.0 109.948 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.28 161.33 37.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.334 1.454 . . . . 10.0 109.157 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.96 156.54 21.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 165.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -130.19 108.63 10.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.17 -2.529 . . . . 10.0 104.17 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ptp -157.12 -176.8 6.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.681 1.192 . . . . 10.0 109.461 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.9 m -127.59 119.12 25.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.086 1.355 . . . . 10.0 109.053 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.32 109.23 12.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 103.605 -2.739 . . . . 10.0 103.605 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -95.93 70.65 2.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.482 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.51 130.25 35.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.272 -0.971 . . . . 10.0 109.829 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -136.1 56.26 1.83 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 p -157.83 166.14 33.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.312 0.577 . . . . 10.0 110.821 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -107.89 27.26 9.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.901 2.88 . . . . 10.0 110.33 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -114.73 134.4 22.41 Favored Pre-proline 0 C--N 1.342 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 107.609 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.63 122.01 8.48 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.113 1.875 . . . . 10.0 109.891 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.26 81.91 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -79.28 -180.0 7.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.062 0.458 . . . . 10.0 110.32 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -155.64 136.14 13.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.666 -2.346 . . . . 10.0 104.666 -170.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -151.55 54.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.276 0.944 . . . . 10.0 109.52 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.18 151.0 20.01 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.783 -1.198 . . . . 10.0 111.116 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.78 70.95 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.484 1.514 . . . . 10.0 108.392 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.64 140.71 32.02 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 t -168.21 145.04 3.35 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 118.562 0.619 . . . . 10.0 111.313 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.95 52.99 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.937 2.425 . . . . 10.0 110.023 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 tp -128.87 -61.24 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.439 1.096 . . . . 10.0 109.564 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.24 162.44 18.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.61 1.564 . . . . 10.0 109.601 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 m -87.86 -42.7 12.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.588 0.755 . . . . 10.0 110.625 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 t -123.38 89.97 50.76 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.654 1.182 . . . . 10.0 110.181 -163.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.68 85.11 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.89 2.393 . . . . 10.0 109.904 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.0 mtt -83.69 117.83 23.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.152 0.981 . . . . 10.0 108.618 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.16 128.63 33.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.458 -0.776 . . . . 10.0 109.571 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.76 144.68 39.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.918 1.287 . . . . 10.0 110.787 -174.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.89 170.11 13.43 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.467 0.651 . . . . 10.0 111.991 164.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -98.46 177.43 5.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.42 1.888 . . . . 10.0 113.527 164.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -95.21 72.05 3.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.046 1.739 . . . . 10.0 108.969 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.09 73.03 0.44 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.245 1.418 . . . . 10.0 112.921 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -164.39 54.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.31 -90.06 0.49 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 106.992 -2.443 . . . . 10.0 106.992 -167.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.37 173.87 19.06 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 117.223 0.511 . . . . 10.0 112.706 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mtp -53.75 -87.48 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.645 1.978 . . . . 10.0 115.547 -158.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -174.94 34.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.666 0.666 . . . . 10.0 111.922 -160.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.79 140.39 2.91 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.827 -0.909 . . . . 10.0 110.827 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.6 ttp -65.62 93.59 0.17 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.739 0.769 . . . . 10.0 110.062 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.26 161.38 38.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.432 0.693 . . . . 10.0 112.464 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 68.9 mtp -82.84 109.42 16.96 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.071 1.748 . . . . 10.0 110.081 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.09 166.51 10.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.391 0.676 . . . . 10.0 111.525 -170.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.414 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.4 Cg_endo -37.73 -53.1 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.251 2.634 . . . . 10.0 111.027 156.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 44.6 p90 175.07 -172.18 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.056 2.142 . . . . 10.0 105.593 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.3 pt? -116.1 102.3 9.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.473 0.654 . . . . 10.0 110.548 174.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.7 m -76.8 120.85 22.52 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 pt -92.48 115.38 64.69 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.315 -1.365 . . . . 10.0 107.315 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.05 59.06 7.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.74 2.293 . . . . 10.0 108.514 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.73 -175.82 0.14 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.26 1.024 . . . . 10.0 109.551 -161.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 54.6 -2.34 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 118.024 2.602 . . . . 10.0 118.024 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.61 77.74 0.49 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.761 1.172 . . . . 10.0 111.986 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.4 t -82.43 56.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 166.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.59 -178.16 4.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.98 0.895 . . . . 10.0 110.656 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -127.75 129.13 46.56 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.18 1.792 . . . . 10.0 106.562 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.77 114.39 26.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 103.752 -2.685 . . . . 10.0 103.752 167.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.99 159.85 38.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.343 1.057 . . . . 10.0 109.971 -164.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -44.89 -54.6 6.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.153 1.381 . . . . 10.0 113.349 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.8 -63.31 1.24 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.783 0.833 . . . . 10.0 111.419 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.24 135.81 3.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -165.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 70.78 119.96 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 130.885 3.674 . . . . 10.0 106.246 -170.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 176.43 171.67 0.43 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.605 0.762 . . . . 10.0 109.242 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.22 123.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.139 -2.171 . . . . 10.0 105.139 154.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 69.0 mtp -82.84 101.6 11.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.104 -1.443 . . . . 10.0 107.104 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.38 74.3 8.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.708 1.603 . . . . 10.0 107.045 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 52.1 ttm -84.6 149.47 25.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.231 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.46 68.82 1.27 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.704 -0.959 . . . . 10.0 110.704 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -35.37 133.94 0.32 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.121 1.768 . . . . 10.0 112.985 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -67.53 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.745 -0.645 . . . . 10.0 111.689 157.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -168.9 -59.3 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 115.984 1.846 . . . . 10.0 115.984 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.39 75.66 4.81 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.904 1.736 . . . . 10.0 111.113 -166.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.17 48.32 2.41 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.389 1.076 . . . . 10.0 111.882 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -63.69 148.21 49.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.22 108.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.29 55.77 3.0 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -166.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 -179.8 4.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 153.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.1 m -155.66 134.93 12.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.284 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.01 136.7 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.656 -1.609 . . . . 10.0 106.656 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -79.23 114.76 18.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 167.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -81.2 -178.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 168.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 m -139.13 120.19 14.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 160.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 pp -83.69 172.65 12.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -156.72 103.39 2.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 134' ' ' ARG . . . -84.45 120.69 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.06 -1.089 . . . . 10.0 108.06 157.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -48.33 -34.51 10.72 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.594 1.558 . . . . 10.0 111.053 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.1 -33.75 53.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.759 2.023 . . . . 10.0 111.806 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.82 56.84 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.231 0.92 . . . . 10.0 111.032 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 130' ' ' ALA . 68.2 ttt180 -141.65 133.72 27.64 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.5 t -156.01 59.6 0.59 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.659 0.663 . . . . 10.0 110.754 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.98 148.97 27.27 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.005 0.522 . . . . 10.0 109.885 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -95.92 65.81 2.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 127.735 2.414 . . . . 10.0 108.262 -174.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.77 146.96 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -155.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.73 130.53 35.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.62 115.08 23.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.951 1.3 . . . . 10.0 109.453 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.7 m -84.41 132.73 34.55 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.37 120.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -159.7 94.1 1.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.057 0.844 . . . . 10.0 112.379 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 15.9 ptmt -65.96 -39.05 90.09 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.18 60.98 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.852 0.861 . . . . 10.0 110.87 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.7 mm -144.28 -54.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 127.93 2.492 . . . . 10.0 106.018 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -52.66 -59.11 4.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.849 1.66 . . . . 10.0 110.784 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.05 34.22 58.77 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.16 -1.356 . . . . 10.0 115.796 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 129.841 3.256 . . . . 10.0 104.363 162.326 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.606 -1.627 . . . . 10.0 106.606 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.87 165.03 7.15 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -167.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -107.28 157.19 18.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.319 1.448 . . . . 10.0 109.402 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.4 p -145.23 170.57 16.02 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.374 1.47 . . . . 10.0 107.112 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.24 148.45 21.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.904 -1.147 . . . . 10.0 107.904 175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.43 68.37 6.89 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.141 2.56 . . . . 10.0 110.317 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.56 64.8 1.22 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.687 0.795 . . . . 10.0 110.734 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -146.44 174.61 11.23 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.59 1.556 . . . . 10.0 108.577 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 m -153.43 134.77 8.54 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 106.148 -1.797 . . . . 10.0 106.148 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 144.78 48.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.673 1.582 . . . . 10.0 109.953 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.16 -35.93 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.536 2.157 . . . . 10.0 110.327 173.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.99 123.86 21.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.17 0.588 . . . . 10.0 110.186 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -65.51 163.02 16.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.288 0.635 . . . . 10.0 109.843 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -42.51 135.93 2.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.819 1.648 . . . . 10.0 112.032 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.05 140.59 69.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 10.0 111.294 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.37 151.4 53.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.908 2.405 . . . . 10.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.83 96.3 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.044 0.537 . . . . 10.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 67.53 -65.31 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.228 1.811 . . . . 10.0 113.344 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -72.45 71.56 0.94 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.103 . . . . 10.0 110.745 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -152.77 -81.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.848 0.459 . . . . 10.0 110.02 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.12 170.94 8.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.355 1.062 . . . . 10.0 110.39 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.48 -71.31 1.29 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.595 0.617 . . . . 10.0 112.239 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.73 109.6 0.59 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.394 1.078 . . . . 10.0 112.377 -168.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -77.64 131.84 37.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 168.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 176.45 -47.52 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.551 1.94 . . . . 10.0 108.631 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.29 128.68 85.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.954 0.901 . . . . 10.0 110.533 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.21 179.11 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.706 2.271 . . . . 10.0 110.36 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.23 56.1 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.688 -0.632 . . . . 10.0 111.237 -165.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 p -156.13 57.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.507 -0.746 . . . . 10.0 109.995 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.24 58.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 CA-C-O 122.569 1.176 . . . . 10.0 110.632 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.95 155.75 41.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 164.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.52 -163.23 6.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.366 -1.094 . . . . 10.0 110.366 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.0 133.77 30.52 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -120.46 110.64 16.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.65 128.78 53.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.397 0.679 . . . . 10.0 109.375 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.08 110.34 12.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.873 0.368 . . . . 10.0 111.314 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.44 127.14 14.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.572 -0.728 . . . . 10.0 109.617 167.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -13.05 95.74 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 128.29 2.636 . . . . 10.0 113.281 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.47 178.86 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.692 2.261 . . . . 10.0 109.377 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -67.52 68.05 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.408 2.072 . . . . 10.0 108.548 156.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -153.8 35.28 0.44 Allowed 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 126.216 1.806 . . . . 10.0 108.206 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 43' ' ' ARG . 18.2 mt 64.8 -176.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -70.19 32.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.468 -1.395 . . . . 10.0 113.552 170.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 155.16 20.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 163.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -164.94 -178.15 5.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.669 -1.234 . . . . 10.0 107.669 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 165.0 29.32 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.883 0.873 . . . . 10.0 109.887 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.69 33.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.308 -1.314 . . . . 10.0 107.71 164.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.16 104.36 12.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 -173.4 4.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.49 1.116 . . . . 10.0 110.423 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.8 m -116.56 143.96 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.038 1.735 . . . . 10.0 107.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.42 121.7 40.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.723 -1.955 . . . . 10.0 105.723 158.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -129.42 114.93 16.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.583 1.553 . . . . 10.0 109.045 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -93.29 136.93 33.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.82 0.848 . . . . 10.0 112.317 -172.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -134.2 56.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.713 -1.218 . . . . 10.0 107.713 161.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -137.33 -51.5 0.65 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.82 0.848 . . . . 10.0 111.031 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.5 48.43 3.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.659 1.584 . . . . 10.0 110.449 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.69 137.99 31.06 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.63 119.04 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.876 2.384 . . . . 10.0 109.705 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 mt -122.96 135.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -98.6 99.73 10.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.385 1.074 . . . . 10.0 108.904 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -87.2 117.56 26.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.75 -1.944 . . . . 10.0 105.75 -178.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.17 51.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.485 0.714 . . . . 10.0 109.488 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.95 138.34 5.35 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.925 -1.27 . . . . 10.0 109.925 160.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.56 66.57 0.49 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.257 1.423 . . . . 10.0 107.73 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.0 21.09 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.061 0.544 . . . . 10.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 t -173.46 140.22 0.85 Allowed Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.39 65.82 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.27 2.646 . . . . 10.0 108.932 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.26 -50.68 0.08 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.957 1.303 . . . . 10.0 108.766 -164.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.93 31.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m -88.98 -22.31 23.09 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 167.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -134.3 88.15 31.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.709 1.204 . . . . 10.0 108.492 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.79 124.36 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.324 2.683 . . . . 10.0 110.424 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -132.04 152.04 51.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.578 1.151 . . . . 10.0 108.95 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.1 157.06 18.45 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.236 0.615 . . . . 10.0 110.217 166.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.93 153.81 32.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.794 1.237 . . . . 10.0 109.354 -176.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 15.1 t -139.57 121.04 15.08 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.947 0.794 . . . . 10.0 112.408 -173.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -146.88 51.22 1.1 Allowed 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.559 -1.338 . . . . 10.0 110.305 165.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.6 m -150.28 90.74 1.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.487 1.115 . . . . 10.0 111.85 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -34.67 -42.98 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.805 2.442 . . . . 10.0 113.566 172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -50.29 -26.29 4.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.644 1.178 . . . . 10.0 113.409 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.22 -51.41 0.11 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 -124.57 4.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.162 0.887 . . . . 10.0 111.245 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.3 tpp -141.74 -121.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.067 0.934 . . . . 10.0 111.186 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.07 62.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -166.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.32 87.36 0.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.795 -1.722 . . . . 10.0 108.795 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 64.43 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.463 -0.94 . . . . 10.0 108.463 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -147.08 172.89 13.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.674 2.39 . . . . 10.0 107.847 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttp -80.15 74.73 6.95 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.799 0.809 . . . . 10.0 109.054 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.73 160.81 24.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.701 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.23 80.14 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.957 2.438 . . . . 10.0 109.69 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 58.21 -164.95 0.18 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.954 2.102 . . . . 10.0 113.482 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.75 99.15 5.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.797 0.839 . . . . 10.0 109.27 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.0 m -82.15 125.46 30.91 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.726 -0.608 . . . . 10.0 109.649 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.33 122.11 60.34 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.34 65.45 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.816 2.344 . . . . 10.0 110.847 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.99 -175.32 0.15 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.877 0.871 . . . . 10.0 109.462 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . 0.258 0.1 OUTLIER 5.9 44.21 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 130.164 3.385 . . . . 10.0 118.831 -169.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -54.29 138.01 40.56 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.316 0.96 . . . . 10.0 113.534 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.8 m -149.85 59.63 0.99 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.433 1.493 . . . . 10.0 107.177 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.96 164.75 12.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.677 0.275 . . . . 10.0 110.524 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.8 m -124.19 104.73 9.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.54 122.21 27.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.63 -1.618 . . . . 10.0 106.63 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -156.17 157.51 36.04 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.606 1.963 . . . . 10.0 107.726 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 0.25 0.2 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.476 1.658 . . . . 10.0 115.476 -161.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.45 -72.04 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.994 1.717 . . . . 10.0 108.09 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.28 76.61 1.45 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 125.136 1.351 . . . . 10.0 111.176 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 8.9 t70 70.03 134.58 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.095 1.758 . . . . 10.0 110.696 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -177.47 176.22 1.32 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.896 0.855 . . . . 10.0 113.013 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.59 121.37 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 157.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.2 mtp -82.22 104.99 12.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 165.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.63 74.52 6.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.628 1.971 . . . . 10.0 109.148 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -91.16 149.13 21.92 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.934 -0.479 . . . . 10.0 112.271 -170.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 33.56 3.0 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.582 0.993 . . . . 10.0 115.582 157.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 37.95 46.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 128.424 2.69 . . . . 10.0 116.769 160.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.092 -1.005 . . . . 10.0 112.719 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -133.11 151.72 78.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 107.086 -1.45 . . . . 10.0 107.086 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.39 75.06 2.5 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.003 2.468 . . . . 10.0 109.279 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mp -40.54 105.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.386 2.274 . . . . 10.0 113.3 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.73 131.64 34.41 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.1 p -60.67 103.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 162.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.69 -0.61 15.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.978 -0.901 . . . . 10.0 112.148 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.16 179.97 4.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 123.94 1.828 . . . . 10.0 108.281 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -155.81 132.75 10.59 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.534 -2.121 . . . . 10.0 106.55 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.75 143.88 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -79.22 124.64 28.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 tt -81.52 170.4 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -146.42 118.44 8.24 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.155 -0.966 . . . . 10.0 109.073 165.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.1 151.54 24.06 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.318 -1.364 . . . . 10.0 107.318 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -154.48 78.7 1.08 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.1 123.56 27.47 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p 44.89 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.175 1.79 . . . . 10.0 110.001 -161.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -164.32 58.36 0.15 Allowed 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.731 0.813 . . . . 10.0 109.521 156.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.71 27.44 1.63 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.22 61.04 1.17 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.186 0.994 . . . . 10.0 108.428 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.1 m -83.0 60.11 5.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.794 0.838 . . . . 10.0 110.27 -170.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.88 149.92 26.82 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -130.55 60.74 1.62 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.543 1.937 . . . . 10.0 109.509 -169.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.0 151.12 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 121.938 -0.476 . . . . 10.0 109.991 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.96 119.6 24.64 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.364 -0.835 . . . . 10.0 109.294 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.85 133.45 42.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.222 1.009 . . . . 10.0 108.799 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.6 m -83.0 144.29 30.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.525 -1.287 . . . . 10.0 107.525 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.43 107.28 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 172.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -156.69 147.11 21.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -63.7 162.55 13.03 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.603 0.716 . . . . 10.0 111.024 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -145.66 107.38 4.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.024 1.33 . . . . 10.0 107.433 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp 56.4 78.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.106 1.362 . . . . 10.0 109.262 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.01 121.84 1.06 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.037 -2.208 . . . . 10.0 105.037 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.43 41.33 11.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.701 -1.76 . . . . 10.0 108.701 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 . . . . . 0 C--O 1.256 1.436 0 C-N-CA 125.689 1.596 . . . . 10.0 109.209 -167.43 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 106.697 -1.594 . . . . 10.0 106.697 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.73 166.09 2.34 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 108.931 -1.668 . . . . 10.0 108.931 -137.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -170.2 172.71 6.16 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.527 1.531 . . . . 10.0 106.888 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -134.37 173.58 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.262 1.425 . . . . 10.0 108.514 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.7 ptm -148.73 150.58 33.53 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 108.299 -1.001 . . . . 10.0 108.299 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.07 178.28 7.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.987 2.458 . . . . 10.0 110.359 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.38 159.08 44.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -165.33 174.26 10.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -139.59 148.0 54.3 Favored Pre-proline 0 C--O 1.232 0.138 0 C-N-CA 125.001 1.32 . . . . 10.0 108.417 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -65.84 159.95 46.29 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 N-CA-C 108.803 -1.268 . . . . 10.0 108.803 162.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.08 -173.76 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.488 2.792 . . . . 10.0 110.053 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.14 166.48 23.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.007 1.323 . . . . 10.0 107.447 170.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -158.88 171.13 20.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.085 0.954 . . . . 10.0 108.688 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.3 p -134.3 -179.69 5.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.851 1.66 . . . . 10.0 107.727 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.53 148.36 67.13 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 -174.14 2.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.292 2.662 . . . . 10.0 110.474 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.85 170.71 15.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.149 1.38 . . . . 10.0 107.486 170.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.4 13.59 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.412 1.085 . . . . 10.0 108.321 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -139.16 163.44 32.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.933 1.293 . . . . 10.0 107.598 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -73.51 155.36 39.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 172.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.97 176.69 10.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.9 167.33 35.9 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 107.451 -2.26 . . . . 10.0 107.451 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.16 -73.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.828 0.814 . . . . 10.0 111.942 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -144.56 45.06 1.4 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.864 . . . . 10.0 109.076 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.24 -168.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.573 1.149 . . . . 10.0 109.985 -167.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 151.51 94.25 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.794 -0.622 . . . . 10.0 109.653 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.15 -90.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.932 2.421 . . . . 10.0 110.29 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.35 49.31 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.824 0.849 . . . . 10.0 110.466 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 m -159.18 106.5 1.78 Allowed 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.948 -1.095 . . . . 10.0 109.505 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.23 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.63 0.65 . . . . 10.0 111.01 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -157.51 153.58 27.24 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 163.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.1 107.95 3.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.748 1.166 . . . . 10.0 112.178 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.73 153.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.746 0.818 . . . . 10.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 p -135.68 151.86 50.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.287 -1.375 . . . . 10.0 107.287 164.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.84 137.91 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.06 47.33 0.77 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.288 0.949 . . . . 10.0 113.416 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 28.89 -124.29 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.014 2.126 . . . . 10.0 111.243 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.38 118.89 55.63 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 157.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.8 168.49 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.038 2.492 . . . . 10.0 107.996 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.47 69.43 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.786 1.657 . . . . 10.0 108.846 170.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.433 ' CB ' HH12 ' A' ' 104' ' ' ARG . 7.4 m -155.84 38.67 0.37 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.645 1.178 . . . . 10.0 109.078 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.4 mm 68.34 178.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.361 1.064 . . . . 10.0 110.291 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.4 tpt180 -46.51 -33.59 4.17 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.37 2.268 . . . . 10.0 114.774 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.31 151.71 45.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.362 1.077 . . . . 10.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 t -161.65 175.4 12.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.634 -1.617 . . . . 10.0 106.634 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.02 160.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.07 0.548 . . . . 10.0 110.529 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.76 142.44 32.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.114 0.884 . . . . 10.0 108.855 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -117.93 108.62 15.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 165.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.74 -179.16 7.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.313 1.845 . . . . 10.0 106.332 -160.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -150.66 138.02 19.52 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.411 1.46 . . . . 10.0 110.071 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.97 116.37 27.97 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -93.76 87.25 5.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.843 1.657 . . . . 10.0 108.304 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -78.05 79.53 4.51 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 121.89 0.852 . . . . 10.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 58.28 4.64 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m -172.76 144.21 1.34 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.986 0.915 . . . . 10.0 108.796 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.09 49.12 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.447 1.499 . . . . 10.0 109.838 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.2 127.19 18.88 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.805 0.842 . . . . 10.0 109.376 -170.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -85.71 121.85 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.538 2.825 . . . . 10.0 110.702 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mp -150.44 116.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 150.08 30.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.347 0.521 . . . . 10.0 110.677 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.415 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -110.04 138.32 46.59 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 171.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.88 54.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.56 1.073 . . . . 10.0 108.914 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.04 144.35 9.64 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.623 -1.791 . . . . 10.0 108.623 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.98 65.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.571 1.548 . . . . 10.0 107.981 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.12 160.89 23.03 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t -173.75 152.2 1.98 Allowed Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 107.608 -1.256 . . . . 10.0 107.608 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.34 -1.41 11.32 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.603 2.202 . . . . 10.0 112.155 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.61 -53.67 5.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.608 1.163 . . . . 10.0 110.46 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.77 178.44 5.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.323 1.449 . . . . 10.0 110.62 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 m -143.13 0.63 1.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.314 -0.866 . . . . 10.0 112.456 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.6 m -148.07 80.41 8.7 Favored Pre-proline 0 N--CA 1.448 -0.551 0 O-C-N 120.589 -1.319 . . . . 10.0 108.06 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.87 98.39 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.972 3.115 . . . . 10.0 111.12 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -103.64 120.55 41.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.672 0.789 . . . . 10.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.87 140.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 ttm -145.08 149.0 34.29 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.667 0.787 . . . . 10.0 110.135 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -140.63 112.02 7.33 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.577 0.584 . . . . 10.0 112.577 -166.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -146.64 49.55 1.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.431 -1.418 . . . . 10.0 110.807 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -130.35 94.85 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.39 1.476 . . . . 10.0 108.92 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -68.79 85.38 0.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.885 1.674 . . . . 10.0 110.823 -163.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t 163.83 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.789 2.035 . . . . 10.0 107.784 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.11 84.37 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.722 -1.351 . . . . 10.0 109.722 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 -170.41 23.63 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.103 -1.599 . . . . 10.0 109.103 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.7 ttm -106.57 -136.98 0.36 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.611 0.764 . . . . 10.0 109.317 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.53 51.09 1.19 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.743 1.217 . . . . 10.0 108.075 -164.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 90.48 0.14 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.243 -1.543 . . . . 10.0 109.243 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.41 60.14 1.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.865 -1.161 . . . . 10.0 107.865 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -143.43 171.45 14.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.807 2.043 . . . . 10.0 107.921 -170.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 27.6 ttm -81.46 69.21 8.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.051 0.929 . . . . 10.0 110.482 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.04 163.99 14.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.326 1.05 . . . . 10.0 109.676 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -52.2 -36.77 68.38 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.552 2.168 . . . . 10.0 112.673 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 -156.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.75 2.02 . . . . 10.0 110.681 -164.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.16 131.26 47.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.645 -1.613 . . . . 10.0 106.645 162.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 m -95.67 106.05 18.11 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -85.16 109.71 23.11 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -88.21 52.22 2.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.368 1.379 . . . . 10.0 110.655 -167.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.44 163.85 0.14 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.74 0.781 . . . . 10.0 110.993 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.82 20.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.678 1.591 . . . . 10.0 112.718 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.31 69.77 1.09 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 124.935 1.255 . . . . 10.0 110.253 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -84.69 57.7 4.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -94.44 155.46 16.94 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.283 -175.557 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.1 t -126.05 117.16 22.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 -165.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.99 128.32 34.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.76 165.84 35.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.678 0.791 . . . . 10.0 109.4 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.433 HH12 ' CB ' ' A' ' 41' ' ' SER . 2.6 ttp180 -67.4 89.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.488 -0.758 . . . . 10.0 110.606 174.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 131.02 -70.21 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 131.342 3.857 . . . . 10.0 108.112 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.02 71.23 0.96 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 125.448 1.499 . . . . 10.0 112.506 -167.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 66.61 138.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.41 1.884 . . . . 10.0 110.367 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -179.38 179.41 0.62 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.181 0.592 . . . . 10.0 110.789 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.3 t -114.84 128.79 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 156.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 77.1 mtp -82.25 94.2 7.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 166.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.84 65.5 7.0 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.193 -1.41 . . . . 10.0 107.193 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 21.0 ptm -84.71 179.57 7.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.274 1.035 . . . . 10.0 110.17 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 47.44 45.61 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.901 -1.28 . . . . 10.0 109.901 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.49 118.93 10.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.204 1.002 . . . . 10.0 109.18 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -61.57 2.43 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 117.443 0.111 . . . . 10.0 111.226 -171.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.1 mtt-85 -166.54 -59.58 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.23 1.412 . . . . 10.0 111.86 -162.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.25 69.6 7.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 120.848 1.339 . . . . 10.0 112.934 -165.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 56.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.261 -0.9 . . . . 10.0 111.875 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 96.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.217 -0.927 . . . . 10.0 109.258 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.63 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.471 1.108 . . . . 10.0 109.512 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.13 -10.05 5.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.324 -0.709 . . . . 10.0 113.003 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -78.82 -177.89 5.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.838 1.304 . . . . 10.0 108.369 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.0 m -150.9 131.55 13.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.758 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.55 141.42 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.378 1.471 . . . . 10.0 107.32 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -68.25 127.82 34.3 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.544 -0.722 . . . . 10.0 109.927 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 126' ' ' ILE . 8.6 tt -82.27 173.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.401 -1.703 . . . . 10.0 106.401 162.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 38.9 m -144.55 115.69 7.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.311 -0.868 . . . . 10.0 109.439 160.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 pp -87.7 173.0 9.28 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.829 0.307 . . . . 10.0 111.829 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -156.99 109.38 2.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.004 0.922 . . . . 10.0 108.972 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.55 126.34 32.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 160.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 t -79.86 62.5 4.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.754 0.788 . . . . 10.0 108.909 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.81 -65.86 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.727 2.411 . . . . 10.0 107.14 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 -79.11 0.45 Allowed Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.609 -0.723 . . . . 10.0 113.778 -167.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 -177.8 5.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.871 -0.782 . . . . 10.0 112.982 -175.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 m -128.74 142.26 51.06 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.48 3.512 . . . . 10.0 103.606 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.25 147.13 22.02 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -121.16 59.45 0.94 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.05 1.74 . . . . 10.0 110.088 -157.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.1 t -78.32 147.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -161.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.36 109.88 16.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.56 43.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.145 0.978 . . . . 10.0 110.527 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.8 m -83.51 126.79 33.15 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.669 0.388 . . . . 10.0 110.256 -177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.4 t -91.31 97.37 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.72 -1.956 . . . . 10.0 105.72 -173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 102.33 2.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.766 -0.584 . . . . 10.0 110.753 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -63.24 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.58 1.152 . . . . 10.0 110.266 162.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.86 -164.89 0.24 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.703 0.801 . . . . 10.0 111.929 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.4 pt -57.09 -31.21 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.169 0.588 . . . . 10.0 111.573 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -58.8 -63.48 1.28 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.145 0.978 . . . . 10.0 109.506 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.47 56.22 4.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.933 -0.867 . . . . 10.0 110.933 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.15 1.78 . . . . 10.0 107.086 170.41 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 2.456 9.8 ptm . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.91 54.62 2.15 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.607 -1.107 . . . . 10.0 111.054 -169.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 43.33 89.05 0.01 OUTLIER 'General case' 0 C--N 1.346 0.451 1 C-N-CA 132.107 4.163 . . . . 10.0 114.349 1.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.4 0.5 OUTLIER 77.97 -24.92 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.326 3.851 . . . . 10.0 113.666 9.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 87.7 mtp 44.7 96.93 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.076 1.75 . . . . 10.0 115.175 161.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -61.1 30.66 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.9 3.733 . . . . 10.0 117.195 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.24 62.15 1.23 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . 2.443 63.2 t-80 61.77 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -148.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 2.454 0.2 OUTLIER 52.54 -133.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 -165.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . 2.547 54.0 Cg_exo 62.91 -102.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.9 2.4 . . . . 10.0 108.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' CB ' ' HA ' ' A' ' 12' ' ' ALA 2.411 8.7 Cg_endo 22.04 116.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.755 1 C-N-CA 127.475 5.45 . . . . 10.0 116.482 154.25 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 11' ' ' PRO 2.445 . . 41.22 19.99 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 O-C-N 117.556 -3.215 . . . . 10.0 112.976 56.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 2.383 5.6 tp60 47.23 84.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.959 2.104 . . . . 10.0 112.148 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.661 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 0.7 OUTLIER 84.4 148.71 0.07 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.443 1.897 . . . . 10.0 106.538 -178.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' A' ' 14' ' ' THR 0.308 . . 83.74 19.62 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.843 1 C-N-CA 135.07 5.348 . . . . 10.0 116.241 13.553 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 17' ' ' ALA 0.337 37.6 Cg_endo -64.62 -83.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 CA-C-N 122.883 2.065 . . . . 10.0 115.021 -170.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 16' ' ' PRO 0.599 . . 79.52 -19.16 0.46 Allowed 'General case' 0 N--CA 1.466 0.372 3 C-N-CA 138.642 6.777 . . . . 10.0 117.485 -4.5 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.21 108.53 21.28 Favored 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 105.622 -1.992 . . . . 10.0 105.622 157.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 177.28 -58.59 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.381 1.473 . . . . 10.0 110.8 -160.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 2.469 0.0 OUTLIER 106.38 -110.54 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 130.795 3.638 . . . . 10.0 106.284 9.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 2.424 . . 73.06 39.06 0.65 Allowed 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 23' ' ' ALA . . . -108.26 98.96 1.27 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.882 1.706 . . . . 10.0 111.811 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.458 ' C ' ' HA2' ' A' ' 22' ' ' GLY 0.288 . . 41.61 -117.78 0.38 Allowed 'General case' 0 CA--C 1.536 0.419 1 C-N-CA 132.533 4.333 . . . . 10.0 116.202 -2.24 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 42.75 -135.57 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 -160.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.52 136.33 17.2 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.131 -2.174 . . . . 10.0 105.131 160.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 54' ' ' LYS . 2.9 tt -106.48 130.09 23.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.16 127.97 24.86 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 N-CA-C 106.732 -2.064 . . . . 10.0 106.732 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.38 54.2 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 122.027 0.918 . . . . 10.0 112.083 -153.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.4 p -153.91 54.2 0.71 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.667 1.587 . . . . 10.0 107.209 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -83.66 63.51 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -137.19 154.21 50.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.831 1.252 . . . . 10.0 110.967 -169.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.91 136.79 13.68 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.913 -2.075 . . . . 10.0 107.913 168.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.59 25.3 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.605 1.203 . . . . 10.0 109.995 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 p -134.56 141.75 46.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.2 134.04 67.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.69 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 36.08 -122.55 0.15 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.933 1.693 . . . . 10.0 111.031 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.48 109.69 58.12 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.963 0.905 . . . . 10.0 108.85 169.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.57 163.45 27.19 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.959 2.439 . . . . 10.0 110.394 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.42 61.0 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.914 2.41 . . . . 10.0 109.421 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -160.49 47.8 0.24 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.379 1.072 . . . . 10.0 108.522 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.9 mm 75.45 167.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.444 1.498 . . . . 10.0 109.17 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -58.2 -26.7 63.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.95 0.722 . . . . 10.0 112.95 -177.451 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.91 140.12 1.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.632 2.373 . . . . 10.0 110.807 172.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -159.98 -178.63 7.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.14 157.85 43.24 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.401 0.68 . . . . 10.0 110.654 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.7 150.3 25.21 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 124.001 0.813 . . . . 10.0 110.097 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -128.45 103.62 7.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.442 -2.059 . . . . 10.0 105.442 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -159.82 -176.67 5.84 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.969 0.508 . . . . 10.0 110.909 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -133.71 122.9 24.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.14 0.976 . . . . 10.0 111.501 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mp -80.52 132.45 35.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.214 -2.513 . . . . 10.0 104.214 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -130.56 104.76 7.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 124.58 1.175 . . . . 10.0 107.982 -160.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.82 130.34 35.03 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 117.804 0.274 . . . . 10.0 111.199 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.487 ' HB2' HD22 ' A' ' 26' ' ' LEU . 32.0 mmmt -140.93 59.29 1.54 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -168.02 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.015 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 65.9 78.46 0.27 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.253 1.421 . . . . 10.0 111.512 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.22 154.72 50.25 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.732 1.613 . . . . 10.0 108.533 170.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.52 72.93 6.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.651 2.901 . . . . 10.0 111.768 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.4 115.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -89.11 144.73 25.92 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.477 -0.765 . . . . 10.0 109.372 168.092 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -121.99 126.83 49.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 56.63 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.876 0.845 . . . . 10.0 110.044 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.98 150.77 21.21 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.004 -1.238 . . . . 10.0 110.004 163.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.08 58.84 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.252 1.021 . . . . 10.0 108.805 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.82 139.74 31.7 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.898 -0.501 . . . . 10.0 109.791 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 t -160.76 145.6 10.69 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.94 57.37 4.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.178 2.586 . . . . 10.0 109.878 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 tt -139.74 -63.06 0.51 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.357 1.463 . . . . 10.0 107.849 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.74 146.71 27.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.674 1.19 . . . . 10.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.1 m -82.07 -38.32 25.08 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.725 0.81 . . . . 10.0 109.196 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.61 80.13 39.23 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.012 0.925 . . . . 10.0 110.182 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.74 92.93 1.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.829 2.353 . . . . 10.0 109.993 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.7 mtt -103.62 131.18 51.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.598 1.159 . . . . 10.0 110.115 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.76 144.62 29.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.482 1.113 . . . . 10.0 109.087 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.5 ttm -146.27 157.78 43.83 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.431 0.692 . . . . 10.0 110.775 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 13.0 t -155.1 107.13 2.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.873 0.844 . . . . 10.0 112.531 -162.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 t -146.2 57.98 1.21 Allowed 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.793 -1.192 . . . . 10.0 111.023 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -150.24 93.46 2.0 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.277 1.431 . . . . 10.0 109.829 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -32.09 -46.06 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 128.682 2.793 . . . . 10.0 113.27 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -54.91 -23.59 19.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.267 1.427 . . . . 10.0 114.032 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.85 -50.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.437 -1.065 . . . . 10.0 110.437 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.93 -162.63 32.21 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.271 0.938 . . . . 10.0 111.621 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 ttt -81.72 -159.79 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.415 0.686 . . . . 10.0 109.3 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.579 1.152 . . . . 10.0 108.078 -167.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.28 108.86 0.36 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.015 -1.634 . . . . 10.0 109.015 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.88 65.6 1.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 10.0 109.86 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -125.63 165.1 19.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.343 2.257 . . . . 10.0 109.718 -170.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 35.2 ttm -81.47 72.82 8.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.879 0.847 . . . . 10.0 109.93 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 76' ' ' THR . 16.3 m -63.03 159.33 47.86 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.938 0.895 . . . . 10.0 111.195 173.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 95.3 Cg_endo -61.85 -30.86 84.8 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.907 2.404 . . . . 10.0 112.507 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 90' ' ' PRO . 44.4 p90 177.88 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.797 2.439 . . . . 10.0 105.344 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -128.14 115.72 18.84 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.58 0.705 . . . . 10.0 110.959 168.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 m -78.27 126.5 30.88 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.7 pt -100.77 103.07 22.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.182 0.901 . . . . 10.0 109.043 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.86 70.19 6.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.227 1.951 . . . . 10.0 111.347 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 60.43 168.96 0.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.611 -0.68 . . . . 10.0 109.796 -163.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 41.59 31.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.768 1.766 . . . . 10.0 115.768 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.05 72.26 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 124.41 1.005 . . . . 10.0 113.209 167.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -107.26 57.23 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.518 -1.66 . . . . 10.0 106.518 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -93.73 151.9 19.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.546 1.138 . . . . 10.0 108.1 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.6 m -119.19 117.13 27.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.885 -1.894 . . . . 10.0 105.885 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.31 102.17 10.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.217 -2.142 . . . . 10.0 105.217 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.02 156.77 48.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.463 1.505 . . . . 10.0 110.428 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -48.96 -42.99 39.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.287 1.035 . . . . 10.0 112.303 -166.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -114.31 29.84 7.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.771 0.828 . . . . 10.0 111.897 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.18 69.13 0.19 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 121.346 -0.847 . . . . 10.0 111.387 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 10.2 t70 64.96 138.99 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 126.381 1.872 . . . . 10.0 110.524 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -178.09 179.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 10.0 111.149 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -110.86 122.0 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 162.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 67.2 mtp -83.86 100.24 10.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 165.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.19 73.24 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.5 154.64 20.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.966 0.906 . . . . 10.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.27 66.34 2.24 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.93 141.68 44.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.344 0.658 . . . . 10.0 112.106 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -86.44 -48.65 8.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 10.0 112.549 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -144.48 158.94 53.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.624 0.77 . . . . 10.0 110.559 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -67.65 160.51 47.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.559 2.84 . . . . 10.0 111.911 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.42 159.61 41.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.769 1.628 . . . . 10.0 108.179 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -113.16 144.43 42.68 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.615 0.643 . . . . 10.0 109.503 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.88 104.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 165.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.68 -13.73 6.46 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.166 -0.797 . . . . 10.0 111.61 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -178.25 3.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.787 1.755 . . . . 10.0 109.119 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.0 m -155.56 131.36 9.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.031 -1.895 . . . . 10.0 107.708 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.66 149.57 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -84.71 130.99 34.62 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -103.99 130.24 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.077 0.951 . . . . 10.0 109.147 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 m -103.1 107.46 18.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 166.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.29 154.3 26.62 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 160.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -150.23 90.15 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.27 143.31 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -50.54 -36.32 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.44 1.096 . . . . 10.0 110.876 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -70.11 44.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 10.0 112.649 173.366 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.04 48.54 38.61 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.219 1.866 . . . . 10.0 113.206 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -110.57 146.75 35.54 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 171.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.0 m -156.41 101.32 2.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.742 2.017 . . . . 10.0 105.659 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -112.05 -178.46 3.43 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.843 0.747 . . . . 10.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -149.93 64.03 0.98 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.744 2.017 . . . . 10.0 108.614 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.73 156.74 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.12 130.77 35.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.81 112.55 23.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.698 1.199 . . . . 10.0 109.222 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 m -83.86 125.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.7 112.84 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -158.09 125.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.686 -0.673 . . . . 10.0 109.693 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.546 ' HB3' ' HG3' ' A' ' 147' ' ' GLU . 10.0 mmmt -41.97 -71.63 0.08 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.289 1.836 . . . . 10.0 110.025 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.91 102.65 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.54 1.536 . . . . 10.0 114.777 157.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.314 35.8 pt 53.18 64.62 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 123.448 1.594 . . . . 10.0 109.574 -166.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -149.24 149.26 30.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.353 -2.832 . . . . 10.0 103.353 -167.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.68 33.24 66.85 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.733 -1.347 . . . . 10.0 109.733 -162.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.537 2.735 . . . . 10.0 104.458 176.832 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 105.739 -1.949 . . . . 10.0 105.739 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.4 -161.29 9.45 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.375 0.988 . . . . 10.0 110.927 171.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 110.11 149.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 129.639 3.176 . . . . 10.0 108.452 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.0 p -146.84 154.89 41.87 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.2 tpt -121.66 108.81 34.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.62 1.168 . . . . 10.0 108.466 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.37 171.9 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.594 2.196 . . . . 10.0 110.496 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.32 157.14 29.89 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.611 1.164 . . . . 10.0 108.07 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -155.06 178.06 10.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.88 1.672 . . . . 10.0 107.39 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -146.03 146.82 29.75 Favored Pre-proline 0 C--O 1.232 0.174 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.49 164.55 35.29 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.842 1.695 . . . . 10.0 108.938 163.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.47 -171.42 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.941 3.094 . . . . 10.0 109.603 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.91 160.79 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.296 -1.001 . . . . 10.0 108.296 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -147.31 161.45 40.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.628 1.571 . . . . 10.0 107.031 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -140.79 131.97 26.45 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.841 0.856 . . . . 10.0 108.84 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 119.2 57.55 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.909 0.884 . . . . 10.0 109.843 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.94 -166.97 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.793 2.328 . . . . 10.0 110.055 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -164.53 154.71 14.27 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.75 156.38 43.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.833 1.253 . . . . 10.0 107.862 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -147.52 157.94 43.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.45 143.29 51.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 165.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 157.53 25.68 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 172.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.03 -143.62 2.58 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.553 -1.019 . . . . 10.0 110.553 175.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.19 64.51 1.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.642 0.777 . . . . 10.0 111.526 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 39.91 66.68 0.56 Allowed 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.89 2.076 . . . . 10.0 112.806 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.85 167.05 30.99 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.176 1.39 . . . . 10.0 108.331 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 155.52 73.22 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.294 1.437 . . . . 10.0 108.463 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.28 -85.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.007 2.471 . . . . 10.0 110.42 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.5 m -140.47 48.0 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 122.365 1.079 . . . . 10.0 109.301 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.8 p -156.75 82.72 0.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.214 -0.903 . . . . 10.0 108.694 -165.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 55.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 123.113 1.435 . . . . 10.0 107.377 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -83.89 129.94 34.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.721 -1.582 . . . . 10.0 107.05 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.66 -39.06 78.14 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.708 -0.557 . . . . 10.0 111.708 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 68.73 116.84 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.736 2.414 . . . . 10.0 113.33 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p -116.28 91.92 3.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.577 1.951 . . . . 10.0 108.789 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.445 -0.946 . . . . 10.0 108.445 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.92 42.92 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.67 -133.94 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.347 1.459 . . . . 10.0 110.208 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.4 t -104.05 110.75 64.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 160.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.89 172.04 10.24 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.115 2.543 . . . . 10.0 108.93 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.02 59.6 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 10.0 109.882 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -157.8 50.88 0.43 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 10.0 109.844 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.7 mm 66.36 174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.869 0.868 . . . . 10.0 110.291 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.582 ' H ' HG22 ' A' ' 42' ' ' ILE . 8.1 tpp180 -69.07 22.85 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.245 1.418 . . . . 10.0 114.379 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.486 ' CG ' HH21 ' A' ' 104' ' ' ARG . 0.0 OUTLIER -94.45 157.62 15.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.807 1.185 . . . . 10.0 108.161 168.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -172.5 179.73 2.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.39 -1.707 . . . . 10.0 106.39 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.91 173.29 16.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.385 0.274 . . . . 10.0 111.004 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.14 149.22 26.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 125.202 1.564 . . . . 10.0 109.056 165.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.28 71.1 1.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.549 1.14 . . . . 10.0 108.237 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -174.06 4.76 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.79 1.236 . . . . 10.0 109.417 -159.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -123.94 141.26 52.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.041 1.292 . . . . 10.0 109.598 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 150.18 25.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.314 -1.736 . . . . 10.0 106.314 161.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -140.42 118.11 11.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.219 0.949 . . . . 10.0 110.879 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.27 132.91 37.7 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.77 58.6 1.72 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.745 -1.205 . . . . 10.0 107.745 166.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -163.9 -46.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.267 1.027 . . . . 10.0 109.594 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . 0.318 95.4 m-20 67.01 54.91 0.73 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.474 1.91 . . . . 10.0 110.583 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -131.23 150.87 77.73 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.425 1.89 . . . . 10.0 107.803 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.16 86.27 1.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.542 2.828 . . . . 10.0 111.275 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.15 119.61 59.49 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -83.87 150.66 25.58 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.681 0.392 . . . . 10.0 110.431 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.472 ' C ' HD22 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.21 143.42 50.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.847 -0.797 . . . . 10.0 108.847 173.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 p -151.62 56.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.08 145.67 11.57 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.299 -1.12 . . . . 10.0 110.299 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.09 69.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.49 107.41 15.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.325 -1.361 . . . . 10.0 107.325 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -125.22 146.39 53.84 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.652 0.781 . . . . 10.0 110.494 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.1 -12.27 19.43 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.85 2.367 . . . . 10.0 110.985 166.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 tp -80.97 -57.26 3.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.328 0.967 . . . . 10.0 111.507 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.96 139.68 38.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.07 0.948 . . . . 10.0 112.297 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 m -75.86 -42.03 50.65 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.384 -0.823 . . . . 10.0 110.144 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.96 81.94 50.41 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.947 0.899 . . . . 10.0 109.391 -167.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.01 86.34 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.66 2.907 . . . . 10.0 110.527 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.58 127.58 34.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.08 141.63 31.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.5 ttm -148.96 157.85 43.73 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.665 0.786 . . . . 10.0 110.063 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 89' ' ' VAL . 6.7 t -155.11 102.38 2.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.561 0.696 . . . . 10.0 112.546 -157.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 86' ' ' MET . 8.8 t -150.58 53.98 0.89 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.812 -1.18 . . . . 10.0 113.13 168.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -116.22 100.57 8.01 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.918 1.287 . . . . 10.0 109.054 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -46.65 -44.86 18.77 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 126.167 1.787 . . . . 10.0 111.871 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 t -82.96 23.25 0.85 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.05 -67.16 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.535 1.061 . . . . 10.0 111.111 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.87 96.76 0.44 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.391 1.472 . . . . 10.0 111.765 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.88 -159.4 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.258 1.823 . . . . 10.0 114.014 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.21 39.0 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.882 0.873 . . . . 10.0 109.54 -166.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.63 105.95 0.27 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.445 ' HB2' HG21 ' A' ' 77' ' ' THR . 1.2 tmm? -77.47 55.42 1.27 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.306 1.042 . . . . 10.0 110.844 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.96 165.44 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.831 2.052 . . . . 10.0 109.379 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.6 ttm -81.89 69.78 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.312 1.053 . . . . 10.0 110.334 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 76' ' ' THR . 16.5 m -60.07 165.02 5.32 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.469 1.907 . . . . 10.0 111.741 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.48 -38.63 54.31 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.333 2.689 . . . . 10.0 113.579 164.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -165.8 0.04 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.987 1.315 . . . . 10.0 112.512 -161.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.2 116.18 25.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.068 1.347 . . . . 10.0 108.012 159.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.3 m -83.34 136.87 34.2 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.1 140.44 38.09 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.26 -178.19 4.44 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.354 2.036 . . . . 10.0 111.456 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.17 139.56 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 151.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 58.67 17.32 4.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.822 1.045 . . . . 10.0 113.822 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.94 97.45 0.25 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.064 -1.614 . . . . 10.0 109.064 166.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -138.72 79.35 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.876 -2.268 . . . . 10.0 104.876 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 pp -103.37 -177.0 3.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.56 -0.745 . . . . 10.0 110.494 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 99.58 6.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.817 1.647 . . . . 10.0 106.792 -165.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.88 93.7 5.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -118.97 140.09 50.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.804 2.042 . . . . 10.0 108.259 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 44' ' ' ASP . 4.5 tmt_? -55.33 -21.3 14.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 -167.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -90.25 -71.62 0.61 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.487 1.515 . . . . 10.0 109.749 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.45 80.9 1.6 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.596 1.57 . . . . 10.0 111.524 -166.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 64.46 133.67 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.74 0 C-N-CA 126.0 1.72 . . . . 10.0 110.37 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -178.17 178.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.752 -1.218 . . . . 10.0 111.629 -169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.48 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 162.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.8 mtp -81.76 98.27 8.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.376 -1.712 . . . . 10.0 106.376 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.11 67.55 9.2 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.927 1.291 . . . . 10.0 108.34 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.1 mtp -84.38 157.09 21.55 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.921 0.867 . . . . 10.0 111.601 -166.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.02 60.7 3.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.554 -1.018 . . . . 10.0 110.554 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.23 129.95 44.23 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.612 0.706 . . . . 10.0 111.9 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -105.2 -59.61 1.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.472 1.509 . . . . 10.0 110.83 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -59.58 142.47 87.44 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.5 132.8 32.3 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.107 1.871 . . . . 10.0 109.526 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.435 ' CD1' ' H ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.83 161.16 29.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.108 0.563 . . . . 10.0 111.52 175.105 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 120.19 3.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.473 -2.047 . . . . 10.0 105.473 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.37 116.54 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.3 62.72 1.7 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.206 -1.957 . . . . 10.0 108.206 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -133.35 -172.99 3.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 159.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.9 m -152.54 123.25 7.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.388 -1.278 . . . . 10.0 107.894 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.59 126.67 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.423 1.089 . . . . 10.0 108.528 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -70.82 128.18 35.15 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 pt -114.43 148.04 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.245 1.418 . . . . 10.0 107.877 168.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -110.24 133.49 53.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.001 0.92 . . . . 10.0 109.114 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 129' ' ' LYS . 1.1 tt -83.65 155.58 23.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.024 -1.473 . . . . 10.0 107.024 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' H ' HD23 ' A' ' 128' ' ' LEU . 82.5 tttt -155.43 86.09 1.07 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.643 -1.243 . . . . 10.0 107.643 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.63 25.96 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.028 -0.42 . . . . 10.0 110.059 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.8 t -54.26 -31.57 53.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.802 1.241 . . . . 10.0 112.108 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.78 -32.8 14.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.664 1.186 . . . . 10.0 112.896 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 104.19 8.66 38.23 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.082 1.325 . . . . 10.0 110.046 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 95.3 8.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.1 t -83.87 147.93 27.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.098 -0.955 . . . . 10.0 108.498 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tp -157.03 174.91 14.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -134.78 139.22 44.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.62 140.0 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.51 98.63 10.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.685 -0.858 . . . . 10.0 108.685 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.98 123.36 29.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.957 0.903 . . . . 10.0 110.36 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -83.75 137.51 33.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.41 112.27 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -148.57 107.48 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.084 0.954 . . . . 10.0 109.58 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -99.64 -177.13 3.48 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.744 0.817 . . . . 10.0 113.012 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 75.15 -168.92 0.09 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.674 1.989 . . . . 10.0 108.169 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -53.02 120.83 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 109.028 -0.731 . . . . 10.0 109.028 170.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.27 165.97 28.38 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -170.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.91 62.04 0.9 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 125.27 1.415 . . . . 10.0 111.773 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.096 0 N-CA-C 105.109 -2.182 . . . . 10.0 105.109 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.6 151.02 6.25 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -170.04 158.93 7.33 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.541 -1.652 . . . . 10.0 106.541 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t -164.32 178.69 7.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.1 ttm -163.62 69.07 1.73 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.337 1.455 . . . . 10.0 108.922 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.96 136.72 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.277 1.985 . . . . 10.0 110.011 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.09 155.52 20.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 10.0 107.819 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -164.41 167.07 20.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.522 -1.658 . . . . 10.0 106.522 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -166.06 67.09 1.06 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.387 1.075 . . . . 10.0 109.571 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -69.38 118.93 5.98 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.333 2.022 . . . . 10.0 109.923 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.81 153.03 22.58 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.305 2.003 . . . . 10.0 110.582 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.25 143.01 14.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 172.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -171.16 162.13 6.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.87 1.268 . . . . 10.0 108.112 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -169.8 -178.52 2.98 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.53 1.532 . . . . 10.0 107.001 171.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.15 65.46 0.69 Allowed Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.569 1.148 . . . . 10.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.46 128.14 14.13 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.293 1.996 . . . . 10.0 109.872 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.63 149.72 17.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.57 8.44 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.56 1.544 . . . . 10.0 107.088 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -162.88 157.95 21.9 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -159.7 174.78 14.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.663 1.985 . . . . 10.0 106.446 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.91 175.74 8.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.668 1.187 . . . . 10.0 107.964 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.01 161.53 33.46 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.191 -2.364 . . . . 10.0 107.191 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -169.74 -174.2 1.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.43 1.092 . . . . 10.0 108.255 -175.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 73.29 175.42 0.27 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.236 1.814 . . . . 10.0 111.888 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.7 9.5 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.974 1.709 . . . . 10.0 106.903 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.27 134.88 9.49 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.1 153.5 62.65 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.649 1.566 . . . . 10.0 108.601 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.7 53.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 122.178 0.989 . . . . 10.0 110.86 -170.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -153.11 59.47 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -162.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.53 55.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -100.38 138.27 37.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.238 1.015 . . . . 10.0 108.482 165.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.55 -136.06 4.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.798 -2.121 . . . . 10.0 107.798 163.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.91 143.68 14.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.998 0.899 . . . . 10.0 109.802 162.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.2 p -133.59 153.58 51.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.142 -1.799 . . . . 10.0 106.142 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -128.08 138.93 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 125.128 1.371 . . . . 10.0 107.372 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.07 37.76 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.128 0.788 . . . . 10.0 113.128 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 31.86 -124.99 0.05 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.337 1.855 . . . . 10.0 110.456 -161.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.61 112.13 58.84 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 105.927 -1.879 . . . . 10.0 105.927 162.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 160.48 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.977 1.785 . . . . 10.0 108.68 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.17 61.73 5.85 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.523 2.148 . . . . 10.0 110.615 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -163.42 62.22 0.17 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.427 1.091 . . . . 10.0 108.264 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt 77.07 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.52 1.528 . . . . 10.0 110.339 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 39.03 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.196 0.998 . . . . 10.0 113.509 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 158.43 16.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.305 -1.368 . . . . 10.0 107.305 161.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 t -156.62 -169.15 2.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.89 -1.522 . . . . 10.0 106.89 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.96 160.46 42.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.999 -1.111 . . . . 10.0 107.999 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.43 161.8 22.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 165.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -134.73 102.47 5.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.762 -1.57 . . . . 10.0 106.762 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -170.0 2.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.747 2.019 . . . . 10.0 109.503 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m -147.85 124.77 11.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.371 -1.456 . . . . 10.0 109.049 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.16 129.56 34.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 171.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -121.65 95.53 4.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.022 0.826 . . . . 10.0 110.302 -158.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.26 58.62 1.65 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.015 1.388 . . . . 10.0 112.454 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 174.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -179.98 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.95 1.093 . . . . 10.0 113.95 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.13 84.76 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.456 1.503 . . . . 10.0 112.164 -167.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -147.59 144.32 19.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.011 0.925 . . . . 10.0 109.729 165.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -88.14 100.62 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.813 3.009 . . . . 10.0 111.485 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.59 103.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.815 0.846 . . . . 10.0 109.299 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 96.78 8.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.029 -1.044 . . . . 10.0 110.019 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.02 124.44 29.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.386 0.674 . . . . 10.0 109.906 -175.158 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.69 54.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 122.265 1.031 . . . . 10.0 109.535 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.23 145.33 11.06 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.79 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.895 1.678 . . . . 10.0 107.296 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.18 149.08 29.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -169.65 151.87 4.46 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 -164.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.72 -3.55 13.36 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.736 2.291 . . . . 10.0 111.964 167.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -101.79 -40.51 6.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.512 1.125 . . . . 10.0 113.437 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.31 126.23 46.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.443 1.097 . . . . 10.0 110.046 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 m -72.81 -30.66 64.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.327 0.651 . . . . 10.0 109.783 172.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 m -131.13 67.75 81.01 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 124.983 1.313 . . . . 10.0 110.105 -171.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.39 114.12 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.752 2.301 . . . . 10.0 110.527 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -141.07 141.66 34.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.886 0.474 . . . . 10.0 110.815 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.95 149.81 26.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.727 1.211 . . . . 10.0 109.781 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.69 169.32 21.89 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.474 1.51 . . . . 10.0 109.88 -171.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 t -143.8 158.77 43.45 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 121.203 -0.199 . . . . 10.0 110.884 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.42 59.55 0.63 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.435 -0.791 . . . . 10.0 109.201 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -155.56 130.91 9.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -71.34 -39.69 71.18 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -44.61 96.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.602 1.161 . . . . 10.0 111.488 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.96 -129.01 3.35 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.051 -0.82 . . . . 10.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -69.57 1.25 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.528 0.585 . . . . 10.0 113.339 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -170.01 163.83 9.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.282 1.033 . . . . 10.0 109.592 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.68 54.41 2.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 175.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.08 67.05 0.56 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.483 -0.647 . . . . 10.0 111.483 -156.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.07 64.27 5.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.067 0.937 . . . . 10.0 110.069 -171.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -136.4 168.67 19.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.008 2.123 . . . . 10.0 109.394 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 61.4 mtp -81.35 73.76 8.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.57 0.7 . . . . 10.0 109.355 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.49 159.8 83.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.513 -0.767 . . . . 10.0 110.731 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -42.92 -52.2 4.86 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.634 2.889 . . . . 10.0 112.099 163.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.48 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 173.4 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 127.195 2.198 . . . . 10.0 108.52 -175.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.0 mm? -128.5 138.92 52.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 161.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -84.99 98.56 10.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.261 -1.755 . . . . 10.0 106.261 160.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.51 121.97 80.38 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.104 -1.813 . . . . 10.0 106.104 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.15 -173.98 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.621 2.214 . . . . 10.0 111.774 -166.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.88 149.3 1.87 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 154.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.5 6.96 0.12 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.112 1.365 . . . . 10.0 114.156 -166.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.29 84.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -109.7 61.18 0.6 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.337 1.455 . . . . 10.0 107.782 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mp -86.07 154.07 21.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.683 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.0 p -114.47 110.85 20.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.45 -2.056 . . . . 10.0 105.45 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.78 109.51 16.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.291 -2.114 . . . . 10.0 105.291 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.45 170.12 22.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.212 0.915 . . . . 10.0 111.12 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.55 -45.81 0.37 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.567 1.147 . . . . 10.0 112.622 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.91 98.47 3.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.729 1.612 . . . . 10.0 106.776 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.83 116.46 1.12 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.803 1.668 . . . . 10.0 110.296 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 23.86 65.64 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.078 2.951 . . . . 10.0 114.184 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -119.14 164.8 15.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -164.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.0 121.01 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 47.9 mtp -83.19 99.47 9.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.49 -1.3 . . . . 10.0 107.49 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.17 58.74 3.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 171.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 40.8 ttp -84.57 161.8 20.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.566 1.146 . . . . 10.0 110.784 -168.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.13 -4.32 30.11 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.059 -1.411 . . . . 10.0 114.809 155.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 tp 47.41 89.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.253 1.821 . . . . 10.0 113.054 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -96.05 -40.47 9.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.443 1.097 . . . . 10.0 110.534 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.75 152.66 68.78 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 105.765 -1.939 . . . . 10.0 105.765 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -57.8 120.71 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.825 2.35 . . . . 10.0 111.725 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.16 73.65 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -74.39 104.9 5.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.859 1.264 . . . . 10.0 109.765 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 p -42.0 116.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.551 1.141 . . . . 10.0 111.425 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 116.46 -27.82 7.82 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.999 -0.89 . . . . 10.0 111.196 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -173.82 3.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.67 1.7 . . . . 10.0 110.082 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.7 m -150.35 130.26 13.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.371 -1.74 . . . . 10.0 107.749 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.03 134.11 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.383 1.073 . . . . 10.0 108.537 -170.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.76 110.87 8.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 pt -85.27 -179.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 160.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.0 m -147.08 121.53 9.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.403 -0.811 . . . . 10.0 109.147 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.3 177.52 7.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.654 0.381 . . . . 10.0 111.441 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -156.95 99.48 1.83 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.596 1.558 . . . . 10.0 107.96 171.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.82 33.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.949 -0.469 . . . . 10.0 109.89 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.2 t -82.94 61.36 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -169.54 -60.1 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 129.08 2.952 . . . . 10.0 105.482 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.42 -92.27 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.687 -1.142 . . . . 10.0 111.61 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -160.55 173.22 15.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.813 -0.816 . . . . 10.0 109.739 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 t -94.49 144.73 25.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.145 -1.798 . . . . 10.0 106.145 153.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.3 tp -156.45 143.76 19.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -87.97 132.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.955 1.702 . . . . 10.0 106.918 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.39 125.66 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.586 -1.265 . . . . 10.0 107.586 -164.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 111.37 18.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.029 -0.73 . . . . 10.0 109.029 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.08 119.17 38.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.079 0.952 . . . . 10.0 110.496 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -83.62 126.89 33.31 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.865 0.466 . . . . 10.0 110.387 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.25 110.29 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.628 -1.249 . . . . 10.0 107.628 -165.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -158.11 150.24 21.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.095 0.861 . . . . 10.0 110.86 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.38 150.8 24.19 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.113 0.87 . . . . 10.0 112.573 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.257 1.4 p-10 56.85 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.04 2.136 . . . . 10.0 112.715 -172.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.02 116.2 2.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 103.913 -2.625 . . . . 10.0 103.913 167.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -150.92 107.67 3.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.756 -1.572 . . . . 10.0 106.756 -157.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.46 -70.56 0.67 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.127 -1.589 . . . . 10.0 109.127 -160.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 103.839 -2.652 . . . . 10.0 103.839 163.331 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.0 173.02 23.95 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -173.55 -174.6 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.249 1.82 . . . . 10.0 106.537 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -158.98 -177.84 6.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.33 108.03 1.52 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.185 1.394 . . . . 10.0 107.953 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.33 155.86 16.75 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.676 2.25 . . . . 10.0 110.228 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.61 173.06 15.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.418 1.087 . . . . 10.0 108.148 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -160.45 -173.9 4.22 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.763 1.225 . . . . 10.0 107.719 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 m -150.13 135.28 9.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.306 -1.739 . . . . 10.0 106.306 169.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.59 158.56 55.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.165 1.91 . . . . 10.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.59 179.32 6.05 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.261 2.641 . . . . 10.0 110.822 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.79 169.91 18.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.011 1.324 . . . . 10.0 107.669 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -160.75 -179.59 7.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.326 1.051 . . . . 10.0 108.468 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -159.75 -173.31 4.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.07 -1.455 . . . . 10.0 107.07 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.86 108.84 1.29 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.717 1.207 . . . . 10.0 109.304 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.69 177.26 9.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.493 2.129 . . . . 10.0 110.192 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.22 169.58 23.84 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.565 1.146 . . . . 10.0 108.0 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.38 169.27 24.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.669 1.188 . . . . 10.0 107.954 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -146.64 179.09 7.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.315 1.446 . . . . 10.0 107.702 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -155.06 174.69 14.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.61 -176.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.768 1.227 . . . . 10.0 107.867 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.82 -177.72 29.31 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 107.691 -2.164 . . . . 10.0 107.691 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.81 -59.44 0.44 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 117.794 0.797 . . . . 10.0 110.516 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 123.81 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.589 0.356 . . . . 10.0 110.655 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.37 -68.78 0.82 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.757 0.823 . . . . 10.0 110.389 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -158.84 131.36 4.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.27 159.13 54.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.62 1.546 . . . . 10.0 109.676 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m -81.86 53.68 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.903 -0.498 . . . . 10.0 110.833 -171.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 p -156.48 53.34 0.54 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.315 0.646 . . . . 10.0 110.181 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.74 80.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 165.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' NE2' ' H ' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -123.91 133.08 53.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 128.252 2.621 . . . . 10.0 108.407 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.06 97.09 1.29 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.27 -1.532 . . . . 10.0 109.27 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.12 9.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.705 0.753 . . . . 10.0 111.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.3 p -115.96 149.61 38.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.737 -1.208 . . . . 10.0 107.737 163.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.96 142.16 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.46 16.97 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.832 0.825 . . . . 10.0 111.044 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.792 1.637 . . . . 10.0 110.811 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 t 45.45 74.66 0.76 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.741 1.616 . . . . 10.0 111.144 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.26 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.296 2.664 . . . . 10.0 110.044 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.16 77.68 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.801 3.001 . . . . 10.0 112.473 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 t -157.11 -49.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.374 3.07 . . . . 10.0 106.008 165.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 67.56 162.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 C-N-CA 125.615 1.566 . . . . 10.0 107.438 -161.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 72.79 -50.18 0.7 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.428 1.491 . . . . 10.0 111.89 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.23 155.64 16.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.008 1.723 . . . . 10.0 109.69 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -164.41 -176.73 4.52 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 10.0 108.045 162.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 153.91 34.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.487 1.115 . . . . 10.0 110.73 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.59 150.03 22.58 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.073 0.858 . . . . 10.0 110.442 170.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -125.0 123.75 40.53 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -160.66 -172.41 3.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.228 1.411 . . . . 10.0 107.701 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 m -144.86 122.59 11.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.444 -0.785 . . . . 10.0 109.598 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.42 102.77 10.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.332 -1.729 . . . . 10.0 106.332 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 m -92.56 94.16 8.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.651 -1.613 . . . . 10.0 106.653 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.86 56.03 3.27 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.79 -0.569 . . . . 10.0 110.434 -167.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -91.76 111.09 22.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.34 0.59 . . . . 10.0 109.5 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 133.27 -19.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 131.564 3.946 . . . . 10.0 106.942 -165.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.78 61.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.638 -1.245 . . . . 10.0 107.638 150.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -145.04 137.45 13.4 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.319 1.848 . . . . 10.0 110.633 -170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.69 92.83 0.94 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 10.0 112.212 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.77 112.11 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.957 0.903 . . . . 10.0 108.924 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 168.64 17.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.675 0.79 . . . . 10.0 110.48 174.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -132.93 127.78 35.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.41 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.522 0.677 . . . . 10.0 109.755 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.4 147.25 13.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.191 -1.164 . . . . 10.0 110.191 163.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.22 66.95 0.51 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.019 1.327 . . . . 10.0 109.665 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.48 145.04 28.34 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.706 -0.849 . . . . 10.0 108.706 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 t -170.35 151.58 3.8 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 118.943 0.792 . . . . 10.0 110.47 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.86 45.79 0.96 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.992 2.461 . . . . 10.0 111.323 166.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.16 -77.28 0.47 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.929 1.291 . . . . 10.0 108.609 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.92 143.53 55.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.032 0.533 . . . . 10.0 110.948 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 m -96.72 -29.22 13.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.609 0.763 . . . . 10.0 109.64 165.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.0 t -126.03 67.41 61.86 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.074 1.75 . . . . 10.0 109.092 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.73 106.1 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.679 2.253 . . . . 10.0 109.777 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 128.56 53.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.222 1.009 . . . . 10.0 109.478 -174.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.73 136.8 35.44 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.229 -1.026 . . . . 10.0 108.229 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 ttp -136.07 152.44 50.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.055 1.342 . . . . 10.0 108.812 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -148.19 110.24 4.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.413 0.685 . . . . 10.0 110.058 -166.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -141.41 55.95 1.53 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.447 -0.783 . . . . 10.0 111.828 175.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -137.2 110.57 7.92 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.039 1.336 . . . . 10.0 109.093 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -52.27 -42.65 63.87 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.461 1.104 . . . . 10.0 111.195 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.3 p -82.45 16.53 2.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.901 1.28 . . . . 10.0 112.334 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.95 -142.99 5.2 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.396 1.474 . . . . 10.0 110.1 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.01 -68.63 1.58 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 117.169 0.484 . . . . 10.0 112.266 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -144.67 169.9 17.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.568 1.547 . . . . 10.0 108.24 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -117.71 54.5 0.9 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.93 75.01 0.22 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 118.742 -1.032 . . . . 10.0 111.591 -166.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 ttp -49.36 98.36 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 122.324 1.059 . . . . 10.0 111.717 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -155.76 166.53 33.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.274 2.229 . . . . 10.0 105.955 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.8 mtm -80.82 132.62 35.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.031 -1.47 . . . . 10.0 107.031 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -134.64 168.22 18.91 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.733 . . . . 10.0 110.668 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -37.74 -56.4 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.63 2.887 . . . . 10.0 111.464 159.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 178.47 -159.27 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.47 1.508 . . . . 10.0 110.258 -175.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.431 HD13 ' N ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -124.54 142.78 51.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 126.386 1.874 . . . . 10.0 106.362 161.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m -110.47 134.87 51.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.005 -1.85 . . . . 10.0 106.005 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 pp -121.83 138.94 29.31 Favored Pre-proline 0 N--CA 1.452 -0.35 0 N-CA-C 106.679 -1.601 . . . . 10.0 106.679 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.87 176.48 8.94 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.862 1.708 . . . . 10.0 110.699 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.6 129.74 8.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.88 -1.054 . . . . 10.0 109.63 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 59.15 26.27 14.97 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 129.674 3.19 . . . . 10.0 113.342 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.69 144.71 45.96 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.965 -0.854 . . . . 10.0 110.965 167.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -129.21 65.42 1.46 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.572 -2.01 . . . . 10.0 105.572 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.25 129.25 34.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.943 -2.243 . . . . 10.0 104.943 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.8 m -123.45 93.45 3.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.013 -2.217 . . . . 10.0 105.013 -158.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.82 122.45 26.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 -162.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -151.86 154.33 35.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.956 1.303 . . . . 10.0 108.47 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -8.53 6.91 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.507 1.299 . . . . 10.0 114.507 -164.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 37.67 1.48 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.812 0.733 . . . . 10.0 110.979 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.45 64.97 0.22 Allowed Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.37 -1.092 . . . . 10.0 110.37 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 t0 70.01 133.78 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.199 1.799 . . . . 10.0 109.748 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -177.19 169.82 2.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.574 -0.704 . . . . 10.0 110.728 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.95 115.64 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.527 -2.027 . . . . 10.0 105.527 169.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 81.5 mtp -83.84 95.92 8.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.88 65.39 6.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 10.0 107.891 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 75.8 mtp -82.6 162.53 21.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.847 0.832 . . . . 10.0 110.782 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.99 69.66 1.38 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.429 -1.068 . . . . 10.0 110.429 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.33 82.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.672 0.789 . . . . 10.0 109.611 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -55.92 -47.25 77.85 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.892 -0.505 . . . . 10.0 112.084 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -114.05 155.5 45.34 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.937 -1.135 . . . . 10.0 107.937 157.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.56 173.83 12.65 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.447 2.765 . . . . 10.0 110.034 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.38 175.37 8.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.144 1.378 . . . . 10.0 110.113 -174.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.31 150.3 49.65 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.36 1.464 . . . . 10.0 107.953 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.8 t -69.79 134.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.46 42.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.074 -0.81 . . . . 10.0 111.074 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.64 -169.37 1.7 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.84 1.305 . . . . 10.0 108.813 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 m -154.74 82.78 1.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.027 -1.472 . . . . 10.0 107.027 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -89.83 126.49 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.883 -1.154 . . . . 10.0 107.883 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.31 150.88 45.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.102 -0.639 . . . . 10.0 110.372 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.98 148.61 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.379 -1.712 . . . . 10.0 106.379 170.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -123.15 117.59 25.72 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.79 157.04 18.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.481 -0.563 . . . . 10.0 109.481 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -157.38 86.23 0.94 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.578 1.551 . . . . 10.0 107.895 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.74 157.61 23.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.096 -0.377 . . . . 10.0 110.046 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 t -54.36 -32.77 57.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.523 1.129 . . . . 10.0 112.504 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -5.74 4.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.918 0.887 . . . . 10.0 113.063 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.21 9.67 65.07 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.404 1.002 . . . . 10.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -79.34 95.1 5.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 105.916 -1.883 . . . . 10.0 105.916 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -116.37 123.97 48.91 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.076 1.751 . . . . 10.0 107.141 -171.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.4 tp -155.55 141.59 18.28 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -102.52 132.98 48.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.477 1.911 . . . . 10.0 106.742 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.87 162.14 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.05 131.86 54.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.868 1.267 . . . . 10.0 107.604 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.77 133.81 55.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.643 1.177 . . . . 10.0 109.892 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -83.89 128.33 34.47 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.87 108.1 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.324 -1.362 . . . . 10.0 107.324 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -157.58 125.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.582 -0.895 . . . . 10.0 108.582 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -71.7 73.11 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.37 0.605 . . . . 10.0 111.357 176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -52.02 104.54 0.09 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 109.199 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.275 10.9 pt 60.67 -23.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 128.147 2.579 . . . . 10.0 116.821 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -51.58 115.86 1.83 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.023 1.329 . . . . 10.0 110.854 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.59 -62.75 2.32 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 10.0 110.911 -171.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.3 ttm105 . . . . . 0 C--O 1.247 0.952 0 C-N-CA 127.782 2.433 . . . . 10.0 109.562 -176.42 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 106.629 -1.619 . . . . 10.0 106.629 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.61 124.97 1.27 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.28 -1.128 . . . . 10.0 110.28 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -165.43 155.39 13.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -166.54 -179.46 4.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.166 -1.42 . . . . 10.0 107.166 169.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.7 ttm -167.3 71.44 0.99 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.658 1.583 . . . . 10.0 108.712 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -71.48 143.74 43.51 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.222 1.948 . . . . 10.0 109.893 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.35 151.44 15.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.173 -1.047 . . . . 10.0 108.173 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -164.17 169.44 17.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.534 -1.654 . . . . 10.0 106.534 171.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -172.51 68.67 0.4 Allowed Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 10.0 109.898 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.15 118.66 5.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.254 1.969 . . . . 10.0 110.113 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.99 159.4 18.27 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.519 2.146 . . . . 10.0 110.787 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.32 150.5 16.41 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.758 -1.201 . . . . 10.0 107.758 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -169.92 157.39 6.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.773 1.229 . . . . 10.0 108.276 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -169.14 174.4 6.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.405 1.482 . . . . 10.0 107.172 168.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.2 68.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 10.0 110.5 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.19 145.23 38.7 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.115 1.877 . . . . 10.0 110.056 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.4 152.2 16.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.034 0.934 . . . . 10.0 108.507 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.39 156.62 8.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.587 1.555 . . . . 10.0 107.01 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -164.02 160.78 22.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -177.59 169.68 2.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.261 2.224 . . . . 10.0 106.641 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.21 -177.41 2.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.784 1.634 . . . . 10.0 107.215 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.16 164.86 32.07 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.51 -2.236 . . . . 10.0 107.51 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.27 -177.39 3.65 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.263 1.025 . . . . 10.0 108.58 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 71.12 178.21 0.26 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.072 1.749 . . . . 10.0 111.76 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.04 178.18 9.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.87 1.668 . . . . 10.0 106.952 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.15 132.18 8.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.22 150.49 87.44 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.605 1.537 . . . . 10.0 109.002 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.04 51.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 121.785 0.803 . . . . 10.0 111.168 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -157.85 55.17 0.48 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 -165.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.57 58.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.11 0.957 . . . . 10.0 108.981 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -97.9 -179.91 4.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.112 1.365 . . . . 10.0 110.396 171.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.0 -136.92 3.51 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.056 -2.418 . . . . 10.0 107.056 166.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.98 132.4 6.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.981 1.39 . . . . 10.0 110.683 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.7 p -126.76 135.2 50.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.288 -1.745 . . . . 10.0 106.288 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.7 t -121.71 135.29 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 119.158 0.89 . . . . 10.0 109.061 -171.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.83 44.62 0.56 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.631 0.974 . . . . 10.0 113.631 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 26.77 -119.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.643 1.977 . . . . 10.0 111.546 -164.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.69 113.94 50.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.093 -1.817 . . . . 10.0 106.093 161.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.97 163.99 20.65 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.17 1.913 . . . . 10.0 108.774 168.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.92 62.41 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.449 2.1 . . . . 10.0 110.523 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.5 p -163.4 62.31 0.17 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.209 1.004 . . . . 10.0 108.628 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 mt 75.15 160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.932 1.293 . . . . 10.0 110.222 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -66.76 25.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.741 1.386 . . . . 10.0 114.741 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.95 158.44 15.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 168.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -165.39 -175.54 3.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.728 -1.953 . . . . 10.0 105.728 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.56 168.98 24.93 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.319 -0.622 . . . . 10.0 109.319 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.47 161.09 22.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -131.4 104.7 7.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.632 -1.988 . . . . 10.0 105.632 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -171.16 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.139 1.775 . . . . 10.0 110.443 -169.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -152.29 129.57 11.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.718 -1.238 . . . . 10.0 108.029 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.11 135.44 33.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 m -123.96 104.27 8.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 124.168 0.918 . . . . 10.0 110.581 -167.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.18 113.18 15.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.706 -0.479 . . . . 10.0 109.706 167.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -135.36 68.44 1.46 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.668 -1.604 . . . . 10.0 106.668 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -178.5 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.388 1.475 . . . . 10.0 111.473 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 72.72 78.13 0.15 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.551 1.94 . . . . 10.0 112.17 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -143.16 147.0 38.97 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.331 0.652 . . . . 10.0 109.817 168.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.513 ' C ' HD12 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -86.29 112.23 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.759 2.973 . . . . 10.0 111.001 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 58' ' ' PRO . 1.7 mp -123.92 99.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.71 103.94 12.59 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.109 -0.994 . . . . 10.0 111.139 -173.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -82.68 124.95 30.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.697 0.799 . . . . 10.0 110.201 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.66 54.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.117 0.961 . . . . 10.0 109.626 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.65 144.49 10.0 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -1.323 . . . . 10.0 109.792 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.45 66.73 0.56 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.972 1.709 . . . . 10.0 107.205 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 148.71 28.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 t -170.3 151.78 3.9 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 109.879 -0.415 . . . . 10.0 109.879 -164.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.28 -1.41 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.802 2.335 . . . . 10.0 112.021 167.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -104.82 -35.91 7.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.471 1.108 . . . . 10.0 113.415 -163.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.43 124.29 48.97 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.558 1.143 . . . . 10.0 109.844 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -29.79 65.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.795 0.838 . . . . 10.0 110.108 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.7 m -135.36 68.43 68.14 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.024 1.33 . . . . 10.0 109.959 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.1 115.76 4.22 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.616 2.21 . . . . 10.0 110.365 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -139.34 140.4 37.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.821 0.448 . . . . 10.0 111.203 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mt -83.57 145.83 28.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 10.0 109.8 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.65 169.37 18.12 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 125.596 1.558 . . . . 10.0 109.817 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 t -145.71 157.44 43.95 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.318 -0.238 . . . . 10.0 110.677 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.54 61.14 0.61 Allowed 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.342 -0.849 . . . . 10.0 109.25 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -155.15 138.63 15.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -80.55 -39.21 28.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.38 -44.99 95.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.798 1.239 . . . . 10.0 111.514 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.94 -126.7 3.49 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.065 -0.814 . . . . 10.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.4 -75.3 0.33 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.828 0.727 . . . . 10.0 113.923 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -163.73 160.98 23.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.774 0.83 . . . . 10.0 109.972 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.97 53.81 2.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.621 -1.251 . . . . 10.0 107.621 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.67 71.2 0.5 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.324 -0.709 . . . . 10.0 111.962 -156.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.51 64.32 4.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.182 0.991 . . . . 10.0 110.24 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -136.11 170.26 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.971 2.108 . . . . 10.0 109.275 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.86 72.79 7.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.52 0.728 . . . . 10.0 109.155 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.1 158.8 86.52 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.341 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -44.49 -53.41 4.96 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.373 2.715 . . . . 10.0 111.995 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.52 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 174.3 -157.62 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.021 2.129 . . . . 10.0 108.931 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.52 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.1 mm? -128.76 139.9 51.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.646 -1.613 . . . . 10.0 106.646 165.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.1 m -88.4 100.13 12.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.444 -1.687 . . . . 10.0 106.444 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.31 123.11 79.49 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 106.095 -1.817 . . . . 10.0 106.095 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.17 -172.24 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.566 2.177 . . . . 10.0 111.771 -168.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.83 149.23 3.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 155.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.21 7.61 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.809 1.411 . . . . 10.0 114.809 -165.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 90.74 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.885 -1.286 . . . . 10.0 109.885 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -115.93 64.78 0.7 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.134 1.774 . . . . 10.0 107.326 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -88.73 154.68 20.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.648 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -118.5 109.76 16.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 -167.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -83.62 102.99 12.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -152.07 170.62 19.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.816 0.735 . . . . 10.0 111.295 -170.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -36.55 -47.38 0.63 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.772 1.229 . . . . 10.0 111.712 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -129.93 95.05 3.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.776 1.63 . . . . 10.0 107.75 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.7 117.68 1.1 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.7 -1.056 . . . . 10.0 111.264 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.2 t0 24.86 64.79 0.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.565 2.746 . . . . 10.0 113.533 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -116.59 159.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.269 0.557 . . . . 10.0 112.419 -165.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.77 114.53 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.769 -1.937 . . . . 10.0 105.769 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 mtp -81.98 96.92 7.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.802 -1.184 . . . . 10.0 107.802 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.0 mt -81.0 59.41 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 46.5 ttp -82.99 158.4 22.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.387 0.675 . . . . 10.0 110.474 -169.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.16 -7.93 9.15 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.097 -1.39 . . . . 10.0 115.207 156.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.7 tp 46.63 68.54 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.243 1.417 . . . . 10.0 111.777 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -77.92 -37.71 47.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.432 0.693 . . . . 10.0 110.695 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.73 153.02 67.4 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 105.747 -1.946 . . . . 10.0 105.747 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.21 109.97 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.885 2.39 . . . . 10.0 111.415 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.04 99.81 1.14 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -97.8 115.78 28.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.228 1.411 . . . . 10.0 108.673 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -46.97 120.0 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.238 0.615 . . . . 10.0 110.067 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.88 -23.71 18.64 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.704 -1.053 . . . . 10.0 111.766 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -175.02 3.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.723 1.725 . . . . 10.0 109.55 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -153.9 131.74 11.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.284 -1.78 . . . . 10.0 107.493 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.7 136.84 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.404 1.082 . . . . 10.0 108.676 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.9 114.15 15.36 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.2 pt -92.88 176.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.747 0.819 . . . . 10.0 109.068 164.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.2 m -147.75 125.41 11.81 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.596 -0.69 . . . . 10.0 109.609 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 pp -91.77 179.18 5.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.22 0.608 . . . . 10.0 111.92 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -157.74 103.46 1.9 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.826 1.65 . . . . 10.0 108.068 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.18 123.35 33.93 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.006 -0.434 . . . . 10.0 110.488 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -83.0 64.0 7.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -174.86 -61.2 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.916 2.887 . . . . 10.0 105.47 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.75 -96.81 0.6 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.629 -1.169 . . . . 10.0 111.567 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -160.47 175.86 12.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.857 -0.79 . . . . 10.0 109.619 -171.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.6 t -90.42 150.36 21.87 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.868 1.667 . . . . 10.0 107.007 156.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.9 tp -155.16 142.89 19.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.801 -1.925 . . . . 10.0 105.801 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.89 132.18 37.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.198 1.799 . . . . 10.0 106.667 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.48 128.36 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.686 -1.227 . . . . 10.0 107.686 -166.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.65 108.03 16.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.26 118.89 31.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.005 0.922 . . . . 10.0 109.838 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.4 m -83.95 132.41 34.77 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.42 111.34 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.432 ' NZ ' ' OXT' ' A' ' 149' ' ' ARG . 31.9 pttt -157.67 116.98 3.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.577 0.626 . . . . 10.0 111.283 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -84.73 175.43 9.19 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.731 -0.605 . . . . 10.0 111.088 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 56.04 179.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.677 1.591 . . . . 10.0 112.191 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.28 111.79 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 104.39 -2.448 . . . . 10.0 104.39 165.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -146.8 134.26 20.83 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 -171.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.3 -69.24 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.437 1.494 . . . . 10.0 113.046 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.432 ' OXT' ' NZ ' ' A' ' 143' ' ' LYS . 27.4 mtt180 . . . . . 0 C--O 1.247 0.948 0 C-N-CA 128.457 2.703 . . . . 10.0 105.611 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.53 -35.32 36.7 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.303 0.956 . . . . 10.0 111.365 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -141.79 -177.56 5.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t 177.58 152.99 0.26 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.031 2.933 . . . . 10.0 106.149 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.0 ttt -151.81 132.46 7.46 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -175.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.32 178.49 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.097 2.531 . . . . 10.0 110.661 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.07 166.77 31.43 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.829 1.251 . . . . 10.0 107.693 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -162.87 171.91 15.94 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -153.04 140.52 13.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.158 -1.053 . . . . 10.0 108.158 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 155.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.355 2.037 . . . . 10.0 111.052 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.75 176.05 10.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.22 2.613 . . . . 10.0 110.387 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 156.36 41.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.37 167.61 17.58 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.791 -1.559 . . . . 10.0 106.791 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -150.42 -179.83 7.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 170.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.06 104.67 1.56 Allowed Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 10.0 109.46 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.07 107.04 2.39 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.191 1.927 . . . . 10.0 110.342 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.79 74.01 0.42 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.703 0.801 . . . . 10.0 110.537 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.45 66.28 0.47 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.179 1.392 . . . . 10.0 112.801 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -64.72 157.25 27.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.084 0.554 . . . . 10.0 109.647 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -165.28 148.36 8.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 -174.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.13 -175.81 2.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 107.714 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.51 42.93 79.67 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.095 0.379 . . . . 10.0 112.465 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.32 -44.87 43.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.669 0.388 . . . . 10.0 111.43 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.06 167.15 19.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.24 0.616 . . . . 10.0 112.243 -174.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.36 175.31 10.63 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.626 1.571 . . . . 10.0 108.315 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tt -153.79 131.81 6.43 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.65 140.7 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.145 1.897 . . . . 10.0 109.491 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.17 54.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.007 0.523 . . . . 10.0 112.329 -158.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -160.45 54.06 0.32 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.124 0.964 . . . . 10.0 109.974 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.75 64.74 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 120.984 -1.073 . . . . 10.0 110.774 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -155.35 149.9 26.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.131 0.572 . . . . 10.0 109.731 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.61 145.42 17.83 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.001 -1.64 . . . . 10.0 109.001 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.45 161.0 22.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.264 1.032 . . . . 10.0 111.302 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -123.41 139.97 53.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.907 -1.516 . . . . 10.0 106.907 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.92 136.71 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 107.358 -1.349 . . . . 10.0 107.358 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.45 41.46 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 34.94 -137.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.956 2.102 . . . . 10.0 112.083 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.75 108.75 47.59 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 160.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.31 166.6 29.13 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 N-CA-C 107.528 -1.758 . . . . 10.0 107.528 166.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.36 64.78 3.62 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.048 2.499 . . . . 10.0 111.032 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.3 t -164.55 56.51 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.842 1.257 . . . . 10.0 108.985 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt 71.56 170.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.589 1.156 . . . . 10.0 109.005 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -44.92 -41.35 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.064 -1.023 . . . . 10.0 112.747 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -51.43 141.35 15.73 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 127.072 2.149 . . . . 10.0 111.983 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 114' ' ' LEU . 14.3 t -162.03 -172.45 3.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.652 -165.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.34 159.09 44.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.792 0.837 . . . . 10.0 111.555 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.09 144.07 26.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.94 1.296 . . . . 10.0 109.238 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -128.53 119.22 24.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.569 -2.752 . . . . 10.0 103.569 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 ptp -161.04 -173.9 4.11 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.367 1.067 . . . . 10.0 108.522 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -131.39 135.85 47.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.216 1.407 . . . . 10.0 108.111 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.88 120.97 37.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 103.952 -2.611 . . . . 10.0 103.952 160.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -110.55 79.74 1.24 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.424 -1.324 . . . . 10.0 107.424 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -81.33 92.9 6.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.317 0.58 . . . . 10.0 110.433 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -83.31 57.11 3.82 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.798 -0.564 . . . . 10.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 t -171.1 157.96 5.37 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.936 0.895 . . . . 10.0 109.182 166.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.78 61.96 6.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -134.91 117.46 12.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.783 0.833 . . . . 10.0 111.04 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 122.82 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.094 2.529 . . . . 10.0 110.337 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.61 106.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.499 0.72 . . . . 10.0 109.08 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 121.46 32.61 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.204 -0.935 . . . . 10.0 111.563 -171.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.288 0.0 OUTLIER -102.59 128.06 49.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.047 -0.408 . . . . 10.0 110.22 -171.509 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.59 57.21 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.536 1.16 . . . . 10.0 109.079 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.78 153.23 24.22 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.939 -1.665 . . . . 10.0 108.939 166.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.94 62.19 0.46 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 168.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.92 138.87 32.24 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -168.82 151.32 4.94 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 118.602 0.637 . . . . 10.0 109.693 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.94 56.37 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.77 2.313 . . . . 10.0 109.656 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.7 mt -136.55 -82.33 0.38 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.97 1.708 . . . . 10.0 107.982 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.74 136.86 45.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.043 0.937 . . . . 10.0 111.681 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.8 m -81.48 -31.43 32.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.251 0.62 . . . . 10.0 109.433 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.2 t -119.82 72.2 16.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.503 1.121 . . . . 10.0 111.448 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.84 97.22 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.916 2.411 . . . . 10.0 111.153 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.7 mmt -105.23 128.72 53.56 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.378 1.071 . . . . 10.0 110.063 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 145.28 28.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.926 0.89 . . . . 10.0 110.105 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.05 163.85 31.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.888 1.275 . . . . 10.0 111.507 172.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.451 ' CG2' ' H ' ' A' ' 83' ' ' MET 0.25 26.1 m -102.0 164.23 11.82 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.485 3.114 . . . . 10.0 110.805 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.8 t -95.93 173.98 7.17 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.367 1.067 . . . . 10.0 112.837 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -99.26 55.82 1.0 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.003 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.9 p80 171.87 -170.33 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.698 2.399 . . . . 10.0 107.69 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 m -46.84 171.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.881 2.872 . . . . 10.0 114.654 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.92 -65.72 2.2 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.908 -2.077 . . . . 10.0 107.908 -169.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.62 -146.61 2.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.474 -1.05 . . . . 10.0 110.474 155.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.451 ' H ' ' CG2' ' A' ' 76' ' ' THR . 65.8 mtt -114.1 -82.47 0.6 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.865 1.266 . . . . 10.0 109.922 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.02 51.81 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.841 1.256 . . . . 10.0 109.385 -172.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.18 147.48 4.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.051 -0.595 . . . . 10.0 113.905 166.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -78.3 43.6 0.46 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.126 1.77 . . . . 10.0 112.047 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -83.04 157.77 22.75 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.572 0.749 . . . . 10.0 109.872 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.3 ttp -81.49 70.38 8.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.417 1.103 . . . . 10.0 109.36 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -58.09 162.02 6.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.876 1.671 . . . . 10.0 111.718 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 50.3 Cg_exo -47.57 -37.65 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.553 2.836 . . . . 10.0 113.341 163.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.91 -158.56 0.01 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.978 1.311 . . . . 10.0 111.049 -161.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.55 115.04 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.937 0.495 . . . . 10.0 110.05 164.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -84.46 103.14 13.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 159.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.28 120.16 76.45 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 105.998 -1.852 . . . . 10.0 105.998 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -85.89 137.16 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 109.283 -1.083 . . . . 10.0 109.283 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 50.73 -137.25 1.16 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.302 0.641 . . . . 10.0 110.911 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.89 59.39 0.1 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.291 2.237 . . . . 10.0 112.316 176.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 87.1 0.12 Allowed Glycine 0 N--CA 1.441 -0.974 0 O-C-N 121.583 -0.698 . . . . 10.0 111.372 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.1 m -86.4 67.67 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.63 1.572 . . . . 10.0 107.602 163.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.5 pt? -102.82 175.48 5.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.833 -0.802 . . . . 10.0 108.833 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -155.85 129.88 8.67 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.675 0.75 . . . . 10.0 110.437 -169.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.92 126.14 32.71 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.52 1.528 . . . . 10.0 108.574 -168.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.29 154.58 42.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.548 1.939 . . . . 10.0 109.123 -170.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.438 HH21 ' HA ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -56.62 -27.81 59.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.073 0.949 . . . . 10.0 112.855 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.438 ' HA ' HH21 ' A' ' 104' ' ' ARG . 36.1 m-20 -78.55 -59.99 2.56 Favored 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 121.473 -0.767 . . . . 10.0 111.406 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.88 136.87 5.55 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.833 -1.307 . . . . 10.0 109.833 -167.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t0 70.06 120.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 129.063 2.945 . . . . 10.0 106.761 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 177.42 171.17 0.58 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.549 1.522 . . . . 10.0 111.759 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.36 124.4 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 105.066 -2.198 . . . . 10.0 105.066 156.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.4 mtm -82.32 96.69 7.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 161.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.52 69.18 5.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.911 -1.514 . . . . 10.0 106.911 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 66.4 mtp -85.37 166.95 15.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.967 0.889 . . . . 10.0 112.961 -169.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.96 57.8 17.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.081 -1.208 . . . . 10.0 110.081 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 45' ' ' THR . 86.5 mt -61.36 123.38 17.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.075 0.938 . . . . 10.0 109.098 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.82 -61.91 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.595 0.358 . . . . 10.0 111.423 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -70.75 157.18 90.78 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.076 0.55 . . . . 10.0 111.354 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.98 139.62 39.89 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.577 2.184 . . . . 10.0 110.288 169.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -88.05 179.43 6.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.005 1.322 . . . . 10.0 111.592 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 100.64 0.93 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.64 117.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.208 -1.034 . . . . 10.0 108.208 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.15 -13.28 31.35 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.194 -0.781 . . . . 10.0 111.995 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -77.78 -169.85 1.66 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.493 1.615 . . . . 10.0 108.303 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.8 m -155.3 137.27 14.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.3 154.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.22 -1.4 . . . . 10.0 107.22 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -80.52 145.67 31.71 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 126' ' ' ILE . 17.9 tt -108.71 146.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 162.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.7 m -117.57 111.82 19.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.871 -1.899 . . . . 10.0 105.871 172.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 145.71 24.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 125.935 1.694 . . . . 10.0 107.258 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -144.27 97.58 3.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.45 142.28 32.05 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.3 t -62.14 -29.05 70.07 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.695 -1.253 . . . . 10.0 111.082 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.664 -0.647 . . . . 10.0 110.595 171.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.81 91.16 0.13 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.177 1.37 . . . . 10.0 110.602 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 53.61 1.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.521 0.728 . . . . 10.0 110.643 -174.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.5 m -157.8 87.8 0.95 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.934 0.494 . . . . 10.0 110.896 -170.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mt -153.94 156.06 36.79 Favored 'General case' 0 C--O 1.23 0.036 0 CA-C-N 119.085 0.857 . . . . 10.0 109.109 167.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -149.32 136.28 19.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.4 163.63 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.55 137.66 32.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.387 0.675 . . . . 10.0 110.359 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.34 114.34 24.18 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.205 1.802 . . . . 10.0 109.318 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -83.01 125.3 31.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.297 1.439 . . . . 10.0 108.203 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.84 97.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 O-C-N 120.513 -1.367 . . . . 10.0 108.305 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -147.44 103.03 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.315 0.646 . . . . 10.0 110.917 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -52.11 127.44 21.64 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.952 -0.468 . . . . 10.0 110.3 161.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -149.13 143.16 25.81 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 mp 43.16 55.66 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.418 1.104 . . . . 10.0 108.663 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -83.22 51.45 1.97 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.103 -0.953 . . . . 10.0 112.365 -158.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.71 -55.02 0.4 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.836 -0.906 . . . . 10.0 110.836 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.491 0 C-N-CA 126.596 1.958 . . . . 10.0 110.388 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.96 148.79 11.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.118 -1.593 . . . . 10.0 109.118 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -119.98 67.41 0.82 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.046 1.738 . . . . 10.0 109.36 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 p -73.04 75.68 1.21 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.559 0.744 . . . . 10.0 109.919 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 60.4 ttp -93.47 106.38 20.36 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.996 1.318 . . . . 10.0 109.818 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.21 175.04 11.58 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.253 1.969 . . . . 10.0 110.316 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.37 165.57 30.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.874 1.27 . . . . 10.0 107.669 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -160.39 165.86 30.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -167.25 69.15 0.95 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 10.0 109.497 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.51 122.4 9.61 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.197 1.932 . . . . 10.0 110.007 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 168.3 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.719 2.279 . . . . 10.0 110.895 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 142.09 20.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.794 -1.188 . . . . 10.0 107.794 173.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -167.04 164.89 15.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.516 -1.661 . . . . 10.0 106.516 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -158.99 -177.24 6.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 173.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.98 73.31 1.26 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.584 1.553 . . . . 10.0 109.691 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.04 78.01 2.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.016 2.477 . . . . 10.0 111.164 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 152.22 17.89 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.033 0.533 . . . . 10.0 110.769 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.34 171.84 19.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.206 1.002 . . . . 10.0 108.927 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -143.84 174.96 10.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.542 1.537 . . . . 10.0 107.761 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -137.52 107.76 6.43 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.377 1.071 . . . . 10.0 108.871 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.7 98.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.101 0.56 . . . . 10.0 111.419 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.36 -59.96 3.99 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.907 -0.496 . . . . 10.0 111.957 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.8 149.71 43.84 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.997 0.919 . . . . 10.0 109.431 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 69.12 142.87 0.04 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.885 1.674 . . . . 10.0 110.29 -168.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 70.85 -39.77 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.714 1.605 . . . . 10.0 113.931 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 tt -51.65 120.31 15.34 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.442 1.497 . . . . 10.0 109.602 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -68.16 165.3 28.94 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.416 1.411 . . . . 10.0 108.583 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.09 56.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.123 0.963 . . . . 10.0 110.554 -169.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -155.08 58.02 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.237 1.015 . . . . 10.0 108.777 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.56 85.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -145.52 158.67 43.81 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.107 1.763 . . . . 10.0 107.586 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.62 -163.08 32.74 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.437 -1.865 . . . . 10.0 108.437 161.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.55 149.51 23.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.994 0.897 . . . . 10.0 109.96 169.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.6 p -133.76 153.99 51.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 170.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.4 133.55 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 123.514 0.726 . . . . 10.0 109.928 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.17 110.45 7.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.82 34.65 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.464 -0.772 . . . . 10.0 109.112 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -19.35 99.31 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 127.523 2.329 . . . . 10.0 113.558 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 163.01 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.688 2.926 . . . . 10.0 109.683 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.09 52.58 3.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.22 1.947 . . . . 10.0 110.164 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -157.68 56.0 0.49 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.182 -1.044 . . . . 10.0 108.182 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt 70.08 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.333 1.053 . . . . 10.0 109.008 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.462 HH11 ' CG ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -50.6 -42.71 56.25 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' CG ' HH11 ' A' ' 43' ' ' ARG . 63.4 m-20 -59.09 127.32 31.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.706 0.765 . . . . 10.0 109.929 -163.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -145.68 -165.84 2.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.315 -1.311 . . . . 10.0 111.21 -164.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.86 157.94 41.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.611 1.164 . . . . 10.0 112.107 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.42 158.95 20.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.492 -0.777 . . . . 10.0 110.022 165.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.3 128.14 48.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 163.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -157.64 177.8 10.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 p -98.19 168.81 10.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.39 146.4 46.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.364 -1.717 . . . . 10.0 106.364 163.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.6 m -140.79 111.66 7.04 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.975 0.797 . . . . 10.0 112.302 -166.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 119.69 24.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.314 0.506 . . . . 10.0 109.652 167.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 80.74 1.63 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.971 -1.122 . . . . 10.0 107.971 157.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m 164.53 -19.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 129.184 2.994 . . . . 10.0 109.557 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 74.13 53.24 0.1 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.495 0.589 . . . . 10.0 110.407 140.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -145.98 157.71 49.96 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 125.004 1.322 . . . . 10.0 109.129 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.31 70.59 7.14 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.543 2.829 . . . . 10.0 111.301 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mm -85.89 152.01 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.44 0.638 . . . . 10.0 109.653 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -139.26 81.83 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.592 2.357 . . . . 10.0 108.791 -162.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.01 63.4 7.07 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.155 0.982 . . . . 10.0 111.961 -166.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.39 60.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.481 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 149.2 18.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.365 -1.398 . . . . 10.0 113.304 163.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.28 59.89 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.505 1.522 . . . . 10.0 108.891 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.29 132.88 35.3 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.726 -0.609 . . . . 10.0 109.604 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 t -161.69 150.09 12.64 Favored Pre-proline 0 C--O 1.24 0.568 0 O-C-N 121.464 -0.772 . . . . 10.0 111.198 -168.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.57 42.84 1.23 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.895 2.396 . . . . 10.0 111.115 170.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.07 -68.34 0.83 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.058 1.343 . . . . 10.0 109.169 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.23 138.74 31.18 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.777 1.231 . . . . 10.0 110.517 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -78.77 -34.71 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 165.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t -121.65 73.65 32.66 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 124.939 1.296 . . . . 10.0 110.034 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.74 114.27 3.99 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.455 2.104 . . . . 10.0 109.728 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.6 mtp -129.3 133.63 47.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.925 0.89 . . . . 10.0 110.129 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -84.37 149.74 25.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.647 1.179 . . . . 10.0 111.156 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -174.47 3.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.98 1.312 . . . . 10.0 113.126 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -159.68 134.32 7.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.937 1.295 . . . . 10.0 108.55 -172.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 4.4 t -92.0 -174.05 3.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.466 1.127 . . . . 10.0 112.246 173.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.7 m -80.04 72.29 6.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.791 -1.55 . . . . 10.0 107.581 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 m80 75.06 165.07 0.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.609 1.964 . . . . 10.0 111.4 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m 67.93 -67.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.989 1.716 . . . . 10.0 111.608 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.16 87.26 0.99 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.31 -2.316 . . . . 10.0 107.31 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.55 -160.7 54.15 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 112.156 -0.378 . . . . 10.0 112.156 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.2 mtt -69.65 -73.78 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.466 1.284 . . . . 10.0 114.466 -166.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.06 66.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.477 0.711 . . . . 10.0 109.341 -159.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.59 170.1 32.89 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.925 0.774 . . . . 10.0 114.309 164.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.9 56.49 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.585 2.354 . . . . 10.0 113.372 -157.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -97.2 155.57 16.79 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.374 1.87 . . . . 10.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.4 mtm -79.25 76.34 5.79 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.349 -1.723 . . . . 10.0 106.349 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.34 153.08 77.45 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.099 -1.41 . . . . 10.0 109.631 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -36.88 -52.33 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.743 2.962 . . . . 10.0 112.748 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -179.41 175.69 0.89 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.286 2.634 . . . . 10.0 104.778 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.09 100.84 12.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 m -76.49 136.7 39.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 pt -106.54 98.65 21.0 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.66 52.85 4.51 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.919 3.079 . . . . 10.0 111.903 -160.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.62 144.23 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.6 1.19 . . . . 10.0 110.578 -157.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 61.06 3.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.508 1.923 . . . . 10.0 113.706 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.5 110.21 3.14 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.998 -1.641 . . . . 10.0 108.998 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.2 m -149.93 76.55 1.29 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 -165.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.08 -158.55 0.69 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.652 -166.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.5 m -151.83 118.63 5.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.877 -1.527 . . . . 10.0 106.877 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.34 120.79 26.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.46 155.0 32.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.112 1.365 . . . . 10.0 108.285 -159.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -80.49 51.04 1.38 Allowed 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.622 -0.673 . . . . 10.0 111.264 -173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.63 -71.02 0.73 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.083 1.753 . . . . 10.0 107.187 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 77' ' ' THR . . . -139.45 -55.75 0.04 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.287 -1.125 . . . . 10.0 110.287 -166.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.408 ' N ' ' HB ' ' A' ' 77' ' ' THR . 9.2 t70 -99.59 129.21 45.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 125.177 1.391 . . . . 10.0 107.335 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 178.0 179.22 0.32 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.11 122.33 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.104 -2.554 . . . . 10.0 104.104 158.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.7 mtp -82.27 102.5 11.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.951 -1.5 . . . . 10.0 106.951 164.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.5 77.54 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 10.0 106.882 171.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.73 165.69 13.54 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.681 0.753 . . . . 10.0 111.571 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.57 69.95 1.22 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.1 tp -46.62 134.68 9.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.541 1.136 . . . . 10.0 110.391 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -119.51 -60.32 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.229 0.612 . . . . 10.0 111.553 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -93.91 143.48 26.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.574 0.75 . . . . 10.0 109.085 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.43 159.98 51.08 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.222 2.615 . . . . 10.0 111.349 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.71 156.94 36.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.368 1.467 . . . . 10.0 110.61 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 144.98 48.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.772 1.229 . . . . 10.0 108.869 170.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.15 69.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 10.0 108.744 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.18 -15.88 0.59 Allowed Glycine 0 CA--C 1.524 0.646 0 O-C-N 120.536 -1.352 . . . . 10.0 112.648 -159.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -177.42 0.56 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.958 1.837 . . . . 10.0 108.913 171.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.1 m -155.08 128.74 8.57 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.062 -1.881 . . . . 10.0 106.186 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.31 146.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -75.93 132.9 40.55 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.51 126.68 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 164.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.9 103.02 13.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.29 119.59 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -130.2 82.45 2.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.321 1.449 . . . . 10.0 107.256 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.79 154.4 24.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.024 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -60.89 -14.49 22.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.588 0.355 . . . . 10.0 111.526 168.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -9.59 20.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.692 1.197 . . . . 10.0 111.865 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.99 56.62 1.92 Allowed Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.503 1.049 . . . . 10.0 111.305 164.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -138.55 176.89 8.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.067 0.547 . . . . 10.0 110.147 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 m -155.49 88.69 1.15 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.716 -1.957 . . . . 10.0 105.716 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.0 172.14 10.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.5 93.16 2.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.603 -1.999 . . . . 10.0 105.603 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.1 t -102.02 137.74 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.56 115.46 22.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.52 123.23 46.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.864 0.866 . . . . 10.0 110.092 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 m -82.82 126.17 32.13 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.931 0.493 . . . . 10.0 109.819 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -84.26 104.8 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 O-C-N 120.688 -1.257 . . . . 10.0 107.929 -174.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -141.64 106.87 4.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.738 1.615 . . . . 10.0 109.521 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -40.32 -80.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.145 2.578 . . . . 10.0 111.736 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.42 107.38 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.641 1.576 . . . . 10.0 113.608 159.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mt 72.26 70.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 126.545 1.938 . . . . 10.0 106.83 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.49 30.67 5.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.355 1.462 . . . . 10.0 112.658 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.9 -49.64 53.01 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 172.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 103.693 -2.706 . . . . 10.0 103.693 160.143 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.89 167.85 29.15 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.125 -1.99 . . . . 10.0 108.125 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -165.91 173.59 10.37 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 t -170.96 158.04 5.55 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.849 1.26 . . . . 10.0 107.867 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 88.8 mtp -139.59 73.9 34.56 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.973 1.309 . . . . 10.0 108.646 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.38 155.18 70.09 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.186 1.924 . . . . 10.0 110.023 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.9 169.04 25.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.932 -1.136 . . . . 10.0 107.932 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -160.06 -179.82 8.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 t -157.71 91.38 2.28 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.45 138.33 29.66 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.558 1.505 . . . . 10.0 109.168 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.47 142.07 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.359 2.039 . . . . 10.0 110.056 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.57 161.64 35.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -161.95 -66.02 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p 49.02 53.33 12.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.079 0.952 . . . . 10.0 111.567 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.11 78.31 4.32 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.256 1.022 . . . . 10.0 110.186 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.99 169.43 21.37 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.146 1.897 . . . . 10.0 109.977 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.77 165.31 36.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.03 143.73 21.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -162.02 64.57 0.24 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.328 1.051 . . . . 10.0 108.323 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -152.63 156.62 39.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.76 -124.59 0.28 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.08 -179.42 41.65 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 107.393 -2.283 . . . . 10.0 107.393 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.22 169.91 23.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.53 146.01 54.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -161.61 -179.44 7.29 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.488 HD22 ' C ' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -63.44 159.78 47.76 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 119.011 -0.519 . . . . 10.0 110.318 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.03 -91.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.878 1.718 . . . . 10.0 110.548 -172.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.06 56.53 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 107.661 -1.237 . . . . 10.0 107.661 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.1 t -158.22 93.91 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.709 -1.219 . . . . 10.0 107.709 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.31 57.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.434 1.112 . . . . 10.0 108.413 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.54 145.28 40.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.028 -1.471 . . . . 10.0 107.028 164.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.89 132.1 23.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.834 -1.706 . . . . 10.0 108.834 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.74 149.21 41.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.84 0.82 . . . . 10.0 109.791 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -136.93 148.28 46.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.8 t -130.9 139.21 51.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.01 45.64 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.06 -112.04 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.816 1.246 . . . . 10.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.47 140.9 29.88 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 140.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.59 155.7 46.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.451 1.434 . . . . 10.0 108.63 162.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.7 61.36 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.354 2.036 . . . . 10.0 109.641 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -162.22 70.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.956 -1.498 . . . . 10.0 106.956 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt 87.94 154.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.546 2.338 . . . . 10.0 110.009 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -83.82 22.56 1.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.469 1.108 . . . . 10.0 113.121 -168.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.87 -179.88 4.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.068 1.747 . . . . 10.0 109.198 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.1 t -160.71 -177.65 6.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -0.919 . . . . 10.0 108.518 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.09 154.59 39.47 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.626 -0.715 . . . . 10.0 109.22 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.87 147.76 26.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.058 0.849 . . . . 10.0 109.229 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -124.44 102.02 7.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.42 -176.71 5.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.945 0.898 . . . . 10.0 109.187 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -131.81 131.92 43.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.724 0.81 . . . . 10.0 110.257 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.94 109.2 17.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.5 m -108.18 111.26 23.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.179 1.791 . . . . 10.0 108.378 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.96 136.13 36.56 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 112.368 0.507 . . . . 10.0 112.368 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -144.94 58.76 1.3 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 161.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -160.18 -25.22 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 65.78 51.31 1.43 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.194 0.998 . . . . 10.0 111.992 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -143.3 158.59 57.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.66 1.184 . . . . 10.0 109.102 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.81 82.7 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.271 2.647 . . . . 10.0 110.015 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mm -96.83 146.81 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.305 -0.861 . . . . 10.0 108.989 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' NE1' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -148.46 87.71 1.6 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.322 1.058 . . . . 10.0 111.145 -172.402 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.26 73.64 9.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.811 1.644 . . . . 10.0 112.498 -164.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 8.3 p -82.22 57.75 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.592 -0.693 . . . . 10.0 112.516 -173.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.83 151.82 22.6 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 121.002 -1.061 . . . . 10.0 110.804 163.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 62.71 0.38 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.123 0.969 . . . . 10.0 108.436 168.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.82 23.32 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.652 -0.655 . . . . 10.0 109.963 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -163.7 149.68 9.65 Favored Pre-proline 0 CA--C 1.529 0.159 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.81 3.58 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.077 1.852 . . . . 10.0 113.026 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -49.14 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.639 1.109 . . . . 10.0 109.915 173.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.9 156.06 43.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.358 1.063 . . . . 10.0 110.171 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -87.99 -39.76 14.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.729 1.211 . . . . 10.0 112.568 -159.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -116.43 84.24 14.39 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.232 1.013 . . . . 10.0 109.722 -166.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.15 116.95 3.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.256 2.637 . . . . 10.0 110.785 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -121.58 151.0 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.413 1.085 . . . . 10.0 108.676 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.49 143.3 30.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.619 0.768 . . . . 10.0 109.061 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 ttp -134.6 162.8 31.27 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.948 1.299 . . . . 10.0 108.788 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 134.0 10.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.626 -0.671 . . . . 10.0 111.682 169.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 t -150.01 47.67 0.92 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.504 -0.316 . . . . 10.0 111.822 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.8 m -135.86 99.23 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.725 0.81 . . . . 10.0 109.285 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -46.67 -38.24 9.47 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.616 1.966 . . . . 10.0 114.221 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 t -75.52 0.71 16.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.998 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -117.42 -122.66 3.29 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.922 1.249 . . . . 10.0 111.631 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.23 -66.98 2.23 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.129 0.871 . . . . 10.0 113.011 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.8 ttt -148.59 -140.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.839 1.255 . . . . 10.0 108.835 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.01 52.65 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.392 -0.818 . . . . 10.0 108.986 -163.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.62 93.76 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.834 -0.907 . . . . 10.0 110.834 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -61.85 95.38 0.06 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.894 0.854 . . . . 10.0 109.775 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -151.3 176.22 11.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.615 1.566 . . . . 10.0 107.351 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 39.1 mtp -79.59 123.05 27.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.83 164.02 37.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.636 -0.876 . . . . 10.0 108.636 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -47.24 -56.12 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.365 2.043 . . . . 10.0 110.419 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.556 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 174.95 -135.07 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.359 2.263 . . . . 10.0 109.022 -176.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 155.16 40.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.061 2.144 . . . . 10.0 105.303 168.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.7 m -98.98 122.01 41.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.908 -1.516 . . . . 10.0 106.908 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.23 116.6 65.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.896 -1.89 . . . . 10.0 105.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.73 70.03 7.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.676 1.584 . . . . 10.0 109.892 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.23 174.11 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.151 0.58 . . . . 10.0 110.619 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.95 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 117.406 2.373 . . . . 10.0 117.406 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.41 105.87 0.25 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.806 1.194 . . . . 10.0 112.147 -165.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 m -110.81 57.32 0.62 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.969 -1.863 . . . . 10.0 105.969 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 ' HA3' ' A' ' 81' ' ' GLY . 23.3 tp -83.28 152.62 25.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -136.95 147.6 46.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.62 123.8 50.98 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.088 2.155 . . . . 10.0 106.047 -164.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.74 152.39 37.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.527 1.131 . . . . 10.0 108.467 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -44.83 -31.04 1.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.499 1.296 . . . . 10.0 114.499 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.11 -51.99 21.9 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.931 0.892 . . . . 10.0 111.913 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.06 133.05 6.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.26 1.41 . . . . 10.0 110.96 -151.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 38.82 58.4 1.74 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 127.657 2.383 . . . . 10.0 112.82 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -122.46 170.72 9.69 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.866 -1.97 . . . . 10.0 109.476 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -108.65 134.55 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 80.9 mtp -103.41 105.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.21 88.68 7.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.045 -1.094 . . . . 10.0 108.045 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.73 147.18 27.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.525 0.73 . . . . 10.0 110.607 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.75 69.12 1.33 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.163 -0.798 . . . . 10.0 112.266 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 pp -48.36 151.29 1.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.942 0.871 . . . . 10.0 113.155 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -84.58 -71.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.736 0.414 . . . . 10.0 109.953 165.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 173.62 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.206 1.402 . . . . 10.0 112.481 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.15 75.57 4.15 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.211 1.941 . . . . 10.0 110.923 -171.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.76 116.49 18.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.475 1.51 . . . . 10.0 108.788 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -135.54 127.49 29.54 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.074 -1.454 . . . . 10.0 107.074 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.17 90.45 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.35 -45.49 0.51 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.454 -1.058 . . . . 10.0 110.454 -162.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -172.39 1.83 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 123.837 1.779 . . . . 10.0 111.328 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.9 m -149.95 130.72 14.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.095 -1.866 . . . . 10.0 106.918 170.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.05 148.8 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.22 151.26 45.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.921 0.782 . . . . 10.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -115.19 152.16 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -131.29 107.5 9.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.425 -1.694 . . . . 10.0 106.425 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 148.86 26.28 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.81 -1.541 . . . . 10.0 108.974 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.44 100.93 2.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.61 -1.256 . . . . 10.0 107.61 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.84 148.22 30.06 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 172.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.4 t -55.09 -38.36 68.01 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.524 1.056 . . . . 10.0 111.446 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -34.98 70.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.19 1.796 . . . . 10.0 110.705 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.11 75.55 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.74 1.638 . . . . 10.0 109.543 -168.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -83.89 51.26 2.0 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.275 -0.544 . . . . 10.0 110.633 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -161.28 103.53 1.26 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.667 1.187 . . . . 10.0 109.37 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.43 151.58 27.97 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 108.218 -1.03 . . . . 10.0 108.218 160.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -138.84 129.89 26.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.917 -1.883 . . . . 10.0 105.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -142.35 170.47 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.55 -1.648 . . . . 10.0 106.55 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.32 136.87 38.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.113 0.965 . . . . 10.0 109.589 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.44 118.65 32.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.982 1.313 . . . . 10.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -82.38 130.32 35.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.28 105.72 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -146.37 100.71 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.936 0.895 . . . . 10.0 109.571 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -50.17 -72.13 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.866 1.266 . . . . 10.0 111.268 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.35 139.52 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.276 1.831 . . . . 10.0 111.752 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.1 pt 40.02 45.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.523 1.529 . . . . 10.0 113.332 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.58 173.05 10.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.111 0.482 . . . . 10.0 110.969 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.63 -48.83 2.98 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 111.684 -0.567 . . . . 10.0 111.684 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 124.769 1.228 . . . . 10.0 108.63 170.711 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 106.376 -1.713 . . . . 10.0 106.376 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.3 138.21 4.96 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -175.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -153.73 162.83 40.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.497 -1.668 . . . . 10.0 106.497 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -165.24 171.75 13.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.715 -1.217 . . . . 10.0 107.715 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 mtt -152.98 152.63 28.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.223 1.809 . . . . 10.0 107.167 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.97 171.68 16.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.496 2.13 . . . . 10.0 109.929 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.6 165.9 35.06 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.25 -1.019 . . . . 10.0 108.25 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -98.74 -177.43 3.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.007 0.923 . . . . 10.0 108.7 172.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -149.16 140.65 14.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.4 161.8 34.24 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.532 2.155 . . . . 10.0 110.883 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.96 78.41 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.011 2.474 . . . . 10.0 108.989 170.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.16 120.04 2.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.973 1.309 . . . . 10.0 111.614 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -154.61 152.08 29.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t -170.1 -53.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 10.0 109.113 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.75 149.7 24.5 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.34 61.63 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.256 2.637 . . . . 10.0 110.683 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -157.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.8 0.84 . . . . 10.0 109.705 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.3 79.49 0.82 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.482 0.713 . . . . 10.0 109.257 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -153.0 146.16 24.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -75.28 64.76 1.52 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.413 1.085 . . . . 10.0 111.84 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.92 66.75 0.8 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.249 1.02 . . . . 10.0 111.812 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.28 122.87 19.53 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.891 -0.884 . . . . 10.0 110.891 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.56 -45.36 83.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.519 0.66 . . . . 10.0 112.208 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 61.21 -159.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.455 1.102 . . . . 10.0 111.155 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -164.0 175.88 9.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.666 1.587 . . . . 10.0 107.416 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -132.98 128.65 20.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.475 1.11 . . . . 10.0 108.813 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.35 149.48 50.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.325 2.017 . . . . 10.0 108.957 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.04 52.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 113.195 0.813 . . . . 10.0 113.195 -155.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -155.3 51.01 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.72 67.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -138.55 161.31 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.465 1.506 . . . . 10.0 110.65 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.43 73.48 0.38 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.916 1.246 . . . . 10.0 110.002 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -36.03 116.28 0.38 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.544 1.538 . . . . 10.0 111.482 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.5 m -118.58 107.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.6 126.44 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.209 1.404 . . . . 10.0 109.058 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.61 119.3 10.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.512 0.672 . . . . 10.0 109.363 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.94 129.81 39.08 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.583 -1.265 . . . . 10.0 107.583 164.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -30.5 109.72 0.27 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 126.04 1.736 . . . . 10.0 111.778 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.45 170.6 7.9 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.233 1.955 . . . . 10.0 109.889 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.62 57.51 3.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.237 1.958 . . . . 10.0 108.988 166.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m -157.29 43.73 0.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.709 1.204 . . . . 10.0 109.26 -175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 43' ' ' ARG . 22.0 mm 76.03 168.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.831 1.653 . . . . 10.0 111.856 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 42' ' ' ILE . 10.5 tpt180 -62.59 -11.52 17.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.161 2.584 . . . . 10.0 114.35 -170.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -72.04 157.94 36.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.368 -0.832 . . . . 10.0 109.657 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -168.52 -174.71 2.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.65 38.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.266 1.026 . . . . 10.0 111.18 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.32 140.39 35.68 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.001 0.92 . . . . 10.0 109.607 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.34 110.85 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.91 -173.2 3.97 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.486 1.114 . . . . 10.0 109.562 -172.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -106.39 164.93 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 166.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.43 149.91 47.77 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.684 -1.599 . . . . 10.0 106.684 160.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 m -151.63 110.42 3.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.942 0.349 . . . . 10.0 111.942 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.42 142.82 33.97 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.243 1.017 . . . . 10.0 109.447 168.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -137.99 66.0 1.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.407 -1.331 . . . . 10.0 107.407 163.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 p 179.57 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 -171.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 84.01 67.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.772 2.029 . . . . 10.0 108.859 156.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -126.4 159.42 63.09 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 125.649 1.58 . . . . 10.0 107.372 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 70.11 6.27 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.551 2.168 . . . . 10.0 110.746 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.52 90.4 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 4.2 ptpp? -83.57 91.23 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.223 1.011 . . . . 10.0 111.428 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.92 68.52 8.34 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 10.0 112.945 -161.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.426 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 6.8 p -82.23 60.69 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.357 -0.839 . . . . 10.0 112.185 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.34 161.18 31.92 Favored Glycine 0 CA--C 1.521 0.45 0 O-C-N 121.013 -1.055 . . . . 10.0 111.329 157.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.08 57.31 0.47 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.436 1.094 . . . . 10.0 108.417 164.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.39 149.81 26.47 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 t -166.66 146.05 4.78 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.11 68.36 4.05 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.421 2.081 . . . . 10.0 108.032 166.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 tp -154.02 -65.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.774 0.83 . . . . 10.0 109.836 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.99 146.67 30.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.89 0.876 . . . . 10.0 109.989 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -87.18 -34.24 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 10.0 109.287 169.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -122.71 71.06 38.9 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.538 1.535 . . . . 10.0 109.89 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.6 104.45 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.067 2.511 . . . . 10.0 111.428 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -129.43 166.78 18.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.325 1.05 . . . . 10.0 110.279 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.6 144.34 43.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.281 1.432 . . . . 10.0 109.6 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 ttp -141.86 152.66 43.83 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.108 1.363 . . . . 10.0 108.123 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.29 108.6 4.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 -161.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' CA ' ' A' ' 107' ' ' ASP . 22.9 m -139.28 62.58 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.91 -1.119 . . . . 10.0 110.111 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -154.05 120.56 5.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.14 -0.936 . . . . 10.0 110.221 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.406 ' CD2' ' CB ' ' A' ' 84' ' ' ALA . 53.1 m80 -70.11 70.12 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.47 1.108 . . . . 10.0 112.188 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.9 p -168.62 -57.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.364 0.984 . . . . 10.0 113.015 171.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.31 -78.39 0.6 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.54 -141.81 11.32 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.543 0.592 . . . . 10.0 111.862 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.98 176.27 6.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.756 . . . . 10.0 109.786 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' CB ' ' CD2' ' A' ' 79' ' ' HIS . . . -124.59 52.19 1.55 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.713 1.605 . . . . 10.0 107.772 -169.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.98 112.48 0.54 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.174 -1.17 . . . . 10.0 110.174 -171.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 27.25 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.837 1.655 . . . . 10.0 114.181 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -83.03 161.59 21.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.589 1.556 . . . . 10.0 109.42 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.5 ttp -81.42 121.91 26.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.92 166.88 12.39 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 118.468 0.577 . . . . 10.0 111.514 -171.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -37.92 -59.95 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.297 2.665 . . . . 10.0 111.56 156.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -175.71 -172.41 0.53 Allowed 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.042 1.127 . . . . 10.0 114.042 -171.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.65 107.38 19.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.849 1.66 . . . . 10.0 106.856 165.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.0 m -83.92 129.02 34.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.5 pt -114.02 95.33 37.8 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 107.228 -1.397 . . . . 10.0 107.228 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.9 70.35 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.866 1.711 . . . . 10.0 112.508 -157.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.55 152.41 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.709 1.242 . . . . 10.0 111.109 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 36.96 37.2 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.875 1.27 . . . . 10.0 111.869 -155.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 93.21 0.14 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.362 -1.095 . . . . 10.0 110.362 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -138.79 107.17 5.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.6 -171.84 2.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.639 0.776 . . . . 10.0 110.802 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.6 t -140.15 143.51 36.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 103.04 -2.948 . . . . 10.0 103.04 -172.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.68 116.67 19.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.304 -2.48 . . . . 10.0 104.304 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.99 161.55 41.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.736 1.214 . . . . 10.0 108.745 -165.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.0 ttp-105 -62.57 122.89 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.672 -0.694 . . . . 10.0 109.326 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.3 t0 48.76 60.82 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 10.0 112.608 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.34 62.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.897 -1.281 . . . . 10.0 109.897 164.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.423 ' CA ' ' H ' ' A' ' 77' ' ' THR . 7.2 t0 79.02 127.58 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.108 1.763 . . . . 10.0 110.045 -175.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -177.08 157.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.312 0.505 . . . . 10.0 111.465 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.14 123.18 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 105.932 -1.877 . . . . 10.0 105.932 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.1 mtm -94.38 104.9 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.236 1.017 . . . . 10.0 109.095 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.65 68.74 8.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.289 -1.745 . . . . 10.0 106.289 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 23.3 ttt -82.12 154.73 25.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.487 0.661 . . . . 10.0 110.276 -166.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.64 60.92 6.39 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.001 -1.24 . . . . 10.0 110.001 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.82 117.9 4.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -69.83 0.62 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.848 0.749 . . . . 10.0 111.479 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -66.19 156.06 85.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.736 1.214 . . . . 10.0 111.377 -173.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.55 148.62 92.32 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.503 1.469 . . . . 10.0 109.603 165.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.19 147.09 32.07 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.776 1.23 . . . . 10.0 109.587 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -111.98 145.56 39.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.759 1.223 . . . . 10.0 108.659 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.87 99.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.34 -3.89 6.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.058 1.313 . . . . 10.0 112.025 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -75.66 -174.18 2.45 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 123.733 1.73 . . . . 10.0 109.887 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.2 m -153.74 134.17 13.5 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 112.861 -1.972 . . . . 10.0 107.562 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.13 143.54 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.123 0.969 . . . . 10.0 108.689 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.18 119.44 21.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.2 tt -81.99 159.75 3.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.4 m -128.54 114.71 17.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.092 -1.818 . . . . 10.0 106.092 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.96 134.26 34.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -126.73 71.42 1.3 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.879 0.872 . . . . 10.0 109.405 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.36 138.49 39.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.652 -1.24 . . . . 10.0 107.652 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -57.42 -34.36 68.85 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.755 0.707 . . . . 10.0 112.905 -166.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.4 m-20 -65.15 -27.65 68.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.453 1.501 . . . . 10.0 111.734 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.37 81.67 0.12 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.312 -1.915 . . . . 10.0 108.312 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -80.81 53.78 2.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.943 0.497 . . . . 10.0 111.59 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.1 m -158.7 83.88 0.82 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.134 1.374 . . . . 10.0 109.583 -172.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 157.29 45.39 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 168.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -149.03 140.86 23.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.2 t -148.23 147.6 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.87 107.76 16.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.66 138.73 31.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -82.25 150.27 27.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.106 -1.442 . . . . 10.0 107.106 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.43 113.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 164.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -158.73 143.22 15.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.754 -0.832 . . . . 10.0 108.754 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -68.28 -87.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.553 1.141 . . . . 10.0 111.489 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 74.63 148.16 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.234 1.814 . . . . 10.0 111.879 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 36.7 pt 34.74 50.28 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.311 1.844 . . . . 10.0 113.211 -176.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -169.84 73.66 0.08 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.909 -0.494 . . . . 10.0 110.776 -166.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -124.93 10.1 7.93 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.116 0.865 . . . . 10.0 111.772 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.42 67.12 1.25 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.114 -1.594 . . . . 10.0 109.114 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -154.41 172.41 17.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.632 1.173 . . . . 10.0 108.679 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -157.04 -171.35 3.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.275 -1.38 . . . . 10.0 107.275 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.8 mtp -144.12 148.19 40.6 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.063 1.345 . . . . 10.0 108.25 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.36 175.7 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.974 2.449 . . . . 10.0 110.196 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.26 142.65 30.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.754 0.822 . . . . 10.0 108.979 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -73.67 74.21 1.52 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.928 0.891 . . . . 10.0 110.678 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 m -83.37 105.49 5.47 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 10.0 109.688 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.63 159.04 35.67 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.719 1.613 . . . . 10.0 110.245 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.58 66.39 5.63 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.054 2.503 . . . . 10.0 109.298 170.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.18 172.58 14.1 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.489 1.116 . . . . 10.0 109.13 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.86 159.85 41.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -157.49 155.37 30.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.441 -1.688 . . . . 10.0 106.441 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.0 80.4 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.57 43.79 1.51 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.996 2.464 . . . . 10.0 112.814 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.96 52.52 1.77 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.736 -1.227 . . . . 10.0 109.37 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.23 -82.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.1 1.36 . . . . 10.0 112.802 -161.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -79.65 70.83 6.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.77 -65.39 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.729 1.212 . . . . 10.0 109.5 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 68.33 -53.78 0.53 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.768 2.027 . . . . 10.0 114.798 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.26 63.67 1.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.01 1.291 . . . . 10.0 114.31 -167.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -64.67 1.02 Allowed 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 162.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 58.9 57.49 3.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.505 1.122 . . . . 10.0 111.715 172.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.68 -155.06 0.34 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.219 1.407 . . . . 10.0 109.997 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tt -160.09 130.38 3.54 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.75 158.79 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.01 1.806 . . . . 10.0 109.108 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.7 m -82.24 56.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.775 0.798 . . . . 10.0 111.685 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 t -158.98 81.18 0.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.202 1.001 . . . . 10.0 108.762 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.8 85.56 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.733 0.777 . . . . 10.0 109.527 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -157.98 155.79 30.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 162.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.03 137.35 19.8 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.353 -1.099 . . . . 10.0 110.353 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.91 115.69 23.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.77 0.785 . . . . 10.0 110.042 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -109.48 158.21 18.19 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.757 -1.201 . . . . 10.0 107.757 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.17 137.55 54.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.5 113.33 13.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -52.4 127.03 21.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 117.761 -1.114 . . . . 10.0 109.004 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -11.48 102.32 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 127.358 2.263 . . . . 10.0 113.065 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.3 168.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.733 2.288 . . . . 10.0 109.382 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.68 43.32 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.268 1.979 . . . . 10.0 110.545 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -133.96 34.54 3.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.943 2.097 . . . . 10.0 107.578 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.3 mm 73.76 172.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.897 1.279 . . . . 10.0 109.784 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.59 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -72.79 40.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.699 1.6 . . . . 10.0 113.948 -175.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.07 158.97 15.17 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 156.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -157.68 -165.88 1.87 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 155.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.01 174.46 11.26 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.63 161.43 26.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -130.3 102.3 6.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.35 -2.833 . . . . 10.0 103.35 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.2 ttp -158.59 -178.84 7.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.12 2.568 . . . . 10.0 106.142 -172.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 m -152.98 141.01 20.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.823 -1.917 . . . . 10.0 105.823 166.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD23 HD13 ' A' ' 94' ' ' ILE . 3.2 mp -82.29 136.03 35.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 170.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 m -120.78 80.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.069 2.148 . . . . 10.0 108.544 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -81.91 89.7 6.39 Favored 'General case' 0 N--CA 1.46 0.045 0 O-C-N 121.2 -0.938 . . . . 10.0 109.128 -172.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 57.51 3.96 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.244 -0.91 . . . . 10.0 110.189 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t 179.11 149.64 0.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.174 1.79 . . . . 10.0 107.506 167.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.65 67.33 5.39 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.496 1.118 . . . . 10.0 108.895 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -130.71 122.47 19.64 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 10.0 109.736 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.86 116.3 3.14 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.535 2.823 . . . . 10.0 111.032 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.92 96.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.604 0.638 . . . . 10.0 109.649 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -80.4 132.84 35.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.312 0.645 . . . . 10.0 111.022 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.75 140.19 46.59 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.318 1.047 . . . . 10.0 110.209 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 131' ' ' THR . 10.4 p -146.09 56.25 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.923 0.868 . . . . 10.0 110.171 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 154.54 25.59 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 119.82 -1.181 . . . . 10.0 111.971 163.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.23 72.28 0.93 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.304 1.842 . . . . 10.0 106.505 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.39 145.63 28.1 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t 35.8 68.59 1.31 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.778 0.831 . . . . 10.0 109.963 -156.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.19 -86.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.349 2.033 . . . . 10.0 110.079 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.03 43.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.077 -1.453 . . . . 10.0 107.077 156.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HB1' ' C ' ' A' ' 112' ' ' MET . . . -167.31 -157.2 0.23 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -176.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -40.03 6.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.714 0.688 . . . . 10.0 110.868 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -122.09 106.23 36.44 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 125.403 1.481 . . . . 10.0 108.588 -169.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.12 139.65 7.28 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.23 2.62 . . . . 10.0 110.497 173.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -138.31 127.76 24.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.87 139.4 35.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.4 ttm -141.87 154.82 45.41 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.144 0.978 . . . . 10.0 111.429 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -148.47 120.16 8.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CG ' ' A' ' 86' ' ' MET . 6.9 t -156.43 54.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.644 0.778 . . . . 10.0 112.101 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -137.73 179.5 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.618 0.767 . . . . 10.0 111.499 168.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -91.18 -40.32 11.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.312 0.645 . . . . 10.0 110.165 -171.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.1 t -81.71 -147.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 160.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.35 -140.68 42.41 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.09 -67.42 1.7 Allowed Glycine 0 CA--C 1.536 1.365 0 CA-C-N 117.252 0.526 . . . . 10.0 113.145 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.14 174.17 12.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.637 1.975 . . . . 10.0 108.377 -169.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.86 45.42 2.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 10.0 107.8 -159.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.59 84.42 0.12 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 117.574 -1.681 . . . . 10.0 112.902 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.406 ' CG ' HG21 ' A' ' 77' ' ' THR . 1.7 mtt -40.34 98.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.437 0 C-N-CA 126.045 1.738 . . . . 10.0 110.602 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.31 166.23 26.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.705 1.202 . . . . 10.0 109.388 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.5 mtp -77.67 71.16 4.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.7 146.7 98.36 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.963 -1.017 . . . . 10.0 108.534 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -33.59 -51.49 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.205 3.27 . . . . 10.0 113.547 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -179.08 -176.76 0.44 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.44 1.896 . . . . 10.0 106.582 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 102.29 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 10.0 110.294 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 m -75.21 122.51 23.76 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.546 HD13 HD23 ' A' ' 51' ' ' LEU . 2.2 pt -108.73 90.83 7.93 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.163 0.985 . . . . 10.0 108.709 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.04 140.91 35.46 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 120.75 0.966 . . . . 10.0 109.741 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.41 -140.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.256 1.023 . . . . 10.0 112.412 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.19 38.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.958 2.503 . . . . 10.0 114.516 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.0 144.16 10.5 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 121.832 0.684 . . . . 10.0 112.883 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' LEU 0.265 7.2 t -134.48 99.3 4.32 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.863 -1.532 . . . . 10.0 106.863 158.198 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.84 126.26 55.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.046 -2.205 . . . . 10.0 105.046 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 m -82.01 153.23 26.29 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.708 -0.849 . . . . 10.0 108.708 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.67 76.55 1.64 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.984 -1.487 . . . . 10.0 106.984 176.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 158.49 44.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.738 0.815 . . . . 10.0 110.198 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -73.72 60.81 0.71 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.081 0.952 . . . . 10.0 112.123 -168.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -176.23 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.154 1.381 . . . . 10.0 109.784 -164.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.4 74.33 0.27 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 123.336 0.494 . . . . 10.0 112.101 -161.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 69.13 139.74 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 128.296 2.638 . . . . 10.0 109.211 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 175.65 178.44 0.18 Allowed 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.091 0.556 . . . . 10.0 112.42 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 t -108.67 118.21 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.7 mtp -80.43 103.19 10.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.545 -1.65 . . . . 10.0 106.545 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.84 105.47 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.584 -1.189 . . . . 10.0 109.178 169.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.471 ' C ' ' HB1' ' A' ' 69' ' ' ALA . 26.8 ttt -111.59 152.69 27.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.15 1.38 . . . . 10.0 111.22 -172.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.79 -6.82 6.95 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.528 -1.707 . . . . 10.0 115.957 155.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 77.29 92.46 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.677 1.739 . . . . 10.0 111.067 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -70.39 -56.44 6.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.66 -0.65 . . . . 10.0 110.3 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 149.86 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 129.833 3.253 . . . . 10.0 110.767 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.33 66.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.043 2.495 . . . . 10.0 114.311 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.49 96.62 10.68 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.106 -0.996 . . . . 10.0 109.481 158.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -137.71 147.8 45.11 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 162.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.07 68.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.872 0.869 . . . . 10.0 108.951 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.69 8.24 0.7 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.376 -1.236 . . . . 10.0 113.187 -168.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.66 173.0 5.52 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 119.797 1.799 . . . . 10.0 108.481 161.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 m -156.34 129.96 8.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.849 -1.523 . . . . 10.0 109.356 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.54 140.55 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.204 0.602 . . . . 10.0 109.766 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -70.05 123.12 20.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 108.971 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.9 tt -102.2 141.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.68 -1.23 . . . . 10.0 107.68 166.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.6 m -119.78 110.1 16.38 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 171.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.03 173.1 10.77 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 122.183 -0.323 . . . . 10.0 111.8 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.62 96.72 2.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.527 1.131 . . . . 10.0 108.022 -172.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.75 143.12 29.35 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.68 -0.637 . . . . 10.0 110.647 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 62' ' ' VAL . 58.8 p -58.29 -23.13 55.36 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.713 0.805 . . . . 10.0 113.019 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.71 -17.7 16.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.987 0.915 . . . . 10.0 112.081 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.09 30.22 3.24 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.896 1.712 . . . . 10.0 110.578 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -90.36 166.9 13.04 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-N 117.334 0.567 . . . . 10.0 110.301 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.8 m -158.49 59.49 0.44 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.077 -2.194 . . . . 10.0 105.077 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.1 tp -85.18 141.9 29.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.848 -1.167 . . . . 10.0 107.848 -174.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -111.48 136.42 50.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.0 t -136.3 159.38 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.217 -1.771 . . . . 10.0 106.217 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.68 109.57 21.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.936 0.894 . . . . 10.0 108.879 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.36 118.48 24.26 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -94.83 127.38 40.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.178 0.991 . . . . 10.0 109.28 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 37' ' ' ALA . 51.1 t -86.76 104.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 120.762 -1.211 . . . . 10.0 108.951 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -141.59 116.3 9.72 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.578 1.151 . . . . 10.0 108.451 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -41.5 -63.0 0.77 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.781 1.232 . . . . 10.0 112.164 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 57.97 -161.83 0.23 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.7 78.47 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.225 -1.028 . . . . 10.0 108.225 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.58 31.73 0.06 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -168.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.45 -78.61 0.45 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.243 0.925 . . . . 10.0 110.971 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.917 1.687 . . . . 10.0 106.567 -174.538 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 106.94 -1.504 . . . . 10.0 106.94 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.88 44.45 61.38 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.05 0.844 . . . . 10.0 112.8 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -156.31 132.35 9.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -159.14 151.9 21.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.049 -2.574 . . . . 10.0 104.049 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -156.67 145.91 15.11 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.76 175.42 11.02 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.07 2.513 . . . . 10.0 110.275 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.0 24.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 169.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -168.67 154.53 6.68 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -61.01 135.22 93.14 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.594 0.757 . . . . 10.0 110.299 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.49 161.82 39.43 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.778 1.652 . . . . 10.0 109.89 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 77.21 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.31 2.673 . . . . 10.0 110.794 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.91 75.1 0.2 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.619 1.168 . . . . 10.0 110.315 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -42.98 128.59 4.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.497 1.519 . . . . 10.0 112.357 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -163.28 144.62 9.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 105.241 -2.133 . . . . 10.0 105.241 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.16 148.37 14.51 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 107.785 -1.191 . . . . 10.0 107.785 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.34 140.53 30.58 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.42 2.08 . . . . 10.0 109.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.71 57.78 1.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.378 0.671 . . . . 10.0 110.453 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.46 155.14 16.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.306 1.042 . . . . 10.0 110.193 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -71.85 69.32 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 10.0 109.728 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -145.06 -45.51 0.23 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.588 1.955 . . . . 10.0 109.056 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.46 26.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.942 0.897 . . . . 10.0 111.49 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.77 165.63 32.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.922 -2.071 . . . . 10.0 107.922 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.48 172.98 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.504 1.521 . . . . 10.0 106.961 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -143.91 162.15 36.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.91 158.28 21.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.464 1.106 . . . . 10.0 108.034 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -139.77 152.27 67.85 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 108.344 -0.984 . . . . 10.0 108.344 166.176 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -65.57 164.91 24.58 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.659 1.573 . . . . 10.0 108.946 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.12 58.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.964 0.888 . . . . 10.0 109.119 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -153.67 58.05 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.445 -0.785 . . . . 10.0 109.163 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.15 67.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 162.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -97.66 166.04 11.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.903 -1.499 . . . . 10.0 108.928 164.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.91 -145.96 19.74 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.581 -1.807 . . . . 10.0 108.581 160.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.02 115.73 0.73 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.97 1.708 . . . . 10.0 108.458 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.3 p -124.66 138.47 54.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.17 147.34 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.726 0.81 . . . . 10.0 109.54 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.63 113.53 25.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.375 0.534 . . . . 10.0 111.103 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.45 128.99 34.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.926 0.49 . . . . 10.0 110.095 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -20.7 103.87 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 127.024 2.13 . . . . 10.0 112.924 -164.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -62.15 167.01 11.54 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.314 2.676 . . . . 10.0 110.476 171.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.54 57.8 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.647 2.231 . . . . 10.0 109.127 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -154.44 42.8 0.5 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.881 1.272 . . . . 10.0 109.313 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.7 mt 77.43 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.438 1.495 . . . . 10.0 109.098 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -36.34 -46.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.304 1.842 . . . . 10.0 111.603 168.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.57 141.28 1.05 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.24 2.616 . . . . 10.0 112.727 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -158.67 -175.47 5.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 172.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.51 158.32 43.88 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.542 1.137 . . . . 10.0 110.596 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' SD ' ' A' ' 49' ' ' MET . . . -93.6 163.25 13.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 124.109 0.881 . . . . 10.0 110.51 171.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -134.06 130.57 37.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.516 -2.031 . . . . 10.0 105.516 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.405 ' SD ' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mpp? -156.04 -176.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.848 1.659 . . . . 10.0 108.5 -173.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 137.43 36.58 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 161.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.28 149.37 23.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.634 -0.876 . . . . 10.0 108.634 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -135.84 85.76 2.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.291 0.994 . . . . 10.0 111.632 -157.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 113.73 12.4 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 121.354 -0.841 . . . . 10.0 109.156 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.59 ' HB2' HD23 ' A' ' 26' ' ' LEU . 31.2 mmmt -128.36 57.65 1.57 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 164.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 m -163.46 -33.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.129 1.372 . . . . 10.0 112.134 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 60.42 59.66 2.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.079 0.854 . . . . 10.0 111.26 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -143.3 147.13 39.07 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.972 0.909 . . . . 10.0 109.907 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -86.36 84.34 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.906 3.071 . . . . 10.0 112.408 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.31 94.24 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -80.36 134.51 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.621 -0.674 . . . . 10.0 110.919 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 61' ' ' LEU . 1.2 tm? -99.38 115.89 30.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.881 1.672 . . . . 10.0 107.375 -165.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.69 47.78 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.997 . . . . 10.0 108.855 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.84 156.82 29.0 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.766 -1.209 . . . . 10.0 111.339 159.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.28 59.74 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.656 1.582 . . . . 10.0 107.846 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 132.52 33.8 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 t -157.91 139.55 9.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.88 65.16 5.96 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.671 2.914 . . . . 10.0 109.42 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -157.54 -57.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 -164.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.48 152.21 25.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.277 0.631 . . . . 10.0 109.31 171.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.2 m -107.13 -18.83 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.939 0.895 . . . . 10.0 110.219 160.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.6 m -133.1 64.45 70.47 Favored Pre-proline 0 N--CA 1.445 -0.689 0 C-N-CA 124.469 1.108 . . . . 10.0 109.028 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 101.32 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.178 2.585 . . . . 10.0 109.905 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.06 126.18 54.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 10.0 109.251 -171.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.58 146.03 31.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.045 0.538 . . . . 10.0 109.717 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 86' ' ' MET . 0.3 OUTLIER -148.03 166.7 26.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.758 1.223 . . . . 10.0 111.527 179.393 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.254 40.7 m -137.96 133.87 34.23 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.004 1.44 . . . . 10.0 111.898 -156.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.447 ' HB ' ' N ' ' A' ' 107' ' ' ASP . 9.2 t -83.55 -178.99 7.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 123.995 1.855 . . . . 10.0 113.873 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.4 m -79.88 66.61 5.41 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 129.561 3.144 . . . . 10.0 109.803 -160.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 60.71 65.33 1.05 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.167 1.387 . . . . 10.0 110.735 172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.3 t -161.53 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.294 1.037 . . . . 10.0 108.369 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.31 -125.46 3.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 10.0 110.504 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.36 -49.95 8.16 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.527 1.371 . . . . 10.0 116.527 -168.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.35 -82.46 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.749 1.275 . . . . 10.0 111.229 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.0 74.77 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.729 1.212 . . . . 10.0 108.07 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.77 159.65 27.69 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.01 1.29 . . . . 10.0 113.656 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 75' ' ' MET . 40.1 ttp -77.61 62.37 2.52 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.088 1.355 . . . . 10.0 111.417 -168.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -81.81 162.64 22.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.1 ttm -80.03 74.11 6.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.72 142.79 61.91 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.818 -1.083 . . . . 10.0 109.046 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.26 -18.28 64.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.845 1.697 . . . . 10.0 113.597 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -178.14 174.27 1.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.659 -1.978 . . . . 10.0 105.659 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 tp -97.6 101.14 12.58 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.448 1.022 . . . . 10.0 109.667 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -76.3 123.9 26.65 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.539 -0.911 . . . . 10.0 108.539 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.9 pt -115.26 115.28 42.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.18 -170.24 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.605 2.204 . . . . 10.0 110.737 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.43 149.66 20.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 158.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.87 17.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.168 1.349 . . . . 10.0 113.563 -166.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 83.62 0.41 Allowed Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 108.815 -1.714 . . . . 10.0 108.815 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.1 t -121.9 108.33 13.31 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 166.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 -172.33 2.68 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.335 0.654 . . . . 10.0 109.955 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.3 t -143.81 122.49 12.57 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 104.041 -2.577 . . . . 10.0 104.041 -164.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.78 123.92 47.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.57 -1.641 . . . . 10.0 106.57 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.63 155.39 41.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.171 1.389 . . . . 10.0 108.533 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 55.57 0.89 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.644 0.778 . . . . 10.0 111.181 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.55 -57.3 0.44 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.69 -75.48 0.3 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.689 0.661 . . . . 10.0 112.051 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -100.0 133.2 44.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 -171.393 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 174.51 178.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 120.115 1.325 . . . . 10.0 109.861 -176.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.76 122.57 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.137 -2.171 . . . . 10.0 105.137 158.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.0 mtp -81.37 96.83 7.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.25 61.82 3.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 22.2 ptm -89.97 177.91 6.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.115 0.959 . . . . 10.0 110.544 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.21 46.62 86.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 109.13 -1.588 . . . . 10.0 109.13 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.55 119.74 15.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 10.0 110.321 -168.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -64.16 -73.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.055 0.542 . . . . 10.0 111.705 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -95.2 152.98 39.79 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.7 0.8 . . . . 10.0 112.21 -160.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.66 100.68 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.571 2.181 . . . . 10.0 109.154 170.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 42.0 mt -77.72 158.4 29.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.032 -0.417 . . . . 10.0 111.032 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 142.31 47.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.717 1.207 . . . . 10.0 109.07 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.35 72.32 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.174 1.39 . . . . 10.0 109.214 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 151.76 -12.6 0.75 Allowed Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.962 -1.086 . . . . 10.0 112.614 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.89 179.27 2.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 123.693 1.711 . . . . 10.0 109.404 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -155.05 127.41 7.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.693 -2.049 . . . . 10.0 108.48 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -127.34 148.57 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -71.24 144.66 49.99 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.579 -0.7 . . . . 10.0 110.316 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.3 tt -123.19 139.3 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.1 m -117.39 119.24 34.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.2 176.89 8.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 10.0 111.723 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -154.09 90.8 1.38 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.202 1.001 . . . . 10.0 109.023 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 134' ' ' ARG . . . -86.74 153.24 21.86 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.135 -0.978 . . . . 10.0 110.989 170.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 p -46.45 -39.32 10.42 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 -165.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.38 18.35 0.56 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.767 0.827 . . . . 10.0 111.925 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 32.92 35.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.851 -1.3 . . . . 10.0 109.851 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.431 ' CB ' ' HB3' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -82.55 94.71 7.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -178.373 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 125.83 47.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.264 1.826 . . . . 10.0 107.064 169.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.6 144.29 50.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 103.796 -2.668 . . . . 10.0 103.796 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -107.95 113.84 27.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.571 -2.381 . . . . 10.0 104.571 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.27 153.1 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -171.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.94 112.06 22.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.55 -0.907 . . . . 10.0 108.55 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.13 109.73 20.11 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.486 0.714 . . . . 10.0 109.135 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 m -90.31 124.64 35.07 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.935 0.894 . . . . 10.0 108.911 -175.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.76 108.22 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.172 -0.955 . . . . 10.0 109.078 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -136.73 111.63 8.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.262 . . . . 10.0 108.169 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.74 123.04 22.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.154 0.888 . . . . 10.0 110.731 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.66 167.6 9.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.543 1.137 . . . . 10.0 108.066 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.0 pt 40.71 42.14 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.154 1.781 . . . . 10.0 113.734 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -94.62 86.99 4.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.316 0.579 . . . . 10.0 110.392 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.56 101.28 0.12 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.459 -1.456 . . . . 10.0 109.459 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 116.478 -1.725 . . . . 10.0 110.208 169.91 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.73 -169.25 5.6 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 -150.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -171.09 173.14 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.887 2.075 . . . . 10.0 106.08 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -160.08 175.32 13.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.035 0.834 . . . . 10.0 109.367 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.9 ttp -162.29 135.51 4.56 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.043 1.337 . . . . 10.0 107.784 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.08 177.77 8.47 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.703 2.269 . . . . 10.0 110.811 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.18 164.55 37.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.794 1.238 . . . . 10.0 107.926 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -158.75 172.93 17.35 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.752 1.621 . . . . 10.0 107.549 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 t -153.54 142.71 14.74 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.049 -1.463 . . . . 10.0 107.049 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.94 155.02 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.432 2.088 . . . . 10.0 111.313 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.37 -178.68 4.77 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.371 2.714 . . . . 10.0 110.292 171.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.19 44.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.508 1.123 . . . . 10.0 108.087 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -166.4 165.9 16.85 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.83 -1.545 . . . . 10.0 106.83 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 t -140.35 159.29 42.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.713 -1.217 . . . . 10.0 107.713 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.13 157.94 65.04 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 164.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.1 -169.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.408 2.739 . . . . 10.0 109.413 166.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.91 167.76 24.85 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.43 170.75 20.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.52 1.128 . . . . 10.0 108.162 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -138.05 -71.5 0.42 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 10.0 108.843 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 tptt 76.46 146.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.014 1.726 . . . . 10.0 110.964 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.29 171.63 14.62 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.496 1.518 . . . . 10.0 106.95 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.61 108.5 0.22 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.04 -1.224 . . . . 10.0 110.04 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.34 63.53 1.96 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.709 0.754 . . . . 10.0 110.608 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -124.37 111.25 15.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.233 1.413 . . . . 10.0 108.586 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.66 -47.84 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.289 0.636 . . . . 10.0 111.301 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.1 121.07 82.78 Favored Pre-proline 0 N--CA 1.451 -0.423 0 C-N-CA 123.52 0.728 . . . . 10.0 109.71 -170.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -68.44 166.03 26.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.656 2.237 . . . . 10.0 110.595 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.52 61.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 122.256 1.026 . . . . 10.0 110.526 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -158.35 60.35 0.45 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.497 0.719 . . . . 10.0 109.508 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.96 52.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 122.125 0.964 . . . . 10.0 110.511 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -157.24 145.6 19.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.53 130.49 10.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.794 -1.723 . . . . 10.0 108.794 168.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 159.35 31.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.051 0.926 . . . . 10.0 111.291 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 p -122.39 148.57 44.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.316 -1.364 . . . . 10.0 107.316 165.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.41 134.51 58.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.0 26.29 0.06 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -166.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.21 -138.18 0.71 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.412 1.485 . . . . 10.0 109.692 -170.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.25 110.76 40.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 167.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.32 175.1 11.05 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.252 2.634 . . . . 10.0 109.472 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.78 72.04 3.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.531 2.154 . . . . 10.0 109.627 168.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -152.54 -57.41 0.14 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.722 2.409 . . . . 10.0 106.299 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt 66.37 150.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.141 1.776 . . . . 10.0 108.563 -163.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 74.91 -51.51 0.67 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.292 1.837 . . . . 10.0 111.757 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.31 138.01 37.01 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -150.45 178.57 8.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.659 1.184 . . . . 10.0 108.193 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.15 161.7 41.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.938 0.895 . . . . 10.0 109.458 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.41 160.81 14.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.263 0.977 . . . . 10.0 111.284 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.14 134.96 51.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.275 -2.491 . . . . 10.0 104.275 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 ttt -158.82 177.26 11.36 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.794 -1.187 . . . . 10.0 107.794 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 t -133.27 142.36 48.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 152.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.52 105.77 16.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.287 -2.486 . . . . 10.0 104.287 163.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.84 106.36 15.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.281 1.832 . . . . 10.0 110.427 -170.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.61 129.82 34.74 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.337 0.655 . . . . 10.0 110.206 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -138.98 58.42 1.64 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 158.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -157.98 -50.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.937 2.095 . . . . 10.0 108.103 -171.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 97' ' ' ARG . 40.8 m-20 74.58 58.86 0.07 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.207 1.803 . . . . 10.0 110.384 170.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -123.86 146.29 50.3 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 126.048 1.739 . . . . 10.0 106.456 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.72 121.02 6.4 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.692 2.261 . . . . 10.0 109.554 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.57 146.39 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -117.7 145.47 44.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.316 1.447 . . . . 10.0 107.763 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.09 131.68 17.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.485 -2.413 . . . . 10.0 104.485 -171.14 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.6 55.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.233 1.016 . . . . 10.0 109.034 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.49 149.09 17.48 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.871 -1.292 . . . . 10.0 109.871 167.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -155.54 59.74 0.62 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.758 1.223 . . . . 10.0 108.14 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.19 35.23 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.339 0.656 . . . . 10.0 110.21 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -159.05 144.11 11.7 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 107.143 -1.429 . . . . 10.0 107.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.61 39.74 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.519 2.146 . . . . 10.0 112.738 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -108.82 -54.61 2.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.734 1.613 . . . . 10.0 108.34 -170.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.38 160.41 30.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.974 1.309 . . . . 10.0 107.947 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -83.15 -40.26 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.512 0.725 . . . . 10.0 111.874 -165.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.9 t -119.15 95.53 49.39 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.478 1.111 . . . . 10.0 110.647 -162.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.61 92.2 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.958 2.439 . . . . 10.0 110.36 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 83.8 mtp -103.75 116.51 32.45 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.879 1.272 . . . . 10.0 108.893 -172.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 mp -81.54 134.9 35.57 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.435 0.694 . . . . 10.0 109.735 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.52 -179.83 3.84 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.667 1.187 . . . . 10.0 109.336 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 t -158.79 143.27 15.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.277 -2.49 . . . . 10.0 104.277 159.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.28 5.7 t -156.89 63.68 0.51 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.738 1.608 . . . . 10.0 110.486 167.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -146.04 -178.74 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.72 -0.612 . . . . 10.0 109.665 172.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.57 148.76 22.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m 71.2 -53.8 0.67 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.552 1.541 . . . . 10.0 111.913 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.55 141.16 47.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 17.65 -90.14 0.01 OUTLIER Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.699 2.095 . . . . 10.0 115.585 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.4 mtt -145.39 173.98 11.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.395 1.878 . . . . 10.0 109.454 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.22 47.05 0.98 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.768 1.627 . . . . 10.0 107.128 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.72 102.2 0.22 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.813 -1.315 . . . . 10.0 109.813 -167.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 63.85 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.279 1.831 . . . . 10.0 111.89 -170.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -113.98 165.81 12.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.827 2.051 . . . . 10.0 109.933 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.8 mtm -78.38 98.02 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.716 -1.587 . . . . 10.0 106.716 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.66 161.72 47.06 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 119.47 -0.3 . . . . 10.0 110.387 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -43.17 -50.02 6.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.247 2.631 . . . . 10.0 111.241 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.3 p90 177.52 -170.0 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.194 2.598 . . . . 10.0 104.967 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -127.8 106.6 9.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.754 0.788 . . . . 10.0 110.421 169.175 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 145.77 36.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.04 140.9 40.07 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.527 1.058 . . . . 10.0 111.266 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.1 -174.21 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.123 2.549 . . . . 10.0 111.968 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.4 143.48 23.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 156.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 37.1 mmt-85 52.15 27.07 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.58 0.956 . . . . 10.0 113.58 -163.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.74 96.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.837 -1.705 . . . . 10.0 108.837 167.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -126.59 55.71 1.51 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.706 1.202 . . . . 10.0 108.645 -173.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.21 166.61 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.158 0.98 . . . . 10.0 112.397 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 105.4 3.95 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.9 119.4 23.89 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.503 -1.665 . . . . 10.0 106.503 -171.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -127.83 144.7 51.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.458 1.903 . . . . 10.0 107.456 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -61.71 119.42 8.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.99 37.18 3.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.218 1.407 . . . . 10.0 112.334 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -169.73 74.31 0.11 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.774 -1.73 . . . . 10.0 108.774 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.9 t0 63.41 130.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.967 2.507 . . . . 10.0 111.749 -168.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -177.1 175.82 1.48 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.365 0.984 . . . . 10.0 111.782 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.92 130.27 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.025 -1.843 . . . . 10.0 106.025 163.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 78.6 mtp -88.76 103.21 15.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.747 1.219 . . . . 10.0 107.759 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.27 81.42 8.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.711 -1.589 . . . . 10.0 106.711 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 51.3 ttm -84.79 152.34 23.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.313 1.045 . . . . 10.0 109.639 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.92 53.2 3.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.381 -1.087 . . . . 10.0 110.381 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.8 122.58 5.09 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 125.147 1.379 . . . . 10.0 109.11 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -72.9 -64.16 1.02 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.61 -58.48 0.0 OUTLIER Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 118.276 -0.868 . . . . 10.0 112.987 167.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.73 58.7 5.41 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.805 1.67 . . . . 10.0 111.334 -163.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.69 167.26 22.14 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.839 -0.538 . . . . 10.0 109.717 165.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -149.33 123.56 9.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.253 -1.758 . . . . 10.0 106.253 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.93 120.64 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.66 -4.19 50.16 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.414 -1.214 . . . . 10.0 112.478 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.03 169.4 11.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 119.944 1.872 . . . . 10.0 111.357 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.9 m -132.32 96.75 3.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 111.599 -2.546 . . . . 10.0 108.045 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.12 140.39 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -66.11 130.77 44.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.3 112.19 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 173.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.1 m -94.31 107.04 19.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.44 -0.8 . . . . 10.0 109.541 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.28 171.96 14.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.09 103.36 2.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.05 126.73 32.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.7 t -47.85 -38.53 16.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.51 1.524 . . . . 10.0 111.019 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.1 -35.19 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.019 1.727 . . . . 10.0 113.089 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.28 67.73 0.17 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.126 -1.189 . . . . 10.0 110.126 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -129.76 151.85 49.89 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 m -152.72 55.57 0.79 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.649 1.579 . . . . 10.0 107.823 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.49 128.76 34.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 62.43 0.87 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 127.551 2.34 . . . . 10.0 107.222 -161.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -84.49 153.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.396 -1.274 . . . . 10.0 108.96 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.68 113.44 18.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.922 -1.111 . . . . 10.0 108.999 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.0 146.27 32.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.398 1.079 . . . . 10.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.7 m -103.7 128.64 51.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.559 0.344 . . . . 10.0 110.702 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.34 91.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.899 -1.148 . . . . 10.0 107.899 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -155.66 135.83 13.0 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 121.435 -0.79 . . . . 10.0 110.754 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.76 -44.43 28.23 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.749 1.619 . . . . 10.0 111.868 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.66 76.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.167 0.987 . . . . 10.0 112.342 166.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.4 mm 54.8 47.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 122.5 1.143 . . . . 10.0 109.679 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -138.14 100.63 4.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 104.433 -2.432 . . . . 10.0 104.433 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.26 -44.76 1.09 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.155 -1.578 . . . . 10.0 109.155 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ARG . . . . . 0.403 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.259 1.557 0 N-CA-C 102.744 -3.058 . . . . 10.0 102.744 166.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 CA--C 1.535 0.384 0 CA-C-O 121.656 0.741 . . . . 10.0 112.161 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -161.71 57.42 0.26 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.82 1.248 . . . . 10.0 109.035 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.45 64.68 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -128.94 146.5 50.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.891 1.276 . . . . 10.0 111.443 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.26 90.59 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 108.261 -1.936 . . . . 10.0 108.261 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.41 142.5 17.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.04 0.536 . . . . 10.0 111.847 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 p -125.16 146.13 49.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.28 138.59 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.923 -1.139 . . . . 10.0 107.923 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.34 110.59 17.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.109 0.48 . . . . 10.0 111.486 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.39 136.34 31.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.403 -0.808 . . . . 10.0 109.15 166.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.7 t -17.5 108.22 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.83 2.052 . . . . 10.0 114.837 -162.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.15 158.1 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.814 2.343 . . . . 10.0 110.572 167.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.16 58.64 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.499 2.133 . . . . 10.0 108.987 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.9 t -165.4 44.25 0.08 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.266 1.426 . . . . 10.0 108.589 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' ARG . 16.5 mt 74.2 169.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.207 1.803 . . . . 10.0 109.723 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 42' ' ' ILE . 11.4 ptm180 -46.91 -39.61 12.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.915 1.686 . . . . 10.0 113.87 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.79 151.72 20.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.741 1.216 . . . . 10.0 111.415 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -164.2 -172.66 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.849 -0.797 . . . . 10.0 108.849 -164.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.71 39.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.645 1.178 . . . . 10.0 110.141 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.03 149.29 26.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.764 0.665 . . . . 10.0 109.411 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -124.2 103.32 8.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 104.756 -2.313 . . . . 10.0 104.756 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -159.2 -172.65 3.85 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.927 0.891 . . . . 10.0 111.579 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 m -145.59 125.17 13.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.699 -1.251 . . . . 10.0 110.259 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.28 132.58 35.35 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 103.946 -2.613 . . . . 10.0 103.946 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.8 m -129.35 88.24 2.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 125.001 1.438 . . . . 10.0 107.609 -164.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.39 128.47 33.38 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.388 -0.227 . . . . 10.0 110.388 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -141.82 57.02 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.9 m -156.16 -40.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.307 1.443 . . . . 10.0 111.071 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 65.99 62.22 0.61 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.034 1.734 . . . . 10.0 112.662 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -132.79 155.44 81.17 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.833 1.653 . . . . 10.0 108.052 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 75.97 4.63 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.895 3.063 . . . . 10.0 111.471 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.36 147.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 99.63 5.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.541 1.537 . . . . 10.0 111.019 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -82.6 121.55 26.96 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.595 -2.002 . . . . 10.0 105.595 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.75 54.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 122.207 1.003 . . . . 10.0 108.587 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.21 148.96 16.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.471 -1.051 . . . . 10.0 110.471 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.21 59.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.054 1.742 . . . . 10.0 107.762 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.94 29.68 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -169.59 149.16 3.56 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 118.799 0.727 . . . . 10.0 110.199 -172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.78 49.65 2.53 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.844 2.362 . . . . 10.0 110.434 168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.55 -70.59 0.73 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.59 1.556 . . . . 10.0 107.202 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.48 147.27 33.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.144 1.378 . . . . 10.0 110.26 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -82.41 -36.4 26.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.948 0.899 . . . . 10.0 109.935 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.7 t -120.47 75.12 24.57 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.614 1.165 . . . . 10.0 110.94 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.84 101.09 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 10.0 110.413 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.4 mtt -109.51 128.55 55.26 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.091 1.757 . . . . 10.0 108.854 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.62 142.25 31.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.304 1.042 . . . . 10.0 108.821 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttm -148.24 153.14 38.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.663 0.785 . . . . 10.0 110.84 -173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.0 t -159.07 98.62 1.46 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.046 -1.034 . . . . 10.0 111.547 -161.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -138.94 59.48 1.62 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.795 0.807 . . . . 10.0 110.193 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.4 m -147.73 125.11 11.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.702 0.801 . . . . 10.0 109.436 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -77.47 64.12 2.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.251 1.421 . . . . 10.0 109.671 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 166.01 -20.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.489 2.716 . . . . 10.0 109.484 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.45 -149.41 6.0 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.672 -1.771 . . . . 10.0 108.672 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.48 -52.47 52.68 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 122.455 -0.438 . . . . 10.0 113.235 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -168.1 1.19 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.123 1.369 . . . . 10.0 110.356 -166.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.83 42.97 3.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.618 1.967 . . . . 10.0 108.134 -167.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -149.58 103.04 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.228 -1.149 . . . . 10.0 110.228 -171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.63 63.03 2.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.059 0.929 . . . . 10.0 108.773 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -131.36 167.09 19.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.644 1.977 . . . . 10.0 109.691 -172.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtm -79.67 75.7 6.33 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.037 -1.097 . . . . 10.0 108.037 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.13 163.67 43.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.495 -0.775 . . . . 10.0 111.498 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -37.26 -55.73 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.141 3.227 . . . . 10.0 112.632 161.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.9 p90 172.65 -165.3 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.275 2.63 . . . . 10.0 104.732 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.4 pt? -127.37 111.53 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.701 0.682 . . . . 10.0 110.945 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m -76.59 132.48 39.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 107.055 -1.461 . . . . 10.0 107.055 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.2 pt -100.95 100.95 14.14 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.084 1.354 . . . . 10.0 107.388 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.59 67.69 8.55 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.239 2.626 . . . . 10.0 110.211 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 58.38 177.93 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 -156.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 38.81 33.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.831 2.16 . . . . 10.0 116.831 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.07 70.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.971 1.272 . . . . 10.0 113.113 163.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -111.49 57.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.18 156.45 18.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.793 -0.447 . . . . 10.0 109.793 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.3 m -115.42 115.36 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -82.61 106.36 14.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -137.08 156.56 48.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.6 1.16 . . . . 10.0 110.26 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -47.44 -40.35 17.87 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.805 1.242 . . . . 10.0 113.93 -161.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -132.65 52.05 2.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.825 0.821 . . . . 10.0 109.909 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.9 63.78 0.22 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 19.8 t0 65.45 136.45 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 126.253 1.821 . . . . 10.0 109.891 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 179.82 -179.2 0.44 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.096 -1.003 . . . . 10.0 112.095 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.6 t -110.83 123.02 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 161.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.7 mtp -83.51 100.54 10.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 166.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.15 74.25 4.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.403 -1.703 . . . . 10.0 106.403 171.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.7 ttt -84.72 153.89 22.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.271 1.029 . . . . 10.0 110.567 -170.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 60.17 3.92 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.295 -0.878 . . . . 10.0 111.103 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.67 128.59 26.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.777 1.231 . . . . 10.0 111.008 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -76.45 -72.97 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.642 0.777 . . . . 10.0 111.67 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -116.43 156.98 46.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.509 1.124 . . . . 10.0 111.912 -163.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.75 144.16 99.51 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.091 2.527 . . . . 10.0 111.76 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.0 mt -118.33 142.58 47.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.726 1.61 . . . . 10.0 109.497 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.37 129.01 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.01 107.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 163.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 120.35 -13.34 10.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.675 -0.57 . . . . 10.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.75 -179.54 3.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 123.589 1.661 . . . . 10.0 108.525 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -154.2 129.66 9.87 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.517 -1.674 . . . . 10.0 106.907 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.15 145.79 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.31 -1.367 . . . . 10.0 107.31 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -73.9 143.47 45.76 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.809 -0.557 . . . . 10.0 109.732 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 tt -118.4 139.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 168.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -111.5 108.26 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.91 161.97 19.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -149.9 95.28 2.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.78 133.51 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 170.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -77.23 3.81 12.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.21 -15.57 35.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.375 0.67 . . . . 10.0 111.042 156.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.7 47.38 1.29 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.119 1.818 . . . . 10.0 109.935 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -109.95 155.35 21.88 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 86.0 m -156.35 73.15 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 103.919 -2.623 . . . . 10.0 103.919 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.71 127.85 54.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -161.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -92.68 132.87 36.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.912 1.685 . . . . 10.0 107.471 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.1 152.67 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.767 -1.938 . . . . 10.0 105.767 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.75 29.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.05 119.87 38.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.518 0.727 . . . . 10.0 109.643 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -83.17 127.15 33.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.82 98.45 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -159.27 139.67 12.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 114.643 1.349 . . . . 10.0 114.643 -170.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.605 HG22 ' HG ' ' A' ' 51' ' ' LEU . 9.9 p . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 121.907 0.861 . . . . 10.0 111.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -156.6 59.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.178 -0.952 . . . . 10.0 109.527 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.13 58.35 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 123.101 1.429 . . . . 10.0 110.336 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 138.76 16.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.271 -0.877 . . . . 10.0 109.542 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 166.1 54.82 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.435 -1.466 . . . . 10.0 109.435 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.02 156.28 22.42 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.026 0.913 . . . . 10.0 110.8 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.4 p -123.7 156.71 35.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.1 140.16 48.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 38.49 0.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.02 -145.23 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.351 1.06 . . . . 10.0 109.933 -171.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.6 t -92.15 108.28 29.42 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 105.236 -2.135 . . . . 10.0 105.236 155.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 166.63 27.97 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 N-CA-C 108.017 -1.571 . . . . 10.0 108.017 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.05 64.26 5.13 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.589 2.193 . . . . 10.0 110.441 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -166.99 58.91 0.08 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.05 1.34 . . . . 10.0 108.755 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm 76.3 164.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.795 1.638 . . . . 10.0 110.327 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -37.2 63.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.851 1.26 . . . . 10.0 111.768 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -47.22 148.9 1.1 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.147 1.779 . . . . 10.0 111.52 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.2 t -153.94 -167.11 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.141 -0.688 . . . . 10.0 109.141 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.68 158.23 43.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.965 0.906 . . . . 10.0 108.766 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.22 154.06 24.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 124.051 0.844 . . . . 10.0 109.167 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -122.04 123.24 41.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 103.691 -2.707 . . . . 10.0 103.691 166.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -156.97 -177.03 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 m -149.08 125.67 11.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.591 -1.262 . . . . 10.0 107.591 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -83.56 134.89 34.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.213 -1.773 . . . . 10.0 106.213 171.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -135.77 97.43 3.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.045 1.338 . . . . 10.0 108.628 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -84.1 152.61 24.23 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.713 0.688 . . . . 10.0 109.977 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -139.25 56.72 1.67 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.27 -1.752 . . . . 10.0 106.27 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.5 t -175.15 164.26 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.164 -2.532 . . . . 10.0 104.164 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.67 81.51 1.64 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.969 0.793 . . . . 10.0 108.952 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -146.38 148.95 36.14 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 124.666 1.186 . . . . 10.0 108.43 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.05 72.88 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.41 2.74 . . . . 10.0 109.761 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -83.29 156.99 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 165.44 28.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.475 0.71 . . . . 10.0 110.215 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.455 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -139.13 128.05 23.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.222 -2.51 . . . . 10.0 104.222 179.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.91 52.12 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 122.423 1.106 . . . . 10.0 108.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.47 150.77 20.67 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.366 -0.834 . . . . 10.0 111.269 165.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.47 61.96 0.55 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.804 2.442 . . . . 10.0 106.207 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.45 91.14 6.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 -172.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 69' ' ' ALA . 5.1 t -104.88 133.6 20.07 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.795 1.238 . . . . 10.0 109.454 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.98 62.36 6.62 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.31 2.673 . . . . 10.0 109.001 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -162.97 -48.45 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.25 0.62 . . . . 10.0 111.093 -161.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 66' ' ' THR . . . -96.47 129.22 43.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -69.98 -34.04 72.85 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -128.84 73.07 81.55 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.19 0.996 . . . . 10.0 110.534 -170.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.8 122.68 9.07 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.198 1.932 . . . . 10.0 109.036 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.5 mtt -145.06 124.27 12.94 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.271 1.028 . . . . 10.0 110.015 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.8 mt -83.05 140.88 32.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.081 0.953 . . . . 10.0 109.925 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.9 ttm -141.07 152.17 44.6 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.596 1.158 . . . . 10.0 110.537 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -141.05 115.89 9.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.742 1.217 . . . . 10.0 111.284 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' THR 0.31 0.5 OUTLIER -145.83 59.86 1.25 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.302 1.223 . . . . 10.0 114.302 164.819 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 100' ' ' LEU . 1.1 t -143.84 120.83 11.37 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.416 -1.427 . . . . 10.0 109.854 171.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -77.59 61.5 2.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.224 1.41 . . . . 10.0 109.422 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.5 m -163.32 -58.15 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.045 1.338 . . . . 10.0 109.168 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -95.16 -93.43 1.71 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.663 -1.775 . . . . 10.0 108.663 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.72 97.93 2.02 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.354 0.978 . . . . 10.0 110.777 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -94.39 141.14 28.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 169.75 62.9 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 125.369 1.468 . . . . 10.0 109.817 145.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.2 37.94 4.71 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.045 1.307 . . . . 10.0 114.685 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 ttm 58.81 37.83 24.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.259 1.423 . . . . 10.0 111.64 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 161.78 14.27 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.353 0.661 . . . . 10.0 110.682 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.2 ttp -80.68 114.91 19.9 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.68 168.92 8.56 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -166.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.416 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.9 Cg_endo -36.85 -58.15 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.246 2.631 . . . . 10.0 111.775 151.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 37.9 p90 166.54 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.555 2.742 . . . . 10.0 105.028 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.92 106.79 11.96 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.62 0.768 . . . . 10.0 111.274 175.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.4 m -81.62 130.89 35.22 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 163.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -107.41 131.9 21.37 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.76 139.75 25.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.34 1.36 . . . . 10.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 59.45 -151.7 0.41 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.235 0.614 . . . . 10.0 112.319 159.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 51.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.411 . . . . 10.0 113.649 168.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.56 153.85 43.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.62 1.105 . . . . 10.0 111.843 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.6 t -146.48 90.63 1.96 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 162.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 81' ' ' GLY . 15.8 tp -84.69 160.87 20.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.016 -0.993 . . . . 10.0 110.316 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.2 m -130.89 99.5 4.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.85 122.92 28.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -155.63 154.55 31.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.984 1.313 . . . . 10.0 108.838 -170.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -70.54 76.6 0.58 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.979 0.512 . . . . 10.0 110.833 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 155.56 -94.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.771 3.628 . . . . 10.0 106.207 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.4 73.18 0.32 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.649 2.071 . . . . 10.0 113.898 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 67.22 134.66 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.024 2.53 . . . . 10.0 111.207 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -170.08 171.23 7.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.72 0.771 . . . . 10.0 112.004 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.8 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.698 -2.334 . . . . 10.0 104.698 167.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.5 mtm -82.83 144.43 30.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.964 -1.125 . . . . 10.0 107.964 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -120.25 78.79 1.39 Allowed 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 128.165 2.586 . . . . 10.0 105.154 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.8 mtt -83.69 154.56 23.59 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.15 54.54 32.13 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.22 141.48 57.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -104.43 -64.98 1.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.979 1.312 . . . . 10.0 109.464 -168.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -59.49 150.24 66.33 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 122.098 0.159 . . . . 10.0 110.914 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.42 102.89 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 N-CA-C 107.207 -1.882 . . . . 10.0 107.207 159.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 161.02 1.64 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.64 0.776 . . . . 10.0 113.034 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -133.13 129.39 37.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.178 -1.416 . . . . 10.0 107.178 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.77 94.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.574 -1.639 . . . . 10.0 106.574 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.9 15.65 8.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.618 1.104 . . . . 10.0 111.967 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 167.95 14.97 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.963 1.381 . . . . 10.0 107.791 159.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -155.1 77.41 1.01 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.218 -2.265 . . . . 10.0 107.877 -163.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -92.9 126.57 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 -169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -75.02 123.47 25.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 126' ' ' ILE . 12.6 pt -115.05 133.52 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.877 1.271 . . . . 10.0 108.525 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -91.03 125.81 35.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.068 -0.716 . . . . 10.0 109.068 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 24.8 mt -81.63 172.99 12.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -153.28 101.99 2.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.41 1.084 . . . . 10.0 108.158 164.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.9 149.05 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 162.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -42.04 -35.98 1.02 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.234 1.014 . . . . 10.0 111.493 168.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -11.33 9.32 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.682 2.793 . . . . 10.0 112.256 -175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.73 7.87 70.77 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -82.23 73.41 9.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.581 -1.266 . . . . 10.0 107.581 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -84.22 66.56 9.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.765 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.6 174.42 11.6 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.039 0.936 . . . . 10.0 109.125 -167.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -120.94 128.64 52.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.73 143.43 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.007 -1.108 . . . . 10.0 108.007 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -84.92 126.62 33.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.611 -0.885 . . . . 10.0 108.611 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.1 110.55 22.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.334 1.454 . . . . 10.0 109.323 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -88.77 105.63 17.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.249 1.42 . . . . 10.0 108.968 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.94 95.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 -168.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 57.48 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.943 1.247 . . . . 10.0 114.323 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt . . . . . 0 CA--C 1.541 0.629 0 CA-C-O 122.584 1.183 . . . . 10.0 114.06 170.191 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' VAL . 7.1 p . . . . . 0 CA--C 1.532 0.284 0 CA-C-O 121.824 0.821 . . . . 10.0 110.567 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -157.12 58.19 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.297 -0.877 . . . . 10.0 109.358 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.36 56.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.078 0.942 . . . . 10.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -149.92 136.14 18.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.636 -1.246 . . . . 10.0 107.636 167.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.17 132.77 23.74 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.083 -1.607 . . . . 10.0 109.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.72 150.94 19.99 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.479 0.64 . . . . 10.0 111.633 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 p -116.53 123.68 48.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.962 0.905 . . . . 10.0 108.646 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.22 121.53 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.568 0.747 . . . . 10.0 109.687 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.14 4.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.685 -0.634 . . . . 10.0 111.467 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -41.04 122.64 1.81 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.636 0.653 . . . . 10.0 110.266 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -33.65 124.27 0.46 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 116.032 1.864 . . . . 10.0 116.032 -144.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.31 165.83 2.83 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.929 2.42 . . . . 10.0 112.512 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -79.0 54.51 5.2 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.187 1.925 . . . . 10.0 109.346 163.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.7 p -139.49 51.67 1.75 Allowed 'General case' 0 C--N 1.341 0.225 0 O-C-N 121.477 -0.764 . . . . 10.0 110.576 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 43' ' ' ARG . 23.9 mt 86.5 173.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 127.608 2.363 . . . . 10.0 106.794 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 42' ' ' ILE . 18.6 ptt180 -72.57 50.63 0.24 Allowed 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.019 -1.05 . . . . 10.0 110.271 165.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.59 158.69 19.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.766 1.226 . . . . 10.0 109.432 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -157.82 169.15 25.27 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 157.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.01 153.23 25.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -173.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.91 147.49 23.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.469 1.106 . . . . 10.0 108.523 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -126.9 127.08 44.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.531 -2.396 . . . . 10.0 104.531 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.2 ptm -161.38 -174.63 4.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 10.0 107.06 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -125.5 117.35 23.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.049 0.94 . . . . 10.0 108.848 171.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.86 113.2 20.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.2 m -122.42 95.34 4.6 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.783 1.927 . . . . 10.0 108.616 -162.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -83.65 140.66 32.04 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.064 -0.397 . . . . 10.0 112.004 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -143.75 60.46 1.38 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -151.28 -39.95 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.916 1.286 . . . . 10.0 111.063 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t70 65.97 60.83 0.66 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.556 1.942 . . . . 10.0 110.339 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -140.89 152.15 64.67 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.256 1.823 . . . . 10.0 107.643 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.31 92.82 0.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.123 2.549 . . . . 10.0 110.658 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.96 145.85 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.412 0.625 . . . . 10.0 110.536 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -131.84 83.17 2.07 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.375 2.27 . . . . 10.0 109.792 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.56 72.55 9.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.359 -0.838 . . . . 10.0 111.293 -172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.08 56.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 121.776 -0.577 . . . . 10.0 110.908 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.39 28.21 Favored Glycine 0 C--N 1.334 0.437 0 O-C-N 121.096 -1.002 . . . . 10.0 111.258 162.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 60.38 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.099 0.96 . . . . 10.0 109.338 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.58 162.03 23.29 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.199 -0.938 . . . . 10.0 109.3 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 147.66 3.55 Favored Pre-proline 0 C--O 1.238 0.496 0 O-C-N 121.831 -0.543 . . . . 10.0 109.54 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.04 57.51 6.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.669 2.246 . . . . 10.0 109.038 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -143.42 -70.06 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.182 0.593 . . . . 10.0 109.983 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.33 167.03 11.93 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.911 1.284 . . . . 10.0 110.798 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.6 m -101.89 -39.83 7.18 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.601 1.16 . . . . 10.0 112.168 -157.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -108.95 90.91 8.32 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.533 1.133 . . . . 10.0 109.726 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.55 90.51 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.008 2.472 . . . . 10.0 109.862 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -108.91 114.19 27.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.849 0.833 . . . . 10.0 109.637 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.24 134.22 36.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.728 -0.841 . . . . 10.0 108.728 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.84 174.98 6.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.605 1.562 . . . . 10.0 108.035 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.2 t -159.88 135.06 8.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 173.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.96 56.75 0.53 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 122.507 1.146 . . . . 10.0 107.961 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.6 m -149.58 123.36 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.726 0.81 . . . . 10.0 109.848 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -70.47 80.95 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.7 t 143.9 -9.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.684 3.193 . . . . 10.0 110.507 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.54 -140.7 9.26 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.204 -1.558 . . . . 10.0 109.204 169.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.76 -54.25 39.14 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.633 -0.587 . . . . 10.0 111.633 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.3 tpt -169.92 -166.32 0.55 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.022 2.129 . . . . 10.0 107.479 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -121.69 60.58 0.95 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.65 89.47 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.455 -1.058 . . . . 10.0 110.455 -163.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -76.65 64.65 2.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.196 0.998 . . . . 10.0 110.687 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 167.75 10.71 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.832 2.053 . . . . 10.0 108.181 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.9 mtt -78.83 85.34 4.82 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.012 -1.477 . . . . 10.0 107.012 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.51 156.25 88.89 Favored Pre-proline 0 N--CA 1.453 -0.315 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -51.33 -38.55 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.866 2.377 . . . . 10.0 111.144 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.494 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 30.6 p90 -176.8 171.89 2.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.71 2.404 . . . . 10.0 104.872 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.76 98.11 8.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.494 ' HG1' ' HE1' ' A' ' 91' ' ' TRP . 0.3 OUTLIER -77.34 131.12 37.94 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.95 109.77 60.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.43 69.8 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.723 2.282 . . . . 10.0 110.189 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.73 175.29 0.2 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 -167.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 35.72 23.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 118.651 2.834 . . . . 10.0 118.651 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -45.92 102.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.411 1.005 . . . . 10.0 112.057 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -131.25 55.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.925 -1.88 . . . . 10.0 105.925 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' H ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -101.7 164.29 11.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.2 m -128.85 114.74 16.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.997 -2.223 . . . . 10.0 104.997 -168.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.19 110.34 14.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.552 -2.388 . . . . 10.0 104.552 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -130.99 148.51 52.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.698 1.999 . . . . 10.0 108.981 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -26.56 -53.15 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.159 2.184 . . . . 10.0 113.896 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -139.95 64.85 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.389 0.676 . . . . 10.0 109.622 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.12 66.46 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 9.2 t0 65.34 149.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.462 1.505 . . . . 10.0 109.824 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 160.66 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.478 1.911 . . . . 10.0 111.539 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.56 128.26 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.191 -1.781 . . . . 10.0 106.191 166.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.5 mtm -92.63 109.06 20.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 168.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.32 77.6 9.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.224 -1.769 . . . . 10.0 106.224 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.76 154.34 23.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.86 74.65 1.26 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 121.212 -0.93 . . . . 10.0 110.992 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.24 138.64 16.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.664 1.232 . . . . 10.0 111.626 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -79.86 -59.39 2.75 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 162.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 179.11 -59.64 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.553 1.141 . . . . 10.0 112.763 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.68 89.11 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.84 1.694 . . . . 10.0 111.557 -166.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.82 156.53 44.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.832 1.253 . . . . 10.0 109.05 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.67 145.88 7.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.62 105.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.916 -1.512 . . . . 10.0 106.916 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.54 -60.83 0.26 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -71.99 -174.11 1.16 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.933 3.293 . . . . 10.0 111.618 -163.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.0 m -133.87 128.33 34.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.149 1.78 . . . . 10.0 106.664 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.53 140.09 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -77.97 126.21 30.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.319 -0.993 . . . . 10.0 108.319 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -80.28 179.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.23 -1.767 . . . . 10.0 106.23 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.4 m -144.31 114.24 7.31 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.835 -1.166 . . . . 10.0 108.838 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 140.85 31.62 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -147.08 86.5 1.64 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.129 -1.434 . . . . 10.0 107.129 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.06 145.76 28.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.339 0.256 . . . . 10.0 110.919 -169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -56.39 -24.58 45.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.553 1.141 . . . . 10.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.77 -26.63 14.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.778 1.231 . . . . 10.0 113.238 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.65 52.33 1.22 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 109.75 -1.34 . . . . 10.0 109.75 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -144.78 160.45 41.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 m -131.45 143.79 50.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.6 tp -151.96 154.56 36.29 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -137.98 62.51 1.57 Allowed 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.527 1.531 . . . . 10.0 109.706 -161.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.66 141.11 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.57 124.63 30.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.01 130.61 54.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.057 0.943 . . . . 10.0 109.945 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -84.34 126.75 33.49 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 37' ' ' ALA . 7.8 t -87.12 100.78 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 -174.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -146.59 123.14 11.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.366 1.866 . . . . 10.0 108.194 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? . . . . . 0 N--CA 1.464 0.237 0 C-N-CA 123.591 0.756 . . . . 10.0 110.36 172.53 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 CA--C 1.53 0.18 0 CA-C-O 121.229 0.538 . . . . 10.0 112.073 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.7 p -157.3 62.27 0.49 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -108.85 60.09 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 10.0 109.257 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -133.6 144.4 49.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.961 0.905 . . . . 10.0 110.954 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.94 86.84 1.11 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.38 139.84 29.18 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.809 0.444 . . . . 10.0 111.941 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -117.3 140.51 49.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.0 134.25 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.69 120.96 12.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.96 -68.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.0 110.322 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -142.43 104.96 5.48 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.728 1.611 . . . . 10.0 107.541 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -64.94 164.89 23.08 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.549 2.166 . . . . 10.0 109.882 171.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.75 66.71 5.77 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.784 2.989 . . . . 10.0 109.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -156.32 -48.01 0.07 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.064 2.146 . . . . 10.0 106.628 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mt 72.03 147.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.244 1.818 . . . . 10.0 108.672 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 75.53 -49.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.271 1.429 . . . . 10.0 111.766 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -79.67 153.94 28.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 168.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -171.9 172.57 4.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.144 1.378 . . . . 10.0 109.177 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -157.07 161.76 39.47 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.61 0.764 . . . . 10.0 111.816 -172.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.03 140.4 29.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 124.401 1.063 . . . . 10.0 109.441 167.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 25.7 m-85 -136.18 112.83 10.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.392 -1.336 . . . . 10.0 107.392 -174.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -163.48 -172.23 2.85 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 125.149 1.38 . . . . 10.0 109.396 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -125.11 121.63 34.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 10.0 109.868 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.81 135.69 34.89 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 120.188 1.358 . . . . 10.0 107.62 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -117.75 78.53 1.25 Allowed 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.806 1.316 . . . . 10.0 109.876 -169.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.47 100.33 8.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.438 0.637 . . . . 10.0 109.867 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -109.4 54.68 0.65 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.11 0.964 . . . . 10.0 109.68 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 p -177.89 148.0 0.5 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -88.87 69.32 8.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.772 0.829 . . . . 10.0 109.576 -173.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.97 127.18 23.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.18 99.81 1.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.362 2.708 . . . . 10.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.9 141.79 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -126.62 97.37 4.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.011 1.325 . . . . 10.0 108.516 171.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 HD22 ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -81.42 132.61 35.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 175.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.18 53.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.3 158.94 31.75 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.63 -0.988 . . . . 10.0 110.63 163.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.87 127.21 6.5 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 158.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.46 144.06 23.48 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -172.55 155.99 3.37 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 118.352 0.524 . . . . 10.0 111.223 -163.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.27 -5.5 13.98 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.802 2.334 . . . . 10.0 112.599 164.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.66 -57.26 4.25 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.505 1.048 . . . . 10.0 111.892 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.51 161.07 37.38 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.554 1.141 . . . . 10.0 111.871 -168.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -93.46 -41.31 9.86 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.701 1.2 . . . . 10.0 111.74 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t -115.86 82.45 10.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.685 1.594 . . . . 10.0 109.498 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.75 107.5 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.897 2.398 . . . . 10.0 109.988 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.8 mmt -122.76 122.19 38.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.418 1.487 . . . . 10.0 109.352 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.15 138.33 33.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.726 0.81 . . . . 10.0 109.292 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.03 12.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.877 1.271 . . . . 10.0 110.137 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -139.74 119.86 13.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.88 -1.155 . . . . 10.0 107.88 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -141.18 48.29 1.68 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.3 m -156.43 80.54 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.058 -1.026 . . . . 10.0 109.799 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.57 86.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.257 1.023 . . . . 10.0 110.592 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 165.89 -41.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 127.452 2.301 . . . . 10.0 108.486 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.41 -83.34 1.32 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.168 -2.773 . . . . 10.0 106.168 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.02 -138.62 6.1 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.053 -1.219 . . . . 10.0 110.053 160.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.2 mmt -108.06 -161.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.155 2.182 . . . . 10.0 109.79 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.55 76.26 1.48 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.63 82.32 0.16 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.686 -1.365 . . . . 10.0 109.686 -170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -77.64 60.61 2.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.159 0.981 . . . . 10.0 110.386 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -125.62 170.96 10.98 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.444 2.298 . . . . 10.0 107.481 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.8 mtt -80.24 72.87 7.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.87 155.8 75.91 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.076 -0.966 . . . . 10.0 109.62 176.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -60.69 -25.71 81.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.225 1.95 . . . . 10.0 112.359 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -175.73 179.57 1.37 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.394 1.878 . . . . 10.0 106.451 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -113.77 106.81 14.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.56 150.81 34.7 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.99 88.8 27.68 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.88 57.72 6.55 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.904 3.069 . . . . 10.0 110.718 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.47 154.95 0.06 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.698 1.237 . . . . 10.0 110.108 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 40.3 39.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.201 1.401 . . . . 10.0 114.733 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 69.56 0.17 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.619 -0.993 . . . . 10.0 110.619 160.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -84.55 57.0 4.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.324 -1.361 . . . . 10.0 107.324 167.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.76 171.62 8.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.849 0.833 . . . . 10.0 110.54 -167.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 t -128.4 128.98 45.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.147 -2.168 . . . . 10.0 105.147 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.92 103.58 9.73 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 104.092 -2.558 . . . . 10.0 104.092 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -147.42 175.21 10.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.685 -1.598 . . . . 10.0 106.685 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -39.63 -50.15 2.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.208 0.527 . . . . 10.0 111.877 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -98.76 16.15 23.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.219 2.608 . . . . 10.0 113.911 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.35 151.67 23.89 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 120.559 1.527 . . . . 10.0 111.362 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -34.98 97.41 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.043 1.737 . . . . 10.0 113.633 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -128.29 174.67 9.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.728 1.149 . . . . 10.0 112.003 -166.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.91 107.97 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.6 mtt -84.1 102.72 12.75 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 122.297 1.046 . . . . 10.0 108.906 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.54 70.0 10.18 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 105.669 -1.974 . . . . 10.0 105.669 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.5 ttm -83.72 148.53 27.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 -168.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.34 59.65 2.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.612 -1.395 . . . . 10.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 tt -50.47 128.06 19.12 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.307 1.843 . . . . 10.0 110.241 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.61 -71.64 0.54 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.071 0.549 . . . . 10.0 110.146 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.61 158.0 73.99 Favored Pre-proline 0 CA--C 1.533 0.319 0 O-C-N 121.982 -0.449 . . . . 10.0 110.135 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.3 73.86 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.317 2.012 . . . . 10.0 109.152 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.76 132.3 17.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 112.789 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -96.35 129.63 43.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.336 1.454 . . . . 10.0 109.492 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.4 105.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.08 16.2 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.912 -0.938 . . . . 10.0 112.313 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.19 -178.47 1.67 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.727 1.727 . . . . 10.0 108.735 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.9 m -155.66 124.59 6.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.614 -1.995 . . . . 10.0 105.614 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.97 145.14 29.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.92 130.33 39.2 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.162 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.9 pt -106.91 122.0 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 160.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 m -101.16 119.98 39.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 169.12 8.74 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.645 0.778 . . . . 10.0 110.029 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.65 96.6 2.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.17 1.788 . . . . 10.0 107.872 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.63 132.18 34.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.395 -0.595 . . . . 10.0 109.395 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 t -60.91 -15.49 31.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.262 0.625 . . . . 10.0 111.388 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.432 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 54.6 m-20 -67.17 -21.14 65.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.906 0.883 . . . . 10.0 112.059 171.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 131.33 -13.05 5.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.099 0.857 . . . . 10.0 112.418 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -81.07 73.02 8.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.872 1.336 . . . . 10.0 109.356 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.6 m -83.61 107.05 15.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 156.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.4 tp -156.11 149.42 24.56 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -106.22 131.03 53.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.295 2.238 . . . . 10.0 106.826 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.23 122.93 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.321 -1.733 . . . . 10.0 106.321 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.8 108.28 16.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.22 29.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.626 0.77 . . . . 10.0 109.665 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -82.26 127.21 32.97 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.342 -0.985 . . . . 10.0 108.342 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.1 t -90.0 91.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.204 -1.776 . . . . 10.0 106.204 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -158.67 140.01 13.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 166.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 169.59 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.532 0.288 0 CA-C-O 122.277 1.037 . . . . 10.0 111.647 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -158.03 74.81 0.73 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.1 53.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 122.151 0.977 . . . . 10.0 110.281 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -152.7 139.11 18.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 163.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 147.62 35.55 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.092 -1.203 . . . . 10.0 110.092 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.12 152.52 29.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 10.0 110.443 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -133.44 125.73 29.67 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.751 -1.574 . . . . 10.0 106.751 170.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.47 137.84 45.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.436 1.095 . . . . 10.0 110.012 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.94 2.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.227 -0.589 . . . . 10.0 111.808 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.79 114.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.574 1.15 . . . . 10.0 111.286 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t 2.9 94.57 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.134 2.574 . . . . 10.0 113.365 -167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.23 169.22 20.02 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.95 1.767 . . . . 10.0 108.487 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.74 60.11 4.31 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.812 2.341 . . . . 10.0 109.887 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -160.17 40.61 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.234 1.414 . . . . 10.0 108.429 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 43' ' ' ARG . 9.4 mm 69.48 -179.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.034 1.333 . . . . 10.0 109.081 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.588 ' H ' HG22 ' A' ' 42' ' ' ILE . 9.0 ptm180 -55.55 -29.11 58.38 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.064 0.946 . . . . 10.0 112.108 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.42 135.9 7.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.784 1.634 . . . . 10.0 109.67 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 t -160.82 -171.21 3.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -156.29 167.41 30.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.403 1.081 . . . . 10.0 109.828 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.67 153.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.909 0.755 . . . . 10.0 111.208 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 33.0 m-85 -138.52 112.33 8.39 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.571 -1.64 . . . . 10.0 106.571 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -162.25 -171.96 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.02 1.728 . . . . 10.0 107.634 -168.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -128.01 145.72 50.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.648 0.658 . . . . 10.0 111.592 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.35 113.31 25.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.403 -2.073 . . . . 10.0 105.403 156.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.03 82.17 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.66 137.47 34.46 Favored 'General case' 0 C--N 1.337 0.06 0 O-C-N 121.689 -0.632 . . . . 10.0 110.335 -168.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -128.48 54.66 1.74 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -158.33 128.88 6.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.584 1.954 . . . . 10.0 105.774 170.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.59 61.92 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.863 0.865 . . . . 10.0 110.119 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -134.27 135.98 25.1 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.392 1.477 . . . . 10.0 108.602 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.15 100.58 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.495 2.796 . . . . 10.0 111.167 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.26 95.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.73 117.68 22.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.748 0.819 . . . . 10.0 110.604 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.8 OUTLIER -88.8 123.37 33.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.424 1.49 . . . . 10.0 107.88 -174.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 7.1 p -143.54 55.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.695 0.759 . . . . 10.0 110.425 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.01 148.45 16.41 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.472 -1.451 . . . . 10.0 109.472 162.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.97 75.83 0.84 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.13 0.972 . . . . 10.0 109.029 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.53 157.52 16.18 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.498 0.719 . . . . 10.0 109.676 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -172.54 143.27 1.21 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.94 60.97 6.27 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.242 2.628 . . . . 10.0 109.777 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.68 -51.64 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.435 1.094 . . . . 10.0 108.471 -164.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.43 168.69 10.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.475 1.91 . . . . 10.0 109.837 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 m -134.6 -2.31 2.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.311 0.644 . . . . 10.0 112.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 m -152.11 70.44 7.71 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.852 -1.155 . . . . 10.0 109.885 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.61 128.9 11.35 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.84 2.36 . . . . 10.0 111.29 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 mmt -139.64 128.73 23.73 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.999 1.32 . . . . 10.0 109.453 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.46 136.87 33.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.683 0.793 . . . . 10.0 109.673 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.67 -179.36 3.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.875 1.67 . . . . 10.0 108.93 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.0 t -158.88 100.8 1.6 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.485 0.714 . . . . 10.0 109.687 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 t -149.96 56.82 0.96 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.257 -0.902 . . . . 10.0 109.24 -169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -124.46 146.36 48.98 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.926 1.29 . . . . 10.0 108.91 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -101.74 44.92 0.99 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.0 t -163.93 -52.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.243 0.617 . . . . 10.0 111.184 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.88 -110.4 0.57 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.24 -144.86 0.35 Allowed Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.098 0.949 . . . . 10.0 113.699 170.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.4 ttm -75.82 162.88 27.78 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.865 1.266 . . . . 10.0 109.952 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.6 49.94 0.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.999 1.72 . . . . 10.0 107.756 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.7 92.25 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.565 -1.014 . . . . 10.0 110.565 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 ttp -64.21 84.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.554 1.177 . . . . 10.0 112.052 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -133.28 156.66 47.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.214 2.606 . . . . 10.0 106.769 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.4 mtm -80.38 143.49 33.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.913 -1.514 . . . . 10.0 106.913 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.93 165.1 29.96 Favored Pre-proline 0 N--CA 1.455 -0.205 0 C-N-CA 123.686 0.794 . . . . 10.0 109.776 -171.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -43.51 -54.37 3.67 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.686 2.257 . . . . 10.0 110.404 158.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.424 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 175.36 -149.58 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.151 2.181 . . . . 10.0 108.613 -177.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.86 158.27 43.87 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.332 1.853 . . . . 10.0 106.054 160.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.5 m -97.47 124.57 41.73 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.52 -0.918 . . . . 10.0 108.52 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.49 121.73 68.05 Favored Pre-proline 0 N--CA 1.454 -0.232 0 N-CA-C 105.325 -2.102 . . . . 10.0 105.325 171.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.97 146.15 16.03 Favored 'Trans proline' 0 N--CA 1.441 -1.571 0 N-CA-C 109.261 -1.092 . . . . 10.0 109.261 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 47.36 -138.4 0.71 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.958 0.903 . . . . 10.0 112.539 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.67 32.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.747 2.419 . . . . 10.0 114.494 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.8 150.76 38.6 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.994 -1.066 . . . . 10.0 113.075 -169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -132.01 61.66 1.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.988 1.315 . . . . 10.0 108.359 -171.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.65 148.58 30.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.9 m -135.47 107.54 7.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.22 114.35 18.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -131.53 159.75 37.27 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.249 1.42 . . . . 10.0 109.845 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -25.0 -65.26 0.05 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.201 2.2 . . . . 10.0 113.566 -173.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.09 80.63 1.84 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.377 -1.712 . . . . 10.0 106.377 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.83 86.76 0.1 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 108.86 -1.696 . . . . 10.0 108.86 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 t0 40.95 74.61 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.129 1.771 . . . . 10.0 112.176 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -131.07 172.31 12.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.332 -1.758 . . . . 10.0 110.867 -154.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.7 108.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 125.668 1.587 . . . . 10.0 108.715 -173.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 33.0 mtp -83.04 96.39 8.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.405 0.682 . . . . 10.0 109.723 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.48 70.17 7.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.809 -1.552 . . . . 10.0 106.809 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.22 164.99 22.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.431 -1.322 . . . . 10.0 107.431 -168.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.28 46.57 20.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.323 -1.111 . . . . 10.0 110.323 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.4 mt -55.27 130.27 41.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.737 1.268 . . . . 10.0 108.917 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -69.17 0.13 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.506 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 173.97 -63.63 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.221 1.409 . . . . 10.0 112.91 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.09 50.14 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.544 2.163 . . . . 10.0 112.741 -159.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.54 157.01 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.212 1.005 . . . . 10.0 110.52 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 171.93 7.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.954 -1.128 . . . . 10.0 107.954 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.27 128.09 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 163.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 33.17 39.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.499 -0.64 . . . . 10.0 111.499 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.96 -172.7 4.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.462 1.125 . . . . 10.0 108.486 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.6 m -155.81 124.78 6.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.027 1.731 . . . . 10.0 107.499 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.89 152.5 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.96 -1.496 . . . . 10.0 106.96 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -70.87 132.23 44.95 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.0 154.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 106.125 -1.805 . . . . 10.0 106.125 155.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -129.82 128.49 42.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 158.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.41 156.39 24.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -147.7 69.41 1.14 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.69 117.69 21.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p 40.95 -99.79 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.585 1.554 . . . . 10.0 109.896 -167.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 42.79 0.93 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.27 2.228 . . . . 10.0 107.411 170.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.09 -48.12 0.23 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.22 1.866 . . . . 10.0 110.166 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -115.1 73.2 0.82 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.093 0.947 . . . . 10.0 108.637 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 m -86.29 100.94 12.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 160.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 mt -155.3 164.41 38.81 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 122.736 0.415 . . . . 10.0 110.547 -165.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -132.46 65.28 1.59 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.712 2.005 . . . . 10.0 109.553 -159.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.7 t -81.71 149.3 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 -171.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.32 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.151 -0.968 . . . . 10.0 109.626 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.66 120.48 40.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.844 1.258 . . . . 10.0 109.739 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -83.78 148.47 27.01 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 166.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.73 100.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -156.8 126.81 6.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.294 0.952 . . . . 10.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.388 0 CA-C-N 118.441 0.564 . . . . 10.0 111.39 171.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 122.679 1.228 . . . . 10.0 112.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -78.43 66.26 3.94 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.526 3.131 . . . . 10.0 108.929 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.75 88.96 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.154 1.382 . . . . 10.0 108.951 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -147.94 134.42 19.71 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.67 154.81 47.59 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.589 1.09 . . . . 10.0 112.497 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.42 162.48 13.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.641 0.734 . . . . 10.0 112.22 -170.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 p -139.63 157.98 44.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.557 -1.275 . . . . 10.0 107.557 164.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.91 136.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.243 -1.392 . . . . 10.0 107.243 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.51 40.75 0.74 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.794 -1.191 . . . . 10.0 112.998 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . . . 41.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.107 1.363 . . . . 10.0 110.111 -164.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.58 125.46 47.02 Favored Pre-proline 0 C--O 1.239 0.517 0 CA-C-N 120.095 1.316 . . . . 10.0 107.841 160.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.19 174.06 4.47 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.261 1.974 . . . . 10.0 108.693 162.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.95 54.84 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.215 1.943 . . . . 10.0 109.801 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 m -144.29 62.6 1.34 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.978 1.311 . . . . 10.0 107.711 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 mm 73.72 164.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.923 1.289 . . . . 10.0 109.723 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -77.38 50.07 0.76 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.217 1.407 . . . . 10.0 109.862 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -138.72 159.81 41.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.059 2.144 . . . . 10.0 108.46 -162.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.1 t -172.0 -179.43 2.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.472 1.109 . . . . 10.0 109.948 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.28 161.33 37.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.334 1.454 . . . . 10.0 109.157 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.96 156.54 21.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 165.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -130.19 108.63 10.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.17 -2.529 . . . . 10.0 104.17 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ptp -157.12 -176.8 6.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.681 1.192 . . . . 10.0 109.461 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.9 m -127.59 119.12 25.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.086 1.355 . . . . 10.0 109.053 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.32 109.23 12.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 103.605 -2.739 . . . . 10.0 103.605 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -95.93 70.65 2.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.482 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.51 130.25 35.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.272 -0.971 . . . . 10.0 109.829 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -136.1 56.26 1.83 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 p -157.83 166.14 33.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.312 0.577 . . . . 10.0 110.821 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -107.89 27.26 9.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.901 2.88 . . . . 10.0 110.33 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -114.73 134.4 22.41 Favored Pre-proline 0 C--N 1.342 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 107.609 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.63 122.01 8.48 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.113 1.875 . . . . 10.0 109.891 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.26 81.91 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -79.28 -180.0 7.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.062 0.458 . . . . 10.0 110.32 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -155.64 136.14 13.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.666 -2.346 . . . . 10.0 104.666 -170.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -151.55 54.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.276 0.944 . . . . 10.0 109.52 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.18 151.0 20.01 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.783 -1.198 . . . . 10.0 111.116 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.78 70.95 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.484 1.514 . . . . 10.0 108.392 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.64 140.71 32.02 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 t -168.21 145.04 3.35 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 118.562 0.619 . . . . 10.0 111.313 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.95 52.99 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.937 2.425 . . . . 10.0 110.023 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 tp -128.87 -61.24 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.439 1.096 . . . . 10.0 109.564 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.24 162.44 18.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.61 1.564 . . . . 10.0 109.601 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 m -87.86 -42.7 12.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.588 0.755 . . . . 10.0 110.625 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 t -123.38 89.97 50.76 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.654 1.182 . . . . 10.0 110.181 -163.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.68 85.11 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.89 2.393 . . . . 10.0 109.904 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.0 mtt -83.69 117.83 23.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.152 0.981 . . . . 10.0 108.618 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.16 128.63 33.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.458 -0.776 . . . . 10.0 109.571 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.76 144.68 39.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.918 1.287 . . . . 10.0 110.787 -174.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.89 170.11 13.43 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.467 0.651 . . . . 10.0 111.991 164.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -98.46 177.43 5.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.42 1.888 . . . . 10.0 113.527 164.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -95.21 72.05 3.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.046 1.739 . . . . 10.0 108.969 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.09 73.03 0.44 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.245 1.418 . . . . 10.0 112.921 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -164.39 54.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.31 -90.06 0.49 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 106.992 -2.443 . . . . 10.0 106.992 -167.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.37 173.87 19.06 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 117.223 0.511 . . . . 10.0 112.706 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mtp -53.75 -87.48 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.645 1.978 . . . . 10.0 115.547 -158.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -174.94 34.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.666 0.666 . . . . 10.0 111.922 -160.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.79 140.39 2.91 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.827 -0.909 . . . . 10.0 110.827 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.6 ttp -65.62 93.59 0.17 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.739 0.769 . . . . 10.0 110.062 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.26 161.38 38.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.432 0.693 . . . . 10.0 112.464 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 68.9 mtp -82.84 109.42 16.96 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.071 1.748 . . . . 10.0 110.081 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.09 166.51 10.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.391 0.676 . . . . 10.0 111.525 -170.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.414 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.4 Cg_endo -37.73 -53.1 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.251 2.634 . . . . 10.0 111.027 156.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 44.6 p90 175.07 -172.18 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.056 2.142 . . . . 10.0 105.593 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.3 pt? -116.1 102.3 9.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.473 0.654 . . . . 10.0 110.548 174.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.7 m -76.8 120.85 22.52 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 pt -92.48 115.38 64.69 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.315 -1.365 . . . . 10.0 107.315 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.05 59.06 7.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.74 2.293 . . . . 10.0 108.514 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.73 -175.82 0.14 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.26 1.024 . . . . 10.0 109.551 -161.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 54.6 -2.34 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 118.024 2.602 . . . . 10.0 118.024 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.61 77.74 0.49 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.761 1.172 . . . . 10.0 111.986 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.4 t -82.43 56.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 166.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.59 -178.16 4.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.98 0.895 . . . . 10.0 110.656 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -127.75 129.13 46.56 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.18 1.792 . . . . 10.0 106.562 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.77 114.39 26.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 103.752 -2.685 . . . . 10.0 103.752 167.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.99 159.85 38.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.343 1.057 . . . . 10.0 109.971 -164.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -44.89 -54.6 6.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.153 1.381 . . . . 10.0 113.349 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.8 -63.31 1.24 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.783 0.833 . . . . 10.0 111.419 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.24 135.81 3.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -165.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 70.78 119.96 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 130.885 3.674 . . . . 10.0 106.246 -170.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 176.43 171.67 0.43 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.605 0.762 . . . . 10.0 109.242 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.22 123.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.139 -2.171 . . . . 10.0 105.139 154.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 69.0 mtp -82.84 101.6 11.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.104 -1.443 . . . . 10.0 107.104 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.38 74.3 8.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.708 1.603 . . . . 10.0 107.045 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 52.1 ttm -84.6 149.47 25.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.231 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.46 68.82 1.27 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.704 -0.959 . . . . 10.0 110.704 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -35.37 133.94 0.32 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.121 1.768 . . . . 10.0 112.985 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -67.53 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.745 -0.645 . . . . 10.0 111.689 157.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -168.9 -59.3 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 115.984 1.846 . . . . 10.0 115.984 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.39 75.66 4.81 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.904 1.736 . . . . 10.0 111.113 -166.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.17 48.32 2.41 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.389 1.076 . . . . 10.0 111.882 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -63.69 148.21 49.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.22 108.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.29 55.77 3.0 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -166.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 -179.8 4.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 153.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.1 m -155.66 134.93 12.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.284 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.01 136.7 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.656 -1.609 . . . . 10.0 106.656 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -79.23 114.76 18.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 167.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -81.2 -178.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 168.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 m -139.13 120.19 14.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 160.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 pp -83.69 172.65 12.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -156.72 103.39 2.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 134' ' ' ARG . . . -84.45 120.69 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.06 -1.089 . . . . 10.0 108.06 157.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -48.33 -34.51 10.72 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.594 1.558 . . . . 10.0 111.053 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.1 -33.75 53.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.759 2.023 . . . . 10.0 111.806 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.82 56.84 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.231 0.92 . . . . 10.0 111.032 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 130' ' ' ALA . 68.2 ttt180 -141.65 133.72 27.64 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.5 t -156.01 59.6 0.59 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.659 0.663 . . . . 10.0 110.754 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.98 148.97 27.27 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.005 0.522 . . . . 10.0 109.885 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -95.92 65.81 2.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 127.735 2.414 . . . . 10.0 108.262 -174.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.77 146.96 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -155.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.73 130.53 35.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.62 115.08 23.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.951 1.3 . . . . 10.0 109.453 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.7 m -84.41 132.73 34.55 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.37 120.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -159.7 94.1 1.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.057 0.844 . . . . 10.0 112.379 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 15.9 ptmt . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 CA--C 1.532 0.263 0 CA-C-O 121.276 0.56 . . . . 10.0 111.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 p -156.13 57.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.507 -0.746 . . . . 10.0 109.995 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.24 58.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 CA-C-O 122.569 1.176 . . . . 10.0 110.632 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.95 155.75 41.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 164.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.52 -163.23 6.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.366 -1.094 . . . . 10.0 110.366 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.0 133.77 30.52 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -120.46 110.64 16.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.65 128.78 53.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.397 0.679 . . . . 10.0 109.375 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.08 110.34 12.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.873 0.368 . . . . 10.0 111.314 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.44 127.14 14.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.572 -0.728 . . . . 10.0 109.617 167.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -13.05 95.74 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 128.29 2.636 . . . . 10.0 113.281 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.47 178.86 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.692 2.261 . . . . 10.0 109.377 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -67.52 68.05 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.408 2.072 . . . . 10.0 108.548 156.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -153.8 35.28 0.44 Allowed 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 126.216 1.806 . . . . 10.0 108.206 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 43' ' ' ARG . 18.2 mt 64.8 -176.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -70.19 32.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.468 -1.395 . . . . 10.0 113.552 170.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 155.16 20.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 163.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -164.94 -178.15 5.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.669 -1.234 . . . . 10.0 107.669 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 165.0 29.32 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.883 0.873 . . . . 10.0 109.887 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.69 33.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.308 -1.314 . . . . 10.0 107.71 164.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.16 104.36 12.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 -173.4 4.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.49 1.116 . . . . 10.0 110.423 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.8 m -116.56 143.96 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.038 1.735 . . . . 10.0 107.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.42 121.7 40.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.723 -1.955 . . . . 10.0 105.723 158.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -129.42 114.93 16.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.583 1.553 . . . . 10.0 109.045 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -93.29 136.93 33.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.82 0.848 . . . . 10.0 112.317 -172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -134.2 56.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.713 -1.218 . . . . 10.0 107.713 161.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -137.33 -51.5 0.65 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.82 0.848 . . . . 10.0 111.031 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.5 48.43 3.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.659 1.584 . . . . 10.0 110.449 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.69 137.99 31.06 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.63 119.04 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.876 2.384 . . . . 10.0 109.705 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 mt -122.96 135.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -98.6 99.73 10.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.385 1.074 . . . . 10.0 108.904 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -87.2 117.56 26.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.75 -1.944 . . . . 10.0 105.75 -178.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.17 51.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.485 0.714 . . . . 10.0 109.488 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.95 138.34 5.35 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.925 -1.27 . . . . 10.0 109.925 160.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.56 66.57 0.49 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.257 1.423 . . . . 10.0 107.73 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.0 21.09 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.061 0.544 . . . . 10.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 t -173.46 140.22 0.85 Allowed Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.39 65.82 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.27 2.646 . . . . 10.0 108.932 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.26 -50.68 0.08 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.957 1.303 . . . . 10.0 108.766 -164.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.93 31.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m -88.98 -22.31 23.09 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 167.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -134.3 88.15 31.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.709 1.204 . . . . 10.0 108.492 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.79 124.36 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.324 2.683 . . . . 10.0 110.424 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -132.04 152.04 51.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.578 1.151 . . . . 10.0 108.95 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.1 157.06 18.45 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.236 0.615 . . . . 10.0 110.217 166.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.93 153.81 32.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.794 1.237 . . . . 10.0 109.354 -176.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 15.1 t -139.57 121.04 15.08 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.947 0.794 . . . . 10.0 112.408 -173.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -146.88 51.22 1.1 Allowed 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.559 -1.338 . . . . 10.0 110.305 165.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.6 m -150.28 90.74 1.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.487 1.115 . . . . 10.0 111.85 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -34.67 -42.98 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.805 2.442 . . . . 10.0 113.566 172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -50.29 -26.29 4.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.644 1.178 . . . . 10.0 113.409 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.22 -51.41 0.11 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 -124.57 4.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.162 0.887 . . . . 10.0 111.245 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.3 tpp -141.74 -121.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.067 0.934 . . . . 10.0 111.186 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.07 62.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -166.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.32 87.36 0.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.795 -1.722 . . . . 10.0 108.795 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 64.43 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.463 -0.94 . . . . 10.0 108.463 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -147.08 172.89 13.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.674 2.39 . . . . 10.0 107.847 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttp -80.15 74.73 6.95 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.799 0.809 . . . . 10.0 109.054 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.73 160.81 24.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.701 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.23 80.14 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.957 2.438 . . . . 10.0 109.69 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 58.21 -164.95 0.18 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.954 2.102 . . . . 10.0 113.482 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.75 99.15 5.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.797 0.839 . . . . 10.0 109.27 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.0 m -82.15 125.46 30.91 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.726 -0.608 . . . . 10.0 109.649 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.33 122.11 60.34 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.34 65.45 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.816 2.344 . . . . 10.0 110.847 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.99 -175.32 0.15 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.877 0.871 . . . . 10.0 109.462 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . 0.258 0.1 OUTLIER 5.9 44.21 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 130.164 3.385 . . . . 10.0 118.831 -169.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -54.29 138.01 40.56 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.316 0.96 . . . . 10.0 113.534 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.8 m -149.85 59.63 0.99 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.433 1.493 . . . . 10.0 107.177 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.96 164.75 12.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.677 0.275 . . . . 10.0 110.524 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.8 m -124.19 104.73 9.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.54 122.21 27.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.63 -1.618 . . . . 10.0 106.63 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -156.17 157.51 36.04 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.606 1.963 . . . . 10.0 107.726 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 0.25 0.2 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.476 1.658 . . . . 10.0 115.476 -161.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.45 -72.04 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.994 1.717 . . . . 10.0 108.09 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.28 76.61 1.45 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 125.136 1.351 . . . . 10.0 111.176 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 8.9 t70 70.03 134.58 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.095 1.758 . . . . 10.0 110.696 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -177.47 176.22 1.32 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.896 0.855 . . . . 10.0 113.013 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.59 121.37 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 157.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.2 mtp -82.22 104.99 12.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 165.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.63 74.52 6.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.628 1.971 . . . . 10.0 109.148 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -91.16 149.13 21.92 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.934 -0.479 . . . . 10.0 112.271 -170.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 33.56 3.0 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.582 0.993 . . . . 10.0 115.582 157.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 37.95 46.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 128.424 2.69 . . . . 10.0 116.769 160.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.092 -1.005 . . . . 10.0 112.719 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -133.11 151.72 78.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 107.086 -1.45 . . . . 10.0 107.086 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.39 75.06 2.5 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.003 2.468 . . . . 10.0 109.279 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mp -40.54 105.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.386 2.274 . . . . 10.0 113.3 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.73 131.64 34.41 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.1 p -60.67 103.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 162.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.69 -0.61 15.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.978 -0.901 . . . . 10.0 112.148 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.16 179.97 4.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 123.94 1.828 . . . . 10.0 108.281 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -155.81 132.75 10.59 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.534 -2.121 . . . . 10.0 106.55 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.75 143.88 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -79.22 124.64 28.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 tt -81.52 170.4 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -146.42 118.44 8.24 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.155 -0.966 . . . . 10.0 109.073 165.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.1 151.54 24.06 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.318 -1.364 . . . . 10.0 107.318 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -154.48 78.7 1.08 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.1 123.56 27.47 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p 44.89 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.175 1.79 . . . . 10.0 110.001 -161.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -164.32 58.36 0.15 Allowed 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.731 0.813 . . . . 10.0 109.521 156.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.71 27.44 1.63 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.22 61.04 1.17 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.186 0.994 . . . . 10.0 108.428 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.1 m -83.0 60.11 5.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.794 0.838 . . . . 10.0 110.27 -170.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.88 149.92 26.82 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -130.55 60.74 1.62 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.543 1.937 . . . . 10.0 109.509 -169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.0 151.12 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 121.938 -0.476 . . . . 10.0 109.991 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.96 119.6 24.64 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.364 -0.835 . . . . 10.0 109.294 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.85 133.45 42.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.222 1.009 . . . . 10.0 108.799 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.6 m -83.0 144.29 30.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.525 -1.287 . . . . 10.0 107.525 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.43 107.28 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -156.69 147.11 21.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 121.603 0.716 . . . . 10.0 111.024 171.68 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 121.092 0.472 . . . . 10.0 110.466 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 m -159.18 106.5 1.78 Allowed 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.948 -1.095 . . . . 10.0 109.505 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.23 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.63 0.65 . . . . 10.0 111.01 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -157.51 153.58 27.24 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 163.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.1 107.95 3.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.748 1.166 . . . . 10.0 112.178 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.73 153.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.746 0.818 . . . . 10.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 p -135.68 151.86 50.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.287 -1.375 . . . . 10.0 107.287 164.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.84 137.91 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.06 47.33 0.77 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.288 0.949 . . . . 10.0 113.416 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 28.89 -124.29 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.014 2.126 . . . . 10.0 111.243 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.38 118.89 55.63 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 157.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.8 168.49 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.038 2.492 . . . . 10.0 107.996 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.47 69.43 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.786 1.657 . . . . 10.0 108.846 170.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.433 ' CB ' HH12 ' A' ' 104' ' ' ARG . 7.4 m -155.84 38.67 0.37 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.645 1.178 . . . . 10.0 109.078 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.4 mm 68.34 178.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.361 1.064 . . . . 10.0 110.291 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.4 tpt180 -46.51 -33.59 4.17 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.37 2.268 . . . . 10.0 114.774 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.31 151.71 45.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.362 1.077 . . . . 10.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 t -161.65 175.4 12.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.634 -1.617 . . . . 10.0 106.634 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.02 160.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.07 0.548 . . . . 10.0 110.529 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.76 142.44 32.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.114 0.884 . . . . 10.0 108.855 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -117.93 108.62 15.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 165.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.74 -179.16 7.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.313 1.845 . . . . 10.0 106.332 -160.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -150.66 138.02 19.52 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.411 1.46 . . . . 10.0 110.071 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.97 116.37 27.97 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -93.76 87.25 5.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.843 1.657 . . . . 10.0 108.304 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -78.05 79.53 4.51 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 121.89 0.852 . . . . 10.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 58.28 4.64 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m -172.76 144.21 1.34 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.986 0.915 . . . . 10.0 108.796 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.09 49.12 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.447 1.499 . . . . 10.0 109.838 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.2 127.19 18.88 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.805 0.842 . . . . 10.0 109.376 -170.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -85.71 121.85 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.538 2.825 . . . . 10.0 110.702 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mp -150.44 116.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 150.08 30.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.347 0.521 . . . . 10.0 110.677 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -110.04 138.32 46.59 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 171.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.88 54.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.56 1.073 . . . . 10.0 108.914 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.04 144.35 9.64 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.623 -1.791 . . . . 10.0 108.623 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.98 65.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.571 1.548 . . . . 10.0 107.981 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.12 160.89 23.03 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t -173.75 152.2 1.98 Allowed Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 107.608 -1.256 . . . . 10.0 107.608 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.34 -1.41 11.32 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.603 2.202 . . . . 10.0 112.155 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.61 -53.67 5.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.608 1.163 . . . . 10.0 110.46 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.77 178.44 5.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.323 1.449 . . . . 10.0 110.62 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 m -143.13 0.63 1.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.314 -0.866 . . . . 10.0 112.456 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.6 m -148.07 80.41 8.7 Favored Pre-proline 0 N--CA 1.448 -0.551 0 O-C-N 120.589 -1.319 . . . . 10.0 108.06 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.87 98.39 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.972 3.115 . . . . 10.0 111.12 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -103.64 120.55 41.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.672 0.789 . . . . 10.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.87 140.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 ttm -145.08 149.0 34.29 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.667 0.787 . . . . 10.0 110.135 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -140.63 112.02 7.33 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.577 0.584 . . . . 10.0 112.577 -166.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -146.64 49.55 1.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.431 -1.418 . . . . 10.0 110.807 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -130.35 94.85 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.39 1.476 . . . . 10.0 108.92 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -68.79 85.38 0.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.885 1.674 . . . . 10.0 110.823 -163.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t 163.83 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.789 2.035 . . . . 10.0 107.784 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.11 84.37 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.722 -1.351 . . . . 10.0 109.722 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 -170.41 23.63 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.103 -1.599 . . . . 10.0 109.103 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.7 ttm -106.57 -136.98 0.36 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.611 0.764 . . . . 10.0 109.317 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.53 51.09 1.19 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.743 1.217 . . . . 10.0 108.075 -164.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 90.48 0.14 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.243 -1.543 . . . . 10.0 109.243 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.41 60.14 1.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.865 -1.161 . . . . 10.0 107.865 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -143.43 171.45 14.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.807 2.043 . . . . 10.0 107.921 -170.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 27.6 ttm -81.46 69.21 8.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.051 0.929 . . . . 10.0 110.482 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.04 163.99 14.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.326 1.05 . . . . 10.0 109.676 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -52.2 -36.77 68.38 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.552 2.168 . . . . 10.0 112.673 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 -156.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.75 2.02 . . . . 10.0 110.681 -164.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.16 131.26 47.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.645 -1.613 . . . . 10.0 106.645 162.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 m -95.67 106.05 18.11 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -85.16 109.71 23.11 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -88.21 52.22 2.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.368 1.379 . . . . 10.0 110.655 -167.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.44 163.85 0.14 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.74 0.781 . . . . 10.0 110.993 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.82 20.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.678 1.591 . . . . 10.0 112.718 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.31 69.77 1.09 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 124.935 1.255 . . . . 10.0 110.253 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -84.69 57.7 4.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -94.44 155.46 16.94 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.283 -175.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.1 t -126.05 117.16 22.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 -165.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.99 128.32 34.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.76 165.84 35.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.678 0.791 . . . . 10.0 109.4 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.433 HH12 ' CB ' ' A' ' 41' ' ' SER . 2.6 ttp180 -67.4 89.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.488 -0.758 . . . . 10.0 110.606 174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 131.02 -70.21 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 131.342 3.857 . . . . 10.0 108.112 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.02 71.23 0.96 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 125.448 1.499 . . . . 10.0 112.506 -167.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 66.61 138.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.41 1.884 . . . . 10.0 110.367 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -179.38 179.41 0.62 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.181 0.592 . . . . 10.0 110.789 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.3 t -114.84 128.79 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 156.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 77.1 mtp -82.25 94.2 7.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 166.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.84 65.5 7.0 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.193 -1.41 . . . . 10.0 107.193 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 21.0 ptm -84.71 179.57 7.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.274 1.035 . . . . 10.0 110.17 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 47.44 45.61 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.901 -1.28 . . . . 10.0 109.901 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.49 118.93 10.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.204 1.002 . . . . 10.0 109.18 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -61.57 2.43 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 117.443 0.111 . . . . 10.0 111.226 -171.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.1 mtt-85 -166.54 -59.58 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.23 1.412 . . . . 10.0 111.86 -162.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.25 69.6 7.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 120.848 1.339 . . . . 10.0 112.934 -165.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 56.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.261 -0.9 . . . . 10.0 111.875 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 96.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.217 -0.927 . . . . 10.0 109.258 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.63 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.471 1.108 . . . . 10.0 109.512 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.13 -10.05 5.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.324 -0.709 . . . . 10.0 113.003 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -78.82 -177.89 5.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.838 1.304 . . . . 10.0 108.369 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.0 m -150.9 131.55 13.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.758 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.55 141.42 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.378 1.471 . . . . 10.0 107.32 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -68.25 127.82 34.3 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.544 -0.722 . . . . 10.0 109.927 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 126' ' ' ILE . 8.6 tt -82.27 173.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.401 -1.703 . . . . 10.0 106.401 162.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 38.9 m -144.55 115.69 7.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.311 -0.868 . . . . 10.0 109.439 160.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 pp -87.7 173.0 9.28 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.829 0.307 . . . . 10.0 111.829 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -156.99 109.38 2.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.004 0.922 . . . . 10.0 108.972 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.55 126.34 32.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 160.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 t -79.86 62.5 4.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.754 0.788 . . . . 10.0 108.909 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.81 -65.86 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.727 2.411 . . . . 10.0 107.14 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 -79.11 0.45 Allowed Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.609 -0.723 . . . . 10.0 113.778 -167.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 -177.8 5.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.871 -0.782 . . . . 10.0 112.982 -175.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 m -128.74 142.26 51.06 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.48 3.512 . . . . 10.0 103.606 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.25 147.13 22.02 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -121.16 59.45 0.94 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.05 1.74 . . . . 10.0 110.088 -157.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.1 t -78.32 147.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -161.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.36 109.88 16.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.56 43.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.145 0.978 . . . . 10.0 110.527 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.8 m -83.51 126.79 33.15 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.669 0.388 . . . . 10.0 110.256 -177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.4 t -91.31 97.37 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.72 -1.956 . . . . 10.0 105.72 -173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 102.33 2.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.766 -0.584 . . . . 10.0 110.753 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.339 0.135 0 C-N-CA 124.58 1.152 . . . . 10.0 110.266 162.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 122.027 0.918 . . . . 10.0 112.083 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.4 p -153.91 54.2 0.71 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.667 1.587 . . . . 10.0 107.209 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -83.66 63.51 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -137.19 154.21 50.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.831 1.252 . . . . 10.0 110.967 -169.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.91 136.79 13.68 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.913 -2.075 . . . . 10.0 107.913 168.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.59 25.3 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.605 1.203 . . . . 10.0 109.995 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 p -134.56 141.75 46.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.2 134.04 67.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.69 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 36.08 -122.55 0.15 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.933 1.693 . . . . 10.0 111.031 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.48 109.69 58.12 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.963 0.905 . . . . 10.0 108.85 169.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.57 163.45 27.19 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.959 2.439 . . . . 10.0 110.394 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.42 61.0 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.914 2.41 . . . . 10.0 109.421 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -160.49 47.8 0.24 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.379 1.072 . . . . 10.0 108.522 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.9 mm 75.45 167.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.444 1.498 . . . . 10.0 109.17 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.436 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -58.2 -26.7 63.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.95 0.722 . . . . 10.0 112.95 -177.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.91 140.12 1.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.632 2.373 . . . . 10.0 110.807 172.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -159.98 -178.63 7.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.14 157.85 43.24 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.401 0.68 . . . . 10.0 110.654 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.7 150.3 25.21 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 124.001 0.813 . . . . 10.0 110.097 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -128.45 103.62 7.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.442 -2.059 . . . . 10.0 105.442 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -159.82 -176.67 5.84 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.969 0.508 . . . . 10.0 110.909 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -133.71 122.9 24.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.14 0.976 . . . . 10.0 111.501 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mp -80.52 132.45 35.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.214 -2.513 . . . . 10.0 104.214 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -130.56 104.76 7.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 124.58 1.175 . . . . 10.0 107.982 -160.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.82 130.34 35.03 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 117.804 0.274 . . . . 10.0 111.199 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -140.93 59.29 1.54 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -168.02 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.015 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 65.9 78.46 0.27 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.253 1.421 . . . . 10.0 111.512 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -146.22 154.72 50.25 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.732 1.613 . . . . 10.0 108.533 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.52 72.93 6.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.651 2.901 . . . . 10.0 111.768 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.4 115.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -89.11 144.73 25.92 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.477 -0.765 . . . . 10.0 109.372 168.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -121.99 126.83 49.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 56.63 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.876 0.845 . . . . 10.0 110.044 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.98 150.77 21.21 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.004 -1.238 . . . . 10.0 110.004 163.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.08 58.84 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.252 1.021 . . . . 10.0 108.805 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.82 139.74 31.7 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.898 -0.501 . . . . 10.0 109.791 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 t -160.76 145.6 10.69 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.94 57.37 4.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.178 2.586 . . . . 10.0 109.878 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 tt -139.74 -63.06 0.51 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.357 1.463 . . . . 10.0 107.849 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.74 146.71 27.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.674 1.19 . . . . 10.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.1 m -82.07 -38.32 25.08 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.725 0.81 . . . . 10.0 109.196 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.61 80.13 39.23 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.012 0.925 . . . . 10.0 110.182 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.74 92.93 1.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.829 2.353 . . . . 10.0 109.993 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.7 mtt -103.62 131.18 51.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.598 1.159 . . . . 10.0 110.115 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.76 144.62 29.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.482 1.113 . . . . 10.0 109.087 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.5 ttm -146.27 157.78 43.83 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.431 0.692 . . . . 10.0 110.775 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 13.0 t -155.1 107.13 2.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.873 0.844 . . . . 10.0 112.531 -162.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 t -146.2 57.98 1.21 Allowed 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.793 -1.192 . . . . 10.0 111.023 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -150.24 93.46 2.0 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.277 1.431 . . . . 10.0 109.829 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -32.09 -46.06 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 128.682 2.793 . . . . 10.0 113.27 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -54.91 -23.59 19.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.267 1.427 . . . . 10.0 114.032 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.85 -50.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.437 -1.065 . . . . 10.0 110.437 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.93 -162.63 32.21 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.271 0.938 . . . . 10.0 111.621 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 ttt -81.72 -159.79 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.415 0.686 . . . . 10.0 109.3 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.579 1.152 . . . . 10.0 108.078 -167.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.28 108.86 0.36 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.015 -1.634 . . . . 10.0 109.015 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.88 65.6 1.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 10.0 109.86 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -125.63 165.1 19.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.343 2.257 . . . . 10.0 109.718 -170.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 35.2 ttm -81.47 72.82 8.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.879 0.847 . . . . 10.0 109.93 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 76' ' ' THR . 16.3 m -63.03 159.33 47.86 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.938 0.895 . . . . 10.0 111.195 173.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 95.3 Cg_endo -61.85 -30.86 84.8 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.907 2.404 . . . . 10.0 112.507 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 90' ' ' PRO . 44.4 p90 177.88 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.797 2.439 . . . . 10.0 105.344 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -128.14 115.72 18.84 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.58 0.705 . . . . 10.0 110.959 168.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 m -78.27 126.5 30.88 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.7 pt -100.77 103.07 22.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.182 0.901 . . . . 10.0 109.043 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.86 70.19 6.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.227 1.951 . . . . 10.0 111.347 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 60.43 168.96 0.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.611 -0.68 . . . . 10.0 109.796 -163.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 41.59 31.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.768 1.766 . . . . 10.0 115.768 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.05 72.26 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 124.41 1.005 . . . . 10.0 113.209 167.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -107.26 57.23 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.518 -1.66 . . . . 10.0 106.518 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -93.73 151.9 19.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.546 1.138 . . . . 10.0 108.1 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.6 m -119.19 117.13 27.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.885 -1.894 . . . . 10.0 105.885 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.31 102.17 10.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.217 -2.142 . . . . 10.0 105.217 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.02 156.77 48.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.463 1.505 . . . . 10.0 110.428 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -48.96 -42.99 39.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.287 1.035 . . . . 10.0 112.303 -166.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -114.31 29.84 7.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.771 0.828 . . . . 10.0 111.897 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.18 69.13 0.19 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 121.346 -0.847 . . . . 10.0 111.387 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 10.2 t70 64.96 138.99 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 126.381 1.872 . . . . 10.0 110.524 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -178.09 179.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 10.0 111.149 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -110.86 122.0 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 162.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 67.2 mtp -83.86 100.24 10.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 165.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.19 73.24 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.5 154.64 20.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.966 0.906 . . . . 10.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.27 66.34 2.24 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.93 141.68 44.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.344 0.658 . . . . 10.0 112.106 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -86.44 -48.65 8.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 10.0 112.549 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -144.48 158.94 53.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.624 0.77 . . . . 10.0 110.559 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -67.65 160.51 47.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.559 2.84 . . . . 10.0 111.911 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.42 159.61 41.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.769 1.628 . . . . 10.0 108.179 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -113.16 144.43 42.68 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.615 0.643 . . . . 10.0 109.503 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.88 104.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 165.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.68 -13.73 6.46 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.166 -0.797 . . . . 10.0 111.61 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -178.25 3.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.787 1.755 . . . . 10.0 109.119 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.0 m -155.56 131.36 9.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.031 -1.895 . . . . 10.0 107.708 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.66 149.57 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -84.71 130.99 34.62 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -103.99 130.24 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.077 0.951 . . . . 10.0 109.147 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 m -103.1 107.46 18.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 166.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.29 154.3 26.62 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 160.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -150.23 90.15 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.27 143.31 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -50.54 -36.32 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.44 1.096 . . . . 10.0 110.876 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -70.11 44.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 10.0 112.649 173.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.04 48.54 38.61 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.219 1.866 . . . . 10.0 113.206 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -110.57 146.75 35.54 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 171.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.0 m -156.41 101.32 2.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.742 2.017 . . . . 10.0 105.659 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -112.05 -178.46 3.43 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.843 0.747 . . . . 10.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -149.93 64.03 0.98 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.744 2.017 . . . . 10.0 108.614 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.73 156.74 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.12 130.77 35.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.81 112.55 23.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.698 1.199 . . . . 10.0 109.222 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 m -83.86 125.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.7 112.84 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -158.09 125.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.686 -0.673 . . . . 10.0 109.693 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.0 mmmt . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 126.289 1.836 . . . . 10.0 110.025 176.109 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.5 m . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 122.365 1.079 . . . . 10.0 109.301 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.8 p -156.75 82.72 0.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.214 -0.903 . . . . 10.0 108.694 -165.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 55.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 123.113 1.435 . . . . 10.0 107.377 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -83.89 129.94 34.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.721 -1.582 . . . . 10.0 107.05 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.66 -39.06 78.14 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.708 -0.557 . . . . 10.0 111.708 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 68.73 116.84 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.736 2.414 . . . . 10.0 113.33 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p -116.28 91.92 3.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.577 1.951 . . . . 10.0 108.789 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.445 -0.946 . . . . 10.0 108.445 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.92 42.92 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.67 -133.94 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.347 1.459 . . . . 10.0 110.208 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.4 t -104.05 110.75 64.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 160.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.89 172.04 10.24 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.115 2.543 . . . . 10.0 108.93 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.02 59.6 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 10.0 109.882 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -157.8 50.88 0.43 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 10.0 109.844 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.7 mm 66.36 174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.869 0.868 . . . . 10.0 110.291 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.582 ' H ' HG22 ' A' ' 42' ' ' ILE . 8.1 tpp180 -69.07 22.85 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.245 1.418 . . . . 10.0 114.379 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.486 ' CG ' HH21 ' A' ' 104' ' ' ARG . 0.0 OUTLIER -94.45 157.62 15.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.807 1.185 . . . . 10.0 108.161 168.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -172.5 179.73 2.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.39 -1.707 . . . . 10.0 106.39 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.91 173.29 16.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.385 0.274 . . . . 10.0 111.004 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.14 149.22 26.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 125.202 1.564 . . . . 10.0 109.056 165.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.28 71.1 1.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.549 1.14 . . . . 10.0 108.237 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -174.06 4.76 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.79 1.236 . . . . 10.0 109.417 -159.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -123.94 141.26 52.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.041 1.292 . . . . 10.0 109.598 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 150.18 25.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.314 -1.736 . . . . 10.0 106.314 161.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -140.42 118.11 11.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.219 0.949 . . . . 10.0 110.879 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.27 132.91 37.7 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.77 58.6 1.72 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.745 -1.205 . . . . 10.0 107.745 166.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -163.9 -46.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.267 1.027 . . . . 10.0 109.594 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . 0.318 95.4 m-20 67.01 54.91 0.73 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.474 1.91 . . . . 10.0 110.583 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -131.23 150.87 77.73 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.425 1.89 . . . . 10.0 107.803 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.16 86.27 1.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.542 2.828 . . . . 10.0 111.275 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.15 119.61 59.49 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -83.87 150.66 25.58 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.681 0.392 . . . . 10.0 110.431 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.21 143.42 50.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.847 -0.797 . . . . 10.0 108.847 173.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 p -151.62 56.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.08 145.67 11.57 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.299 -1.12 . . . . 10.0 110.299 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.09 69.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.49 107.41 15.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.325 -1.361 . . . . 10.0 107.325 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -125.22 146.39 53.84 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.652 0.781 . . . . 10.0 110.494 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.1 -12.27 19.43 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.85 2.367 . . . . 10.0 110.985 166.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 tp -80.97 -57.26 3.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.328 0.967 . . . . 10.0 111.507 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.96 139.68 38.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.07 0.948 . . . . 10.0 112.297 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 m -75.86 -42.03 50.65 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.384 -0.823 . . . . 10.0 110.144 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.96 81.94 50.41 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.947 0.899 . . . . 10.0 109.391 -167.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.01 86.34 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.66 2.907 . . . . 10.0 110.527 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.58 127.58 34.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.08 141.63 31.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.5 ttm -148.96 157.85 43.73 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.665 0.786 . . . . 10.0 110.063 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 89' ' ' VAL . 6.7 t -155.11 102.38 2.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.561 0.696 . . . . 10.0 112.546 -157.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 86' ' ' MET . 8.8 t -150.58 53.98 0.89 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.812 -1.18 . . . . 10.0 113.13 168.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -116.22 100.57 8.01 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.918 1.287 . . . . 10.0 109.054 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -46.65 -44.86 18.77 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 126.167 1.787 . . . . 10.0 111.871 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 t -82.96 23.25 0.85 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.05 -67.16 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.535 1.061 . . . . 10.0 111.111 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.87 96.76 0.44 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.391 1.472 . . . . 10.0 111.765 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.88 -159.4 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.258 1.823 . . . . 10.0 114.014 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.21 39.0 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.882 0.873 . . . . 10.0 109.54 -166.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.63 105.95 0.27 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.445 ' HB2' HG21 ' A' ' 77' ' ' THR . 1.2 tmm? -77.47 55.42 1.27 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.306 1.042 . . . . 10.0 110.844 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.96 165.44 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.831 2.052 . . . . 10.0 109.379 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.6 ttm -81.89 69.78 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.312 1.053 . . . . 10.0 110.334 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 76' ' ' THR . 16.5 m -60.07 165.02 5.32 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.469 1.907 . . . . 10.0 111.741 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.48 -38.63 54.31 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.333 2.689 . . . . 10.0 113.579 164.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -165.8 0.04 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.987 1.315 . . . . 10.0 112.512 -161.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.2 116.18 25.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.068 1.347 . . . . 10.0 108.012 159.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.3 m -83.34 136.87 34.2 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.1 140.44 38.09 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.26 -178.19 4.44 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.354 2.036 . . . . 10.0 111.456 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.17 139.56 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 151.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 58.67 17.32 4.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.822 1.045 . . . . 10.0 113.822 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.94 97.45 0.25 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.064 -1.614 . . . . 10.0 109.064 166.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -138.72 79.35 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.876 -2.268 . . . . 10.0 104.876 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 pp -103.37 -177.0 3.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.56 -0.745 . . . . 10.0 110.494 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 99.58 6.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.817 1.647 . . . . 10.0 106.792 -165.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.88 93.7 5.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -118.97 140.09 50.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.804 2.042 . . . . 10.0 108.259 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 44' ' ' ASP . 4.5 tmt_? -55.33 -21.3 14.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 -167.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -90.25 -71.62 0.61 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.487 1.515 . . . . 10.0 109.749 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.45 80.9 1.6 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.596 1.57 . . . . 10.0 111.524 -166.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 64.46 133.67 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.74 0 C-N-CA 126.0 1.72 . . . . 10.0 110.37 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -178.17 178.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.752 -1.218 . . . . 10.0 111.629 -169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.48 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 162.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.8 mtp -81.76 98.27 8.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.376 -1.712 . . . . 10.0 106.376 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.11 67.55 9.2 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.927 1.291 . . . . 10.0 108.34 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.1 mtp -84.38 157.09 21.55 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.921 0.867 . . . . 10.0 111.601 -166.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.02 60.7 3.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.554 -1.018 . . . . 10.0 110.554 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.23 129.95 44.23 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.612 0.706 . . . . 10.0 111.9 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -105.2 -59.61 1.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.472 1.509 . . . . 10.0 110.83 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -59.58 142.47 87.44 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.5 132.8 32.3 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.107 1.871 . . . . 10.0 109.526 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.435 ' H ' ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.83 161.16 29.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.108 0.563 . . . . 10.0 111.52 175.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 120.19 3.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.473 -2.047 . . . . 10.0 105.473 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.37 116.54 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.3 62.72 1.7 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.206 -1.957 . . . . 10.0 108.206 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -133.35 -172.99 3.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 159.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.9 m -152.54 123.25 7.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.388 -1.278 . . . . 10.0 107.894 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.59 126.67 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.423 1.089 . . . . 10.0 108.528 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -70.82 128.18 35.15 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 pt -114.43 148.04 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.245 1.418 . . . . 10.0 107.877 168.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -110.24 133.49 53.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.001 0.92 . . . . 10.0 109.114 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 129' ' ' LYS . 1.1 tt -83.65 155.58 23.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.024 -1.473 . . . . 10.0 107.024 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.473 ' H ' HD23 ' A' ' 128' ' ' LEU . 82.5 tttt -155.43 86.09 1.07 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.643 -1.243 . . . . 10.0 107.643 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.63 25.96 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.028 -0.42 . . . . 10.0 110.059 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.8 t -54.26 -31.57 53.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.802 1.241 . . . . 10.0 112.108 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.78 -32.8 14.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.664 1.186 . . . . 10.0 112.896 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 104.19 8.66 38.23 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.082 1.325 . . . . 10.0 110.046 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 95.3 8.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.1 t -83.87 147.93 27.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.098 -0.955 . . . . 10.0 108.498 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tp -157.03 174.91 14.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -134.78 139.22 44.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.62 140.0 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.51 98.63 10.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.685 -0.858 . . . . 10.0 108.685 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.98 123.36 29.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.957 0.903 . . . . 10.0 110.36 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -83.75 137.51 33.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.41 112.27 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -148.57 107.48 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.084 0.954 . . . . 10.0 109.58 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? . . . . . 0 N--CA 1.461 0.121 0 C-N-CA 123.744 0.817 . . . . 10.0 113.012 -177.279 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 122.178 0.989 . . . . 10.0 110.86 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -153.11 59.47 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -162.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.53 55.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.38 138.27 37.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.238 1.015 . . . . 10.0 108.482 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.55 -136.06 4.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.798 -2.121 . . . . 10.0 107.798 163.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.91 143.68 14.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.998 0.899 . . . . 10.0 109.802 162.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.2 p -133.59 153.58 51.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.142 -1.799 . . . . 10.0 106.142 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -128.08 138.93 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 125.128 1.371 . . . . 10.0 107.372 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.07 37.76 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.128 0.788 . . . . 10.0 113.128 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 31.86 -124.99 0.05 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.337 1.855 . . . . 10.0 110.456 -161.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.61 112.13 58.84 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 105.927 -1.879 . . . . 10.0 105.927 162.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 160.48 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.977 1.785 . . . . 10.0 108.68 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.17 61.73 5.85 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.523 2.148 . . . . 10.0 110.615 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -163.42 62.22 0.17 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.427 1.091 . . . . 10.0 108.264 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt 77.07 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.52 1.528 . . . . 10.0 110.339 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 39.03 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.196 0.998 . . . . 10.0 113.509 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 158.43 16.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.305 -1.368 . . . . 10.0 107.305 161.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 t -156.62 -169.15 2.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.89 -1.522 . . . . 10.0 106.89 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.96 160.46 42.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.999 -1.111 . . . . 10.0 107.999 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.43 161.8 22.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 165.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -134.73 102.47 5.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.762 -1.57 . . . . 10.0 106.762 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -170.0 2.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.747 2.019 . . . . 10.0 109.503 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m -147.85 124.77 11.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.371 -1.456 . . . . 10.0 109.049 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.16 129.56 34.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 171.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -121.65 95.53 4.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.022 0.826 . . . . 10.0 110.302 -158.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.26 58.62 1.65 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.015 1.388 . . . . 10.0 112.454 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 174.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -179.98 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.95 1.093 . . . . 10.0 113.95 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.13 84.76 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.456 1.503 . . . . 10.0 112.164 -167.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -147.59 144.32 19.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.011 0.925 . . . . 10.0 109.729 165.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -88.14 100.62 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.813 3.009 . . . . 10.0 111.485 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.59 103.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.815 0.846 . . . . 10.0 109.299 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 96.78 8.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.029 -1.044 . . . . 10.0 110.019 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.02 124.44 29.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.386 0.674 . . . . 10.0 109.906 -175.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.69 54.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 122.265 1.031 . . . . 10.0 109.535 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.23 145.33 11.06 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.79 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.895 1.678 . . . . 10.0 107.296 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.18 149.08 29.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -169.65 151.87 4.46 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 -164.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.72 -3.55 13.36 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.736 2.291 . . . . 10.0 111.964 167.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -101.79 -40.51 6.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.512 1.125 . . . . 10.0 113.437 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.31 126.23 46.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.443 1.097 . . . . 10.0 110.046 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 m -72.81 -30.66 64.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.327 0.651 . . . . 10.0 109.783 172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 m -131.13 67.75 81.01 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 124.983 1.313 . . . . 10.0 110.105 -171.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.39 114.12 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.752 2.301 . . . . 10.0 110.527 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -141.07 141.66 34.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.886 0.474 . . . . 10.0 110.815 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.95 149.81 26.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.727 1.211 . . . . 10.0 109.781 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.69 169.32 21.89 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.474 1.51 . . . . 10.0 109.88 -171.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 t -143.8 158.77 43.45 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 121.203 -0.199 . . . . 10.0 110.884 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.42 59.55 0.63 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.435 -0.791 . . . . 10.0 109.201 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -155.56 130.91 9.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -71.34 -39.69 71.18 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -44.61 96.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.602 1.161 . . . . 10.0 111.488 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.96 -129.01 3.35 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.051 -0.82 . . . . 10.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -69.57 1.25 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.528 0.585 . . . . 10.0 113.339 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -170.01 163.83 9.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.282 1.033 . . . . 10.0 109.592 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.68 54.41 2.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.08 67.05 0.56 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.483 -0.647 . . . . 10.0 111.483 -156.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.07 64.27 5.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.067 0.937 . . . . 10.0 110.069 -171.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -136.4 168.67 19.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.008 2.123 . . . . 10.0 109.394 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 61.4 mtp -81.35 73.76 8.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.57 0.7 . . . . 10.0 109.355 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.49 159.8 83.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.513 -0.767 . . . . 10.0 110.731 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -42.92 -52.2 4.86 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.634 2.889 . . . . 10.0 112.099 163.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.48 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 173.4 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 127.195 2.198 . . . . 10.0 108.52 -175.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.0 mm? -128.5 138.92 52.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 161.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -84.99 98.56 10.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.261 -1.755 . . . . 10.0 106.261 160.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.51 121.97 80.38 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.104 -1.813 . . . . 10.0 106.104 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.15 -173.98 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.621 2.214 . . . . 10.0 111.774 -166.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.88 149.3 1.87 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 154.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.5 6.96 0.12 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.112 1.365 . . . . 10.0 114.156 -166.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.29 84.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -109.7 61.18 0.6 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.337 1.455 . . . . 10.0 107.782 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mp -86.07 154.07 21.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.683 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.0 p -114.47 110.85 20.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.45 -2.056 . . . . 10.0 105.45 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.78 109.51 16.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.291 -2.114 . . . . 10.0 105.291 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.45 170.12 22.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.212 0.915 . . . . 10.0 111.12 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.55 -45.81 0.37 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.567 1.147 . . . . 10.0 112.622 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.91 98.47 3.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.729 1.612 . . . . 10.0 106.776 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.83 116.46 1.12 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.803 1.668 . . . . 10.0 110.296 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 23.86 65.64 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.078 2.951 . . . . 10.0 114.184 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -119.14 164.8 15.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -164.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.0 121.01 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 47.9 mtp -83.19 99.47 9.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.49 -1.3 . . . . 10.0 107.49 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.17 58.74 3.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 171.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 40.8 ttp -84.57 161.8 20.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.566 1.146 . . . . 10.0 110.784 -168.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.13 -4.32 30.11 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.059 -1.411 . . . . 10.0 114.809 155.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 tp 47.41 89.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.253 1.821 . . . . 10.0 113.054 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -96.05 -40.47 9.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.443 1.097 . . . . 10.0 110.534 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.75 152.66 68.78 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 105.765 -1.939 . . . . 10.0 105.765 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -57.8 120.71 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.825 2.35 . . . . 10.0 111.725 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.16 73.65 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -74.39 104.9 5.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.859 1.264 . . . . 10.0 109.765 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 p -42.0 116.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.551 1.141 . . . . 10.0 111.425 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 116.46 -27.82 7.82 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.999 -0.89 . . . . 10.0 111.196 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -173.82 3.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.67 1.7 . . . . 10.0 110.082 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.7 m -150.35 130.26 13.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.371 -1.74 . . . . 10.0 107.749 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.03 134.11 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.383 1.073 . . . . 10.0 108.537 -170.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.76 110.87 8.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 pt -85.27 -179.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 160.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.0 m -147.08 121.53 9.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.403 -0.811 . . . . 10.0 109.147 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.3 177.52 7.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.654 0.381 . . . . 10.0 111.441 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -156.95 99.48 1.83 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.596 1.558 . . . . 10.0 107.96 171.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.82 33.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.949 -0.469 . . . . 10.0 109.89 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.2 t -82.94 61.36 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -169.54 -60.1 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 129.08 2.952 . . . . 10.0 105.482 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.42 -92.27 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.687 -1.142 . . . . 10.0 111.61 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -160.55 173.22 15.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.813 -0.816 . . . . 10.0 109.739 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 t -94.49 144.73 25.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.145 -1.798 . . . . 10.0 106.145 153.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.3 tp -156.45 143.76 19.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -87.97 132.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.955 1.702 . . . . 10.0 106.918 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.39 125.66 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.586 -1.265 . . . . 10.0 107.586 -164.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 111.37 18.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.029 -0.73 . . . . 10.0 109.029 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.08 119.17 38.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.079 0.952 . . . . 10.0 110.496 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -83.62 126.89 33.31 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.865 0.466 . . . . 10.0 110.387 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.25 110.29 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.628 -1.249 . . . . 10.0 107.628 -165.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -158.11 150.24 21.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.095 0.861 . . . . 10.0 110.86 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.222 -0.344 0 CA-C-N 119.113 0.87 . . . . 10.0 112.573 175.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 CA--C 1.532 0.255 0 CA-C-O 121.029 0.442 . . . . 10.0 110.833 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 p -156.48 53.34 0.54 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.315 0.646 . . . . 10.0 110.181 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.74 80.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 165.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.49 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -123.91 133.08 53.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 128.252 2.621 . . . . 10.0 108.407 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.06 97.09 1.29 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.27 -1.532 . . . . 10.0 109.27 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.12 9.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.705 0.753 . . . . 10.0 111.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.3 p -115.96 149.61 38.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.737 -1.208 . . . . 10.0 107.737 163.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.96 142.16 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.46 16.97 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.832 0.825 . . . . 10.0 111.044 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.792 1.637 . . . . 10.0 110.811 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 t 45.45 74.66 0.76 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.741 1.616 . . . . 10.0 111.144 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.26 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.296 2.664 . . . . 10.0 110.044 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.16 77.68 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.801 3.001 . . . . 10.0 112.473 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 t -157.11 -49.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.374 3.07 . . . . 10.0 106.008 165.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 67.56 162.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 C-N-CA 125.615 1.566 . . . . 10.0 107.438 -161.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 72.79 -50.18 0.7 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.428 1.491 . . . . 10.0 111.89 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.23 155.64 16.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.008 1.723 . . . . 10.0 109.69 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -164.41 -176.73 4.52 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 10.0 108.045 162.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 153.91 34.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.487 1.115 . . . . 10.0 110.73 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.59 150.03 22.58 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.073 0.858 . . . . 10.0 110.442 170.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -125.0 123.75 40.53 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -160.66 -172.41 3.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.228 1.411 . . . . 10.0 107.701 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 m -144.86 122.59 11.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.444 -0.785 . . . . 10.0 109.598 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.42 102.77 10.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.332 -1.729 . . . . 10.0 106.332 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 m -92.56 94.16 8.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.651 -1.613 . . . . 10.0 106.653 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.86 56.03 3.27 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.79 -0.569 . . . . 10.0 110.434 -167.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -91.76 111.09 22.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.34 0.59 . . . . 10.0 109.5 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 133.27 -19.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 131.564 3.946 . . . . 10.0 106.942 -165.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.78 61.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.638 -1.245 . . . . 10.0 107.638 150.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -145.04 137.45 13.4 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.319 1.848 . . . . 10.0 110.633 -170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.69 92.83 0.94 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 10.0 112.212 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.77 112.11 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.957 0.903 . . . . 10.0 108.924 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 168.64 17.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.675 0.79 . . . . 10.0 110.48 174.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -132.93 127.78 35.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.41 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.522 0.677 . . . . 10.0 109.755 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.4 147.25 13.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.191 -1.164 . . . . 10.0 110.191 163.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.22 66.95 0.51 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.019 1.327 . . . . 10.0 109.665 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.48 145.04 28.34 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.706 -0.849 . . . . 10.0 108.706 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 t -170.35 151.58 3.8 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 118.943 0.792 . . . . 10.0 110.47 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.86 45.79 0.96 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.992 2.461 . . . . 10.0 111.323 166.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.16 -77.28 0.47 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.929 1.291 . . . . 10.0 108.609 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.92 143.53 55.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.032 0.533 . . . . 10.0 110.948 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 m -96.72 -29.22 13.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.609 0.763 . . . . 10.0 109.64 165.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.0 t -126.03 67.41 61.86 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.074 1.75 . . . . 10.0 109.092 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.73 106.1 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.679 2.253 . . . . 10.0 109.777 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 128.56 53.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.222 1.009 . . . . 10.0 109.478 -174.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.73 136.8 35.44 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.229 -1.026 . . . . 10.0 108.229 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 ttp -136.07 152.44 50.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.055 1.342 . . . . 10.0 108.812 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -148.19 110.24 4.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.413 0.685 . . . . 10.0 110.058 -166.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -141.41 55.95 1.53 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.447 -0.783 . . . . 10.0 111.828 175.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -137.2 110.57 7.92 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.039 1.336 . . . . 10.0 109.093 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -52.27 -42.65 63.87 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.461 1.104 . . . . 10.0 111.195 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.3 p -82.45 16.53 2.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.901 1.28 . . . . 10.0 112.334 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.95 -142.99 5.2 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.396 1.474 . . . . 10.0 110.1 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.01 -68.63 1.58 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 117.169 0.484 . . . . 10.0 112.266 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -144.67 169.9 17.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.568 1.547 . . . . 10.0 108.24 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -117.71 54.5 0.9 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.93 75.01 0.22 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 118.742 -1.032 . . . . 10.0 111.591 -166.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 ttp -49.36 98.36 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 122.324 1.059 . . . . 10.0 111.717 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -155.76 166.53 33.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.274 2.229 . . . . 10.0 105.955 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.8 mtm -80.82 132.62 35.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.031 -1.47 . . . . 10.0 107.031 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -134.64 168.22 18.91 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.733 . . . . 10.0 110.668 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -37.74 -56.4 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.63 2.887 . . . . 10.0 111.464 159.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 178.47 -159.27 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.47 1.508 . . . . 10.0 110.258 -175.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -124.54 142.78 51.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 126.386 1.874 . . . . 10.0 106.362 161.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m -110.47 134.87 51.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.005 -1.85 . . . . 10.0 106.005 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 pp -121.83 138.94 29.31 Favored Pre-proline 0 N--CA 1.452 -0.35 0 N-CA-C 106.679 -1.601 . . . . 10.0 106.679 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.87 176.48 8.94 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.862 1.708 . . . . 10.0 110.699 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.6 129.74 8.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.88 -1.054 . . . . 10.0 109.63 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 59.15 26.27 14.97 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 129.674 3.19 . . . . 10.0 113.342 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.69 144.71 45.96 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.965 -0.854 . . . . 10.0 110.965 167.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -129.21 65.42 1.46 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.572 -2.01 . . . . 10.0 105.572 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.25 129.25 34.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.943 -2.243 . . . . 10.0 104.943 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.8 m -123.45 93.45 3.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.013 -2.217 . . . . 10.0 105.013 -158.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.82 122.45 26.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 -162.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -151.86 154.33 35.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.956 1.303 . . . . 10.0 108.47 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -8.53 6.91 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.507 1.299 . . . . 10.0 114.507 -164.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 37.67 1.48 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.812 0.733 . . . . 10.0 110.979 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.45 64.97 0.22 Allowed Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.37 -1.092 . . . . 10.0 110.37 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 t0 70.01 133.78 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.199 1.799 . . . . 10.0 109.748 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -177.19 169.82 2.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.574 -0.704 . . . . 10.0 110.728 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.95 115.64 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.527 -2.027 . . . . 10.0 105.527 169.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 81.5 mtp -83.84 95.92 8.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.88 65.39 6.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 10.0 107.891 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 75.8 mtp -82.6 162.53 21.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.847 0.832 . . . . 10.0 110.782 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.99 69.66 1.38 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.429 -1.068 . . . . 10.0 110.429 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.33 82.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.672 0.789 . . . . 10.0 109.611 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -55.92 -47.25 77.85 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.892 -0.505 . . . . 10.0 112.084 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -114.05 155.5 45.34 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.937 -1.135 . . . . 10.0 107.937 157.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.56 173.83 12.65 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.447 2.765 . . . . 10.0 110.034 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.38 175.37 8.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.144 1.378 . . . . 10.0 110.113 -174.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.31 150.3 49.65 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.36 1.464 . . . . 10.0 107.953 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.8 t -69.79 134.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.46 42.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.074 -0.81 . . . . 10.0 111.074 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.64 -169.37 1.7 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.84 1.305 . . . . 10.0 108.813 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 m -154.74 82.78 1.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.027 -1.472 . . . . 10.0 107.027 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -89.83 126.49 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.883 -1.154 . . . . 10.0 107.883 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.31 150.88 45.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.102 -0.639 . . . . 10.0 110.372 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.98 148.61 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.379 -1.712 . . . . 10.0 106.379 170.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -123.15 117.59 25.72 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.79 157.04 18.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.481 -0.563 . . . . 10.0 109.481 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -157.38 86.23 0.94 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.578 1.551 . . . . 10.0 107.895 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.74 157.61 23.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.096 -0.377 . . . . 10.0 110.046 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 t -54.36 -32.77 57.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.523 1.129 . . . . 10.0 112.504 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -5.74 4.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.918 0.887 . . . . 10.0 113.063 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.21 9.67 65.07 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.404 1.002 . . . . 10.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -79.34 95.1 5.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 105.916 -1.883 . . . . 10.0 105.916 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -116.37 123.97 48.91 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.076 1.751 . . . . 10.0 107.141 -171.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.4 tp -155.55 141.59 18.28 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -102.52 132.98 48.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.477 1.911 . . . . 10.0 106.742 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.87 162.14 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.05 131.86 54.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.868 1.267 . . . . 10.0 107.604 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.77 133.81 55.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.643 1.177 . . . . 10.0 109.892 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -83.89 128.33 34.47 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.87 108.1 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.324 -1.362 . . . . 10.0 107.324 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -157.58 125.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.582 -0.895 . . . . 10.0 108.582 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 pttt . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.37 0.605 . . . . 10.0 111.357 176.298 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 121.785 0.803 . . . . 10.0 111.168 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -157.85 55.17 0.48 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 -165.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.57 58.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.11 0.957 . . . . 10.0 108.981 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.432 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -97.9 -179.91 4.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.112 1.365 . . . . 10.0 110.396 171.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.0 -136.92 3.51 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.056 -2.418 . . . . 10.0 107.056 166.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.98 132.4 6.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.981 1.39 . . . . 10.0 110.683 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.7 p -126.76 135.2 50.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.288 -1.745 . . . . 10.0 106.288 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.7 t -121.71 135.29 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 119.158 0.89 . . . . 10.0 109.061 -171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.83 44.62 0.56 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.631 0.974 . . . . 10.0 113.631 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 26.77 -119.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.643 1.977 . . . . 10.0 111.546 -164.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.69 113.94 50.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.093 -1.817 . . . . 10.0 106.093 161.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.97 163.99 20.65 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.17 1.913 . . . . 10.0 108.774 168.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.92 62.41 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.449 2.1 . . . . 10.0 110.523 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.5 p -163.4 62.31 0.17 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.209 1.004 . . . . 10.0 108.628 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 mt 75.15 160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.932 1.293 . . . . 10.0 110.222 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -66.76 25.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.741 1.386 . . . . 10.0 114.741 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.95 158.44 15.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 168.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -165.39 -175.54 3.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.728 -1.953 . . . . 10.0 105.728 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.56 168.98 24.93 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.319 -0.622 . . . . 10.0 109.319 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.47 161.09 22.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -131.4 104.7 7.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.632 -1.988 . . . . 10.0 105.632 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -171.16 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.139 1.775 . . . . 10.0 110.443 -169.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -152.29 129.57 11.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.718 -1.238 . . . . 10.0 108.029 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.11 135.44 33.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 m -123.96 104.27 8.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 124.168 0.918 . . . . 10.0 110.581 -167.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.18 113.18 15.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.706 -0.479 . . . . 10.0 109.706 167.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -135.36 68.44 1.46 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.668 -1.604 . . . . 10.0 106.668 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -178.5 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.388 1.475 . . . . 10.0 111.473 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 72.72 78.13 0.15 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.551 1.94 . . . . 10.0 112.17 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -143.16 147.0 38.97 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.331 0.652 . . . . 10.0 109.817 168.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.513 ' C ' HD12 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -86.29 112.23 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.759 2.973 . . . . 10.0 111.001 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 58' ' ' PRO . 1.7 mp -123.92 99.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.71 103.94 12.59 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.109 -0.994 . . . . 10.0 111.139 -173.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -82.68 124.95 30.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.697 0.799 . . . . 10.0 110.201 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.66 54.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.117 0.961 . . . . 10.0 109.626 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.65 144.49 10.0 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -1.323 . . . . 10.0 109.792 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.45 66.73 0.56 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.972 1.709 . . . . 10.0 107.205 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 148.71 28.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 t -170.3 151.78 3.9 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 109.879 -0.415 . . . . 10.0 109.879 -164.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.28 -1.41 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.802 2.335 . . . . 10.0 112.021 167.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -104.82 -35.91 7.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.471 1.108 . . . . 10.0 113.415 -163.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.43 124.29 48.97 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.558 1.143 . . . . 10.0 109.844 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -29.79 65.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.795 0.838 . . . . 10.0 110.108 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.7 m -135.36 68.43 68.14 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.024 1.33 . . . . 10.0 109.959 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.1 115.76 4.22 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.616 2.21 . . . . 10.0 110.365 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -139.34 140.4 37.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.821 0.448 . . . . 10.0 111.203 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mt -83.57 145.83 28.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 10.0 109.8 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.65 169.37 18.12 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 125.596 1.558 . . . . 10.0 109.817 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 t -145.71 157.44 43.95 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.318 -0.238 . . . . 10.0 110.677 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.54 61.14 0.61 Allowed 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.342 -0.849 . . . . 10.0 109.25 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -155.15 138.63 15.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -80.55 -39.21 28.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.38 -44.99 95.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.798 1.239 . . . . 10.0 111.514 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.94 -126.7 3.49 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.065 -0.814 . . . . 10.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.4 -75.3 0.33 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.828 0.727 . . . . 10.0 113.923 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -163.73 160.98 23.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.774 0.83 . . . . 10.0 109.972 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.97 53.81 2.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.621 -1.251 . . . . 10.0 107.621 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.67 71.2 0.5 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.324 -0.709 . . . . 10.0 111.962 -156.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.51 64.32 4.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.182 0.991 . . . . 10.0 110.24 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -136.11 170.26 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.971 2.108 . . . . 10.0 109.275 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.86 72.79 7.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.52 0.728 . . . . 10.0 109.155 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.1 158.8 86.52 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.341 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -44.49 -53.41 4.96 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.373 2.715 . . . . 10.0 111.995 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.52 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 174.3 -157.62 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.021 2.129 . . . . 10.0 108.931 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.52 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.1 mm? -128.76 139.9 51.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.646 -1.613 . . . . 10.0 106.646 165.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.1 m -88.4 100.13 12.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.444 -1.687 . . . . 10.0 106.444 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.31 123.11 79.49 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 106.095 -1.817 . . . . 10.0 106.095 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.17 -172.24 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.566 2.177 . . . . 10.0 111.771 -168.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.83 149.23 3.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 155.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.21 7.61 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.809 1.411 . . . . 10.0 114.809 -165.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 90.74 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.885 -1.286 . . . . 10.0 109.885 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -115.93 64.78 0.7 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.134 1.774 . . . . 10.0 107.326 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -88.73 154.68 20.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.648 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -118.5 109.76 16.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 -167.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -83.62 102.99 12.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -152.07 170.62 19.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.816 0.735 . . . . 10.0 111.295 -170.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -36.55 -47.38 0.63 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.772 1.229 . . . . 10.0 111.712 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -129.93 95.05 3.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.776 1.63 . . . . 10.0 107.75 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.7 117.68 1.1 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.7 -1.056 . . . . 10.0 111.264 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.2 t0 24.86 64.79 0.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.565 2.746 . . . . 10.0 113.533 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -116.59 159.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.269 0.557 . . . . 10.0 112.419 -165.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.77 114.53 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.769 -1.937 . . . . 10.0 105.769 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 mtp -81.98 96.92 7.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.802 -1.184 . . . . 10.0 107.802 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.0 mt -81.0 59.41 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 46.5 ttp -82.99 158.4 22.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.387 0.675 . . . . 10.0 110.474 -169.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.16 -7.93 9.15 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.097 -1.39 . . . . 10.0 115.207 156.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.7 tp 46.63 68.54 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.243 1.417 . . . . 10.0 111.777 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -77.92 -37.71 47.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.432 0.693 . . . . 10.0 110.695 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.73 153.02 67.4 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 105.747 -1.946 . . . . 10.0 105.747 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.21 109.97 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.885 2.39 . . . . 10.0 111.415 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.04 99.81 1.14 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -97.8 115.78 28.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.228 1.411 . . . . 10.0 108.673 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -46.97 120.0 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.238 0.615 . . . . 10.0 110.067 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.88 -23.71 18.64 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.704 -1.053 . . . . 10.0 111.766 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -175.02 3.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.723 1.725 . . . . 10.0 109.55 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -153.9 131.74 11.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.284 -1.78 . . . . 10.0 107.493 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.7 136.84 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.404 1.082 . . . . 10.0 108.676 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.9 114.15 15.36 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.2 pt -92.88 176.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.747 0.819 . . . . 10.0 109.068 164.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.2 m -147.75 125.41 11.81 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.596 -0.69 . . . . 10.0 109.609 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 pp -91.77 179.18 5.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.22 0.608 . . . . 10.0 111.92 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -157.74 103.46 1.9 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.826 1.65 . . . . 10.0 108.068 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.18 123.35 33.93 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.006 -0.434 . . . . 10.0 110.488 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -83.0 64.0 7.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -174.86 -61.2 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.916 2.887 . . . . 10.0 105.47 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.75 -96.81 0.6 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.629 -1.169 . . . . 10.0 111.567 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -160.47 175.86 12.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.857 -0.79 . . . . 10.0 109.619 -171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.6 t -90.42 150.36 21.87 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.868 1.667 . . . . 10.0 107.007 156.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.9 tp -155.16 142.89 19.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.801 -1.925 . . . . 10.0 105.801 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.89 132.18 37.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.198 1.799 . . . . 10.0 106.667 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.48 128.36 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.686 -1.227 . . . . 10.0 107.686 -166.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.65 108.03 16.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.26 118.89 31.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.005 0.922 . . . . 10.0 109.838 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.4 m -83.95 132.41 34.77 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.42 111.34 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 31.9 pttt -157.67 116.98 3.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.577 0.626 . . . . 10.0 111.283 179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 pttm . . . . . 0 C--O 1.225 -0.217 0 O-C-N 121.731 -0.605 . . . . 10.0 111.088 173.98 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 112.329 0.492 . . . . 10.0 112.329 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -160.45 54.06 0.32 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.124 0.964 . . . . 10.0 109.974 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.75 64.74 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 120.984 -1.073 . . . . 10.0 110.774 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -155.35 149.9 26.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.131 0.572 . . . . 10.0 109.731 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.61 145.42 17.83 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.001 -1.64 . . . . 10.0 109.001 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.45 161.0 22.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.264 1.032 . . . . 10.0 111.302 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -123.41 139.97 53.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.907 -1.516 . . . . 10.0 106.907 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.92 136.71 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 107.358 -1.349 . . . . 10.0 107.358 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.45 41.46 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 34.94 -137.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.956 2.102 . . . . 10.0 112.083 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.75 108.75 47.59 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 160.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.31 166.6 29.13 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 N-CA-C 107.528 -1.758 . . . . 10.0 107.528 166.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.36 64.78 3.62 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.048 2.499 . . . . 10.0 111.032 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.3 t -164.55 56.51 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.842 1.257 . . . . 10.0 108.985 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt 71.56 170.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.589 1.156 . . . . 10.0 109.005 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -44.92 -41.35 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.064 -1.023 . . . . 10.0 112.747 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -51.43 141.35 15.73 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 127.072 2.149 . . . . 10.0 111.983 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 114' ' ' LEU . 14.3 t -162.03 -172.45 3.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.652 -165.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.34 159.09 44.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.792 0.837 . . . . 10.0 111.555 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.09 144.07 26.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.94 1.296 . . . . 10.0 109.238 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -128.53 119.22 24.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.569 -2.752 . . . . 10.0 103.569 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 ptp -161.04 -173.9 4.11 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.367 1.067 . . . . 10.0 108.522 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -131.39 135.85 47.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.216 1.407 . . . . 10.0 108.111 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.88 120.97 37.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 103.952 -2.611 . . . . 10.0 103.952 160.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -110.55 79.74 1.24 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.424 -1.324 . . . . 10.0 107.424 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -81.33 92.9 6.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.317 0.58 . . . . 10.0 110.433 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -83.31 57.11 3.82 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.798 -0.564 . . . . 10.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 t -171.1 157.96 5.37 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.936 0.895 . . . . 10.0 109.182 166.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.78 61.96 6.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -134.91 117.46 12.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.783 0.833 . . . . 10.0 111.04 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 122.82 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.094 2.529 . . . . 10.0 110.337 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.61 106.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.499 0.72 . . . . 10.0 109.08 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 121.46 32.61 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.204 -0.935 . . . . 10.0 111.563 -171.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.288 0.0 OUTLIER -102.59 128.06 49.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.047 -0.408 . . . . 10.0 110.22 -171.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.59 57.21 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.536 1.16 . . . . 10.0 109.079 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.78 153.23 24.22 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.939 -1.665 . . . . 10.0 108.939 166.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.94 62.19 0.46 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 168.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.92 138.87 32.24 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -168.82 151.32 4.94 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 118.602 0.637 . . . . 10.0 109.693 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.94 56.37 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.77 2.313 . . . . 10.0 109.656 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.7 mt -136.55 -82.33 0.38 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.97 1.708 . . . . 10.0 107.982 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.74 136.86 45.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.043 0.937 . . . . 10.0 111.681 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.8 m -81.48 -31.43 32.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.251 0.62 . . . . 10.0 109.433 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.2 t -119.82 72.2 16.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.503 1.121 . . . . 10.0 111.448 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.84 97.22 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.916 2.411 . . . . 10.0 111.153 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.7 mmt -105.23 128.72 53.56 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.378 1.071 . . . . 10.0 110.063 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 145.28 28.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.926 0.89 . . . . 10.0 110.105 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.05 163.85 31.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.888 1.275 . . . . 10.0 111.507 172.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.451 ' CG2' ' H ' ' A' ' 83' ' ' MET 0.25 26.1 m -102.0 164.23 11.82 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.485 3.114 . . . . 10.0 110.805 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.8 t -95.93 173.98 7.17 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.367 1.067 . . . . 10.0 112.837 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -99.26 55.82 1.0 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.003 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.9 p80 171.87 -170.33 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.698 2.399 . . . . 10.0 107.69 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 m -46.84 171.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.881 2.872 . . . . 10.0 114.654 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.92 -65.72 2.2 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.908 -2.077 . . . . 10.0 107.908 -169.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.62 -146.61 2.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.474 -1.05 . . . . 10.0 110.474 155.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.451 ' H ' ' CG2' ' A' ' 76' ' ' THR . 65.8 mtt -114.1 -82.47 0.6 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.865 1.266 . . . . 10.0 109.922 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.02 51.81 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.841 1.256 . . . . 10.0 109.385 -172.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.18 147.48 4.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.051 -0.595 . . . . 10.0 113.905 166.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -78.3 43.6 0.46 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.126 1.77 . . . . 10.0 112.047 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -83.04 157.77 22.75 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.572 0.749 . . . . 10.0 109.872 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.3 ttp -81.49 70.38 8.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.417 1.103 . . . . 10.0 109.36 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -58.09 162.02 6.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.876 1.671 . . . . 10.0 111.718 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 50.3 Cg_exo -47.57 -37.65 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.553 2.836 . . . . 10.0 113.341 163.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.91 -158.56 0.01 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.978 1.311 . . . . 10.0 111.049 -161.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.55 115.04 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.937 0.495 . . . . 10.0 110.05 164.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -84.46 103.14 13.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 159.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.28 120.16 76.45 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 105.998 -1.852 . . . . 10.0 105.998 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -85.89 137.16 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 109.283 -1.083 . . . . 10.0 109.283 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 50.73 -137.25 1.16 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.302 0.641 . . . . 10.0 110.911 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.89 59.39 0.1 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.291 2.237 . . . . 10.0 112.316 176.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 87.1 0.12 Allowed Glycine 0 N--CA 1.441 -0.974 0 O-C-N 121.583 -0.698 . . . . 10.0 111.372 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.1 m -86.4 67.67 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.63 1.572 . . . . 10.0 107.602 163.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.5 pt? -102.82 175.48 5.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.833 -0.802 . . . . 10.0 108.833 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -155.85 129.88 8.67 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.675 0.75 . . . . 10.0 110.437 -169.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.92 126.14 32.71 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.52 1.528 . . . . 10.0 108.574 -168.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.29 154.58 42.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.548 1.939 . . . . 10.0 109.123 -170.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.438 HH21 ' HA ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -56.62 -27.81 59.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.073 0.949 . . . . 10.0 112.855 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.438 ' HA ' HH21 ' A' ' 104' ' ' ARG . 36.1 m-20 -78.55 -59.99 2.56 Favored 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 121.473 -0.767 . . . . 10.0 111.406 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.88 136.87 5.55 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.833 -1.307 . . . . 10.0 109.833 -167.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t0 70.06 120.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 129.063 2.945 . . . . 10.0 106.761 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 177.42 171.17 0.58 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.549 1.522 . . . . 10.0 111.759 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.36 124.4 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 105.066 -2.198 . . . . 10.0 105.066 156.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.4 mtm -82.32 96.69 7.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 161.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.52 69.18 5.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.911 -1.514 . . . . 10.0 106.911 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 66.4 mtp -85.37 166.95 15.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.967 0.889 . . . . 10.0 112.961 -169.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.96 57.8 17.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.081 -1.208 . . . . 10.0 110.081 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 45' ' ' THR . 86.5 mt -61.36 123.38 17.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.075 0.938 . . . . 10.0 109.098 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.82 -61.91 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.595 0.358 . . . . 10.0 111.423 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -70.75 157.18 90.78 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.076 0.55 . . . . 10.0 111.354 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.98 139.62 39.89 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.577 2.184 . . . . 10.0 110.288 169.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -88.05 179.43 6.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.005 1.322 . . . . 10.0 111.592 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 100.64 0.93 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.64 117.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.208 -1.034 . . . . 10.0 108.208 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.15 -13.28 31.35 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.194 -0.781 . . . . 10.0 111.995 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -77.78 -169.85 1.66 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.493 1.615 . . . . 10.0 108.303 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.8 m -155.3 137.27 14.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.3 154.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.22 -1.4 . . . . 10.0 107.22 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -80.52 145.67 31.71 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 126' ' ' ILE . 17.9 tt -108.71 146.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 162.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.7 m -117.57 111.82 19.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.871 -1.899 . . . . 10.0 105.871 172.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 145.71 24.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 125.935 1.694 . . . . 10.0 107.258 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -144.27 97.58 3.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.45 142.28 32.05 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.3 t -62.14 -29.05 70.07 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.695 -1.253 . . . . 10.0 111.082 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.664 -0.647 . . . . 10.0 110.595 171.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.81 91.16 0.13 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.177 1.37 . . . . 10.0 110.602 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 53.61 1.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.521 0.728 . . . . 10.0 110.643 -174.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.5 m -157.8 87.8 0.95 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.934 0.494 . . . . 10.0 110.896 -170.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mt -153.94 156.06 36.79 Favored 'General case' 0 C--O 1.23 0.036 0 CA-C-N 119.085 0.857 . . . . 10.0 109.109 167.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.32 136.28 19.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.4 163.63 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.55 137.66 32.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.387 0.675 . . . . 10.0 110.359 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.34 114.34 24.18 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.205 1.802 . . . . 10.0 109.318 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -83.01 125.3 31.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.297 1.439 . . . . 10.0 108.203 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.84 97.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 O-C-N 120.513 -1.367 . . . . 10.0 108.305 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -147.44 103.03 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.315 0.646 . . . . 10.0 110.917 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 pttp . . . . . 0 CA--C 1.536 0.437 0 O-C-N 121.952 -0.468 . . . . 10.0 110.3 161.035 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 122.123 0.963 . . . . 10.0 110.554 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -155.08 58.02 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.237 1.015 . . . . 10.0 108.777 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.56 85.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -145.52 158.67 43.81 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.107 1.763 . . . . 10.0 107.586 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.62 -163.08 32.74 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.437 -1.865 . . . . 10.0 108.437 161.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.55 149.51 23.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.994 0.897 . . . . 10.0 109.96 169.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.6 p -133.76 153.99 51.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 170.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.4 133.55 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 123.514 0.726 . . . . 10.0 109.928 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.17 110.45 7.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.82 34.65 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.464 -0.772 . . . . 10.0 109.112 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -19.35 99.31 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 127.523 2.329 . . . . 10.0 113.558 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 163.01 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.688 2.926 . . . . 10.0 109.683 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.09 52.58 3.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.22 1.947 . . . . 10.0 110.164 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -157.68 56.0 0.49 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.182 -1.044 . . . . 10.0 108.182 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt 70.08 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.333 1.053 . . . . 10.0 109.008 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.462 HH11 ' CG ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -50.6 -42.71 56.25 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' CG ' HH11 ' A' ' 43' ' ' ARG . 63.4 m-20 -59.09 127.32 31.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.706 0.765 . . . . 10.0 109.929 -163.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -145.68 -165.84 2.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.315 -1.311 . . . . 10.0 111.21 -164.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.86 157.94 41.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.611 1.164 . . . . 10.0 112.107 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.42 158.95 20.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.492 -0.777 . . . . 10.0 110.022 165.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.3 128.14 48.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 163.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -157.64 177.8 10.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 p -98.19 168.81 10.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.39 146.4 46.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.364 -1.717 . . . . 10.0 106.364 163.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.6 m -140.79 111.66 7.04 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.975 0.797 . . . . 10.0 112.302 -166.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 119.69 24.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.314 0.506 . . . . 10.0 109.652 167.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 80.74 1.63 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.971 -1.122 . . . . 10.0 107.971 157.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m 164.53 -19.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 129.184 2.994 . . . . 10.0 109.557 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 74.13 53.24 0.1 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.495 0.589 . . . . 10.0 110.407 140.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -145.98 157.71 49.96 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 125.004 1.322 . . . . 10.0 109.129 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.31 70.59 7.14 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.543 2.829 . . . . 10.0 111.301 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mm -85.89 152.01 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.44 0.638 . . . . 10.0 109.653 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -139.26 81.83 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.592 2.357 . . . . 10.0 108.791 -162.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.01 63.4 7.07 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.155 0.982 . . . . 10.0 111.961 -166.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.39 60.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.481 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 149.2 18.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.365 -1.398 . . . . 10.0 113.304 163.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.28 59.89 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.505 1.522 . . . . 10.0 108.891 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.29 132.88 35.3 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.726 -0.609 . . . . 10.0 109.604 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 t -161.69 150.09 12.64 Favored Pre-proline 0 C--O 1.24 0.568 0 O-C-N 121.464 -0.772 . . . . 10.0 111.198 -168.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.57 42.84 1.23 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.895 2.396 . . . . 10.0 111.115 170.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.07 -68.34 0.83 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.058 1.343 . . . . 10.0 109.169 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.23 138.74 31.18 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.777 1.231 . . . . 10.0 110.517 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -78.77 -34.71 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 165.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t -121.65 73.65 32.66 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 124.939 1.296 . . . . 10.0 110.034 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.74 114.27 3.99 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.455 2.104 . . . . 10.0 109.728 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.6 mtp -129.3 133.63 47.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.925 0.89 . . . . 10.0 110.129 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -84.37 149.74 25.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.647 1.179 . . . . 10.0 111.156 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -174.47 3.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.98 1.312 . . . . 10.0 113.126 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -159.68 134.32 7.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.937 1.295 . . . . 10.0 108.55 -172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 4.4 t -92.0 -174.05 3.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.466 1.127 . . . . 10.0 112.246 173.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.7 m -80.04 72.29 6.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.791 -1.55 . . . . 10.0 107.581 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 m80 75.06 165.07 0.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.609 1.964 . . . . 10.0 111.4 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m 67.93 -67.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.989 1.716 . . . . 10.0 111.608 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.16 87.26 0.99 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.31 -2.316 . . . . 10.0 107.31 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.55 -160.7 54.15 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 112.156 -0.378 . . . . 10.0 112.156 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.2 mtt -69.65 -73.78 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.466 1.284 . . . . 10.0 114.466 -166.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.06 66.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.477 0.711 . . . . 10.0 109.341 -159.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.59 170.1 32.89 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.925 0.774 . . . . 10.0 114.309 164.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.9 56.49 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.585 2.354 . . . . 10.0 113.372 -157.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -97.2 155.57 16.79 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.374 1.87 . . . . 10.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.4 mtm -79.25 76.34 5.79 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.349 -1.723 . . . . 10.0 106.349 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.34 153.08 77.45 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.099 -1.41 . . . . 10.0 109.631 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -36.88 -52.33 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.743 2.962 . . . . 10.0 112.748 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -179.41 175.69 0.89 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.286 2.634 . . . . 10.0 104.778 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.09 100.84 12.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 m -76.49 136.7 39.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 pt -106.54 98.65 21.0 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.66 52.85 4.51 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.919 3.079 . . . . 10.0 111.903 -160.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.62 144.23 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.6 1.19 . . . . 10.0 110.578 -157.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 61.06 3.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.508 1.923 . . . . 10.0 113.706 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.5 110.21 3.14 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.998 -1.641 . . . . 10.0 108.998 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.2 m -149.93 76.55 1.29 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 -165.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.08 -158.55 0.69 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.652 -166.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.5 m -151.83 118.63 5.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.877 -1.527 . . . . 10.0 106.877 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.34 120.79 26.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.46 155.0 32.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.112 1.365 . . . . 10.0 108.285 -159.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -80.49 51.04 1.38 Allowed 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.622 -0.673 . . . . 10.0 111.264 -173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.63 -71.02 0.73 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.083 1.753 . . . . 10.0 107.187 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 77' ' ' THR . . . -139.45 -55.75 0.04 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.287 -1.125 . . . . 10.0 110.287 -166.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.408 ' N ' ' HB ' ' A' ' 77' ' ' THR . 9.2 t70 -99.59 129.21 45.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 125.177 1.391 . . . . 10.0 107.335 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 178.0 179.22 0.32 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.11 122.33 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.104 -2.554 . . . . 10.0 104.104 158.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.7 mtp -82.27 102.5 11.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.951 -1.5 . . . . 10.0 106.951 164.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.5 77.54 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 10.0 106.882 171.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.73 165.69 13.54 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.681 0.753 . . . . 10.0 111.571 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.57 69.95 1.22 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.1 tp -46.62 134.68 9.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.541 1.136 . . . . 10.0 110.391 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -119.51 -60.32 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.229 0.612 . . . . 10.0 111.553 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -93.91 143.48 26.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.574 0.75 . . . . 10.0 109.085 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.43 159.98 51.08 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.222 2.615 . . . . 10.0 111.349 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.71 156.94 36.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.368 1.467 . . . . 10.0 110.61 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 144.98 48.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.772 1.229 . . . . 10.0 108.869 170.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.15 69.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 10.0 108.744 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.18 -15.88 0.59 Allowed Glycine 0 CA--C 1.524 0.646 0 O-C-N 120.536 -1.352 . . . . 10.0 112.648 -159.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -177.42 0.56 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.958 1.837 . . . . 10.0 108.913 171.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.1 m -155.08 128.74 8.57 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.062 -1.881 . . . . 10.0 106.186 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.31 146.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -75.93 132.9 40.55 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.51 126.68 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 164.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.9 103.02 13.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.29 119.59 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -130.2 82.45 2.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.321 1.449 . . . . 10.0 107.256 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.79 154.4 24.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.024 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -60.89 -14.49 22.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.588 0.355 . . . . 10.0 111.526 168.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -9.59 20.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.692 1.197 . . . . 10.0 111.865 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.99 56.62 1.92 Allowed Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.503 1.049 . . . . 10.0 111.305 164.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -138.55 176.89 8.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.067 0.547 . . . . 10.0 110.147 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 m -155.49 88.69 1.15 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.716 -1.957 . . . . 10.0 105.716 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.0 172.14 10.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.5 93.16 2.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.603 -1.999 . . . . 10.0 105.603 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.1 t -102.02 137.74 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.56 115.46 22.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.52 123.23 46.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.864 0.866 . . . . 10.0 110.092 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 m -82.82 126.17 32.13 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.931 0.493 . . . . 10.0 109.819 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -84.26 104.8 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 O-C-N 120.688 -1.257 . . . . 10.0 107.929 -174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -141.64 106.87 4.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.738 1.615 . . . . 10.0 109.521 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 tttt . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 128.145 2.578 . . . . 10.0 111.736 175.133 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.224 -0.255 0 N-CA-C 107.661 -1.237 . . . . 10.0 107.661 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.1 t -158.22 93.91 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.709 -1.219 . . . . 10.0 107.709 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.31 57.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.434 1.112 . . . . 10.0 108.413 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.54 145.28 40.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.028 -1.471 . . . . 10.0 107.028 164.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.89 132.1 23.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.834 -1.706 . . . . 10.0 108.834 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.74 149.21 41.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.84 0.82 . . . . 10.0 109.791 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -136.93 148.28 46.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.8 t -130.9 139.21 51.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.01 45.64 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.06 -112.04 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.816 1.246 . . . . 10.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.47 140.9 29.88 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 140.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.59 155.7 46.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.451 1.434 . . . . 10.0 108.63 162.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.7 61.36 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.354 2.036 . . . . 10.0 109.641 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -162.22 70.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.956 -1.498 . . . . 10.0 106.956 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt 87.94 154.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.546 2.338 . . . . 10.0 110.009 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -83.82 22.56 1.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.469 1.108 . . . . 10.0 113.121 -168.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.87 -179.88 4.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.068 1.747 . . . . 10.0 109.198 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.1 t -160.71 -177.65 6.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -0.919 . . . . 10.0 108.518 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.09 154.59 39.47 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.626 -0.715 . . . . 10.0 109.22 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.87 147.76 26.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.058 0.849 . . . . 10.0 109.229 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -124.44 102.02 7.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.42 -176.71 5.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.945 0.898 . . . . 10.0 109.187 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -131.81 131.92 43.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.724 0.81 . . . . 10.0 110.257 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.94 109.2 17.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.5 m -108.18 111.26 23.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.179 1.791 . . . . 10.0 108.378 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.96 136.13 36.56 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 112.368 0.507 . . . . 10.0 112.368 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -144.94 58.76 1.3 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 161.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -160.18 -25.22 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 65.78 51.31 1.43 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.194 0.998 . . . . 10.0 111.992 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -143.3 158.59 57.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.66 1.184 . . . . 10.0 109.102 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.81 82.7 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.271 2.647 . . . . 10.0 110.015 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mm -96.83 146.81 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.305 -0.861 . . . . 10.0 108.989 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' NE1' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -148.46 87.71 1.6 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.322 1.058 . . . . 10.0 111.145 -172.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.26 73.64 9.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.811 1.644 . . . . 10.0 112.498 -164.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 8.3 p -82.22 57.75 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.592 -0.693 . . . . 10.0 112.516 -173.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.83 151.82 22.6 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 121.002 -1.061 . . . . 10.0 110.804 163.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 62.71 0.38 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.123 0.969 . . . . 10.0 108.436 168.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.82 23.32 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.652 -0.655 . . . . 10.0 109.963 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -163.7 149.68 9.65 Favored Pre-proline 0 CA--C 1.529 0.159 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.81 3.58 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.077 1.852 . . . . 10.0 113.026 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -49.14 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.639 1.109 . . . . 10.0 109.915 173.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.9 156.06 43.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.358 1.063 . . . . 10.0 110.171 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -87.99 -39.76 14.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.729 1.211 . . . . 10.0 112.568 -159.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -116.43 84.24 14.39 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.232 1.013 . . . . 10.0 109.722 -166.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.15 116.95 3.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.256 2.637 . . . . 10.0 110.785 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -121.58 151.0 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.413 1.085 . . . . 10.0 108.676 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.49 143.3 30.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.619 0.768 . . . . 10.0 109.061 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 ttp -134.6 162.8 31.27 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.948 1.299 . . . . 10.0 108.788 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 134.0 10.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.626 -0.671 . . . . 10.0 111.682 169.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 t -150.01 47.67 0.92 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.504 -0.316 . . . . 10.0 111.822 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.8 m -135.86 99.23 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.725 0.81 . . . . 10.0 109.285 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -46.67 -38.24 9.47 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.616 1.966 . . . . 10.0 114.221 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 t -75.52 0.71 16.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.998 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -117.42 -122.66 3.29 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.922 1.249 . . . . 10.0 111.631 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.23 -66.98 2.23 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.129 0.871 . . . . 10.0 113.011 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.8 ttt -148.59 -140.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.839 1.255 . . . . 10.0 108.835 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.01 52.65 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.392 -0.818 . . . . 10.0 108.986 -163.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.62 93.76 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.834 -0.907 . . . . 10.0 110.834 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -61.85 95.38 0.06 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.894 0.854 . . . . 10.0 109.775 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -151.3 176.22 11.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.615 1.566 . . . . 10.0 107.351 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 39.1 mtp -79.59 123.05 27.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.83 164.02 37.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.636 -0.876 . . . . 10.0 108.636 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -47.24 -56.12 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.365 2.043 . . . . 10.0 110.419 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.556 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 174.95 -135.07 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.359 2.263 . . . . 10.0 109.022 -176.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 155.16 40.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.061 2.144 . . . . 10.0 105.303 168.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.7 m -98.98 122.01 41.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.908 -1.516 . . . . 10.0 106.908 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.23 116.6 65.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.896 -1.89 . . . . 10.0 105.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.73 70.03 7.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.676 1.584 . . . . 10.0 109.892 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.23 174.11 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.151 0.58 . . . . 10.0 110.619 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.95 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 117.406 2.373 . . . . 10.0 117.406 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.41 105.87 0.25 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.806 1.194 . . . . 10.0 112.147 -165.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 m -110.81 57.32 0.62 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.969 -1.863 . . . . 10.0 105.969 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 ' HA3' ' A' ' 81' ' ' GLY . 23.3 tp -83.28 152.62 25.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -136.95 147.6 46.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.62 123.8 50.98 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.088 2.155 . . . . 10.0 106.047 -164.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.74 152.39 37.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.527 1.131 . . . . 10.0 108.467 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -44.83 -31.04 1.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.499 1.296 . . . . 10.0 114.499 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.11 -51.99 21.9 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.931 0.892 . . . . 10.0 111.913 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.06 133.05 6.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.26 1.41 . . . . 10.0 110.96 -151.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 38.82 58.4 1.74 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 127.657 2.383 . . . . 10.0 112.82 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -122.46 170.72 9.69 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.866 -1.97 . . . . 10.0 109.476 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -108.65 134.55 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 80.9 mtp -103.41 105.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.21 88.68 7.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.045 -1.094 . . . . 10.0 108.045 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.73 147.18 27.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.525 0.73 . . . . 10.0 110.607 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.75 69.12 1.33 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.163 -0.798 . . . . 10.0 112.266 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 pp -48.36 151.29 1.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.942 0.871 . . . . 10.0 113.155 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -84.58 -71.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.736 0.414 . . . . 10.0 109.953 165.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 173.62 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.206 1.402 . . . . 10.0 112.481 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.15 75.57 4.15 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.211 1.941 . . . . 10.0 110.923 -171.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.76 116.49 18.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.475 1.51 . . . . 10.0 108.788 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -135.54 127.49 29.54 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.074 -1.454 . . . . 10.0 107.074 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.17 90.45 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.35 -45.49 0.51 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.454 -1.058 . . . . 10.0 110.454 -162.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -172.39 1.83 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 123.837 1.779 . . . . 10.0 111.328 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.9 m -149.95 130.72 14.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.095 -1.866 . . . . 10.0 106.918 170.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.05 148.8 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.22 151.26 45.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.921 0.782 . . . . 10.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -115.19 152.16 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -131.29 107.5 9.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.425 -1.694 . . . . 10.0 106.425 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 148.86 26.28 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.81 -1.541 . . . . 10.0 108.974 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.44 100.93 2.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.61 -1.256 . . . . 10.0 107.61 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.84 148.22 30.06 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 172.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.4 t -55.09 -38.36 68.01 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.524 1.056 . . . . 10.0 111.446 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -34.98 70.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.19 1.796 . . . . 10.0 110.705 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.11 75.55 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.74 1.638 . . . . 10.0 109.543 -168.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -83.89 51.26 2.0 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.275 -0.544 . . . . 10.0 110.633 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -161.28 103.53 1.26 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.667 1.187 . . . . 10.0 109.37 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.43 151.58 27.97 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 108.218 -1.03 . . . . 10.0 108.218 160.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -138.84 129.89 26.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.917 -1.883 . . . . 10.0 105.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -142.35 170.47 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.55 -1.648 . . . . 10.0 106.55 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.32 136.87 38.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.113 0.965 . . . . 10.0 109.589 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.44 118.65 32.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.982 1.313 . . . . 10.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -82.38 130.32 35.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.28 105.72 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -146.37 100.71 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.936 0.895 . . . . 10.0 109.571 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt . . . . . 0 N--CA 1.464 0.241 0 C-N-CA 124.866 1.266 . . . . 10.0 111.268 179.828 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m . . . . . 0 N--CA 1.462 0.16 0 N-CA-C 113.195 0.813 . . . . 10.0 113.195 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -155.3 51.01 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.72 67.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -138.55 161.31 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.465 1.506 . . . . 10.0 110.65 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.43 73.48 0.38 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.916 1.246 . . . . 10.0 110.002 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -36.03 116.28 0.38 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.544 1.538 . . . . 10.0 111.482 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.5 m -118.58 107.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.6 126.44 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.209 1.404 . . . . 10.0 109.058 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.61 119.3 10.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.512 0.672 . . . . 10.0 109.363 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.94 129.81 39.08 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.583 -1.265 . . . . 10.0 107.583 164.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -30.5 109.72 0.27 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 126.04 1.736 . . . . 10.0 111.778 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.45 170.6 7.9 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.233 1.955 . . . . 10.0 109.889 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.62 57.51 3.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.237 1.958 . . . . 10.0 108.988 166.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m -157.29 43.73 0.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.709 1.204 . . . . 10.0 109.26 -175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 43' ' ' ARG . 22.0 mm 76.03 168.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.831 1.653 . . . . 10.0 111.856 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 42' ' ' ILE . 10.5 tpt180 -62.59 -11.52 17.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.161 2.584 . . . . 10.0 114.35 -170.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -72.04 157.94 36.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.368 -0.832 . . . . 10.0 109.657 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -168.52 -174.71 2.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.65 38.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.266 1.026 . . . . 10.0 111.18 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.32 140.39 35.68 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.001 0.92 . . . . 10.0 109.607 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.34 110.85 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.91 -173.2 3.97 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.486 1.114 . . . . 10.0 109.562 -172.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -106.39 164.93 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 166.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.43 149.91 47.77 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.684 -1.599 . . . . 10.0 106.684 160.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 m -151.63 110.42 3.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.942 0.349 . . . . 10.0 111.942 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.42 142.82 33.97 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.243 1.017 . . . . 10.0 109.447 168.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -137.99 66.0 1.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.407 -1.331 . . . . 10.0 107.407 163.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 p 179.57 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 -171.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 84.01 67.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.772 2.029 . . . . 10.0 108.859 156.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -126.4 159.42 63.09 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 125.649 1.58 . . . . 10.0 107.372 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 70.11 6.27 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.551 2.168 . . . . 10.0 110.746 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.52 90.4 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 4.2 ptpp? -83.57 91.23 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.223 1.011 . . . . 10.0 111.428 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.92 68.52 8.34 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 10.0 112.945 -161.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.426 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 6.8 p -82.23 60.69 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.357 -0.839 . . . . 10.0 112.185 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.34 161.18 31.92 Favored Glycine 0 CA--C 1.521 0.45 0 O-C-N 121.013 -1.055 . . . . 10.0 111.329 157.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.08 57.31 0.47 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.436 1.094 . . . . 10.0 108.417 164.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.39 149.81 26.47 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 t -166.66 146.05 4.78 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.11 68.36 4.05 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.421 2.081 . . . . 10.0 108.032 166.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 tp -154.02 -65.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.774 0.83 . . . . 10.0 109.836 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.99 146.67 30.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.89 0.876 . . . . 10.0 109.989 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -87.18 -34.24 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 10.0 109.287 169.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -122.71 71.06 38.9 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.538 1.535 . . . . 10.0 109.89 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.6 104.45 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.067 2.511 . . . . 10.0 111.428 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -129.43 166.78 18.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.325 1.05 . . . . 10.0 110.279 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.6 144.34 43.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.281 1.432 . . . . 10.0 109.6 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 ttp -141.86 152.66 43.83 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.108 1.363 . . . . 10.0 108.123 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.29 108.6 4.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 -161.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' CA ' ' A' ' 107' ' ' ASP . 22.9 m -139.28 62.58 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.91 -1.119 . . . . 10.0 110.111 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -154.05 120.56 5.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.14 -0.936 . . . . 10.0 110.221 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.406 ' CD2' ' CB ' ' A' ' 84' ' ' ALA . 53.1 m80 -70.11 70.12 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.47 1.108 . . . . 10.0 112.188 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.9 p -168.62 -57.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.364 0.984 . . . . 10.0 113.015 171.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.31 -78.39 0.6 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.54 -141.81 11.32 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.543 0.592 . . . . 10.0 111.862 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.98 176.27 6.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.756 . . . . 10.0 109.786 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' CB ' ' CD2' ' A' ' 79' ' ' HIS . . . -124.59 52.19 1.55 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.713 1.605 . . . . 10.0 107.772 -169.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.98 112.48 0.54 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.174 -1.17 . . . . 10.0 110.174 -171.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 27.25 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.837 1.655 . . . . 10.0 114.181 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -83.03 161.59 21.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.589 1.556 . . . . 10.0 109.42 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.5 ttp -81.42 121.91 26.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.92 166.88 12.39 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 118.468 0.577 . . . . 10.0 111.514 -171.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -37.92 -59.95 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.297 2.665 . . . . 10.0 111.56 156.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -175.71 -172.41 0.53 Allowed 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.042 1.127 . . . . 10.0 114.042 -171.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.65 107.38 19.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.849 1.66 . . . . 10.0 106.856 165.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.0 m -83.92 129.02 34.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.5 pt -114.02 95.33 37.8 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 107.228 -1.397 . . . . 10.0 107.228 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.9 70.35 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.866 1.711 . . . . 10.0 112.508 -157.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.55 152.41 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.709 1.242 . . . . 10.0 111.109 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 36.96 37.2 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.875 1.27 . . . . 10.0 111.869 -155.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 93.21 0.14 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.362 -1.095 . . . . 10.0 110.362 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -138.79 107.17 5.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.6 -171.84 2.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.639 0.776 . . . . 10.0 110.802 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.6 t -140.15 143.51 36.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 103.04 -2.948 . . . . 10.0 103.04 -172.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.68 116.67 19.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.304 -2.48 . . . . 10.0 104.304 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.99 161.55 41.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.736 1.214 . . . . 10.0 108.745 -165.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.0 ttp-105 -62.57 122.89 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.672 -0.694 . . . . 10.0 109.326 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.3 t0 48.76 60.82 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 10.0 112.608 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.34 62.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.897 -1.281 . . . . 10.0 109.897 164.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.423 ' CA ' ' H ' ' A' ' 77' ' ' THR . 7.2 t0 79.02 127.58 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.108 1.763 . . . . 10.0 110.045 -175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -177.08 157.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.312 0.505 . . . . 10.0 111.465 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.14 123.18 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 105.932 -1.877 . . . . 10.0 105.932 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.1 mtm -94.38 104.9 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.236 1.017 . . . . 10.0 109.095 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.65 68.74 8.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.289 -1.745 . . . . 10.0 106.289 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 23.3 ttt -82.12 154.73 25.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.487 0.661 . . . . 10.0 110.276 -166.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.64 60.92 6.39 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.001 -1.24 . . . . 10.0 110.001 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.82 117.9 4.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -69.83 0.62 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.848 0.749 . . . . 10.0 111.479 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -66.19 156.06 85.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.736 1.214 . . . . 10.0 111.377 -173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.55 148.62 92.32 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.503 1.469 . . . . 10.0 109.603 165.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.19 147.09 32.07 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.776 1.23 . . . . 10.0 109.587 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -111.98 145.56 39.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.759 1.223 . . . . 10.0 108.659 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.87 99.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.34 -3.89 6.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.058 1.313 . . . . 10.0 112.025 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -75.66 -174.18 2.45 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 123.733 1.73 . . . . 10.0 109.887 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.2 m -153.74 134.17 13.5 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 112.861 -1.972 . . . . 10.0 107.562 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.13 143.54 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.123 0.969 . . . . 10.0 108.689 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.18 119.44 21.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.2 tt -81.99 159.75 3.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.4 m -128.54 114.71 17.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.092 -1.818 . . . . 10.0 106.092 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.96 134.26 34.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -126.73 71.42 1.3 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.879 0.872 . . . . 10.0 109.405 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.36 138.49 39.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.652 -1.24 . . . . 10.0 107.652 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -57.42 -34.36 68.85 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.755 0.707 . . . . 10.0 112.905 -166.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.4 m-20 -65.15 -27.65 68.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.453 1.501 . . . . 10.0 111.734 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.37 81.67 0.12 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.312 -1.915 . . . . 10.0 108.312 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -80.81 53.78 2.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.943 0.497 . . . . 10.0 111.59 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.1 m -158.7 83.88 0.82 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.134 1.374 . . . . 10.0 109.583 -172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 157.29 45.39 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 168.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -149.03 140.86 23.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.2 t -148.23 147.6 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.87 107.76 16.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.66 138.73 31.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -82.25 150.27 27.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.106 -1.442 . . . . 10.0 107.106 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.43 113.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 164.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -158.73 143.22 15.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.754 -0.832 . . . . 10.0 108.754 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? . . . . . 0 CA--C 1.534 0.332 0 C-N-CA 124.553 1.141 . . . . 10.0 111.489 177.613 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.7 m . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 121.775 0.798 . . . . 10.0 111.685 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 t -158.98 81.18 0.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.202 1.001 . . . . 10.0 108.762 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.8 85.56 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.733 0.777 . . . . 10.0 109.527 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -157.98 155.79 30.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 162.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.03 137.35 19.8 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.353 -1.099 . . . . 10.0 110.353 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.91 115.69 23.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.77 0.785 . . . . 10.0 110.042 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -109.48 158.21 18.19 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.757 -1.201 . . . . 10.0 107.757 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.17 137.55 54.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.5 113.33 13.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -52.4 127.03 21.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 117.761 -1.114 . . . . 10.0 109.004 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -11.48 102.32 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 127.358 2.263 . . . . 10.0 113.065 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.3 168.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.733 2.288 . . . . 10.0 109.382 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.68 43.32 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.268 1.979 . . . . 10.0 110.545 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -133.96 34.54 3.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.943 2.097 . . . . 10.0 107.578 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.3 mm 73.76 172.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.897 1.279 . . . . 10.0 109.784 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.59 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -72.79 40.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.699 1.6 . . . . 10.0 113.948 -175.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.07 158.97 15.17 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 156.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -157.68 -165.88 1.87 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 155.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.01 174.46 11.26 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.63 161.43 26.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -130.3 102.3 6.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.35 -2.833 . . . . 10.0 103.35 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.2 ttp -158.59 -178.84 7.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.12 2.568 . . . . 10.0 106.142 -172.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 m -152.98 141.01 20.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.823 -1.917 . . . . 10.0 105.823 166.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.546 HD23 HD13 ' A' ' 94' ' ' ILE . 3.2 mp -82.29 136.03 35.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 170.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 m -120.78 80.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.069 2.148 . . . . 10.0 108.544 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.804 HD21 HD12 ' A' ' 94' ' ' ILE . 4.6 m-20 -81.91 89.7 6.39 Favored 'General case' 0 N--CA 1.46 0.045 0 O-C-N 121.2 -0.938 . . . . 10.0 109.128 -172.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 57.51 3.96 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.244 -0.91 . . . . 10.0 110.189 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t 179.11 149.64 0.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.174 1.79 . . . . 10.0 107.506 167.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.65 67.33 5.39 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.496 1.118 . . . . 10.0 108.895 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -130.71 122.47 19.64 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 10.0 109.736 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.86 116.3 3.14 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.535 2.823 . . . . 10.0 111.032 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.92 96.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.604 0.638 . . . . 10.0 109.649 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -80.4 132.84 35.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.312 0.645 . . . . 10.0 111.022 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.75 140.19 46.59 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.318 1.047 . . . . 10.0 110.209 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 131' ' ' THR . 10.4 p -146.09 56.25 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.923 0.868 . . . . 10.0 110.171 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 154.54 25.59 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 119.82 -1.181 . . . . 10.0 111.971 163.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.23 72.28 0.93 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.304 1.842 . . . . 10.0 106.505 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.39 145.63 28.1 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t 35.8 68.59 1.31 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.778 0.831 . . . . 10.0 109.963 -156.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.19 -86.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.349 2.033 . . . . 10.0 110.079 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.03 43.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.077 -1.453 . . . . 10.0 107.077 156.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HB1' ' C ' ' A' ' 112' ' ' MET . . . -167.31 -157.2 0.23 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -176.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -40.03 6.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.714 0.688 . . . . 10.0 110.868 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -122.09 106.23 36.44 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 125.403 1.481 . . . . 10.0 108.588 -169.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.12 139.65 7.28 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.23 2.62 . . . . 10.0 110.497 173.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -138.31 127.76 24.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.87 139.4 35.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.4 ttm -141.87 154.82 45.41 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.144 0.978 . . . . 10.0 111.429 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -148.47 120.16 8.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CG ' ' A' ' 86' ' ' MET . 6.9 t -156.43 54.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.644 0.778 . . . . 10.0 112.101 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -137.73 179.5 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.618 0.767 . . . . 10.0 111.499 168.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -91.18 -40.32 11.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.312 0.645 . . . . 10.0 110.165 -171.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.1 t -81.71 -147.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 160.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.35 -140.68 42.41 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.09 -67.42 1.7 Allowed Glycine 0 CA--C 1.536 1.365 0 CA-C-N 117.252 0.526 . . . . 10.0 113.145 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.14 174.17 12.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.637 1.975 . . . . 10.0 108.377 -169.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.86 45.42 2.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 10.0 107.8 -159.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.59 84.42 0.12 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 117.574 -1.681 . . . . 10.0 112.902 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.406 ' CG ' HG21 ' A' ' 77' ' ' THR . 1.7 mtt -40.34 98.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.437 0 C-N-CA 126.045 1.738 . . . . 10.0 110.602 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.31 166.23 26.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.705 1.202 . . . . 10.0 109.388 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.5 mtp -77.67 71.16 4.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.7 146.7 98.36 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.963 -1.017 . . . . 10.0 108.534 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -33.59 -51.49 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.205 3.27 . . . . 10.0 113.547 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -179.08 -176.76 0.44 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.44 1.896 . . . . 10.0 106.582 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 102.29 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 10.0 110.294 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 m -75.21 122.51 23.76 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.804 HD12 HD21 ' A' ' 53' ' ' ASN . 2.2 pt -108.73 90.83 7.93 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.163 0.985 . . . . 10.0 108.709 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.04 140.91 35.46 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 120.75 0.966 . . . . 10.0 109.741 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.41 -140.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.256 1.023 . . . . 10.0 112.412 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.19 38.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.958 2.503 . . . . 10.0 114.516 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.0 144.16 10.5 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 121.832 0.684 . . . . 10.0 112.883 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' LEU 0.265 7.2 t -134.48 99.3 4.32 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.863 -1.532 . . . . 10.0 106.863 158.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.84 126.26 55.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.046 -2.205 . . . . 10.0 105.046 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 m -82.01 153.23 26.29 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.708 -0.849 . . . . 10.0 108.708 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.67 76.55 1.64 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.984 -1.487 . . . . 10.0 106.984 176.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 158.49 44.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.738 0.815 . . . . 10.0 110.198 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -73.72 60.81 0.71 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.081 0.952 . . . . 10.0 112.123 -168.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -176.23 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.154 1.381 . . . . 10.0 109.784 -164.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.4 74.33 0.27 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 123.336 0.494 . . . . 10.0 112.101 -161.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 69.13 139.74 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 128.296 2.638 . . . . 10.0 109.211 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 175.65 178.44 0.18 Allowed 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.091 0.556 . . . . 10.0 112.42 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 t -108.67 118.21 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.7 mtp -80.43 103.19 10.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.545 -1.65 . . . . 10.0 106.545 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.84 105.47 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.584 -1.189 . . . . 10.0 109.178 169.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.471 ' C ' ' HB1' ' A' ' 69' ' ' ALA . 26.8 ttt -111.59 152.69 27.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.15 1.38 . . . . 10.0 111.22 -172.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.79 -6.82 6.95 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.528 -1.707 . . . . 10.0 115.957 155.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 77.29 92.46 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.677 1.739 . . . . 10.0 111.067 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -70.39 -56.44 6.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.66 -0.65 . . . . 10.0 110.3 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 149.86 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 129.833 3.253 . . . . 10.0 110.767 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.33 66.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.043 2.495 . . . . 10.0 114.311 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.49 96.62 10.68 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.106 -0.996 . . . . 10.0 109.481 158.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -137.71 147.8 45.11 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 162.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.07 68.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.872 0.869 . . . . 10.0 108.951 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.69 8.24 0.7 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.376 -1.236 . . . . 10.0 113.187 -168.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.66 173.0 5.52 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 119.797 1.799 . . . . 10.0 108.481 161.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 m -156.34 129.96 8.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.849 -1.523 . . . . 10.0 109.356 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.54 140.55 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.204 0.602 . . . . 10.0 109.766 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -70.05 123.12 20.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 108.971 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.9 tt -102.2 141.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.68 -1.23 . . . . 10.0 107.68 166.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.6 m -119.78 110.1 16.38 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 171.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.03 173.1 10.77 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 122.183 -0.323 . . . . 10.0 111.8 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.62 96.72 2.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.527 1.131 . . . . 10.0 108.022 -172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.75 143.12 29.35 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.68 -0.637 . . . . 10.0 110.647 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 62' ' ' VAL . 58.8 p -58.29 -23.13 55.36 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.713 0.805 . . . . 10.0 113.019 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.71 -17.7 16.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.987 0.915 . . . . 10.0 112.081 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.09 30.22 3.24 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.896 1.712 . . . . 10.0 110.578 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -90.36 166.9 13.04 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-N 117.334 0.567 . . . . 10.0 110.301 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.8 m -158.49 59.49 0.44 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.077 -2.194 . . . . 10.0 105.077 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.1 tp -85.18 141.9 29.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.848 -1.167 . . . . 10.0 107.848 -174.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -111.48 136.42 50.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.0 t -136.3 159.38 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.217 -1.771 . . . . 10.0 106.217 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.68 109.57 21.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.936 0.894 . . . . 10.0 108.879 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.36 118.48 24.26 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -94.83 127.38 40.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.178 0.991 . . . . 10.0 109.28 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 37' ' ' ALA . 51.1 t -86.76 104.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 120.762 -1.211 . . . . 10.0 108.951 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -141.59 116.3 9.72 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.578 1.151 . . . . 10.0 108.451 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.6 mttm . . . . . 0 C--N 1.341 0.223 0 C-N-CA 124.781 1.232 . . . . 10.0 112.164 175.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.964 0.888 . . . . 10.0 109.119 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -153.67 58.05 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.445 -0.785 . . . . 10.0 109.163 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.15 67.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 162.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -97.66 166.04 11.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.903 -1.499 . . . . 10.0 108.928 164.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.91 -145.96 19.74 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.581 -1.807 . . . . 10.0 108.581 160.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.02 115.73 0.73 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.97 1.708 . . . . 10.0 108.458 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.3 p -124.66 138.47 54.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.17 147.34 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.726 0.81 . . . . 10.0 109.54 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.63 113.53 25.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.375 0.534 . . . . 10.0 111.103 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.45 128.99 34.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.926 0.49 . . . . 10.0 110.095 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -20.7 103.87 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 127.024 2.13 . . . . 10.0 112.924 -164.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -62.15 167.01 11.54 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.314 2.676 . . . . 10.0 110.476 171.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.54 57.8 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.647 2.231 . . . . 10.0 109.127 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -154.44 42.8 0.5 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.881 1.272 . . . . 10.0 109.313 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.7 mt 77.43 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.438 1.495 . . . . 10.0 109.098 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -36.34 -46.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.304 1.842 . . . . 10.0 111.603 168.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.57 141.28 1.05 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.24 2.616 . . . . 10.0 112.727 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -158.67 -175.47 5.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 172.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.51 158.32 43.88 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.542 1.137 . . . . 10.0 110.596 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' SD ' ' A' ' 49' ' ' MET . . . -93.6 163.25 13.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 124.109 0.881 . . . . 10.0 110.51 171.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -134.06 130.57 37.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.516 -2.031 . . . . 10.0 105.516 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.405 ' SD ' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mpp? -156.04 -176.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.848 1.659 . . . . 10.0 108.5 -173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 137.43 36.58 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 161.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.28 149.37 23.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.634 -0.876 . . . . 10.0 108.634 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -135.84 85.76 2.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.291 0.994 . . . . 10.0 111.632 -157.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 113.73 12.4 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 121.354 -0.841 . . . . 10.0 109.156 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -128.36 57.65 1.57 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 164.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 m -163.46 -33.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.129 1.372 . . . . 10.0 112.134 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 60.42 59.66 2.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.079 0.854 . . . . 10.0 111.26 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -143.3 147.13 39.07 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.972 0.909 . . . . 10.0 109.907 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -86.36 84.34 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.906 3.071 . . . . 10.0 112.408 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.31 94.24 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -80.36 134.51 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.621 -0.674 . . . . 10.0 110.919 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 61' ' ' LEU . 1.2 tm? -99.38 115.89 30.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.881 1.672 . . . . 10.0 107.375 -165.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.69 47.78 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.997 . . . . 10.0 108.855 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.84 156.82 29.0 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.766 -1.209 . . . . 10.0 111.339 159.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.28 59.74 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.656 1.582 . . . . 10.0 107.846 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 132.52 33.8 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 t -157.91 139.55 9.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.88 65.16 5.96 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.671 2.914 . . . . 10.0 109.42 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -157.54 -57.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 -164.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.48 152.21 25.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.277 0.631 . . . . 10.0 109.31 171.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.2 m -107.13 -18.83 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.939 0.895 . . . . 10.0 110.219 160.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.6 m -133.1 64.45 70.47 Favored Pre-proline 0 N--CA 1.445 -0.689 0 C-N-CA 124.469 1.108 . . . . 10.0 109.028 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 101.32 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.178 2.585 . . . . 10.0 109.905 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.06 126.18 54.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 10.0 109.251 -171.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.58 146.03 31.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.045 0.538 . . . . 10.0 109.717 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 86' ' ' MET . 0.3 OUTLIER -148.03 166.7 26.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.758 1.223 . . . . 10.0 111.527 179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.254 40.7 m -137.96 133.87 34.23 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.004 1.44 . . . . 10.0 111.898 -156.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.447 ' HB ' ' N ' ' A' ' 107' ' ' ASP . 9.2 t -83.55 -178.99 7.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 123.995 1.855 . . . . 10.0 113.873 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.4 m -79.88 66.61 5.41 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 129.561 3.144 . . . . 10.0 109.803 -160.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 60.71 65.33 1.05 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.167 1.387 . . . . 10.0 110.735 172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.3 t -161.53 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.294 1.037 . . . . 10.0 108.369 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.31 -125.46 3.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 10.0 110.504 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.36 -49.95 8.16 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.527 1.371 . . . . 10.0 116.527 -168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.35 -82.46 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.749 1.275 . . . . 10.0 111.229 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.0 74.77 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.729 1.212 . . . . 10.0 108.07 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.77 159.65 27.69 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.01 1.29 . . . . 10.0 113.656 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 75' ' ' MET . 40.1 ttp -77.61 62.37 2.52 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.088 1.355 . . . . 10.0 111.417 -168.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -81.81 162.64 22.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.1 ttm -80.03 74.11 6.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.72 142.79 61.91 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.818 -1.083 . . . . 10.0 109.046 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.26 -18.28 64.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.845 1.697 . . . . 10.0 113.597 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -178.14 174.27 1.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.659 -1.978 . . . . 10.0 105.659 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 tp -97.6 101.14 12.58 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.448 1.022 . . . . 10.0 109.667 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -76.3 123.9 26.65 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.539 -0.911 . . . . 10.0 108.539 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.9 pt -115.26 115.28 42.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.18 -170.24 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.605 2.204 . . . . 10.0 110.737 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.43 149.66 20.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 158.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.87 17.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.168 1.349 . . . . 10.0 113.563 -166.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 83.62 0.41 Allowed Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 108.815 -1.714 . . . . 10.0 108.815 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.1 t -121.9 108.33 13.31 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 166.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 -172.33 2.68 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.335 0.654 . . . . 10.0 109.955 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.3 t -143.81 122.49 12.57 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 104.041 -2.577 . . . . 10.0 104.041 -164.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.78 123.92 47.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.57 -1.641 . . . . 10.0 106.57 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.63 155.39 41.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.171 1.389 . . . . 10.0 108.533 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 55.57 0.89 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.644 0.778 . . . . 10.0 111.181 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.55 -57.3 0.44 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.69 -75.48 0.3 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.689 0.661 . . . . 10.0 112.051 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -100.0 133.2 44.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 -171.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 174.51 178.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 120.115 1.325 . . . . 10.0 109.861 -176.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.76 122.57 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.137 -2.171 . . . . 10.0 105.137 158.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.0 mtp -81.37 96.83 7.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.25 61.82 3.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 22.2 ptm -89.97 177.91 6.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.115 0.959 . . . . 10.0 110.544 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.21 46.62 86.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 109.13 -1.588 . . . . 10.0 109.13 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.55 119.74 15.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 10.0 110.321 -168.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -64.16 -73.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.055 0.542 . . . . 10.0 111.705 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -95.2 152.98 39.79 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.7 0.8 . . . . 10.0 112.21 -160.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.66 100.68 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.571 2.181 . . . . 10.0 109.154 170.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 42.0 mt -77.72 158.4 29.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.032 -0.417 . . . . 10.0 111.032 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 142.31 47.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.717 1.207 . . . . 10.0 109.07 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.35 72.32 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.174 1.39 . . . . 10.0 109.214 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 151.76 -12.6 0.75 Allowed Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.962 -1.086 . . . . 10.0 112.614 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.89 179.27 2.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 123.693 1.711 . . . . 10.0 109.404 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -155.05 127.41 7.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.693 -2.049 . . . . 10.0 108.48 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -127.34 148.57 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -71.24 144.66 49.99 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.579 -0.7 . . . . 10.0 110.316 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.3 tt -123.19 139.3 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.1 m -117.39 119.24 34.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.2 176.89 8.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 10.0 111.723 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -154.09 90.8 1.38 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.202 1.001 . . . . 10.0 109.023 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 134' ' ' ARG . . . -86.74 153.24 21.86 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.135 -0.978 . . . . 10.0 110.989 170.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 p -46.45 -39.32 10.42 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 -165.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.38 18.35 0.56 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.767 0.827 . . . . 10.0 111.925 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 32.92 35.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.851 -1.3 . . . . 10.0 109.851 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.431 ' CB ' ' HB3' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -82.55 94.71 7.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -178.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 125.83 47.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.264 1.826 . . . . 10.0 107.064 169.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.6 144.29 50.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 103.796 -2.668 . . . . 10.0 103.796 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -107.95 113.84 27.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.571 -2.381 . . . . 10.0 104.571 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.27 153.1 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -171.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.94 112.06 22.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.55 -0.907 . . . . 10.0 108.55 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.13 109.73 20.11 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.486 0.714 . . . . 10.0 109.135 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 m -90.31 124.64 35.07 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.935 0.894 . . . . 10.0 108.911 -175.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.76 108.22 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.172 -0.955 . . . . 10.0 109.078 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -136.73 111.63 8.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.262 . . . . 10.0 108.169 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt . . . . . 0 C--O 1.232 0.155 0 CA-C-N 119.154 0.888 . . . . 10.0 110.731 172.757 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 CA--C 1.534 0.351 0 CA-C-O 122.256 1.026 . . . . 10.0 110.526 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -158.35 60.35 0.45 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.497 0.719 . . . . 10.0 109.508 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.96 52.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 122.125 0.964 . . . . 10.0 110.511 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -157.24 145.6 19.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.53 130.49 10.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.794 -1.723 . . . . 10.0 108.794 168.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 159.35 31.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.051 0.926 . . . . 10.0 111.291 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 p -122.39 148.57 44.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.316 -1.364 . . . . 10.0 107.316 165.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.41 134.51 58.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.0 26.29 0.06 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -166.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.21 -138.18 0.71 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.412 1.485 . . . . 10.0 109.692 -170.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.25 110.76 40.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 167.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.32 175.1 11.05 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.252 2.634 . . . . 10.0 109.472 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.78 72.04 3.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.531 2.154 . . . . 10.0 109.627 168.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -152.54 -57.41 0.14 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.722 2.409 . . . . 10.0 106.299 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt 66.37 150.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.141 1.776 . . . . 10.0 108.563 -163.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 74.91 -51.51 0.67 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.292 1.837 . . . . 10.0 111.757 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.31 138.01 37.01 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -150.45 178.57 8.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.659 1.184 . . . . 10.0 108.193 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.15 161.7 41.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.938 0.895 . . . . 10.0 109.458 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.41 160.81 14.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.263 0.977 . . . . 10.0 111.284 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.14 134.96 51.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.275 -2.491 . . . . 10.0 104.275 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 ttt -158.82 177.26 11.36 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.794 -1.187 . . . . 10.0 107.794 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 t -133.27 142.36 48.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 152.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.52 105.77 16.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.287 -2.486 . . . . 10.0 104.287 163.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.84 106.36 15.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.281 1.832 . . . . 10.0 110.427 -170.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.61 129.82 34.74 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.337 0.655 . . . . 10.0 110.206 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -138.98 58.42 1.64 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 158.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -157.98 -50.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.937 2.095 . . . . 10.0 108.103 -171.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 97' ' ' ARG . 40.8 m-20 74.58 58.86 0.07 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.207 1.803 . . . . 10.0 110.384 170.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -123.86 146.29 50.3 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 126.048 1.739 . . . . 10.0 106.456 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.72 121.02 6.4 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.692 2.261 . . . . 10.0 109.554 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.57 146.39 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -117.7 145.47 44.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.316 1.447 . . . . 10.0 107.763 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.09 131.68 17.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.485 -2.413 . . . . 10.0 104.485 -171.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.6 55.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.233 1.016 . . . . 10.0 109.034 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.49 149.09 17.48 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.871 -1.292 . . . . 10.0 109.871 167.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -155.54 59.74 0.62 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.758 1.223 . . . . 10.0 108.14 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.19 35.23 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.339 0.656 . . . . 10.0 110.21 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -159.05 144.11 11.7 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 107.143 -1.429 . . . . 10.0 107.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.61 39.74 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.519 2.146 . . . . 10.0 112.738 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -108.82 -54.61 2.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.734 1.613 . . . . 10.0 108.34 -170.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.38 160.41 30.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.974 1.309 . . . . 10.0 107.947 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -83.15 -40.26 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.512 0.725 . . . . 10.0 111.874 -165.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.9 t -119.15 95.53 49.39 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.478 1.111 . . . . 10.0 110.647 -162.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.61 92.2 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.958 2.439 . . . . 10.0 110.36 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 83.8 mtp -103.75 116.51 32.45 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.879 1.272 . . . . 10.0 108.893 -172.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 mp -81.54 134.9 35.57 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.435 0.694 . . . . 10.0 109.735 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.52 -179.83 3.84 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.667 1.187 . . . . 10.0 109.336 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 t -158.79 143.27 15.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.277 -2.49 . . . . 10.0 104.277 159.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.28 5.7 t -156.89 63.68 0.51 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.738 1.608 . . . . 10.0 110.486 167.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -146.04 -178.74 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.72 -0.612 . . . . 10.0 109.665 172.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.57 148.76 22.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m 71.2 -53.8 0.67 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.552 1.541 . . . . 10.0 111.913 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.55 141.16 47.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 17.65 -90.14 0.01 OUTLIER Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.699 2.095 . . . . 10.0 115.585 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.4 mtt -145.39 173.98 11.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.395 1.878 . . . . 10.0 109.454 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.22 47.05 0.98 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.768 1.627 . . . . 10.0 107.128 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.72 102.2 0.22 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.813 -1.315 . . . . 10.0 109.813 -167.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 63.85 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.279 1.831 . . . . 10.0 111.89 -170.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -113.98 165.81 12.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.827 2.051 . . . . 10.0 109.933 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.8 mtm -78.38 98.02 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.716 -1.587 . . . . 10.0 106.716 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.66 161.72 47.06 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 119.47 -0.3 . . . . 10.0 110.387 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -43.17 -50.02 6.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.247 2.631 . . . . 10.0 111.241 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.3 p90 177.52 -170.0 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.194 2.598 . . . . 10.0 104.967 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -127.8 106.6 9.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.754 0.788 . . . . 10.0 110.421 169.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 145.77 36.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.04 140.9 40.07 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.527 1.058 . . . . 10.0 111.266 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.1 -174.21 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.123 2.549 . . . . 10.0 111.968 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.4 143.48 23.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 156.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 37.1 mmt-85 52.15 27.07 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.58 0.956 . . . . 10.0 113.58 -163.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.74 96.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.837 -1.705 . . . . 10.0 108.837 167.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -126.59 55.71 1.51 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.706 1.202 . . . . 10.0 108.645 -173.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.21 166.61 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.158 0.98 . . . . 10.0 112.397 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 105.4 3.95 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.9 119.4 23.89 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.503 -1.665 . . . . 10.0 106.503 -171.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -127.83 144.7 51.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.458 1.903 . . . . 10.0 107.456 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -61.71 119.42 8.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.99 37.18 3.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.218 1.407 . . . . 10.0 112.334 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -169.73 74.31 0.11 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.774 -1.73 . . . . 10.0 108.774 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.9 t0 63.41 130.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.967 2.507 . . . . 10.0 111.749 -168.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -177.1 175.82 1.48 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.365 0.984 . . . . 10.0 111.782 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.92 130.27 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.025 -1.843 . . . . 10.0 106.025 163.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 78.6 mtp -88.76 103.21 15.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.747 1.219 . . . . 10.0 107.759 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.27 81.42 8.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.711 -1.589 . . . . 10.0 106.711 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 51.3 ttm -84.79 152.34 23.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.313 1.045 . . . . 10.0 109.639 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.92 53.2 3.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.381 -1.087 . . . . 10.0 110.381 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.8 122.58 5.09 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 125.147 1.379 . . . . 10.0 109.11 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -72.9 -64.16 1.02 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.61 -58.48 0.0 OUTLIER Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 118.276 -0.868 . . . . 10.0 112.987 167.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.73 58.7 5.41 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.805 1.67 . . . . 10.0 111.334 -163.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.69 167.26 22.14 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.839 -0.538 . . . . 10.0 109.717 165.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -149.33 123.56 9.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.253 -1.758 . . . . 10.0 106.253 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.93 120.64 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.66 -4.19 50.16 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.414 -1.214 . . . . 10.0 112.478 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.03 169.4 11.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 119.944 1.872 . . . . 10.0 111.357 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.9 m -132.32 96.75 3.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 111.599 -2.546 . . . . 10.0 108.045 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.12 140.39 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -66.11 130.77 44.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.3 112.19 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 173.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.1 m -94.31 107.04 19.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.44 -0.8 . . . . 10.0 109.541 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.28 171.96 14.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.09 103.36 2.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.05 126.73 32.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.7 t -47.85 -38.53 16.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.51 1.524 . . . . 10.0 111.019 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.1 -35.19 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.019 1.727 . . . . 10.0 113.089 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.28 67.73 0.17 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.126 -1.189 . . . . 10.0 110.126 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -129.76 151.85 49.89 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 m -152.72 55.57 0.79 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.649 1.579 . . . . 10.0 107.823 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.49 128.76 34.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 62.43 0.87 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 127.551 2.34 . . . . 10.0 107.222 -161.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -84.49 153.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.396 -1.274 . . . . 10.0 108.96 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.68 113.44 18.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.922 -1.111 . . . . 10.0 108.999 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.0 146.27 32.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.398 1.079 . . . . 10.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.7 m -103.7 128.64 51.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.559 0.344 . . . . 10.0 110.702 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.34 91.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.899 -1.148 . . . . 10.0 107.899 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -155.66 135.83 13.0 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 121.435 -0.79 . . . . 10.0 110.754 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.224 -0.259 0 C-N-CA 125.749 1.619 . . . . 10.0 111.868 177.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 113.59 0.959 . . . . 10.0 113.59 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.407 ' HA2' ' CG ' ' A' ' 3' ' ' HIS . . . 100.38 79.73 1.46 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.278 -1.29 . . . . 10.0 110.732 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' CG ' ' HA2' ' A' ' 2' ' ' GLY 2.174 0.2 OUTLIER -95.46 24.79 4.87 Favored 'General case' 0 N--CA 1.47 0.559 1 C-N-CA 134.799 5.239 . . . . 10.0 113.622 -1.489 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 2.334 1.7 t -58.57 85.12 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.179 0.991 . . . . 10.0 110.28 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.403 ' HA ' ' O ' ' A' ' 6' ' ' PRO 2.281 25.0 ptt? -62.05 -158.34 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 126.448 1.899 . . . . 10.0 110.019 149.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' MET 2.553 63.2 Cg_endo 51.62 -167.87 0.0 OUTLIER 'Cis proline' 0 C--N 1.351 0.71 0 CA-C-N 122.475 1.92 . . . . 10.0 114.07 6.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 61.87 -94.41 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 115.751 1.76 . . . . 10.0 115.751 162.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . 2.299 1.2 p-80 -136.79 -58.48 0.72 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 129.95 3.3 . . . . 10.0 109.508 117.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 2.344 19.0 m -13.79 -76.21 0.0 OUTLIER Pre-proline 0 C--N 1.348 0.501 1 C-N-CA 134.73 5.212 . . . . 10.0 114.34 -12.245 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . 2.54 32.1 Cg_exo 61.61 -109.14 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.719 2.279 . . . . 10.0 109.723 172.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -23.32 66.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.659 1 C-N-CA 128.331 6.02 . . . . 10.0 121.006 179.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -103.64 52.19 0.77 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 104.306 -2.479 . . . . 10.0 104.306 132.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 2.453 8.7 pt20 59.51 -164.06 0.22 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.048 -0.978 . . . . 10.0 109.258 -145.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 t 71.52 26.36 3.21 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 114.732 1.382 . . . . 10.0 114.732 172.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -135.08 50.99 5.25 Favored Pre-proline 0 N--CA 1.465 0.299 0 N-CA-C 107.162 -1.421 . . . . 10.0 107.162 141.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . 0.538 0.7 OUTLIER -28.85 -91.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-O 115.949 -1.771 . . . . 10.0 115.239 -105.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . 0.27 . . 55.88 34.33 23.33 Favored 'General case' 0 CA--C 1.532 0.27 2 C-N-CA 134.161 4.984 . . . . 10.0 116.548 -7.321 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.24 106.58 8.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.065 0.848 . . . . 10.0 112.253 170.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 93.03 -64.51 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 1 C-N-CA 133.067 4.547 . . . . 10.0 115.909 -14.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp 165.01 -44.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.249 1.42 . . . . 10.0 109.221 -151.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.13 156.22 18.74 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.523 -0.736 . . . . 10.0 109.949 176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.92 25.4 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.557 -1.817 . . . . 10.0 108.557 -144.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 80.82 -54.93 0.32 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.45 2.3 . . . . 10.0 110.266 168.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.82 -65.03 0.36 Allowed 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 125.133 1.373 . . . . 10.0 107.494 -166.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 162.5 136.64 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.808 1 C-N-CA 131.852 4.061 . . . . 10.0 105.368 172.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.517 HD22 ' HB2' ' A' ' 54' ' ' LYS . 4.6 tt -101.78 122.21 48.31 Favored Pre-proline 0 C--O 1.234 0.257 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 168.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -58.75 129.42 32.14 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 N-CA-C 107.779 -1.662 . . . . 10.0 107.779 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -84.11 52.64 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.656 0.741 . . . . 10.0 112.161 -148.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 t -161.71 57.42 0.26 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.82 1.248 . . . . 10.0 109.035 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.45 64.68 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 N-CA-C 108.155 -1.054 . . . . 10.0 108.155 176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -128.94 146.5 50.94 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.891 1.276 . . . . 10.0 111.443 -170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -102.26 90.59 0.82 Allowed Glycine 0 CA--C 1.524 0.635 0 N-CA-C 108.261 -1.936 . . . . 10.0 108.261 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -52.41 142.5 17.3 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.04 0.536 . . . . 10.0 111.847 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 9.0 p -125.16 146.13 49.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.136 -1.061 . . . . 10.0 108.136 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.28 138.59 53.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 107.923 -1.139 . . . . 10.0 107.923 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -82.34 110.59 17.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.109 0.48 . . . . 10.0 111.486 -173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.39 136.34 31.56 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 118.403 -0.808 . . . . 10.0 109.15 166.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.7 t -17.5 108.22 0.06 OUTLIER Pre-proline 0 N--CA 1.475 0.799 0 C-N-CA 126.83 2.052 . . . . 10.0 114.837 -162.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.15 158.1 31.83 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.814 2.343 . . . . 10.0 110.572 167.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.16 58.64 4.33 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.499 2.133 . . . . 10.0 108.987 169.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.9 t -165.4 44.25 0.08 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.266 1.426 . . . . 10.0 108.589 -175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.44 HG22 ' H ' ' A' ' 43' ' ' ARG . 16.5 mt 74.2 169.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 126.207 1.803 . . . . 10.0 109.723 174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.44 ' H ' HG22 ' A' ' 42' ' ' ILE . 11.4 ptm180 -46.91 -39.61 12.55 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.915 1.686 . . . . 10.0 113.87 -175.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -58.79 151.72 20.68 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.741 1.216 . . . . 10.0 111.415 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -164.2 -172.66 2.84 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 108.849 -0.797 . . . . 10.0 108.849 -164.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.92 162.71 39.8 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 124.645 1.178 . . . . 10.0 110.141 -175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.03 149.29 26.35 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 123.764 0.665 . . . . 10.0 109.411 167.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -124.2 103.32 8.18 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 104.756 -2.313 . . . . 10.0 104.756 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.2 ptt? -159.2 -172.65 3.85 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.927 0.891 . . . . 10.0 111.579 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.5 m -145.59 125.17 13.23 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 120.699 -1.251 . . . . 10.0 110.259 175.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.28 132.58 35.35 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 103.946 -2.613 . . . . 10.0 103.946 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.8 m -129.35 88.24 2.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 125.001 1.438 . . . . 10.0 107.609 -164.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -79.39 128.47 33.38 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.388 -0.227 . . . . 10.0 110.388 -170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.517 ' HB2' HD22 ' A' ' 26' ' ' LEU . 32.1 mmmt -141.82 57.02 1.49 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.698 -1.593 . . . . 10.0 106.698 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.9 m -156.16 -40.63 0.08 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.307 1.443 . . . . 10.0 111.071 175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 65.99 62.22 0.61 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.034 1.734 . . . . 10.0 112.662 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -132.79 155.44 81.17 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.833 1.653 . . . . 10.0 108.052 175.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -78.28 75.97 4.63 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.895 3.063 . . . . 10.0 111.471 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -83.36 147.77 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.03 -0.73 . . . . 10.0 109.03 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.32 99.63 5.09 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 125.541 1.537 . . . . 10.0 111.019 176.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -82.6 121.55 26.96 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 105.595 -2.002 . . . . 10.0 105.595 179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.75 54.28 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-O 122.207 1.003 . . . . 10.0 108.587 178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.21 148.96 16.71 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.471 -1.051 . . . . 10.0 110.471 166.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.21 59.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.054 1.742 . . . . 10.0 107.762 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.34 141.94 29.68 Favored 'General case' 0 C--O 1.227 -0.096 0 N-CA-C 109.241 -0.652 . . . . 10.0 109.241 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.2 t -169.59 149.16 3.56 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 118.799 0.727 . . . . 10.0 110.199 -172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.78 49.65 2.53 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.844 2.362 . . . . 10.0 110.434 168.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.55 -70.59 0.73 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.59 1.556 . . . . 10.0 107.202 -178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.48 147.27 33.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.144 1.378 . . . . 10.0 110.26 -174.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.3 m -82.41 -36.4 26.71 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.948 0.899 . . . . 10.0 109.935 -178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.7 t -120.47 75.12 24.57 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 124.614 1.165 . . . . 10.0 110.94 -169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.84 101.09 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.567 2.178 . . . . 10.0 110.413 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 32.4 mtt -109.51 128.55 55.26 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 126.091 1.757 . . . . 10.0 108.854 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.5 mt -82.62 142.25 31.89 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.304 1.042 . . . . 10.0 108.821 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.4 ttm -148.24 153.14 38.33 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.663 0.785 . . . . 10.0 110.84 -173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.0 t -159.07 98.62 1.46 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.046 -1.034 . . . . 10.0 111.547 -161.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.3 t -138.94 59.48 1.62 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-O 121.795 0.807 . . . . 10.0 110.193 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.4 m -147.73 125.11 11.6 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.702 0.801 . . . . 10.0 109.436 172.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -77.47 64.12 2.76 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.251 1.421 . . . . 10.0 109.671 -170.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 166.01 -20.59 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 128.489 2.716 . . . . 10.0 109.484 -174.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.45 -149.41 6.0 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 108.672 -1.771 . . . . 10.0 108.672 161.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -58.48 -52.47 52.68 Favored Glycine 0 CA--C 1.536 1.372 0 O-C-N 122.455 -0.438 . . . . 10.0 113.235 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.05 -168.1 1.19 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.123 1.369 . . . . 10.0 110.356 -166.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -128.83 42.97 3.23 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 126.618 1.967 . . . . 10.0 108.134 -167.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -149.58 103.04 0.24 Allowed Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.228 -1.149 . . . . 10.0 110.228 -171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.63 63.03 2.65 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.059 0.929 . . . . 10.0 108.773 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -131.36 167.09 19.87 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 126.644 1.977 . . . . 10.0 109.691 -172.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.2 mtm -79.67 75.7 6.33 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 108.037 -1.097 . . . . 10.0 108.037 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.4 m -67.13 163.67 43.12 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.495 -0.775 . . . . 10.0 111.498 -178.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -37.26 -55.73 0.92 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.141 3.227 . . . . 10.0 112.632 161.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.9 p90 172.65 -165.3 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 128.275 2.63 . . . . 10.0 104.732 -174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.497 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.4 pt? -127.37 111.53 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 118.701 0.682 . . . . 10.0 110.945 168.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.3 m -76.59 132.48 39.49 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 107.055 -1.461 . . . . 10.0 107.055 170.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.2 pt -100.95 100.95 14.14 Favored Pre-proline 0 CA--C 1.536 0.407 0 C-N-CA 125.084 1.354 . . . . 10.0 107.388 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.59 67.69 8.55 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 123.239 2.626 . . . . 10.0 110.211 -166.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 58.38 177.93 0.06 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.542 -0.54 . . . . 10.0 109.542 -156.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 38.81 33.99 0.08 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 116.831 2.16 . . . . 10.0 116.831 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.07 70.93 0.01 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.971 1.272 . . . . 10.0 113.113 163.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.6 m -111.49 57.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.334 -1.358 . . . . 10.0 107.334 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -105.18 156.45 18.09 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.793 -0.447 . . . . 10.0 109.793 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.3 m -115.42 115.36 26.42 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 -171.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -82.61 106.36 14.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -137.08 156.56 48.24 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.6 1.16 . . . . 10.0 110.26 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -47.44 -40.35 17.87 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.805 1.242 . . . . 10.0 113.93 -161.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -132.65 52.05 2.11 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.825 0.821 . . . . 10.0 109.909 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.9 63.78 0.22 Allowed Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.537 -1.025 . . . . 10.0 110.537 176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 19.8 t0 65.45 136.45 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.45 0 C-N-CA 126.253 1.821 . . . . 10.0 109.891 -172.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 179.82 -179.2 0.44 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.096 -1.003 . . . . 10.0 112.095 -171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 84.6 t -110.83 123.02 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 106.187 -1.783 . . . . 10.0 106.187 161.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.7 mtp -83.51 100.54 10.83 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 166.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 94.4 mt -78.15 74.25 4.7 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 106.403 -1.703 . . . . 10.0 106.403 171.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 17.7 ttt -84.72 153.89 22.79 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.271 1.029 . . . . 10.0 110.567 -170.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.23 60.17 3.92 Favored Glycine 0 CA--C 1.528 0.864 0 O-C-N 121.295 -0.878 . . . . 10.0 111.103 174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.67 128.59 26.85 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.777 1.231 . . . . 10.0 111.008 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -76.45 -72.97 0.3 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.642 0.777 . . . . 10.0 111.67 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -116.43 156.98 46.76 Favored Pre-proline 0 N--CA 1.469 0.481 0 C-N-CA 124.509 1.124 . . . . 10.0 111.912 -163.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -60.75 144.16 99.51 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.091 2.527 . . . . 10.0 111.76 -176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.0 mt -118.33 142.58 47.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.726 1.61 . . . . 10.0 109.497 -171.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.37 129.01 54.97 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 109.443 -0.577 . . . . 10.0 109.443 168.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 91.4 t -54.01 107.37 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.893 -1.151 . . . . 10.0 107.893 163.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 120.35 -13.34 10.26 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.675 -0.57 . . . . 10.0 111.675 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -72.75 -179.54 3.16 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 123.589 1.661 . . . . 10.0 108.525 175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 21.8 m -154.2 129.66 9.87 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.517 -1.674 . . . . 10.0 106.907 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 73.1 t -127.15 145.79 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 107.31 -1.367 . . . . 10.0 107.31 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -73.9 143.47 45.76 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 121.809 -0.557 . . . . 10.0 109.732 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.5 tt -118.4 139.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 168.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.1 m -111.5 108.26 17.73 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 168.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -84.91 161.97 19.64 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.816 -0.438 . . . . 10.0 109.816 170.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -149.9 95.28 2.28 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 -173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.78 133.51 34.35 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.388 -0.597 . . . . 10.0 109.388 170.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.8 t -77.23 3.81 12.0 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.062 0.393 . . . . 10.0 112.062 -177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -61.21 -15.57 35.81 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.375 0.67 . . . . 10.0 111.042 156.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 103.7 47.38 1.29 Allowed Glycine 0 C--N 1.339 0.723 0 C-N-CA 126.119 1.818 . . . . 10.0 109.935 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 14.6 mmp_? -109.95 155.35 21.88 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 86.0 m -156.35 73.15 0.78 Allowed 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 103.919 -2.623 . . . . 10.0 103.919 -177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.8 tp -107.71 127.85 54.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -161.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -92.68 132.87 36.55 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.912 1.685 . . . . 10.0 107.471 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.2 t -141.1 152.67 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.767 -1.938 . . . . 10.0 105.767 -173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.54 116.75 29.15 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -100.05 119.87 38.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.518 0.727 . . . . 10.0 109.643 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.2 m -83.17 127.15 33.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 63.4 t -94.82 98.45 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -171.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -159.27 139.67 12.22 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.585 -0.524 . . . . 10.0 109.585 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -61.16 -51.48 68.86 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 114.643 1.349 . . . . 10.0 114.643 -170.338 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 55.7 m-20 65.47 110.68 0.03 OUTLIER 'General case' 0 C--N 1.344 0.348 0 C-N-CA 124.525 1.13 . . . . 10.0 111.606 174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.9 pt 43.73 53.71 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 124.322 1.049 . . . . 10.0 112.121 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -130.32 163.15 27.45 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.836 1.254 . . . . 10.0 108.244 -177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 62.16 28.27 70.4 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 108.733 -1.747 . . . . 10.0 108.733 -151.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 C--O 1.261 1.69 0 C-N-CA 130.198 3.399 . . . . 10.0 102.374 176.116 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.473 0.702 0 N-CA-C 106.185 -1.783 . . . . 10.0 106.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.1 171.25 37.96 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.03 -2.028 . . . . 10.0 108.03 178.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -163.83 162.82 23.88 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 106.847 -1.538 . . . . 10.0 106.847 -176.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -160.52 174.68 13.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.886 -1.153 . . . . 10.0 107.886 171.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.2 ttt -158.03 88.83 2.37 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 125.18 1.392 . . . . 10.0 108.389 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -70.99 158.02 56.46 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 121.925 1.75 . . . . 10.0 109.991 178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.78 163.98 31.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -165.36 168.9 16.35 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 177.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.3 t -152.99 122.83 3.34 Favored Pre-proline 0 CA--C 1.537 0.471 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 172.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -81.55 141.49 12.47 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.331 2.021 . . . . 10.0 109.896 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -74.56 165.52 31.46 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.33 2.02 . . . . 10.0 109.9 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.92 151.93 27.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.054 -1.091 . . . . 10.0 108.054 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -171.04 173.56 5.02 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.508 1.523 . . . . 10.0 107.453 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -164.27 -179.94 6.42 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 170.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.61 68.65 0.74 Allowed Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 125.213 1.405 . . . . 10.0 109.935 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.56 146.51 49.63 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.248 1.965 . . . . 10.0 110.259 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.26 156.12 23.62 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.813 -1.18 . . . . 10.0 107.813 175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -166.35 162.1 16.93 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.894 1.278 . . . . 10.0 107.569 177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -147.75 168.25 22.61 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.799 1.24 . . . . 10.0 108.184 175.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.54 173.63 12.81 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 171.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -160.45 178.13 9.86 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -169.58 177.04 43.32 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.104 -1.998 . . . . 10.0 108.104 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.08 173.56 15.0 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.549 -1.278 . . . . 10.0 107.549 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -142.51 166.05 25.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.684 -1.228 . . . . 10.0 107.684 175.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -156.75 165.07 37.27 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -149.9 138.14 12.14 Favored Pre-proline 0 CA--C 1.535 0.384 0 C-N-CA 123.566 0.747 . . . . 10.0 109.035 -176.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -79.41 173.08 13.63 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.815 2.343 . . . . 10.0 110.438 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.605 HG22 ' HG ' ' A' ' 51' ' ' LEU . 9.9 p -81.89 62.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.907 0.861 . . . . 10.0 111.333 -166.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.6 t -156.6 59.32 0.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.178 -0.952 . . . . 10.0 109.527 -178.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.9 p -127.13 58.35 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 123.101 1.429 . . . . 10.0 110.336 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -154.3 138.76 16.79 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.271 -0.877 . . . . 10.0 109.542 176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.8 166.1 54.82 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 109.435 -1.466 . . . . 10.0 109.435 167.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -112.02 156.28 22.42 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.026 0.913 . . . . 10.0 110.8 -178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 33.4 p -123.7 156.71 35.44 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.885 -1.524 . . . . 10.0 106.885 167.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.8 t -132.1 140.16 48.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.11 38.49 0.35 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.466 0.913 . . . . 10.0 113.466 -169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.02 -145.23 0.26 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.351 1.06 . . . . 10.0 109.933 -171.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.6 t -92.15 108.28 29.42 Favored Pre-proline 0 CA--C 1.531 0.247 0 N-CA-C 105.236 -2.135 . . . . 10.0 105.236 155.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.58 166.63 27.97 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 N-CA-C 108.017 -1.571 . . . . 10.0 108.017 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.05 64.26 5.13 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.589 2.193 . . . . 10.0 110.441 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 7.1 t -166.99 58.91 0.08 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.05 1.34 . . . . 10.0 108.755 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 15.2 mm 76.3 164.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 C-N-CA 125.795 1.638 . . . . 10.0 110.327 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -37.2 63.65 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.851 1.26 . . . . 10.0 111.768 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -47.22 148.9 1.1 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 126.147 1.779 . . . . 10.0 111.52 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.2 t -153.94 -167.11 2.56 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.141 -0.688 . . . . 10.0 109.141 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.68 158.23 43.14 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 123.965 0.906 . . . . 10.0 108.766 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.22 154.06 24.4 Favored 'General case' 0 N--CA 1.447 -0.589 0 O-C-N 124.051 0.844 . . . . 10.0 109.167 171.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -122.04 123.24 41.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 103.691 -2.707 . . . . 10.0 103.691 166.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 4.8 tmm? -156.97 -177.03 6.31 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.8 m -149.08 125.67 11.03 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.591 -1.262 . . . . 10.0 107.591 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.605 ' HG ' HG22 ' A' ' 28' ' ' VAL . 0.8 OUTLIER -83.56 134.89 34.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.213 -1.773 . . . . 10.0 106.213 171.441 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -135.77 97.43 3.65 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 125.045 1.338 . . . . 10.0 108.628 -174.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -84.1 152.61 24.23 Favored 'General case' 0 C--N 1.34 0.156 0 CA-C-N 118.713 0.688 . . . . 10.0 109.977 -178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -139.25 56.72 1.67 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.27 -1.752 . . . . 10.0 106.27 170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.5 t -175.15 164.26 3.27 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 104.164 -2.532 . . . . 10.0 104.164 177.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.67 81.51 1.64 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 123.969 0.793 . . . . 10.0 108.952 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -146.38 148.95 36.14 Favored Pre-proline 0 N--CA 1.453 -0.324 0 C-N-CA 124.666 1.186 . . . . 10.0 108.43 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -73.05 72.88 3.24 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.41 2.74 . . . . 10.0 109.761 174.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 58.8 mt -83.29 156.99 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.88 165.44 28.9 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.475 0.71 . . . . 10.0 110.215 -175.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.455 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.5 OUTLIER -139.13 128.05 23.61 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 104.222 -2.51 . . . . 10.0 104.222 179.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -136.91 52.12 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 122.423 1.106 . . . . 10.0 108.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.47 150.77 20.67 Favored Glycine 0 N--CA 1.447 -0.601 0 O-C-N 121.366 -0.834 . . . . 10.0 111.269 165.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.47 61.96 0.55 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.804 2.442 . . . . 10.0 106.207 169.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.45 91.14 6.81 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 -172.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 69' ' ' ALA . 5.1 t -104.88 133.6 20.07 Favored Pre-proline 0 N--CA 1.449 -0.496 0 C-N-CA 124.795 1.238 . . . . 10.0 109.454 -178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.98 62.36 6.62 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.31 2.673 . . . . 10.0 109.001 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.0 tp -162.97 -48.45 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.156 0 C-N-CA 123.25 0.62 . . . . 10.0 111.093 -161.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' H ' HG23 ' A' ' 66' ' ' THR . . . -96.47 129.22 43.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 18.5 m -69.98 -34.04 72.85 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.07 -0.715 . . . . 10.0 109.07 167.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.6 t -128.84 73.07 81.55 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 124.19 0.996 . . . . 10.0 110.534 -170.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.8 122.68 9.07 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.198 1.932 . . . . 10.0 109.036 170.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 48.5 mtt -145.06 124.27 12.94 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 124.271 1.028 . . . . 10.0 110.015 -172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 69.8 mt -83.05 140.88 32.43 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.081 0.953 . . . . 10.0 109.925 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 37.9 ttm -141.07 152.17 44.6 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.596 1.158 . . . . 10.0 110.537 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.3 p -141.05 115.89 9.72 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.742 1.217 . . . . 10.0 111.284 -161.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 77' ' ' THR 0.31 0.5 OUTLIER -145.83 59.86 1.25 Allowed 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.302 1.223 . . . . 10.0 114.302 164.819 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.475 HG21 HD11 ' A' ' 100' ' ' LEU . 1.1 t -143.84 120.83 11.37 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 120.416 -1.427 . . . . 10.0 109.854 171.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -77.59 61.5 2.35 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.224 1.41 . . . . 10.0 109.422 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.5 m -163.32 -58.15 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 125.045 1.338 . . . . 10.0 109.168 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.6 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -95.16 -93.43 1.71 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 108.663 -1.775 . . . . 10.0 108.663 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.72 97.93 2.02 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 124.354 0.978 . . . . 10.0 110.777 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -94.39 141.14 28.92 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 109.394 -0.595 . . . . 10.0 109.394 171.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 169.75 62.9 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 125.369 1.468 . . . . 10.0 109.817 145.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 44.2 37.94 4.71 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 125.045 1.307 . . . . 10.0 114.685 170.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.4 ttm 58.81 37.83 24.83 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.259 1.423 . . . . 10.0 111.64 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.26 161.78 14.27 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.353 0.661 . . . . 10.0 110.682 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.2 ttp -80.68 114.91 19.9 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 106.992 -1.484 . . . . 10.0 106.992 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.68 168.92 8.56 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 112.888 0.699 . . . . 10.0 112.888 -166.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.416 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.9 Cg_endo -36.85 -58.15 0.57 Allowed 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.246 2.631 . . . . 10.0 111.775 151.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.416 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 37.9 p90 166.54 -170.07 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 128.555 2.742 . . . . 10.0 105.028 -169.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.92 106.79 11.96 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.62 0.768 . . . . 10.0 111.274 175.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 61.4 m -81.62 130.89 35.22 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 107.371 -1.344 . . . . 10.0 107.371 163.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -107.41 131.9 21.37 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.024 -1.102 . . . . 10.0 108.024 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -74.76 139.75 25.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 121.34 1.36 . . . . 10.0 109.834 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 59.45 -151.7 0.41 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.235 0.614 . . . . 10.0 112.319 159.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.72 51.02 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.226 1.411 . . . . 10.0 113.649 168.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.56 153.85 43.13 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.62 1.105 . . . . 10.0 111.843 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 51' ' ' LEU . 13.6 t -146.48 90.63 1.96 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.424 -0.954 . . . . 10.0 108.424 162.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.6 HD13 ' HA3' ' A' ' 81' ' ' GLY . 15.8 tp -84.69 160.87 20.25 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 115.016 -0.993 . . . . 10.0 110.316 -177.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.2 m -130.89 99.5 4.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 105.934 -1.876 . . . . 10.0 105.934 -172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.9 mp -81.85 122.92 28.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 -169.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -155.63 154.55 31.79 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.984 1.313 . . . . 10.0 108.838 -170.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -70.54 76.6 0.58 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.979 0.512 . . . . 10.0 110.833 -172.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.8 t70 155.56 -94.43 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 130.771 3.628 . . . . 10.0 106.207 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.4 73.18 0.32 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.649 2.071 . . . . 10.0 113.898 -168.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.3 t70 67.22 134.66 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.024 2.53 . . . . 10.0 111.207 -172.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -170.08 171.23 7.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.72 0.771 . . . . 10.0 112.004 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.8 t -99.45 116.83 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 104.698 -2.334 . . . . 10.0 104.698 167.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 49.5 mtm -82.83 144.43 30.12 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.964 -1.125 . . . . 10.0 107.964 164.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 81.2 mt -120.25 78.79 1.39 Allowed 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 128.165 2.586 . . . . 10.0 105.154 173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 29.8 mtt -83.69 154.56 23.59 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.15 54.54 32.13 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.393 -1.083 . . . . 10.0 110.393 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.4 tp -61.22 141.48 57.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.532 -0.544 . . . . 10.0 109.532 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -104.43 -64.98 1.06 Allowed 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.979 1.312 . . . . 10.0 109.464 -168.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -59.49 150.24 66.33 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 122.098 0.159 . . . . 10.0 110.914 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.42 102.89 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.016 0 N-CA-C 107.207 -1.882 . . . . 10.0 107.207 159.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 161.02 1.64 Allowed 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.64 0.776 . . . . 10.0 113.034 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 mptt -133.13 129.39 37.84 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.178 -1.416 . . . . 10.0 107.178 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.1 t -65.77 94.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 106.574 -1.639 . . . . 10.0 106.574 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 113.9 15.65 8.46 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.618 1.104 . . . . 10.0 111.967 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.1 167.95 14.97 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 118.963 1.381 . . . . 10.0 107.791 159.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.4 m -155.1 77.41 1.01 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.218 -2.265 . . . . 10.0 107.877 -163.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.1 t -92.9 126.57 45.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 -169.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -75.02 123.47 25.23 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 126' ' ' ILE . 12.6 pt -115.05 133.52 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.877 1.271 . . . . 10.0 108.525 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.7 m -91.03 125.81 35.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.068 -0.716 . . . . 10.0 109.068 174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 24.8 mt -81.63 172.99 12.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.731 -0.84 . . . . 10.0 108.731 173.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -153.28 101.99 2.58 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.41 1.084 . . . . 10.0 108.158 164.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.9 149.05 27.32 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.481 -0.933 . . . . 10.0 108.481 162.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.0 p -42.04 -35.98 1.02 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.234 1.014 . . . . 10.0 111.493 168.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.3 -11.33 9.32 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.682 2.793 . . . . 10.0 112.256 -175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.73 7.87 70.77 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.057 -0.817 . . . . 10.0 111.057 -174.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -82.23 73.41 9.26 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.581 -1.266 . . . . 10.0 107.581 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -84.22 66.56 9.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.753 -1.112 . . . . 10.0 108.765 178.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.6 174.42 11.6 Favored 'General case' 0 C--O 1.224 -0.238 0 C-N-CA 124.039 0.936 . . . . 10.0 109.125 -167.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -120.94 128.64 52.94 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.653 -1.98 . . . . 10.0 105.653 174.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.0 t -125.73 143.43 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.007 -1.108 . . . . 10.0 108.007 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -84.92 126.62 33.65 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.611 -0.885 . . . . 10.0 108.611 172.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -105.1 110.55 22.98 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.334 1.454 . . . . 10.0 109.323 173.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.4 m -88.77 105.63 17.84 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.249 1.42 . . . . 10.0 108.968 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 47.2 t -85.94 95.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.929 -1.138 . . . . 10.0 107.929 -168.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.97 57.48 0.48 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.943 1.247 . . . . 10.0 114.323 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt 62.04 169.91 0.12 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 122.584 1.183 . . . . 10.0 114.06 170.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 30.5 t30 -75.09 95.22 3.03 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.703 -0.851 . . . . 10.0 108.703 -178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 61.0 mt 75.17 -47.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 126.311 1.844 . . . . 10.0 111.963 175.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -34.48 123.52 0.52 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.586 1.954 . . . . 10.0 113.178 -177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 -96.61 0.7 Allowed Glycine 0 CA--C 1.523 0.586 0 N-CA-C 110.268 -1.133 . . . . 10.0 110.268 172.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.108 0 C-N-CA 126.188 1.795 . . . . 10.0 106.578 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.4 162.15 16.22 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.212 -1.155 . . . . 10.0 110.212 -168.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -109.13 -159.9 0.7 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.364 1.466 . . . . 10.0 109.027 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -155.62 -175.94 5.7 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.558 -1.645 . . . . 10.0 106.558 165.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.9 ptm -155.94 146.43 16.07 Favored Pre-proline 0 CA--C 1.531 0.247 0 C-N-CA 124.5 1.12 . . . . 10.0 108.845 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -76.61 165.02 29.6 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.729 2.286 . . . . 10.0 110.63 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -72.98 71.55 1.08 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.357 0.663 . . . . 10.0 109.26 171.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -70.01 74.74 0.47 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.105 0.962 . . . . 10.0 111.818 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 t -58.05 144.6 75.45 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.687 -0.486 . . . . 10.0 109.687 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -66.49 157.37 60.88 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 N-CA-C 108.529 -1.373 . . . . 10.0 108.529 161.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.81 -179.36 5.25 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 123.398 2.732 . . . . 10.0 109.848 171.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.16 151.47 40.14 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 109.308 -0.627 . . . . 10.0 109.308 164.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -117.92 158.88 24.09 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.126 0.97 . . . . 10.0 110.406 -177.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -164.7 169.41 16.88 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.178 -1.786 . . . . 10.0 106.178 171.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.12 144.7 4.81 Favored Pre-proline 0 CA--C 1.531 0.236 0 C-N-CA 123.787 0.835 . . . . 10.0 108.93 178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -80.46 -172.29 1.48 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.236 2.624 . . . . 10.0 109.636 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.83 161.89 35.42 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.146 -1.427 . . . . 10.0 107.146 168.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.51 133.89 11.7 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.187 0.595 . . . . 10.0 109.574 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -60.27 161.9 6.62 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.099 1.36 . . . . 10.0 111.165 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -145.33 -175.22 4.62 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.146 1.379 . . . . 10.0 107.725 -175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 57.04 54.88 6.51 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.024 0.93 . . . . 10.0 111.389 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.05 70.49 1.0 Allowed Glycine 0 CA--C 1.529 0.946 0 N-CA-C 111.166 -0.774 . . . . 10.0 111.166 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.64 69.82 0.44 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.219 1.408 . . . . 10.0 111.085 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -65.68 87.91 0.09 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.014 1.726 . . . . 10.0 109.457 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -171.92 -44.44 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.004 1.321 . . . . 10.0 110.919 -173.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tt -60.7 127.5 87.23 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 121.984 -0.447 . . . . 10.0 110.429 -174.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -74.58 166.77 28.63 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.388 2.059 . . . . 10.0 110.356 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' HG13 ' A' ' 28' ' ' VAL . 7.1 p -82.19 60.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 124.141 0.976 . . . . 10.0 110.567 -166.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 t -157.12 58.19 0.52 Allowed 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.297 -0.877 . . . . 10.0 109.358 -176.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.36 56.98 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 122.078 0.942 . . . . 10.0 110.033 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 -149.92 136.14 18.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.636 -1.246 . . . . 10.0 107.636 167.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.17 132.77 23.74 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 109.083 -1.607 . . . . 10.0 109.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.72 150.94 19.99 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.479 0.64 . . . . 10.0 111.633 -173.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 66.1 p -116.53 123.68 48.02 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.962 0.905 . . . . 10.0 108.646 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 91.4 t -107.22 121.53 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 C-N-CA 123.568 0.747 . . . . 10.0 109.687 -176.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.65 88.14 4.56 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 121.685 -0.634 . . . . 10.0 111.467 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -41.04 122.64 1.81 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 118.636 0.653 . . . . 10.0 110.266 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.2 m -33.65 124.27 0.46 Allowed Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 116.032 1.864 . . . . 10.0 116.032 -144.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -55.31 165.83 2.83 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.929 2.42 . . . . 10.0 112.512 163.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -79.0 54.51 5.2 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.187 1.925 . . . . 10.0 109.346 163.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.7 p -139.49 51.67 1.75 Allowed 'General case' 0 C--N 1.341 0.225 0 O-C-N 121.477 -0.764 . . . . 10.0 110.576 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 43' ' ' ARG . 23.9 mt 86.5 173.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 127.608 2.363 . . . . 10.0 106.794 -167.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 42' ' ' ILE . 18.6 ptt180 -72.57 50.63 0.24 Allowed 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.019 -1.05 . . . . 10.0 110.271 165.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -86.59 158.69 19.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.766 1.226 . . . . 10.0 109.432 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 t -157.82 169.15 25.27 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 157.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -158.01 153.23 25.72 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.984 -1.488 . . . . 10.0 106.984 -173.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.91 147.49 23.7 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 124.469 1.106 . . . . 10.0 108.523 167.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -126.9 127.08 44.35 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.531 -2.396 . . . . 10.0 104.531 173.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 23.2 ptm -161.38 -174.63 4.38 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.06 -1.459 . . . . 10.0 107.06 -172.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -125.5 117.35 23.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.049 0.94 . . . . 10.0 108.848 171.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.86 113.2 20.78 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.479 -2.415 . . . . 10.0 104.479 176.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.2 m -122.42 95.34 4.6 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 125.783 1.927 . . . . 10.0 108.616 -162.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -83.65 140.66 32.04 Favored 'General case' 0 CA--C 1.528 0.127 0 O-C-N 122.064 -0.397 . . . . 10.0 112.004 -169.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -143.75 60.46 1.38 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.075 -1.083 . . . . 10.0 108.075 166.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 17.4 t -151.28 -39.95 0.12 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.916 1.286 . . . . 10.0 111.063 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.4 t70 65.97 60.83 0.66 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 126.556 1.942 . . . . 10.0 110.339 175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -140.89 152.15 64.67 Favored Pre-proline 0 CA--C 1.536 0.408 0 C-N-CA 126.256 1.823 . . . . 10.0 107.643 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.31 92.82 0.91 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.123 2.549 . . . . 10.0 110.658 -178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.2 mm -94.96 145.85 7.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.412 0.625 . . . . 10.0 110.536 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -131.84 83.17 2.07 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 127.375 2.27 . . . . 10.0 109.792 -170.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.0 mt -82.56 72.55 9.62 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.359 -0.838 . . . . 10.0 111.293 -172.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -83.08 56.19 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 121.776 -0.577 . . . . 10.0 110.908 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.39 28.21 Favored Glycine 0 C--N 1.334 0.437 0 O-C-N 121.096 -1.002 . . . . 10.0 111.258 162.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 60.38 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.099 0.96 . . . . 10.0 109.338 164.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.58 162.03 23.29 Favored 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.199 -0.938 . . . . 10.0 109.3 -176.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 147.66 3.55 Favored Pre-proline 0 C--O 1.238 0.496 0 O-C-N 121.831 -0.543 . . . . 10.0 109.54 -177.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.04 57.51 6.5 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.669 2.246 . . . . 10.0 109.038 168.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -143.42 -70.06 0.32 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.182 0.593 . . . . 10.0 109.983 -174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.33 167.03 11.93 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.911 1.284 . . . . 10.0 110.798 178.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 29.6 m -101.89 -39.83 7.18 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.601 1.16 . . . . 10.0 112.168 -157.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.9 t -108.95 90.91 8.32 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 124.533 1.133 . . . . 10.0 109.726 -171.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -77.55 90.51 1.25 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.008 2.472 . . . . 10.0 109.862 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -108.91 114.19 27.73 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.849 0.833 . . . . 10.0 109.637 -170.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.1 mp -80.24 134.22 36.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.728 -0.841 . . . . 10.0 108.728 -176.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.84 174.98 6.53 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.605 1.562 . . . . 10.0 108.035 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 9.2 t -159.88 135.06 8.07 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 173.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.96 56.75 0.53 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 122.507 1.146 . . . . 10.0 107.961 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.6 m -149.58 123.36 9.26 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 123.726 0.81 . . . . 10.0 109.848 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -70.47 80.95 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 173.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.7 t 143.9 -9.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.684 3.193 . . . . 10.0 110.507 -178.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.54 -140.7 9.26 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 109.204 -1.558 . . . . 10.0 109.204 169.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.76 -54.25 39.14 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 111.633 -0.587 . . . . 10.0 111.633 177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.3 tpt -169.92 -166.32 0.55 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.022 2.129 . . . . 10.0 107.479 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -121.69 60.58 0.95 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 -177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.65 89.47 0.11 Allowed Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.455 -1.058 . . . . 10.0 110.455 -163.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -76.65 64.65 2.31 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.196 0.998 . . . . 10.0 110.687 -171.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.08 167.75 10.71 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.832 2.053 . . . . 10.0 108.181 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.9 mtt -78.83 85.34 4.82 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.012 -1.477 . . . . 10.0 107.012 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.1 m -73.51 156.25 88.89 Favored Pre-proline 0 N--CA 1.453 -0.315 0 N-CA-C 109.562 -0.533 . . . . 10.0 109.562 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -51.33 -38.55 62.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.866 2.377 . . . . 10.0 111.144 171.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.494 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 30.6 p90 -176.8 171.89 2.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 127.71 2.404 . . . . 10.0 104.872 174.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -99.76 98.11 8.97 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 108.883 -0.784 . . . . 10.0 108.883 170.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.494 ' HG1' ' HE1' ' A' ' 91' ' ' TRP . 0.3 OUTLIER -77.34 131.12 37.94 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.9 pp -101.95 109.77 60.61 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -80.43 69.8 7.79 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 122.723 2.282 . . . . 10.0 110.189 -170.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.73 175.29 0.2 Allowed 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 -167.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 35.72 23.59 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 118.651 2.834 . . . . 10.0 118.651 178.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -45.92 102.76 0.05 OUTLIER Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.411 1.005 . . . . 10.0 112.057 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.6 m -131.25 55.97 1.83 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 105.925 -1.88 . . . . 10.0 105.925 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.494 HD13 ' H ' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -101.7 164.29 11.82 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.2 m -128.85 114.74 16.9 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 104.997 -2.223 . . . . 10.0 104.997 -168.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mp -79.19 110.34 14.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 104.552 -2.388 . . . . 10.0 104.552 -175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -130.99 148.51 52.76 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.698 1.999 . . . . 10.0 108.981 -172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -26.56 -53.15 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.159 2.184 . . . . 10.0 113.896 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -139.95 64.85 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.389 0.676 . . . . 10.0 109.622 170.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.12 66.46 0.2 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 177.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 9.2 t0 65.34 149.15 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.55 0 C-N-CA 125.462 1.505 . . . . 10.0 109.824 -165.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 160.66 175.12 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 126.478 1.911 . . . . 10.0 111.539 -174.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.56 128.26 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.191 -1.781 . . . . 10.0 106.191 166.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.5 mtm -92.63 109.06 20.47 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.093 -1.077 . . . . 10.0 108.093 168.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -84.32 77.6 9.96 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.224 -1.769 . . . . 10.0 106.224 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 25.4 ttt -83.76 154.34 23.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 109.57 -0.53 . . . . 10.0 109.57 -168.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.86 74.65 1.26 Allowed Glycine 0 C--N 1.336 0.556 0 O-C-N 121.212 -0.93 . . . . 10.0 110.992 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.5 pp -50.24 138.64 16.11 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.664 1.232 . . . . 10.0 111.626 175.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -79.86 -59.39 2.75 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 108.504 -0.924 . . . . 10.0 108.504 162.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 179.11 -59.64 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 124.553 1.141 . . . . 10.0 112.763 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.68 89.11 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 121.84 1.694 . . . . 10.0 111.557 -166.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.82 156.53 44.51 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.832 1.253 . . . . 10.0 109.05 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.67 145.88 7.98 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 105.977 -1.86 . . . . 10.0 105.977 177.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 79.8 t -71.62 105.75 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 106.916 -1.512 . . . . 10.0 106.916 165.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 163.54 -60.83 0.26 Allowed Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.517 -1.033 . . . . 10.0 110.517 177.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -71.99 -174.11 1.16 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 129.933 3.293 . . . . 10.0 111.618 -163.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.0 m -133.87 128.33 34.41 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 126.149 1.78 . . . . 10.0 106.664 174.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 71.9 t -122.53 140.09 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -77.97 126.21 30.5 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 108.319 -0.993 . . . . 10.0 108.319 174.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -80.28 179.12 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 106.23 -1.767 . . . . 10.0 106.23 170.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.4 m -144.31 114.24 7.31 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 120.835 -1.166 . . . . 10.0 108.838 166.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.99 140.85 31.62 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.373 -1.714 . . . . 10.0 106.373 170.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -147.08 86.5 1.64 Allowed 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.129 -1.434 . . . . 10.0 107.129 173.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.06 145.76 28.3 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 122.339 0.256 . . . . 10.0 110.919 -169.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 3.9 t -56.39 -24.58 45.56 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.553 1.141 . . . . 10.0 111.375 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.77 -26.63 14.88 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 124.778 1.231 . . . . 10.0 113.238 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 99.65 52.33 1.22 Allowed Glycine 0 C--N 1.335 0.508 0 N-CA-C 109.75 -1.34 . . . . 10.0 109.75 175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -144.78 160.45 41.23 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 172.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 32.3 m -131.45 143.79 50.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.006 -2.22 . . . . 10.0 105.006 175.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 28.6 tp -151.96 154.56 36.29 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 108.09 -1.078 . . . . 10.0 108.09 -177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.8 p-10 -137.98 62.51 1.57 Allowed 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 125.527 1.531 . . . . 10.0 109.706 -161.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 42.1 t -80.66 141.11 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 109.318 -0.623 . . . . 10.0 109.318 -169.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.57 124.63 30.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -120.01 130.61 54.81 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.057 0.943 . . . . 10.0 109.945 -178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -84.34 126.75 33.49 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 108.478 -0.934 . . . . 10.0 108.478 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.56 HG12 ' HB2' ' A' ' 37' ' ' ALA . 7.8 t -87.12 100.78 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 N-CA-C 106.586 -1.635 . . . . 10.0 106.586 -174.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -146.59 123.14 11.1 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.366 1.866 . . . . 10.0 108.194 -170.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -55.68 -50.6 69.84 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.591 0.756 . . . . 10.0 110.36 172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 62.0 -171.56 0.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.133 -0.692 . . . . 10.0 109.133 -159.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 31.3 pt -67.26 145.2 13.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 168.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -149.17 -179.42 7.03 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 106.208 -1.775 . . . . 10.0 106.208 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 145.81 56.16 0.02 OUTLIER Glycine 0 C--N 1.336 0.557 0 N-CA-C 109.634 -1.387 . . . . 10.0 109.634 175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 . . . . . 0 C--O 1.262 1.721 0 N-CA-C 102.404 -3.184 . . . . 10.0 102.404 -135.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 107.497 -1.297 . . . . 10.0 107.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.28 -178.79 47.61 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.369 -2.292 . . . . 10.0 107.369 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.4 t-80 -160.01 164.25 33.39 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.0 m -152.53 147.06 25.76 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.236 -1.765 . . . . 10.0 106.236 172.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.61 151.69 54.53 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 125.329 1.452 . . . . 10.0 108.561 -177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -72.27 177.03 7.77 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.642 2.228 . . . . 10.0 110.52 176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.85 165.68 30.8 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.19 -1.411 . . . . 10.0 107.19 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -148.72 176.18 10.58 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 124.598 1.159 . . . . 10.0 108.042 -175.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -154.07 135.45 8.84 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 106.846 -1.539 . . . . 10.0 106.846 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.86 159.42 48.28 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.167 1.911 . . . . 10.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -74.81 -178.69 4.29 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.231 2.621 . . . . 10.0 110.448 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.47 164.89 28.67 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.915 1.286 . . . . 10.0 107.649 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -144.25 166.94 23.64 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.582 1.153 . . . . 10.0 108.339 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 p -138.74 141.52 38.88 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.528 1.531 . . . . 10.0 107.396 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.83 149.76 66.72 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 124.495 1.118 . . . . 10.0 108.941 178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -75.85 178.41 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 123.136 2.557 . . . . 10.0 110.692 177.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -153.1 166.52 32.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.96 1.304 . . . . 10.0 107.613 174.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -162.16 168.84 21.85 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.634 1.174 . . . . 10.0 107.923 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.33 148.6 27.7 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 106.97 -1.493 . . . . 10.0 106.97 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.94 136.96 7.2 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.05 1.34 . . . . 10.0 107.748 174.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -159.77 172.29 17.96 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 107.302 -1.369 . . . . 10.0 107.302 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.67 -160.01 28.08 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.303 -1.119 . . . . 10.0 110.303 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 56.32 -157.11 0.27 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.774 1.23 . . . . 10.0 110.146 -173.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 59.57 -143.21 0.58 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.195 0.598 . . . . 10.0 109.712 173.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.47 148.6 26.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 171.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tt -94.48 122.07 61.89 Favored Pre-proline 0 N--CA 1.453 -0.309 0 N-CA-C 108.601 -0.889 . . . . 10.0 108.601 -177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.85 159.35 48.47 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 121.907 1.738 . . . . 10.0 109.607 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.5 m -82.45 53.12 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.229 0.538 . . . . 10.0 112.073 -167.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 76.7 p -157.3 62.27 0.49 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.624 -0.88 . . . . 10.0 108.624 -176.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.3 p -108.85 60.09 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.722 0.809 . . . . 10.0 109.257 176.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -133.6 144.4 49.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.961 0.905 . . . . 10.0 110.954 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.94 86.84 1.11 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.38 139.84 29.18 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.809 0.444 . . . . 10.0 111.941 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.6 p -117.3 140.51 49.47 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.851 -1.166 . . . . 10.0 107.851 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.0 134.25 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.224 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 171.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.69 120.96 12.81 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 172.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -52.96 -68.89 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.563 0.697 . . . . 10.0 110.322 178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -142.43 104.96 5.48 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 125.728 1.611 . . . . 10.0 107.541 172.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -64.94 164.89 23.08 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.549 2.166 . . . . 10.0 109.882 171.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.75 66.71 5.77 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.784 2.989 . . . . 10.0 109.601 173.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.9 t -156.32 -48.01 0.07 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.064 2.146 . . . . 10.0 106.628 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.6 mt 72.03 147.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 126.244 1.818 . . . . 10.0 108.672 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 47.3 ttt85 75.53 -49.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.271 1.429 . . . . 10.0 111.766 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -79.67 153.94 28.99 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.833 -0.803 . . . . 10.0 108.833 168.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -171.9 172.57 4.74 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.144 1.378 . . . . 10.0 109.177 172.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -157.07 161.76 39.47 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 123.61 0.764 . . . . 10.0 111.816 -172.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.03 140.4 29.86 Favored 'General case' 0 N--CA 1.456 -0.169 0 O-C-N 124.401 1.063 . . . . 10.0 109.441 167.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 25.7 m-85 -136.18 112.83 10.11 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 107.392 -1.336 . . . . 10.0 107.392 -174.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -163.48 -172.23 2.85 Favored 'General case' 0 C--O 1.224 -0.287 0 C-N-CA 125.149 1.38 . . . . 10.0 109.396 -174.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.0 m -125.11 121.63 34.83 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.253 1.021 . . . . 10.0 109.868 177.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.81 135.69 34.89 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 120.188 1.358 . . . . 10.0 107.62 175.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.2 m -117.75 78.53 1.25 Allowed 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 124.806 1.316 . . . . 10.0 109.876 -169.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.47 100.33 8.47 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.438 0.637 . . . . 10.0 109.867 -177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -109.4 54.68 0.65 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.11 0.964 . . . . 10.0 109.68 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.0 p -177.89 148.0 0.5 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 175.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -88.87 69.32 8.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.772 0.829 . . . . 10.0 109.576 -173.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -128.97 127.18 23.37 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 109.347 -0.612 . . . . 10.0 109.347 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.18 99.81 1.12 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.362 2.708 . . . . 10.0 110.61 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -97.9 141.79 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.432 ' NZ ' ' OD1' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -126.62 97.37 4.99 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.011 1.325 . . . . 10.0 108.516 171.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 HD22 ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -81.42 132.61 35.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 175.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.2 t -139.18 53.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 107.373 -1.343 . . . . 10.0 107.373 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.3 158.94 31.75 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 110.63 -0.988 . . . . 10.0 110.63 163.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.87 127.21 6.5 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 158.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -152.46 144.06 23.48 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.729 -1.212 . . . . 10.0 107.729 -177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -172.55 155.99 3.37 Favored Pre-proline 0 C--O 1.237 0.407 0 CA-C-N 118.352 0.524 . . . . 10.0 111.223 -163.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.27 -5.5 13.98 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.802 2.334 . . . . 10.0 112.599 164.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 tt -72.66 -57.26 4.25 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.505 1.048 . . . . 10.0 111.892 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.51 161.07 37.38 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.554 1.141 . . . . 10.0 111.871 -168.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.7 m -93.46 -41.31 9.86 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.701 1.2 . . . . 10.0 111.74 -168.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.7 t -115.86 82.45 10.71 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.685 1.594 . . . . 10.0 109.498 -172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.75 107.5 2.46 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.897 2.398 . . . . 10.0 109.988 176.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 24.8 mmt -122.76 122.19 38.12 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.418 1.487 . . . . 10.0 109.352 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 22.6 mt -83.15 138.33 33.7 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.726 0.81 . . . . 10.0 109.292 178.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.03 168.03 12.42 Favored 'General case' 0 CA--C 1.521 -0.143 0 C-N-CA 124.877 1.271 . . . . 10.0 110.137 173.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 9.9 t -139.74 119.86 13.68 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 107.88 -1.155 . . . . 10.0 107.88 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 m -141.18 48.29 1.68 Allowed 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.3 m -156.43 80.54 0.97 Allowed 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.058 -1.026 . . . . 10.0 109.799 -178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 42.0 t-80 -59.57 86.28 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.257 1.023 . . . . 10.0 110.592 175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 35.9 t 165.89 -41.56 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 127.452 2.301 . . . . 10.0 108.486 -173.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.41 -83.34 1.32 Allowed Glycine 0 C--N 1.338 0.655 0 N-CA-C 106.168 -2.773 . . . . 10.0 106.168 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -88.02 -138.62 6.1 Favored Glycine 0 CA--C 1.533 1.183 0 N-CA-C 110.053 -1.219 . . . . 10.0 110.053 160.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.2 mmt -108.06 -161.5 0.78 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 127.155 2.182 . . . . 10.0 109.79 -177.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -124.55 76.26 1.48 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -156.63 82.32 0.16 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.686 -1.365 . . . . 10.0 109.686 -170.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.5 tmm? -77.64 60.61 2.2 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 122.159 0.981 . . . . 10.0 110.386 -172.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -125.62 170.96 10.98 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.444 2.298 . . . . 10.0 107.481 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 63.8 mtt -80.24 72.87 7.1 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.67 -0.863 . . . . 10.0 108.67 -172.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.87 155.8 75.91 Favored Pre-proline 0 N--CA 1.451 -0.413 0 CA-C-N 115.076 -0.966 . . . . 10.0 109.62 176.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -60.69 -25.71 81.49 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.225 1.95 . . . . 10.0 112.359 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -175.73 179.57 1.37 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.394 1.878 . . . . 10.0 106.451 171.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 2.2 pp -113.77 106.81 14.92 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.56 150.81 34.7 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 108.405 -0.961 . . . . 10.0 108.405 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.9 pt -116.99 88.8 27.68 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -78.88 57.72 6.55 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.904 3.069 . . . . 10.0 110.718 -169.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.47 154.95 0.06 Allowed 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 122.698 1.237 . . . . 10.0 110.108 -164.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 12.5 mmt180 40.3 39.94 0.75 Allowed 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.201 1.401 . . . . 10.0 114.733 -175.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 69.56 0.17 Allowed Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.619 -0.993 . . . . 10.0 110.619 160.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 2.8 t -84.55 57.0 4.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.324 -1.361 . . . . 10.0 107.324 167.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.76 171.62 8.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.849 0.833 . . . . 10.0 110.54 -167.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 t -128.4 128.98 45.51 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.147 -2.168 . . . . 10.0 105.147 -170.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.9 mp -118.92 103.58 9.73 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 104.092 -2.558 . . . . 10.0 104.092 -171.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.2 pm0 -147.42 175.21 10.99 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.685 -1.598 . . . . 10.0 106.685 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -39.63 -50.15 2.24 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.208 0.527 . . . . 10.0 111.877 174.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -98.76 16.15 23.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 128.219 2.608 . . . . 10.0 113.911 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.35 151.67 23.89 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 120.559 1.527 . . . . 10.0 111.362 -179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -34.98 97.41 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.043 1.737 . . . . 10.0 113.633 -169.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.6 p-80 -128.29 174.67 9.1 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 119.728 1.149 . . . . 10.0 112.003 -166.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 t -110.91 107.97 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 106.603 -1.629 . . . . 10.0 106.603 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 6.6 mtt -84.1 102.72 12.75 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-O 122.297 1.046 . . . . 10.0 108.906 172.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.8 mt -83.54 70.0 10.18 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 105.669 -1.974 . . . . 10.0 105.669 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.5 ttm -83.72 148.53 27.02 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.459 -0.571 . . . . 10.0 109.459 -168.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 81.34 59.65 2.36 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 109.612 -1.395 . . . . 10.0 109.612 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.4 tt -50.47 128.06 19.12 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.307 1.843 . . . . 10.0 110.241 176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -86.61 -71.64 0.54 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.071 0.549 . . . . 10.0 110.146 174.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -79.61 158.0 73.99 Favored Pre-proline 0 CA--C 1.533 0.319 0 O-C-N 121.982 -0.449 . . . . 10.0 110.135 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.3 73.86 3.78 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.317 2.012 . . . . 10.0 109.152 169.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -48.76 132.3 17.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.03 0.932 . . . . 10.0 112.789 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -96.35 129.63 43.65 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.336 1.454 . . . . 10.0 109.492 -171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 86.2 t -56.4 105.82 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 164.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 117.95 -5.08 16.2 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.912 -0.938 . . . . 10.0 112.313 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -70.19 -178.47 1.67 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.727 1.727 . . . . 10.0 108.735 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.9 m -155.66 124.59 6.11 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 105.614 -1.995 . . . . 10.0 105.614 173.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 64.7 t -137.97 145.14 29.27 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.115 -0.698 . . . . 10.0 109.115 -168.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -74.92 130.33 39.2 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.388 -0.369 . . . . 10.0 110.162 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 23.9 pt -106.91 122.0 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 107.561 -1.274 . . . . 10.0 107.561 160.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.2 m -101.16 119.98 39.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.32 169.12 8.74 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.645 0.778 . . . . 10.0 110.029 174.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -143.65 96.6 2.93 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.17 1.788 . . . . 10.0 107.872 177.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.63 132.18 34.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.395 -0.595 . . . . 10.0 109.395 164.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.8 t -60.91 -15.49 31.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.262 0.625 . . . . 10.0 111.388 172.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.432 ' OD1' ' NZ ' ' A' ' 60' ' ' LYS . 54.6 m-20 -67.17 -21.14 65.81 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.906 0.883 . . . . 10.0 112.059 171.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 131.33 -13.05 5.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.099 0.857 . . . . 10.0 112.418 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 66.0 mtp85 -81.07 73.02 8.13 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.872 1.336 . . . . 10.0 109.356 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 51.6 m -83.61 107.05 15.81 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.88 -1.896 . . . . 10.0 105.88 156.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 48.4 tp -156.11 149.42 24.56 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -170.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 14.6 p-10 -106.22 131.03 53.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.295 2.238 . . . . 10.0 106.826 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.8 t -131.23 122.93 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 106.321 -1.733 . . . . 10.0 106.321 -170.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.8 108.28 16.03 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -99.07 143.22 29.59 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.626 0.77 . . . . 10.0 109.665 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -82.26 127.21 32.97 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.342 -0.985 . . . . 10.0 108.342 -176.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 91.1 t -90.0 91.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.204 -1.776 . . . . 10.0 106.204 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.9 pttt -158.67 140.01 13.26 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 107.555 -1.276 . . . . 10.0 107.555 166.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -74.07 153.12 39.76 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -145.53 141.02 27.88 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 105.023 -2.214 . . . . 10.0 105.023 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 43.4 pt 44.85 37.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 125.252 1.421 . . . . 10.0 112.315 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -150.28 95.26 2.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.101 -1.444 . . . . 10.0 107.101 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.53 -59.03 4.12 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 109.077 -1.609 . . . . 10.0 109.077 -162.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 89.1 mtt-85 . . . . . 0 C--O 1.25 1.094 0 N-CA-C 105.472 -2.048 . . . . 10.0 105.472 161.062 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 106.657 -1.608 . . . . 10.0 106.657 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.49 152.95 8.61 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.266 -1.134 . . . . 10.0 110.266 -171.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -168.88 172.24 7.86 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.5 t -160.75 179.37 8.59 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.805 0.729 . . . . 10.0 109.408 174.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.24 74.85 0.73 Allowed Pre-proline 0 CA--C 1.539 0.545 0 C-N-CA 126.363 1.865 . . . . 10.0 108.042 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.82 154.85 67.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.894 1.729 . . . . 10.0 109.757 175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.09 170.62 18.87 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -158.25 167.63 29.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 107.04 -1.467 . . . . 10.0 107.04 176.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 t -157.23 69.06 4.33 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.149 1.379 . . . . 10.0 108.566 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.35 151.69 82.7 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.187 1.925 . . . . 10.0 110.639 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.89 176.12 10.3 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.197 2.598 . . . . 10.0 111.03 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -144.3 164.81 29.69 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 125.058 1.343 . . . . 10.0 107.529 173.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -161.14 164.03 30.9 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 107.035 -1.469 . . . . 10.0 107.035 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -156.25 -175.25 5.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.98 87.14 2.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 C-N-CA 124.831 1.252 . . . . 10.0 109.344 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -73.5 162.8 39.19 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.242 1.961 . . . . 10.0 110.599 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.19 171.96 18.27 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.258 1.423 . . . . 10.0 107.302 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.85 166.05 32.79 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.864 0.866 . . . . 10.0 108.816 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -78.33 -172.55 2.89 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.397 0.679 . . . . 10.0 110.332 173.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 pttt -156.47 174.48 15.37 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.241 1.016 . . . . 10.0 108.459 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 61.07 -146.75 0.44 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.432 1.093 . . . . 10.0 110.574 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.34 -63.12 2.6 Favored Glycine 0 CA--C 1.529 0.966 0 N-CA-C 111.241 -0.743 . . . . 10.0 111.241 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.72 97.22 0.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.446 0.698 . . . . 10.0 110.04 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -71.23 75.36 0.71 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.463 0.705 . . . . 10.0 110.941 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -158.13 172.82 17.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.442 1.897 . . . . 10.0 106.769 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tt -143.27 128.89 10.08 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 118.597 0.635 . . . . 10.0 109.739 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -77.86 177.48 8.75 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 122.634 2.222 . . . . 10.0 109.647 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 p -82.32 61.29 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 122.277 1.037 . . . . 10.0 111.647 -166.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -158.03 74.81 0.73 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.1 53.4 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 122.151 0.977 . . . . 10.0 110.281 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -152.7 139.11 18.54 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.963 -1.125 . . . . 10.0 107.963 163.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -75.75 147.62 35.55 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.092 -1.203 . . . . 10.0 110.092 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.12 152.52 29.24 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 117.764 0.782 . . . . 10.0 110.443 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.7 p -133.44 125.73 29.67 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.751 -1.574 . . . . 10.0 106.751 170.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.47 137.84 45.18 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 C-N-CA 124.436 1.095 . . . . 10.0 110.012 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.45 98.94 2.36 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 120.227 -0.589 . . . . 10.0 111.808 -175.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.79 114.32 0.96 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.574 1.15 . . . . 10.0 111.286 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.7 t 2.9 94.57 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 128.134 2.574 . . . . 10.0 113.365 -167.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -70.23 169.22 20.02 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.95 1.767 . . . . 10.0 108.487 175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.74 60.11 4.31 Favored 'Trans proline' 0 CA--C 1.537 0.626 0 C-N-CA 122.812 2.341 . . . . 10.0 109.887 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.2 t -160.17 40.61 0.18 Allowed 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.234 1.414 . . . . 10.0 108.429 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.588 HG22 ' H ' ' A' ' 43' ' ' ARG . 9.4 mm 69.48 -179.31 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.034 1.333 . . . . 10.0 109.081 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.588 ' H ' HG22 ' A' ' 42' ' ' ILE . 9.0 ptm180 -55.55 -29.11 58.38 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.064 0.946 . . . . 10.0 112.108 176.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.42 135.9 7.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.784 1.634 . . . . 10.0 109.67 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.4 t -160.82 -171.21 3.01 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 -174.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . . . -156.29 167.41 30.53 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.403 1.081 . . . . 10.0 109.828 170.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -105.67 153.12 22.27 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 123.909 0.755 . . . . 10.0 111.208 171.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 46' ' ' ALA . 33.0 m-85 -138.52 112.33 8.39 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.571 -1.64 . . . . 10.0 106.571 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -162.25 -171.96 3.02 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 126.02 1.728 . . . . 10.0 107.634 -168.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.3 t -128.01 145.72 50.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.648 0.658 . . . . 10.0 111.592 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.3 mp -90.35 113.31 25.16 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 105.403 -2.073 . . . . 10.0 105.403 156.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.1 m -120.03 82.17 1.85 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.322 -0.992 . . . . 10.0 108.322 -170.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -82.66 137.47 34.46 Favored 'General case' 0 C--N 1.337 0.06 0 O-C-N 121.689 -0.632 . . . . 10.0 110.335 -168.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 mmmt -128.48 54.66 1.74 Allowed 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 106.947 -1.501 . . . . 10.0 106.947 171.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -158.33 128.88 6.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.584 1.954 . . . . 10.0 105.774 170.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -76.59 61.92 1.86 Allowed 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.863 0.865 . . . . 10.0 110.119 177.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -134.27 135.98 25.1 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 125.392 1.477 . . . . 10.0 108.602 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -78.15 100.58 1.39 Allowed 'Trans proline' 0 CA--C 1.535 0.545 0 C-N-CA 123.495 2.796 . . . . 10.0 111.167 -177.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -110.26 95.99 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 109.271 -0.64 . . . . 10.0 109.271 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -82.73 117.68 22.82 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.748 0.819 . . . . 10.0 110.604 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.8 OUTLIER -88.8 123.37 33.13 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 125.424 1.49 . . . . 10.0 107.88 -174.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.424 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 7.1 p -143.54 55.52 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 121.695 0.759 . . . . 10.0 110.425 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.01 148.45 16.41 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.472 -1.451 . . . . 10.0 109.472 162.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.97 75.83 0.84 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.13 0.972 . . . . 10.0 109.029 171.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.53 157.52 16.18 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.498 0.719 . . . . 10.0 109.676 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -172.54 143.27 1.21 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.206 -1.405 . . . . 10.0 107.206 178.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -75.94 60.97 6.27 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 123.242 2.628 . . . . 10.0 109.777 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.68 -51.64 0.08 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.435 1.094 . . . . 10.0 108.471 -164.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -96.43 168.69 10.4 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 126.475 1.91 . . . . 10.0 109.837 169.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.1 m -134.6 -2.31 2.72 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.311 0.644 . . . . 10.0 112.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 m -152.11 70.44 7.71 Favored Pre-proline 0 CA--C 1.536 0.411 0 O-C-N 120.852 -1.155 . . . . 10.0 109.885 -170.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.61 128.9 11.35 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.84 2.36 . . . . 10.0 111.29 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 21.9 mmt -139.64 128.73 23.73 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.999 1.32 . . . . 10.0 109.453 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.3 mt -84.46 136.87 33.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.683 0.793 . . . . 10.0 109.673 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -104.67 -179.36 3.92 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.875 1.67 . . . . 10.0 108.93 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.0 t -158.88 100.8 1.6 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.485 0.714 . . . . 10.0 109.687 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 t -149.96 56.82 0.96 Allowed 'General case' 0 C--O 1.221 -0.395 0 O-C-N 121.257 -0.902 . . . . 10.0 109.24 -169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 t -124.46 146.36 48.98 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.926 1.29 . . . . 10.0 108.91 176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -101.74 44.92 0.99 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 169.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.0 t -163.93 -52.59 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.243 0.617 . . . . 10.0 111.184 -174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -83.88 -110.4 0.57 Allowed Glycine 0 CA--C 1.532 1.139 0 N-CA-C 111.232 -0.747 . . . . 10.0 111.232 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -71.24 -144.86 0.35 Allowed Glycine 0 CA--C 1.537 1.423 0 CA-C-N 118.098 0.949 . . . . 10.0 113.699 170.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 38.4 ttm -75.82 162.88 27.78 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.865 1.266 . . . . 10.0 109.952 -177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.6 49.94 0.94 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.999 1.72 . . . . 10.0 107.756 -171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -145.7 92.25 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.565 -1.014 . . . . 10.0 110.565 -166.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 30.2 ttp -64.21 84.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.554 1.177 . . . . 10.0 112.052 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -133.28 156.66 47.16 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.214 2.606 . . . . 10.0 106.769 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.4 mtm -80.38 143.49 33.46 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 106.913 -1.514 . . . . 10.0 106.913 174.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -141.93 165.1 29.96 Favored Pre-proline 0 N--CA 1.455 -0.205 0 C-N-CA 123.686 0.794 . . . . 10.0 109.776 -171.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -43.51 -54.37 3.67 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.686 2.257 . . . . 10.0 110.404 158.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.424 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 175.36 -149.58 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 127.151 2.181 . . . . 10.0 108.613 -177.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.86 158.27 43.87 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.332 1.853 . . . . 10.0 106.054 160.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 29.5 m -97.47 124.57 41.73 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 108.52 -0.918 . . . . 10.0 108.52 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -90.49 121.73 68.05 Favored Pre-proline 0 N--CA 1.454 -0.232 0 N-CA-C 105.325 -2.102 . . . . 10.0 105.325 171.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -80.97 146.15 16.03 Favored 'Trans proline' 0 N--CA 1.441 -1.571 0 N-CA-C 109.261 -1.092 . . . . 10.0 109.261 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 47.36 -138.4 0.71 Allowed 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.958 0.903 . . . . 10.0 112.539 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -65.67 32.83 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 127.747 2.419 . . . . 10.0 114.494 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.8 150.76 38.6 Favored Glycine 0 CA--C 1.532 1.133 0 O-C-N 120.994 -1.066 . . . . 10.0 113.075 -169.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 11.0 t -132.01 61.66 1.65 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.988 1.315 . . . . 10.0 108.359 -171.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -80.65 148.58 30.17 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 107.365 -1.346 . . . . 10.0 107.365 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 27.9 m -135.47 107.54 7.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 -173.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.3 mp -79.22 114.35 18.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.775 -2.306 . . . . 10.0 104.775 -175.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -131.53 159.75 37.27 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 125.249 1.42 . . . . 10.0 109.845 -171.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 48' ' ' TYR . 0.0 OUTLIER -25.0 -65.26 0.05 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 127.201 2.2 . . . . 10.0 113.566 -173.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -124.09 80.63 1.84 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 106.377 -1.712 . . . . 10.0 106.377 163.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.83 86.76 0.1 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 108.86 -1.696 . . . . 10.0 108.86 -175.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.5 t0 40.95 74.61 0.1 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.129 1.771 . . . . 10.0 112.176 170.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -131.07 172.31 12.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.332 -1.758 . . . . 10.0 110.867 -154.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.7 108.21 24.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 125.668 1.587 . . . . 10.0 108.715 -173.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 33.0 mtp -83.04 96.39 8.34 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.405 0.682 . . . . 10.0 109.723 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.48 70.17 7.12 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.809 -1.552 . . . . 10.0 106.809 172.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -80.22 164.99 22.82 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.431 -1.322 . . . . 10.0 107.431 -168.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.28 46.57 20.33 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.323 -1.111 . . . . 10.0 110.323 174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 98.4 mt -55.27 130.27 41.65 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 118.737 1.268 . . . . 10.0 108.917 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.84 -69.17 0.13 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.927 -0.559 . . . . 10.0 109.506 -177.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 173.97 -63.63 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 125.221 1.409 . . . . 10.0 112.91 177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -83.09 50.14 3.24 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.544 2.163 . . . . 10.0 112.741 -159.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pp -100.54 157.01 16.97 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.212 1.005 . . . . 10.0 110.52 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 171.93 7.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.954 -1.128 . . . . 10.0 107.954 -172.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 6.5 p -95.27 128.09 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.247 -1.76 . . . . 10.0 106.247 163.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 78.56 33.17 39.42 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.499 -0.64 . . . . 10.0 111.499 -174.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -84.96 -172.7 4.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 122.462 1.125 . . . . 10.0 108.486 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 35.6 m -155.81 124.78 6.09 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 126.027 1.731 . . . . 10.0 107.499 171.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.3 t -138.89 152.5 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 106.96 -1.496 . . . . 10.0 106.96 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -70.87 132.23 44.95 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 109.139 -0.689 . . . . 10.0 109.139 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.0 154.03 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 106.125 -1.805 . . . . 10.0 106.125 155.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.7 m -129.82 128.49 42.44 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 158.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.3 pp -114.41 156.39 24.58 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.257 -1.016 . . . . 10.0 108.257 173.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 11.1 tmtt? -147.7 69.41 1.14 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.906 -1.516 . . . . 10.0 106.906 -169.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.69 117.69 21.59 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 108.727 -0.842 . . . . 10.0 108.727 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.1 p 40.95 -99.79 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.585 1.554 . . . . 10.0 109.896 -167.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -149.26 42.79 0.93 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.27 2.228 . . . . 10.0 107.411 170.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -124.09 -48.12 0.23 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.22 1.866 . . . . 10.0 110.166 -172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -115.1 73.2 0.82 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.093 0.947 . . . . 10.0 108.637 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 70.4 m -86.29 100.94 12.63 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 160.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.2 mt -155.3 164.41 38.81 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 122.736 0.415 . . . . 10.0 110.547 -165.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -132.46 65.28 1.59 Allowed 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 126.712 2.005 . . . . 10.0 109.553 -159.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 54.7 t -81.71 149.3 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 -171.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.9 137.32 35.23 Favored 'General case' 0 C--O 1.233 0.217 0 O-C-N 121.151 -0.968 . . . . 10.0 109.626 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -114.66 120.48 40.29 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.844 1.258 . . . . 10.0 109.739 175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 14.2 t -83.78 148.47 27.01 Favored 'General case' 0 N--CA 1.461 0.123 0 N-CA-C 107.69 -1.226 . . . . 10.0 107.69 166.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.9 t -112.73 100.03 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -156.8 126.81 6.37 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 119.294 0.952 . . . . 10.0 110.829 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 98.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.441 0.564 . . . . 10.0 111.39 171.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -72.45 75.84 1.04 Allowed 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.496 0.718 . . . . 10.0 109.958 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 29.5 mt 67.5 77.03 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 124.45 1.1 . . . . 10.0 108.877 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -145.91 105.93 4.02 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 78.56 -64.31 3.59 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 108.27 -1.932 . . . . 10.0 108.27 -158.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 . . . . . 0 C--O 1.255 1.353 0 N-CA-C 105.886 -1.894 . . . . 10.0 105.886 165.465 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ptm . . . . . 0 N--CA 1.474 0.77 0 CA-C-O 117.907 -1.044 . . . . 10.0 108.374 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.96 76.59 1.16 Allowed Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.519 -1.032 . . . . 10.0 110.519 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -155.25 157.5 37.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 107.246 -1.39 . . . . 10.0 107.246 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -173.51 -178.56 1.68 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.611 1.564 . . . . 10.0 107.87 176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.56 75.55 0.29 Allowed Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 126.387 1.875 . . . . 10.0 108.435 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.18 145.15 30.49 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.241 1.961 . . . . 10.0 110.062 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.66 161.17 23.5 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.272 1.029 . . . . 10.0 108.29 176.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -163.45 177.71 8.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 106.853 -1.536 . . . . 10.0 106.853 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -167.99 68.06 0.81 Allowed Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 124.408 1.083 . . . . 10.0 109.724 -176.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.06 121.47 8.65 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 122.321 2.014 . . . . 10.0 110.19 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -81.89 168.58 15.54 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.86 2.373 . . . . 10.0 111.28 -177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.74 36.14 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.19 1.396 . . . . 10.0 107.438 172.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -172.58 172.31 4.31 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.185 1.394 . . . . 10.0 108.289 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.8 t -164.43 -179.27 5.91 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.881 1.272 . . . . 10.0 107.6 170.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 74.41 0.53 Allowed Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 125.461 1.505 . . . . 10.0 109.773 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.72 130.76 18.66 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.371 2.047 . . . . 10.0 111.301 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.06 86.88 0.56 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.31 0.644 . . . . 10.0 109.815 176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.26 64.34 0.15 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.865 1.266 . . . . 10.0 112.677 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -74.94 70.61 1.99 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.772 1.229 . . . . 10.0 109.921 178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mtpt -71.04 75.94 0.66 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.963 0.905 . . . . 10.0 110.873 -178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.25 78.5 0.06 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.74 1.216 . . . . 10.0 111.061 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.49 120.67 5.09 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.897 1.236 . . . . 10.0 112.252 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.9 71.4 1.53 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.131 0.972 . . . . 10.0 111.698 -175.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 73.71 147.7 0.09 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.572 1.949 . . . . 10.0 112.445 172.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -157.24 167.55 30.01 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 124.302 1.041 . . . . 10.0 108.495 174.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.68 158.04 73.89 Favored Pre-proline 0 N--CA 1.443 -0.812 0 C-N-CA 125.602 1.561 . . . . 10.0 107.439 172.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.95 -36.11 1.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 121.177 1.251 . . . . 10.0 111.462 -171.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 m -135.89 172.49 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 122.679 1.228 . . . . 10.0 112.047 -171.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 17.8 p -78.43 66.26 3.94 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.526 3.131 . . . . 10.0 108.929 -171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.1 p -89.75 88.96 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.154 1.382 . . . . 10.0 108.951 -176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -147.94 134.42 19.71 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.349 -0.982 . . . . 10.0 108.349 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.67 154.81 47.59 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.589 1.09 . . . . 10.0 112.497 -175.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.42 162.48 13.14 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-O 121.641 0.734 . . . . 10.0 112.22 -170.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 43.2 p -139.63 157.98 44.88 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.557 -1.275 . . . . 10.0 107.557 164.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.91 136.08 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.243 -1.392 . . . . 10.0 107.243 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.51 40.75 0.74 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 120.794 -1.191 . . . . 10.0 112.998 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 144' ' ' LYS . . . 41.39 -149.3 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.107 1.363 . . . . 10.0 110.111 -164.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.7 m -96.58 125.46 47.02 Favored Pre-proline 0 C--O 1.239 0.517 0 CA-C-N 120.095 1.316 . . . . 10.0 107.841 160.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.19 174.06 4.47 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.261 1.974 . . . . 10.0 108.693 162.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.95 54.84 4.23 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.215 1.943 . . . . 10.0 109.801 171.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 21.0 m -144.29 62.6 1.34 Allowed 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 124.978 1.311 . . . . 10.0 107.711 -169.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 20.4 mm 73.72 164.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.923 1.289 . . . . 10.0 109.723 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -77.38 50.07 0.76 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.217 1.407 . . . . 10.0 109.862 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -138.72 159.81 41.19 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 127.059 2.144 . . . . 10.0 108.46 -162.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.1 t -172.0 -179.43 2.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.472 1.109 . . . . 10.0 109.948 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -139.28 161.33 37.71 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 125.334 1.454 . . . . 10.0 109.157 174.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.96 156.54 21.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.768 -0.456 . . . . 10.0 109.768 165.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -130.19 108.63 10.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 104.17 -2.529 . . . . 10.0 104.17 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.7 ptp -157.12 -176.8 6.17 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 124.681 1.192 . . . . 10.0 109.461 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 85.9 m -127.59 119.12 25.24 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 125.086 1.355 . . . . 10.0 109.053 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.32 109.23 12.26 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 103.605 -2.739 . . . . 10.0 103.605 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.7 m -95.93 70.65 2.91 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.76 -1.564 . . . . 10.0 108.482 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -83.51 130.25 35.0 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 119.272 -0.971 . . . . 10.0 109.829 -177.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.8 mtpp -136.1 56.26 1.83 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 43.3 p -157.83 166.14 33.46 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.312 0.577 . . . . 10.0 110.821 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -107.89 27.26 9.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 128.901 2.88 . . . . 10.0 110.33 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -114.73 134.4 22.41 Favored Pre-proline 0 C--N 1.342 0.255 0 C-N-CA 125.798 1.639 . . . . 10.0 107.609 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.63 122.01 8.48 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.113 1.875 . . . . 10.0 109.891 176.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -134.26 81.91 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 N-CA-C 109.395 -0.594 . . . . 10.0 109.395 -177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -79.28 -180.0 7.08 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.062 0.458 . . . . 10.0 110.32 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.513 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -155.64 136.14 13.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.666 -2.346 . . . . 10.0 104.666 -170.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.3 p -151.55 54.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 119.276 0.944 . . . . 10.0 109.52 176.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.18 151.0 20.01 Favored Glycine 0 C--N 1.335 0.511 0 O-C-N 120.783 -1.198 . . . . 10.0 111.116 167.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.78 70.95 0.59 Allowed 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.484 1.514 . . . . 10.0 108.392 167.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.64 140.71 32.02 Favored 'General case' 0 C--N 1.333 -0.135 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 -177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 t -168.21 145.04 3.35 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 118.562 0.619 . . . . 10.0 111.313 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.95 52.99 4.24 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.937 2.425 . . . . 10.0 110.023 169.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 67.3 tp -128.87 -61.24 1.06 Allowed 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.439 1.096 . . . . 10.0 109.564 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.24 162.44 18.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.61 1.564 . . . . 10.0 109.601 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.3 m -87.86 -42.7 12.35 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.588 0.755 . . . . 10.0 110.625 -176.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 t -123.38 89.97 50.76 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.654 1.182 . . . . 10.0 110.181 -163.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.68 85.11 1.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.89 2.393 . . . . 10.0 109.904 173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 66.0 mtt -83.69 117.83 23.47 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.152 0.981 . . . . 10.0 108.618 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mt -80.16 128.63 33.74 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 121.458 -0.776 . . . . 10.0 109.571 -178.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.76 144.68 39.36 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.918 1.287 . . . . 10.0 110.787 -174.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.89 170.11 13.43 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.467 0.651 . . . . 10.0 111.991 164.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 6.6 t -98.46 177.43 5.34 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.42 1.888 . . . . 10.0 113.527 164.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.4 m -95.21 72.05 3.3 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.046 1.739 . . . . 10.0 108.969 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 55.09 73.03 0.44 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.245 1.418 . . . . 10.0 112.921 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.9 t -164.39 54.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 118.31 -90.06 0.49 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 106.992 -2.443 . . . . 10.0 106.992 -167.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -65.37 173.87 19.06 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 117.223 0.511 . . . . 10.0 112.706 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 89.1 mtp -53.75 -87.48 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.645 1.978 . . . . 10.0 115.547 -158.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -174.94 34.87 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.666 0.666 . . . . 10.0 111.922 -160.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.79 140.39 2.91 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.827 -0.909 . . . . 10.0 110.827 168.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 18.6 ttp -65.62 93.59 0.17 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.739 0.769 . . . . 10.0 110.062 176.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.26 161.38 38.02 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.432 0.693 . . . . 10.0 112.464 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 68.9 mtp -82.84 109.42 16.96 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.071 1.748 . . . . 10.0 110.081 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.09 166.51 10.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.391 0.676 . . . . 10.0 111.525 -170.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.414 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 9.4 Cg_endo -37.73 -53.1 1.55 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.251 2.634 . . . . 10.0 111.027 156.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 44.6 p90 175.07 -172.18 0.06 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.056 2.142 . . . . 10.0 105.593 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.502 HD23 ' H ' ' A' ' 92' ' ' LEU . 1.3 pt? -116.1 102.3 9.49 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.473 0.654 . . . . 10.0 110.548 174.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.7 m -76.8 120.85 22.52 Favored 'General case' 0 CA--C 1.528 0.1 0 N-CA-C 107.723 -1.214 . . . . 10.0 107.723 175.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 pt -92.48 115.38 64.69 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 107.315 -1.365 . . . . 10.0 107.315 167.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -81.05 59.06 7.3 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.74 2.293 . . . . 10.0 108.514 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.73 -175.82 0.14 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.26 1.024 . . . . 10.0 109.551 -161.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 54.6 -2.34 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 118.024 2.602 . . . . 10.0 118.024 170.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.61 77.74 0.49 Allowed Glycine 0 CA--C 1.523 0.577 0 C-N-CA 124.761 1.172 . . . . 10.0 111.986 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.4 t -82.43 56.32 3.23 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.605 -1.257 . . . . 10.0 107.605 166.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.8 pp -96.59 -178.16 4.17 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.98 0.895 . . . . 10.0 110.656 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.4 t -127.75 129.13 46.56 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.18 1.792 . . . . 10.0 106.562 -166.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.9 mp -95.77 114.39 26.12 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 103.752 -2.685 . . . . 10.0 103.752 167.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -156.99 159.85 38.45 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.343 1.057 . . . . 10.0 109.971 -164.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -44.89 -54.6 6.27 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.153 1.381 . . . . 10.0 113.349 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.8 -63.31 1.24 Allowed 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 123.783 0.833 . . . . 10.0 111.419 -172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.24 135.81 3.94 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.618 -1.393 . . . . 10.0 109.618 -165.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 70.78 119.96 0.04 OUTLIER 'General case' 0 CA--C 1.513 -0.45 0 C-N-CA 130.885 3.674 . . . . 10.0 106.246 -170.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 176.43 171.67 0.43 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.605 0.762 . . . . 10.0 109.242 -175.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 18.8 t -100.22 123.7 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.139 -2.171 . . . . 10.0 105.139 154.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 69.0 mtp -82.84 101.6 11.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.104 -1.443 . . . . 10.0 107.104 163.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.9 mt -81.38 74.3 8.39 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.708 1.603 . . . . 10.0 107.045 176.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 52.1 ttm -84.6 149.47 25.84 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.634 -0.712 . . . . 10.0 110.231 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.46 68.82 1.27 Allowed Glycine 0 CA--C 1.525 0.702 0 N-CA-C 110.704 -0.959 . . . . 10.0 110.704 172.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.7 tt -35.37 133.94 0.32 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.121 1.768 . . . . 10.0 112.985 170.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.81 -67.53 0.85 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 118.745 -0.645 . . . . 10.0 111.689 157.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -168.9 -59.3 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 115.984 1.846 . . . . 10.0 115.984 -171.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -78.39 75.66 4.81 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 121.904 1.736 . . . . 10.0 111.113 -166.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.17 48.32 2.41 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.389 1.076 . . . . 10.0 111.882 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -63.69 148.21 49.64 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 173.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.22 108.36 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 107.327 -1.36 . . . . 10.0 107.327 162.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.29 55.77 3.0 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 107.981 -2.048 . . . . 10.0 107.981 -166.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -105.36 -179.8 4.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 153.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 18.1 m -155.66 134.93 12.28 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 113.9 -1.5 . . . . 10.0 107.284 167.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.01 136.7 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 106.656 -1.609 . . . . 10.0 106.656 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -79.23 114.76 18.43 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 167.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.2 pt -81.2 -178.49 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 168.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.2 m -139.13 120.19 14.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.885 -1.154 . . . . 10.0 107.885 160.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 pp -83.69 172.65 12.05 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.049 -0.723 . . . . 10.0 109.049 176.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -156.72 103.39 2.09 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.179 -0.674 . . . . 10.0 109.179 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.408 ' HB3' ' HB3' ' A' ' 134' ' ' ARG . . . -84.45 120.69 26.6 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.06 -1.089 . . . . 10.0 108.06 157.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.9 t -48.33 -34.51 10.72 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 125.594 1.558 . . . . 10.0 111.053 174.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -53.1 -33.75 53.6 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.759 2.023 . . . . 10.0 111.806 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 127.82 56.84 0.12 Allowed Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.231 0.92 . . . . 10.0 111.032 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.408 ' HB3' ' HB3' ' A' ' 130' ' ' ALA . 68.2 ttt180 -141.65 133.72 27.64 Favored 'General case' 0 C--O 1.227 -0.104 0 N-CA-C 106.469 -1.678 . . . . 10.0 106.469 172.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 4.5 t -156.01 59.6 0.59 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.659 0.663 . . . . 10.0 110.754 -167.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.98 148.97 27.27 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 123.005 0.522 . . . . 10.0 109.885 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -95.92 65.81 2.55 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 127.735 2.414 . . . . 10.0 108.262 -174.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 24.9 t -78.77 146.96 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.683 -0.488 . . . . 10.0 109.683 -155.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.73 130.53 35.14 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.217 -0.66 . . . . 10.0 109.217 179.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.62 115.08 23.24 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.951 1.3 . . . . 10.0 109.453 172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 38.7 m -84.41 132.73 34.55 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.729 -0.841 . . . . 10.0 108.729 173.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 15.8 t -102.37 120.21 51.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.331 -2.1 . . . . 10.0 105.331 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -159.7 94.1 1.13 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 119.057 0.844 . . . . 10.0 112.379 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 15.9 ptmt -65.96 -39.05 90.09 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.103 0.779 . . . . 10.0 113.103 179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -77.18 60.98 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 123.852 0.861 . . . . 10.0 110.87 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 33.7 mm -144.28 -54.34 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 127.93 2.492 . . . . 10.0 106.018 175.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -52.66 -59.11 4.87 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.849 1.66 . . . . 10.0 110.784 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 73.05 34.22 58.77 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.16 -1.356 . . . . 10.0 115.796 163.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 . . . . . 0 C--O 1.251 1.15 0 C-N-CA 129.841 3.256 . . . . 10.0 104.363 162.326 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 106.606 -1.627 . . . . 10.0 106.606 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.87 165.03 7.15 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -167.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -107.28 157.19 18.11 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.319 1.448 . . . . 10.0 109.402 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.4 p -145.23 170.57 16.02 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.374 1.47 . . . . 10.0 107.112 175.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -152.24 148.45 21.22 Favored Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 107.904 -1.147 . . . . 10.0 107.904 175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -76.43 68.37 6.89 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.141 2.56 . . . . 10.0 110.317 -177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.56 64.8 1.22 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.687 0.795 . . . . 10.0 110.734 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -146.44 174.61 11.23 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 125.59 1.556 . . . . 10.0 108.577 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 m -153.43 134.77 8.54 Favored Pre-proline 0 CA--C 1.531 0.246 0 N-CA-C 106.148 -1.797 . . . . 10.0 106.148 175.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 144.78 48.73 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.673 1.582 . . . . 10.0 109.953 -177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.16 -35.93 6.3 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.536 2.157 . . . . 10.0 110.327 173.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.99 123.86 21.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.17 0.588 . . . . 10.0 110.186 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -65.51 163.02 16.82 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.288 0.635 . . . . 10.0 109.843 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 m -42.51 135.93 2.6 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.819 1.648 . . . . 10.0 112.032 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.05 140.59 69.78 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 10.0 111.294 -177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.37 151.4 53.88 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.908 2.405 . . . . 10.0 110.71 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.83 96.3 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.044 0.537 . . . . 10.0 111.566 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 67.53 -65.31 0.24 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.228 1.811 . . . . 10.0 113.344 177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -72.45 71.56 0.94 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.103 . . . . 10.0 110.745 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -152.77 -81.31 0.09 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 122.848 0.459 . . . . 10.0 110.02 -174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.12 170.94 8.34 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 124.355 1.062 . . . . 10.0 110.39 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.48 -71.31 1.29 Allowed Glycine 0 CA--C 1.528 0.885 0 C-N-CA 123.595 0.617 . . . . 10.0 112.239 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -55.73 109.6 0.59 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.394 1.078 . . . . 10.0 112.377 -168.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -77.64 131.84 37.95 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.127 -1.064 . . . . 10.0 108.127 168.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 176.45 -47.52 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 126.551 1.94 . . . . 10.0 108.631 -177.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.29 128.68 85.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.954 0.901 . . . . 10.0 110.533 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -72.21 179.11 5.27 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.706 2.271 . . . . 10.0 110.36 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.23 56.1 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 O-C-N 121.688 -0.632 . . . . 10.0 111.237 -165.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 32.1 p -156.13 57.13 0.59 Allowed 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.507 -0.746 . . . . 10.0 109.995 -165.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.9 p -128.24 58.5 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.092 0 CA-C-O 122.569 1.176 . . . . 10.0 110.632 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.95 155.75 41.9 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 106.143 -1.799 . . . . 10.0 106.143 164.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.52 -163.23 6.82 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.366 -1.094 . . . . 10.0 110.366 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.0 133.77 30.52 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 174.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.4 p -120.46 110.64 16.73 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 107.876 -1.157 . . . . 10.0 107.876 175.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.65 128.78 53.75 Favored 'Isoleucine or valine' 0 C--O 1.231 0.097 0 C-N-CA 123.397 0.679 . . . . 10.0 109.375 -172.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.08 110.34 12.95 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.873 0.368 . . . . 10.0 111.314 -172.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.44 127.14 14.69 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 118.572 -0.728 . . . . 10.0 109.617 167.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -13.05 95.74 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.628 0 C-N-CA 128.29 2.636 . . . . 10.0 113.281 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -69.47 178.86 3.97 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.692 2.261 . . . . 10.0 109.377 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -67.52 68.05 0.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 122.408 2.072 . . . . 10.0 108.548 156.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 68.9 m -153.8 35.28 0.44 Allowed 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 126.216 1.806 . . . . 10.0 108.206 174.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 43' ' ' ARG . 18.2 mt 64.8 -176.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 108.242 -1.022 . . . . 10.0 108.242 177.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.603 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -70.19 32.46 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.622 0 O-C-N 120.468 -1.395 . . . . 10.0 113.552 170.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.79 155.16 20.54 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 163.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -164.94 -178.15 5.05 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 107.669 -1.234 . . . . 10.0 107.669 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -144.74 165.0 29.32 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 123.883 0.873 . . . . 10.0 109.887 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.17 138.69 33.54 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.308 -1.314 . . . . 10.0 107.71 164.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -112.16 104.36 12.57 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 -173.4 4.07 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.49 1.116 . . . . 10.0 110.423 -178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.8 m -116.56 143.96 44.95 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 126.038 1.735 . . . . 10.0 107.856 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.42 121.7 40.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 105.723 -1.955 . . . . 10.0 105.723 158.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.8 m -129.42 114.93 16.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.583 1.553 . . . . 10.0 109.045 -166.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -93.29 136.93 33.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.82 0.848 . . . . 10.0 112.317 -172.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.8 mmmm -134.2 56.68 1.84 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.713 -1.218 . . . . 10.0 107.713 161.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 58.6 m -137.33 -51.5 0.65 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 123.82 0.848 . . . . 10.0 111.031 -177.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 63.5 48.43 3.46 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 125.659 1.584 . . . . 10.0 110.449 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -125.69 137.99 31.06 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.63 119.04 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.876 2.384 . . . . 10.0 109.705 177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 15.9 mt -122.96 135.38 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.363 -0.606 . . . . 10.0 109.363 -175.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 15.2 ptpt -98.6 99.73 10.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.385 1.074 . . . . 10.0 108.904 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.511 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -87.2 117.56 26.03 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 105.75 -1.944 . . . . 10.0 105.75 -178.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.17 51.74 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 123.485 0.714 . . . . 10.0 109.488 177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.95 138.34 5.35 Favored Glycine 0 C--N 1.338 0.658 0 N-CA-C 109.925 -1.27 . . . . 10.0 109.925 160.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.56 66.57 0.49 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.257 1.423 . . . . 10.0 107.73 176.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.22 159.0 21.09 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.061 0.544 . . . . 10.0 109.548 -176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.2 t -173.46 140.22 0.85 Allowed Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -75.39 65.82 6.38 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.27 2.646 . . . . 10.0 108.932 175.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -156.26 -50.68 0.08 Allowed 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.957 1.303 . . . . 10.0 108.766 -164.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.93 31.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 168.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m -88.98 -22.31 23.09 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.634 -0.506 . . . . 10.0 109.634 167.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.0 t -134.3 88.15 31.17 Favored Pre-proline 0 CA--C 1.54 0.563 0 C-N-CA 124.709 1.204 . . . . 10.0 108.492 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.79 124.36 1.55 Allowed 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.324 2.683 . . . . 10.0 110.424 175.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -132.04 152.04 51.4 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 124.578 1.151 . . . . 10.0 108.95 178.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.8 mt -89.1 157.06 18.45 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.236 0.615 . . . . 10.0 110.217 166.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.93 153.81 32.7 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.794 1.237 . . . . 10.0 109.354 -176.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 15.1 t -139.57 121.04 15.08 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.947 0.794 . . . . 10.0 112.408 -173.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.8 m -146.88 51.22 1.1 Allowed 'General case' 0 CA--C 1.529 0.146 0 O-C-N 120.559 -1.338 . . . . 10.0 110.305 165.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.6 m -150.28 90.74 1.69 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.487 1.115 . . . . 10.0 111.85 171.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -34.67 -42.98 0.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 127.805 2.442 . . . . 10.0 113.566 172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -50.29 -26.29 4.65 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.644 1.178 . . . . 10.0 113.409 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.22 -51.41 0.11 Allowed Glycine 0 C--N 1.338 0.65 0 N-CA-C 110.651 -0.98 . . . . 10.0 110.651 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -95.78 -124.57 4.48 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 124.162 0.887 . . . . 10.0 111.245 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.3 tpp -141.74 -121.74 0.1 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.067 0.934 . . . . 10.0 111.186 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.07 62.44 0.15 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.451 -1.314 . . . . 10.0 107.451 -166.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -158.32 87.36 0.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 108.795 -1.722 . . . . 10.0 108.795 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.7 64.43 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.463 -0.94 . . . . 10.0 108.463 -178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.5 pttt -147.08 172.89 13.05 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.674 2.39 . . . . 10.0 107.847 -173.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttp -80.15 74.73 6.95 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.799 0.809 . . . . 10.0 109.054 -176.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.0 m -61.73 160.81 24.67 Favored Pre-proline 0 CA--C 1.537 0.444 0 CA-C-N 115.574 -0.739 . . . . 10.0 110.701 171.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -65.23 80.14 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.957 2.438 . . . . 10.0 109.69 165.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 11.0 p90 58.21 -164.95 0.18 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.954 2.102 . . . . 10.0 113.482 168.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -129.75 99.15 5.03 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.797 0.839 . . . . 10.0 109.27 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.0 m -82.15 125.46 30.91 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 121.726 -0.608 . . . . 10.0 109.649 169.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.2 pp -95.33 122.11 60.34 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 172.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -81.34 65.45 8.76 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.816 2.344 . . . . 10.0 110.847 -175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.99 -175.32 0.15 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.877 0.871 . . . . 10.0 109.462 -171.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . 0.258 0.1 OUTLIER 5.9 44.21 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 130.164 3.385 . . . . 10.0 118.831 -169.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -54.29 138.01 40.56 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 124.316 0.96 . . . . 10.0 113.534 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.8 m -149.85 59.63 0.99 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.433 1.493 . . . . 10.0 107.177 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -94.96 164.75 12.77 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.677 0.275 . . . . 10.0 110.524 175.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 76.8 m -124.19 104.73 9.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 -172.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.7 mp -81.54 122.21 27.28 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.63 -1.618 . . . . 10.0 106.63 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -156.17 157.51 36.04 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 126.606 1.963 . . . . 10.0 107.726 -176.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.48 0.25 0.2 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 115.476 1.658 . . . . 10.0 115.476 -161.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -130.45 -72.04 0.58 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 125.994 1.717 . . . . 10.0 108.09 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -76.28 76.61 1.45 Allowed Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 125.136 1.351 . . . . 10.0 111.176 -174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 8.9 t70 70.03 134.58 0.03 OUTLIER 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 126.095 1.758 . . . . 10.0 110.696 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -177.47 176.22 1.32 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.896 0.855 . . . . 10.0 113.013 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 13.7 t -98.59 121.37 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.498 -1.667 . . . . 10.0 106.498 157.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 68.2 mtp -82.22 104.99 12.94 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.743 -1.206 . . . . 10.0 107.743 165.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 89.0 mt -90.63 74.52 6.7 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.628 1.971 . . . . 10.0 109.148 176.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -91.16 149.13 21.92 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.934 -0.479 . . . . 10.0 112.271 -170.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 107.93 33.56 3.0 Favored Glycine 0 CA--C 1.532 1.106 0 N-CA-C 115.582 0.993 . . . . 10.0 115.582 157.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 37.95 46.86 0.84 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 128.424 2.69 . . . . 10.0 116.769 160.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.0 tttp -69.93 -17.2 63.31 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.092 -1.005 . . . . 10.0 112.719 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 78.5 mtp85 -133.11 151.72 78.34 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 107.086 -1.45 . . . . 10.0 107.086 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.39 75.06 2.5 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.003 2.468 . . . . 10.0 109.279 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.2 mp -40.54 105.77 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 127.386 2.274 . . . . 10.0 113.3 -173.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.73 131.64 34.41 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.852 -0.425 . . . . 10.0 109.852 171.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.1 p -60.67 103.03 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 107.759 -1.2 . . . . 10.0 107.759 162.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 118.69 -0.61 15.57 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-O 118.978 -0.901 . . . . 10.0 112.148 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -74.16 179.97 4.17 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 123.94 1.828 . . . . 10.0 108.281 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 17.7 m -155.81 132.75 10.59 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.534 -2.121 . . . . 10.0 106.55 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -136.75 143.88 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -79.22 124.64 28.55 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.348 -0.612 . . . . 10.0 109.348 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.0 tt -81.52 170.4 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 107.167 -1.42 . . . . 10.0 107.167 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -146.42 118.44 8.24 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.155 -0.966 . . . . 10.0 109.073 165.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.1 151.54 24.06 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.318 -1.364 . . . . 10.0 107.318 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -154.48 78.7 1.08 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.061 -1.088 . . . . 10.0 108.061 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -79.1 123.56 27.47 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 175.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 58.8 p 44.89 -88.4 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.175 1.79 . . . . 10.0 110.001 -161.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -164.32 58.36 0.15 Allowed 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.731 0.813 . . . . 10.0 109.521 156.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -146.71 27.44 1.63 Allowed Glycine 0 CA--C 1.524 0.645 0 CA-C-N 116.066 -0.516 . . . . 10.0 111.835 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -147.22 61.04 1.17 Allowed 'General case' 0 CA--C 1.526 0.057 0 C-N-CA 124.186 0.994 . . . . 10.0 108.428 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.1 m -83.0 60.11 5.28 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.794 0.838 . . . . 10.0 110.27 -170.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.0 mp -82.88 149.92 26.82 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.433 -0.58 . . . . 10.0 109.433 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -130.55 60.74 1.62 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 126.543 1.937 . . . . 10.0 109.509 -169.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 45.1 t -82.0 151.12 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 O-C-N 121.938 -0.476 . . . . 10.0 109.991 -170.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.96 119.6 24.64 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.364 -0.835 . . . . 10.0 109.294 176.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -97.85 133.45 42.34 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.222 1.009 . . . . 10.0 108.799 175.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.6 m -83.0 144.29 30.06 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 107.525 -1.287 . . . . 10.0 107.525 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.0 t -101.43 107.28 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 172.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -156.69 147.11 21.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.178 -0.675 . . . . 10.0 109.178 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -63.7 162.55 13.03 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.603 0.716 . . . . 10.0 111.024 171.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -145.66 107.38 4.28 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.024 1.33 . . . . 10.0 107.433 -175.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 5.0 mp 56.4 78.38 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.106 1.362 . . . . 10.0 109.262 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.01 121.84 1.06 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.037 -2.208 . . . . 10.0 105.037 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.43 41.33 11.61 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 108.701 -1.76 . . . . 10.0 108.701 -165.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 . . . . . 0 C--O 1.256 1.436 0 C-N-CA 125.689 1.596 . . . . 10.0 109.209 -167.43 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 106.697 -1.594 . . . . 10.0 106.697 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.73 166.09 2.34 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 108.931 -1.668 . . . . 10.0 108.931 -137.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -170.2 172.71 6.16 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.527 1.531 . . . . 10.0 106.888 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 39.1 p -134.37 173.58 11.47 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.262 1.425 . . . . 10.0 108.514 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 26.7 ptm -148.73 150.58 33.53 Favored Pre-proline 0 CA--C 1.531 0.232 0 N-CA-C 108.299 -1.001 . . . . 10.0 108.299 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -78.07 178.28 7.78 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.987 2.458 . . . . 10.0 110.359 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.38 159.08 44.43 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 169.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -165.33 174.26 10.31 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 -177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 t -139.59 148.0 54.3 Favored Pre-proline 0 C--O 1.232 0.138 0 C-N-CA 125.001 1.32 . . . . 10.0 108.417 175.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -65.84 159.95 46.29 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 N-CA-C 108.803 -1.268 . . . . 10.0 108.803 162.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.08 -173.76 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.488 2.792 . . . . 10.0 110.053 171.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.14 166.48 23.3 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 125.007 1.323 . . . . 10.0 107.447 170.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -158.88 171.13 20.62 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.085 0.954 . . . . 10.0 108.688 -177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 35.3 p -134.3 -179.69 5.73 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.851 1.66 . . . . 10.0 107.727 176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -134.53 148.36 67.13 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 108.166 -1.049 . . . . 10.0 108.166 175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.35 -174.14 2.13 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.292 2.662 . . . . 10.0 110.474 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.85 170.71 15.58 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.149 1.38 . . . . 10.0 107.486 170.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.49 172.4 13.59 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 124.412 1.085 . . . . 10.0 108.321 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.1 mp0 -139.16 163.44 32.43 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.933 1.293 . . . . 10.0 107.598 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 tppp? -73.51 155.36 39.27 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 172.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.97 176.69 10.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.857 -1.164 . . . . 10.0 107.857 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.9 167.33 35.9 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 107.451 -2.26 . . . . 10.0 107.451 176.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.16 -73.66 0.16 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.828 0.814 . . . . 10.0 111.942 -171.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -144.56 45.06 1.4 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.859 0.864 . . . . 10.0 109.076 -175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 59.24 -168.57 0.15 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.573 1.149 . . . . 10.0 109.985 -167.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.5 151.51 94.25 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-O 118.794 -0.622 . . . . 10.0 109.653 172.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.15 -90.51 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.932 2.421 . . . . 10.0 110.29 -177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.35 49.31 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 123.824 0.849 . . . . 10.0 110.466 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 m -159.18 106.5 1.78 Allowed 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.948 -1.095 . . . . 10.0 109.505 177.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.23 88.41 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 118.63 0.65 . . . . 10.0 111.01 169.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 tm0? -157.51 153.58 27.24 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 108.627 -0.879 . . . . 10.0 108.627 163.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.1 107.95 3.04 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.748 1.166 . . . . 10.0 112.178 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.73 153.5 16.61 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.746 0.818 . . . . 10.0 113.031 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 6.2 p -135.68 151.86 50.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.287 -1.375 . . . . 10.0 107.287 164.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 41.0 t -114.84 137.91 46.76 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.038 -1.467 . . . . 10.0 107.038 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.06 47.33 0.77 Allowed 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 119.288 0.949 . . . . 10.0 113.416 -174.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 28.89 -124.29 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 127.014 2.126 . . . . 10.0 111.243 -174.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.38 118.89 55.63 Favored Pre-proline 0 CA--C 1.539 0.552 0 N-CA-C 108.07 -1.085 . . . . 10.0 108.07 157.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -80.8 168.49 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.038 2.492 . . . . 10.0 107.996 167.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.47 69.43 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 121.786 1.657 . . . . 10.0 108.846 170.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.433 ' CB ' HH12 ' A' ' 104' ' ' ARG . 7.4 m -155.84 38.67 0.37 Allowed 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.645 1.178 . . . . 10.0 109.078 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.652 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.4 mm 68.34 178.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.361 1.064 . . . . 10.0 110.291 -178.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.652 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.4 tpt180 -46.51 -33.59 4.17 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 127.37 2.268 . . . . 10.0 114.774 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.31 151.71 45.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 122.362 1.077 . . . . 10.0 110.719 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 12.1 t -161.65 175.4 12.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 106.634 -1.617 . . . . 10.0 106.634 -172.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -142.02 160.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 123.07 0.548 . . . . 10.0 110.529 -173.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.76 142.44 32.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 124.114 0.884 . . . . 10.0 108.855 169.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -117.93 108.62 15.52 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 103.556 -2.757 . . . . 10.0 103.556 165.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 tmt? -157.74 -179.16 7.89 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.313 1.845 . . . . 10.0 106.332 -160.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.6 m -150.66 138.02 19.52 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 120.411 1.46 . . . . 10.0 110.071 173.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.97 116.37 27.97 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 107.052 -1.462 . . . . 10.0 107.052 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.0 m -93.76 87.25 5.38 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.843 1.657 . . . . 10.0 108.304 175.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -78.05 79.53 4.51 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 121.89 0.852 . . . . 10.0 110.501 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 58.28 4.64 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 176.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.5 m -172.76 144.21 1.34 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.986 0.915 . . . . 10.0 108.796 169.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -75.09 49.12 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 125.447 1.499 . . . . 10.0 109.838 169.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.2 127.19 18.88 Favored Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 123.805 0.842 . . . . 10.0 109.376 -170.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -85.71 121.85 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.538 2.825 . . . . 10.0 110.702 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.0 mp -150.44 116.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 108.416 -0.957 . . . . 10.0 108.416 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.8 150.08 30.85 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 118.347 0.521 . . . . 10.0 110.677 -177.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -110.04 138.32 46.59 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 108.88 -0.785 . . . . 10.0 108.88 171.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.88 54.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 119.56 1.073 . . . . 10.0 108.914 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -162.04 144.35 9.64 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 108.623 -1.791 . . . . 10.0 108.623 169.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.98 65.52 0.41 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.571 1.548 . . . . 10.0 107.981 175.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.12 160.89 23.03 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.142 -0.688 . . . . 10.0 109.142 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t -173.75 152.2 1.98 Allowed Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 107.608 -1.256 . . . . 10.0 107.608 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.34 -1.41 11.32 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.603 2.202 . . . . 10.0 112.155 167.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -83.61 -53.67 5.5 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.608 1.163 . . . . 10.0 110.46 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.77 178.44 5.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.323 1.449 . . . . 10.0 110.62 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 81.6 m -143.13 0.63 1.2 Allowed 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.314 -0.866 . . . . 10.0 112.456 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 57.6 m -148.07 80.41 8.7 Favored Pre-proline 0 N--CA 1.448 -0.551 0 O-C-N 120.589 -1.319 . . . . 10.0 108.06 -177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -85.87 98.39 0.59 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.972 3.115 . . . . 10.0 111.12 -179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -103.64 120.55 41.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.672 0.789 . . . . 10.0 108.99 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 mp -80.87 140.51 35.33 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.3 ttm -145.08 149.0 34.29 Favored 'General case' 0 C--O 1.227 -0.107 0 C-N-CA 123.667 0.787 . . . . 10.0 110.135 -171.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.8 t -140.63 112.02 7.33 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.577 0.584 . . . . 10.0 112.577 -166.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.9 m -146.64 49.55 1.15 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.431 -1.418 . . . . 10.0 110.807 172.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -130.35 94.85 3.76 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.39 1.476 . . . . 10.0 108.92 172.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -68.79 85.38 0.32 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.885 1.674 . . . . 10.0 110.823 -163.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 11.7 t 163.83 -72.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.789 2.035 . . . . 10.0 107.784 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.22 -42.11 84.37 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 109.722 -1.351 . . . . 10.0 109.722 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -105.63 -170.41 23.63 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.103 -1.599 . . . . 10.0 109.103 169.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 30.7 ttm -106.57 -136.98 0.36 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.611 0.764 . . . . 10.0 109.317 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -145.53 51.09 1.19 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.743 1.217 . . . . 10.0 108.075 -164.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -150.52 90.48 0.14 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 109.243 -1.543 . . . . 10.0 109.243 -172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.41 60.14 1.13 Allowed 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 107.865 -1.161 . . . . 10.0 107.865 177.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -143.43 171.45 14.13 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.807 2.043 . . . . 10.0 107.921 -170.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 27.6 ttm -81.46 69.21 8.05 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 122.051 0.929 . . . . 10.0 110.482 -172.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.7 m -63.04 163.99 14.92 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.326 1.05 . . . . 10.0 109.676 166.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -52.2 -36.77 68.38 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 122.552 2.168 . . . . 10.0 112.673 170.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 172.68 -156.32 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.75 2.02 . . . . 10.0 110.681 -164.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.16 131.26 47.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.645 -1.613 . . . . 10.0 106.645 162.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 66.0 m -95.67 106.05 18.11 Favored 'General case' 0 C--O 1.226 -0.164 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 174.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 7.1 pt -85.16 109.71 23.11 Favored Pre-proline 0 CA--C 1.533 0.303 0 N-CA-C 108.54 -0.911 . . . . 10.0 108.54 -175.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -88.21 52.22 2.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.368 1.379 . . . . 10.0 110.655 -167.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 64.44 163.85 0.14 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.74 0.781 . . . . 10.0 110.993 -165.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 50.82 20.32 0.75 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.678 1.591 . . . . 10.0 112.718 -177.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.31 69.77 1.09 Allowed Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 124.935 1.255 . . . . 10.0 110.253 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -84.69 57.7 4.51 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.395 -1.335 . . . . 10.0 107.395 170.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . 0.306 0.0 OUTLIER -94.44 155.46 16.94 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 120.201 -0.599 . . . . 10.0 110.283 -175.557 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.1 t -126.05 117.16 22.62 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 -165.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -82.99 128.32 34.36 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.499 -1.667 . . . . 10.0 106.499 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -155.76 165.84 35.31 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 123.678 0.791 . . . . 10.0 109.4 -172.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.433 HH12 ' CB ' ' A' ' 41' ' ' SER . 2.6 ttp180 -67.4 89.73 0.22 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.488 -0.758 . . . . 10.0 110.606 174.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.6 t70 131.02 -70.21 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 131.342 3.857 . . . . 10.0 108.112 169.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -72.02 71.23 0.96 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 125.448 1.499 . . . . 10.0 112.506 -167.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.5 t70 66.61 138.63 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.41 1.884 . . . . 10.0 110.367 -174.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -179.38 179.41 0.62 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.181 0.592 . . . . 10.0 110.789 -176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 36.3 t -114.84 128.79 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 156.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 77.1 mtp -82.25 94.2 7.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.036 -1.839 . . . . 10.0 106.036 166.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mt -81.84 65.5 7.0 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.193 -1.41 . . . . 10.0 107.193 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 21.0 ptm -84.71 179.57 7.33 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 122.274 1.035 . . . . 10.0 110.17 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.09 47.44 45.61 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 109.901 -1.28 . . . . 10.0 109.901 -174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.49 118.93 10.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 118.204 1.002 . . . . 10.0 109.18 178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.78 -61.57 2.43 Favored 'General case' 0 C--N 1.342 0.251 0 CA-C-N 117.443 0.111 . . . . 10.0 111.226 -171.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 22.1 mtt-85 -166.54 -59.58 0.01 OUTLIER Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.23 1.412 . . . . 10.0 111.86 -162.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -79.25 69.6 7.86 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 120.848 1.339 . . . . 10.0 112.934 -165.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.92 56.31 0.58 Allowed 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.261 -0.9 . . . . 10.0 111.875 171.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.31 96.41 2.3 Favored 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 121.217 -0.927 . . . . 10.0 109.258 176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.0 t -57.63 89.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.471 1.108 . . . . 10.0 109.512 172.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 133.13 -10.05 5.1 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-O 119.324 -0.709 . . . . 10.0 113.003 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -78.82 -177.89 5.71 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.838 1.304 . . . . 10.0 108.369 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.0 m -150.9 131.55 13.96 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.488 -1.233 . . . . 10.0 108.758 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.6 t -133.55 141.42 44.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 125.378 1.471 . . . . 10.0 107.32 -175.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -68.25 127.82 34.3 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.544 -0.722 . . . . 10.0 109.927 176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 126' ' ' ILE . 8.6 tt -82.27 173.7 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.401 -1.703 . . . . 10.0 106.401 162.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 38.9 m -144.55 115.69 7.93 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 121.311 -0.868 . . . . 10.0 109.439 160.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.0 pp -87.7 173.0 9.28 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 111.829 0.307 . . . . 10.0 111.829 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -156.99 109.38 2.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 124.004 0.922 . . . . 10.0 108.972 174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.55 126.34 32.71 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.02 -0.733 . . . . 10.0 109.02 160.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.0 t -79.86 62.5 4.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.754 0.788 . . . . 10.0 108.909 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 173.81 -65.86 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 127.727 2.411 . . . . 10.0 107.14 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -72.13 -79.11 0.45 Allowed Glycine 0 CA--C 1.529 0.944 0 CA-C-N 115.609 -0.723 . . . . 10.0 113.778 -167.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 -177.8 5.95 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.871 -0.782 . . . . 10.0 112.982 -175.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.7 m -128.74 142.26 51.06 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.48 3.512 . . . . 10.0 103.606 175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -156.25 147.13 22.02 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 106.268 -1.753 . . . . 10.0 106.268 -170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.6 p-10 -121.16 59.45 0.94 Allowed 'General case' 0 C--O 1.231 0.099 0 C-N-CA 126.05 1.74 . . . . 10.0 110.088 -157.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 86.1 t -78.32 147.46 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 N-CA-C 109.424 -0.584 . . . . 10.0 109.424 -161.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -81.36 109.88 16.28 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.404 -0.962 . . . . 10.0 108.404 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -101.14 122.56 43.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.145 0.978 . . . . 10.0 110.527 -174.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.8 m -83.51 126.79 33.15 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.669 0.388 . . . . 10.0 110.256 -177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 84.4 t -91.31 97.37 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 105.72 -1.956 . . . . 10.0 105.72 -173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.42 102.33 2.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 121.766 -0.584 . . . . 10.0 110.753 -173.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.83 -63.24 1.21 Allowed 'General case' 0 C--N 1.339 0.135 0 C-N-CA 124.58 1.152 . . . . 10.0 110.266 162.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.86 -164.89 0.24 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.703 0.801 . . . . 10.0 111.929 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 26.4 pt -57.09 -31.21 36.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 C-N-CA 123.169 0.588 . . . . 10.0 111.573 177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -58.8 -63.48 1.28 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.145 0.978 . . . . 10.0 109.506 174.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -78.47 56.22 4.11 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.933 -0.867 . . . . 10.0 110.933 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 . . . . . 0 C--O 1.253 1.28 0 C-N-CA 126.15 1.78 . . . . 10.0 107.086 170.41 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 2.456 9.8 ptm . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 107.742 -1.207 . . . . 10.0 107.742 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.91 54.62 2.15 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.607 -1.107 . . . . 10.0 111.054 -169.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 43.33 89.05 0.01 OUTLIER 'General case' 0 C--N 1.346 0.451 1 C-N-CA 132.107 4.163 . . . . 10.0 114.349 1.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.4 0.5 OUTLIER 77.97 -24.92 0.21 Allowed 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 131.326 3.851 . . . . 10.0 113.666 9.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 87.7 mtp 44.7 96.93 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 126.076 1.75 . . . . 10.0 115.175 161.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -61.1 30.66 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 124.9 3.733 . . . . 10.0 117.195 174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -75.24 62.15 1.23 Allowed 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 163.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . 2.443 63.2 t-80 61.77 -81.01 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 107.972 -1.122 . . . . 10.0 107.972 -148.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 2.454 0.2 OUTLIER 52.54 -133.0 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 107.428 -1.323 . . . . 10.0 107.428 -165.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . 2.547 54.0 Cg_exo 62.91 -102.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.9 2.4 . . . . 10.0 108.675 175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' CB ' ' HA ' ' A' ' 12' ' ' ALA 2.411 8.7 Cg_endo 22.04 116.37 0.0 OUTLIER 'Trans proline' 0 CA--C 1.539 0.755 1 C-N-CA 127.475 5.45 . . . . 10.0 116.482 154.25 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HA ' ' CB ' ' A' ' 11' ' ' PRO 2.445 . . 41.22 19.99 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 O-C-N 117.556 -3.215 . . . . 10.0 112.976 56.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . 2.383 5.6 tp60 47.23 84.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.959 2.104 . . . . 10.0 112.148 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.661 ' HA ' ' HB3' ' A' ' 15' ' ' ALA . 0.7 OUTLIER 84.4 148.71 0.07 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.443 1.897 . . . . 10.0 106.538 -178.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.661 ' HB3' ' HA ' ' A' ' 14' ' ' THR 0.308 . . 83.74 19.62 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.843 1 C-N-CA 135.07 5.348 . . . . 10.0 116.241 13.553 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.808 ' HB2' ' HB3' ' A' ' 17' ' ' ALA 0.337 37.6 Cg_endo -64.62 -83.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.018 0 CA-C-N 122.883 2.065 . . . . 10.0 115.021 -170.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.808 ' HB3' ' HB2' ' A' ' 16' ' ' PRO 0.599 . . 79.52 -19.16 0.46 Allowed 'General case' 0 N--CA 1.466 0.372 3 C-N-CA 138.642 6.777 . . . . 10.0 117.485 -4.5 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -97.21 108.53 21.28 Favored 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 105.622 -1.992 . . . . 10.0 105.622 157.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 177.28 -58.59 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.381 1.473 . . . . 10.0 110.8 -160.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . 2.469 0.0 OUTLIER 106.38 -110.54 0.0 OUTLIER 'General case' 0 C--N 1.343 0.295 0 C-N-CA 130.795 3.638 . . . . 10.0 106.284 9.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . 2.424 . . 73.06 39.06 0.65 Allowed 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' HA2' ' C ' ' A' ' 23' ' ' ALA . . . -108.26 98.96 1.27 Allowed Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.882 1.706 . . . . 10.0 111.811 -165.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.458 ' C ' ' HA2' ' A' ' 22' ' ' GLY 0.288 . . 41.61 -117.78 0.38 Allowed 'General case' 0 CA--C 1.536 0.419 1 C-N-CA 132.533 4.333 . . . . 10.0 116.202 -2.24 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 42.75 -135.57 0.38 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 108.323 -0.991 . . . . 10.0 108.323 -160.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.52 136.33 17.2 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 105.131 -2.174 . . . . 10.0 105.131 160.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.487 HD22 ' HB2' ' A' ' 54' ' ' LYS . 2.9 tt -106.48 130.09 23.47 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 106.357 -1.72 . . . . 10.0 106.357 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.16 127.97 24.86 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 N-CA-C 106.732 -2.064 . . . . 10.0 106.732 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -83.38 54.2 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 122.027 0.918 . . . . 10.0 112.083 -153.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.4 p -153.91 54.2 0.71 Allowed 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 125.667 1.587 . . . . 10.0 107.209 -175.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.5 p -83.66 63.51 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -137.19 154.21 50.25 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.831 1.252 . . . . 10.0 110.967 -169.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -107.91 136.79 13.68 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.913 -2.075 . . . . 10.0 107.913 168.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.55 151.59 25.3 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 118.605 1.203 . . . . 10.0 109.995 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.2 p -134.56 141.75 46.77 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.2 134.04 67.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 N-CA-C 108.589 -0.893 . . . . 10.0 108.589 -176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.33 37.69 0.21 Allowed 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.795 1.035 . . . . 10.0 113.795 -171.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 36.08 -122.55 0.15 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.933 1.693 . . . . 10.0 111.031 -170.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.7 t -110.48 109.69 58.12 Favored Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.963 0.905 . . . . 10.0 108.85 169.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.57 163.45 27.19 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.959 2.439 . . . . 10.0 110.394 167.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.42 61.0 5.08 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.914 2.41 . . . . 10.0 109.421 173.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.0 t -160.49 47.8 0.24 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.379 1.072 . . . . 10.0 108.522 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.436 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.9 mm 75.45 167.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 125.444 1.498 . . . . 10.0 109.17 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -58.2 -26.7 63.14 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.95 0.722 . . . . 10.0 112.95 -177.451 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -41.91 140.12 1.12 Allowed 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 127.632 2.373 . . . . 10.0 110.807 172.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.0 t -159.98 -178.63 7.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.473 -0.936 . . . . 10.0 108.473 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -151.14 157.85 43.24 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.401 0.68 . . . . 10.0 110.654 -173.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.7 150.3 25.21 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 124.001 0.813 . . . . 10.0 110.097 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -128.45 103.62 7.23 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 105.442 -2.059 . . . . 10.0 105.442 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -159.82 -176.67 5.84 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.969 0.508 . . . . 10.0 110.909 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.2 m -133.71 122.9 24.04 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.14 0.976 . . . . 10.0 111.501 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 mp -80.52 132.45 35.68 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 104.214 -2.513 . . . . 10.0 104.214 172.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.6 m -130.56 104.76 7.41 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 124.58 1.175 . . . . 10.0 107.982 -160.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.82 130.34 35.03 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 117.804 0.274 . . . . 10.0 111.199 -172.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.487 ' HB2' HD22 ' A' ' 26' ' ' LEU . 32.0 mmmt -140.93 59.29 1.54 Allowed 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 t -168.02 -41.55 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 115.843 -0.617 . . . . 10.0 111.015 172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 65.9 78.46 0.27 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.253 1.421 . . . . 10.0 111.512 -170.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -146.22 154.72 50.25 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 125.732 1.613 . . . . 10.0 108.533 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.52 72.93 6.12 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.651 2.901 . . . . 10.0 111.768 -178.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp -84.4 115.18 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 107.577 -1.268 . . . . 10.0 107.577 175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 0.7 OUTLIER -89.11 144.73 25.92 Favored 'General case' 0 CA--C 1.528 0.132 0 O-C-N 121.477 -0.765 . . . . 10.0 109.372 168.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -121.99 126.83 49.42 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.936 -2.246 . . . . 10.0 104.936 -179.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.6 p -144.51 56.63 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-O 121.876 0.845 . . . . 10.0 110.044 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.98 150.77 21.21 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.004 -1.238 . . . . 10.0 110.004 163.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.08 58.84 0.52 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.252 1.021 . . . . 10.0 108.805 174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.82 139.74 31.7 Favored 'General case' 0 N--CA 1.457 -0.117 0 O-C-N 121.898 -0.501 . . . . 10.0 109.791 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 t -160.76 145.6 10.69 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 -179.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.94 57.37 4.51 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.178 2.586 . . . . 10.0 109.878 171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 9.6 tt -139.74 -63.06 0.51 Allowed 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 125.357 1.463 . . . . 10.0 107.849 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.74 146.71 27.38 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.674 1.19 . . . . 10.0 110.57 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.1 m -82.07 -38.32 25.08 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.725 0.81 . . . . 10.0 109.196 174.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -121.61 80.13 39.23 Favored Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 124.012 0.925 . . . . 10.0 110.182 -170.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -77.74 92.93 1.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.829 2.353 . . . . 10.0 109.993 176.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 41.7 mtt -103.62 131.18 51.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.598 1.159 . . . . 10.0 110.115 -175.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 mt -83.76 144.62 29.2 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.482 1.113 . . . . 10.0 109.087 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 4.5 ttm -146.27 157.78 43.83 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.431 0.692 . . . . 10.0 110.775 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 13.0 t -155.1 107.13 2.68 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.873 0.844 . . . . 10.0 112.531 -162.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.7 t -146.2 57.98 1.21 Allowed 'General case' 0 N--CA 1.456 -0.139 0 O-C-N 120.793 -1.192 . . . . 10.0 111.023 174.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -150.24 93.46 2.0 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.277 1.431 . . . . 10.0 109.829 172.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -32.09 -46.06 0.11 Allowed 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 128.682 2.793 . . . . 10.0 113.27 175.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.7 m -54.91 -23.59 19.56 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.267 1.427 . . . . 10.0 114.032 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -140.85 -50.71 0.05 OUTLIER Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.437 -1.065 . . . . 10.0 110.437 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -96.93 -162.63 32.21 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.271 0.938 . . . . 10.0 111.621 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 2.5 ttt -81.72 -159.79 0.31 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.415 0.686 . . . . 10.0 109.3 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.67 45.07 1.71 Allowed 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.579 1.152 . . . . 10.0 108.078 -167.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -162.28 108.86 0.36 Allowed Glycine 0 C--N 1.336 0.54 0 N-CA-C 109.015 -1.634 . . . . 10.0 109.015 -174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.88 65.6 1.07 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.839 1.256 . . . . 10.0 109.86 -171.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -125.63 165.1 19.16 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 127.343 2.257 . . . . 10.0 109.718 -170.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 35.2 ttm -81.47 72.82 8.52 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.879 0.847 . . . . 10.0 109.93 -173.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.409 HG11 ' CG2' ' A' ' 76' ' ' THR . 16.3 m -63.03 159.33 47.86 Favored Pre-proline 0 CA--C 1.536 0.43 0 C-N-CA 123.938 0.895 . . . . 10.0 111.195 173.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HB2' ' CZ3' ' A' ' 91' ' ' TRP . 95.3 Cg_endo -61.85 -30.86 84.8 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.907 2.404 . . . . 10.0 112.507 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.447 ' CZ3' ' HB2' ' A' ' 90' ' ' PRO . 44.4 p90 177.88 -165.35 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.797 2.439 . . . . 10.0 105.344 174.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.417 HD13 ' H ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -128.14 115.72 18.84 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.58 0.705 . . . . 10.0 110.959 168.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.2 m -78.27 126.5 30.88 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.185 -1.043 . . . . 10.0 108.185 174.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 9.7 pt -100.77 103.07 22.09 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 119.182 0.901 . . . . 10.0 109.043 170.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -82.86 70.19 6.89 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 122.227 1.951 . . . . 10.0 111.347 -166.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 60.43 168.96 0.09 Allowed 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.611 -0.68 . . . . 10.0 109.796 -163.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 21.9 mmt85 41.59 31.22 0.18 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 115.768 1.766 . . . . 10.0 115.768 -173.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.05 72.26 0.03 OUTLIER Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 124.41 1.005 . . . . 10.0 113.209 167.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 6.9 m -107.26 57.23 0.63 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 106.518 -1.66 . . . . 10.0 106.518 167.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 42.2 tp -93.73 151.9 19.32 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.546 1.138 . . . . 10.0 108.1 -176.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 18.6 m -119.19 117.13 27.84 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 105.885 -1.894 . . . . 10.0 105.885 -176.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 9.9 mp -81.31 102.17 10.25 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.217 -2.142 . . . . 10.0 105.217 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -135.02 156.77 48.46 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 125.463 1.505 . . . . 10.0 110.428 177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -48.96 -42.99 39.45 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.287 1.035 . . . . 10.0 112.303 -166.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -114.31 29.84 7.72 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.771 0.828 . . . . 10.0 111.897 -177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -166.18 69.13 0.19 Allowed Glycine 0 C--N 1.338 0.676 0 O-C-N 121.346 -0.847 . . . . 10.0 111.387 -176.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 76' ' ' THR . 10.2 t70 64.96 138.99 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 126.381 1.872 . . . . 10.0 110.524 -175.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -178.09 179.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.643 1.11 . . . . 10.0 111.149 -172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 64.6 t -110.86 122.0 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.016 -1.846 . . . . 10.0 106.016 162.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 67.2 mtp -83.86 100.24 10.85 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.485 -1.302 . . . . 10.0 107.485 165.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.19 73.24 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 106.692 -1.596 . . . . 10.0 106.692 172.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.5 154.64 20.96 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.966 0.906 . . . . 10.0 111.578 -169.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.27 66.34 2.24 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.667 -0.973 . . . . 10.0 110.667 173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.2 tp -56.93 141.68 44.31 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.344 0.658 . . . . 10.0 112.106 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -86.44 -48.65 8.24 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.389 0.675 . . . . 10.0 112.549 174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -144.48 158.94 53.16 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 123.624 0.77 . . . . 10.0 110.559 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -67.65 160.51 47.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.559 2.84 . . . . 10.0 111.911 -175.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.42 159.61 41.75 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.769 1.628 . . . . 10.0 108.179 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -113.16 144.43 42.68 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-N 118.615 0.643 . . . . 10.0 109.503 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.0 t -63.88 104.51 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.974 -1.491 . . . . 10.0 106.974 165.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 127.68 -13.73 6.46 Favored Glycine 0 CA--C 1.523 0.577 0 CA-C-O 119.166 -0.797 . . . . 10.0 111.61 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -75.3 -178.25 3.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.787 1.755 . . . . 10.0 109.119 176.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.0 m -155.56 131.36 9.88 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.031 -1.895 . . . . 10.0 107.708 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.66 149.57 30.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 N-CA-C 107.62 -1.252 . . . . 10.0 107.62 175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -84.71 130.99 34.62 Favored 'General case' 0 CA--C 1.527 0.086 0 N-CA-C 109.01 -0.737 . . . . 10.0 109.01 178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.9 tt -103.99 130.24 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 124.077 0.951 . . . . 10.0 109.147 172.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.6 m -103.1 107.46 18.28 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 166.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -81.29 154.3 26.62 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 160.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -150.23 90.15 1.64 Allowed 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.625 -1.25 . . . . 10.0 107.625 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.27 143.31 30.49 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.906 -0.405 . . . . 10.0 109.906 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.9 t -50.54 -36.32 33.76 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.44 1.096 . . . . 10.0 110.876 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -70.11 44.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.72 1.608 . . . . 10.0 112.649 173.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 50.04 48.54 38.61 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.219 1.866 . . . . 10.0 113.206 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? -110.57 146.75 35.54 Favored 'General case' 0 N--CA 1.461 0.116 0 N-CA-C 107.384 -1.339 . . . . 10.0 107.384 171.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.0 m -156.41 101.32 2.02 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 126.742 2.017 . . . . 10.0 105.659 -178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.0 mp -112.05 -178.46 3.43 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.843 0.747 . . . . 10.0 111.197 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -149.93 64.03 0.98 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.744 2.017 . . . . 10.0 108.614 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 20.4 t -84.73 156.74 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -171.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.12 130.77 35.14 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 173.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -113.81 112.55 23.59 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 124.698 1.199 . . . . 10.0 109.222 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 12.0 m -83.86 125.64 32.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.998 -0.741 . . . . 10.0 108.998 -176.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 92.0 t -84.7 112.84 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -158.09 125.37 5.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 118.686 -0.673 . . . . 10.0 109.693 170.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.546 ' HB3' ' HG3' ' A' ' 147' ' ' GLU . 10.0 mmmt -41.97 -71.63 0.08 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.289 1.836 . . . . 10.0 110.025 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 55.91 102.65 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.54 1.536 . . . . 10.0 114.777 157.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.314 35.8 pt 53.18 64.62 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 123.448 1.594 . . . . 10.0 109.574 -166.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -149.24 149.26 30.67 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 103.353 -2.832 . . . . 10.0 103.353 -167.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.68 33.24 66.85 Favored Glycine 0 CA--C 1.53 1.012 0 N-CA-C 109.733 -1.347 . . . . 10.0 109.733 -162.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? . . . . . 0 C--O 1.254 1.292 0 C-N-CA 128.537 2.735 . . . . 10.0 104.458 176.832 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.471 0.618 0 N-CA-C 105.739 -1.949 . . . . 10.0 105.739 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.4 -161.29 9.45 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 119.375 0.988 . . . . 10.0 110.927 171.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 110.11 149.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 129.639 3.176 . . . . 10.0 108.452 -172.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.0 p -146.84 154.89 41.87 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.825 -1.176 . . . . 10.0 107.825 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.2 tpt -121.66 108.81 34.87 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 124.62 1.168 . . . . 10.0 108.466 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.37 171.9 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.594 2.196 . . . . 10.0 110.496 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -159.32 157.14 29.89 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.611 1.164 . . . . 10.0 108.07 174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -155.06 178.06 10.63 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.88 1.672 . . . . 10.0 107.39 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 t -146.03 146.82 29.75 Favored Pre-proline 0 C--O 1.232 0.174 0 N-CA-C 107.597 -1.26 . . . . 10.0 107.597 170.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.49 164.55 35.29 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 121.842 1.695 . . . . 10.0 108.938 163.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -80.47 -171.42 1.24 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.941 3.094 . . . . 10.0 109.603 165.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.91 160.79 43.07 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 108.296 -1.001 . . . . 10.0 108.296 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -147.31 161.45 40.96 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.628 1.571 . . . . 10.0 107.031 175.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.6 m -140.79 131.97 26.45 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.841 0.856 . . . . 10.0 108.84 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 119.2 57.55 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.909 0.884 . . . . 10.0 109.843 178.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -73.94 -166.97 0.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.793 2.328 . . . . 10.0 110.055 175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -164.53 154.71 14.27 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.734 -1.21 . . . . 10.0 107.734 169.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.75 156.38 43.57 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.833 1.253 . . . . 10.0 107.862 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -147.52 157.94 43.78 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -70.45 143.29 51.82 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 107.803 -1.184 . . . . 10.0 107.803 165.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.26 157.53 25.68 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 110.274 -0.269 . . . . 10.0 110.274 172.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -79.03 -143.62 2.58 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.553 -1.019 . . . . 10.0 110.553 175.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.19 64.51 1.44 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.642 0.777 . . . . 10.0 111.526 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 39.91 66.68 0.56 Allowed 'General case' 0 C--N 1.338 0.096 0 C-N-CA 126.89 2.076 . . . . 10.0 112.806 174.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.85 167.05 30.99 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.176 1.39 . . . . 10.0 108.331 -176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 155.52 73.22 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 125.294 1.437 . . . . 10.0 108.463 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -83.28 -85.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.007 2.471 . . . . 10.0 110.42 -177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.5 m -140.47 48.0 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 122.365 1.079 . . . . 10.0 109.301 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.8 p -156.75 82.72 0.95 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.214 -0.903 . . . . 10.0 108.694 -165.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p -142.39 55.93 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 123.113 1.435 . . . . 10.0 107.377 169.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -83.89 129.94 34.92 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 113.721 -1.582 . . . . 10.0 107.05 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.66 -39.06 78.14 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 111.708 -0.557 . . . . 10.0 111.708 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 68.73 116.84 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 127.736 2.414 . . . . 10.0 113.33 -173.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.1 p -116.28 91.92 3.73 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.577 1.951 . . . . 10.0 108.789 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.4 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 108.445 -0.946 . . . . 10.0 108.445 -173.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.92 42.92 0.48 Allowed 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 113.946 1.091 . . . . 10.0 113.946 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 42.67 -133.94 0.45 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.347 1.459 . . . . 10.0 110.208 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.4 t -104.05 110.75 64.58 Favored Pre-proline 0 CA--C 1.538 0.482 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 160.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -66.89 172.04 10.24 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.115 2.543 . . . . 10.0 108.93 168.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -75.02 59.6 5.24 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 122.288 1.992 . . . . 10.0 109.882 173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.1 p -157.8 50.88 0.43 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.655 0.782 . . . . 10.0 109.844 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 43' ' ' ARG . 10.7 mm 66.36 174.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.869 0.868 . . . . 10.0 110.291 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.582 ' H ' HG22 ' A' ' 42' ' ' ILE . 8.1 tpp180 -69.07 22.85 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.245 1.418 . . . . 10.0 114.379 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.486 ' CG ' HH21 ' A' ' 104' ' ' ARG . 0.0 OUTLIER -94.45 157.62 15.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 119.807 1.185 . . . . 10.0 108.161 168.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -172.5 179.73 2.41 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 106.39 -1.707 . . . . 10.0 106.39 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.91 173.29 16.98 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 122.385 0.274 . . . . 10.0 111.004 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.14 149.22 26.33 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 125.202 1.564 . . . . 10.0 109.056 165.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -131.28 71.1 1.46 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.549 1.14 . . . . 10.0 108.237 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.4 -174.06 4.76 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 124.79 1.236 . . . . 10.0 109.417 -159.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.1 p -123.94 141.26 52.2 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 120.041 1.292 . . . . 10.0 109.598 -172.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.49 150.18 25.45 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.314 -1.736 . . . . 10.0 106.314 161.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.9 m -140.42 118.11 11.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 124.219 0.949 . . . . 10.0 110.879 -173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -78.27 132.91 37.7 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 109.002 -0.74 . . . . 10.0 109.002 173.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -136.77 58.6 1.72 Allowed 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 107.745 -1.205 . . . . 10.0 107.745 166.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.8 p -163.9 -46.96 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.267 1.027 . . . . 10.0 109.594 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . 0.318 95.4 m-20 67.01 54.91 0.73 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.474 1.91 . . . . 10.0 110.583 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -131.23 150.87 77.73 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 126.425 1.89 . . . . 10.0 107.803 166.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.16 86.27 1.72 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.542 2.828 . . . . 10.0 111.275 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.3 mt -110.15 119.61 59.49 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.06 0 N-CA-C 108.041 -1.096 . . . . 10.0 108.041 -177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -83.87 150.66 25.58 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.681 0.392 . . . . 10.0 110.431 175.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.472 HD22 ' C ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.21 143.42 50.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.847 -0.797 . . . . 10.0 108.847 173.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 p -151.62 56.91 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 108.827 -0.805 . . . . 10.0 108.827 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.08 145.67 11.57 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 110.299 -1.12 . . . . 10.0 110.299 168.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.09 69.42 0.65 Allowed 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 106.421 -1.696 . . . . 10.0 106.421 173.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.49 107.41 15.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.325 -1.361 . . . . 10.0 107.325 -173.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 t -125.22 146.39 53.84 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.652 0.781 . . . . 10.0 110.494 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -76.1 -12.27 19.43 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.85 2.367 . . . . 10.0 110.985 166.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 20.3 tp -80.97 -57.26 3.62 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.328 0.967 . . . . 10.0 111.507 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -103.96 139.68 38.76 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.07 0.948 . . . . 10.0 112.297 -173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 63.4 m -75.86 -42.03 50.65 Favored 'General case' 0 C--N 1.333 -0.151 0 O-C-N 121.384 -0.823 . . . . 10.0 110.144 177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -122.96 81.94 50.41 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.947 0.899 . . . . 10.0 109.391 -167.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -85.01 86.34 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.66 2.907 . . . . 10.0 110.527 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -84.58 127.58 34.14 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 177.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 21.5 mt -83.08 141.63 31.87 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 167.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 9.5 ttm -148.96 157.85 43.73 Favored 'General case' 0 C--O 1.225 -0.2 0 C-N-CA 123.665 0.786 . . . . 10.0 110.063 -172.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.418 HG22 HG21 ' A' ' 89' ' ' VAL . 6.7 t -155.11 102.38 2.31 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.561 0.696 . . . . 10.0 112.546 -157.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 86' ' ' MET . 8.8 t -150.58 53.98 0.89 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 120.812 -1.18 . . . . 10.0 113.13 168.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -116.22 100.57 8.01 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 124.918 1.287 . . . . 10.0 109.054 164.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.4 m80 -46.65 -44.86 18.77 Favored 'General case' 0 CA--C 1.527 0.085 0 C-N-CA 126.167 1.787 . . . . 10.0 111.871 -175.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.2 t -82.96 23.25 0.85 Allowed 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.739 0.644 . . . . 10.0 112.739 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.05 -67.16 0.02 OUTLIER Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.535 1.061 . . . . 10.0 111.111 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -127.87 96.76 0.44 Allowed Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.391 1.472 . . . . 10.0 111.765 -178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 51.88 -159.4 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.258 1.823 . . . . 10.0 114.014 164.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -162.21 39.0 0.12 Allowed 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.882 0.873 . . . . 10.0 109.54 -166.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -160.63 105.95 0.27 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 -178.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.445 ' HB2' HG21 ' A' ' 77' ' ' THR . 1.2 tmm? -77.47 55.42 1.27 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.306 1.042 . . . . 10.0 110.844 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -110.96 165.44 11.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 126.831 2.052 . . . . 10.0 109.379 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 36.6 ttm -81.89 69.78 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 122.312 1.053 . . . . 10.0 110.334 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.418 HG21 HG22 ' A' ' 76' ' ' THR . 16.5 m -60.07 165.02 5.32 Favored Pre-proline 0 CA--C 1.537 0.469 0 C-N-CA 126.469 1.907 . . . . 10.0 111.741 172.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.48 -38.63 54.31 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.333 2.689 . . . . 10.0 113.579 164.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 176.89 -165.8 0.04 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.987 1.315 . . . . 10.0 112.512 -161.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.2 116.18 25.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.068 1.347 . . . . 10.0 108.012 159.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 24.3 m -83.34 136.87 34.2 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 163.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.1 140.44 38.09 Favored Pre-proline 0 N--CA 1.449 -0.478 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -79.26 -178.19 4.44 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.354 2.036 . . . . 10.0 111.456 -170.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.17 139.56 14.33 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 108.272 -1.01 . . . . 10.0 108.272 151.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 58.67 17.32 4.99 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.822 1.045 . . . . 10.0 113.822 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.94 97.45 0.25 Allowed Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.064 -1.614 . . . . 10.0 109.064 166.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.9 m -138.72 79.35 1.73 Allowed 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 104.876 -2.268 . . . . 10.0 104.876 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 pp -103.37 -177.0 3.24 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.56 -0.745 . . . . 10.0 110.494 -169.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.35 99.58 6.28 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.817 1.647 . . . . 10.0 106.792 -165.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mp -79.88 93.7 5.7 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 107.834 -1.173 . . . . 10.0 107.834 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -118.97 140.09 50.58 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.804 2.042 . . . . 10.0 108.259 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.486 HH21 ' CG ' ' A' ' 44' ' ' ASP . 4.5 tmt_? -55.33 -21.3 14.45 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.879 1.066 . . . . 10.0 113.879 -167.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 27.1 p-10 -90.25 -71.62 0.61 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.487 1.515 . . . . 10.0 109.749 163.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -80.45 80.9 1.6 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 125.596 1.57 . . . . 10.0 111.524 -166.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.3 t70 64.46 133.67 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.74 0 C-N-CA 126.0 1.72 . . . . 10.0 110.37 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.5 p-80 -178.17 178.49 0.9 Allowed 'General case' 0 C--N 1.33 -0.278 0 O-C-N 120.752 -1.218 . . . . 10.0 111.629 -169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.48 116.31 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 105.838 -1.912 . . . . 10.0 105.838 162.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.8 mtp -81.76 98.27 8.37 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.376 -1.712 . . . . 10.0 106.376 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 22.9 mt -83.11 67.55 9.2 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.927 1.291 . . . . 10.0 108.34 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 55.1 mtp -84.38 157.09 21.55 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 121.921 0.867 . . . . 10.0 111.601 -166.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 73.02 60.7 3.76 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 110.554 -1.018 . . . . 10.0 110.554 170.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.23 129.95 44.23 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 117.612 0.706 . . . . 10.0 111.9 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.0 pttt -105.2 -59.61 1.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.472 1.509 . . . . 10.0 110.83 -177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -59.58 142.47 87.44 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 108.451 -0.944 . . . . 10.0 108.451 166.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -65.5 132.8 32.3 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.107 1.871 . . . . 10.0 109.526 176.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.435 ' H ' ' CD1' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -68.83 161.16 29.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.108 0.563 . . . . 10.0 111.52 175.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.97 120.19 3.34 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.473 -2.047 . . . . 10.0 105.473 176.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.1 t -68.37 116.54 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 N-CA-C 108.315 -0.994 . . . . 10.0 108.315 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 84.3 62.72 1.7 Allowed Glycine 0 CA--C 1.521 0.45 0 N-CA-C 108.206 -1.957 . . . . 10.0 108.206 -173.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -133.35 -172.99 3.09 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 159.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 51.9 m -152.54 123.25 7.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.388 -1.278 . . . . 10.0 107.894 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.59 126.67 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 124.423 1.089 . . . . 10.0 108.528 -170.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -70.82 128.18 35.15 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.667 -0.494 . . . . 10.0 109.667 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 36.1 pt -114.43 148.04 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 125.245 1.418 . . . . 10.0 107.877 168.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.0 m -110.24 133.49 53.18 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.001 0.92 . . . . 10.0 109.114 178.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 129' ' ' LYS . 1.1 tt -83.65 155.58 23.11 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.024 -1.473 . . . . 10.0 107.024 172.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.473 ' H ' HD23 ' A' ' 128' ' ' LEU . 82.5 tttt -155.43 86.09 1.07 Allowed 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.643 -1.243 . . . . 10.0 107.643 168.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.63 25.96 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.028 -0.42 . . . . 10.0 110.059 -177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.8 t -54.26 -31.57 53.95 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.802 1.241 . . . . 10.0 112.108 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -49.78 -32.8 14.73 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.664 1.186 . . . . 10.0 112.896 171.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 104.19 8.66 38.23 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.082 1.325 . . . . 10.0 110.046 -164.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.71 95.3 8.35 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 3.1 t -83.87 147.93 27.26 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.098 -0.955 . . . . 10.0 108.498 164.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tp -157.03 174.91 14.81 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.049 -1.834 . . . . 10.0 106.049 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -134.78 139.22 44.97 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.703 -1.591 . . . . 10.0 106.703 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 4.6 t -133.62 140.0 47.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.51 98.63 10.09 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.685 -0.858 . . . . 10.0 108.685 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -83.98 123.36 29.91 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.957 0.903 . . . . 10.0 110.36 -171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.4 m -83.75 137.51 33.71 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.316 -0.994 . . . . 10.0 108.316 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.41 112.27 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.504 -1.295 . . . . 10.0 107.504 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -148.57 107.48 3.85 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.084 0.954 . . . . 10.0 109.58 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -99.64 -177.13 3.48 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 123.744 0.817 . . . . 10.0 113.012 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 27.0 m-20 75.15 -168.92 0.09 Allowed 'General case' 0 C--N 1.34 0.189 0 C-N-CA 126.674 1.989 . . . . 10.0 108.169 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -53.02 120.83 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 109.028 -0.731 . . . . 10.0 109.028 170.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.27 165.97 28.38 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 107.102 -1.444 . . . . 10.0 107.102 -170.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 97.91 62.04 0.9 Allowed Glycine 0 CA--C 1.524 0.596 0 C-N-CA 125.27 1.415 . . . . 10.0 111.773 -178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.096 0 N-CA-C 105.109 -2.182 . . . . 10.0 105.109 173.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.473 0.684 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.6 151.02 6.25 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 110.499 -1.04 . . . . 10.0 110.499 -172.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -170.04 158.93 7.33 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 106.541 -1.652 . . . . 10.0 106.541 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 t -164.32 178.69 7.32 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 51.1 ttm -163.62 69.07 1.73 Allowed Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 125.337 1.455 . . . . 10.0 108.922 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.96 136.72 30.45 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.277 1.985 . . . . 10.0 110.011 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.09 155.52 20.83 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.819 -1.178 . . . . 10.0 107.819 175.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -164.41 167.07 20.04 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 106.522 -1.658 . . . . 10.0 106.522 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -166.06 67.09 1.06 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 124.387 1.075 . . . . 10.0 109.571 -177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -69.38 118.93 5.98 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.333 2.022 . . . . 10.0 109.923 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.81 153.03 22.58 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.305 2.003 . . . . 10.0 110.582 -178.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.25 143.01 14.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 107.461 -1.311 . . . . 10.0 107.461 172.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -171.16 162.13 6.91 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.87 1.268 . . . . 10.0 108.112 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -169.8 -178.52 2.98 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.53 1.532 . . . . 10.0 107.001 171.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.15 65.46 0.69 Allowed Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 124.569 1.148 . . . . 10.0 110.989 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.46 128.14 14.13 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.293 1.996 . . . . 10.0 109.872 177.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -160.63 149.72 17.0 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -169.17 158.57 8.44 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.56 1.544 . . . . 10.0 107.088 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -162.88 157.95 21.9 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -159.7 174.78 14.02 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.663 1.985 . . . . 10.0 106.446 169.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -165.91 175.74 8.39 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.668 1.187 . . . . 10.0 107.964 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.01 161.53 33.46 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 107.191 -2.364 . . . . 10.0 107.191 174.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -169.74 -174.2 1.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.43 1.092 . . . . 10.0 108.255 -175.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 73.29 175.42 0.27 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.236 1.814 . . . . 10.0 111.888 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.04 177.7 9.5 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.974 1.709 . . . . 10.0 106.903 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.27 134.88 9.49 Favored Pre-proline 0 CA--C 1.532 0.279 0 N-CA-C 107.152 -1.425 . . . . 10.0 107.152 -175.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.1 153.5 62.65 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.649 1.566 . . . . 10.0 108.601 172.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.9 m -82.7 53.63 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-O 122.178 0.989 . . . . 10.0 110.86 -170.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -153.11 59.47 0.78 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -162.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 8.3 p -121.53 55.26 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.38 138.27 37.67 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.238 1.015 . . . . 10.0 108.482 165.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.55 -136.06 4.35 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 107.798 -2.121 . . . . 10.0 107.798 163.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.91 143.68 14.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 117.998 0.899 . . . . 10.0 109.802 162.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 28.2 p -133.59 153.58 51.55 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 106.142 -1.799 . . . . 10.0 106.142 162.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 18.2 t -128.08 138.93 53.31 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.243 0 C-N-CA 125.128 1.371 . . . . 10.0 107.372 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.07 37.76 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.128 0.788 . . . . 10.0 113.128 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 31.86 -124.99 0.05 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.337 1.855 . . . . 10.0 110.456 -161.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 54.8 t -109.61 112.13 58.84 Favored Pre-proline 0 CA--C 1.53 0.211 0 N-CA-C 105.927 -1.879 . . . . 10.0 105.927 162.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -60.69 160.48 24.52 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.977 1.785 . . . . 10.0 108.68 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -75.17 61.73 5.85 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.523 2.148 . . . . 10.0 110.615 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -163.42 62.22 0.17 Allowed 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.427 1.091 . . . . 10.0 108.264 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 19.9 mt 77.07 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 C-N-CA 125.52 1.528 . . . . 10.0 110.339 174.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.97 39.03 0.07 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.196 0.998 . . . . 10.0 113.509 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -104.01 158.43 16.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.305 -1.368 . . . . 10.0 107.305 161.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.0 t -156.62 -169.15 2.91 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.89 -1.522 . . . . 10.0 106.89 175.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.96 160.46 42.32 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.999 -1.111 . . . . 10.0 107.999 172.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.43 161.8 22.33 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 165.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -134.73 102.47 5.28 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.762 -1.57 . . . . 10.0 106.762 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.83 -170.0 2.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.747 2.019 . . . . 10.0 109.503 -175.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 16.8 m -147.85 124.77 11.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 O-C-N 120.371 -1.456 . . . . 10.0 109.049 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.16 129.56 34.86 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 105.894 -1.891 . . . . 10.0 105.894 171.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.9 m -121.65 95.53 4.71 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 124.022 0.826 . . . . 10.0 110.302 -158.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -77.26 58.62 1.65 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 123.015 1.388 . . . . 10.0 112.454 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -84.37 58.92 5.1 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 107.459 -1.311 . . . . 10.0 107.459 174.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 t -179.98 -32.29 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 113.95 1.093 . . . . 10.0 113.95 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 68.13 84.76 0.15 Allowed 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.456 1.503 . . . . 10.0 112.164 -167.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -147.59 144.32 19.17 Favored Pre-proline 0 CA--C 1.543 0.684 0 C-N-CA 124.011 0.925 . . . . 10.0 109.729 165.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -88.14 100.62 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.813 3.009 . . . . 10.0 111.485 175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.5 mp -112.59 103.46 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.815 0.846 . . . . 10.0 109.299 -177.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.98 96.78 8.43 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.029 -1.044 . . . . 10.0 110.019 -175.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -82.02 124.44 29.8 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.386 0.674 . . . . 10.0 109.906 -175.158 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.0 p -145.69 54.82 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.17 0 CA-C-O 122.265 1.031 . . . . 10.0 109.535 -174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.23 145.33 11.06 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 109.398 -1.481 . . . . 10.0 109.398 168.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.8 64.79 0.47 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.895 1.678 . . . . 10.0 107.296 166.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -81.18 149.08 29.25 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.47 -1.307 . . . . 10.0 107.47 -178.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -169.65 151.87 4.46 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.753 -0.462 . . . . 10.0 109.753 -164.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.72 -3.55 13.36 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.736 2.291 . . . . 10.0 111.964 167.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 16.7 tp -101.79 -40.51 6.91 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.512 1.125 . . . . 10.0 113.437 -163.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.31 126.23 46.62 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 124.443 1.097 . . . . 10.0 110.046 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 m -72.81 -30.66 64.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.327 0.651 . . . . 10.0 109.783 172.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 m -131.13 67.75 81.01 Favored Pre-proline 0 N--CA 1.45 -0.454 0 C-N-CA 124.983 1.313 . . . . 10.0 110.105 -171.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.39 114.12 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.752 2.301 . . . . 10.0 110.527 177.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -141.07 141.66 34.24 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.886 0.474 . . . . 10.0 110.815 -178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.7 mt -83.95 149.81 26.07 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.727 1.211 . . . . 10.0 109.781 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.69 169.32 21.89 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.474 1.51 . . . . 10.0 109.88 -171.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.3 t -143.8 158.77 43.45 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 121.203 -0.199 . . . . 10.0 110.884 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.42 59.55 0.63 Allowed 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.435 -0.791 . . . . 10.0 109.201 172.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 t -155.56 130.91 9.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.576 -0.898 . . . . 10.0 108.576 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -71.34 -39.69 71.18 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.39 -44.61 96.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.602 1.161 . . . . 10.0 111.488 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.96 -129.01 3.35 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.051 -0.82 . . . . 10.0 111.051 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -59.81 -69.57 1.25 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.528 0.585 . . . . 10.0 113.339 -174.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -170.01 163.83 9.4 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.282 1.033 . . . . 10.0 109.592 -177.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.68 54.41 2.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 107.627 -1.249 . . . . 10.0 107.627 175.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -129.08 67.05 0.56 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.483 -0.647 . . . . 10.0 111.483 -156.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.07 64.27 5.75 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 122.067 0.937 . . . . 10.0 110.069 -171.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -136.4 168.67 19.0 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 127.008 2.123 . . . . 10.0 109.394 -177.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 61.4 mtp -81.35 73.76 8.37 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 121.57 0.7 . . . . 10.0 109.355 -172.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 27.1 m -70.49 159.8 83.65 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.513 -0.767 . . . . 10.0 110.731 177.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -42.92 -52.2 4.86 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.634 2.889 . . . . 10.0 112.099 163.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.48 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 173.4 -158.0 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 127.195 2.198 . . . . 10.0 108.52 -175.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.48 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.0 mm? -128.5 138.92 52.51 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 161.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 51.3 m -84.99 98.56 10.46 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.261 -1.755 . . . . 10.0 106.261 160.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.0 pp -81.51 121.97 80.38 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 106.104 -1.813 . . . . 10.0 106.104 -178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -82.15 -173.98 1.95 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.621 2.214 . . . . 10.0 111.774 -166.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -48.88 149.3 1.87 Allowed 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 109.094 -0.706 . . . . 10.0 109.094 154.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 54.5 6.96 0.12 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.112 1.365 . . . . 10.0 114.156 -166.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.29 84.25 0.25 Allowed Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 -177.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.9 m -109.7 61.18 0.6 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.337 1.455 . . . . 10.0 107.782 -175.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.8 mp -86.07 154.07 21.67 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.119 -0.946 . . . . 10.0 109.683 -169.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.0 p -114.47 110.85 20.48 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 105.45 -2.056 . . . . 10.0 105.45 -169.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -82.78 109.51 16.99 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.291 -2.114 . . . . 10.0 105.291 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -155.45 170.12 22.67 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 119.212 0.915 . . . . 10.0 111.12 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.55 -45.81 0.37 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.567 1.147 . . . . 10.0 112.622 179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -135.91 98.47 3.9 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.729 1.612 . . . . 10.0 106.776 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 143.83 116.46 1.12 Allowed Glycine 0 CA--C 1.535 1.32 0 C-N-CA 125.803 1.668 . . . . 10.0 110.296 -175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.6 t0 23.86 65.64 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 129.078 2.951 . . . . 10.0 114.184 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -119.14 164.8 15.02 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 113.519 0.933 . . . . 10.0 113.519 -164.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 65.0 t -102.0 121.01 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 105.487 -2.042 . . . . 10.0 105.487 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 47.9 mtp -83.19 99.47 9.96 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 107.49 -1.3 . . . . 10.0 107.49 165.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.8 mt -80.17 58.74 3.11 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 107.74 -1.207 . . . . 10.0 107.74 171.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 40.8 ttp -84.57 161.8 20.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.566 1.146 . . . . 10.0 110.784 -168.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 110.13 -4.32 30.11 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.059 -1.411 . . . . 10.0 114.809 155.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.5 tp 47.41 89.47 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.253 1.821 . . . . 10.0 113.054 178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -96.05 -40.47 9.22 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.443 1.097 . . . . 10.0 110.534 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -139.75 152.66 68.78 Favored Pre-proline 0 N--CA 1.455 -0.185 0 N-CA-C 105.765 -1.939 . . . . 10.0 105.765 175.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -57.8 120.71 8.8 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.825 2.35 . . . . 10.0 111.725 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 5.9 mp -74.16 73.65 1.76 Allowed 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.577 -0.897 . . . . 10.0 108.577 175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -74.39 104.9 5.3 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.859 1.264 . . . . 10.0 109.765 -170.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.2 p -42.0 116.08 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 124.551 1.141 . . . . 10.0 111.425 175.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 116.46 -27.82 7.82 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-O 118.999 -0.89 . . . . 10.0 111.196 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.8 -173.82 3.22 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 123.67 1.7 . . . . 10.0 110.082 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 23.7 m -150.35 130.26 13.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.371 -1.74 . . . . 10.0 107.749 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.03 134.11 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 C-N-CA 124.383 1.073 . . . . 10.0 108.537 -170.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.0 m-20 -73.76 110.87 8.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 109.431 -0.581 . . . . 10.0 109.431 177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 29.6 pt -85.27 -179.81 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 160.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.0 m -147.08 121.53 9.68 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 121.403 -0.811 . . . . 10.0 109.147 173.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.3 177.52 7.12 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.654 0.381 . . . . 10.0 111.441 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -156.95 99.48 1.83 Allowed 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.596 1.558 . . . . 10.0 107.96 171.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.98 122.82 33.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 121.949 -0.469 . . . . 10.0 109.89 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.2 t -82.94 61.36 5.92 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.286 -1.005 . . . . 10.0 108.286 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -169.54 -60.1 0.02 OUTLIER 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 129.08 2.952 . . . . 10.0 105.482 178.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -82.42 -92.27 0.59 Allowed Glycine 0 CA--C 1.525 0.69 0 CA-C-N 114.687 -1.142 . . . . 10.0 111.61 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -160.55 173.22 15.85 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.813 -0.816 . . . . 10.0 109.739 -173.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.1 t -94.49 144.73 25.33 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.145 -1.798 . . . . 10.0 106.145 153.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 55.3 tp -156.45 143.76 19.05 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -87.97 132.05 34.39 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.955 1.702 . . . . 10.0 106.918 177.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.1 t -137.39 125.66 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 107.586 -1.265 . . . . 10.0 107.586 -164.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.25 111.37 18.89 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.029 -0.73 . . . . 10.0 109.029 -174.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -102.08 119.17 38.37 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.079 0.952 . . . . 10.0 110.496 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -83.62 126.89 33.31 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 122.865 0.466 . . . . 10.0 110.387 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 40.2 t -107.25 110.29 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.628 -1.249 . . . . 10.0 107.628 -165.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -158.11 150.24 21.96 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 119.095 0.861 . . . . 10.0 110.86 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.38 150.8 24.19 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.113 0.87 . . . . 10.0 112.573 175.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . 0.257 1.4 p-10 56.85 176.37 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 127.04 2.136 . . . . 10.0 112.715 -172.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.3 mp -63.02 116.2 2.73 Favored 'Isoleucine or valine' 0 C--N 1.339 0.143 0 N-CA-C 103.913 -2.625 . . . . 10.0 103.913 167.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -150.92 107.67 3.53 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.756 -1.572 . . . . 10.0 106.756 -157.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.46 -70.56 0.67 Allowed Glycine 0 CA--C 1.531 1.047 0 N-CA-C 109.127 -1.589 . . . . 10.0 109.127 -160.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 . . . . . 0 C--O 1.25 1.09 0 N-CA-C 103.839 -2.652 . . . . 10.0 103.839 163.331 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 106.267 -1.753 . . . . 10.0 106.267 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.0 173.02 23.95 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.955 -0.858 . . . . 10.0 110.955 -172.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -173.55 -174.6 1.01 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.249 1.82 . . . . 10.0 106.537 -175.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 t -158.98 -177.84 6.8 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 2.0 tmt? -159.33 108.03 1.52 Allowed Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 125.185 1.394 . . . . 10.0 107.953 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.33 155.86 16.75 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.676 2.25 . . . . 10.0 110.228 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.61 173.06 15.1 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.418 1.087 . . . . 10.0 108.148 177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -160.45 -173.9 4.22 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.763 1.225 . . . . 10.0 107.719 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 m -150.13 135.28 9.83 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.306 -1.739 . . . . 10.0 106.306 169.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.59 158.56 55.51 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.165 1.91 . . . . 10.0 110.638 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.59 179.32 6.05 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.261 2.641 . . . . 10.0 110.822 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.79 169.91 18.09 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.011 1.324 . . . . 10.0 107.669 174.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -160.75 -179.59 7.72 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.326 1.051 . . . . 10.0 108.468 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 t -159.75 -173.31 4.04 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.07 -1.455 . . . . 10.0 107.07 172.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.86 108.84 1.29 Allowed Pre-proline 0 CA--C 1.535 0.388 0 C-N-CA 124.717 1.207 . . . . 10.0 109.304 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.69 177.26 9.04 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.493 2.129 . . . . 10.0 110.192 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.22 169.58 23.84 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.565 1.146 . . . . 10.0 108.0 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -159.38 169.27 24.34 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.669 1.188 . . . . 10.0 107.954 178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -146.64 179.09 7.8 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.315 1.446 . . . . 10.0 107.702 177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 ttmt -155.06 174.69 14.83 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.74 -1.578 . . . . 10.0 106.74 173.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -154.61 -176.91 6.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.768 1.227 . . . . 10.0 107.867 178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.82 -177.72 29.31 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 107.691 -2.164 . . . . 10.0 107.691 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -142.81 -59.44 0.44 Allowed 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 117.794 0.797 . . . . 10.0 110.516 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -57.52 123.81 16.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 122.589 0.356 . . . . 10.0 110.655 179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.37 -68.78 0.82 Allowed 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.757 0.823 . . . . 10.0 110.389 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -158.84 131.36 4.38 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 -173.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.27 159.13 54.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.62 1.546 . . . . 10.0 109.676 176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.0 m -81.86 53.68 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 O-C-N 121.903 -0.498 . . . . 10.0 110.833 -171.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.0 p -156.48 53.34 0.54 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.315 0.646 . . . . 10.0 110.181 -173.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.74 80.85 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.112 -1.44 . . . . 10.0 107.112 165.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.49 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 0.5 OUTLIER -123.91 133.08 53.81 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 128.252 2.621 . . . . 10.0 108.407 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.06 97.09 1.29 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 109.27 -1.532 . . . . 10.0 109.27 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.12 9.99 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.705 0.753 . . . . 10.0 111.979 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.3 p -115.96 149.61 38.5 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.737 -1.208 . . . . 10.0 107.737 163.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.96 142.16 44.48 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.064 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -72.72 119.46 16.97 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 121.832 0.825 . . . . 10.0 111.044 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.06 86.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.792 1.637 . . . . 10.0 110.811 175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.9 t 45.45 74.66 0.76 Allowed Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.741 1.616 . . . . 10.0 111.144 175.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.26 170.26 20.3 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.296 2.664 . . . . 10.0 110.044 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.16 77.68 0.32 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.801 3.001 . . . . 10.0 112.473 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.3 t -157.11 -49.09 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.374 3.07 . . . . 10.0 106.008 165.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER 67.56 162.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.489 0 C-N-CA 125.615 1.566 . . . . 10.0 107.438 -161.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 72.79 -50.18 0.7 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.428 1.491 . . . . 10.0 111.89 -177.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -96.23 155.64 16.68 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.008 1.723 . . . . 10.0 109.69 -177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.6 t -164.41 -176.73 4.52 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.461 1.104 . . . . 10.0 108.045 162.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 153.91 34.26 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.487 1.115 . . . . 10.0 110.73 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.59 150.03 22.58 Favored 'General case' 0 C--N 1.341 0.2 0 O-C-N 124.073 0.858 . . . . 10.0 110.442 170.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -125.0 123.75 40.53 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 104.302 -2.481 . . . . 10.0 104.302 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -160.66 -172.41 3.51 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.228 1.411 . . . . 10.0 107.701 -177.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 73.6 m -144.86 122.59 11.87 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 121.444 -0.785 . . . . 10.0 109.598 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.3 mp -81.42 102.77 10.72 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.332 -1.729 . . . . 10.0 106.332 169.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 26.4 m -92.56 94.16 8.91 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 113.651 -1.613 . . . . 10.0 106.653 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.86 56.03 3.27 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.79 -0.569 . . . . 10.0 110.434 -167.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.8 tptt -91.76 111.09 22.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.34 0.59 . . . . 10.0 109.5 -168.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m 133.27 -19.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 131.564 3.946 . . . . 10.0 106.942 -165.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 76.78 61.7 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 107.638 -1.245 . . . . 10.0 107.638 150.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -145.04 137.45 13.4 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.319 1.848 . . . . 10.0 110.633 -170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -74.69 92.83 0.94 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.191 2.594 . . . . 10.0 112.212 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.4 mp -120.77 112.11 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 123.957 0.903 . . . . 10.0 108.924 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 168.64 17.96 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.675 0.79 . . . . 10.0 110.48 174.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.7 OUTLIER -132.93 127.78 35.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.679 -1.971 . . . . 10.0 105.679 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.0 p -144.41 56.18 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 121.522 0.677 . . . . 10.0 109.755 176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.4 147.25 13.52 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 110.191 -1.164 . . . . 10.0 110.191 163.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.22 66.95 0.51 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.019 1.327 . . . . 10.0 109.665 174.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.48 145.04 28.34 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 108.706 -0.849 . . . . 10.0 108.706 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 t -170.35 151.58 3.8 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 118.943 0.792 . . . . 10.0 110.47 -174.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.86 45.79 0.96 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.992 2.461 . . . . 10.0 111.323 166.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 tt -134.16 -77.28 0.47 Allowed 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.929 1.291 . . . . 10.0 108.609 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.92 143.53 55.63 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.032 0.533 . . . . 10.0 110.948 -176.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.4 m -96.72 -29.22 13.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.609 0.763 . . . . 10.0 109.64 165.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 31.0 t -126.03 67.41 61.86 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 126.074 1.75 . . . . 10.0 109.092 -177.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.73 106.1 1.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.679 2.253 . . . . 10.0 109.777 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.48 128.56 53.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.222 1.009 . . . . 10.0 109.478 -174.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 mt -81.73 136.8 35.44 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 108.229 -1.026 . . . . 10.0 108.229 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.8 ttp -136.07 152.44 50.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.055 1.342 . . . . 10.0 108.812 -177.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.7 t -148.19 110.24 4.56 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.413 0.685 . . . . 10.0 110.058 -166.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.283 0.7 OUTLIER -141.41 55.95 1.53 Allowed 'General case' 0 CA--C 1.534 0.351 0 O-C-N 121.447 -0.783 . . . . 10.0 111.828 175.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.5 m -137.2 110.57 7.92 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 125.039 1.336 . . . . 10.0 109.093 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -52.27 -42.65 63.87 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.461 1.104 . . . . 10.0 111.195 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.3 p -82.45 16.53 2.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.901 1.28 . . . . 10.0 112.334 177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.95 -142.99 5.2 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 125.396 1.474 . . . . 10.0 110.1 -176.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.01 -68.63 1.58 Allowed Glycine 0 CA--C 1.529 0.966 0 CA-C-N 117.169 0.484 . . . . 10.0 112.266 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 3.5 mmt -144.67 169.9 17.11 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.568 1.547 . . . . 10.0 108.24 179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -117.71 54.5 0.9 Allowed 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -173.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -155.93 75.01 0.22 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-O 118.742 -1.032 . . . . 10.0 111.591 -166.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 3.8 ttp -49.36 98.36 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 122.324 1.059 . . . . 10.0 111.717 176.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.5 pttt -155.76 166.53 33.21 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.274 2.229 . . . . 10.0 105.955 167.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.8 mtm -80.82 132.62 35.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.031 -1.47 . . . . 10.0 107.031 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 m -134.64 168.22 18.91 Favored Pre-proline 0 CA--C 1.534 0.332 0 C-N-CA 123.531 0.733 . . . . 10.0 110.668 -168.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -37.74 -56.4 0.92 Allowed 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.63 2.887 . . . . 10.0 111.464 159.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 178.47 -159.27 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.47 1.508 . . . . 10.0 110.258 -175.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -124.54 142.78 51.09 Favored 'General case' 0 N--CA 1.44 -0.957 0 C-N-CA 126.386 1.874 . . . . 10.0 106.362 161.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 27.6 m -110.47 134.87 51.94 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.005 -1.85 . . . . 10.0 106.005 169.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.5 pp -121.83 138.94 29.31 Favored Pre-proline 0 N--CA 1.452 -0.35 0 N-CA-C 106.679 -1.601 . . . . 10.0 106.679 -172.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -80.87 176.48 8.94 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 C-N-CA 121.862 1.708 . . . . 10.0 110.699 -173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -45.6 129.74 8.82 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 114.88 -1.054 . . . . 10.0 109.63 161.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 59.15 26.27 14.97 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 129.674 3.19 . . . . 10.0 113.342 -178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -59.69 144.71 45.96 Favored Glycine 0 CA--C 1.534 1.276 0 N-CA-C 110.965 -0.854 . . . . 10.0 110.965 167.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.3 m -129.21 65.42 1.46 Allowed 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 105.572 -2.01 . . . . 10.0 105.572 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 18.5 tp -80.25 129.25 34.37 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.943 -2.243 . . . . 10.0 104.943 -172.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 91.8 m -123.45 93.45 3.95 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 105.013 -2.217 . . . . 10.0 105.013 -158.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -79.82 122.45 26.64 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 107.538 -1.282 . . . . 10.0 107.538 -162.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -151.86 154.33 35.95 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.956 1.303 . . . . 10.0 108.47 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -8.53 6.91 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 114.507 1.299 . . . . 10.0 114.507 -164.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.65 37.67 1.48 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.812 0.733 . . . . 10.0 110.979 172.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -165.45 64.97 0.22 Allowed Glycine 0 C--N 1.337 0.636 0 N-CA-C 110.37 -1.092 . . . . 10.0 110.37 177.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.5 t0 70.01 133.78 0.03 OUTLIER 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 126.199 1.799 . . . . 10.0 109.748 -177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -177.19 169.82 2.24 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 121.574 -0.704 . . . . 10.0 110.728 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 42.6 t -98.95 115.64 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 105.527 -2.027 . . . . 10.0 105.527 169.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 81.5 mtp -83.84 95.92 8.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.297 -1.371 . . . . 10.0 107.297 172.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 43.1 mt -81.88 65.39 6.99 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.877 1.671 . . . . 10.0 107.891 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 75.8 mtp -82.6 162.53 21.89 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.847 0.832 . . . . 10.0 110.782 -169.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 79.99 69.66 1.38 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.429 -1.068 . . . . 10.0 110.429 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -60.33 82.64 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.672 0.789 . . . . 10.0 109.611 168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -55.92 -47.25 77.85 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.892 -0.505 . . . . 10.0 112.084 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -114.05 155.5 45.34 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 107.937 -1.135 . . . . 10.0 107.937 157.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.56 173.83 12.65 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 123.447 2.765 . . . . 10.0 110.034 170.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 mt -129.38 175.37 8.81 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.144 1.378 . . . . 10.0 110.113 -174.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -127.31 150.3 49.65 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.36 1.464 . . . . 10.0 107.953 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 62.8 t -69.79 134.23 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 81.77 28.46 42.49 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.074 -0.81 . . . . 10.0 111.074 178.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -78.64 -169.37 1.7 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 122.84 1.305 . . . . 10.0 108.813 170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.8 m -154.74 82.78 1.09 Allowed 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.027 -1.472 . . . . 10.0 107.027 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.3 t -89.83 126.49 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 N-CA-C 107.883 -1.154 . . . . 10.0 107.883 -175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -70.31 150.88 45.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 120.102 -0.639 . . . . 10.0 110.372 172.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 7.8 tt -129.98 148.61 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.379 -1.712 . . . . 10.0 106.379 170.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 21.7 m -123.15 117.59 25.72 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.629 -1.249 . . . . 10.0 107.629 165.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -89.79 157.04 18.11 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.481 -0.563 . . . . 10.0 109.481 168.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.4 tmmt? -157.38 86.23 0.94 Allowed 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.578 1.551 . . . . 10.0 107.895 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.74 157.61 23.19 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 122.096 -0.377 . . . . 10.0 110.046 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.4 t -54.36 -32.77 57.66 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.523 1.129 . . . . 10.0 112.504 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -5.74 4.35 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.918 0.887 . . . . 10.0 113.063 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 90.21 9.67 65.07 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.404 1.002 . . . . 10.0 111.424 -174.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -79.34 95.1 5.62 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 105.916 -1.883 . . . . 10.0 105.916 -175.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -116.37 123.97 48.91 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.076 1.751 . . . . 10.0 107.141 -171.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 25.4 tp -155.55 141.59 18.28 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 -171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -102.52 132.98 48.22 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.477 1.911 . . . . 10.0 106.742 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -137.87 162.14 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 106.528 -1.656 . . . . 10.0 106.528 -173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.05 131.86 54.68 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.868 1.267 . . . . 10.0 107.604 173.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -119.77 133.81 55.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.643 1.177 . . . . 10.0 109.892 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.8 m -83.89 128.33 34.47 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.263 -0.643 . . . . 10.0 109.263 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 70.2 t -90.87 108.1 19.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.324 -1.362 . . . . 10.0 107.324 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -157.58 125.07 5.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.582 -0.895 . . . . 10.0 108.582 173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -71.7 73.11 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.37 0.605 . . . . 10.0 111.357 176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -52.02 104.54 0.09 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 109.199 175.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . 0.275 10.9 pt 60.67 -23.0 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 128.147 2.579 . . . . 10.0 116.821 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -51.58 115.86 1.83 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.023 1.329 . . . . 10.0 110.854 -175.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.59 -62.75 2.32 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 110.911 -0.876 . . . . 10.0 110.911 -171.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 23.3 ttm105 . . . . . 0 C--O 1.247 0.952 0 C-N-CA 127.782 2.433 . . . . 10.0 109.562 -176.42 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.473 0.698 0 N-CA-C 106.629 -1.619 . . . . 10.0 106.629 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.61 124.97 1.27 Allowed Glycine 0 CA--C 1.529 0.936 0 N-CA-C 110.28 -1.128 . . . . 10.0 110.28 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -165.43 155.39 13.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.7 t -166.54 -179.46 4.91 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.166 -1.42 . . . . 10.0 107.166 169.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 55.7 ttm -167.3 71.44 0.99 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 125.658 1.583 . . . . 10.0 108.712 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -71.48 143.74 43.51 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.222 1.948 . . . . 10.0 109.893 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.35 151.44 15.4 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.173 -1.047 . . . . 10.0 108.173 176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -164.17 169.44 17.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 106.534 -1.654 . . . . 10.0 106.534 171.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 t -172.51 68.67 0.4 Allowed Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.245 1.018 . . . . 10.0 109.898 -175.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -69.15 118.66 5.81 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.254 1.969 . . . . 10.0 110.113 -179.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -81.99 159.4 18.27 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.519 2.146 . . . . 10.0 110.787 -178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.32 150.5 16.41 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.758 -1.201 . . . . 10.0 107.758 172.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -169.92 157.39 6.67 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.773 1.229 . . . . 10.0 108.276 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 t -169.14 174.4 6.24 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.405 1.482 . . . . 10.0 107.172 168.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.2 68.01 0.27 Allowed Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.115 1.366 . . . . 10.0 110.5 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -73.19 145.23 38.7 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.115 1.877 . . . . 10.0 110.056 177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.4 152.2 16.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 124.034 0.934 . . . . 10.0 108.507 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -168.39 156.62 8.46 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.587 1.555 . . . . 10.0 107.01 175.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -164.02 160.78 22.15 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.798 -1.186 . . . . 10.0 107.798 178.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt -177.59 169.68 2.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.261 2.224 . . . . 10.0 106.641 171.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -169.21 -177.41 2.86 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.784 1.634 . . . . 10.0 107.215 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -155.16 164.86 32.07 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 107.51 -2.236 . . . . 10.0 107.51 173.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.27 -177.39 3.65 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.263 1.025 . . . . 10.0 108.58 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 71.12 178.21 0.26 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.072 1.749 . . . . 10.0 111.76 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -162.04 178.18 9.07 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 125.87 1.668 . . . . 10.0 106.952 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -149.15 132.18 8.17 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.541 -1.281 . . . . 10.0 107.541 -175.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -65.22 150.49 87.44 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 121.605 1.537 . . . . 10.0 109.002 174.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.1 m -83.04 51.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-O 121.785 0.803 . . . . 10.0 111.168 -166.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.8 p -157.85 55.17 0.48 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.455 -0.572 . . . . 10.0 109.455 -165.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.57 58.3 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 122.11 0.957 . . . . 10.0 108.981 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.432 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -97.9 -179.91 4.58 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.112 1.365 . . . . 10.0 110.396 171.112 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -138.0 -136.92 3.51 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.056 -2.418 . . . . 10.0 107.056 166.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.98 132.4 6.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 118.981 1.39 . . . . 10.0 110.683 165.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 40.7 p -126.76 135.2 50.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.288 -1.745 . . . . 10.0 106.288 165.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 64.7 t -121.71 135.29 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 119.158 0.89 . . . . 10.0 109.061 -171.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.83 44.62 0.56 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.631 0.974 . . . . 10.0 113.631 -171.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 26.77 -119.06 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.643 1.977 . . . . 10.0 111.546 -164.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -112.69 113.94 50.01 Favored Pre-proline 0 CA--C 1.533 0.296 0 N-CA-C 106.093 -1.817 . . . . 10.0 106.093 161.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -62.97 163.99 20.65 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.17 1.913 . . . . 10.0 108.774 168.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.92 62.41 5.78 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.449 2.1 . . . . 10.0 110.523 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 80.5 p -163.4 62.31 0.17 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 124.209 1.004 . . . . 10.0 108.628 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 18.7 mt 75.15 160.94 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 124.932 1.293 . . . . 10.0 110.222 172.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -66.76 25.19 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 114.741 1.386 . . . . 10.0 114.741 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.95 158.44 15.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 168.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 9.8 t -165.39 -175.54 3.63 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 105.728 -1.953 . . . . 10.0 105.728 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.56 168.98 24.93 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 109.319 -0.622 . . . . 10.0 109.319 174.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -82.47 161.09 22.52 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 167.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -131.4 104.7 7.15 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.632 -1.988 . . . . 10.0 105.632 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.81 -171.16 2.8 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.139 1.775 . . . . 10.0 110.443 -169.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -152.29 129.57 11.26 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 120.718 -1.238 . . . . 10.0 108.029 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.11 135.44 33.98 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 106.966 -1.494 . . . . 10.0 106.966 167.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 70.9 m -123.96 104.27 8.81 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 124.168 0.918 . . . . 10.0 110.581 -167.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -78.18 113.18 15.88 Favored 'General case' 0 N--CA 1.461 0.082 0 N-CA-C 109.706 -0.479 . . . . 10.0 109.706 167.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -135.36 68.44 1.46 Allowed 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.668 -1.604 . . . . 10.0 106.668 165.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 t -178.5 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 125.388 1.475 . . . . 10.0 111.473 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 72.72 78.13 0.15 Allowed 'General case' 0 C--N 1.343 0.308 0 C-N-CA 126.551 1.94 . . . . 10.0 112.17 -171.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -143.16 147.0 38.97 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.331 0.652 . . . . 10.0 109.817 168.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.513 ' C ' HD12 ' A' ' 59' ' ' ILE . 93.6 Cg_endo -86.29 112.23 1.1 Allowed 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.759 2.973 . . . . 10.0 111.001 173.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.513 HD12 ' C ' ' A' ' 58' ' ' PRO . 1.7 mp -123.92 99.68 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 108.796 -0.816 . . . . 10.0 108.796 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -82.71 103.94 12.59 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.109 -0.994 . . . . 10.0 111.139 -173.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.27 0.0 OUTLIER -82.68 124.95 30.68 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.697 0.799 . . . . 10.0 110.201 -176.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.66 54.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.2 0 CA-C-O 122.117 0.961 . . . . 10.0 109.626 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.65 144.49 10.0 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -1.323 . . . . 10.0 109.792 169.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -156.45 66.73 0.56 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.972 1.709 . . . . 10.0 107.205 167.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -82.37 148.71 28.1 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 t -170.3 151.78 3.9 Favored Pre-proline 0 N--CA 1.451 -0.405 0 N-CA-C 109.879 -0.415 . . . . 10.0 109.879 -164.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.28 -1.41 11.58 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.802 2.335 . . . . 10.0 112.021 167.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 14.0 tp -104.82 -35.91 7.57 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.471 1.108 . . . . 10.0 113.415 -163.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.43 124.29 48.97 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.558 1.143 . . . . 10.0 109.844 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.49 -29.79 65.22 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.795 0.838 . . . . 10.0 110.108 172.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.7 m -135.36 68.43 68.14 Favored Pre-proline 0 N--CA 1.45 -0.429 0 C-N-CA 125.024 1.33 . . . . 10.0 109.959 -169.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -76.1 115.76 4.22 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.616 2.21 . . . . 10.0 110.365 176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -139.34 140.4 37.5 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.821 0.448 . . . . 10.0 111.203 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.5 mt -83.57 145.83 28.65 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.765 1.226 . . . . 10.0 109.8 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.65 169.37 18.12 Favored 'General case' 0 CA--C 1.521 -0.141 0 C-N-CA 125.596 1.558 . . . . 10.0 109.817 -175.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 6.5 t -145.71 157.44 43.95 Favored 'General case' 0 C--O 1.224 -0.275 0 O-C-N 122.318 -0.238 . . . . 10.0 110.677 164.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -155.54 61.14 0.61 Allowed 'General case' 0 CA--C 1.53 0.185 0 O-C-N 121.342 -0.849 . . . . 10.0 109.25 172.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.9 t -155.15 138.63 15.91 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.228 -0.656 . . . . 10.0 109.228 -176.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -80.55 -39.21 28.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.4 m -62.38 -44.99 95.16 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 124.798 1.239 . . . . 10.0 111.514 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.94 -126.7 3.49 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 111.065 -0.814 . . . . 10.0 111.065 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -62.4 -75.3 0.33 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.828 0.727 . . . . 10.0 113.923 -174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -163.73 160.98 23.21 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.774 0.83 . . . . 10.0 109.972 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -87.97 53.81 2.89 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.621 -1.251 . . . . 10.0 107.621 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -133.67 71.2 0.5 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-O 119.324 -0.709 . . . . 10.0 111.962 -156.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.51 64.32 4.36 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.182 0.991 . . . . 10.0 110.24 -172.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -136.11 170.26 16.31 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.971 2.108 . . . . 10.0 109.275 -177.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.0 mtp -80.86 72.79 7.87 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.52 0.728 . . . . 10.0 109.155 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.1 m -70.1 158.8 86.52 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 115.568 -0.742 . . . . 10.0 110.341 176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -44.49 -53.41 4.96 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.373 2.715 . . . . 10.0 111.995 163.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.52 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER 174.3 -157.62 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.021 2.129 . . . . 10.0 108.931 -175.166 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.52 HD22 ' C ' ' A' ' 91' ' ' TRP . 3.1 mm? -128.76 139.9 51.98 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 106.646 -1.613 . . . . 10.0 106.646 165.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.1 m -88.4 100.13 12.8 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 106.444 -1.687 . . . . 10.0 106.444 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -82.31 123.11 79.49 Favored Pre-proline 0 CA--C 1.535 0.393 0 N-CA-C 106.095 -1.817 . . . . 10.0 106.095 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -84.17 -172.24 1.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.566 2.177 . . . . 10.0 111.771 -168.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.83 149.23 3.54 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.026 -0.731 . . . . 10.0 109.026 155.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.21 7.61 0.06 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.809 1.411 . . . . 10.0 114.809 -165.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 90.74 0.09 OUTLIER Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.885 -1.286 . . . . 10.0 109.885 179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 9.5 m -115.93 64.78 0.7 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.134 1.774 . . . . 10.0 107.326 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.0 mp -88.73 154.68 20.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.55 -0.75 . . . . 10.0 109.648 -169.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.2 p -118.5 109.76 16.59 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.871 -1.9 . . . . 10.0 105.871 -167.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -83.62 102.99 12.58 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.081 -1.822 . . . . 10.0 106.081 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -152.07 170.62 19.48 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 118.816 0.735 . . . . 10.0 111.295 -170.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -36.55 -47.38 0.63 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.772 1.229 . . . . 10.0 111.712 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -129.93 95.05 3.85 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.776 1.63 . . . . 10.0 107.75 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 145.7 117.68 1.1 Allowed Glycine 0 CA--C 1.531 1.043 0 CA-C-O 118.7 -1.056 . . . . 10.0 111.264 -178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.2 t0 24.86 64.79 0.05 Allowed 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 128.565 2.746 . . . . 10.0 113.533 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -116.59 159.54 22.0 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.269 0.557 . . . . 10.0 112.419 -165.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.77 114.53 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 105.769 -1.937 . . . . 10.0 105.769 171.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 mtp -81.98 96.92 7.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.802 -1.184 . . . . 10.0 107.802 170.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 75.0 mt -81.0 59.41 3.79 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 46.5 ttp -82.99 158.4 22.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.387 0.675 . . . . 10.0 110.474 -169.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 123.16 -7.93 9.15 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 118.097 -1.39 . . . . 10.0 115.207 156.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.7 tp 46.63 68.54 0.6 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.243 1.417 . . . . 10.0 111.777 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.3 tttp -77.92 -37.71 47.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 123.432 0.693 . . . . 10.0 110.695 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -140.73 153.02 67.4 Favored Pre-proline 0 N--CA 1.453 -0.293 0 N-CA-C 105.747 -1.946 . . . . 10.0 105.747 174.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -60.21 109.97 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.885 2.39 . . . . 10.0 111.415 -174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.6 mp -69.04 99.81 1.14 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 108.81 -0.811 . . . . 10.0 108.81 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -97.8 115.78 28.72 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.228 1.411 . . . . 10.0 108.673 -172.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.4 p -46.97 120.0 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.238 0.615 . . . . 10.0 110.067 171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.88 -23.71 18.64 Favored Glycine 0 CA--C 1.524 0.613 0 CA-C-O 118.704 -1.053 . . . . 10.0 111.766 175.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -175.02 3.86 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.723 1.725 . . . . 10.0 109.55 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 19.8 m -153.9 131.74 11.61 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.284 -1.78 . . . . 10.0 107.493 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.7 136.84 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 124.404 1.082 . . . . 10.0 108.676 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -76.9 114.15 15.36 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.686 -0.487 . . . . 10.0 109.686 178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 24.2 pt -92.88 176.65 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 123.747 0.819 . . . . 10.0 109.068 164.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 93.2 m -147.75 125.41 11.81 Favored 'General case' 0 CA--C 1.531 0.235 0 O-C-N 121.596 -0.69 . . . . 10.0 109.609 174.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.7 pp -91.77 179.18 5.7 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.22 0.608 . . . . 10.0 111.92 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -157.74 103.46 1.9 Allowed 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.826 1.65 . . . . 10.0 108.068 172.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -90.18 123.35 33.93 Favored 'General case' 0 C--N 1.33 -0.274 0 O-C-N 122.006 -0.434 . . . . 10.0 110.488 168.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.6 t -83.0 64.0 7.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.84 -1.17 . . . . 10.0 107.84 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -174.86 -61.2 0.01 OUTLIER 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 128.916 2.887 . . . . 10.0 105.47 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -83.75 -96.81 0.6 Allowed Glycine 0 CA--C 1.526 0.765 0 CA-C-N 114.629 -1.169 . . . . 10.0 111.567 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -160.47 175.86 12.28 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.857 -0.79 . . . . 10.0 109.619 -171.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.6 t -90.42 150.36 21.87 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.868 1.667 . . . . 10.0 107.007 156.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 36.9 tp -155.16 142.89 19.84 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 105.801 -1.925 . . . . 10.0 105.801 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -92.89 132.18 37.25 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.198 1.799 . . . . 10.0 106.667 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 3.7 t -138.48 128.36 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 107.686 -1.227 . . . . 10.0 107.686 -166.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.65 108.03 16.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.815 -0.809 . . . . 10.0 108.815 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -93.26 118.89 31.8 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 124.005 0.922 . . . . 10.0 109.838 -179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 84.4 m -83.95 132.41 34.77 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.795 -0.446 . . . . 10.0 109.795 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 90.6 t -102.42 111.34 31.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 106.973 -1.492 . . . . 10.0 106.973 -168.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.432 ' NZ ' ' OXT' ' A' ' 149' ' ' ARG . 31.9 pttt -157.67 116.98 3.28 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.577 0.626 . . . . 10.0 111.283 179.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -84.73 175.43 9.19 Favored 'General case' 0 C--O 1.225 -0.217 0 O-C-N 121.731 -0.605 . . . . 10.0 111.088 173.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 56.04 179.56 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 125.677 1.591 . . . . 10.0 112.191 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.28 111.79 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 104.39 -2.448 . . . . 10.0 104.39 165.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -146.8 134.26 20.83 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 -171.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.3 -69.24 0.5 Allowed Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.437 1.494 . . . . 10.0 113.046 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.432 ' OXT' ' NZ ' ' A' ' 143' ' ' LYS . 27.4 mtt180 . . . . . 0 C--O 1.247 0.948 0 C-N-CA 128.457 2.703 . . . . 10.0 105.611 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.4 mtt . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -51.53 -35.32 36.7 Favored Glycine 0 CA--C 1.529 0.956 0 CA-C-N 119.303 0.956 . . . . 10.0 111.365 172.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -141.79 -177.56 5.25 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.341 -0.985 . . . . 10.0 108.341 167.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 t 177.58 152.99 0.26 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 129.031 2.933 . . . . 10.0 106.149 176.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 28.0 ttt -151.81 132.46 7.46 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -175.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.32 178.49 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.097 2.531 . . . . 10.0 110.661 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.07 166.77 31.43 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.829 1.251 . . . . 10.0 107.693 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -162.87 171.91 15.94 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.1 t -153.04 140.52 13.26 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 108.158 -1.053 . . . . 10.0 108.158 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.66 155.98 40.01 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.355 2.037 . . . . 10.0 111.052 -176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -75.75 176.05 10.51 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.22 2.613 . . . . 10.0 110.387 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.52 156.36 41.26 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.873 -1.158 . . . . 10.0 107.873 173.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -165.37 167.61 17.58 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 106.791 -1.559 . . . . 10.0 106.791 -176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.8 t -150.42 -179.83 7.54 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 170.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.06 104.67 1.56 Allowed Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 10.0 109.46 -174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.07 107.04 2.39 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.191 1.927 . . . . 10.0 110.342 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.79 74.01 0.42 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.703 0.801 . . . . 10.0 110.537 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.45 66.28 0.47 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.179 1.392 . . . . 10.0 112.801 -173.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -64.72 157.25 27.94 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.084 0.554 . . . . 10.0 109.647 167.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 48.1 pttt -165.28 148.36 8.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 -174.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -170.13 -175.81 2.09 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.338 1.455 . . . . 10.0 107.714 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.51 42.93 79.67 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 123.095 0.379 . . . . 10.0 112.465 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -75.32 -44.87 43.04 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.669 0.388 . . . . 10.0 111.43 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.06 167.15 19.1 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.24 0.616 . . . . 10.0 112.243 -174.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.36 175.31 10.63 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.626 1.571 . . . . 10.0 108.315 176.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 tt -153.79 131.81 6.43 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -175.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -67.65 140.7 52.43 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.145 1.897 . . . . 10.0 109.491 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 16.9 m -83.17 54.04 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 123.007 0.523 . . . . 10.0 112.329 -158.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -160.45 54.06 0.32 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.124 0.964 . . . . 10.0 109.974 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.7 p -84.75 64.74 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 120.984 -1.073 . . . . 10.0 110.774 -177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -155.35 149.9 26.21 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.131 0.572 . . . . 10.0 109.731 169.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.61 145.42 17.83 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 109.001 -1.64 . . . . 10.0 109.001 171.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.45 161.0 22.58 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 118.264 1.032 . . . . 10.0 111.302 -171.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 91.8 m -123.41 139.97 53.49 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.907 -1.516 . . . . 10.0 106.907 162.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 p -106.92 136.71 40.94 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.191 0 N-CA-C 107.358 -1.349 . . . . 10.0 107.358 166.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -79.45 41.46 0.47 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 113.124 0.787 . . . . 10.0 113.124 -173.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 34.94 -137.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.956 2.102 . . . . 10.0 112.083 -175.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.0 t -97.75 108.75 47.59 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 105.805 -1.924 . . . . 10.0 105.805 160.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.31 166.6 29.13 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 N-CA-C 107.528 -1.758 . . . . 10.0 107.528 166.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.36 64.78 3.62 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.048 2.499 . . . . 10.0 111.032 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 6.3 t -164.55 56.51 0.14 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.842 1.257 . . . . 10.0 108.985 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt 71.56 170.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 124.589 1.156 . . . . 10.0 109.005 177.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -44.92 -41.35 7.14 Favored 'General case' 0 N--CA 1.465 0.278 0 O-C-N 121.064 -1.023 . . . . 10.0 112.747 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -51.43 141.35 15.73 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 127.072 2.149 . . . . 10.0 111.983 -174.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 114' ' ' LEU . 14.3 t -162.03 -172.45 3.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.392 -0.822 . . . . 10.0 109.652 -165.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.34 159.09 44.08 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.792 0.837 . . . . 10.0 111.555 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.09 144.07 26.03 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.94 1.296 . . . . 10.0 109.238 171.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -128.53 119.22 24.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.569 -2.752 . . . . 10.0 103.569 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 19.1 ptp -161.04 -173.9 4.11 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 124.367 1.067 . . . . 10.0 108.522 -177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 25.9 m -131.39 135.85 47.55 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.216 1.407 . . . . 10.0 108.111 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.4 mp -95.88 120.97 37.09 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 103.952 -2.611 . . . . 10.0 103.952 160.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.9 m -110.55 79.74 1.24 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.424 -1.324 . . . . 10.0 107.424 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.7 t-20 -81.33 92.9 6.46 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.317 0.58 . . . . 10.0 110.433 -171.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -83.31 57.11 3.82 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.798 -0.564 . . . . 10.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 t -171.1 157.96 5.37 Favored 'General case' 0 C--O 1.226 -0.152 0 C-N-CA 123.936 0.895 . . . . 10.0 109.182 166.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -82.78 61.96 6.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 176.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -134.91 117.46 12.81 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 123.783 0.833 . . . . 10.0 111.04 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.98 122.82 7.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.094 2.529 . . . . 10.0 110.337 177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.61 106.57 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.499 0.72 . . . . 10.0 109.08 177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 121.46 32.61 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.204 -0.935 . . . . 10.0 111.563 -171.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . 0.288 0.0 OUTLIER -102.59 128.06 49.41 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 122.047 -0.408 . . . . 10.0 110.22 -171.509 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.59 57.21 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-O 122.536 1.16 . . . . 10.0 109.079 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.78 153.23 24.22 Favored Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 108.939 -1.665 . . . . 10.0 108.939 166.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.94 62.19 0.46 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 168.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.92 138.87 32.24 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 108.543 -0.91 . . . . 10.0 108.543 -173.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 4.8 t -168.82 151.32 4.94 Favored Pre-proline 0 C--O 1.242 0.675 0 CA-C-N 118.602 0.637 . . . . 10.0 109.693 -173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.94 56.37 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.77 2.313 . . . . 10.0 109.656 165.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 23.7 mt -136.55 -82.33 0.38 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 125.97 1.708 . . . . 10.0 107.982 171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.74 136.86 45.6 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 124.043 0.937 . . . . 10.0 111.681 -173.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 92.8 m -81.48 -31.43 32.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.251 0.62 . . . . 10.0 109.433 159.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.2 t -119.82 72.2 16.14 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.503 1.121 . . . . 10.0 111.448 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.84 97.22 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.916 2.411 . . . . 10.0 111.153 174.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 14.7 mmt -105.23 128.72 53.56 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 124.378 1.071 . . . . 10.0 110.063 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 145.28 28.18 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.926 0.89 . . . . 10.0 110.105 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.05 163.85 31.33 Favored 'General case' 0 CA--C 1.52 -0.206 0 C-N-CA 124.888 1.275 . . . . 10.0 111.507 172.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.451 ' CG2' ' H ' ' A' ' 83' ' ' MET 0.25 26.1 m -102.0 164.23 11.82 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.485 3.114 . . . . 10.0 110.805 -178.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.8 t -95.93 173.98 7.17 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.367 1.067 . . . . 10.0 112.837 172.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.6 m -99.26 55.82 1.0 Allowed 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 114.929 -1.032 . . . . 10.0 109.003 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.9 p80 171.87 -170.33 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.698 2.399 . . . . 10.0 107.69 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.1 m -46.84 171.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 128.881 2.872 . . . . 10.0 114.654 173.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.92 -65.72 2.2 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 107.908 -2.077 . . . . 10.0 107.908 -169.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -77.62 -146.61 2.65 Favored Glycine 0 CA--C 1.533 1.157 0 N-CA-C 110.474 -1.05 . . . . 10.0 110.474 155.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.451 ' H ' ' CG2' ' A' ' 76' ' ' THR . 65.8 mtt -114.1 -82.47 0.6 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.865 1.266 . . . . 10.0 109.922 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.02 51.81 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.841 1.256 . . . . 10.0 109.385 -172.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.18 147.48 4.68 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 121.051 -0.595 . . . . 10.0 113.905 166.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -78.3 43.6 0.46 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.126 1.77 . . . . 10.0 112.047 -175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -83.04 157.77 22.75 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.572 0.749 . . . . 10.0 109.872 -176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 48.3 ttp -81.49 70.38 8.35 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 122.417 1.103 . . . . 10.0 109.36 -175.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 m -58.09 162.02 6.25 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.876 1.671 . . . . 10.0 111.718 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HB2' ' CE3' ' A' ' 91' ' ' TRP . 50.3 Cg_exo -47.57 -37.65 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.553 2.836 . . . . 10.0 113.341 163.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 90' ' ' PRO . 0.0 OUTLIER 172.91 -158.56 0.01 OUTLIER 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.978 1.311 . . . . 10.0 111.049 -161.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.55 115.04 20.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 122.937 0.495 . . . . 10.0 110.05 164.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 55.3 m -84.46 103.14 13.36 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 159.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.28 120.16 76.45 Favored Pre-proline 0 N--CA 1.451 -0.383 0 N-CA-C 105.998 -1.852 . . . . 10.0 105.998 174.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -85.89 137.16 5.4 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 N-CA-C 109.283 -1.083 . . . . 10.0 109.283 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 50.73 -137.25 1.16 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.302 0.641 . . . . 10.0 110.911 174.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.89 59.39 0.1 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.291 2.237 . . . . 10.0 112.316 176.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.72 87.1 0.12 Allowed Glycine 0 N--CA 1.441 -0.974 0 O-C-N 121.583 -0.698 . . . . 10.0 111.372 176.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.1 m -86.4 67.67 9.98 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.63 1.572 . . . . 10.0 107.602 163.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.473 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.5 pt? -102.82 175.48 5.47 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.833 -0.802 . . . . 10.0 108.833 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.1 t -155.85 129.88 8.67 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.675 0.75 . . . . 10.0 110.437 -169.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.92 126.14 32.71 Favored 'General case' 0 N--CA 1.435 -1.194 0 C-N-CA 125.52 1.528 . . . . 10.0 108.574 -168.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -145.29 154.58 42.51 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.548 1.939 . . . . 10.0 109.123 -170.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.438 HH21 ' HA ' ' A' ' 105' ' ' ASP . 0.0 OUTLIER -56.62 -27.81 59.12 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.073 0.949 . . . . 10.0 112.855 176.483 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.438 ' HA ' HH21 ' A' ' 104' ' ' ARG . 36.1 m-20 -78.55 -59.99 2.56 Favored 'General case' 0 CA--C 1.518 -0.275 0 O-C-N 121.473 -0.767 . . . . 10.0 111.406 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.88 136.87 5.55 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.833 -1.307 . . . . 10.0 109.833 -167.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.8 t0 70.06 120.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 129.063 2.945 . . . . 10.0 106.761 -173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 177.42 171.17 0.58 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 120.549 1.522 . . . . 10.0 111.759 -176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.1 t -107.36 124.4 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 105.066 -2.198 . . . . 10.0 105.066 156.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 24.4 mtm -82.32 96.69 7.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.741 -1.948 . . . . 10.0 105.741 161.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.9 mt -79.52 69.18 5.74 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.911 -1.514 . . . . 10.0 106.911 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 66.4 mtp -85.37 166.95 15.99 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.967 0.889 . . . . 10.0 112.961 -169.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 56.96 57.8 17.87 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.081 -1.208 . . . . 10.0 110.081 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 45' ' ' THR . 86.5 mt -61.36 123.38 17.62 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.075 0.938 . . . . 10.0 109.098 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.82 -61.91 1.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.595 0.358 . . . . 10.0 111.423 -178.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -70.75 157.18 90.78 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 123.076 0.55 . . . . 10.0 111.354 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.98 139.62 39.89 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.577 2.184 . . . . 10.0 110.288 169.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -88.05 179.43 6.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 125.005 1.322 . . . . 10.0 111.592 -176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.43 100.64 0.93 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 -177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 98.8 t -55.64 117.98 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 108.208 -1.034 . . . . 10.0 108.208 175.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 110.15 -13.28 31.35 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-O 119.194 -0.781 . . . . 10.0 111.995 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -77.78 -169.85 1.66 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 123.493 1.615 . . . . 10.0 108.303 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 26.8 m -155.3 137.27 14.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 178.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.9 t -129.3 154.38 40.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 107.22 -1.4 . . . . 10.0 107.22 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -80.52 145.67 31.71 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 109.541 -0.54 . . . . 10.0 109.541 176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 126' ' ' ILE . 17.9 tt -108.71 146.09 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 162.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 28.7 m -117.57 111.82 19.73 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 105.871 -1.899 . . . . 10.0 105.871 172.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.47 145.71 24.3 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 125.935 1.694 . . . . 10.0 107.258 -178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -144.27 97.58 3.07 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.958 -1.497 . . . . 10.0 106.958 175.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.45 142.28 32.05 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 108.195 -1.039 . . . . 10.0 108.195 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 6.3 t -62.14 -29.05 70.07 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 120.695 -1.253 . . . . 10.0 111.082 -175.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -65.37 -36.56 84.36 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.664 -0.647 . . . . 10.0 110.595 171.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -151.81 91.16 0.13 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 125.177 1.37 . . . . 10.0 110.602 -174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.44 53.61 1.57 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.521 0.728 . . . . 10.0 110.643 -174.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 9.5 m -157.8 87.8 0.95 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.934 0.494 . . . . 10.0 110.896 -170.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.5 mt -153.94 156.06 36.79 Favored 'General case' 0 C--O 1.23 0.036 0 CA-C-N 119.085 0.857 . . . . 10.0 109.109 167.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -149.32 136.28 19.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 175.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 21.8 t -145.4 163.63 11.94 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 -168.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -87.55 137.66 32.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.387 0.675 . . . . 10.0 110.359 174.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -116.34 114.34 24.18 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.205 1.802 . . . . 10.0 109.318 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -83.01 125.3 31.28 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.297 1.439 . . . . 10.0 108.203 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 67.2 t -84.84 97.34 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 O-C-N 120.513 -1.367 . . . . 10.0 108.305 -172.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -147.44 103.03 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.315 0.646 . . . . 10.0 110.917 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -52.11 127.44 21.64 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.952 -0.468 . . . . 10.0 110.3 161.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -149.13 143.16 25.81 Favored 'General case' 0 CA--C 1.527 0.077 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.9 mp 43.16 55.66 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.418 1.104 . . . . 10.0 108.663 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -83.22 51.45 1.97 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.103 -0.953 . . . . 10.0 112.365 -158.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 156.71 -55.02 0.4 Allowed Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.836 -0.906 . . . . 10.0 110.836 177.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.491 0 C-N-CA 126.596 1.958 . . . . 10.0 110.388 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.474 0.759 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.96 148.79 11.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 109.118 -1.593 . . . . 10.0 109.118 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -119.98 67.41 0.82 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 126.046 1.738 . . . . 10.0 109.36 -173.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.9 p -73.04 75.68 1.21 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.559 0.744 . . . . 10.0 109.919 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 60.4 ttp -93.47 106.38 20.36 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 124.996 1.318 . . . . 10.0 109.818 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.21 175.04 11.58 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.253 1.969 . . . . 10.0 110.316 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -160.37 165.57 30.93 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.874 1.27 . . . . 10.0 107.669 172.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -160.39 165.86 30.36 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 106.945 -1.502 . . . . 10.0 106.945 175.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 t -167.25 69.15 0.95 Allowed Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.583 1.153 . . . . 10.0 109.497 -175.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -67.51 122.4 9.61 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.197 1.932 . . . . 10.0 110.007 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -79.83 168.3 19.41 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.719 2.279 . . . . 10.0 110.895 -178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.2 142.09 20.13 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.794 -1.188 . . . . 10.0 107.794 173.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -167.04 164.89 15.96 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 106.516 -1.661 . . . . 10.0 106.516 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 t -158.99 -177.24 6.36 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 173.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.98 73.31 1.26 Allowed Pre-proline 0 CA--C 1.538 0.488 0 C-N-CA 125.584 1.553 . . . . 10.0 109.691 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.04 78.01 2.64 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.016 2.477 . . . . 10.0 111.164 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.3 152.22 17.89 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.033 0.533 . . . . 10.0 110.769 170.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -155.34 171.84 19.19 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.206 1.002 . . . . 10.0 108.927 -178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -143.84 174.96 10.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.542 1.537 . . . . 10.0 107.761 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -137.52 107.76 6.43 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.377 1.071 . . . . 10.0 108.871 -176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.7 98.45 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.101 0.56 . . . . 10.0 111.419 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.36 -59.96 3.99 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.907 -0.496 . . . . 10.0 111.957 177.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -139.8 149.71 43.84 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.997 0.919 . . . . 10.0 109.431 179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 69.12 142.87 0.04 OUTLIER 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.885 1.674 . . . . 10.0 110.29 -168.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 70.85 -39.77 0.46 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.714 1.605 . . . . 10.0 113.931 177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 tt -51.65 120.31 15.34 Favored Pre-proline 0 N--CA 1.447 -0.617 0 C-N-CA 125.442 1.497 . . . . 10.0 109.602 176.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -68.16 165.3 28.94 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.416 1.411 . . . . 10.0 108.583 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.0 m -82.09 56.08 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 122.123 0.963 . . . . 10.0 110.554 -169.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.1 p -155.08 58.02 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.237 1.015 . . . . 10.0 108.777 -167.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.56 85.32 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.144 -1.058 . . . . 10.0 108.144 173.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 pm0 -145.52 158.67 43.81 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.107 1.763 . . . . 10.0 107.586 174.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.62 -163.08 32.74 Favored Glycine 0 CA--C 1.529 0.932 0 N-CA-C 108.437 -1.865 . . . . 10.0 108.437 161.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.55 149.51 23.99 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 117.994 0.897 . . . . 10.0 109.96 169.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 56.6 p -133.76 153.99 51.31 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 170.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 56.7 t -126.4 133.55 68.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 C-N-CA 123.514 0.726 . . . . 10.0 109.928 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.17 110.45 7.47 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 109.351 -0.611 . . . . 10.0 109.351 175.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.37 144.82 34.65 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.464 -0.772 . . . . 10.0 109.112 164.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.7 t -19.35 99.31 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 127.523 2.329 . . . . 10.0 113.558 -172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 163.01 7.96 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.688 2.926 . . . . 10.0 109.683 169.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.09 52.58 3.51 Favored 'Trans proline' 0 CA--C 1.538 0.683 0 C-N-CA 122.22 1.947 . . . . 10.0 110.164 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.6 t -157.68 56.0 0.49 Allowed 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.182 -1.044 . . . . 10.0 108.182 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.6 mt 70.08 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 124.333 1.053 . . . . 10.0 109.008 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.462 HH11 ' CG ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -50.6 -42.71 56.25 Favored 'General case' 0 CA--C 1.52 -0.212 0 N-CA-C 113.216 0.821 . . . . 10.0 113.216 -179.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.462 ' CG ' HH11 ' A' ' 43' ' ' ARG . 63.4 m-20 -59.09 127.32 31.61 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 121.706 0.765 . . . . 10.0 109.929 -163.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.0 t -145.68 -165.84 2.29 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.315 -1.311 . . . . 10.0 111.21 -164.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.86 157.94 41.45 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.611 1.164 . . . . 10.0 112.107 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.42 158.95 20.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.492 -0.777 . . . . 10.0 110.022 165.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -124.3 128.14 48.68 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 104.505 -2.406 . . . . 10.0 104.505 163.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 22.9 ptp -157.64 177.8 10.99 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.769 -0.456 . . . . 10.0 109.769 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 p -98.19 168.81 10.02 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 164.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.39 146.4 46.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 106.364 -1.717 . . . . 10.0 106.364 163.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.6 m -140.79 111.66 7.04 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.975 0.797 . . . . 10.0 112.302 -166.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.75 119.69 24.66 Favored 'General case' 0 C--N 1.342 0.265 0 CA-C-N 118.314 0.506 . . . . 10.0 109.652 167.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.99 80.74 1.63 Allowed 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.971 -1.122 . . . . 10.0 107.971 157.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 m 164.53 -19.54 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 129.184 2.994 . . . . 10.0 109.557 -173.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 74.13 53.24 0.1 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.495 0.589 . . . . 10.0 110.407 140.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -145.98 157.71 49.96 Favored Pre-proline 0 CA--C 1.534 0.342 0 C-N-CA 125.004 1.322 . . . . 10.0 109.129 -170.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -78.31 70.59 7.14 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.543 2.829 . . . . 10.0 111.301 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.4 mm -85.89 152.01 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.44 0.638 . . . . 10.0 109.653 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 4.0 pttm -139.26 81.83 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.592 2.357 . . . . 10.0 108.791 -162.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 84.2 mt -83.01 63.4 7.07 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 124.155 0.982 . . . . 10.0 111.961 -166.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.5 p -82.39 60.18 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.804 -0.635 . . . . 10.0 111.481 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 149.2 18.62 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.365 -1.398 . . . . 10.0 113.304 163.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -157.28 59.89 0.5 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.505 1.522 . . . . 10.0 108.891 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -90.29 132.88 35.3 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.726 -0.609 . . . . 10.0 109.604 -170.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.3 t -161.69 150.09 12.64 Favored Pre-proline 0 C--O 1.24 0.568 0 O-C-N 121.464 -0.772 . . . . 10.0 111.198 -168.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -77.57 42.84 1.23 Allowed 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.895 2.396 . . . . 10.0 111.115 170.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -126.07 -68.34 0.83 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.058 1.343 . . . . 10.0 109.169 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.23 138.74 31.18 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 124.777 1.231 . . . . 10.0 110.517 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 25.9 m -78.77 -34.71 45.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 165.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.0 t -121.65 73.65 32.66 Favored Pre-proline 0 CA--C 1.537 0.458 0 C-N-CA 124.939 1.296 . . . . 10.0 110.034 -174.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.74 114.27 3.99 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.455 2.104 . . . . 10.0 109.728 170.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 73.6 mtp -129.3 133.63 47.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.925 0.89 . . . . 10.0 110.129 -175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.3 mt -84.37 149.74 25.82 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.647 1.179 . . . . 10.0 111.156 -173.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.62 -174.47 3.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.98 1.312 . . . . 10.0 113.126 -177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 1.2 m -159.68 134.32 7.81 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.937 1.295 . . . . 10.0 108.55 -172.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.458 ' HA ' ' HA3' ' A' ' 106' ' ' GLY . 4.4 t -92.0 -174.05 3.67 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-O 122.466 1.127 . . . . 10.0 112.246 173.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 25.7 m -80.04 72.29 6.82 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.791 -1.55 . . . . 10.0 107.581 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 43.6 m80 75.06 165.07 0.28 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.609 1.964 . . . . 10.0 111.4 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m 67.93 -67.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.989 1.716 . . . . 10.0 111.608 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.16 87.26 0.99 Allowed Glycine 0 CA--C 1.525 0.689 0 N-CA-C 107.31 -2.316 . . . . 10.0 107.31 169.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 72.55 -160.7 54.15 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 112.156 -0.378 . . . . 10.0 112.156 -175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 63.2 mtt -69.65 -73.78 0.15 Allowed 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 114.466 1.284 . . . . 10.0 114.466 -166.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -179.06 66.07 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.477 0.711 . . . . 10.0 109.341 -159.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.59 170.1 32.89 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.925 0.774 . . . . 10.0 114.309 164.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -73.9 56.49 0.58 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 127.585 2.354 . . . . 10.0 113.372 -157.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.0 ptmm? -97.2 155.57 16.79 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 126.374 1.87 . . . . 10.0 109.644 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.4 mtm -79.25 76.34 5.79 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 106.349 -1.723 . . . . 10.0 106.349 174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.9 p -62.34 153.08 77.45 Favored Pre-proline 0 CA--C 1.542 0.64 0 CA-C-N 114.099 -1.41 . . . . 10.0 109.631 -178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -36.88 -52.33 1.3 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.743 2.962 . . . . 10.0 112.748 164.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -179.41 175.69 0.89 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.286 2.634 . . . . 10.0 104.778 178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.09 100.84 12.03 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.404 -0.591 . . . . 10.0 109.404 175.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.9 m -76.49 136.7 39.36 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.309 -1.367 . . . . 10.0 107.309 173.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 4.3 pt -106.54 98.65 21.0 Favored Pre-proline 0 N--CA 1.446 -0.637 0 N-CA-C 106.41 -1.7 . . . . 10.0 106.41 176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -80.66 52.85 4.51 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.919 3.079 . . . . 10.0 111.903 -160.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.62 144.23 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.6 1.19 . . . . 10.0 110.578 -157.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 61.06 3.24 0.66 Allowed 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.508 1.923 . . . . 10.0 113.706 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -62.5 110.21 3.14 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 108.998 -1.641 . . . . 10.0 108.998 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 88.2 m -149.93 76.55 1.29 Allowed 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 104.984 -2.228 . . . . 10.0 104.984 -165.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.08 -158.55 0.69 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.847 -1.07 . . . . 10.0 109.652 -166.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 38.5 m -151.83 118.63 5.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 106.877 -1.527 . . . . 10.0 106.877 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.34 120.79 26.67 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 105.556 -2.016 . . . . 10.0 105.556 178.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -155.46 155.0 32.73 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.112 1.365 . . . . 10.0 108.285 -159.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -80.49 51.04 1.38 Allowed 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.622 -0.673 . . . . 10.0 111.264 -173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -124.63 -71.02 0.73 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 126.083 1.753 . . . . 10.0 107.187 179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 77' ' ' THR . . . -139.45 -55.75 0.04 OUTLIER Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.287 -1.125 . . . . 10.0 110.287 -166.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.408 ' N ' ' HB ' ' A' ' 77' ' ' THR . 9.2 t70 -99.59 129.21 45.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 C-N-CA 125.177 1.391 . . . . 10.0 107.335 -175.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 178.0 179.22 0.32 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -173.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.11 122.33 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 104.104 -2.554 . . . . 10.0 104.104 158.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 73.7 mtp -82.27 102.5 11.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.951 -1.5 . . . . 10.0 106.951 164.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 76.9 mt -78.5 77.54 4.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 10.0 106.882 171.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.73 165.69 13.54 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.681 0.753 . . . . 10.0 111.571 -173.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.57 69.95 1.22 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.194 -0.763 . . . . 10.0 111.194 175.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.1 tp -46.62 134.68 9.33 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.541 1.136 . . . . 10.0 110.391 170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -119.51 -60.32 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.229 0.612 . . . . 10.0 111.553 171.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 29.3 mmt85 -93.91 143.48 26.56 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.574 0.75 . . . . 10.0 109.085 176.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.43 159.98 51.08 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.222 2.615 . . . . 10.0 111.349 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.71 156.94 36.82 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.368 1.467 . . . . 10.0 110.61 -170.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 144.98 48.59 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.772 1.229 . . . . 10.0 108.869 170.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 25.1 t -73.15 69.41 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.707 1.603 . . . . 10.0 108.744 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 154.18 -15.88 0.59 Allowed Glycine 0 CA--C 1.524 0.646 0 O-C-N 120.536 -1.352 . . . . 10.0 112.648 -159.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.52 -177.42 0.56 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 123.958 1.837 . . . . 10.0 108.913 171.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 38.1 m -155.08 128.74 8.57 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.062 -1.881 . . . . 10.0 106.186 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 41.0 t -131.31 146.27 34.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -75.93 132.9 40.55 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.618 -0.512 . . . . 10.0 109.618 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.3 tt -102.51 126.68 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 164.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.9 103.02 13.67 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.209 -1.404 . . . . 10.0 107.209 -176.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.29 119.59 24.31 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.199 -1.408 . . . . 10.0 107.199 177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -130.2 82.45 2.06 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.321 1.449 . . . . 10.0 107.256 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.79 154.4 24.75 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.933 -0.576 . . . . 10.0 110.024 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 14.0 t -60.89 -14.49 22.59 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.588 0.355 . . . . 10.0 111.526 168.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -64.53 -9.59 20.06 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.692 1.197 . . . . 10.0 111.865 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 88.99 56.62 1.92 Allowed Glycine 0 C--N 1.34 0.799 0 C-N-CA 124.503 1.049 . . . . 10.0 111.305 164.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.5 mtt-85 -138.55 176.89 8.3 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.067 0.547 . . . . 10.0 110.147 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 16.5 m -155.49 88.69 1.15 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 105.716 -1.957 . . . . 10.0 105.716 176.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.0 172.14 10.21 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 108.047 -1.094 . . . . 10.0 108.047 175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -149.5 93.16 2.02 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.603 -1.999 . . . . 10.0 105.603 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.1 t -102.02 137.74 28.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.56 115.46 22.12 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.633 -0.877 . . . . 10.0 108.633 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -103.52 123.23 46.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.864 0.866 . . . . 10.0 110.092 -177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.6 m -82.82 126.17 32.13 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.931 0.493 . . . . 10.0 109.819 -174.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 73.2 t -84.26 104.8 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 O-C-N 120.688 -1.257 . . . . 10.0 107.929 -174.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -141.64 106.87 4.98 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.738 1.615 . . . . 10.0 109.521 -178.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -40.32 -80.41 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 128.145 2.578 . . . . 10.0 111.736 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 66.42 107.38 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 125.641 1.576 . . . . 10.0 113.608 159.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.9 mt 72.26 70.78 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 126.545 1.938 . . . . 10.0 106.83 -176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -126.49 30.67 5.51 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.355 1.462 . . . . 10.0 112.658 -168.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.9 -49.64 53.01 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 172.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 . . . . . 0 C--O 1.249 1.04 0 N-CA-C 103.693 -2.706 . . . . 10.0 103.693 160.143 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 N-CA-C 106.445 -1.687 . . . . 10.0 106.445 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.89 167.85 29.15 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 108.125 -1.99 . . . . 10.0 108.125 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -165.91 173.59 10.37 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 175.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.7 t -170.96 158.04 5.55 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.849 1.26 . . . . 10.0 107.867 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 88.8 mtp -139.59 73.9 34.56 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.973 1.309 . . . . 10.0 108.646 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.38 155.18 70.09 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.186 1.924 . . . . 10.0 110.023 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.9 169.04 25.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.932 -1.136 . . . . 10.0 107.932 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -160.06 -179.82 8.11 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 106.77 -1.567 . . . . 10.0 106.77 176.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.0 t -157.71 91.38 2.28 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -72.45 138.33 29.66 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.558 1.505 . . . . 10.0 109.168 -177.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.47 142.07 43.92 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.359 2.039 . . . . 10.0 110.056 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -159.57 161.64 35.21 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.635 -1.246 . . . . 10.0 107.635 176.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -161.95 -66.02 0.05 Allowed 'General case' 0 N--CA 1.457 -0.119 0 N-CA-C 107.741 -1.207 . . . . 10.0 107.741 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 16.0 p 49.02 53.33 12.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.079 0.952 . . . . 10.0 111.567 174.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -114.11 78.31 4.32 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 124.256 1.022 . . . . 10.0 110.186 -177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -71.99 169.43 21.37 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.146 1.897 . . . . 10.0 109.977 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.77 165.31 36.89 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.516 -1.29 . . . . 10.0 107.516 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.03 143.73 21.71 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -162.02 64.57 0.24 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.328 1.051 . . . . 10.0 108.323 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -152.63 156.62 39.62 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.76 -124.59 0.28 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.908 -1.145 . . . . 10.0 107.908 170.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.08 -179.42 41.65 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 107.393 -2.283 . . . . 10.0 107.393 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.22 169.91 23.08 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.714 -1.217 . . . . 10.0 107.714 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -63.53 146.01 54.53 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.36 -0.607 . . . . 10.0 109.36 174.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -161.61 -179.44 7.29 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.688 -1.227 . . . . 10.0 107.688 -178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.488 ' C ' HD22 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -63.44 159.78 47.76 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 119.011 -0.519 . . . . 10.0 110.318 175.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.03 -91.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 121.878 1.718 . . . . 10.0 110.548 -172.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.0 t -143.06 56.53 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 107.661 -1.237 . . . . 10.0 107.661 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.1 t -158.22 93.91 1.26 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.709 -1.219 . . . . 10.0 107.709 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.0 p -153.31 57.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 CA-C-O 122.434 1.112 . . . . 10.0 108.413 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -138.54 145.28 40.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.028 -1.471 . . . . 10.0 107.028 164.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.89 132.1 23.83 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 108.834 -1.706 . . . . 10.0 108.834 175.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.74 149.21 41.95 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.84 0.82 . . . . 10.0 109.791 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 10.6 p -136.93 148.28 46.89 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.114 -1.439 . . . . 10.0 107.114 166.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.8 t -130.9 139.21 51.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.437 -0.949 . . . . 10.0 108.437 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.01 45.64 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.183 0.809 . . . . 10.0 113.183 -171.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 41.06 -112.04 0.15 Allowed 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.816 1.246 . . . . 10.0 109.003 -168.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.9 m -119.47 140.9 29.88 Favored Pre-proline 0 C--O 1.235 0.326 0 N-CA-C 106.338 -1.727 . . . . 10.0 106.338 140.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -60.59 155.7 46.38 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.451 1.434 . . . . 10.0 108.63 162.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.7 61.36 6.18 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.354 2.036 . . . . 10.0 109.641 171.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.6 t -162.22 70.43 0.3 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 106.956 -1.498 . . . . 10.0 106.956 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt 87.94 154.08 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 127.546 2.338 . . . . 10.0 110.009 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -83.82 22.56 1.11 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.469 1.108 . . . . 10.0 113.121 -168.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.87 -179.88 4.13 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.068 1.747 . . . . 10.0 109.198 174.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.1 t -160.71 -177.65 6.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 108.518 -0.919 . . . . 10.0 108.518 174.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.09 154.59 39.47 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.626 -0.715 . . . . 10.0 109.22 178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.87 147.76 26.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 124.058 0.849 . . . . 10.0 109.229 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -124.44 102.02 7.45 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 105.685 -1.969 . . . . 10.0 105.685 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -161.42 -176.71 5.52 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 123.945 0.898 . . . . 10.0 109.187 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.2 m -131.81 131.92 43.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.724 0.81 . . . . 10.0 110.257 -175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.5 mp -83.94 109.2 17.42 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.015 -2.217 . . . . 10.0 105.015 163.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.5 m -108.18 111.26 23.17 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 126.179 1.791 . . . . 10.0 108.378 -178.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.96 136.13 36.56 Favored 'General case' 0 CA--C 1.523 -0.082 0 N-CA-C 112.368 0.507 . . . . 10.0 112.368 -173.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.1 mtmt -144.94 58.76 1.3 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.972 -0.751 . . . . 10.0 108.972 161.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 m -160.18 -25.22 0.06 Allowed 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.686 1.365 . . . . 10.0 114.686 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.2 t70 65.78 51.31 1.43 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.194 0.998 . . . . 10.0 111.992 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -143.3 158.59 57.68 Favored Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 124.66 1.184 . . . . 10.0 109.102 -170.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -74.81 82.7 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.271 2.647 . . . . 10.0 110.015 176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.1 mm -96.83 146.81 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.305 -0.861 . . . . 10.0 108.989 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HB2' ' NE1' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -148.46 87.71 1.6 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.322 1.058 . . . . 10.0 111.145 -172.402 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.9 mt -82.26 73.64 9.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.811 1.644 . . . . 10.0 112.498 -164.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.556 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 8.3 p -82.22 57.75 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 O-C-N 121.592 -0.693 . . . . 10.0 112.516 -173.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.83 151.82 22.6 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 121.002 -1.061 . . . . 10.0 110.804 163.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -159.56 62.71 0.38 Allowed 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.123 0.969 . . . . 10.0 108.436 168.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.34 148.82 23.32 Favored 'General case' 0 C--O 1.226 -0.147 0 O-C-N 121.652 -0.655 . . . . 10.0 109.963 -175.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 t -163.7 149.68 9.65 Favored Pre-proline 0 CA--C 1.529 0.159 0 N-CA-C 106.68 -1.6 . . . . 10.0 106.68 175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.81 3.58 3.73 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.077 1.852 . . . . 10.0 113.026 174.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.68 -49.14 77.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 119.639 1.109 . . . . 10.0 109.915 173.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.9 156.06 43.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 124.358 1.063 . . . . 10.0 110.171 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.6 m -87.99 -39.76 14.44 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.729 1.211 . . . . 10.0 112.568 -159.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.3 t -116.43 84.24 14.39 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.232 1.013 . . . . 10.0 109.722 -166.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -79.15 116.95 3.74 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.256 2.637 . . . . 10.0 110.785 176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -121.58 151.0 40.86 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 124.413 1.085 . . . . 10.0 108.676 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mp -100.49 143.3 30.84 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.619 0.768 . . . . 10.0 109.061 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 2.8 ttp -134.6 162.8 31.27 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.948 1.299 . . . . 10.0 108.788 -175.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -156.46 134.0 10.84 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.626 -0.671 . . . . 10.0 111.682 169.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 14.2 t -150.01 47.67 0.92 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.504 -0.316 . . . . 10.0 111.822 169.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.8 m -135.86 99.23 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 123.725 0.81 . . . . 10.0 109.285 173.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -46.67 -38.24 9.47 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 126.616 1.966 . . . . 10.0 114.221 -169.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 17.8 t -75.52 0.71 16.34 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 118.536 -0.745 . . . . 10.0 112.998 -178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.502 ' HA3' HD13 ' A' ' 100' ' ' LEU . . . -117.42 -122.66 3.29 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 124.922 1.249 . . . . 10.0 111.631 -174.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -64.23 -66.98 2.23 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 124.129 0.871 . . . . 10.0 113.011 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 9.8 ttt -148.59 -140.8 0.1 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.839 1.255 . . . . 10.0 108.835 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -170.01 52.65 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.392 -0.818 . . . . 10.0 108.986 -163.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -172.62 93.76 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 110.834 -0.907 . . . . 10.0 110.834 -176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 1.7 ttp -61.85 95.38 0.06 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.894 0.854 . . . . 10.0 109.775 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -151.3 176.22 11.45 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.615 1.566 . . . . 10.0 107.351 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 39.1 mtp -79.59 123.05 27.25 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 176.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.7 m -126.83 164.02 37.54 Favored Pre-proline 0 CA--C 1.532 0.259 0 N-CA-C 108.636 -0.876 . . . . 10.0 108.636 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -47.24 -56.12 3.33 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.365 2.043 . . . . 10.0 110.419 165.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.556 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER 174.95 -135.07 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.359 2.263 . . . . 10.0 109.022 -176.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.38 155.16 40.89 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 127.061 2.144 . . . . 10.0 105.303 168.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 97.7 m -98.98 122.01 41.69 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 106.908 -1.516 . . . . 10.0 106.908 160.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 1.8 pp -84.23 116.6 65.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 105.896 -1.89 . . . . 10.0 105.896 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -82.73 70.03 7.01 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.676 1.584 . . . . 10.0 109.892 -171.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 62.23 174.11 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.151 0.58 . . . . 10.0 110.619 -170.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.95 -7.04 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 117.406 2.373 . . . . 10.0 117.406 177.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -51.41 105.87 0.25 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 124.806 1.194 . . . . 10.0 112.147 -165.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 13.0 m -110.81 57.32 0.62 Allowed 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 105.969 -1.863 . . . . 10.0 105.969 172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 ' HA3' ' A' ' 81' ' ' GLY . 23.3 tp -83.28 152.62 25.06 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.267 -1.383 . . . . 10.0 107.267 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.9 t -136.95 147.6 46.44 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -111.62 123.8 50.98 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.088 2.155 . . . . 10.0 106.047 -164.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.74 152.39 37.67 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.527 1.131 . . . . 10.0 108.467 174.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -44.83 -31.04 1.09 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 114.499 1.296 . . . . 10.0 114.499 -175.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -71.11 -51.99 21.9 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.931 0.892 . . . . 10.0 111.913 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -137.06 133.05 6.26 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 125.26 1.41 . . . . 10.0 110.96 -151.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 38.82 58.4 1.74 Allowed 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 127.657 2.383 . . . . 10.0 112.82 170.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 46.7 p-80 -122.46 170.72 9.69 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 112.866 -1.97 . . . . 10.0 109.476 -175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.7 m -108.65 134.55 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 176.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 80.9 mtp -103.41 105.38 15.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mp -90.21 88.68 7.33 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.045 -1.094 . . . . 10.0 108.045 173.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 27.0 ttt -83.73 147.18 27.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.525 0.73 . . . . 10.0 110.607 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.75 69.12 1.33 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.163 -0.798 . . . . 10.0 112.266 168.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.9 pp -48.36 151.29 1.09 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.942 0.871 . . . . 10.0 113.155 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -84.58 -71.6 0.51 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.736 0.414 . . . . 10.0 109.953 165.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 12.9 mtt180 173.62 -56.92 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.206 1.402 . . . . 10.0 112.481 -169.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.15 75.57 4.15 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.211 1.941 . . . . 10.0 110.923 -171.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.76 116.49 18.83 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.475 1.51 . . . . 10.0 108.788 176.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -135.54 127.49 29.54 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.074 -1.454 . . . . 10.0 107.074 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.4 p -59.17 90.45 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 108.255 -1.017 . . . . 10.0 108.255 172.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 156.35 -45.49 0.51 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.454 -1.058 . . . . 10.0 110.454 -162.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 -172.39 1.83 Allowed 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 123.837 1.779 . . . . 10.0 111.328 -163.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 33.9 m -149.95 130.72 14.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.095 -1.866 . . . . 10.0 106.918 170.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 54.0 t -128.05 148.8 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 106.217 -1.772 . . . . 10.0 106.217 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -70.22 151.26 45.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 118.921 0.782 . . . . 10.0 110.529 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.2 tt -115.19 152.16 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.325 0 N-CA-C 106.855 -1.535 . . . . 10.0 106.855 164.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 18.8 m -131.29 107.5 9.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.425 -1.694 . . . . 10.0 106.425 -177.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.54 148.86 26.28 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 113.81 -1.541 . . . . 10.0 108.974 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -150.44 100.93 2.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.61 -1.256 . . . . 10.0 107.61 167.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -80.84 148.22 30.06 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.322 -1.362 . . . . 10.0 107.322 172.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 15.4 t -55.09 -38.36 68.01 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.524 1.056 . . . . 10.0 111.446 -174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -34.98 70.46 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.19 1.796 . . . . 10.0 110.705 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -139.11 75.55 0.37 Allowed Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.74 1.638 . . . . 10.0 109.543 -168.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -83.89 51.26 2.0 Allowed 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.275 -0.544 . . . . 10.0 110.633 -170.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 84.2 m -161.28 103.53 1.26 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.667 1.187 . . . . 10.0 109.37 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.43 151.58 27.97 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 108.218 -1.03 . . . . 10.0 108.218 160.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -138.84 129.89 26.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.917 -1.883 . . . . 10.0 105.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 57.9 t -142.35 170.47 11.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 N-CA-C 106.55 -1.648 . . . . 10.0 106.55 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -99.32 136.87 38.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.113 0.965 . . . . 10.0 109.589 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -117.44 118.65 32.79 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.982 1.313 . . . . 10.0 110.035 175.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -82.38 130.32 35.08 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.373 -0.603 . . . . 10.0 109.373 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 48.1 t -90.28 105.72 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.858 -1.534 . . . . 10.0 106.858 -174.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -146.37 100.71 3.4 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.936 0.895 . . . . 10.0 109.571 -173.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -50.17 -72.13 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.866 1.266 . . . . 10.0 111.268 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 68.35 139.52 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.276 1.831 . . . . 10.0 111.752 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 41.1 pt 40.02 45.26 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 125.523 1.529 . . . . 10.0 113.332 177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.58 173.05 10.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.111 0.482 . . . . 10.0 110.969 -178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.63 -48.83 2.98 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 111.684 -0.567 . . . . 10.0 111.684 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 . . . . . 0 C--O 1.251 1.158 0 C-N-CA 124.769 1.228 . . . . 10.0 108.63 170.711 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 106.376 -1.713 . . . . 10.0 106.376 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.3 138.21 4.96 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.998 -1.241 . . . . 10.0 109.998 -175.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -153.73 162.83 40.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.497 -1.668 . . . . 10.0 106.497 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -165.24 171.75 13.25 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.715 -1.217 . . . . 10.0 107.715 173.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 53.6 mtt -152.98 152.63 28.51 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 126.223 1.809 . . . . 10.0 107.167 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -71.97 171.68 16.17 Favored 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.496 2.13 . . . . 10.0 109.929 171.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -154.6 165.9 35.06 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.25 -1.019 . . . . 10.0 108.25 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -98.74 -177.43 3.65 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.007 0.923 . . . . 10.0 108.7 172.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.1 t -149.16 140.65 14.42 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 106.917 -1.512 . . . . 10.0 106.917 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.4 161.8 34.24 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 122.532 2.155 . . . . 10.0 110.883 -175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -69.96 78.41 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.011 2.474 . . . . 10.0 108.989 170.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -46.16 120.04 2.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.973 1.309 . . . . 10.0 111.614 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -154.61 152.08 29.58 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.272 -1.381 . . . . 10.0 107.272 -178.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t -170.1 -53.54 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.973 0.909 . . . . 10.0 109.113 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.75 149.7 24.5 Favored Pre-proline 0 N--CA 1.454 -0.272 0 N-CA-C 107.21 -1.404 . . . . 10.0 107.21 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.34 61.63 7.39 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 123.256 2.637 . . . . 10.0 110.683 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -157.9 45.44 0.34 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.8 0.84 . . . . 10.0 109.705 -178.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -158.3 79.49 0.82 Allowed 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.482 0.713 . . . . 10.0 109.257 -176.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -153.0 146.16 24.71 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -75.28 64.76 1.52 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.413 1.085 . . . . 10.0 111.84 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.92 66.75 0.8 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.249 1.02 . . . . 10.0 111.812 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.28 122.87 19.53 Favored Glycine 0 CA--C 1.531 1.066 0 N-CA-C 110.891 -0.884 . . . . 10.0 110.891 176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.56 -45.36 83.64 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 117.519 0.66 . . . . 10.0 112.208 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 61.21 -159.93 0.31 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.455 1.102 . . . . 10.0 111.155 -174.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -164.0 175.88 9.89 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.666 1.587 . . . . 10.0 107.416 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.3 tt -132.98 128.65 20.74 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.475 1.11 . . . . 10.0 108.813 -174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.35 149.48 50.89 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.325 2.017 . . . . 10.0 108.957 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.9 m -83.04 52.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 N-CA-C 113.195 0.813 . . . . 10.0 113.195 -155.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -155.3 51.01 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.237 -0.653 . . . . 10.0 109.237 -172.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.3 p -84.72 67.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 108.544 -0.91 . . . . 10.0 108.544 174.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -138.55 161.31 37.4 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.465 1.506 . . . . 10.0 110.65 -177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -122.43 73.48 0.38 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.916 1.246 . . . . 10.0 110.002 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -36.03 116.28 0.38 Allowed 'General case' 0 C--N 1.338 0.092 0 C-N-CA 125.544 1.538 . . . . 10.0 111.482 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.5 m -118.58 107.72 14.08 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.977 -1.12 . . . . 10.0 107.977 -177.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.2 t -84.6 126.44 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 C-N-CA 125.209 1.404 . . . . 10.0 109.058 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.61 119.3 10.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.512 0.672 . . . . 10.0 109.363 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.94 129.81 39.08 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 107.583 -1.265 . . . . 10.0 107.583 164.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.5 t -30.5 109.72 0.27 Allowed Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 126.04 1.736 . . . . 10.0 111.778 -171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -63.45 170.6 7.9 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.233 1.955 . . . . 10.0 109.889 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -72.62 57.51 3.02 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.237 1.958 . . . . 10.0 108.988 166.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 m -157.29 43.73 0.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.709 1.204 . . . . 10.0 109.26 -175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.494 HG22 ' H ' ' A' ' 43' ' ' ARG . 22.0 mm 76.03 168.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 125.831 1.653 . . . . 10.0 111.856 170.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.494 ' H ' HG22 ' A' ' 42' ' ' ILE . 10.5 tpt180 -62.59 -11.52 17.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 128.161 2.584 . . . . 10.0 114.35 -170.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -72.04 157.94 36.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.368 -0.832 . . . . 10.0 109.657 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -168.52 -174.71 2.28 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -155.08 164.65 38.57 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 124.266 1.026 . . . . 10.0 111.18 -171.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -101.32 140.39 35.68 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.001 0.92 . . . . 10.0 109.607 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -127.34 110.85 13.23 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -159.91 -173.2 3.97 Favored 'General case' 0 C--O 1.225 -0.226 0 C-N-CA 124.486 1.114 . . . . 10.0 109.562 -172.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.0 t -106.39 164.93 11.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 108.756 -0.831 . . . . 10.0 108.756 166.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.43 149.91 47.77 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.684 -1.599 . . . . 10.0 106.684 160.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 29.9 m -151.63 110.42 3.84 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 111.942 0.349 . . . . 10.0 111.942 -167.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -80.42 142.82 33.97 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 124.243 1.017 . . . . 10.0 109.447 168.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -137.99 66.0 1.46 Allowed 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 107.407 -1.331 . . . . 10.0 107.407 163.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 24.4 p 179.57 -49.02 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 107.411 -1.329 . . . . 10.0 107.411 -171.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 84.01 67.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.772 2.029 . . . . 10.0 108.859 156.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -126.4 159.42 63.09 Favored Pre-proline 0 N--CA 1.451 -0.381 0 C-N-CA 125.649 1.58 . . . . 10.0 107.372 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.29 70.11 6.27 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.551 2.168 . . . . 10.0 110.746 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 18.3 mm -83.52 90.4 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 -173.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' NZ ' ' OD2' ' A' ' 132' ' ' ASP . 4.2 ptpp? -83.57 91.23 7.38 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 122.223 1.011 . . . . 10.0 111.428 -170.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 77.4 mt -81.92 68.52 8.34 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.095 1.358 . . . . 10.0 112.945 -161.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.426 ' HB ' ' CD1' ' A' ' 91' ' ' TRP . 6.8 p -82.23 60.69 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.357 -0.839 . . . . 10.0 112.185 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.34 161.18 31.92 Favored Glycine 0 CA--C 1.521 0.45 0 O-C-N 121.013 -1.055 . . . . 10.0 111.329 157.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.08 57.31 0.47 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.436 1.094 . . . . 10.0 108.417 164.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -83.39 149.81 26.47 Favored 'General case' 0 C--O 1.226 -0.14 0 N-CA-C 108.848 -0.797 . . . . 10.0 108.848 -172.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 t -166.66 146.05 4.78 Favored Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.11 68.36 4.05 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.421 2.081 . . . . 10.0 108.032 166.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.9 tp -154.02 -65.68 0.14 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.774 0.83 . . . . 10.0 109.836 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.99 146.67 30.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.89 0.876 . . . . 10.0 109.989 175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.6 m -87.18 -34.24 19.09 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 123.703 0.801 . . . . 10.0 109.287 169.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -122.71 71.06 38.9 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 125.538 1.535 . . . . 10.0 109.89 -175.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.6 104.45 1.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.067 2.511 . . . . 10.0 111.428 177.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -129.43 166.78 18.9 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.325 1.05 . . . . 10.0 110.279 -177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 mp -114.6 144.34 43.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.281 1.432 . . . . 10.0 109.6 -173.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 1.4 ttp -141.86 152.66 43.83 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.108 1.363 . . . . 10.0 108.123 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.2 t -147.29 108.6 4.28 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.187 -0.672 . . . . 10.0 109.187 -161.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.423 ' H ' ' CA ' ' A' ' 107' ' ' ASP . 22.9 m -139.28 62.58 1.53 Allowed 'General case' 0 C--N 1.331 -0.221 0 O-C-N 120.91 -1.119 . . . . 10.0 110.111 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 3.3 m -154.05 120.56 5.49 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.14 -0.936 . . . . 10.0 110.221 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.406 ' CD2' ' CB ' ' A' ' 84' ' ' ALA . 53.1 m80 -70.11 70.12 0.37 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.47 1.108 . . . . 10.0 112.188 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 2.9 p -168.62 -57.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.364 0.984 . . . . 10.0 113.015 171.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -74.31 -78.39 0.6 Allowed Glycine 0 CA--C 1.522 0.496 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.54 -141.81 11.32 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 123.543 0.592 . . . . 10.0 111.862 171.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.98 176.27 6.4 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.089 1.756 . . . . 10.0 109.786 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' CB ' ' CD2' ' A' ' 79' ' ' HIS . . . -124.59 52.19 1.55 Allowed 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.713 1.605 . . . . 10.0 107.772 -169.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.98 112.48 0.54 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.174 -1.17 . . . . 10.0 110.174 -171.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.14 27.25 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.837 1.655 . . . . 10.0 114.181 -167.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.2 pttt -83.03 161.59 21.66 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.589 1.556 . . . . 10.0 109.42 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 52.5 ttp -81.42 121.91 26.84 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.611 -1.626 . . . . 10.0 106.611 176.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.8 m -117.92 166.88 12.39 Favored Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 118.468 0.577 . . . . 10.0 111.514 -171.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -37.92 -59.95 0.49 Allowed 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.297 2.665 . . . . 10.0 111.56 156.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.426 ' CD1' ' HB ' ' A' ' 62' ' ' VAL . 0.0 OUTLIER -175.71 -172.41 0.53 Allowed 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 114.042 1.127 . . . . 10.0 114.042 -171.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 tp -100.65 107.38 19.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 125.849 1.66 . . . . 10.0 106.856 165.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 90.0 m -83.92 129.02 34.93 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 106.502 -1.666 . . . . 10.0 106.502 164.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 11.5 pt -114.02 95.33 37.8 Favored Pre-proline 0 CA--C 1.542 0.636 0 N-CA-C 107.228 -1.397 . . . . 10.0 107.228 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -84.9 70.35 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.866 1.711 . . . . 10.0 112.508 -157.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 63.55 152.41 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.709 1.242 . . . . 10.0 111.109 -172.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 36.96 37.2 0.06 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.875 1.27 . . . . 10.0 111.869 -155.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.48 93.21 0.14 Allowed Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 110.362 -1.095 . . . . 10.0 110.362 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 15.0 t -138.79 107.17 5.81 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.475 -0.935 . . . . 10.0 108.475 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 tp -122.6 -171.84 2.36 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.639 0.776 . . . . 10.0 110.802 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.6 t -140.15 143.51 36.2 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 103.04 -2.948 . . . . 10.0 103.04 -172.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.9 mp -129.68 116.67 19.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.304 -2.48 . . . . 10.0 104.304 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -147.99 161.55 41.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.736 1.214 . . . . 10.0 108.745 -165.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 20.0 ttp-105 -62.57 122.89 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.672 -0.694 . . . . 10.0 109.326 177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 44.3 t0 48.76 60.82 3.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.68 1.592 . . . . 10.0 112.608 -174.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 178.34 62.19 0.07 OUTLIER Glycine 0 C--N 1.336 0.529 0 N-CA-C 109.897 -1.281 . . . . 10.0 109.897 164.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.423 ' CA ' ' H ' ' A' ' 77' ' ' THR . 7.2 t0 79.02 127.58 0.05 OUTLIER 'General case' 0 C--N 1.343 0.303 0 C-N-CA 126.108 1.763 . . . . 10.0 110.045 -175.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -177.08 157.62 1.42 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.312 0.505 . . . . 10.0 111.465 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 90.8 t -94.14 123.18 46.15 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.16 0 N-CA-C 105.932 -1.877 . . . . 10.0 105.932 174.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 41.1 mtm -94.38 104.9 16.87 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 122.236 1.017 . . . . 10.0 109.095 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 57.8 mt -88.65 68.74 8.71 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.289 -1.745 . . . . 10.0 106.289 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 23.3 ttt -82.12 154.73 25.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 121.487 0.661 . . . . 10.0 110.276 -166.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.64 60.92 6.39 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.001 -1.24 . . . . 10.0 110.001 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -57.82 117.9 4.76 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 174.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.88 -69.83 0.62 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 118.848 0.749 . . . . 10.0 111.479 176.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -66.19 156.06 85.85 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.736 1.214 . . . . 10.0 111.377 -173.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.55 148.62 92.32 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.503 1.469 . . . . 10.0 109.603 165.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -145.19 147.09 32.07 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.776 1.23 . . . . 10.0 109.587 178.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' NZ ' ' OE2' ' A' ' 122' ' ' GLU . 0.1 OUTLIER -111.98 145.56 39.41 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 124.759 1.223 . . . . 10.0 108.659 177.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 1.8 p -63.87 99.85 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.285 -1.376 . . . . 10.0 107.285 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 129.34 -3.89 6.27 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.058 1.313 . . . . 10.0 112.025 -172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.404 ' OE2' ' NZ ' ' A' ' 119' ' ' LYS . 0.5 OUTLIER -75.66 -174.18 2.45 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 123.733 1.73 . . . . 10.0 109.887 178.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 32.2 m -153.74 134.17 13.5 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 112.861 -1.972 . . . . 10.0 107.562 176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 49.6 t -136.13 143.54 35.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 124.123 0.969 . . . . 10.0 108.689 175.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -78.18 119.44 21.57 Favored 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 109.298 -0.63 . . . . 10.0 109.298 177.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 9.2 tt -81.99 159.75 3.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 107.244 -1.391 . . . . 10.0 107.244 169.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 23.4 m -128.54 114.71 17.08 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 106.092 -1.818 . . . . 10.0 106.092 171.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.96 134.26 34.62 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -126.73 71.42 1.3 Allowed 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.879 0.872 . . . . 10.0 109.405 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -77.36 138.49 39.35 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.652 -1.24 . . . . 10.0 107.652 -176.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.7 t -57.42 -34.36 68.85 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 118.755 0.707 . . . . 10.0 112.905 -166.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.412 ' OD2' ' NZ ' ' A' ' 60' ' ' LYS . 1.4 m-20 -65.15 -27.65 68.87 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.453 1.501 . . . . 10.0 111.734 178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -164.37 81.67 0.12 Allowed Glycine 0 C--N 1.336 0.543 0 N-CA-C 108.312 -1.915 . . . . 10.0 108.312 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -80.81 53.78 2.0 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.943 0.497 . . . . 10.0 111.59 -166.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 20.1 m -158.7 83.88 0.82 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.134 1.374 . . . . 10.0 109.583 -172.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 157.29 45.39 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.086 -1.079 . . . . 10.0 108.086 168.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -149.03 140.86 23.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 106.196 -1.779 . . . . 10.0 106.196 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 61.2 t -148.23 147.6 16.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 106.796 -1.557 . . . . 10.0 106.796 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.87 107.76 16.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.446 -0.946 . . . . 10.0 108.446 174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -86.66 138.73 31.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.692 -0.855 . . . . 10.0 108.692 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 24.6 m -82.25 150.27 27.39 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.106 -1.442 . . . . 10.0 107.106 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.43 113.88 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 106.219 -1.771 . . . . 10.0 106.219 164.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.1 tttt -158.73 143.22 15.8 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 108.754 -0.832 . . . . 10.0 108.754 171.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -68.28 -87.84 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.553 1.141 . . . . 10.0 111.489 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 74.63 148.16 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 126.234 1.814 . . . . 10.0 111.879 -173.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 36.7 pt 34.74 50.28 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 126.311 1.844 . . . . 10.0 113.211 -176.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -169.84 73.66 0.08 Allowed 'General case' 0 C--O 1.236 0.351 0 O-C-N 121.909 -0.494 . . . . 10.0 110.776 -166.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -124.93 10.1 7.93 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.116 0.865 . . . . 10.0 111.772 171.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.14 0 N-CA-C 103.994 -2.595 . . . . 10.0 103.994 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.471 0.591 0 N-CA-C 106.232 -1.766 . . . . 10.0 106.232 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.42 67.12 1.25 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 109.114 -1.594 . . . . 10.0 109.114 167.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -154.41 172.41 17.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.632 1.173 . . . . 10.0 108.679 -175.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -157.04 -171.35 3.61 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.275 -1.38 . . . . 10.0 107.275 173.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.8 mtp -144.12 148.19 40.6 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 125.063 1.345 . . . . 10.0 108.25 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -74.36 175.7 10.64 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.974 2.449 . . . . 10.0 110.196 174.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.26 142.65 30.59 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.754 0.822 . . . . 10.0 108.979 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 56.1 m80 -73.67 74.21 1.52 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.928 0.891 . . . . 10.0 110.678 -177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 m -83.37 105.49 5.47 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.843 0.857 . . . . 10.0 109.688 174.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -76.63 159.04 35.67 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.719 1.613 . . . . 10.0 110.245 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.58 66.39 5.63 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.054 2.503 . . . . 10.0 109.298 170.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.18 172.58 14.1 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 124.489 1.116 . . . . 10.0 109.13 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -138.86 159.85 41.12 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 106.971 -1.492 . . . . 10.0 106.971 174.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -157.49 155.37 30.24 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 106.441 -1.688 . . . . 10.0 106.441 178.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.06 134.0 80.4 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 108.866 -0.79 . . . . 10.0 108.866 172.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -78.57 43.79 1.51 Allowed 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.996 2.464 . . . . 10.0 112.814 -168.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.96 52.52 1.77 Allowed 'General case' 0 CA--C 1.531 0.248 0 O-C-N 120.736 -1.227 . . . . 10.0 109.37 176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.23 -82.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.1 1.36 . . . . 10.0 112.802 -161.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.5 tp60 -79.65 70.83 6.21 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 176.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -167.77 -65.39 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.729 1.212 . . . . 10.0 109.5 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 68.33 -53.78 0.53 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.768 2.027 . . . . 10.0 114.798 173.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -73.26 63.67 1.72 Allowed Glycine 0 CA--C 1.53 1.013 0 C-N-CA 125.01 1.291 . . . . 10.0 114.31 -167.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -100.39 -64.67 1.02 Allowed 'General case' 0 C--O 1.226 -0.141 0 N-CA-C 107.773 -1.195 . . . . 10.0 107.773 162.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 58.9 57.49 3.59 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.505 1.122 . . . . 10.0 111.715 172.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 62.68 -155.06 0.34 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.219 1.407 . . . . 10.0 109.997 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tt -160.09 130.38 3.54 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 106.872 -1.529 . . . . 10.0 106.872 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -69.75 158.79 55.75 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.01 1.806 . . . . 10.0 109.108 175.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.7 m -82.24 56.84 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.775 0.798 . . . . 10.0 111.685 -166.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 7.0 t -158.98 81.18 0.78 Allowed 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.202 1.001 . . . . 10.0 108.762 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p -132.8 85.56 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 121.733 0.777 . . . . 10.0 109.527 173.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -157.98 155.79 30.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.719 -1.586 . . . . 10.0 106.719 162.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -78.03 137.35 19.8 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 110.353 -1.099 . . . . 10.0 110.353 176.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.91 115.69 23.69 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 117.77 0.785 . . . . 10.0 110.042 176.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 53.9 m -109.48 158.21 18.19 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.757 -1.201 . . . . 10.0 107.757 170.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -132.17 137.55 54.36 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -76.5 113.33 13.98 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HB2' HG12 ' A' ' 142' ' ' VAL . . . -52.4 127.03 21.07 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 117.761 -1.114 . . . . 10.0 109.004 174.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 52.9 t -11.48 102.32 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.674 0 C-N-CA 127.358 2.263 . . . . 10.0 113.065 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.3 168.62 13.94 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.733 2.288 . . . . 10.0 109.382 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -74.68 43.32 0.92 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.268 1.979 . . . . 10.0 110.545 172.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 30.3 t -133.96 34.54 3.35 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.943 2.097 . . . . 10.0 107.578 -176.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' H ' ' A' ' 43' ' ' ARG . 11.3 mm 73.76 172.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.897 1.279 . . . . 10.0 109.784 177.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.59 ' H ' HG22 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -72.79 40.01 0.09 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.699 1.6 . . . . 10.0 113.948 -175.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.07 158.97 15.17 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.297 -1.001 . . . . 10.0 108.297 156.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.7 t -157.68 -165.88 1.87 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 106.457 -1.683 . . . . 10.0 106.457 155.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.01 174.46 11.26 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.494 -0.928 . . . . 10.0 108.494 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.63 161.43 26.95 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.619 -1.252 . . . . 10.0 107.619 167.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -130.3 102.3 6.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 103.35 -2.833 . . . . 10.0 103.35 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 44.2 ttp -158.59 -178.84 7.56 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 128.12 2.568 . . . . 10.0 106.142 -172.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.2 m -152.98 141.01 20.31 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.823 -1.917 . . . . 10.0 105.823 166.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD23 HD13 ' A' ' 94' ' ' ILE . 3.2 mp -82.29 136.03 35.11 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 170.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.5 m -120.78 80.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.069 2.148 . . . . 10.0 108.544 -175.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.804 HD21 HD12 ' A' ' 94' ' ' ILE . 4.6 m-20 -81.91 89.7 6.39 Favored 'General case' 0 N--CA 1.46 0.045 0 O-C-N 121.2 -0.938 . . . . 10.0 109.128 -172.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -83.09 57.51 3.96 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.244 -0.91 . . . . 10.0 110.189 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.0 t 179.11 149.64 0.26 Allowed 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.174 1.79 . . . . 10.0 107.506 167.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -79.65 67.33 5.39 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.496 1.118 . . . . 10.0 108.895 -179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -130.71 122.47 19.64 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 124.487 1.115 . . . . 10.0 109.736 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.86 116.3 3.14 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.535 2.823 . . . . 10.0 111.032 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mp -135.92 96.75 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 118.604 0.638 . . . . 10.0 109.649 176.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -80.4 132.84 35.82 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.312 0.645 . . . . 10.0 111.022 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.4 mp -111.75 140.19 46.59 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 124.318 1.047 . . . . 10.0 110.209 -177.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 131' ' ' THR . 10.4 p -146.09 56.25 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-O 121.923 0.868 . . . . 10.0 110.171 -178.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.9 154.54 25.59 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 119.82 -1.181 . . . . 10.0 111.971 163.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -153.23 72.28 0.93 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.304 1.842 . . . . 10.0 106.505 171.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -84.39 145.63 28.1 Favored 'General case' 0 C--O 1.23 0.064 0 N-CA-C 108.171 -1.048 . . . . 10.0 108.171 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 t 35.8 68.59 1.31 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.778 0.831 . . . . 10.0 109.963 -156.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -64.19 -86.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.349 2.033 . . . . 10.0 110.079 -170.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -166.03 43.61 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 107.077 -1.453 . . . . 10.0 107.077 156.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HB1' ' C ' ' A' ' 112' ' ' MET . . . -167.31 -157.2 0.23 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.24 -2.133 . . . . 10.0 105.24 -176.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.81 -40.03 6.41 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 118.714 0.688 . . . . 10.0 110.868 -178.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 t -122.09 106.23 36.44 Favored Pre-proline 0 N--CA 1.452 -0.334 0 C-N-CA 125.403 1.481 . . . . 10.0 108.588 -169.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -85.12 139.65 7.28 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.23 2.62 . . . . 10.0 110.497 173.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -138.31 127.76 24.71 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.3 mt -80.87 139.4 35.96 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 8.4 ttm -141.87 154.82 45.41 Favored 'General case' 0 CA--C 1.528 0.105 0 C-N-CA 124.144 0.978 . . . . 10.0 111.429 -173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.9 t -148.47 120.16 8.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 106.539 -1.652 . . . . 10.0 106.539 -172.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 ' CG ' ' A' ' 86' ' ' MET . 6.9 t -156.43 54.16 0.55 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.644 0.778 . . . . 10.0 112.101 -177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.1 t -137.73 179.5 6.39 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.618 0.767 . . . . 10.0 111.499 168.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 62.8 m170 -91.18 -40.32 11.63 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.312 0.645 . . . . 10.0 110.165 -171.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 33.1 t -81.71 -147.96 0.07 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 107.131 -1.433 . . . . 10.0 107.131 160.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 56.35 -140.68 42.41 Favored Glycine 0 CA--C 1.529 0.94 0 N-CA-C 110.628 -0.989 . . . . 10.0 110.628 176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -76.09 -67.42 1.7 Allowed Glycine 0 CA--C 1.536 1.365 0 CA-C-N 117.252 0.526 . . . . 10.0 113.145 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.14 174.17 12.53 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.637 1.975 . . . . 10.0 108.377 -169.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -122.86 45.42 2.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 10.0 107.8 -159.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -161.59 84.42 0.12 Allowed Glycine 0 N--CA 1.446 -0.697 0 CA-C-O 117.574 -1.681 . . . . 10.0 112.902 -170.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.406 ' CG ' HG21 ' A' ' 77' ' ' THR . 1.7 mtt -40.34 98.29 0.01 OUTLIER 'General case' 0 C--N 1.346 0.437 0 C-N-CA 126.045 1.738 . . . . 10.0 110.602 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.31 166.23 26.9 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.705 1.202 . . . . 10.0 109.388 175.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.5 mtp -77.67 71.16 4.13 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.1 p -64.7 146.7 98.36 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.963 -1.017 . . . . 10.0 108.534 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -33.59 -51.49 0.5 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 124.205 3.27 . . . . 10.0 113.547 167.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 39.0 p90 -179.08 -176.76 0.44 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.44 1.896 . . . . 10.0 106.582 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 102.29 11.67 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.644 0.778 . . . . 10.0 110.294 173.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.6 m -75.21 122.51 23.76 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.804 HD12 HD21 ' A' ' 53' ' ' ASN . 2.2 pt -108.73 90.83 7.93 Favored Pre-proline 0 CA--C 1.53 0.191 0 C-N-CA 124.163 0.985 . . . . 10.0 108.709 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -72.04 140.91 35.46 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 120.75 0.966 . . . . 10.0 109.741 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . 51.41 -140.76 0.85 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.256 1.023 . . . . 10.0 112.412 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.8 ptp180 -68.19 38.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.958 2.503 . . . . 10.0 114.516 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -50.0 144.16 10.5 Favored Glycine 0 N--CA 1.438 -1.232 0 CA-C-O 121.832 0.684 . . . . 10.0 112.883 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 51' ' ' LEU 0.265 7.2 t -134.48 99.3 4.32 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.863 -1.532 . . . . 10.0 106.863 158.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 7.4 tt -112.84 126.26 55.26 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 105.046 -2.205 . . . . 10.0 105.046 -173.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 14.4 m -82.01 153.23 26.29 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.708 -0.849 . . . . 10.0 108.708 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.67 76.55 1.64 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.984 -1.487 . . . . 10.0 106.984 176.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 158.49 44.23 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.738 0.815 . . . . 10.0 110.198 174.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -73.72 60.81 0.71 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.081 0.952 . . . . 10.0 112.123 -168.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -176.23 -45.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 125.154 1.381 . . . . 10.0 109.784 -164.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.4 74.33 0.27 Allowed Glycine 0 C--N 1.339 0.719 0 C-N-CA 123.336 0.494 . . . . 10.0 112.101 -161.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 69.13 139.74 0.04 OUTLIER 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 128.296 2.638 . . . . 10.0 109.211 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 175.65 178.44 0.18 Allowed 'General case' 0 C--N 1.344 0.333 0 C-N-CA 123.091 0.556 . . . . 10.0 112.42 -171.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.0 t -108.67 118.21 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 106.393 -1.706 . . . . 10.0 106.393 161.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 58.7 mtp -80.43 103.19 10.13 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 106.545 -1.65 . . . . 10.0 106.545 167.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.84 105.47 17.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.584 -1.189 . . . . 10.0 109.178 169.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.471 ' C ' ' HB1' ' A' ' 69' ' ' ALA . 26.8 ttt -111.59 152.69 27.3 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.15 1.38 . . . . 10.0 111.22 -172.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 127.79 -6.82 6.95 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-O 117.528 -1.707 . . . . 10.0 115.957 155.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 77.29 92.46 0.07 Allowed 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.677 1.739 . . . . 10.0 111.067 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -70.39 -56.44 6.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 121.66 -0.65 . . . . 10.0 110.3 175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 149.86 -58.4 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 129.833 3.253 . . . . 10.0 110.767 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.33 66.07 2.12 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.043 2.495 . . . . 10.0 114.311 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.49 96.62 10.68 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.106 -0.996 . . . . 10.0 109.481 158.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 40.9 mttp -137.71 147.8 45.11 Favored 'General case' 0 C--O 1.231 0.084 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 162.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.2 t -73.07 68.19 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.872 0.869 . . . . 10.0 108.951 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 141.69 8.24 0.7 Allowed Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.376 -1.236 . . . . 10.0 113.187 -168.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -68.66 173.0 5.52 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 119.797 1.799 . . . . 10.0 108.481 161.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 45.1 m -156.34 129.96 8.3 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 113.849 -1.523 . . . . 10.0 109.356 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.54 140.55 47.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 123.204 0.602 . . . . 10.0 109.766 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -70.05 123.12 20.77 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.679 0.792 . . . . 10.0 108.971 172.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 11.9 tt -102.2 141.92 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 107.68 -1.23 . . . . 10.0 107.68 166.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.6 m -119.78 110.1 16.38 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.264 -0.643 . . . . 10.0 109.264 171.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.03 173.1 10.77 Favored 'General case' 0 CA--C 1.53 0.177 0 O-C-N 122.183 -0.323 . . . . 10.0 111.8 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.3 tptt -149.62 96.72 2.52 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.527 1.131 . . . . 10.0 108.022 -172.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -84.75 143.12 29.35 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.68 -0.637 . . . . 10.0 110.647 171.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.4 HG23 HG12 ' A' ' 62' ' ' VAL . 58.8 p -58.29 -23.13 55.36 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.713 0.805 . . . . 10.0 113.019 -177.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -57.71 -17.7 16.76 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.987 0.915 . . . . 10.0 112.081 172.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 111.09 30.22 3.24 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 125.896 1.712 . . . . 10.0 110.578 172.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 79.1 mtt180 -90.36 166.9 13.04 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-N 117.334 0.567 . . . . 10.0 110.301 -172.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.8 m -158.49 59.49 0.44 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 105.077 -2.194 . . . . 10.0 105.077 -175.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 22.1 tp -85.18 141.9 29.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.848 -1.167 . . . . 10.0 107.848 -174.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -111.48 136.42 50.67 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.878 -1.527 . . . . 10.0 106.878 179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 18.0 t -136.3 159.38 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.217 -1.771 . . . . 10.0 106.217 -177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.68 109.57 21.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 123.936 0.894 . . . . 10.0 108.879 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -84.36 118.48 24.26 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 9.4 m -94.83 127.38 40.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.178 0.991 . . . . 10.0 109.28 -175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.471 HG12 ' HB2' ' A' ' 37' ' ' ALA . 51.1 t -86.76 104.57 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 120.762 -1.211 . . . . 10.0 108.951 -175.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -141.59 116.3 9.72 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.578 1.151 . . . . 10.0 108.451 173.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -41.5 -63.0 0.77 Allowed 'General case' 0 C--N 1.341 0.223 0 C-N-CA 124.781 1.232 . . . . 10.0 112.164 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 57.97 -161.83 0.23 Allowed 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.497 -0.927 . . . . 10.0 108.497 -167.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 24.1 mm -71.7 78.47 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.225 -1.028 . . . . 10.0 108.225 174.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -72.58 31.73 0.06 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.353 1.612 . . . . 10.0 115.353 -168.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.45 -78.61 0.45 Allowed Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.243 0.925 . . . . 10.0 110.971 -177.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 46.2 tpt85 . . . . . 0 C--O 1.249 1.046 0 C-N-CA 125.917 1.687 . . . . 10.0 106.567 -174.538 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.2 mtm . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 106.94 -1.504 . . . . 10.0 106.94 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.88 44.45 61.38 Favored Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.05 0.844 . . . . 10.0 112.8 175.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -156.31 132.35 9.83 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.795 -0.817 . . . . 10.0 108.795 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.8 m -159.14 151.9 21.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 104.049 -2.574 . . . . 10.0 104.049 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -156.67 145.91 15.11 Favored Pre-proline 0 CA--C 1.531 0.237 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -78.76 175.42 11.02 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.07 2.513 . . . . 10.0 110.275 176.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.66 150.0 24.31 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.758 -1.571 . . . . 10.0 106.758 169.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.0 p-80 -168.67 154.53 6.68 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -61.01 135.22 93.14 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.594 0.757 . . . . 10.0 110.299 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -66.49 161.82 39.43 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 121.778 1.652 . . . . 10.0 109.89 172.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.27 77.21 1.66 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.31 2.673 . . . . 10.0 110.794 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.91 75.1 0.2 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.619 1.168 . . . . 10.0 110.315 174.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -42.98 128.59 4.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.497 1.519 . . . . 10.0 112.357 -178.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.2 m -163.28 144.62 9.53 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 105.241 -2.133 . . . . 10.0 105.241 176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.16 148.37 14.51 Favored Pre-proline 0 CA--C 1.53 0.206 0 N-CA-C 107.785 -1.191 . . . . 10.0 107.785 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.34 140.53 30.58 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.42 2.08 . . . . 10.0 109.464 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.71 57.78 1.32 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.378 0.671 . . . . 10.0 110.453 177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.46 155.14 16.87 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.306 1.042 . . . . 10.0 110.193 -178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -71.85 69.32 0.68 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.027 0.931 . . . . 10.0 109.728 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -145.06 -45.51 0.23 Allowed 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 126.588 1.955 . . . . 10.0 109.056 178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . 54.97 36.46 26.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.942 0.897 . . . . 10.0 111.49 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.77 165.63 32.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 107.922 -2.071 . . . . 10.0 107.922 -178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.48 172.98 9.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.504 1.521 . . . . 10.0 106.961 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -143.91 162.15 36.86 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.005 -1.109 . . . . 10.0 108.005 174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.91 158.28 21.66 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.464 1.106 . . . . 10.0 108.034 169.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.59 HD23 ' HB2' ' A' ' 54' ' ' LYS . 0.3 OUTLIER -139.77 152.27 67.85 Favored Pre-proline 0 N--CA 1.447 -0.588 0 N-CA-C 108.344 -0.984 . . . . 10.0 108.344 166.176 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -65.57 164.91 24.58 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 121.659 1.573 . . . . 10.0 108.946 -172.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -81.12 58.78 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.964 0.888 . . . . 10.0 109.119 -173.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.7 p -153.67 58.05 0.74 Allowed 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 121.445 -0.785 . . . . 10.0 109.163 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.15 67.65 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 N-CA-C 106.609 -1.626 . . . . 10.0 106.609 162.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -97.66 166.04 11.68 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 113.903 -1.499 . . . . 10.0 108.928 164.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -94.91 -145.96 19.74 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 108.581 -1.807 . . . . 10.0 108.581 160.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -168.02 115.73 0.73 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.97 1.708 . . . . 10.0 108.458 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 77.3 p -124.66 138.47 54.3 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 107.163 -1.421 . . . . 10.0 107.163 175.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.8 t -132.17 147.34 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 123.726 0.81 . . . . 10.0 109.54 -172.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -92.63 113.53 25.83 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 118.375 0.534 . . . . 10.0 111.103 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -54.45 128.99 34.26 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.926 0.49 . . . . 10.0 110.095 170.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 64.7 t -20.7 103.87 0.08 OUTLIER Pre-proline 0 N--CA 1.471 0.624 0 C-N-CA 127.024 2.13 . . . . 10.0 112.924 -164.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -62.15 167.01 11.54 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.314 2.676 . . . . 10.0 110.476 171.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -74.54 57.8 4.37 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.647 2.231 . . . . 10.0 109.127 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 8.4 m -154.44 42.8 0.5 Allowed 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.881 1.272 . . . . 10.0 109.313 -170.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 11.7 mt 77.43 165.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.438 1.495 . . . . 10.0 109.098 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -36.34 -46.59 0.55 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.304 1.842 . . . . 10.0 111.603 168.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.57 141.28 1.05 Allowed 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 128.24 2.616 . . . . 10.0 112.727 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.9 t -158.67 -175.47 5.33 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 172.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -146.51 158.32 43.88 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.542 1.137 . . . . 10.0 110.596 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' SD ' ' A' ' 49' ' ' MET . . . -93.6 163.25 13.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 124.109 0.881 . . . . 10.0 110.51 171.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -134.06 130.57 37.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.516 -2.031 . . . . 10.0 105.516 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.405 ' SD ' ' HB1' ' A' ' 47' ' ' ALA . 3.6 mpp? -156.04 -176.87 6.19 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.848 1.659 . . . . 10.0 108.5 -173.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.8 t -138.85 137.43 36.58 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.6 -1.63 . . . . 10.0 106.6 161.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.28 149.37 23.19 Favored 'General case' 0 CA--C 1.52 -0.209 0 N-CA-C 108.634 -0.876 . . . . 10.0 108.634 173.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -135.84 85.76 2.18 Favored 'General case' 0 CA--C 1.532 0.286 0 O-C-N 124.291 0.994 . . . . 10.0 111.632 -157.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.78 113.73 12.4 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 121.354 -0.841 . . . . 10.0 109.156 178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.59 ' HB2' HD23 ' A' ' 26' ' ' LEU . 31.2 mmmt -128.36 57.65 1.57 Allowed 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.938 -1.504 . . . . 10.0 106.938 164.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 m -163.46 -33.54 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.129 1.372 . . . . 10.0 112.134 -173.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 60.42 59.66 2.2 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 119.079 0.854 . . . . 10.0 111.26 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -143.3 147.13 39.07 Favored Pre-proline 0 CA--C 1.539 0.52 0 C-N-CA 123.972 0.909 . . . . 10.0 109.907 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -86.36 84.34 1.1 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.906 3.071 . . . . 10.0 112.408 -177.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp -100.31 94.24 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 107.889 -1.152 . . . . 10.0 107.889 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -80.36 134.51 36.05 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.621 -0.674 . . . . 10.0 110.919 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.485 ' C ' HD13 ' A' ' 61' ' ' LEU . 1.2 tm? -99.38 115.89 30.27 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 125.881 1.672 . . . . 10.0 107.375 -165.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -127.69 47.78 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 124.191 0.997 . . . . 10.0 108.855 -176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -165.84 156.82 29.0 Favored Glycine 0 C--N 1.333 0.416 0 O-C-N 120.766 -1.209 . . . . 10.0 111.339 159.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -158.28 59.74 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.656 1.582 . . . . 10.0 107.846 171.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -86.86 132.52 33.8 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.646 -0.502 . . . . 10.0 109.646 -168.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 t -157.91 139.55 9.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 108.139 -1.06 . . . . 10.0 108.139 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.88 65.16 5.96 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.671 2.914 . . . . 10.0 109.42 178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.5 tt -157.54 -57.02 0.08 Allowed 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.226 -1.398 . . . . 10.0 107.226 -164.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.48 152.21 25.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.277 0.631 . . . . 10.0 109.31 171.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.2 m -107.13 -18.83 13.79 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.939 0.895 . . . . 10.0 110.219 160.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.6 m -133.1 64.45 70.47 Favored Pre-proline 0 N--CA 1.445 -0.689 0 C-N-CA 124.469 1.108 . . . . 10.0 109.028 -175.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.27 101.32 1.22 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 123.178 2.585 . . . . 10.0 109.905 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -114.06 126.18 54.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.473 1.109 . . . . 10.0 109.251 -171.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.5 mt -80.58 146.03 31.45 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.045 0.538 . . . . 10.0 109.717 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 86' ' ' MET . 0.3 OUTLIER -148.03 166.7 26.97 Favored 'General case' 0 CA--C 1.521 -0.153 0 C-N-CA 124.758 1.223 . . . . 10.0 111.527 179.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . 0.254 40.7 m -137.96 133.87 34.23 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 125.004 1.44 . . . . 10.0 111.898 -156.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.447 ' HB ' ' N ' ' A' ' 107' ' ' ASP . 9.2 t -83.55 -178.99 7.22 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 123.995 1.855 . . . . 10.0 113.873 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.4 m -79.88 66.61 5.41 Favored 'General case' 0 N--CA 1.437 -1.116 0 C-N-CA 129.561 3.144 . . . . 10.0 109.803 -160.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.8 t-160 60.71 65.33 1.05 Allowed 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.167 1.387 . . . . 10.0 110.735 172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.3 t -161.53 -45.96 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 124.294 1.037 . . . . 10.0 108.369 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.31 -125.46 3.32 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.504 -1.038 . . . . 10.0 110.504 173.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -44.36 -49.95 8.16 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 116.527 1.371 . . . . 10.0 116.527 -168.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.35 -82.46 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.749 1.275 . . . . 10.0 111.229 -170.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 178.0 74.77 0.01 OUTLIER 'General case' 0 C--N 1.343 0.319 0 C-N-CA 124.729 1.212 . . . . 10.0 108.07 -171.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.77 159.65 27.69 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.01 1.29 . . . . 10.0 113.656 167.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.422 ' HG2' ' HG2' ' A' ' 75' ' ' MET . 40.1 ttp -77.61 62.37 2.52 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 125.088 1.355 . . . . 10.0 111.417 -168.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.7 ptpt -81.81 162.64 22.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 167.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 59.1 ttm -80.03 74.11 6.81 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.17 -1.789 . . . . 10.0 106.17 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p -55.72 142.79 61.91 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 114.818 -1.083 . . . . 10.0 109.046 -178.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.26 -18.28 64.07 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 121.845 1.697 . . . . 10.0 113.597 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -178.14 174.27 1.37 Allowed 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 105.659 -1.978 . . . . 10.0 105.659 175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.6 tp -97.6 101.14 12.58 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 119.448 1.022 . . . . 10.0 109.667 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.1 m -76.3 123.9 26.65 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.539 -0.911 . . . . 10.0 108.539 171.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 5.9 pt -115.26 115.28 42.74 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 106.473 -1.677 . . . . 10.0 106.473 169.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.18 -170.24 0.93 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.605 2.204 . . . . 10.0 110.737 -174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.43 149.66 20.29 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 158.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.87 17.14 0.39 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 120.168 1.349 . . . . 10.0 113.563 -166.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.1 83.62 0.41 Allowed Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 108.815 -1.714 . . . . 10.0 108.815 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 10.1 t -121.9 108.33 13.31 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.096 -1.446 . . . . 10.0 107.096 166.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.59 -172.33 2.68 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 123.335 0.654 . . . . 10.0 109.955 -178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.3 t -143.81 122.49 12.57 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 104.041 -2.577 . . . . 10.0 104.041 -164.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.1 mp -102.78 123.92 47.34 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.57 -1.641 . . . . 10.0 106.57 -171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.63 155.39 41.0 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.171 1.389 . . . . 10.0 108.533 -176.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 55.57 0.89 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.644 0.778 . . . . 10.0 111.181 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -142.55 -57.3 0.44 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.578 -1.267 . . . . 10.0 107.578 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.69 -75.48 0.3 Allowed Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.689 0.661 . . . . 10.0 112.051 -173.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.447 ' N ' ' HB ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -100.0 133.2 44.73 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 106.491 -1.67 . . . . 10.0 106.491 -171.393 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 174.51 178.72 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 120.115 1.325 . . . . 10.0 109.861 -176.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.76 122.57 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.137 -2.171 . . . . 10.0 105.137 158.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 56.0 mtp -81.37 96.83 7.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.156 -1.794 . . . . 10.0 106.156 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.25 61.82 3.45 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 106.976 -1.49 . . . . 10.0 106.976 174.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 22.2 ptm -89.97 177.91 6.35 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 122.115 0.959 . . . . 10.0 110.544 -173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.21 46.62 86.8 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 109.13 -1.588 . . . . 10.0 109.13 -171.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.55 119.74 15.15 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.125 0.97 . . . . 10.0 110.321 -168.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -64.16 -73.14 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.055 0.542 . . . . 10.0 111.705 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 27.9 mmt85 -95.2 152.98 39.79 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 123.7 0.8 . . . . 10.0 112.21 -160.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -67.66 100.68 0.6 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.571 2.181 . . . . 10.0 109.154 170.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 42.0 mt -77.72 158.4 29.65 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 122.032 -0.417 . . . . 10.0 111.032 -177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 142.31 47.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.717 1.207 . . . . 10.0 109.07 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.35 72.32 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 125.174 1.39 . . . . 10.0 109.214 -173.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 151.76 -12.6 0.75 Allowed Glycine 0 CA--C 1.527 0.844 0 O-C-N 120.962 -1.086 . . . . 10.0 112.614 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -70.89 179.27 2.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-O 123.693 1.711 . . . . 10.0 109.404 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -155.05 127.41 7.83 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 112.693 -2.049 . . . . 10.0 108.48 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -127.34 148.57 32.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -71.24 144.66 49.99 Favored 'General case' 0 C--O 1.232 0.16 0 O-C-N 121.579 -0.7 . . . . 10.0 110.316 177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.3 tt -123.19 139.3 50.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 107.973 -1.121 . . . . 10.0 107.973 164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.1 m -117.39 119.24 34.51 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.797 -0.816 . . . . 10.0 108.797 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.0 pp -84.2 176.89 8.46 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.222 0.609 . . . . 10.0 111.723 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -154.09 90.8 1.38 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.202 1.001 . . . . 10.0 109.023 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.431 ' HB3' ' CB ' ' A' ' 134' ' ' ARG . . . -86.74 153.24 21.86 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 121.135 -0.978 . . . . 10.0 110.989 170.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 1.7 p -46.45 -39.32 10.42 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 -165.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -78.38 18.35 0.56 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.767 0.827 . . . . 10.0 111.925 -178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.64 32.92 35.88 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 109.851 -1.3 . . . . 10.0 109.851 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.431 ' CB ' ' HB3' ' A' ' 130' ' ' ALA . 0.9 OUTLIER -82.55 94.71 7.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 107.225 -1.398 . . . . 10.0 107.225 -178.373 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 6.9 t -101.14 125.83 47.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 126.264 1.826 . . . . 10.0 107.064 169.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 mp -131.6 144.29 50.95 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 103.796 -2.668 . . . . 10.0 103.796 166.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -107.95 113.84 27.32 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.571 -2.381 . . . . 10.0 104.571 176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.27 153.1 23.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -171.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -88.94 112.06 22.86 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.55 -0.907 . . . . 10.0 108.55 175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -88.13 109.73 20.11 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 123.486 0.714 . . . . 10.0 109.135 173.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.3 m -90.31 124.64 35.07 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 123.935 0.894 . . . . 10.0 108.911 -175.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.9 t -93.76 108.22 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 O-C-N 121.172 -0.955 . . . . 10.0 109.078 -172.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -136.73 111.63 8.87 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.856 1.262 . . . . 10.0 108.169 172.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -72.74 123.04 22.52 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.154 0.888 . . . . 10.0 110.731 172.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -169.66 167.6 9.49 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.543 1.137 . . . . 10.0 108.066 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.0 pt 40.71 42.14 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 126.154 1.781 . . . . 10.0 113.734 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -94.62 86.99 4.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.316 0.579 . . . . 10.0 110.392 -174.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -55.56 101.28 0.12 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 109.459 -1.456 . . . . 10.0 109.459 172.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 24.4 mtp-105 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 116.478 -1.725 . . . . 10.0 110.208 169.91 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.73 -169.25 5.6 Favored Glycine 0 CA--C 1.535 1.283 0 N-CA-C 109.553 -1.419 . . . . 10.0 109.553 -150.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -171.09 173.14 5.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.887 2.075 . . . . 10.0 106.08 172.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.7 t -160.08 175.32 13.1 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.035 0.834 . . . . 10.0 109.367 172.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.9 ttp -162.29 135.51 4.56 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 125.043 1.337 . . . . 10.0 107.784 -177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.08 177.77 8.47 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.703 2.269 . . . . 10.0 110.811 177.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.18 164.55 37.86 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.794 1.238 . . . . 10.0 107.926 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -158.75 172.93 17.35 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.752 1.621 . . . . 10.0 107.549 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 t -153.54 142.71 14.74 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 107.049 -1.463 . . . . 10.0 107.049 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.94 155.02 33.98 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.432 2.088 . . . . 10.0 111.313 -174.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -77.37 -178.68 4.77 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 123.371 2.714 . . . . 10.0 110.292 171.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -148.03 159.19 44.16 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 124.508 1.123 . . . . 10.0 108.087 173.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -166.4 165.9 16.85 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 106.83 -1.545 . . . . 10.0 106.83 -176.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.5 t -140.35 159.29 42.53 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.713 -1.217 . . . . 10.0 107.713 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.13 157.94 65.04 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.153 -1.054 . . . . 10.0 108.153 164.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.1 -169.63 0.8 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.408 2.739 . . . . 10.0 109.413 166.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.91 167.76 24.85 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -160.43 170.75 20.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.52 1.128 . . . . 10.0 108.162 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -138.05 -71.5 0.42 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.334 1.054 . . . . 10.0 108.843 175.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 36.5 tptt 76.46 146.48 0.09 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.014 1.726 . . . . 10.0 110.964 -177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -164.29 171.63 14.62 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.496 1.518 . . . . 10.0 106.95 175.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.61 108.5 0.22 Allowed Glycine 0 CA--C 1.527 0.795 0 N-CA-C 110.04 -1.224 . . . . 10.0 110.04 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.34 63.53 1.96 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 117.709 0.754 . . . . 10.0 110.608 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -124.37 111.25 15.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 125.233 1.413 . . . . 10.0 108.586 -177.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -166.66 -47.84 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.289 0.636 . . . . 10.0 111.301 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.1 121.07 82.78 Favored Pre-proline 0 N--CA 1.451 -0.423 0 C-N-CA 123.52 0.728 . . . . 10.0 109.71 -170.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -68.44 166.03 26.98 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.656 2.237 . . . . 10.0 110.595 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.52 61.94 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 122.256 1.026 . . . . 10.0 110.526 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.8 t -158.35 60.35 0.45 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.497 0.719 . . . . 10.0 109.508 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.9 p -120.96 52.62 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 122.125 0.964 . . . . 10.0 110.511 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -157.24 145.6 19.43 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.863 -0.791 . . . . 10.0 108.863 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.53 130.49 10.34 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.794 -1.723 . . . . 10.0 108.794 168.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 159.35 31.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 118.051 0.926 . . . . 10.0 111.291 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 54.1 p -122.39 148.57 44.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 107.316 -1.364 . . . . 10.0 107.316 165.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.41 134.51 58.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 N-CA-C 107.053 -1.462 . . . . 10.0 107.053 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.0 26.29 0.06 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -166.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 47.21 -138.18 0.71 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.412 1.485 . . . . 10.0 109.692 -170.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -89.25 110.76 40.85 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 107.787 -1.19 . . . . 10.0 107.787 167.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.32 175.1 11.05 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.252 2.634 . . . . 10.0 109.472 172.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.78 72.04 3.23 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.531 2.154 . . . . 10.0 109.627 168.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -152.54 -57.41 0.14 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.722 2.409 . . . . 10.0 106.299 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 13.2 mt 66.37 150.97 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 126.141 1.776 . . . . 10.0 108.563 -163.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 74.91 -51.51 0.67 Allowed 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.292 1.837 . . . . 10.0 111.757 -177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -99.31 138.01 37.01 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.422 -0.955 . . . . 10.0 108.422 -174.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.7 t -150.45 178.57 8.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.659 1.184 . . . . 10.0 108.193 171.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.15 161.7 41.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 123.938 0.895 . . . . 10.0 109.458 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.41 160.81 14.21 Favored 'General case' 0 N--CA 1.454 -0.24 0 O-C-N 124.263 0.977 . . . . 10.0 111.284 172.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -126.14 134.96 51.16 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.275 -2.491 . . . . 10.0 104.275 169.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 26.1 ttt -158.82 177.26 11.36 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 107.794 -1.187 . . . . 10.0 107.794 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 t -133.27 142.36 48.48 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.704 -0.48 . . . . 10.0 109.704 152.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -101.52 105.77 16.79 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 104.287 -2.486 . . . . 10.0 104.287 163.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.6 m -109.84 106.36 15.92 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.281 1.832 . . . . 10.0 110.427 -170.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.61 129.82 34.74 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.337 0.655 . . . . 10.0 110.206 179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -138.98 58.42 1.64 Allowed 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.589 -1.263 . . . . 10.0 107.589 158.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 p -157.98 -50.2 0.07 Allowed 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 126.937 2.095 . . . . 10.0 108.103 -171.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 97' ' ' ARG . 40.8 m-20 74.58 58.86 0.07 Allowed 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 126.207 1.803 . . . . 10.0 110.384 170.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -123.86 146.29 50.3 Favored Pre-proline 0 N--CA 1.448 -0.569 0 C-N-CA 126.048 1.739 . . . . 10.0 106.456 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.72 121.02 6.4 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.692 2.261 . . . . 10.0 109.554 174.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp -115.57 146.39 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 108.782 -0.821 . . . . 10.0 108.782 177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? -117.7 145.47 44.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 125.316 1.447 . . . . 10.0 107.763 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.493 ' C ' HD13 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -147.09 131.68 17.78 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.485 -2.413 . . . . 10.0 104.485 -171.14 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.6 55.79 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.233 1.016 . . . . 10.0 109.034 177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.49 149.09 17.48 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 109.871 -1.292 . . . . 10.0 109.871 167.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -155.54 59.74 0.62 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.758 1.223 . . . . 10.0 108.14 171.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -88.39 130.19 35.23 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 123.339 0.656 . . . . 10.0 110.21 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.5 t -159.05 144.11 11.7 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 107.143 -1.429 . . . . 10.0 107.143 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.61 39.74 0.78 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.519 2.146 . . . . 10.0 112.738 -172.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -108.82 -54.61 2.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.734 1.613 . . . . 10.0 108.34 -170.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -126.38 160.41 30.51 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.974 1.309 . . . . 10.0 107.947 169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.1 m -83.15 -40.26 19.97 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 123.512 0.725 . . . . 10.0 111.874 -165.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.9 t -119.15 95.53 49.39 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 124.478 1.111 . . . . 10.0 110.647 -162.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.61 92.2 1.15 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.958 2.439 . . . . 10.0 110.36 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' MET . . . . . . . . . . . . . 83.8 mtp -103.75 116.51 32.45 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.879 1.272 . . . . 10.0 108.893 -172.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 mp -81.54 134.9 35.57 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.435 0.694 . . . . 10.0 109.735 -170.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.52 -179.83 3.84 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.667 1.187 . . . . 10.0 109.336 176.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 4.4 t -158.79 143.27 15.75 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 104.277 -2.49 . . . . 10.0 104.277 159.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . 0.28 5.7 t -156.89 63.68 0.51 Allowed 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 120.738 1.608 . . . . 10.0 110.486 167.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.8 t -146.04 -178.74 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 121.72 -0.612 . . . . 10.0 109.665 172.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.7 m80 -95.57 148.76 22.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.566 -0.901 . . . . 10.0 108.566 173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.7 m 71.2 -53.8 0.67 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.552 1.541 . . . . 10.0 111.913 -176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.55 141.16 47.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.907 -1.277 . . . . 10.0 109.907 166.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 17.65 -90.14 0.01 OUTLIER Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.699 2.095 . . . . 10.0 115.585 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 53.4 mtt -145.39 173.98 11.52 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.395 1.878 . . . . 10.0 109.454 174.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.22 47.05 0.98 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.768 1.627 . . . . 10.0 107.128 -175.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -151.72 102.2 0.22 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.813 -1.315 . . . . 10.0 109.813 -167.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.0 63.85 0.5 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.279 1.831 . . . . 10.0 111.89 -170.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -113.98 165.81 12.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.827 2.051 . . . . 10.0 109.933 -176.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.8 mtm -78.38 98.02 5.84 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 106.716 -1.587 . . . . 10.0 106.716 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.66 161.72 47.06 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 119.47 -0.3 . . . . 10.0 110.387 -176.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -43.17 -50.02 6.77 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.247 2.631 . . . . 10.0 111.241 162.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 43.3 p90 177.52 -170.0 0.08 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.194 2.598 . . . . 10.0 104.967 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . 0.272 0.0 OUTLIER -127.8 106.6 9.23 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.754 0.788 . . . . 10.0 110.421 169.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 145.77 36.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.6 pp -131.04 140.9 40.07 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.527 1.058 . . . . 10.0 111.266 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -82.1 -174.21 2.04 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 123.123 2.549 . . . . 10.0 111.968 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -54.4 143.48 23.61 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.278 -1.008 . . . . 10.0 108.278 156.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' A' ' 56' ' ' ASP . 37.1 mmt-85 52.15 27.07 4.29 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 113.58 0.956 . . . . 10.0 113.58 -163.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -63.74 96.0 0.17 Allowed Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 108.837 -1.705 . . . . 10.0 108.837 167.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.3 m -126.59 55.71 1.51 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.706 1.202 . . . . 10.0 108.645 -173.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -86.21 166.61 15.58 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 122.158 0.98 . . . . 10.0 112.397 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 105.4 3.95 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 104.853 -2.277 . . . . 10.0 104.853 -167.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.6 mp -81.9 119.4 23.89 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.503 -1.665 . . . . 10.0 106.503 -171.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -127.83 144.7 51.08 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 126.458 1.903 . . . . 10.0 107.456 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 62.3 ttp85 -61.71 119.42 8.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.902 -1.147 . . . . 10.0 107.902 177.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.99 37.18 3.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.218 1.407 . . . . 10.0 112.334 -174.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -169.73 74.31 0.11 Allowed Glycine 0 C--N 1.341 0.807 0 N-CA-C 108.774 -1.73 . . . . 10.0 108.774 168.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.9 t0 63.41 130.19 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 127.967 2.507 . . . . 10.0 111.749 -168.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 36.8 p-80 -177.1 175.82 1.48 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 119.365 0.984 . . . . 10.0 111.782 -177.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.92 130.27 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 106.025 -1.843 . . . . 10.0 106.025 163.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 78.6 mtp -88.76 103.21 15.75 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 124.747 1.219 . . . . 10.0 107.759 170.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 mp -82.27 81.42 8.16 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.711 -1.589 . . . . 10.0 106.711 171.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 51.3 ttm -84.79 152.34 23.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.313 1.045 . . . . 10.0 109.639 -171.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 85.92 53.2 3.07 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.381 -1.087 . . . . 10.0 110.381 177.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 23.9 mt -47.8 122.58 5.09 Favored 'General case' 0 C--N 1.338 0.083 0 C-N-CA 125.147 1.379 . . . . 10.0 109.11 172.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -72.9 -64.16 1.02 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.922 -0.399 . . . . 10.0 109.922 -172.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.61 -58.48 0.0 OUTLIER Pre-proline 0 C--O 1.235 0.318 0 CA-C-O 118.276 -0.868 . . . . 10.0 112.987 167.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -84.73 58.7 5.41 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 121.805 1.67 . . . . 10.0 111.334 -163.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.69 167.26 22.14 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.839 -0.538 . . . . 10.0 109.717 165.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -149.33 123.56 9.54 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.253 -1.758 . . . . 10.0 106.253 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.93 120.64 5.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 177.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 102.66 -4.19 50.16 Favored Glycine 0 CA--C 1.525 0.699 0 CA-C-O 118.414 -1.214 . . . . 10.0 112.478 178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -69.03 169.4 11.87 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 119.944 1.872 . . . . 10.0 111.357 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 57.9 m -132.32 96.75 3.94 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 111.599 -2.546 . . . . 10.0 108.045 -171.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.12 140.39 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 -172.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -66.11 130.77 44.39 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.501 -0.555 . . . . 10.0 109.501 175.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.3 112.19 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.327 -1.731 . . . . 10.0 106.327 173.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 8.1 m -94.31 107.04 19.01 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.44 -0.8 . . . . 10.0 109.541 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 pp -79.28 171.96 14.46 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.413 -0.588 . . . . 10.0 109.413 172.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.09 103.36 2.72 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -82.05 126.73 32.33 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.996 -1.483 . . . . 10.0 106.996 161.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 8.7 t -47.85 -38.53 16.27 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.51 1.524 . . . . 10.0 111.019 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -46.1 -35.19 4.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.019 1.727 . . . . 10.0 113.089 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 126.28 67.73 0.17 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 110.126 -1.189 . . . . 10.0 110.126 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -129.76 151.85 49.89 Favored 'General case' 0 CA--C 1.528 0.113 0 N-CA-C 108.982 -0.748 . . . . 10.0 108.982 172.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 5.8 m -152.72 55.57 0.79 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.649 1.579 . . . . 10.0 107.823 -173.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.2 mp -82.49 128.76 34.59 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 106.671 -1.603 . . . . 10.0 106.671 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.82 62.43 0.87 Allowed 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 127.551 2.34 . . . . 10.0 107.222 -161.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 6.7 t -84.49 153.41 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 114.396 -1.274 . . . . 10.0 108.96 -158.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.68 113.44 18.88 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 120.922 -1.111 . . . . 10.0 108.999 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -108.0 146.27 32.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.398 1.079 . . . . 10.0 110.306 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 5.7 m -103.7 128.64 51.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.559 0.344 . . . . 10.0 110.702 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 55.1 t -89.34 91.81 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.899 -1.148 . . . . 10.0 107.899 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -155.66 135.83 13.0 Favored 'General case' 0 C--O 1.226 -0.162 0 O-C-N 121.435 -0.79 . . . . 10.0 110.754 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.76 -44.43 28.23 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 125.749 1.619 . . . . 10.0 111.868 177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.66 76.28 0.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.167 0.987 . . . . 10.0 112.342 166.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 12.4 mm 54.8 47.33 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 122.5 1.143 . . . . 10.0 109.679 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -138.14 100.63 4.19 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 104.433 -2.432 . . . . 10.0 104.433 173.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 138.26 -44.76 1.09 Allowed Glycine 0 CA--C 1.523 0.562 0 N-CA-C 109.155 -1.578 . . . . 10.0 109.155 -176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . 0.403 ' O ' ' HD3' ' A' ' 149' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.259 1.557 0 N-CA-C 102.744 -3.058 . . . . 10.0 102.744 166.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_